TW202330513A - ) inhibitors and methods using same - Google Patents
) inhibitors and methods using same Download PDFInfo
- Publication number
- TW202330513A TW202330513A TW111136366A TW111136366A TW202330513A TW 202330513 A TW202330513 A TW 202330513A TW 111136366 A TW111136366 A TW 111136366A TW 111136366 A TW111136366 A TW 111136366A TW 202330513 A TW202330513 A TW 202330513A
- Authority
- TW
- Taiwan
- Prior art keywords
- azabicyclo
- carboxamide
- octane
- cyano
- ethyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 70
- 239000003112 inhibitor Substances 0.000 title claims description 5
- 150000001875 compounds Chemical class 0.000 claims abstract description 161
- 239000000203 mixture Substances 0.000 claims abstract description 149
- 208000001528 Coronaviridae Infections Diseases 0.000 claims abstract description 14
- -1 N(R B )(R C ) Inorganic materials 0.000 claims description 2329
- KAIODGZZEANQLB-UHFFFAOYSA-N 1,2,3,3a,4,5,6,6a-octahydrocyclopenta[c]pyrrole-3-carboxamide Chemical compound C1CCC2C(C(=O)N)NCC21 KAIODGZZEANQLB-UHFFFAOYSA-N 0.000 claims description 609
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 588
- ZHNUHDYFZUAESO-UHFFFAOYSA-N formamide Substances NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 claims description 371
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 277
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 claims description 264
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims description 160
- YIYBQIKDCADOSF-UHFFFAOYSA-N alpha-Butylen-alpha-carbonsaeure Natural products CCC=CC(O)=O YIYBQIKDCADOSF-UHFFFAOYSA-N 0.000 claims description 130
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims description 129
- AGMKVZDPATUSMS-UHFFFAOYSA-N ethyl pent-2-enoate Chemical compound CCOC(=O)C=CCC AGMKVZDPATUSMS-UHFFFAOYSA-N 0.000 claims description 128
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 109
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 claims description 69
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 68
- ZUVPLKVDZNDZCM-UHFFFAOYSA-N 6-chloro-2-aminotoluene Natural products CC1=C(N)C=CC=C1Cl ZUVPLKVDZNDZCM-UHFFFAOYSA-N 0.000 claims description 66
- AOFZLQPFVNKHSR-UHFFFAOYSA-N 2-ethylheptanamide Chemical compound CCCCCC(CC)C(N)=O AOFZLQPFVNKHSR-UHFFFAOYSA-N 0.000 claims description 64
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 64
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 60
- 239000008194 pharmaceutical composition Substances 0.000 claims description 56
- 239000001273 butane Substances 0.000 claims description 48
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 claims description 48
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims description 48
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 41
- 125000001424 substituent group Chemical group 0.000 claims description 38
- 125000001072 heteroaryl group Chemical group 0.000 claims description 37
- 150000003839 salts Chemical class 0.000 claims description 34
- 229910052736 halogen Inorganic materials 0.000 claims description 30
- 150000002367 halogens Chemical class 0.000 claims description 30
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 27
- 229910052740 iodine Inorganic materials 0.000 claims description 27
- 241000004176 Alphacoronavirus Species 0.000 claims description 26
- 125000000623 heterocyclic group Chemical group 0.000 claims description 24
- 125000001624 naphthyl group Chemical group 0.000 claims description 23
- 229910052799 carbon Inorganic materials 0.000 claims description 22
- 239000003795 chemical substances by application Substances 0.000 claims description 21
- 239000003937 drug carrier Substances 0.000 claims description 18
- 125000000000 cycloalkoxy group Chemical group 0.000 claims description 17
- 125000004432 carbon atom Chemical group C* 0.000 claims description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 14
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims description 13
- 241000008904 Betacoronavirus Species 0.000 claims description 13
- 239000003814 drug Substances 0.000 claims description 13
- 229910052717 sulfur Inorganic materials 0.000 claims description 13
- 125000000217 alkyl group Chemical group 0.000 claims description 11
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 11
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 11
- 229910052757 nitrogen Inorganic materials 0.000 claims description 11
- 125000004429 atom Chemical group 0.000 claims description 10
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 10
- 241000711467 Human coronavirus 229E Species 0.000 claims description 9
- 241001109669 Human coronavirus HKU1 Species 0.000 claims description 9
- 241000482741 Human coronavirus NL63 Species 0.000 claims description 9
- 241001428935 Human coronavirus OC43 Species 0.000 claims description 9
- 241000124008 Mammalia Species 0.000 claims description 9
- 241000315672 SARS coronavirus Species 0.000 claims description 8
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 8
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 claims description 7
- 125000003545 alkoxy group Chemical group 0.000 claims description 7
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 7
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims description 7
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 7
- 239000012453 solvate Substances 0.000 claims description 7
- 108060004795 Methyltransferase Proteins 0.000 claims description 6
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- 125000004076 pyridyl group Chemical group 0.000 claims description 6
- 125000004737 (C1-C6) haloalkoxy group Chemical group 0.000 claims description 5
- 125000006693 (C2-C9) heterocyclyl group Chemical group 0.000 claims description 5
- 229910052794 bromium Inorganic materials 0.000 claims description 5
- 229910052801 chlorine Inorganic materials 0.000 claims description 5
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 5
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 5
- 229910052731 fluorine Inorganic materials 0.000 claims description 5
- 125000005843 halogen group Chemical group 0.000 claims description 5
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 5
- LUMXDKZMUPIRHM-FKJUYZFESA-N (3S,3aS,6aR)-N-[(2S)-4-hydroxy-3-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl]-2-(4-methoxy-1H-indole-2-carbonyl)-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxamide Chemical compound COC1=C(C=C(C(N(C[C@H]2[C@@H]3CCC2)[C@@H]3C(N[C@@H](C[C@H](CCN2)C2=O)C(CO)=O)=O)=O)N2)C2=CC=C1 LUMXDKZMUPIRHM-FKJUYZFESA-N 0.000 claims description 4
- XRMDCWJNPDVAFI-UHFFFAOYSA-N 2,2,6,6-tetramethyl-1-oxopiperidin-1-ium-4-ol Chemical compound CC1(C)CC(O)CC(C)(C)[N+]1=O XRMDCWJNPDVAFI-UHFFFAOYSA-N 0.000 claims description 4
- 125000006577 C1-C6 hydroxyalkyl group Chemical group 0.000 claims description 4
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 4
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 4
- 125000006769 halocycloalkoxy group Chemical group 0.000 claims description 4
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 4
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 claims description 4
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- LDNSHTVNGGHGQJ-UHFFFAOYSA-N pyrrole-1-carboxamide Chemical compound NC(=O)N1C=CC=C1 LDNSHTVNGGHGQJ-UHFFFAOYSA-N 0.000 claims description 4
- SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 claims description 4
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 4
- 101800000504 3C-like protease Proteins 0.000 claims description 3
- 241000127282 Middle East respiratory syndrome-related coronavirus Species 0.000 claims description 3
- 101800001016 Picornain 3C-like protease Proteins 0.000 claims description 3
- 101800000596 Probable picornain 3C-like protease Proteins 0.000 claims description 3
- 125000002947 alkylene group Chemical group 0.000 claims description 3
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 3
- 125000004851 cyclopentylmethyl group Chemical group C1(CCCC1)C* 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 3
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 3
- 125000005244 neohexyl group Chemical group [H]C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 claims description 3
- 239000000651 prodrug Substances 0.000 claims description 3
- 229940002612 prodrug Drugs 0.000 claims description 3
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 3
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims description 3
- 101800000535 3C-like proteinase Proteins 0.000 claims description 2
- 101800002396 3C-like proteinase nsp5 Proteins 0.000 claims description 2
- GETXPMNCPVBRQO-UHFFFAOYSA-N bicyclo[2.2.2]octane-3-carboxamide Chemical compound C1CC2C(C(=O)N)CC1CC2 GETXPMNCPVBRQO-UHFFFAOYSA-N 0.000 claims description 2
- 125000004850 cyclobutylmethyl group Chemical group C1(CCC1)C* 0.000 claims description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims description 2
- 241000008910 Severe acute respiratory syndrome-related coronavirus Species 0.000 claims 2
- 238000011282 treatment Methods 0.000 abstract description 5
- 230000002265 prevention Effects 0.000 abstract description 2
- 239000002585 base Substances 0.000 description 142
- 238000009472 formulation Methods 0.000 description 57
- 239000004480 active ingredient Substances 0.000 description 38
- 239000000243 solution Substances 0.000 description 33
- 239000002904 solvent Substances 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- 238000006243 chemical reaction Methods 0.000 description 21
- 239000004615 ingredient Substances 0.000 description 21
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 19
- 239000000463 material Substances 0.000 description 18
- 239000000460 chlorine Substances 0.000 description 17
- 239000003826 tablet Substances 0.000 description 17
- 239000007788 liquid Substances 0.000 description 16
- 201000010099 disease Diseases 0.000 description 15
- 239000007787 solid Substances 0.000 description 15
- 239000000725 suspension Substances 0.000 description 15
- 125000003118 aryl group Chemical group 0.000 description 14
- 239000003755 preservative agent Substances 0.000 description 14
- 229920006395 saturated elastomer Polymers 0.000 description 14
- 230000001225 therapeutic effect Effects 0.000 description 14
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- 239000000546 pharmaceutical excipient Substances 0.000 description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 11
- 229940079593 drug Drugs 0.000 description 11
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- 239000002253 acid Substances 0.000 description 10
- 239000002552 dosage form Substances 0.000 description 10
- 239000000843 powder Substances 0.000 description 10
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 9
- 108010010803 Gelatin Proteins 0.000 description 9
- 150000002148 esters Chemical class 0.000 description 9
- 235000019441 ethanol Nutrition 0.000 description 9
- 239000008273 gelatin Substances 0.000 description 9
- 229920000159 gelatin Polymers 0.000 description 9
- 235000019322 gelatine Nutrition 0.000 description 9
- 235000011852 gelatine desserts Nutrition 0.000 description 9
- 210000003491 skin Anatomy 0.000 description 9
- 238000013268 sustained release Methods 0.000 description 9
- 239000012730 sustained-release form Substances 0.000 description 9
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 239000011230 binding agent Substances 0.000 description 8
- 239000002270 dispersing agent Substances 0.000 description 8
- 239000000839 emulsion Substances 0.000 description 8
- 239000008187 granular material Substances 0.000 description 8
- 238000007911 parenteral administration Methods 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 238000000746 purification Methods 0.000 description 8
- 239000000375 suspending agent Substances 0.000 description 8
- 208000025721 COVID-19 Diseases 0.000 description 7
- 150000001335 aliphatic alkanes Chemical class 0.000 description 7
- 239000003963 antioxidant agent Substances 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 7
- 239000002738 chelating agent Substances 0.000 description 7
- 239000003085 diluting agent Substances 0.000 description 7
- 230000036541 health Effects 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- 230000000670 limiting effect Effects 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- 239000000080 wetting agent Substances 0.000 description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 239000003995 emulsifying agent Substances 0.000 description 6
- 235000019439 ethyl acetate Nutrition 0.000 description 6
- 125000000524 functional group Chemical group 0.000 description 6
- 125000005842 heteroatom Chemical group 0.000 description 6
- 239000000314 lubricant Substances 0.000 description 6
- 239000012074 organic phase Substances 0.000 description 6
- 230000036961 partial effect Effects 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 235000010356 sorbitol Nutrition 0.000 description 6
- 239000000600 sorbitol Substances 0.000 description 6
- 210000000434 stratum corneum Anatomy 0.000 description 6
- 235000015112 vegetable and seed oil Nutrition 0.000 description 6
- 239000008158 vegetable oil Substances 0.000 description 6
- 239000003981 vehicle Substances 0.000 description 6
- 239000001993 wax Substances 0.000 description 6
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 5
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 5
- 241001678559 COVID-19 virus Species 0.000 description 5
- 238000005481 NMR spectroscopy Methods 0.000 description 5
- 239000003513 alkali Substances 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 238000004587 chromatography analysis Methods 0.000 description 5
- 230000003111 delayed effect Effects 0.000 description 5
- 238000001647 drug administration Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 150000002430 hydrocarbons Chemical group 0.000 description 5
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 5
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 235000010445 lecithin Nutrition 0.000 description 5
- 239000000787 lecithin Substances 0.000 description 5
- 229940067606 lecithin Drugs 0.000 description 5
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 5
- 231100000252 nontoxic Toxicity 0.000 description 5
- 230000003000 nontoxic effect Effects 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 239000004006 olive oil Substances 0.000 description 5
- 230000035515 penetration Effects 0.000 description 5
- 239000000377 silicon dioxide Substances 0.000 description 5
- 235000012239 silicon dioxide Nutrition 0.000 description 5
- 238000006467 substitution reaction Methods 0.000 description 5
- 239000000829 suppository Substances 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- 239000003765 sweetening agent Substances 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 4
- 229920002261 Corn starch Polymers 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 4
- 241000792859 Enema Species 0.000 description 4
- 239000007821 HATU Substances 0.000 description 4
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 235000019270 ammonium chloride Nutrition 0.000 description 4
- 235000010323 ascorbic acid Nutrition 0.000 description 4
- 239000011668 ascorbic acid Substances 0.000 description 4
- 229960005070 ascorbic acid Drugs 0.000 description 4
- 239000012267 brine Substances 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 150000001721 carbon Chemical group 0.000 description 4
- 235000010980 cellulose Nutrition 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 229910052681 coesite Inorganic materials 0.000 description 4
- 239000003086 colorant Substances 0.000 description 4
- 239000008120 corn starch Substances 0.000 description 4
- 229940099112 cornstarch Drugs 0.000 description 4
- 229910052906 cristobalite Inorganic materials 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 239000007920 enema Substances 0.000 description 4
- 229940095399 enema Drugs 0.000 description 4
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000003599 food sweetener Nutrition 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 229940093915 gynecological organic acid Drugs 0.000 description 4
- 125000004404 heteroalkyl group Chemical group 0.000 description 4
- 239000007972 injectable composition Substances 0.000 description 4
- 238000001990 intravenous administration Methods 0.000 description 4
- 239000012669 liquid formulation Substances 0.000 description 4
- 229940057995 liquid paraffin Drugs 0.000 description 4
- 239000006194 liquid suspension Substances 0.000 description 4
- 239000007937 lozenge Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 4
- 235000008390 olive oil Nutrition 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 235000005985 organic acids Nutrition 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 4
- 239000004334 sorbic acid Substances 0.000 description 4
- 235000010199 sorbic acid Nutrition 0.000 description 4
- 229940075582 sorbic acid Drugs 0.000 description 4
- 229910052682 stishovite Inorganic materials 0.000 description 4
- 230000000699 topical effect Effects 0.000 description 4
- 229910052905 tridymite Inorganic materials 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 235000019489 Almond oil Nutrition 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
- 244000105624 Arachis hypogaea Species 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 3
- XFJBHQSJYHXLGJ-GEMLJDPKSA-N COC(=O)[C@H](C[C@@H]1CCNC1=O)N.Cl Chemical compound COC(=O)[C@H](C[C@@H]1CCNC1=O)N.Cl XFJBHQSJYHXLGJ-GEMLJDPKSA-N 0.000 description 3
- 241000711573 Coronaviridae Species 0.000 description 3
- 102000008100 Human Serum Albumin Human genes 0.000 description 3
- 108091006905 Human Serum Albumin Proteins 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 240000007472 Leucaena leucocephala Species 0.000 description 3
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 229920001615 Tragacanth Polymers 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 235000010443 alginic acid Nutrition 0.000 description 3
- 239000000783 alginic acid Substances 0.000 description 3
- 229920000615 alginic acid Polymers 0.000 description 3
- 229960001126 alginic acid Drugs 0.000 description 3
- 150000004781 alginic acids Chemical class 0.000 description 3
- 239000008168 almond oil Substances 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 description 3
- 239000001506 calcium phosphate Substances 0.000 description 3
- 229910000389 calcium phosphate Inorganic materials 0.000 description 3
- 235000011010 calcium phosphates Nutrition 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000013270 controlled release Methods 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 125000004122 cyclic group Chemical group 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 235000013355 food flavoring agent Nutrition 0.000 description 3
- 150000002334 glycols Chemical class 0.000 description 3
- 239000007902 hard capsule Substances 0.000 description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 238000007909 melt granulation Methods 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000002480 mineral oil Substances 0.000 description 3
- 150000007522 mineralic acids Chemical class 0.000 description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 239000006072 paste Substances 0.000 description 3
- 239000000312 peanut oil Substances 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 150000003077 polyols Chemical class 0.000 description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 3
- 229920000053 polysorbate 80 Polymers 0.000 description 3
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 3
- 125000006239 protecting group Chemical group 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 239000008159 sesame oil Substances 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 239000007901 soft capsule Substances 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 238000010189 synthetic method Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 238000011200 topical administration Methods 0.000 description 3
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- RWCCIYJJIFJDQO-YUMQZZPRSA-N (2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-[(3S)-2-oxopyrrolidin-3-yl]propanoic acid Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)C[C@@H]1CCNC1=O RWCCIYJJIFJDQO-YUMQZZPRSA-N 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- LBUJPTNKIBCYBY-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinoline Chemical compound C1=CC=C2CCCNC2=C1 LBUJPTNKIBCYBY-UHFFFAOYSA-N 0.000 description 2
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- ARGCQEVBJHPOGB-UHFFFAOYSA-N 2,5-dihydrofuran Chemical compound C1OCC=C1 ARGCQEVBJHPOGB-UHFFFAOYSA-N 0.000 description 2
- WOUPIOIURYZNRU-UHFFFAOYSA-N 2-bromo-4-chloro-1,3-thiazole Chemical compound ClC1=CSC(Br)=N1 WOUPIOIURYZNRU-UHFFFAOYSA-N 0.000 description 2
- IZHVBANLECCAGF-UHFFFAOYSA-N 2-hydroxy-3-(octadecanoyloxy)propyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCC IZHVBANLECCAGF-UHFFFAOYSA-N 0.000 description 2
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 2
- HVBSAKJJOYLTQU-UHFFFAOYSA-N 4-aminobenzenesulfonic acid Chemical compound NC1=CC=C(S(O)(=O)=O)C=C1 HVBSAKJJOYLTQU-UHFFFAOYSA-N 0.000 description 2
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- 235000003911 Arachis Nutrition 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 241000711506 Canine coronavirus Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 241001461743 Deltacoronavirus Species 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical class OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 241000725579 Feline coronavirus Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 241000008920 Gammacoronavirus Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- 208000025370 Middle East respiratory syndrome Diseases 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- 241000008906 Murine coronavirus Species 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 235000019483 Peanut oil Nutrition 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 108010076039 Polyproteins Proteins 0.000 description 2
- 241001135549 Porcine epidemic diarrhea virus Species 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 208000002847 Surgical Wound Diseases 0.000 description 2
- 241000711484 Transmissible gastroenteritis virus Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 125000000304 alkynyl group Chemical group 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000008135 aqueous vehicle Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 125000003943 azolyl group Chemical group 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 235000010216 calcium carbonate Nutrition 0.000 description 2
- 239000007894 caplet Substances 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 229940110456 cocoa butter Drugs 0.000 description 2
- 235000019868 cocoa butter Nutrition 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 230000000112 colonic effect Effects 0.000 description 2
- 239000007859 condensation product Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 238000010511 deprotection reaction Methods 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000007888 film coating Substances 0.000 description 2
- 238000009501 film coating Methods 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- 235000021472 generally recognized as safe Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 125000001188 haloalkyl group Chemical group 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000013632 homeostatic process Effects 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 239000003752 hydrotrope Substances 0.000 description 2
- 229960003943 hypromellose Drugs 0.000 description 2
- 239000012729 immediate-release (IR) formulation Substances 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000003701 inert diluent Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 238000007912 intraperitoneal administration Methods 0.000 description 2
- 238000007913 intrathecal administration Methods 0.000 description 2
- 239000002563 ionic surfactant Substances 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229960003639 laurocapram Drugs 0.000 description 2
- 229960003136 leucine Drugs 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 239000006193 liquid solution Substances 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- HTQMBOWAEPNWLI-IUCAKERBSA-N methyl (2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-[(3s)-2-oxopyrrolidin-3-yl]propanoate Chemical compound CC(C)(C)OC(=O)N[C@H](C(=O)OC)C[C@@H]1CCNC1=O HTQMBOWAEPNWLI-IUCAKERBSA-N 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- 125000002950 monocyclic group Chemical group 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 239000002324 mouth wash Substances 0.000 description 2
- XBXCNNQPRYLIDE-UHFFFAOYSA-M n-tert-butylcarbamate Chemical compound CC(C)(C)NC([O-])=O XBXCNNQPRYLIDE-UHFFFAOYSA-M 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 229940055577 oleyl alcohol Drugs 0.000 description 2
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 239000001301 oxygen Chemical group 0.000 description 2
- WLJNZVDCPSBLRP-UHFFFAOYSA-N pamoic acid Chemical compound C1=CC=C2C(CC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C(C(O)=O)=CC2=C1 WLJNZVDCPSBLRP-UHFFFAOYSA-N 0.000 description 2
- 239000003961 penetration enhancing agent Substances 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- DHHVAGZRUROJKS-UHFFFAOYSA-N phentermine Chemical compound CC(C)(N)CC1=CC=CC=C1 DHHVAGZRUROJKS-UHFFFAOYSA-N 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 125000003367 polycyclic group Chemical group 0.000 description 2
- 229920001592 potato starch Polymers 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- ARIWANIATODDMH-UHFFFAOYSA-N rac-1-monolauroylglycerol Chemical compound CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 2
- 238000004007 reversed phase HPLC Methods 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- 229940081974 saccharin Drugs 0.000 description 2
- 235000019204 saccharin Nutrition 0.000 description 2
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 235000011803 sesame oil Nutrition 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- QUCDWLYKDRVKMI-UHFFFAOYSA-M sodium;3,4-dimethylbenzenesulfonate Chemical compound [Na+].CC1=CC=C(S([O-])(=O)=O)C=C1C QUCDWLYKDRVKMI-UHFFFAOYSA-M 0.000 description 2
- 239000007962 solid dispersion Substances 0.000 description 2
- 239000006104 solid solution Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 125000004434 sulfur atom Chemical group 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 230000004797 therapeutic response Effects 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 230000017613 viral reproduction Effects 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 description 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-M 1,1-dioxo-1,2-benzothiazol-3-olate Chemical compound C1=CC=C2C([O-])=NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-M 0.000 description 1
- 125000004605 1,2,3,4-tetrahydroisoquinolinyl group Chemical group C1(NCCC2=CC=CC=C12)* 0.000 description 1
- 125000001399 1,2,3-triazolyl group Chemical group N1N=NC(=C1)* 0.000 description 1
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 description 1
- CZLMRJZAHXYRIX-UHFFFAOYSA-N 1,3-dioxepane Chemical compound C1CCOCOC1 CZLMRJZAHXYRIX-UHFFFAOYSA-N 0.000 description 1
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 description 1
- YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical compound C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 description 1
- 125000000196 1,4-pentadienyl group Chemical group [H]C([*])=C([H])C([H])([H])C([H])=C([H])[H] 0.000 description 1
- PJUPKRYGDFTMTM-UHFFFAOYSA-N 1-hydroxybenzotriazole;hydrate Chemical compound O.C1=CC=C2N(O)N=NC2=C1 PJUPKRYGDFTMTM-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- JKTCBAGSMQIFNL-UHFFFAOYSA-N 2,3-dihydrofuran Chemical compound C1CC=CO1 JKTCBAGSMQIFNL-UHFFFAOYSA-N 0.000 description 1
- SWFYIOVXCUTUOB-UHFFFAOYSA-N 2,3-dihydroxypropylphosphonic acid Chemical compound OCC(O)CP(O)(O)=O SWFYIOVXCUTUOB-UHFFFAOYSA-N 0.000 description 1
- JECYNCQXXKQDJN-UHFFFAOYSA-N 2-(2-methylhexan-2-yloxymethyl)oxirane Chemical group CCCCC(C)(C)OCC1CO1 JECYNCQXXKQDJN-UHFFFAOYSA-N 0.000 description 1
- WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- RSEBUVRVKCANEP-UHFFFAOYSA-N 2-pyrroline Chemical compound C1CC=CN1 RSEBUVRVKCANEP-UHFFFAOYSA-N 0.000 description 1
- MGADZUXDNSDTHW-UHFFFAOYSA-N 2H-pyran Chemical compound C1OC=CC=C1 MGADZUXDNSDTHW-UHFFFAOYSA-N 0.000 description 1
- VMUXSMXIQBNMGZ-UHFFFAOYSA-N 3,4-dihydrocoumarin Chemical compound C1=CC=C2OC(=O)CCC2=C1 VMUXSMXIQBNMGZ-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- FTAHXMZRJCZXDL-UHFFFAOYSA-N 3-piperideine Chemical compound C1CC=CCN1 FTAHXMZRJCZXDL-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- ZZAVIQXQBBOHBB-UHFFFAOYSA-N 4-methoxy-1h-indole-2-carboxylic acid Chemical compound COC1=CC=CC2=C1C=C(C(O)=O)N2 ZZAVIQXQBBOHBB-UHFFFAOYSA-N 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- KDDQRKBRJSGMQE-UHFFFAOYSA-N 4-thiazolyl Chemical group [C]1=CSC=N1 KDDQRKBRJSGMQE-UHFFFAOYSA-N 0.000 description 1
- MRUWJENAYHTDQG-UHFFFAOYSA-N 4H-pyran Chemical compound C1C=COC=C1 MRUWJENAYHTDQG-UHFFFAOYSA-N 0.000 description 1
- 125000004938 5-pyridyl group Chemical group N1=CC=CC(=C1)* 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 241000008921 Avian coronavirus Species 0.000 description 1
- 241000112287 Bat coronavirus Species 0.000 description 1
- 241000639360 Bat coronavirus 1 Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000008905 Betacoronavirus 1 Species 0.000 description 1
- 241000711443 Bovine coronavirus Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 241001218594 Bulbul coronavirus HKU11 Species 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- PMPVIKIVABFJJI-UHFFFAOYSA-N Cyclobutane Chemical compound C1CCC1 PMPVIKIVABFJJI-UHFFFAOYSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- DSLZVSRJTYRBFB-LLEIAEIESA-N D-glucaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O DSLZVSRJTYRBFB-LLEIAEIESA-N 0.000 description 1
- 241000283323 Delphinapterus leucas Species 0.000 description 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 241000282324 Felis Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- DSLZVSRJTYRBFB-UHFFFAOYSA-N Galactaric acid Natural products OC(=O)C(O)C(O)C(O)C(O)C(O)=O DSLZVSRJTYRBFB-UHFFFAOYSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241001123922 Hedgehog coronavirus 1 Species 0.000 description 1
- 244000309467 Human Coronavirus Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241000008903 Miniopterus bat coronavirus HKU8 Species 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- MDXGYYOJGPFFJL-QMMMGPOBSA-N N(alpha)-t-butoxycarbonyl-L-leucine Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)OC(C)(C)C MDXGYYOJGPFFJL-QMMMGPOBSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 1
- 241000008909 Pipistrellus bat coronavirus HKU5 Species 0.000 description 1
- 108010002885 Polygeline Proteins 0.000 description 1
- 241001461748 Porcine coronavirus HKU15 Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 241000289052 Pteropus Species 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 241000004178 Rhinolophus bat coronavirus HKU2 Species 0.000 description 1
- 241000008907 Rousettus bat coronavirus HKU9 Species 0.000 description 1
- 208000037847 SARS-CoV-2-infection Diseases 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- 241000008908 Tylonycteris bat coronavirus HKU4 Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000003070 absorption delaying agent Substances 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 description 1
- 201000009840 acute diarrhea Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000001668 ameliorated effect Effects 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 230000000949 anxiolytic effect Effects 0.000 description 1
- 229940005530 anxiolytics Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical compound C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 description 1
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 description 1
- 125000004069 aziridinyl group Chemical group 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- JUHORIMYRDESRB-UHFFFAOYSA-N benzathine Chemical compound C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- BVCRERJDOOBZOH-UHFFFAOYSA-N bicyclo[2.2.1]heptanyl Chemical group C1C[C+]2CC[C-]1C2 BVCRERJDOOBZOH-UHFFFAOYSA-N 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 1
- 125000004623 carbolinyl group Chemical group 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000004720 cerebrum Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229960004926 chlorobutanol Drugs 0.000 description 1
- VDANGULDQQJODZ-UHFFFAOYSA-N chloroprocaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1Cl VDANGULDQQJODZ-UHFFFAOYSA-N 0.000 description 1
- 229960002023 chloroprocaine Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 239000007891 compressed tablet Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 229940109275 cyclamate Drugs 0.000 description 1
- 125000001047 cyclobutenyl group Chemical group C1(=CCC1)* 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000000058 cyclopentadienyl group Chemical group C1(=CC=CC1)* 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 125000000298 cyclopropenyl group Chemical group [H]C1=C([H])C1([H])* 0.000 description 1
- 125000004855 decalinyl group Chemical group C1(CCCC2CCCCC12)* 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940043237 diethanolamine Drugs 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- DMSHWWDRAYHEBS-UHFFFAOYSA-N dihydrocoumarin Natural products C1CC(=O)OC2=C1C=C(OC)C(OC)=C2 DMSHWWDRAYHEBS-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- OPGYRRGJRBEUFK-UHFFFAOYSA-L disodium;diacetate Chemical compound [Na+].[Na+].CC([O-])=O.CC([O-])=O OPGYRRGJRBEUFK-UHFFFAOYSA-L 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- ZSWFCLXCOIISFI-UHFFFAOYSA-N endo-cyclopentadiene Natural products C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 description 1
- 244000309457 enveloped RNA virus Species 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 229940012017 ethylenediamine Drugs 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- DSLZVSRJTYRBFB-DUHBMQHGSA-N galactaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O DSLZVSRJTYRBFB-DUHBMQHGSA-N 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 229940074045 glyceryl distearate Drugs 0.000 description 1
- 229940068939 glyceryl monolaurate Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229960004275 glycolic acid Drugs 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 238000009474 hot melt extrusion Methods 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- USZLCYNVCCDPLQ-UHFFFAOYSA-N hydron;n-methoxymethanamine;chloride Chemical compound Cl.CNOC USZLCYNVCCDPLQ-UHFFFAOYSA-N 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 239000003326 hypnotic agent Substances 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000000266 injurious effect Effects 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 108010059642 isinglass Proteins 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000012931 lyophilized formulation Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 229960003194 meglumine Drugs 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910052751 metal Chemical class 0.000 description 1
- 239000002184 metal Chemical class 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- LVWZTYCIRDMTEY-UHFFFAOYSA-N metamizole Chemical compound O=C1C(N(CS(O)(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 LVWZTYCIRDMTEY-UHFFFAOYSA-N 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- DODCBMODXGJOKD-RGMNGODLSA-N methyl (2s)-2-amino-4-methylpentanoate;hydrochloride Chemical compound Cl.COC(=O)[C@@H](N)CC(C)C DODCBMODXGJOKD-RGMNGODLSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000007932 molded tablet Substances 0.000 description 1
- 125000006682 monohaloalkyl group Chemical group 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 239000002687 nonaqueous vehicle Substances 0.000 description 1
- 239000000346 nonvolatile oil Substances 0.000 description 1
- OIPZNTLJVJGRCI-UHFFFAOYSA-M octadecanoyloxyaluminum;dihydrate Chemical compound O.O.CCCCCCCCCCCCCCCCCC(=O)O[Al] OIPZNTLJVJGRCI-UHFFFAOYSA-M 0.000 description 1
- UZGLIIJVICEWHF-UHFFFAOYSA-N octogen Chemical compound [O-][N+](=O)N1CN([N+]([O-])=O)CN([N+]([O-])=O)CN([N+]([O-])=O)C1 UZGLIIJVICEWHF-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- UHHKSVZZTYJVEG-UHFFFAOYSA-N oxepane Chemical compound C1CCCOCC1 UHHKSVZZTYJVEG-UHFFFAOYSA-N 0.000 description 1
- AHHWIHXENZJRFG-UHFFFAOYSA-N oxetane Chemical compound C1COC1 AHHWIHXENZJRFG-UHFFFAOYSA-N 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N p-hydroxybenzoic acid methyl ester Natural products COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 125000005003 perfluorobutyl group Chemical group FC(F)(F)C(F)(F)C(F)(F)C(F)(F)* 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 229960003742 phenol Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 125000004585 polycyclic heterocycle group Chemical group 0.000 description 1
- 125000006684 polyhaloalkyl group Polymers 0.000 description 1
- 229920002959 polymer blend Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000012254 powdered material Substances 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 125000003186 propargylic group Chemical group 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- USPWKWBDZOARPV-UHFFFAOYSA-N pyrazolidine Chemical compound C1CNNC1 USPWKWBDZOARPV-UHFFFAOYSA-N 0.000 description 1
- RDRCCJPEJDWSRJ-UHFFFAOYSA-N pyridine;1h-pyrrole Chemical compound C=1C=CNC=1.C1=CC=NC=C1 RDRCCJPEJDWSRJ-UHFFFAOYSA-N 0.000 description 1
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 description 1
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- ZVJHJDDKYZXRJI-UHFFFAOYSA-N pyrroline Natural products C1CC=NC1 ZVJHJDDKYZXRJI-UHFFFAOYSA-N 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 125000006413 ring segment Chemical group 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 238000009097 single-agent therapy Methods 0.000 description 1
- 238000005549 size reduction Methods 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 229940048842 sodium xylenesulfonate Drugs 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000005017 substituted alkenyl group Chemical group 0.000 description 1
- 125000004426 substituted alkynyl group Chemical group 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 229950000244 sulfanilic acid Drugs 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 239000011593 sulfur Chemical group 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- LFKDJXLFVYVEFG-UHFFFAOYSA-N tert-butyl carbamate Chemical compound CC(C)(C)OC(N)=O LFKDJXLFVYVEFG-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- RAOIDOHSFRTOEL-UHFFFAOYSA-N tetrahydrothiophene Chemical compound C1CCSC1 RAOIDOHSFRTOEL-UHFFFAOYSA-N 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 150000003557 thiazoles Chemical class 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- XSROQCDVUIHRSI-UHFFFAOYSA-N thietane Chemical compound C1CSC1 XSROQCDVUIHRSI-UHFFFAOYSA-N 0.000 description 1
- VOVUARRWDCVURC-UHFFFAOYSA-N thiirane Chemical compound C1CS1 VOVUARRWDCVURC-UHFFFAOYSA-N 0.000 description 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
- 229940033663 thimerosal Drugs 0.000 description 1
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000440 toxicity profile Toxicity 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 235000012431 wafers Nutrition 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
根據35 U.S.C.§ 119(e),本申請要求2021年9月28日提交的美國臨時專利申請號63/249,450和2022年7月15日申請的美國臨時專利申請號63/389,713的優先權,在此其全部內容通過引用以其整體併入本文。 Pursuant to 35 U.S.C. § 119(e), this application claims priority to U.S. Provisional Patent Application No. 63/249,450, filed September 28, 2021, and U.S. Provisional Patent Application No. 63/389,713, filed July 15, 2022, at This is hereby incorporated by reference in its entirety in its entirety.
本揭示係關於主要蛋白酶(Mpro)抑制劑及其使用方法。 The present disclosure relates to major protease (M pro ) inhibitors and methods of their use.
SARS-COV-2是人類冠狀病毒家族中的一種,是導致冠狀病毒病2019(COVID-19)的病原體。該病毒最初於2019年12月在武漢確定,隨後遍佈全球,並於2020年3月11日被世界衛生組織宣佈為大流行。儘管有幾種疫苗可用於預防COVID-19,但是迫切需要降低已經患有COVID-19、尚未接受疫苗和/或已感染了更具耐藥性的SARS-COV-2變體的患者的發病率和/或死亡率的有效的新藥物治療方法。此外,這些治療方法對於未來的冠狀病毒大流行病可能是必不可少的。 SARS-COV-2, a member of the human coronavirus family, is the causative agent of coronavirus disease 2019 (COVID-19). Initially identified in Wuhan in December 2019, the virus has since spread across the globe and was declared a pandemic by the World Health Organization on March 11, 2020. Although several vaccines are available to prevent COVID-19, there is an urgent need to reduce morbidity in patients who already have COVID-19, have not received the vaccine, and/or have been infected with more resistant variants of SARS-COV-2 and/or mortality with effective new drug treatments. Furthermore, these treatments may be essential for future coronavirus pandemics.
SARS-COV-2是一種正股、有套膜的RNA病毒。像許多冠狀病毒一樣,除了其他附件基因以外,其基因組還包括六個主要的開放閱讀框(ORF)。在大量的蛋白水解處理之後,由ORF 1a和ORF 1ab編碼的多蛋白與許多有關病毒複製、轉錄、病毒組裝和免疫反應調製的基本任務有關。使由ORF 1a和ORF 1ab編碼的多蛋白具有功能性的處理取決於主蛋白酶(即,Mpro或3CLpro)。因此,Mpro是病毒生命週期的必要元素,並且代表了病毒生命週期破壞的關鍵治療標靶。 SARS-COV-2 is a straight-stranded, enveloped RNA virus. Like many coronaviruses, its genome includes six major open reading frames (ORFs), in addition to other accessory genes. Following extensive proteolytic processing, the polyproteins encoded by ORF 1a and ORF 1ab are involved in many fundamental tasks related to viral replication, transcription, viral assembly and immune response modulation. The processing to make the polyproteins encoded by ORF 1a and ORF 1ab functional depends on the main protease (ie, M pro or 3CL pro ). Thus, M pro is an essential element of the viral life cycle and represents a key therapeutic target for disruption of the viral life cycle.
因此本領域需要用於治療、改善和/或預防受試者中的冠狀病毒感染的化合物和使用其的方法。本揭露內容解決了這一需要。 There is therefore a need in the art for compounds and methods of using same for treating, ameliorating and/or preventing coronavirus infection in a subject. The present disclosure addresses this need.
本揭露內容提供式(I)的某些化合物,或其鹽、溶劑合物、幾何異構物、立體異構物或互變異構物或其任何混合物,其中(I)中的取代基如本文其他地方所定義: The present disclosure provides certain compounds of formula (I), or salts, solvates, geometric isomers, stereoisomers or tautomers thereof, or any mixtures thereof, wherein the substituents in (I) are as described herein Defined elsewhere:
本揭露內容進一步提供醫藥組成物,其包括至少一種本揭露內容的化合物和至少一種醫藥上可接受的載劑。在某些實施方式中,醫藥組成物進一步包括至少一種用於治療、改善和/或預防冠狀病毒感染的另外的藥劑。 The present disclosure further provides pharmaceutical compositions comprising at least one compound of the present disclosure and at least one pharmaceutically acceptable carrier. In some embodiments, the pharmaceutical composition further includes at least one additional agent for treating, improving and/or preventing coronavirus infection.
本揭露內容進一步提供治療、改善或預防冠狀病毒感染的方法。在某些實施方式中,該方法包括向需要其的受試者施用治療有效量的至少一種本揭露內容的化合物和/或至少一種本揭露內容的醫藥組成物。在某些實施方式中,冠狀病毒選自α冠狀病毒和β冠狀病毒。在某些實施方式中,α冠狀病毒選自人類冠狀病毒229E(HCoV-229E)和人類冠狀病毒NL63(HCoV-NL63)。在某些實施方式中,β冠狀病毒選自嚴重急性呼吸綜合征相關的冠狀病毒2(SARS-CoV-2)、嚴重急性呼吸綜合征相關的冠狀病毒1(SARS-CoV或SARS-CoV-1)、中東呼吸綜合征相關的冠狀病毒(MERS-CoV)、人類冠狀病毒OC43(HCoV-OC43)和人類冠狀病毒HKU1(HCoV-HKU1)。在某些實施方式中,冠狀病毒主蛋白酶(Mpro)被抑制。在某些實施方式中,Mpro是3C-樣蛋白酶(3CLpro)。 The present disclosure further provides methods for treating, improving or preventing coronavirus infection. In certain embodiments, the method comprises administering to a subject in need thereof a therapeutically effective amount of at least one compound of the disclosure and/or at least one pharmaceutical composition of the disclosure. In certain embodiments, the coronavirus is selected from alphacoronaviruses and betacoronaviruses. In certain embodiments, the alphacoronavirus is selected from human coronavirus 229E (HCoV-229E) and human coronavirus NL63 (HCoV-NL63). In certain embodiments, the betacoronavirus is selected from severe acute respiratory syndrome-associated coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome-associated coronavirus 1 (SARS-CoV or SARS-CoV-1 ), Middle East respiratory syndrome-associated coronavirus (MERS-CoV), human coronavirus OC43 (HCoV-OC43) and human coronavirus HKU1 (HCoV-HKU1). In certain embodiments, the coronavirus major protease (M pro ) is inhibited. In certain embodiments, M pro is a 3C-like protease (3CL pro ).
本發明在一個方面中提供可用於治療、改善和/或預防冠狀病毒感染,比如但不限於SARS-CoV-2感染的化合物和組成物。在某些實施方式中,該化合物抑制病毒Mpro。 In one aspect, the present invention provides compounds and compositions useful for treating, improving and/or preventing coronavirus infection, such as but not limited to SARS-CoV-2 infection. In certain embodiments, the compound inhibits the virus M pro .
現在,將詳細參考本公開主題的某些實施方式。雖然公開的主題將結合列舉的權利要求書進行描述,但是可以理解,示例的主題並非旨在將權利要求限於公開的主題。 Reference will now be made in detail to certain embodiments of the disclosed subject matter. While the disclosed subject matter will be described in conjunction with the enumerated claims, it will be understood that the illustrated subject matter is not intended to limit the claims to the disclosed subject matter.
在整篇文檔中,應以靈活的方式解釋以範圍格式表達的值,不僅包括將數值明確列出作為範圍界限的數值,而且還包括包含在該範圍內包含的所有單個數值或子範圍,好像每個數值和子範圍都被明確列舉。例如,範圍「約0.1%至約5%」或「約0.1%至5%」應解釋為不僅包括約0.1%至約5%,而且包括在指定範圍內的單個值(例如1%、2%、3%和4%)和子範圍(例如0.1%至0.5%、1.1%至2.2%、3.3%至4.4%)。除非另有說明,否則語句「約X至Y」與「約X至約Y」具有相同的含義。同樣,除非另有說明,否則語句「約X、Y或約Z」與「約X、約Y或約Z」具有相同的含義。 Throughout the document, values expressed in range format should be interpreted in a flexible manner, including not only the numerical values explicitly listed as the boundaries of the range, but also all individual numerical values or subranges contained within that range, as if Each value and subrange is explicitly enumerated. For example, a range of "about 0.1% to about 5%" or "about 0.1% to 5%" should be construed to include not only about 0.1% to about 5%, but also individual values within the specified range (e.g., 1%, 2% , 3% and 4%) and subranges (such as 0.1% to 0.5%, 1.1% to 2.2%, 3.3% to 4.4%). Unless stated otherwise, the phrase "about X to Y" has the same meaning as "about X to about Y". Likewise, the phrase "about X, Y, or about Z" has the same meaning as "about X, about Y, or about Z" unless stated otherwise.
在本文檔中,除非上下文另有明確說明,否則術語「一」、「一種」或「該」用於包括一個或多於一個。除非另有說明,否則使用「或」術語「或」來提及非排他性的「或」。陳述「A和B中的至少一個」或「A或B中的至少一個」與「A、B或A和B」具有相同的含義。此外,應當理解,本文所採用的措辭或術語(而不是其他定義)僅是出於描述而不是限制的目的。章節標題的任何使用均旨在幫助閱讀文件,而不應理解為限制性的;與章節標題相關的信息可能出現在該特定章節之內或之外。該文件中引用的所有出版物、專利和專利文件都通過引用以其整體併入本文,如同通過引用將其單獨併入。 In this document, the terms "a", "an" or "the" are used to include one or more than one unless the context clearly dictates otherwise. Unless stated otherwise, the term "or" is used to refer to a non-exclusive "or". The statement "at least one of A and B" or "at least one of A or B" has the same meaning as "A, B, or A and B". Furthermore, it is to be understood that phraseology or terminology (rather than other definitions) employed herein are for the purpose of description rather than limitation. Any use of section headings is intended to aid in reading the document and should not be construed as limiting; information related to a section heading may appear within or outside of that particular section. All publications, patents, and patent documents cited in this document are hereby incorporated by reference in their entirety, as if individually incorporated by reference.
在本文描述的方法中,可以以任何順序執行動作,除非明確地陳述了時間或操作序列。此外,指定的動作可以同時執行,除非明確的聲明語言陳述了它們是分開執行的。例如,可以在單個操作中同時 進行要求保護的X動作和要求保護的Y動作,並且所得過程將落入要求保護的過程的字面範圍內。 In the methods described herein, actions may be performed in any order, unless a temporal or operational sequence is explicitly stated. Furthermore, specified actions may be performed concurrently unless explicit declarative language states that they are performed separately. For example, it is possible to simultaneously Do claimed action X and claimed action Y, and the resulting process will fall within the literal scope of the claimed process.
定義definition
如本文中所使用的,以下每個術語在本節中具有與之相關的含義。除非另有定義,否則本文使用的所有技術和科學術語通常具有與本揭露內容所屬領域中普通技術人員所理解的相同的含義。通常,本文使用的命名法和動物藥理學、藥物科學、分離科學和有機化學中的實驗室步驟是本領域眾所周知的且通常使用的。應該理解的是,只要目前的教導保持可操作,執行某些動作的步驟或順序就是無關緊要的。此外,可以同時執行兩個或多個步驟或操作。 As used herein, each of the following terms has the meaning associated with it in this section. Unless defined otherwise, all technical and scientific terms used herein generally have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure belongs. Generally, the nomenclature and laboratory procedures in animal pharmacology, pharmaceutical science, separation science and organic chemistry used herein are those well known and commonly used in the art. It should be understood that the order or order in which certain actions are performed is immaterial so long as the present teachings remain operable. Furthermore, two or more steps or operations may be performed concurrently.
如本文所使用的,冠詞「一(a)」和「一(an)」是指本文的語法對象中的一個或多個(即至少一個)。舉例來說,「一個元素(an element)」是指一種元素或多於一種元素。 As used herein, the articles "a" and "an" refer to one or more (ie, at least one) of the grammatical objects herein. By way of example, "an element" means one element or more than one element.
如本文所使用的,除非另有說明,否則單獨或與其他術語組合使用的術語「烯基」是指具有規定數目的碳原子的穩定的單不飽和或二不飽和直鏈或支鏈烴基。實例包括乙烯基、丙烯基(或烯丙基)、丁烯基(crotyl)、異戊烯基、丁二烯基、1,3-戊二烯基、1,4-戊二烯基以及更高的同系物和異構物。代表烯烴的官能團的實例為-CH2-CH=CH2。 As used herein, unless otherwise stated, the term "alkenyl" alone or in combination with other terms refers to a stable monounsaturated or diunsaturated straight or branched chain hydrocarbon group having the specified number of carbon atoms. Examples include vinyl, propenyl (or allyl), crotyl, isopentenyl, butadienyl, 1,3-pentadienyl, 1,4-pentadienyl, and more High homologues and isomers. An example of a functional group representing an alkene is -CH 2 -CH=CH 2 .
如本文所使用的,除非另有說明,否則單獨或與其他術語組合使用的術語「烷氧基(alkoxy)」是指經由氧原子連接到分子的其餘部分的如本文其他地方所定義的具有指定數目的碳原子的烷基,諸如例如甲氧基、乙氧基、1-丙氧基、2-丙氧基(或異丙氧基)和更高的同系物和異構物。具體實例是(C1-C3)烷氧基,比如,但不限於乙氧基和甲氧基。 As used herein, unless otherwise stated, the term "alkoxy" used alone or in combination with other terms means an alkoxy group, as defined elsewhere herein, having the specified number of carbon atoms, such as, for example, methoxy, ethoxy, 1-propoxy, 2-propoxy (or isopropoxy) and higher homologues and isomers. A specific example is (C 1 -C 3 )alkoxy such as, but not limited to, ethoxy and methoxy.
如本文所使用的,除非另有說明,術語「烷基(alkyl)」本身或作為另一取代基的一部分是指具有指定數目的碳原子(即,C1-C10表示1至10個碳原子)的直鏈或支鏈烴,並且包括直鏈、支鏈或環狀取 代基。實例包括甲基、乙基、丙基、異丙基、丁基、異丁基、第三丁基、戊基、新戊基、己基和環丙基甲基。具體實施方式是(C1-C6)烷基,比如,但不限於乙基、甲基、異丙基、異丁基、正戊基、正己基和環丙基甲基。 As used herein, unless otherwise stated, the term "alkyl" by itself or as part of another substituent means a group having the indicated number of carbon atoms (i.e., C 1 -C 10 represents 1 to 10 carbon atom), and include straight, branched or cyclic substituents. Examples include methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, pentyl, neopentyl, hexyl and cyclopropylmethyl. A particular embodiment is (C 1 -C 6 )alkyl such as, but not limited to, ethyl, methyl, isopropyl, isobutyl, n-pentyl, n-hexyl and cyclopropylmethyl.
如本文所使用的,除非另有說明,否則單獨或與其他術語組合使用的術語「炔基(alkynyl)」是指具有規定數目的碳原子的具有碳-碳三鍵的穩定的直鏈或支鏈烴基。非限制性實例包括乙炔基和丙炔基,以及更高的同系物和異構物。術語「炔丙基(propargylic)」是指以-CH2-C≡CH為例的基團。術語「均炔丙基(homopropargylic)」是指以-CH2CH2-C≡CH為例的基團。 As used herein, unless otherwise stated, the term "alkynyl" used alone or in combination with other terms refers to a stable straight or branched chain having a carbon-carbon triple bond having the specified number of carbon atoms. chain hydrocarbon group. Non-limiting examples include ethynyl and propynyl, and higher homologues and isomers. The term "propargylic" refers to a group exemplified by -CH 2 -C≡CH. The term "homopropargylic" refers to a group exemplified by -CH 2 CH 2 -C≡CH.
如本文所使用的,術語「芳族」是指具有一個或多個多不飽和環並且具有芳族特徵,即具有(4n+2)個離域的π(pi)電子(其中‘n’是整數)的碳環或雜環。 As used herein, the term "aromatic" means having one or more polyunsaturated rings and having an aromatic character, i.e. having (4n+2) delocalized π(pi) electrons (where 'n' is Integer) carbocycle or heterocycle.
如本文所使用的,除非另有說明,否則單獨或與其他術語組合使用的術語「芳基」是指含有一個或多個環(通常為一個、兩個或三個環)的碳環芳族系統,其中這些環可以以側鏈方式連接在一起,比如聯苯,或者可以稠合,比如萘。實例包括苯基、蒽基和萘基。芳基還包括例如與一個或多個飽和或部分飽和的碳環(例如,雙環[4.2.0]八-1,3,5-三烯基或茚滿基)稠合的苯環或萘環,其可以在芳環和/或飽和或部分飽和的環的一個或多個碳原子處被取代。 As used herein, unless otherwise stated, the term "aryl" alone or in combination with other terms means a carbocyclic aromatic group containing one or more rings (usually one, two or three rings). systems in which the rings can be linked together in a side-chain fashion, as in biphenyl, or can be fused, as in naphthalene. Examples include phenyl, anthracenyl and naphthyl. Aryl also includes, for example, a benzene or naphthalene ring fused to one or more saturated or partially saturated carbocycles (eg, bicyclo[4.2.0]octa-1,3,5-trienyl or indanyl) , which may be substituted at one or more carbon atoms of an aromatic ring and/or a saturated or partially saturated ring.
如本文所使用的,術語「芳基-(C1-C6)烷基」或「芳烷基」是指其中1至6個碳亞烷基鏈連接至芳基的官能團,例如,-CH2CH2-苯基或-CH2-苯基(或苄基)。具體實例是芳基-CH2-和芳基-CH(CH3)-。術語「取代的芳基-(C1-C6)烷基」是指其中芳基被取代的芳基-(C1-C6)烷基官能團。具體實例是取代的芳基(CH2)-。類似地,術語「雜芳基-(C1-C6)烷基」是指其中1至3個碳亞烷基鏈連接至雜芳基的官能團,例如,-CH2CH2-吡啶基。具體實例是雜芳基-(CH2)-。術語「取代的雜 芳基-(C1-C6)烷基」是指其中雜芳基被取代的雜芳基-(C1-C6)烷基官能團。具體實例是取代的雜芳基-(CH2)-。 As used herein, the term "aryl-(C 1 -C 6 )alkyl" or "aralkyl" refers to a functional group in which 1 to 6 carboalkylene chains are attached to an aryl group, for example, -CH 2 CH 2 -phenyl or -CH 2 -phenyl (or benzyl). Specific examples are aryl- CH2- and aryl-CH( CH3 )-. The term "substituted aryl-(C 1 -C 6 )alkyl" refers to an aryl-(C 1 -C 6 )alkyl functional group in which the aryl group is substituted. A specific example is substituted aryl (CH 2 )-. Similarly, the term "heteroaryl-(C 1 -C 6 )alkyl" refers to a functional group in which 1 to 3 carboalkylene chains are attached to a heteroaryl, eg, -CH 2 CH 2 -pyridyl. A specific example is heteroaryl-( CH2 )-. The term "substituted heteroaryl-(C 1 -C 6 )alkyl" refers to a heteroaryl-(C 1 -C 6 )alkyl functional group in which the heteroaryl is substituted. A specific example is substituted heteroaryl-( CH2 )-.
在一方面,與受試者有關的術語「共同施用的」和「共同投予」是指向受試者施用本揭露內容的化合物和/或組成物以及也可以治療或預防本文考慮的疾病或病症的化合物和/或組成物。在某些實施方式中,作為單一治療方法的一部分,共同施用的化合物和/或組成物單獨施用或以任何種類的組合施用。可以以任何種類的組合將共同施用的化合物和/或組成物配製成各種固體、凝膠和液體調配物的固體和液體的混合物以及溶液。 In one aspect, the terms "co-administered" and "co-administered" in relation to a subject refer to administration of a compound and/or composition of the present disclosure to a subject and also to treat or prevent a disease or condition contemplated herein compounds and/or compositions. In certain embodiments, co-administered compounds and/or compositions are administered alone or in any kind of combination as part of a monotherapy approach. The co-administered compounds and/or compositions may be formulated in any kind of combination as solid and liquid mixtures and solutions of various solid, gel and liquid formulations.
如本文中使用的「COVID」或「COVID-19」是指冠狀病毒病2019,這是一種由嚴重急性呼吸綜合征冠狀病毒2(SARS-COV-2)引起的傳染性疾病。 "COVID" or "COVID-19" as used herein refers to coronavirus disease 2019, an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-COV-2).
如本文所使用的,除非另有說明,術語「環烷基」本身或作為另一取代基的一部分是指具有指定數目的碳原子的環鏈烴(即,C3-C6是指包括由3至6個碳原子組成的環基團的環狀基團)並且包括直鏈、支鏈或環狀取代基。(C3-C6)環烷基的實例是環丙基、環丁基、環戊基和環己基。環烷基環可以可選擇地被取代。環烷基的非限制性實例包括:環丙基、2-甲基-環丙基、環丙烯基、環丁基、2,3-二羥基環丁基、環丁烯基、環戊基、環戊烯基、環戊二烯基、環己基、環己烯基、環庚基、環辛基、十氫萘基、2,5-二甲基環戊基、3,5-二氯環己基、4-羥基環己基、3,3,5-三甲基環己-1-基、八氫戊烯基、八氫-1H-茚基、3a,4,5,6,7,7a-六氫-3H-茚-4-基、十氫薁基(decahydroazulenyl);雙環[6.2.0]癸基、十氫萘基和十二氫-1H-茀基。術語「環烷基」還包括雙環烴環,其非限制性實例包括雙環[2.1.1]己烷基、雙環[2.2.1]庚烷基、雙環[3.1.1]庚烷基、1,3-二甲基[2.2.1]庚烷-2-基、雙環[2.2.2]辛烷基和雙環[3.3.3]十一烷醯基。 As used herein, unless otherwise stated, the term "cycloalkyl" by itself or as part of another substituent refers to a cyclic chain hydrocarbon having the specified number of carbon atoms (i.e., C 3 -C 6 means including cyclic groups consisting of 3 to 6 carbon atoms) and include linear, branched or cyclic substituents. Examples of (C 3 -C 6 )cycloalkyl are cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl. Cycloalkyl rings can be optionally substituted. Non-limiting examples of cycloalkyl include: cyclopropyl, 2-methyl-cyclopropyl, cyclopropenyl, cyclobutyl, 2,3-dihydroxycyclobutyl, cyclobutenyl, cyclopentyl, Cyclopentenyl, cyclopentadienyl, cyclohexyl, cyclohexenyl, cycloheptyl, cyclooctyl, decalinyl, 2,5-dimethylcyclopentyl, 3,5-dichlorocyclo Hexyl, 4-hydroxycyclohexyl, 3,3,5-trimethylcyclohex-1-yl, octahydropentenyl, octahydro-1 H -indenyl, 3a,4,5,6,7,7a - hexahydro- 3H -inden-4-yl, decahydroazulenyl; bicyclo[6.2.0]decyl, decahydronaphthyl and dodecahydro- 1H -perylene. The term "cycloalkyl" also includes bicyclic hydrocarbon rings, non-limiting examples of which include bicyclo[2.1.1]hexyl, bicyclo[2.2.1]heptanyl, bicyclo[3.1.1]heptanyl, 1, 3-Dimethyl[2.2.1]heptan-2-yl, bicyclo[2.2.2]octanyl and bicyclo[3.3.3]undecyl.
如本文中所使用的,術語「DCM」指二氯甲烷。 As used herein, the term "DCM" refers to dichloromethane.
如本文所使用的,「疾病」是受試者的健康狀態,其中受試者不能維持體內穩態,並且如果疾病沒有得到改善,則受試者的健康繼續惡化。 As used herein, a "disease" is a state of health of a subject in which the subject is unable to maintain homeostasis, and if the disease is not ameliorated, the subject's health continues to deteriorate.
如本文所使用的,受試者中的「病症」是其中受試者能夠維持穩態的健康狀態,但是其中受試者的健康狀態比沒有病症時的健康狀態不利。如果不及時治療,病症不一定會導致受試者的健康狀態進一步下降。 As used herein, a "condition" in a subject is a state of health in which the subject is able to maintain homeostasis, but wherein the subject's state of health is less favorable than it would be in the absence of the condition. If left untreated, the condition does not necessarily lead to a further decline in the subject's health status.
如本文所使用的,術語「鹵離子」是指帶有負電荷的鹵素原子。鹵化物陰離子是氟離子(F-)、氯離子(Cl-)、溴離子(Br-)和碘離子(I-)。 As used herein, the term "halide" refers to a negatively charged halogen atom. Halide anions are fluoride (F − ), chloride (Cl − ), bromide (Br − ) and iodide (I − ).
如本文所使用的,除非另有說明,術語「鹵基」或「鹵素」單獨或作為另一取代基的一部分是指氟原子、氯原子、溴原子或碘原子。 As used herein, unless otherwise stated, the term "halo" or "halogen" alone or as part of another substituent refers to a fluorine, chlorine, bromine or iodine atom.
本文所用的「鹵代烷基」包括單鹵代烷基、多鹵代烷基(其中所有鹵原子都可以相同或不同)和全鹵代烷基(其中所有氫原子均被獨立選擇的和/或相同的鹵素原子,比如氟取代。鹵代烷基的實例包括三氟甲基、1,1-二氯乙基、1,2-二氯乙基、1,3-二溴-3,3-二氟丙基、全氟丁基等。 "Haloalkyl" as used herein includes monohaloalkyl, polyhaloalkyl (wherein all halogen atoms may be the same or different) and perhaloalkyl (wherein all hydrogen atoms are independently selected and/or the same halogen atoms, such as fluorine Substituted. Examples of haloalkyl include trifluoromethyl, 1,1-dichloroethyl, 1,2-dichloroethyl, 1,3-dibromo-3,3-difluoropropyl, perfluorobutyl wait.
如本文所使用的,除非另有說明,術語「雜烯基」本身或與另一術語組合是指由規定數目的碳原子和選自O、N和S的一個或兩個雜原子組成的穩定的直鏈或支鏈單不飽和或二不飽和烴基,並且其中氮原子和硫原子可可選擇地被氧化,和氮雜原子可可選擇地被季銨化。可以連續放置至多兩個雜原子。實例包括-CH=CH-O-CH3、-CH=CH-CH2-OH、-CH2-CH=N-OCH3、-CH=CH-N(CH3)-CH3和-CH2-CH=CH-CH2-SH。 As used herein, unless otherwise stated, the term "heteroalkenyl" by itself or in combination with another term refers to a stable A linear or branched monounsaturated or diunsaturated hydrocarbon group, and wherein the nitrogen atom and the sulfur atom may be optionally oxidized, and the nitrogen heteroatom may be optionally quaternized. Up to two heteroatoms can be placed consecutively. Examples include -CH=CH-O-CH 3 , -CH=CH-CH 2 -OH, -CH 2 -CH=N-OCH 3 , -CH=CH-N(CH 3 )-CH 3 and -CH 2 -CH=CH- CH2 -SH.
如本文所使用的,除非另有說明,術語「雜烷基」本身或與另一術語組合是指由規定數目的碳原子和選自O、N和S的一個或兩個雜原子組成的穩定的直鏈或支鏈烷基,並且其中氮原子和硫原子可以 可選擇地被氧化,和氮雜原子可以可選擇地被季銨化。雜原子(一個或多個)可位於雜烷基的任何位置,包括在雜烷基的其餘部分和其連接的片段之間,以及連接至雜烷基中最遠端的碳原子。實例包括:-OCH2CH2CH3、-CH2CH2CH2OH、-CH2CH2NHCH3、-CH2SCH2CH3和-CH2CH2S(=O)CH3。至多兩個雜原子可以是連續的,諸如例如-CH2NH-OCH3或-CH2CH2SSCH3。 As used herein, unless otherwise stated, the term "heteroalkyl" by itself or in combination with another term refers to a stable A straight or branched chain alkyl group, and wherein the nitrogen atom and the sulfur atom may be optionally oxidized, and the nitrogen heteroatom may be optionally quaternized. The heteroatom(s) can be located anywhere on the heteroalkyl, including between the remainder of the heteroalkyl and fragments to which it is attached, and attached to the most distal carbon atom in the heteroalkyl. Examples include : -OCH2CH2CH3 , -CH2CH2CH2OH , -CH2CH2NHCH3 , -CH2SCH2CH3 and -CH2CH2S ( = O ) CH3 . Up to two heteroatoms may be consecutive , such as for example -CH2NH - OCH3 or -CH2CH2SSCH3 .
如本文所使用的,術語「雜芳基」或「雜芳族」是指具有芳族特性的雜環。多環雜芳基可以包括一個或多個部分飽和的環。實例包括四氫喹啉和2,3-二氫苯并呋喃基。 As used herein, the term "heteroaryl" or "heteroaromatic" refers to a heterocyclic ring having aromatic character. Polycyclic heteroaryl groups may include one or more partially saturated rings. Examples include tetrahydroquinoline and 2,3-dihydrobenzofuranyl.
如本文所使用的,除非另有說明,否則術語「雜環」或「雜環基」或「雜環的」本身或作為另一取代基的一部分是指包括碳原子和選自N、O和S的至少一個雜原子的未取代或取代的、穩定的單環或多環雜環系統,並且其中氮和硫雜原子可以可選擇地被氧化,和氮原子可以可選擇地被季銨化。除非另有說明,雜環系統可以連接在提供穩定結構的任何雜原子或碳原子上。雜環本質上可以是芳族的或非芳族的。在某些實施方式中,雜環是雜芳基。 As used herein, unless otherwise stated, the term "heterocycle" or "heterocyclyl" or "heterocyclic" by itself or as part of another substituent means comprising carbon atoms and elements selected from the group consisting of N, O and An unsubstituted or substituted, stable monocyclic or polycyclic heterocyclic ring system of at least one heteroatom of S, and wherein the nitrogen and sulfur heteroatoms can be optionally oxidized, and the nitrogen atom can be optionally quaternized. Unless otherwise stated, the heterocyclic ring system can be attached at any heteroatom or carbon atom that provides a stable structure. Heterocycles can be aromatic or non-aromatic in nature. In certain embodiments, the heterocycle is heteroaryl.
非芳族雜環的實例包括單環基團,比如氮丙啶、環氧乙烷、硫環丙環(thiirane)、氮雜環丁烷、氧雜環丁烷、硫雜環丁烷、吡咯啶、吡咯啉、咪唑啉、吡唑烷、二氧戊環、環丁碸、2,3-二氫呋喃、2,5-二氫呋喃、四氫呋喃、四氫噻吩、哌啶、1,2,3,6-四氫吡啶、1,4-二氫吡啶、哌、嗎啉、硫代嗎啉、哌喃、2,3-二氫哌喃、四氫哌喃、1,4-二烷、1,3-二烷、高哌、高哌啶、1,3-二氧雜環庚烷、4,7-二氫-1,3-二噁庚(dioxepin)和環氧己烷(hexamethyleneoxide)。 Examples of non-aromatic heterocycles include monocyclic groups such as aziridine, oxirane, thiirane, azetidine, oxetane, thietane, pyrrole Pyridine, pyrroline, imidazoline, pyrazolidine, dioxolane, cyclobutane, 2,3-dihydrofuran, 2,5-dihydrofuran, tetrahydrofuran, tetrahydrothiophene, piperidine, 1,2, 3,6-tetrahydropyridine, 1,4-dihydropyridine, piperidine , morpholine, thiomorpholine, pyran, 2,3-dihydropyran, tetrahydropyran, 1,4-dihydropyran Alkane, 1,3-bis alkane, homopiper , Homopiperidine, 1,3-dioxepane, 4,7-dihydro-1,3-dioxepin (dioxepin) and epoxyhexane (hexamethyleneoxide).
雜芳基的實例包括吡啶基、吡基、嘧啶基(比如,但不限於2-和4-嘧啶基)、嗒基、噻吩基、呋喃基、吡咯基、咪唑基、噻唑基、唑基、吡唑基、異噻唑基、1,2,3-三唑基、1,2,4-三唑基、1,3,4-三唑基、四唑基、1,2,3-噻唑基、1,2,3-二唑基、1,3,4-噻唑基和1,3,4-二唑基。 Examples of heteroaryl groups include pyridyl, pyridyl base, pyrimidinyl (such as, but not limited to, 2- and 4-pyrimidinyl), pyridyl base, thienyl, furyl, pyrrolyl, imidazolyl, thiazolyl, Azolyl, pyrazolyl, isothiazolyl, 1,2,3-triazolyl, 1,2,4-triazolyl, 1,3,4-triazolyl, tetrazolyl, 1,2,3 -Thiazolyl, 1,2,3- Diazolyl, 1,3,4-thiazolyl and 1,3,4- Diazolyl.
多環雜環的實例包括吲哚基(比如,但不限於3-、4-、5-、6-和7-吲哚基)、二氫吲哚基、喹啉基、四氫喹啉基、異喹啉基(比如,但不限於1-和5-異喹啉基)、1,2,3,4-四氫異喹啉基、啉基(cinnolinyl)、喹啉基(比如,但不限於2-和5-喹啉基)、喹唑啉基、呔基、1,8-啶基、1,4-苯并二烷基、香豆素、二氫香豆素、1,5-啶基、苯并呋喃基(比如,但不限於3-、4-、5-、6-和7-苯并呋喃基)、2,3-二氫苯并呋喃基、1,2-苯并唑基、苯并噻吩基(比如,但不限於3-、4-、5-、6-和7-苯并噻吩基)、苯并唑基、苯并噻唑基(比如,但不限於2-苯并噻唑基和5-苯并噻唑基)、嘌呤基、苯并咪唑基、苯并三唑基、硫代黃嘌呤基(thioxanthinyl)、咔唑基、咔啉基、吖啶基、吡咯啶基(pyrrolizidinyl)和喹啶基(quinolizidinyl)。 Examples of polycyclic heterocycles include indolyl (such as, but not limited to, 3-, 4-, 5-, 6-, and 7-indolyl), indolinyl, quinolinyl, tetrahydroquinolyl , isoquinolinyl (such as, but not limited to, 1- and 5-isoquinolinyl), 1,2,3,4-tetrahydroisoquinolinyl, Cinnolinyl (cinnolinyl), quinone Linyl (such as, but not limited to, 2- and 5-quinolinyl Linyl), Quinazolinyl, Tie base, 1,8- Pyridyl, 1,4-benzodi Alkyl, coumarin, dihydrocoumarin, 1,5- Pyridyl, benzofuryl (such as, but not limited to, 3-, 4-, 5-, 6-, and 7-benzofuryl), 2,3-dihydrobenzofuryl, 1,2-benzofuryl Azolyl, benzothienyl (such as, but not limited to, 3-, 4-, 5-, 6-, and 7-benzothienyl), benzothienyl Azolyl, benzothiazolyl (such as, but not limited to, 2-benzothiazolyl and 5-benzothiazolyl), purinyl, benzimidazolyl, benzotriazolyl, thioxanthinyl , carbazolyl, carbolinyl, acridinyl, pyrrolidinyl (pyrrolizidinyl) and quinone Quinolizidinyl.
雜環基和雜芳基部分的上述列舉旨在是代表性的,而不是限制性的。 The above listing of heterocyclyl and heteroaryl moieties is intended to be representative and not limiting.
如本文所使用的,術語「醫藥組成物」或「組成物」是指在本揭露內容中有用的至少一種化合物與醫藥上可接受的載劑的混合物。醫藥組成物促進將化合物施用至受試者。 As used herein, the term "pharmaceutical composition" or "composition" refers to a mixture of at least one compound useful in the present disclosure and a pharmaceutically acceptable carrier. Pharmaceutical compositions facilitate administration of a compound to a subject.
如本文所使用的,術語「醫藥上可接受的」是指不消除本揭露內容中有用的化合物的生物活性或特性並且相對無毒的材料,比如載劑或稀釋劑,即可以在不引起不良生物效應或不會以有害方式與包含其的組成物的任何組分相互作用的情況下將該材料施用至受試者。 As used herein, the term "pharmaceutically acceptable" refers to a material, such as a carrier or diluent, that does not abrogate the biological activity or properties of the compounds useful in the present disclosure and is relatively nontoxic, i.e., can be produced without causing adverse biological effects. The material is administered to a subject without affecting or interacting in a deleterious manner with any component of the composition comprising it.
如本文所使用的,術語「醫藥上可接受的載劑」是指參與在受試者中或向受試者攜帶或運輸本揭露內容中有用的化合物使得它可以執行預期的功能的醫藥上可接受的材料、組成物或載劑,比如液體或固體填充劑、穩定劑、分散劑、懸浮劑、稀釋劑、賦形劑、增稠劑、溶劑或封裝材料。典型地,將這種構建體從一個器官或身體的一部分攜帶或運輸到另一器官或身體的一部分。在與調配物的其他成分(包括本揭露內容中有用的化合物)相容的意義上,每種載劑必須是「可接受的」,並且對受試者無害。可用作醫藥上可接受的載劑的材料的的一些實例 包括:糖,比如乳糖、葡萄糖和蔗糖;澱粉,比如玉米澱粉和馬鈴薯澱粉;纖維素及其衍生物,比如羧甲基纖維素鈉、乙基纖維素和乙酸纖維素;粉末狀黃著膠;麥芽;明膠;滑石;賦形劑,比如可可脂和栓劑蠟;油,比如花生油、棉籽油、紅花油、芝麻油、橄欖油、玉米油和大豆油;二醇,比如丙二醇;多元醇,比如甘油、山梨糖醇、甘露糖醇和聚乙二醇;酯,比如油酸乙酯和月桂酸乙酯;瓊脂;緩衝劑,比如氫氧化鎂和氫氧化鋁;表面活性劑;藻酸;無熱原水;等滲鹽水;林格氏溶液;乙醇;磷酸鹽緩衝溶液;和醫藥調配物中使用的其他無毒的相容性物質。如本文所使用的,「醫藥上可接受的載劑」還包括與本揭露內容中有用的化合物的活性相容的並且是受試者生理上可接受的任何和所有包衣、抗細菌和抗真菌劑,以及吸收延遲劑等。補充活性化合物也可以併入組成物中。「醫藥上可接受的載劑」可以進一步包括在本揭露內容中有用的化合物的醫藥上可接受的鹽。在本揭露內容的實踐中使用的醫藥組成物中可以包含的其他另外的成分是本領域已知的,並且在例如《雷明頓藥物科學》(Genaro,Ed.,Mack Publishing Co.,1985,Easton,PA)中描述,其通過引用併入本文。 As used herein, the term "pharmaceutically acceptable carrier" refers to a pharmaceutically acceptable carrier that participates in carrying or transporting a compound useful in the present disclosure in or to a subject so that it can perform its intended function. Acceptable materials, compositions or carriers, such as liquid or solid fillers, stabilizers, dispersants, suspending agents, diluents, excipients, thickeners, solvents or encapsulating materials. Typically, such constructs are carried or transported from one organ or part of the body to another organ or part of the body. Each carrier must be "acceptable" in the sense of being compatible with the other ingredients of the formulation, including compounds useful in the present disclosure, and not injurious to the subject. Some examples of materials that can be used as pharmaceutically acceptable carriers Includes: sugars, such as lactose, glucose, and sucrose; starches, such as cornstarch and potato starch; cellulose and its derivatives, such as sodium carboxymethylcellulose, ethylcellulose, and cellulose acetate; powdered tragacanth gum; Malt; gelatin; talc; excipients, such as cocoa butter and suppository waxes; oils, such as peanut, cottonseed, safflower, sesame, olive, corn, and soybean oils; glycols, such as propylene glycol; polyols, such as Glycerin, sorbitol, mannitol, and polyethylene glycol; esters, such as ethyl oleate and ethyl laurate; agar; buffers, such as magnesium hydroxide and aluminum hydroxide; surfactants; alginic acid; athermal Raw water; isotonic saline; Ringer's solution; ethanol; phosphate buffered saline; and other nontoxic compatible substances used in pharmaceutical formulations. As used herein, "pharmaceutically acceptable carrier" also includes any and all coatings, antibacterial and antibacterial agents that are compatible with the activity of the compounds useful in this disclosure and that are physiologically acceptable to the subject. Fungal agents, and absorption delaying agents, etc. Supplementary active compounds can also be incorporated into the compositions. A "pharmaceutically acceptable carrier" can further include pharmaceutically acceptable salts of compounds useful in this disclosure. Other additional ingredients that may be included in pharmaceutical compositions used in the practice of the present disclosure are known in the art and described, for example, in Remington Pharmaceutical Sciences (Genaro, Ed., Mack Publishing Co., 1985, Easton , PA), which is incorporated herein by reference.
如本文所使用的,語言「醫藥上可接受的鹽」是指由包括無機酸、無機堿、有機酸、無機堿、溶劑合物(包括水合物)和其晶籠化合物(clathrate)的醫藥上可接受的無毒酸和/或堿製備的施用化合物的鹽。 As used herein, the language "pharmaceutically acceptable salt" refers to pharmaceutically acceptable salts consisting of inorganic acids, inorganic alkalis, organic acids, inorganic alkalis, solvates (including hydrates) and clathrates thereof. Salts of the administration compounds prepared from acceptable non-toxic acids and/or alkalis.
如本文所使用的,化合物的「醫藥上有效量」、「治療有效量」或「有效量」是足以向施用化合物的受試者提供有益作用的化合物的量。 As used herein, a "pharmaceutically effective amount", "therapeutically effective amount" or "effective amount" of a compound is an amount of the compound sufficient to provide a beneficial effect to a subject to which the compound is administered.
如本文所使用的,術語「預防」、「防止」和「避免」是指在開始施用藥劑或化合物時在未發展出這種症狀的受試者中避免或延遲與疾病或病症相關的症狀的發作。疾病、病症和紊亂在本文可互換使用。 As used herein, the terms "prevent," "prevent," and "avoid" refer to avoiding or delaying symptoms associated with a disease or disorder in subjects who do not develop such symptoms at the time of initiation of administration of an agent or compound. attack. Disease, condition and disorder are used interchangeably herein.
如本文所使用的術語「特異性結合」或「特異性結合的」是指第一分子優先結合第二分子(例如,特定受體或酶),但不一定僅結合該第二分子。 The term "specifically binds" or "specifically binds" as used herein means that a first molecule binds preferentially to a second molecule (eg, a particular receptor or enzyme), but not necessarily only to that second molecule.
如本文所使用的,術語「受試者」和「個體」和「患者」可以互換使用,並且可以指人類或非人類哺乳動物或鳥類。非人類哺乳動物包括例如牲畜和寵物,比如綿羊、牛科、豬科、犬科、貓科和鼠科哺乳動物。在某些實施方式中,受試者是人類。 As used herein, the terms "subject" and "individual" and "patient" are used interchangeably and may refer to a human or non-human mammal or bird. Non-human mammals include, for example, livestock and pets, such as ovine, bovine, porcine, canine, feline, and murine mammals. In certain embodiments, the subject is a human.
如本文所使用的,術語「取代的」是指原子或原子團已取代氫作為連接至另一基團的取代基。 As used herein, the term "substituted" means that an atom or group of atoms has replaced a hydrogen as a substituent attached to another group.
如本文所使用的,術語「取代的烷基」、「取代的環烷基」、「取代的烯基」或「取代的炔基」是指如本文其他地方所定義的烷基、環烷基、烯基或炔基,其被獨立地選自鹵素、-OH、烷氧基、四氫-2-H-哌喃基、-NH2、-NH(C1-C6烷基)、-N(C1-C6烷基)2、1-甲基-咪唑-2-基、吡啶-2-基、吡啶-3-基、吡啶-4-基、-C(=O)OH、-C(=O)O(C1-C6)烷基、三氟甲基、-C≡N、-C(=O)NH2、-C(=O)NH(C1-C6)烷基、-C(=O)N((C1-C6)烷基)2、-SO2NH2、-SO2NH(C1-C6烷基)、-SO2N(C1-C6烷基)2、-C(=NH)NH2和-NO2的一個、兩個或三個取代基取代,在某些實施方式中含有獨立地選自鹵素、-OH、烷氧基、-NH2、三氟甲基、-N(CH3)2和-C(=O)OH的一個或兩個取代基,在某些實施方式中獨立地選自鹵素、烷氧基和-OH。取代的烷基的實例包括但不限於2,2-二氟丙基、2-羧基環戊基和3-氯丙基。 As used herein, the term "substituted alkyl", "substituted cycloalkyl", "substituted alkenyl" or "substituted alkynyl" means an alkyl, cycloalkyl, , alkenyl or alkynyl, which are independently selected from halogen, -OH, alkoxy, tetrahydro-2-H-pyranyl, -NH 2 , -NH(C 1 -C 6 alkyl), - N(C 1 -C 6 alkyl) 2 , 1-methyl-imidazol-2-yl, pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, -C(=O)OH, - C(=O)O(C 1 -C 6 )alkyl, trifluoromethyl, -C≡N, -C(=O)NH 2 , -C(=O)NH(C 1 -C 6 )alkane group, -C(=O)N((C 1 -C 6 )alkyl) 2 , -SO 2 NH 2 , -SO 2 NH(C 1 -C 6 alkyl), -SO 2 N(C 1 - C 6 alkyl) 2 , -C(=NH)NH 2 and -NO 2 are substituted with one, two or three substituents, in certain embodiments containing independently selected from halogen, -OH, alkoxy , -NH 2 , trifluoromethyl, -N(CH 3 ) 2 , and one or two substituents of -C(=O)OH, independently selected in certain embodiments from halogen, alkoxy, and - Oh. Examples of substituted alkyl groups include, but are not limited to, 2,2-difluoropropyl, 2-carboxycyclopentyl, and 3-chloropropyl.
對於芳基、芳基-(C1-C3)烷基和雜環基,應用於這些基團的環的術語「取代的」是指在允許這種取代的地方的任何取代水平,即單、二、三、四或五取代。取代基是獨立選擇的,並且取代可以在任何化學可及的位置。在某些實施方式中,取代基的數目在1和4之間變化。在其他實施方式中,取代基的數目在1和3之間變化。在另一個實施方式中,取代基的數目在1和2之間變化。在又其他實施方式中,取代基獨立地選自C1-C6烷基、-OH、C1-C6烷氧基、鹵素、胺基、乙醯胺 基和硝基。如本文所使用的,當取代基是烷基或烷氧基時,碳鏈可以是支鏈、直鏈或環狀的。 For aryl, aryl-(C 1 -C 3 )alkyl, and heterocyclyl, the term "substituted" applied to the rings of these groups means any level of substitution where such substitution is permissible, i.e. mono , two, three, four or five substitutions. Substituents are independently selected, and substitution can be at any chemically accessible position. In certain embodiments, the number of substituents varies between 1 and 4. In other embodiments, the number of substituents varies between 1 and 3. In another embodiment, the number of substituents varies between 1 and 2. In yet other embodiments, the substituents are independently selected from C 1 -C 6 alkyl, —OH, C 1 -C 6 alkoxy, halogen, amine, acetamido, and nitro. As used herein, when a substituent is an alkyl or alkoxy group, the carbon chain may be branched, straight or cyclic.
除非另有說明,當兩個取代基一起形成具有指定數目的環原子的環時(例如,R2和R3與它們所連接的氮一起形成具有3至7個環成員的環),該環可以具有碳原子和可選擇地一個或多個(例如,1至3個)獨立地選自氮、氧或硫的另外的雜原子。該環可以是飽和的或部分飽和的,並且可以可選擇地被取代。 Unless otherwise stated, when two substituents are taken together to form a ring having the indicated number of ring atoms (for example, R2 and R3 together with the nitrogen to which they are attached form a ring having 3 to 7 ring members), the ring There may be carbon atoms and optionally one or more (eg, 1 to 3) additional heteroatoms independently selected from nitrogen, oxygen or sulfur. The ring may be saturated or partially saturated and may be optionally substituted.
每當術語或其前綴根中的任一個出現在取代基的名稱中時,該名稱應解釋為包括本文提供的那些限制。例如,每當術語「烷基」或「芳基」或其前綴根中的任一個出現在取代基(例如芳基烷基、烷基胺基)的名稱中時,該名稱應解釋為包括本文其他地方分別對「烷基」和「芳基」給出的那些限制。 Whenever either the term or its prefixed root appears in the name of a substituent, that name should be construed as including those limitations provided herein. For example, whenever the term "alkyl" or "aryl" or either of its prefixed radicals appears in the name of a substituent (e.g., arylalkyl, alkylamino), that name should be construed to include Those limitations given elsewhere for "alkyl" and "aryl" respectively.
在某些實施方式中,化合物的取代基以組或範圍公開。具體期望該描述包括這些組和範圍的成員的每個和每一個單獨的子組合。例如,術語「C1-6烷基」明確地旨在單獨公開C1、C2、C3、C4、C5、C6、C1-C6、C1-C5、C1-C4、C1-C3、C1-C2、C2-C6、C2-C5、C2-C4、C2-C3、C3-C6、C3-C5、C3-C4、C4-C6、C4-C5和C5-C6烷基。 In certain embodiments, substituents of compounds are disclosed in groups or ranges. It is specifically intended that this description include each and every individual subcombination of members of such groups and ranges. For example, the term "C 1-6 alkyl" is expressly intended to disclose individually C 1 , C 2 , C 3 , C 4 , C 5 , C 6 , C 1 -C 6 , C 1 -C 5 , C 1 - C 4 , C 1 -C 3 , C 1 -C 2 , C 2 -C 6 , C 2 -C 5 , C 2 -C 4 , C 2 -C 3 , C 3 -C 6 , C 3 -C 5 , C 3 -C 4 , C 4 -C 6 , C 4 -C 5 and C 5 -C 6 alkyl.
本文所用的術語「治療」、「處理」和「醫治」是指通過向受試者施用藥劑或化合物來降低受試者經歷疾病或病症的症狀的頻率或嚴重程度。 The terms "treat", "treat" and "treat" as used herein refer to reducing the frequency or severity with which a subject experiences symptoms of a disease or disorder by administering an agent or compound to the subject.
範圍:在整篇公開內容中,可以以範圍格式來呈現本揭露內容的各個方面。應當理解,範圍格式的描述僅是為了方便和簡潔,而不應被解釋為對本揭露內容範圍的僵化限制。因此,應該將範圍的描述視為已明確公開了所有可能的子範圍以及該範圍內的各個數值。例如,對範圍比如從1至6的描述應視為已明確公開了子範圍,比如從1至3、從1至4、從1至5、從2至4、從2至6、從3至6等,以及該範圍內的單個數值和部分數值,例如,1、2、2.7、3、4、5、5.3和6。無論範圍的廣度如何,這都適用。 Scope: Throughout this disclosure, various aspects of the disclosure may be presented in a range format. It should be understood that the description in range format is merely for convenience and brevity and should not be construed as an inflexible limitation on the scope of the present disclosure. Accordingly, the description of a range should be considered as having expressly disclosed all the possible subranges and individual values within that range. For example, a description of a range such as from 1 to 6 should be considered to have explicitly disclosed subranges such as from 1 to 3, from 1 to 4, from 1 to 5, from 2 to 4, from 2 to 6, from 3 to 6 etc., and individual values and sub-values within the range, for example, 1, 2, 2.7, 3, 4, 5, 5.3 and 6. This applies regardless of the breadth of the scope.
化合物compound
本揭露內容提供式(I)的化合物,或其鹽、溶劑合物、幾何異構物、立體異構物、互變異構物或任何混合物: The present disclosure provides a compound of formula (I), or a salt, solvate, geometric isomer, stereoisomer, tautomer or any mixture thereof:
其中: in:
R1選自、、、 R 1 is selected from , , ,
R2a和R2b各自獨立地選自H、可選擇地取代的C1-C12烷基、可選擇地取代的C3-C12環烷基、可選擇地取代的C2-C12雜環基和C7-C12芳烷基, R 2a and R 2b are each independently selected from H, optionally substituted C 1 -C 12 alkyl, optionally substituted C 3 -C 12 cycloalkyl, optionally substituted C 2 -C 12 hetero Cyclic and C 7 -C 12 aralkyl,
其中R2a和RA以及R2a和R2b中的一個或多個可以與它們所鍵合的原子結合以形成可選擇地取代的C3-C12雜環基或可選擇地取代的C3-C12環烷基,其中其兩個可選擇的取代基可以與它們所鍵合的原子結合以形成可選擇地取代的C3-C12環烷基、可選擇地取代的C2-C12雜環基或可選擇地取代的苯基; R3是; wherein R 2a and R A and one or more of R 2a and R 2b may be combined with the atoms to which they are bonded to form an optionally substituted C 3- C 12 heterocyclyl or an optionally substituted C 3 -C 12 cycloalkyl, wherein two optional substituents thereof can combine with the atoms to which they are bonded to form optionally substituted C 3 -C 12 cycloalkyl, optionally substituted C 2 -C 12 heterocyclyl or optionally substituted phenyl; R 3 is ;
L選自可選擇地取代的C1-C3亞烷基、-C(=O)-*、-C(=O)(可選擇地取代的C1-C2亞烷基)-*、-(可選擇地取代的C1-C2亞烷基)-C(=O)-*和鍵,其中*表示L和R4a之間的鍵; L is selected from optionally substituted C 1 -C 3 alkylene, -C(=O)-*, -C(=O)(optionally substituted C 1 -C 2 alkylene)-*, -(optionally substituted C 1 -C 2 alkylene)-C(=O)-* and a bond, wherein * represents the bond between L and R 4a ;
R4a選自可選擇地取代的苯基、可選擇地取代的C2-C9雜芳基、 R 4a is selected from optionally substituted phenyl, optionally substituted C 2 -C 9 heteroaryl,
其中在R4a中,可選擇地取代的苯基或可選擇地取代的C2-C9雜芳基被至少一個鹵素取代;R4b是H; Wherein in R 4a , optionally substituted phenyl or optionally substituted C 2 -C 9 heteroaryl is substituted by at least one halogen; R 4b is H;
R4c選自、和; R 4c is selected from , and ;
R5a選自H、-C(=O)(可選擇地取代的C1-C6烷基)、-C(=O)(C1-C6鹵代烷基)和可選擇地取代的C1-C6烷基; R 5a is selected from H, -C(=O) (optionally substituted C 1 -C 6 alkyl), -C(=O) (C 1 -C 6 haloalkyl) and optionally substituted C 1 -C 6 alkyl;
R5b選自H、可選擇地取代的C1-C6烷基和可選擇地取代的C2-C6烯基; R 5b is selected from H, optionally substituted C 1 -C 6 alkyl and optionally substituted C 2 -C 6 alkenyl;
R5c選自H和鹵素; R is selected from H and halogen;
R6a選自H、可選擇地取代的C1-C6烷基和可選擇地取代的苯基; R 6a is selected from H, optionally substituted C 1 -C 6 alkyl and optionally substituted phenyl;
R6b是H, R6b is H,
或R6a和R6b與它們所鍵合的碳原子結合以形成可選擇地取代 的C3-C8環烷基; or R 6a and R 6b are combined with the carbon atoms to which they are bonded to form an optionally substituted C 3 -C 8 cycloalkyl;
R6c選自C(=O)(可選擇地取代的C1-C6鹵代烷基)、C(=O)(可選擇地取代的C1-C6烷基)、可選擇地取代的C2-C9雜芳基和可選擇地取代的苯基; R 6c is selected from C(=O) (optionally substituted C 1 -C 6 haloalkyl), C(=O) (optionally substituted C 1 -C 6 alkyl), optionally substituted C 2 -C Heteroaryl and optionally substituted phenyl;
R7a和R7b(如果存在)各自獨立地選自H、鹵素、ORB、可選擇地取代的C1-C6烷基、可選擇地取代的C3-C8環烷基、可選擇地取代的C2-C9雜環基和可選擇地取代的萘基; R 7a and R 7b (if present) are each independently selected from H, halogen, OR B , optionally substituted C 1 -C 6 alkyl, optionally substituted C 3 -C 8 cycloalkyl, optionally Ground substituted C 2 -C 9 heterocyclyl and optionally substituted naphthyl;
Ra1、Ra2、Ra3、Ra4、Ra5、Ra6、Ra7、Ra8、Ra9和Ra10(如果存在)的每次出現獨立地選自H、鹵素、CN、NO2、可選擇地取代的C1-C6烷基、可選擇地取代的C3-C8環烷基、可選擇地取代的C1-C6烷氧基、可選擇地取代的C3-C8環烷氧基、可選擇地取代的C2-C9雜環烷基、可選擇地取代的苯基、可選擇地取代的萘基、可選擇地取代的C2-C9雜芳基、ORB、N(RB)(RC)、NO2、C(=O)N(RB)(RC)、C(=O)RB、C(=O)ORB、OC(=O)RB、OC(=O)ORB、SRB、S(=O)RB、S(=O)2RB、N(RB)S(=O)2RC、N(RB)C(=O)RC和S(=O)2N(RB)(RC); Each occurrence of R a1 , R a2 , R a3 , R a4 , R a5 , R a6 , R a7 , R a8 , R a9 and R a10 (if present) is independently selected from H, halogen, CN, NO 2 , Optionally substituted C 1 -C 6 alkyl, optionally substituted C 3 -C 8 cycloalkyl, optionally substituted C 1 -C 6 alkoxy, optionally substituted C 3 -C 8 cycloalkoxy, optionally substituted C 2 -C 9 heterocycloalkyl, optionally substituted phenyl, optionally substituted naphthyl, optionally substituted C 2 -C 9 heteroaryl , OR B , N(R B )(R C ), NO 2 , C(=O)N(R B )(R C ), C(=O)R B , C(=O)OR B , OC( =O)R B , OC(=O)OR B , SR B , S(=O)R B , S(=O) 2 R B , N(R B )S(=O) 2 R C , N( R B )C(=O)R C and S(=O) 2 N(R B )(R C );
Rb1、Rb2和Rb3(如果存在)的每次出現獨立地選自H、鹵素、可選擇地取代的C1-C6烷基、可選擇地取代的C3-C8環烷基、可選擇地取代 的C1-C6烷氧基、可選擇地取代的C3-C8環烷氧基、可選擇地取代的C2-C8雜環烷基、可選擇地取代的苯基、可選擇地取代的萘基、可選擇地取代的C2-C9雜芳基、C(=O)N(RB)(RC)、C(=O)RB、C(=O)ORB、S(=O)RB、S(=O)2RB和S(=O)2N(RB)(RC), Each occurrence of R b1 , R b2 and R b3 (if present) is independently selected from H, halogen, optionally substituted C 1 -C 6 alkyl, optionally substituted C 3 -C 8 cycloalkyl , optionally substituted C 1 -C 6 alkoxy, optionally substituted C 3 -C 8 cycloalkoxy, optionally substituted C 2 -C 8 heterocycloalkyl, optionally substituted Phenyl, optionally substituted naphthyl, optionally substituted C 2 -C 9 heteroaryl, C(=O)N(R B )(R C ), C(=O) RB , C( =O)OR B , S(=O) RB , S(=O) 2 R B and S(=O) 2 N(R B )(R C ),
其中選自Rb1、Rb2和Rb3的兩個成對取代基可以與它們所鍵合的碳原子結合以形成可選擇地取代的C2-C8雜環烷基或可選擇地取代的C3-C8環烷基; wherein two pairs of substituents selected from R b1 , R b2 and R b3 can be combined with the carbon atoms to which they are bonded to form an optionally substituted C 2 -C 8 heterocycloalkyl or an optionally substituted C 3 -C 8 cycloalkyl;
Rc1、Rc2、Rc3、Rc4、Rc5、Rc6、Rc7、Rc8、Rc9、Rc10和Rc11(如果存在)的每次出現獨立地選自H、鹵素、CN、NO2、可選擇地取代的C1-C6烷基、可選擇地取代的C3-C8環烷基、可選擇地取代的C1-C6烷氧基、可選擇地取代的C3-C8環烷氧基、雜環基、苯基、萘基、雜芳基、ORB、N(RB)(RC)、NO2、C(=O)N(RB)(RC)、C(=O)RB、C(=O)ORB、OC(=O)RB、OC(=O)ORB、SRB、S(=O)RB、S(=O)2RB、N(RB)S(=O)2RC、N(RB)C(=O)RC和S(=O)2N(RB)(RC); Each occurrence of R c1 , R c2 , R c3 , R c4 , R c5 , R c6 , R c7 , R c8 , R c9 , R c10 and R c11 (if present) is independently selected from H, halogen, CN, NO 2 , optionally substituted C 1 -C 6 alkyl, optionally substituted C 3 -C 8 cycloalkyl, optionally substituted C 1 -C 6 alkoxy, optionally substituted C 3 -C 8 cycloalkoxy, heterocyclyl, phenyl, naphthyl, heteroaryl, OR B , N(R B )(R C ), NO 2 , C(=O)N(R B )( R C ), C(=O)R B , C(=O)OR B , OC(=O)R B , OC(=O)OR B , SR B , S(=O)R B , S(= O) 2 R B , N( RB )S(=O) 2 R C , N( RB )C(=O)R C and S(=O) 2 N( RB )(R C );
RA、RB和RC的每次出現獨立地選自H、-C(=O)(可選擇地取代的C1-C6烷基)、-C(=O)(可選擇地取代的C1-C6鹵代烷基)、可選擇地取代的C1-C6烷基、可選擇地取代的C1-C3鹵代烷基、可選擇地取代的C3-C8環烷基、可選擇地取代的C1-C6烷氧基和可選擇地取代的C3-C8環烷氧基、可選擇地取代的苯基、可選擇地取代的萘基和可選擇地取代的C2-C9雜芳基; Each occurrence of R A , R B and R C is independently selected from H, -C(=O) (optionally substituted C 1 -C 6 alkyl), -C(=O) (optionally substituted C 1 -C 6 haloalkyl), optionally substituted C 1 -C 6 alkyl, optionally substituted C 1 -C 3 haloalkyl, optionally substituted C 3 -C 8 cycloalkyl, Optionally substituted C 1 -C 6 alkoxy and optionally substituted C 3 -C 8 cycloalkoxy, optionally substituted phenyl, optionally substituted naphthyl and optionally substituted C 2 -C 9 heteroaryl;
RD選自H、-C(=O)RB和-S(=O)2RB; RD is selected from H, -C( = O) RB and -S(=O) 2RB ;
RE選自H、C1-C6烷基和C1-C6鹵代烷基; R E is selected from H, C 1 -C 6 alkyl and C 1 -C 6 haloalkyl;
X的每次出現獨立地選自O、S和N(RB); each occurrence of X is independently selected from O, S and N( RB );
Y(如果存在)選自I、Br、Cl、F和ORD; Y (if present) is selected from I, Br, Cl, F and OR D ;
Z1和Z2各自獨立地選自H和鹵素;和 Z and Z are each independently selected from H and halogen; and
其中如果R1是4-甲氧基-1H-吲哚基,則適用下列至少一項: Wherein if R is 4-methoxy- 1H -indolyl, at least one of the following applies:
(a)R2a不是異丙基且R2b不是H, (a) R 2a is not isopropyl and R 2b is not H,
(b)R2a不是H且R2b不是異丙基或 (b) R 2a is not H and R 2b is not isopropyl or
(c)R4a不是-C(=O)CH2OH或-C(=O)CH2OP(=O)(OH)2。 (c) R 4a is not -C(=O)CH 2 OH or -C(=O)CH 2 OP(=O)(OH) 2 .
在某些實施方式中,Ra1、Ra2、Ra3、Ra4、Ra5、Ra6、Ra7、Ra8、Ra9和Ra10(如果存在)中的每一個是H。在某些實施方式中,Ra1、Ra2、Ra3、Ra4、Ra5、Ra6、Ra7、Ra8、Ra9和Ra10(如果存在)中的九個是H。在某些實施方式中,Ra1、Ra2、Ra3、Ra4、Ra5、Ra6、Ra7、Ra8、Ra9和Ra10(如果存在)中的八個是H。在某些實施方式中,Ra1、Ra2、Ra3、Ra4、Ra5、Ra6、Ra7、Ra8、Ra9和Ra10(如果存在)中的七個是H。在某些實施方式中,Ra1、Ra2、Ra3、Ra4、Ra5、Ra6、Ra7、Ra8、Ra9和Ra10(如果存在)中的六個是H。在某些實施方式中,Ra1、Ra2、Ra3、Ra4、Ra5、Ra6、Ra7、Ra8、Ra9和Ra10(如果存在)中的五個是H。在某些實施方式中,Ra1、Ra2、Ra3、Ra4、Ra5、Ra6、Ra7、Ra8、Ra9和Ra10(如果存在)中的四個是H。在某些實施方式中,Ra1、Ra2、Ra3、Ra4、Ra5、Ra6、Ra7、Ra8、Ra9和Ra10(如果存在)中的三個是H。在某些實施方式中,Ra1、Ra2、Ra3、Ra4、Ra5、Ra6、Ra7、Ra8、Ra9和Ra10(如果存在)中的兩個是H。在某些實施方式中,Ra1、Ra2、Ra3、Ra4、Ra5、Ra6、Ra7、Ra8、Ra9和Ra10(如果存在)中的一個是H。 In certain embodiments, each of R a1 , R a2 , R a3 , R a4 , R a5 , R a6 , R a7 , R a8 , R a9 , and R a10 (if present) is H. In certain embodiments, nine of R a1 , R a2 , R a3 , R a4 , R a5 , R a6 , R a7 , R a8 , R a9 , and R a10 (if present) are H. In certain embodiments, eight of R a1 , R a2 , R a3 , R a4 , R a5 , R a6 , R a7 , R a8 , R a9 , and R a10 (if present) are H. In certain embodiments, seven of R a1 , R a2 , R a3 , R a4 , R a5 , R a6 , R a7 , R a8 , R a9 , and R a10 (if present) are H. In certain embodiments, six of R a1 , R a2 , R a3 , R a4 , R a5 , R a6 , R a7 , R a8 , R a9 , and R a10 (if present) are H. In certain embodiments, five of R a1 , R a2 , R a3 , R a4 , R a5 , R a6 , R a7 , R a8 , R a9 , and R a10 (if present) are H. In certain embodiments, four of R a1 , R a2 , R a3 , R a4 , R a5 , R a6 , R a7 , R a8 , R a9 , and R a10 (if present) are H. In certain embodiments, three of R a1 , R a2 , R a3 , R a4 , R a5 , R a6 , R a7 , R a8 , R a9 , and R a10 (if present) are H. In certain embodiments, two of R a1 , R a2 , R a3 , R a4 , R a5 , R a6 , R a7 , R a8 , R a9 , and R a10 (if present) are H. In certain embodiments, one of R a1 , R a2 , R a3 , R a4 , R a5 , R a6 , R a7 , R a8 , R a9 and R a10 (if present) is H.
在某些實施方式中,Ra1是H。在某些實施方式中,Ra1是Me。在某些實施方式中,Ra1是Cl。在某些實施方式中,Ra1是F。在某些實施方式中,Ra1是OMe。在某些實施方式中,Ra1是CF2H。在某些實施方式中,Ra1是Br。 In certain embodiments, R a1 is H. In certain embodiments, R a1 is Me. In certain embodiments, R a1 is Cl. In certain embodiments, R a1 is F. In certain embodiments, R a1 is OMe. In certain embodiments, R a1 is CF2H . In certain embodiments, Ra1 is Br.
在某些實施方式中,Ra2是H。在某些實施方式中,Ra2是Me。在某些實施方式中,Ra2是Cl。在某些實施方式中,Ra2是F。在某些實施方式中,Ra2是OMe。在某些實施方式中,Ra2是CF2H。在某些實施方式中,Ra2是Br。 In certain embodiments, Ra2 is H. In certain embodiments, R a2 is Me. In certain embodiments, Ra2 is Cl. In certain embodiments, Ra2 is F. In certain embodiments, R a2 is OMe. In certain embodiments, R a2 is CF 2 H. In certain embodiments, Ra2 is Br.
在某些實施方式中,Ra3是H。在某些實施方式中,Ra3是Me。在某些實施方式中,Ra3是Cl。在某些實施方式中,Ra3是F。在某些實施方式中,Ra3是OMe。在某些實施方式中,Ra3是CF2H。在某些實施方式中,Ra3是Br。 In certain embodiments, Ra3 is H. In certain embodiments, R a3 is Me. In certain embodiments, Ra3 is Cl. In certain embodiments, R a3 is F. In certain embodiments, R a3 is OMe. In certain embodiments, R a3 is CF 2 H. In certain embodiments, Ra3 is Br.
在某些實施方式中,Ra4是H。在某些實施方式中,Ra4是Me。在某些實施方式中,Ra4是Cl。在某些實施方式中,Ra4是F。在某些實施方式中,Ra4是OMe。在某些實施方式中,Ra4是CF2H。在某些實施方式中,Ra4是Br。 In certain embodiments, Ra4 is H. In certain embodiments, R a4 is Me. In certain embodiments, Ra4 is Cl. In certain embodiments, R a4 is F. In certain embodiments, R a4 is OMe. In certain embodiments, R a4 is CF 2 H. In certain embodiments, Ra4 is Br.
在某些實施方式中,Ra5是H。在某些實施方式中,Ra5是Me。在某些實施方式中,Ra5是Cl。在某些實施方式中,Ra5是F。在某些實施方式中,Ra5是OMe。在某些實施方式中,Ra5是CF2H。在某些實施方式中,Ra5是Br。 In certain embodiments, Ra5 is H. In certain embodiments, R a5 is Me. In certain embodiments, Ra5 is Cl. In certain embodiments, R a5 is F. In certain embodiments, R a5 is OMe. In certain embodiments, R a5 is CF 2 H. In certain embodiments, Ra5 is Br.
在某些實施方式中,Ra6是H。在某些實施方式中,Ra6是Me。在某些實施方式中,Ra6是Cl。在某些實施方式中,Ra6是F。在某些實施方式中,Ra6是OMe。在某些實施方式中,Ra6是CF2H。在某些實施方式中,Ra6是Br。 In certain embodiments, Ra6 is H. In certain embodiments, R a6 is Me. In certain embodiments, Ra6 is Cl. In certain embodiments, R a6 is F. In certain embodiments, R a6 is OMe. In certain embodiments, R a6 is CF 2 H. In certain embodiments, Ra6 is Br.
在某些實施方式中,Ra7是H。在某些實施方式中,Ra7是Me。在某些實施方式中,Ra7是Cl。在某些實施方式中,Ra7是F。在某些實施方式中,Ra7是OMe。在某些實施方式中,Ra7是CF2H。在某些實施方式中,Ra7是Br。 In certain embodiments, Ra7 is H. In certain embodiments, R a7 is Me. In certain embodiments, Ra7 is Cl. In certain embodiments, R a7 is F. In certain embodiments, R a7 is OMe. In certain embodiments, R a7 is CF 2 H. In certain embodiments, Ra7 is Br.
在某些實施方式中,Ra8是H。在某些實施方式中,Ra8是Me。在某些實施方式中,Ra8是Cl。在某些實施方式中,Ra8是F。在某些實施方式中,Ra8是OMe。在某些實施方式中,Ra8是CF2H。在某些實施方式中,Ra8是Br。 In certain embodiments, Ra8 is H. In certain embodiments, R a8 is Me. In certain embodiments, Ra8 is Cl. In certain embodiments, R a8 is F. In certain embodiments, R a8 is OMe. In certain embodiments, R a8 is CF 2 H. In certain embodiments, Ra8 is Br.
在某些實施方式中,Ra9是H。在某些實施方式中,Ra9是Me。在某些實施方式中,Ra9是Cl。在某些實施方式中,Ra9是F。在某些實施方式中,Ra9是OMe。在某些實施方式中,Ra9是CF2H。在某些實施方式中,Ra9是Br。 In certain embodiments, Ra9 is H. In certain embodiments, R a9 is Me. In certain embodiments, Ra9 is Cl. In certain embodiments, R a9 is F. In certain embodiments, R a9 is OMe. In certain embodiments, R a9 is CF 2 H. In certain embodiments, Ra9 is Br.
在某些實施方式中,Ra10是H。在某些實施方式中,Ra10是Me。在某些實施方式中,Ra10是Cl。在某些實施方式中,Ra10是F。在某些實施方式中,Ra10是OMe。在某些實施方式中,Ra10是CF2H。在某些實施方式中,Ra10是Br。 In certain embodiments, R a10 is H. In certain embodiments, R a10 is Me. In certain embodiments, R a10 is Cl. In certain embodiments, R a10 is F. In certain embodiments, R a10 is OMe. In certain embodiments, R a10 is CF 2 H. In certain embodiments, R a10 is Br.
在某些實施方式中,式(I)的化合物是: In certain embodiments, the compound of formula (I) is:
在某些實施方式中,式(I)的化合物是: In certain embodiments, the compound of formula (I) is:
在某些實施方式中,式(I)的化合物選自: In certain embodiments, the compound of formula (I) is selected from:
其中: in:
R8選自H、可選擇地取代的C1-C6烷基、可選擇地取代的C2-C6烯基、可選擇地取代的C3-C8環烷基、可選擇地取代的C2-C9雜環基、可選擇地取代的苯基、可選擇地取代的萘基、可選擇地取代的C2-C9雜芳基, R 8 is selected from H, optionally substituted C 1 -C 6 alkyl, optionally substituted C 2 -C 6 alkenyl, optionally substituted C 3 -C 8 cycloalkyl, optionally substituted C 2 -C 9 heterocyclyl, optionally substituted phenyl, optionally substituted naphthyl, optionally substituted C 2 -C 9 heteroaryl,
其中每個可選擇地取代的C1-C6烷基、可選擇地取代的C2-C9雜芳基和可選擇地取代的苯基可選擇地被選自C1-C6烷基、C1-C6烷氧基和可選擇地取代的吡啶基的至少一個取代基取代;和Rd1、Rd2、Rd3、Rd4、Rd5、Rd6、Rd7、Rd8、Rd9和Rd10(如果存在)的每次出現獨立地選自H、鹵素、CN、NO2、可選擇地取代的C1-C6烷基、可選擇地取代的C3-C8環烷基、可選擇地取代的C1-C6烷氧基、可選擇地取代的C3-C8環烷氧基、雜環基、苯基、萘基、雜芳基、ORB、N(RB)(RC)、NO2、C(=O)N(RB)(RC)、C(=O)RB、C(=O)ORB、OC(=O)RB、 OC(=O)ORB、SRB、S(=O)RB、S(=O)2RB、N(RB)S(=O)2RC、N(RB)C(=O)RC和S(=O)2N(RB)(RC), wherein each of the optionally substituted C 1 -C 6 alkyl, the optionally substituted C 2 -C 9 heteroaryl and the optionally substituted phenyl is optionally selected from the group consisting of C 1 -C 6 alkyl , C 1 -C 6 alkoxy and optionally substituted pyridyl by at least one substituent; and R d1 , R d2 , R d3 , R d4 , R d5 , R d6 , R d7 , R d8 , R Each occurrence of d9 and Rd10 (if present) is independently selected from H, halogen, CN, NO2 , optionally substituted C1 - C6 alkyl, optionally substituted C3 - C8 cycloalkane radical, optionally substituted C 1 -C 6 alkoxy, optionally substituted C 3 -C 8 cycloalkoxy, heterocyclyl, phenyl, naphthyl, heteroaryl, OR B , N( R B )(R C ), NO 2 , C(=O)N(R B )(R C ), C(=O)R B , C(=O)OR B , OC(=O)R B , OC(=O)OR B , SR B , S(=O)R B , S(=O) 2 R B , N(R B )S(=O) 2 R C , N(R B )C(= O)R C and S(=O) 2 N(R B )(R C ),
其中選自Rd1、Rd2、Rd3、Rd4、Rd5、Rd6、Rd7、Rd8、Rd9和Rd10的兩個取代基--可以與它們所鍵合的原子結合以形成可選擇地取代的C3-C8環烷基或可選擇地取代的C2-C8雜環烷基。 wherein two substituents selected from R d1 , R d2 , R d3 , R d4 , R d5 , R d6 , R d7 , R d8 , R d9 and R d10 - can combine with the atoms to which they are bonded to form Optionally substituted C 3 -C 8 cycloalkyl or optionally substituted C 2 -C 8 heterocycloalkyl.
在某些實施方式中,式(I)的化合物是:(Ib-1)。在某些實施方式中,式(I)的化合物是:。在某些實施方式中,式(I)的化合物是:。在某些實施方式中,式(I)的化合物是:。在某些實施方 式中,式(I)的化合物是:。在某些實施方式中,式(I)的化合物是:。在某些實施方式中,式(I)的 化合物是:。在某些實施方式中,式(I)的化合物是:。在某些實施方式中,式(I)的化合物是:。在某些實施方式中,式(I)的化合物是:。在某些實施方式中,式(I)的化合物是:。在某些實施方式中,式(I)的化合物是:。在某些實施方式中,式(I)的化合物是。在某些實施方式中,式(I)的化合物是: In certain embodiments, the compound of formula (I) is: (Ib-1). In certain embodiments, the compound of formula (I) is: . In certain embodiments, the compound of formula (I) is: . In certain embodiments, the compound of formula (I) is: . In certain embodiments, the compound of formula (I) is: . In certain embodiments, the compound of formula (I) is: . In certain embodiments, the compound of formula (I) is: . In certain embodiments, the compound of formula (I) is: . In certain embodiments, the compound of formula (I) is: . In certain embodiments, the compound of formula (I) is: . In certain embodiments, the compound of formula (I) is: . In certain embodiments, the compound of formula (I) is: . In certain embodiments, the compound of formula (I) is . In certain embodiments, the compound of formula (I) is:
在某些實施方式中,式(I)的化合物是:2’)。在某些實施方式中,式(I)的化合物是:。在某些實施方式中,式(I)的化合物是:。在某些實施方式中,式(I)的化合物是:。在某些實施方式中,式(I)的化合物是:。在某些實施方式中,式(I)的化合物是:。在某些實施方式中,式(I)的化合物是:。在某些實施方式中,式(I)的化合物是: 。在某些實施方式中,式(I)的化合物是: In certain embodiments, the compound of formula (I) is: 2'). In certain embodiments, the compound of formula (I) is: . In certain embodiments, the compound of formula (I) is: . In certain embodiments, the compound of formula (I) is: . In certain embodiments, the compound of formula (I) is: . In certain embodiments, the compound of formula (I) is: . In certain embodiments, the compound of formula (I) is: . In certain embodiments, the compound of formula (I) is: . In certain embodiments, the compound of formula (I) is:
在某些實施方式中,Rd1、Rd2、Rd3、Rd4、Rd5、Rd6、Rd7、Rd8、Rd9和Rd10(如果存在)中的每一個是H。在某些實施方式中,Rd1、Rd2、Rd3、Rd4、Rd5、Rd6、Rd7、Rd8、Rd9和Rd10(如果存在)中的九個是H。在某些實施方式中,Rd1、Rd2、Rd3、Rd4、Rd5、Rd6、Rd7、Rd8、Rd9和Rd10(如果存在)中的八個是H。在某些實施方式中,Rd1、Rd2、Rd3、Rd4、Rd5、Rd6、Rd7、Rd8、Rd9和Rd10(如果存在)中的七個是H。在某些實施方式中,Rd1、Rd2、Rd3、Rd4、Rd5、Rd6、Rd7、Rd8、Rd9和Rd10(如果存在)中的六個是H。在某些實施方式中,Rd1、Rd2、Rd3、Rd4、Rd5、Rd6、Rd7、Rd8、Rd9和Rd10(如果存在)中的五個是H。在某些實施方式中,Rd1、Rd2、Rd3、Rd4、Rd5、Rd6、Rd7、Rd8、Rd9和Rd10(如果存在)中的四個是H。在某些實施方式中,Rd1、Rd2、Rd3、Rd4、Rd5、Rd6、Rd7、Rd8、Rd9和Rd10(如果存在)中的三個是H。在某些實施方式中,Rd1、Rd2、Rd3、Rd4、Rd5、Rd6、Rd7、Rd8、Rd9和Rd10(如果存在)中的兩個是H。在某些實施方式中,Rd1、Rd2、Rd3、Rd4、Rd5、Rd6、Rd7、Rd8、Rd9和Rd10(如果存在)中的一個是H。 In certain embodiments, each of Rd1 , Rd2 , Rd3 , Rd4 , Rd5 , Rd6 , Rd7 , Rd8 , Rd9 , and Rd10 (if present) is H. In certain embodiments, nine of Rd1 , Rd2 , Rd3 , Rd4 , Rd5 , Rd6 , Rd7 , Rd8 , Rd9 , and Rd10 (if present) are H. In certain embodiments, eight of Rd1 , Rd2 , Rd3 , Rd4 , Rd5 , Rd6 , Rd7 , Rd8 , Rd9 , and Rd10 (if present) are H. In certain embodiments, seven of Rd1 , Rd2 , Rd3 , Rd4 , Rd5 , Rd6 , Rd7 , Rd8 , Rd9 , and Rd10 (if present) are H. In certain embodiments, six of Rd1 , Rd2 , Rd3 , Rd4 , Rd5 , Rd6 , Rd7 , Rd8 , Rd9 , and Rd10 (if present) are H. In certain embodiments, five of Rd1 , Rd2 , Rd3 , Rd4 , Rd5 , Rd6 , Rd7 , Rd8 , Rd9 , and Rd10 (if present) are H. In certain embodiments, four of Rd1 , Rd2 , Rd3 , Rd4 , Rd5 , Rd6 , Rd7 , Rd8 , Rd9 , and Rd10 (if present) are H. In certain embodiments, three of Rd1 , Rd2 , Rd3 , Rd4 , Rd5 , Rd6 , Rd7 , Rd8 , Rd9 , and Rd10 (if present) are H. In certain embodiments, two of Rd1 , Rd2 , Rd3 , Rd4 , Rd5 , Rd6 , Rd7 , Rd8 , Rd9 , and Rd10 (if present) are H. In certain embodiments, one of Rd1 , Rd2 , Rd3 , Rd4 , Rd5 , Rd6 , Rd7 , Rd8 , Rd9 , and Rd10 (if present) is H.
在某些實施方式中,R1是。在某些實施方式中,R1是。 In certain embodiments, R 1 is . In certain embodiments, R 1 is .
在某些實施方式中,R6a是H。在某些實施方式中,R6a是苯基。在某些實施方式中,R6a是甲基。在某些實施方式中,R6a是異丁 基。在某些實施方式中,R6a是第三丁基。在某些實施方式中,R6a是環丙基甲基。在某些實施方式中,R6a是環丁基甲基。 In certain embodiments, R 6a is H. In certain embodiments, R 6a is phenyl. In certain embodiments, R 6a is methyl. In certain embodiments, R 6a is isobutyl. In certain embodiments, R 6a is t-butyl. In certain embodiments, R 6a is cyclopropylmethyl. In certain embodiments, R 6a is cyclobutylmethyl.
在某些實施方式中,R6a和R6b與它們所鍵合的碳原子結合以形成環丙基。 In certain embodiments, R 6a and R 6b combine with the carbon atom to which they are bonded to form cyclopropyl.
在某些實施方式中,R6c是C(=O)CF3。在某些實施方式中,R6c是被選自C1-C6烷基和鹵素的至少一個取代基取代的吡啶基。在某些實施方式中,R6c是被選自C1-C6烷基和鹵素的至少一個取代基取代的吡唑基。在某些實施方式中,R6c是被選自C1-C6烷基和鹵素的至少一個取代基取代的苯基。 In certain embodiments, R 6c is C(=O)CF 3 . In certain embodiments, R 6c is pyridyl substituted with at least one substituent selected from C 1 -C 6 alkyl and halogen. In certain embodiments, R 6c is pyrazolyl substituted with at least one substituent selected from C 1 -C 6 alkyl and halogen. In certain embodiments, R 6c is phenyl substituted with at least one substituent selected from C 1 -C 6 alkyl and halogen.
在某些實施方式中,R6c是C(=O)CF3。在某些實施方式中,R6c是C(=O)CH3。在某些實施方式中,R6c是。在某些實 施方式中,R6c是。在某些實施方式中,R6c是。在某些實施方式中,R6c是。在某些實施方式中,R6c是。在某些實施方式中,R6c是。 In certain embodiments, R 6c is C(=O)CF 3 . In certain embodiments, R 6c is C(=O)CH 3 . In certain embodiments, R 6c is . In certain embodiments, R 6c is . In certain embodiments, R 6c is . In certain embodiments, R 6c is . In certain embodiments, R 6c is . In certain embodiments, R 6c is .
在某些實施方式中,R7a是H。在某些實施方式中,R7a是環戊基。在某些實施方式中,R7a是OH。在某些實施方式中,R7a是Me。在某些實施方式中,R7a是F。 In certain embodiments, R 7a is H. In certain embodiments, R 7a is cyclopentyl. In certain embodiments, R 7a is OH. In certain embodiments, R 7a is Me. In certain embodiments, R 7a is F.
在某些實施方式中,R7b是H。在某些實施方式中,R7b是環戊基。在某些實施方式中,R7b是OH。在某些實施方式中,R7b是Me。在某些實施方式中,R7b是F。 In certain embodiments, R 7b is H. In certain embodiments, R 7b is cyclopentyl. In certain embodiments, R 7b is OH. In certain embodiments, R 7b is Me. In certain embodiments, R 7b is F.
在某些實施方式中,R3是。在某些實施方式中, R3是。在某些實施方式中,R3是。在某些實施方式中,R3是。 In certain embodiments, R 3 is . In certain embodiments, R 3 is . In certain embodiments, R 3 is . In certain embodiments, R 3 is .
在某些實施方式中,L是鍵。 In certain embodiments, L is a bond.
在某些實施方式中,R4c是。在某些實施方式中,R4c是。在某些實施方式中,R4c是。在某些實施方式中,R4c是。在某些實施方式中,R4c是。在某些實施方式中,R4c是。 In certain embodiments, R 4c is . In certain embodiments, R 4c is . In certain embodiments, R 4c is . In certain embodiments, R 4c is . In certain embodiments, R 4c is . In certain embodiments, R 4c is .
在某些實施方式中,Rc1、Rc2、Rc3、Rc4、Rc5、Rc6、Rc7、Rc8、Rc9、Rc10和Rc11(如果存在)中的每一個是H。在某些實施方式中,Rc1、Rc2、Rc3、Rc4、Rc5、Rc6、Rc7、Rc8、Rc9、Rc10和Rc11(如果存在)中的十個是H。在某些實施方式中,Rc1、Rc2、Rc3、Rc4、Rc5、Rc6、Rc7、Rc8、Rc9、Rc10和Rc11(如果存在)中的九個是H。在某些實施方式中,Rc1、Rc2、Rc3、Rc4、Rc5、Rc6、Rc7、Rc8、Rc9、Rc10和Rc11(如果存在)中的八個是H。在某些實施方式中,Rc1、Rc2、Rc3、Rc4、Rc5、Rc6、Rc7、Rc8、Rc9、Rc10和Rc11(如果存在)中的七個是H。在某些實施方式中,Rc1、Rc2、Rc3、Rc4、Rc5、Rc6和Rc7中的六個是H。在某些實施方式中,Rc1、Rc2、Rc3、Rc4、Rc5、Rc6、Rc7、Rc8、Rc9、Rc10和Rc11(如果存在)中的五個是H。在某些實施方式中,Rc1、Rc2、Rc3、Rc4、Rc5、Rc6、Rc7、Rc8、Rc9、Rc10和Rc11(如果存在)中的四個是H。在某些實施方式中,Rc1、Rc2、Rc3、Rc4、Rc5、Rc6、Rc7、Rc8、Rc9、Rc10和Rc11(如果存在)中的三個是H。在某些實施方式中,Rc1、Rc2、Rc3、Rc4、Rc5、Rc6、Rc7、Rc8、Rc9、Rc10和Rc11( 如果存在)中的兩個是H。在某些實施方式中,Rc1、Rc2、Rc3、Rc4、Rc5、Rc6、Rc7、Rc8、Rc9、Rc10和Rc11(如果存在)中的一個是H。 In certain embodiments, each of R c1 , R c2 , R c3 , R c4 , R c5 , R c6 , R c7 , R c8 , R c9 , R c10 , and R c11 (if present) is H. In certain embodiments, ten of R c1 , R c2 , R c3 , R c4 , R c5 , R c6 , R c7 , R c8 , R c9 , R c10 , and R c11 (if present) are H. In certain embodiments, nine of R c1 , R c2 , R c3 , R c4 , R c5 , R c6 , R c7 , R c8 , R c9 , R c10 , and R c11 (if present) are H. In certain embodiments, eight of R c1 , R c2 , R c3 , R c4 , R c5 , R c6 , R c7 , R c8 , R c9 , R c10 , and R c11 (if present) are H. In certain embodiments, seven of R c1 , R c2 , R c3 , R c4 , R c5 , R c6 , R c7 , R c8 , R c9 , R c10 , and R c11 (if present) are H. In certain embodiments, six of R c1 , R c2 , R c3 , R c4 , R c5 , R c6 , and R c7 are H. In certain embodiments, five of R c1 , R c2 , R c3 , R c4 , R c5 , R c6 , R c7 , R c8 , R c9 , R c10 , and R c11 (if present) are H. In certain embodiments, four of R c1 , R c2 , R c3 , R c4 , R c5 , R c6 , R c7 , R c8 , R c9 , R c10 , and R c11 (if present) are H. In certain embodiments, three of R c1 , R c2 , R c3 , R c4 , R c5 , R c6 , R c7 , R c8 , R c9 , R c10 , and R c11 (if present) are H. In certain embodiments, two of R c1 , R c2 , R c3 , R c4 , R c5 , R c6 , R c7 , R c8 , R c9 , R c10 , and R c11 (if present) are H. In certain embodiments, one of R c1 , R c2 , R c3 , R c4 , R c5 , R c6 , R c7 , R c8 , R c9 , R c10 and R c11 (if present) is H.
在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施 方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施 方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。 在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是 。在某些實施方式中,R1是。在某些實施方式中, R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方 式中,R1是。在某些實施方式中,R1是。在某些實 施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式 中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是 。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。在某些實施方式中,R1是。 In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is . In certain embodiments, R 1 is .
在某些實施方式中,R2a是甲基。在某些實施方式中,R2a是乙基。在某些實施方式中,R2a是正丙基。在某些實施方式中,R2a是異丙基。在某些實施方式中,R2a是環丙基。在某些實施方式中,R2a是環丙基甲基。在某些實施方式中,R2a是正丁基。在某些實施方式中,R2a是第二丁基。在某些實施方式中,R2a是第三丁基。在某些實施方式中,R2a是環丁基。在某些實施方式中,R2a是甲基環丁基。在某些實施方式中,R2a是正戊基。在某些實施方式中,R2a是第二戊基。在某些實施方式中,R2a是第三戊基。在某些實施方式中,R2a是新戊基。在某些實施方式中,R2a是環戊基。在某些實施方式中,R2a是環戊基甲基。在某些實施方式中,R2a是正己基。在某些實施方式中,R2a是第二己基。在某些實施方式中,R2a是第三己基。在某些實施方式中,R2a是新己基。在某些實施方式中,R2a是環己基。在某些實施方式中,R2a是環己基甲基。 In certain embodiments, R 2a is methyl. In certain embodiments, R 2a is ethyl. In certain embodiments, R 2a is n-propyl. In certain embodiments, R 2a is isopropyl. In certain embodiments, R 2a is cyclopropyl. In certain embodiments, R 2a is cyclopropylmethyl. In certain embodiments, R 2a is n-butyl. In certain embodiments, R 2a is second-butyl. In certain embodiments, R 2a is t-butyl. In certain embodiments, R 2a is cyclobutyl. In certain embodiments, R 2a is methylcyclobutyl. In certain embodiments, R 2a is n-pentyl. In certain embodiments, R 2a is second pentyl. In certain embodiments, R 2a is third amyl. In certain embodiments, R 2a is neopentyl. In certain embodiments, R 2a is cyclopentyl. In certain embodiments, R 2a is cyclopentylmethyl. In certain embodiments, R 2a is n-hexyl. In certain embodiments, R 2a is second hexyl. In certain embodiments, R 2a is third hexyl. In certain embodiments, R 2a is neohexyl. In certain embodiments, R 2a is cyclohexyl. In certain embodiments, R 2a is cyclohexylmethyl.
在某些實施方式中,R2b是甲基。在某些實施方式中,R2b是乙基。在某些實施方式中,R2b是正丙基。在某些實施方式中,R2b是異丙基。在某些實施方式中,R2b是環丙基。在某些實施方式中,R2b是環丙基甲基。在某些實施方式中,R2b是正丁基。在某些實施方式中, R2b是第二丁基。在某些實施方式中,R2b是第三丁基。在某些實施方式中,R2b是環丁基。在某些實施方式中,R2b是甲基環丁基。在某些實施方式中,R2b是正戊基。在某些實施方式中,R2b是第二戊基。在某些實施方式中,R2b是第三戊基。在某些實施方式中,R2b是新戊基。在某些實施方式中,R2b是環戊基。在某些實施方式中,R2b是環戊基甲基。在某些實施方式中,R2b是正己基。在某些實施方式中,R2b是第二己基。在某些實施方式中,R2b是第三己基。在某些實施方式中,R2b是新己基。在某些實施方式中,R2b是環己基。在某些實施方式中,R2b是環己基甲基。 In certain embodiments, R 2b is methyl. In certain embodiments, R 2b is ethyl. In certain embodiments, R 2b is n-propyl. In certain embodiments, R 2b is isopropyl. In certain embodiments, R 2b is cyclopropyl. In certain embodiments, R 2b is cyclopropylmethyl. In certain embodiments, R 2b is n-butyl. In certain embodiments, R 2b is second butyl. In certain embodiments, R 2b is t-butyl. In certain embodiments, R 2b is cyclobutyl. In certain embodiments, R 2b is methylcyclobutyl. In certain embodiments, R 2b is n-pentyl. In certain embodiments, R 2b is a second pentyl. In certain embodiments, R 2b is third amyl. In certain embodiments, R 2b is neopentyl. In certain embodiments, R 2b is cyclopentyl. In certain embodiments, R 2b is cyclopentylmethyl. In certain embodiments, R 2b is n-hexyl. In certain embodiments, R 2b is second hexyl. In certain embodiments, R 2b is third hexyl. In certain embodiments, R 2b is neohexyl. In certain embodiments, R 2b is cyclohexyl. In certain embodiments, R 2b is cyclohexylmethyl.
在某些實施方式中,R2a和R2b中的一個是H。 In certain embodiments, one of R 2a and R 2b is H.
在某些實施方式中,Rb1、Rb2和Rb3(如果存在)中的每一個是H。在某些實施方式中,Rb1、Rb2和Rb3(如果存在)中的兩個是H。在某些實施方式中,Rb1、Rb2和Rb3(如果存在)中的一個是H。 In certain embodiments, each of R b1 , R b2 and R b3 (if present) is H. In certain embodiments, two of R b1 , R b2 and R b3 (if present) are H. In certain embodiments, one of R b1 , R b2 and R b3 (if present) is H.
在某些實施方式中,R4a是CN。在某些實施方式中,R4a是CHO。在某些實施方式中,R4a是。在某些實施方式中,R4a是。在某些實施方式中,R4a是。在某些實施方式中,R4a是。在某些實施方式中,R4a是。在某些實施方式中,R4a是。在某些實施方式中,R4a是。在某些實施方式中,R4a是。在某些實施方式中,R4a是。在某些實施方式中,R4a是。在某些實施方式中,R4a是。在某些實施方式中,R4a是。 In certain embodiments, R 4a is CN. In certain embodiments, R 4a is CHO. In certain embodiments, R 4a is . In certain embodiments, R 4a is . In certain embodiments, R 4a is . In certain embodiments, R 4a is . In certain embodiments, R 4a is . In certain embodiments, R 4a is . In certain embodiments, R 4a is . In certain embodiments, R 4a is . In certain embodiments, R 4a is . In certain embodiments, R 4a is . In certain embodiments, R 4a is . In certain embodiments, R 4a is .
在某些實施方式中,R4c是。在某些實施方式中,R4c是。在某些實施方式中,R4c是。在某些實施方式中,R4c是。在某些實施方式中,R4c是。在某些實施方式中,R4c是。 In certain embodiments, R 4c is . In certain embodiments, R 4c is . In certain embodiments, R 4c is . In certain embodiments, R 4c is . In certain embodiments, R 4c is . In certain embodiments, R 4c is .
在某些實施方式中,R3是。在某些實施方式中,R3是。在某些實施方式中,R3是。在某些實施方式中,R3是。在某些實施方式中,R3是。在某些實施方式中,R3是。在某些實施方式中,R3是。在某些實施方式中,R3是。在某些實施方式中,R3是。在某些 實施方式中,R3是。在某些實施方式中,R3是。在某些實施方式中,R3是。在某些實施方式中,R3是。在某些實施方式中,R3是。在某些實施方式中,R3是。在某些實施方式中,R3是。在某些實施方式中,R3是。在某些實施方式中,R3是。在某些實施方式中,R3是。在某些實施方式中,R3是。 In certain embodiments, R 3 is . In certain embodiments, R 3 is . In certain embodiments, R 3 is . In certain embodiments, R 3 is . In certain embodiments, R 3 is . In certain embodiments, R 3 is . In certain embodiments, R 3 is . In certain embodiments, R 3 is . In certain embodiments, R 3 is . In certain embodiments, R 3 is . In certain embodiments, R 3 is . In certain embodiments, R 3 is . In certain embodiments, R 3 is . In certain embodiments, R 3 is . In certain embodiments, R 3 is . In certain embodiments, R 3 is . In certain embodiments, R 3 is . In certain embodiments, R 3 is . In certain embodiments, R 3 is . In certain embodiments, R 3 is .
在某些實施方式中,可選擇地取代的烷基、可選擇地取代的環烷基和可選擇地取代的雜環烷基的每次出現獨立地被選自下列的至少一個可選擇地取代:C1-C6烷基、C3-C8環烷基、C1-C6羥烷基、鹵素、CN、ORI、N(RI)(RII)、C1-C6烷氧基、C3-C8環烷氧基、C1-C6鹵 代烷氧基、C3-C8鹵代環烷氧基、可選擇地取代的苯基、可選擇地取代的C2-C9雜芳基、C(=O)RI、C(=O)ORI、OC(=O)RI、OC(=O)ORI、SRI、S(=O)RI、S(=O)2RI、S(=O)2N(RI)(RII)、S(=O)2NRIC(=O)NHRII、N(RI)S(=O)2RII、N(RI)C(=O)RII和C(=O)NRIRII,其中RI和RII各自獨立地選自H、-C(=O)(C1-C6烷基)、-C(=O)(C1-C6鹵代烷基)、C1-C6烷基、C1-C3鹵代烷基、C3-C8環烷基、C1-C6烷氧基和C3-C8環烷氧基、苯基、萘基和C2-C9雜芳基。 In certain embodiments, each occurrence of optionally substituted alkyl, optionally substituted cycloalkyl, and optionally substituted heterocycloalkyl is independently optionally substituted with at least one selected from : C 1 -C 6 alkyl, C 3 -C 8 cycloalkyl, C 1 -C 6 hydroxyalkyl, halogen, CN, OR I , N(R I )(R II ), C 1 -C 6 alkane Oxygen, C 3 -C 8 cycloalkoxy, C 1 -C 6 haloalkoxy, C 3 -C 8 halocycloalkoxy, optionally substituted phenyl, optionally substituted C 2 - C 9 Heteroaryl, C(=O)R I , C(=O)OR I , OC(=O)R I , OC(=O)OR I , SR I , S(=O)R I , S (=O) 2 R I , S(=O) 2 N(R I )(R II ), S(=O) 2 NR I C(=O)NHR II , N(R I )S(=O) 2 R II , N(R I )C(=O)R II and C(=O)NR I R II , wherein R I and R II are each independently selected from H, -C(=O)(C 1 - C 6 alkyl), -C(=O)(C 1 -C 6 haloalkyl), C 1 -C 6 alkyl, C 1 -C 3 haloalkyl, C 3 -C 8 cycloalkyl, C 1 - C 6 alkoxy and C 3 -C 8 cycloalkoxy, phenyl, naphthyl and C 2 -C 9 heteroaryl.
在某些實施方式中,可選擇地取代的苯基、可選擇地取代的萘基、可選擇地取代的雜環基和可選擇地取代的雜芳基的每次出現獨立地可選擇地被選自下列的至少一個取代基取代:C1-C6烷基、C3-C8環烷基、苯基、C1-C6羥烷基、C1-C6烷氧基、C3-C8環烷氧基、C1-C6鹵代烷基、C1-C6鹵代烷氧基、C3-C8鹵代環烷氧基、鹵素、CN、ORI、N(RI)(RII)、NO2、C(=O)N(RI)(RII)、C(=O)RI、C(=O)ORI、OC(=O)RI、OC(=O)ORI、SRI、S(=O)RI、S(=O)2RI、N(RI)S(=O)2RII、N(RI)C(=O)RII和S(=O)2N(RI)(RII),其中RI和RII各自獨立地選自H、-C(=O)(C1-C6烷基)、-C(=O)(C1-C6鹵代烷基)、C1-C6烷基、C1-C3鹵代烷基、C3-C8環烷基、C1-C6烷氧基和C3-C8環烷氧基、苯基、萘基和C2-C9雜芳基。 In certain embodiments, each occurrence of optionally substituted phenyl, optionally substituted naphthyl, optionally substituted heterocyclyl, and optionally substituted heteroaryl is independently optionally substituted by Substituted by at least one substituent selected from the following: C 1 -C 6 alkyl, C 3 -C 8 cycloalkyl, phenyl, C 1 -C 6 hydroxyalkyl, C 1 -C 6 alkoxy, C 3 -C 8 cycloalkoxy, C 1 -C 6 haloalkoxy, C 1 -C 6 haloalkoxy, C 3 -C 8 halocycloalkoxy, halogen, CN, OR I , N(R I ) ( R II ), NO 2 , C(=O)N(R I )(R II ), C(=O)R I , C(=O)OR I , OC(=O)R I , OC(=O )OR I , SR I , S(=O)R I , S(=O) 2 R I , N(R I )S(=O) 2 R II , N(R I )C(=O)R II and S(=O) 2 N(R I )(R II ), wherein R I and R II are each independently selected from H, -C(=O)(C 1 -C 6 alkyl), -C(= O)(C 1 -C 6 haloalkyl), C 1 -C 6 alkyl, C 1 -C 3 haloalkyl, C 3 -C 8 cycloalkyl, C 1 -C 6 alkoxy and C 3 -C 8 cycloalkoxy, phenyl, naphthyl and C 2 -C 9 heteroaryl.
在某些實施方式中,化合物選自: In certain embodiments, the compound is selected from:
N-(3-環己基-1-側氧基-1-((1-側氧基-3-(2-氧代吡咯啶-3-基)丙烷-2-基)胺基)丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-(3-cyclohexyl-1-oxo-1-((1-oxo-3-(2-oxopyrrolidin-3-yl)propan-2-yl)amino)propane-2 -yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-((S)-3-環己基-1-側氧基-1-(((S)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-oxo-1-(((S)-1-oxo-3-((S)-2-oxopyrrolidin-3-yl) Propan-2-yl)amino)propan-2-yl)-9-hydroxyl-9H-tila-9-carboxamide;
N-((S)-3-環己基-1-側氧基-1-(((S)-1-側氧基-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-oxo-1-(((S)-1-oxo-3-((R)-2-oxopyrrolidin-3-yl) Propan-2-yl)amino)propan-2-yl)-9-hydroxyl-9H-tila-9-carboxamide;
N-((S)-3-環己基-1-側氧基-1-(((R)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-oxo-1-(((R)-1-oxo-3-((S)-2-oxopyrrolidin-3-yl) Propan-2-yl)amino)propan-2-yl)-9-hydroxyl-9H-tila-9-carboxamide;
N-((S)-3-環己基-1-側氧基-1-(((R)-1-側氧基-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-oxo-1-(((R)-1-oxo-3-((R)-2-oxopyrrolidin-3-yl) Propan-2-yl)amino)propan-2-yl)-9-hydroxyl-9H-tila-9-carboxamide;
N-((R)-3-環己基-1-側氧基-1-(((S)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-oxo-1-(((S)-1-oxo-3-((S)-2-oxopyrrolidin-3-yl) Propan-2-yl)amino)propan-2-yl)-9-hydroxyl-9H-tila-9-carboxamide;
N-((R)-3-環己基-1-側氧基-1-(((S)-1-側氧基-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-oxo-1-(((S)-1-oxo-3-((R)-2-oxopyrrolidin-3-yl) Propan-2-yl)amino)propan-2-yl)-9-hydroxyl-9H-tila-9-carboxamide;
N-((R)-3-環己基-1-側氧基-1-(((R)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-oxo-1-(((R)-1-oxo-3-((S)-2-oxopyrrolidin-3-yl) Propan-2-yl)amino)propan-2-yl)-9-hydroxyl-9H-tila-9-carboxamide;
N-((R)-3-環己基-1-側氧基-1-(((R)-1-側氧基-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-oxo-1-(((R)-1-oxo-3-((R)-2-oxopyrrolidin-3-yl) Propan-2-yl)amino)propan-2-yl)-9-hydroxyl-9H-tila-9-carboxamide;
N-(4-(環丙基胺基)-3,4-二氧-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-羥基-2,2-二苯基乙醯胺基)-4-甲基戊醯胺; N-(4-(cyclopropylamino)-3,4-dioxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)-2-(2-hydroxyl-2 , 2-diphenylacetamido)-4-methylpentanamide;
(S)-N-((S)-4-(環丙基胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-羥基-2,2-二苯基乙醯胺基)-4-甲基戊醯胺; (S)-N-((S)-4-(cyclopropylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2 -yl)-2-(2-hydroxy-2,2-diphenylacetamido)-4-methylpentanamide;
(S)-N-((S)-4-(環丙基胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-羥基-2,2-二苯基乙醯胺基)-4-甲基戊醯胺; (S)-N-((S)-4-(cyclopropylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2 -yl)-2-(2-hydroxy-2,2-diphenylacetamido)-4-methylpentanamide;
(S)-N-((R)-4-(環丙基胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-羥基-2,2-二苯基乙醯胺基)-4-甲基戊醯胺; (S)-N-((R)-4-(cyclopropylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2 -yl)-2-(2-hydroxy-2,2-diphenylacetamido)-4-methylpentanamide;
(S)-N-((R)-4-(環丙基胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-羥基-2,2-二苯基乙醯胺基)-4-甲基戊醯胺; (S)-N-((R)-4-(cyclopropylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2 -yl)-2-(2-hydroxy-2,2-diphenylacetamido)-4-methylpentanamide;
(R)-N-((S)-4-(環丙基胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-羥基-2,2-二苯基乙醯胺基)-4-甲基戊醯胺; (R)-N-((S)-4-(cyclopropylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2 -yl)-2-(2-hydroxy-2,2-diphenylacetamido)-4-methylpentanamide;
(R)-N-((S)-4-(環丙基胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-羥基-2,2-二苯基乙醯胺基)-4-甲基戊醯胺; (R)-N-((S)-4-(cyclopropylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2 -yl)-2-(2-hydroxy-2,2-diphenylacetamido)-4-methylpentanamide;
(R)-N-((R)-4-(環丙基胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-羥基-2,2-二苯基乙醯胺基)-4-甲基戊醯胺; (R)-N-((R)-4-(cyclopropylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2 -yl)-2-(2-hydroxy-2,2-diphenylacetamido)-4-methylpentanamide;
(R)-N-((R)-4-(環丙基胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-羥基-2,2-二苯基乙醯胺基)-4-甲基戊醯胺; (R)-N-((R)-4-(cyclopropylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2 -yl)-2-(2-hydroxy-2,2-diphenylacetamido)-4-methylpentanamide;
N-(3-環己基-1-((4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-(3-cyclohexyl-1-((4-hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)amino)-1-oxo Propan-2-yl)-9-hydroxyl-9H-oxo-9-carboxamide;
N-((S)-3-環己基-1-(((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-(((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-((S)-3-環己基-1-(((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-(((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-((S)-3-環己基-1-(((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-(((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-((S)-3-環己基-1-(((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-(((R)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-((R)-3-環己基-1-(((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-(((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-((R)-3-環己基-1-(((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-(((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-((R)-3-環己基-1-(((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-(((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-((R)-3-環己基-1-(((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-(((R)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-1-(9-羥基-9H-茀-9-羰基)-4-苯基哌-2-甲醯胺; N-(4-Hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)-1-(9-hydroxy-9H-oxo-9-carbonyl) -4-Phenylpiperidine -2-Formamide;
(S)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-1-(9-羥基-9H-茀-9-羰基)-4-苯基哌-2-甲醯胺; (S)-N-((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-1-( 9-Hydroxy-9H-terpinene-9-carbonyl)-4-phenylpiperene -2-Formamide;
(S)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-1-(9-羥基-9H-茀-9-羰基)-4-苯基哌-2-甲醯胺; (S)-N-((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-1-( 9-Hydroxy-9H-terpinene-9-carbonyl)-4-phenylpiperene -2-Formamide;
(S)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-1-(9-羥基-9H-茀-9-羰基)-4-苯基哌-2-甲醯胺; (S)-N-((R)-4-hydroxyl-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-1-( 9-Hydroxy-9H-terpinene-9-carbonyl)-4-phenylpiperene -2-Formamide;
(S)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-1-(9-羥基-9H-茀-9-羰基)-4-苯基哌-2-甲醯胺; (S)-N-((R)-4-hydroxyl-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-1-( 9-Hydroxy-9H-terpinene-9-carbonyl)-4-phenylpiperene -2-Formamide;
(R)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-1-(9-羥基-9H-茀-9-羰基)-4-苯基哌-2-甲醯胺; (R)-N-((S)-4-hydroxyl-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-1-( 9-Hydroxy-9H-terpinene-9-carbonyl)-4-phenylpiperene -2-Formamide;
(R)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-1-(9-羥基-9H-茀-9-羰基)-4-苯基哌-2-甲醯胺; (R)-N-((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-1-( 9-Hydroxy-9H-terpinene-9-carbonyl)-4-phenylpiperene -2-Formamide;
(R)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-1-(9-羥基-9H-茀-9-羰基)-4-苯基哌-2-甲醯胺; (R)-N-((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-1-( 9-Hydroxy-9H-terpinene-9-carbonyl)-4-phenylpiperene -2-Formamide;
(R)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-1-(9-羥基-9H-茀-9-羰基)-4-苯基哌-2-甲醯胺; (R)-N-((R)-4-hydroxyl-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-1-( 9-Hydroxy-9H-terpinene-9-carbonyl)-4-phenylpiperene -2-Formamide;
9-羥基-N-(4-甲基-1-((4-(甲胺基)-3,4-二氧-1-(2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-(4-methyl-1-((4-(methylamino)-3,4-dioxo-1-(2-oxopyrrolidin-3-yl)butane-2- Base) amino)-1-oxopentan-2-yl)-9H-stilbene-9-carboxamide;
9-羥基-N-((S)-4-甲基-1-(((S)-4-(甲胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((S)-4-methyl-1-(((S)-4-(methylamino)-3,4-dioxo-1-((S)-2-oxo Pyrrolidin-3-yl)butan-2-yl)amino)-1-oxopentan-2-yl)-9H-oxo-9-carboxamide;
9-羥基-N-((S)-4-甲基-1-(((S)-4-(甲胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((S)-4-methyl-1-(((S)-4-(methylamino)-3,4-dioxo-1-((R)-2-oxo Pyrrolidin-3-yl)butan-2-yl)amino)-1-oxopentan-2-yl)-9H-oxo-9-carboxamide;
9-羥基-N-((S)-4-甲基-1-(((R)-4-(甲胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((S)-4-methyl-1-(((R)-4-(methylamino)-3,4-dioxo-1-((S)-2-oxo Pyrrolidin-3-yl)butan-2-yl)amino)-1-oxopentan-2-yl)-9H-oxo-9-carboxamide;
9-羥基-N-((S)-4-甲基-1-(((R)-4-(甲胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((S)-4-methyl-1-(((R)-4-(methylamino)-3,4-dioxo-1-((R)-2-oxo Pyrrolidin-3-yl)butan-2-yl)amino)-1-oxopentan-2-yl)-9H-oxo-9-carboxamide;
9-羥基-N-((R)-4-甲基-1-(((S)-4-(甲胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((R)-4-methyl-1-(((S)-4-(methylamino)-3,4-dioxo-1-((S)-2-oxo Pyrrolidin-3-yl)butan-2-yl)amino)-1-oxopentan-2-yl)-9H-oxo-9-carboxamide;
9-羥基-N-((R)-4-甲基-1-(((S)-4-(甲胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((R)-4-methyl-1-(((S)-4-(methylamino)-3,4-dioxo-1-((R)-2-oxo Pyrrolidin-3-yl)butan-2-yl)amino)-1-oxopentan-2-yl)-9H-oxo-9-carboxamide;
9-羥基-N-((R)-4-甲基-1-(((R)-4-(甲胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((R)-4-methyl-1-(((R)-4-(methylamino)-3,4-dioxo-1-((S)-2-oxo Pyrrolidin-3-yl)butan-2-yl)amino)-1-oxopentan-2-yl)-9H-oxo-9-carboxamide;
9-羥基-N-((R)-4-甲基-1-(((R)-4-(甲胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((R)-4-methyl-1-(((R)-4-(methylamino)-3,4-dioxo-1-((R)-2-oxo Pyrrolidin-3-yl)butan-2-yl)amino)-1-oxopentan-2-yl)-9H-oxo-9-carboxamide;
N-(1-((4-(乙胺基)-3,4-二氧-1-(2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-(1-((4-(ethylamino)-3,4-dioxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)amino)-4-methanol Base-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((S)-1-(((S)-4-(乙胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((S)-4-(ethylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-((S)-1-(((S)-4-(乙胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((S)-4-(ethylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-((S)-1-(((R)-4-(乙胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((R)-4-(ethylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-((S)-1-(((R)-4-(乙胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((R)-4-(ethylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-((R)-1-(((S)-4-(乙胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((S)-4-(ethylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-((R)-1-(((S)-4-(乙胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((S)-4-(ethylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-((R)-1-(((R)-4-(乙胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((R)-4-(ethylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-((R)-1-(((R)-4-(乙胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((R)-4-(ethylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-(1-((1-(4-氯噻唑-2-基)-1-側氧基-3-(2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-(1-((1-(4-chlorothiazol-2-yl)-1-oxo-3-(2-oxopyrrolidin-3-yl)propan-2-yl)amino)- 4-Methyl-1-oxopentan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((S)-1-(((S)-1-(4-氯噻唑-2-基)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((S)-1-(((S)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((S)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((S)-1-(((S)-1-(4-氯噻唑-2-基)-1-側氧基-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((S)-1-(((S)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((R)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((S)-1-(((R)-1-(4-氯噻唑-2-基)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((S)-1-(((R)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((S)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((S)-1-(((R)-1-(4-氯噻唑-2-基)-1-側氧基-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((S)-1-(((R)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((R)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((R)-1-(((S)-1-(4-氯噻唑-2-基)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((R)-1-(((S)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((S)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((R)-1-(((S)-1-(4-氯噻唑-2-基)-1-側氧基-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((R)-1-(((S)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((R)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((R)-1-(((R)-1-(4-氯噻唑-2-基)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((R)-1-(((R)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((S)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((R)-1-(((R)-1-(4-氯噻唑-2-基)-1-側氧基-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((R)-1-(((R)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((R)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-(3-環己基-1-((4-(甲胺基)-3,4-二氧-1-(2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-(3-cyclohexyl-1-((4-(methylamino)-3,4-dioxo-1-(2-oxopyrrolidin-3-yl)butan-2-yl)amino )-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((S)-3-環己基-1-(((S)-4-(甲胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-(((S)-4-(methylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidine-3 -yl)butane-2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((S)-3-環己基-1-(((S)-4-(甲胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-(((S)-4-(methylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidine-3 -yl)butane-2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((S)-3-環己基-1-(((R)-4-(甲胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-(((R)-4-(methylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidine-3 -yl)butane-2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((S)-3-環己基-1-(((R)-4-(甲胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-(((R)-4-(methylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidine-3 -yl)butane-2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-3-環己基-1-(((S)-4-(甲胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-(((S)-4-(methylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidine-3 -yl)butane-2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-3-環己基-1-(((S)-4-(甲胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-(((S)-4-(methylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidine-3 -yl)butane-2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-3-環己基-1-(((R)-4-(甲胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-(((R)-4-(methylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidine-3 -yl)butane-2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-3-環己基-1-(((R)-4-(甲胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-(((R)-4-(methylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidine-3 -yl)butane-2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-(1-((4-胺基-3,4-二氧-1-(2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-(1-((4-amino-3,4-dioxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)amino)-3-cyclohexyl-1 -Oxopropan-2-yl)-9-hydroxy-9H-oxo-9-carboxamide;
N-((S)-1-(((S)-4-胺基-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((S)-4-amino-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-3-cyclohexyl-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((S)-1-(((S)-4-胺基-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((S)-4-amino-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-3-cyclohexyl-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((S)-1-(((R)-4-胺基-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((R)-4-amino-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-3-cyclohexyl-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((S)-1-(((R)-4-胺基-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((R)-4-amino-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-3-cyclohexyl-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-1-(((S)-4-胺基-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((S)-4-amino-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-3-cyclohexyl-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-1-(((S)-4-胺基-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((S)-4-amino-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-3-cyclohexyl-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-1-(((R)-4-胺基-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((R)-4-amino-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-3-cyclohexyl-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-1-(((R)-4-胺基-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((R)-4-amino-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-3-cyclohexyl-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-(1-((4-(環丙基胺基)-3,4-二氧-1-(2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-(1-((4-(cyclopropylamino)-3,4-dioxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)amino)-4 -Methyl-1-oxopentan-2-yl)-9-hydroxy-9H-stilbene-9-carboxamide;
N-((S)-1-(((S)-4-(環丙基胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((S)-4-(cyclopropylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl) Butane-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((S)-1-(((S)-4-(環丙基胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((S)-4-(cyclopropylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl) Butane-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((S)-1-(((R)-4-(環丙基胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((R)-4-(cyclopropylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl) Butane-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((S)-1-(((R)-4-(環丙基胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((R)-4-(cyclopropylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl) Butane-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-1-(((S)-4-(環丙基胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((S)-4-(cyclopropylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl) Butane-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-1-(((S)-4-(環丙基胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((S)-4-(cyclopropylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl) Butane-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-1-(((R)-4-(環丙基胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((R)-4-(cyclopropylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl) Butane-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-1-(((R)-4-(環丙基胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((R)-4-(cyclopropylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl) Butane-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
(3aR,6aS)-N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (3aR,6aS)-N-(4-Hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)-2-(4-methoxy- 1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(3aS,6aR)-N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (3aS,6aR)-N-(4-Hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)-2-(4-methoxy- 1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
N-(1-((4-胺基-3,4-二氧-1-(2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-(1-((4-amino-3,4-dioxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)amino)-4-methyl-1 -Oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((S)-1-(((S)-4-胺基-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((S)-4-amino-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((S)-1-(((S)-4-胺基-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((S)-4-amino-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((S)-1-(((R)-4-胺基-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((R)-4-amino-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((S)-1-(((R)-4-胺基-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((R)-4-amino-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-1-(((S)-4-胺基-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((S)-4-amino-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-1-(((S)-4-胺基-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((S)-4-amino-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-1-(((R)-4-胺基-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((R)-4-amino-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-1-(((R)-4-胺基-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((R)-4-amino-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-(1-((1-(4-氯噻唑-2-基)-1-側氧基-3-(2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-(1-((1-(4-chlorothiazol-2-yl)-1-oxo-3-(2-oxopyrrolidin-3-yl)propan-2-yl)amino)- 3-cyclohexyl-1-oxopropan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((S)-1-(((S)-1-(4-氯噻唑-2-基)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((S)-1-(((S)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((S)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-3-cyclohexyl-1-oxopropan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((S)-1-(((S)-1-(4-氯噻唑-2-基)-1-側氧基-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((S)-1-(((S)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((R)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-3-cyclohexyl-1-oxopropan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((S)-1-(((R)-1-(4-氯噻唑-2-基)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((S)-1-(((R)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((S)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-3-cyclohexyl-1-oxopropan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((S)-1-(((R)-1-(4-氯噻唑-2-基)-1-側氧基-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((S)-1-(((R)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((R)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-3-cyclohexyl-1-oxopropan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((R)-1-(((S)-1-(4-氯噻唑-2-基)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((R)-1-(((S)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((S)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-3-cyclohexyl-1-oxopropan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((R)-1-(((S)-1-(4-氯噻唑-2-基)-1-側氧基-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((R)-1-(((S)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((R)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-3-cyclohexyl-1-oxopropan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((R)-1-(((R)-1-(4-氯噻唑-2-基)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((R)-1-(((R)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((S)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-3-cyclohexyl-1-oxopropan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((R)-1-(((R)-1-(4-氯噻唑-2-基)-1-側氧基-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((R)-1-(((R)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((R)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-3-cyclohexyl-1-oxopropan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
(3aR,6aS)-N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (3aR,6aS)-N-(4-hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)-2-(9-hydroxyl-9H- Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(3aS,6aR)-N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (3aS,6aR)-N-(4-hydroxyl-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)-2-(9-hydroxyl-9H- Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
9-羥基-N-(1-((4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4,4-二甲基-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-(1-((4-hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)amino)-4,4- Dimethyl-1-oxopentan-2-yl)-9H-oxo-9-formamide;
9-羥基-N-((S)-1-(((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4,4-二甲基-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((S)-1-(((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane- 2-yl)amino)-4,4-dimethyl-1-oxopentan-2-yl)-9H-stilbene-9-carboxamide;
9-羥基-N-((S)-1-(((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4,4-二甲基-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((S)-1-(((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane- 2-yl)amino)-4,4-dimethyl-1-oxopentan-2-yl)-9H-stilbene-9-carboxamide;
9-羥基-N-((S)-1-(((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4,4-二甲基-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((S)-1-(((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane- 2-yl)amino)-4,4-dimethyl-1-oxopentan-2-yl)-9H-stilbene-9-carboxamide;
9-羥基-N-((S)-1-(((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4,4-二甲基-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((S)-1-(((R)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane- 2-yl)amino)-4,4-dimethyl-1-oxopentan-2-yl)-9H-stilbene-9-carboxamide;
9-羥基-N-((R)-1-(((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4,4-二甲基-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((R)-1-(((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane- 2-yl)amino)-4,4-dimethyl-1-oxopentan-2-yl)-9H-stilbene-9-carboxamide;
9-羥基-N-((R)-1-(((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4,4-二甲基-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((R)-1-(((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane- 2-yl)amino)-4,4-dimethyl-1-oxopentan-2-yl)-9H-stilbene-9-carboxamide;
9-羥基-N-((R)-1-(((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4,4-二甲基-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((R)-1-(((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane- 2-yl)amino)-4,4-dimethyl-1-oxopentan-2-yl)-9H-stilbene-9-carboxamide;
9-羥基-N-((R)-1-(((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4,4-二甲基-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((R)-1-(((R)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane- 2-yl)amino)-4,4-dimethyl-1-oxopentan-2-yl)-9H-stilbene-9-carboxamide;
N-(3-環己基-1-((4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-(2,2,2-三氟乙醯胺基)-9H-茀-9-甲醯胺; N-(3-cyclohexyl-1-((4-hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)amino)-1-oxo Propan-2-yl)-9-(2,2,2-trifluoroacetamido)-9H-stilbene-9-carboxamide;
N-((S)-3-環己基-1-(((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-(2,2,2-三氟乙醯胺基)-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-(((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-(2,2,2-trifluoroacetamido)-9H-oxo-9-formamide;
N-((S)-3-環己基-1-(((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-(2,2,2-三氟乙醯胺基)-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-(((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-(2,2,2-trifluoroacetamido)-9H-oxo-9-formamide;
N-((S)-3-環己基-1-(((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-(2,2,2-三氟乙醯胺基)-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-(((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-(2,2,2-trifluoroacetamido)-9H-oxo-9-formamide;
N-((S)-3-環己基-1-(((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-(2,2,2-三氟乙醯胺基)-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-(((R)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-(2,2,2-trifluoroacetamido)-9H-oxo-9-formamide;
N-((R)-3-環己基-1-(((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-(2,2,2-三氟乙醯胺基)-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-(((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-(2,2,2-trifluoroacetamido)-9H-oxo-9-formamide;
N-((R)-3-環己基-1-(((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-(2,2,2-三氟乙醯胺基)-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-(((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-(2,2,2-trifluoroacetamido)-9H-oxo-9-formamide;
N-((R)-3-環己基-1-(((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-(2,2,2-三氟乙醯胺基)-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-(((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-(2,2,2-trifluoroacetamido)-9H-oxo-9-formamide;
N-((R)-3-環己基-1-(((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-(2,2,2-三氟乙醯胺基)-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-(((R)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-(2,2,2-trifluoroacetamido)-9H-oxo-9-formamide;
N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(4-Hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)-2-(9-hydroxy-9H-oxo-9-carbonyl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-4-hydroxyl-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 9-Hydroxy-9H-Oxane-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 9-Hydroxy-9H-Oxane-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 9-Hydroxy-9H-Oxane-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 9-Hydroxy-9H-Oxane-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 9-Hydroxy-9H-Oxane-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 9-Hydroxy-9H-Oxane-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 9-Hydroxy-9H-Oxane-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-4-hydroxyl-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 9-Hydroxy-9H-Oxane-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-((4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-丙基-1H-吲哚-2-甲醯胺; N-(1-((4-hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)amino)-4-methyl-1-oxo Pentane-2-yl)-4-methoxy-1-propyl-1H-indole-2-carboxamide;
N-((S)-1-(((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-丙基-1H-吲哚-2-甲醯胺; N-((S)-1-(((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-propyl-1H-indole-2-carboxamide;
N-((S)-1-(((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-丙基-1H-吲哚-2-甲醯胺; N-((S)-1-(((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-propyl-1H-indole-2-carboxamide;
N-((S)-1-(((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-丙基-1H-吲哚-2-甲醯胺; N-((S)-1-(((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-propyl-1H-indole-2-carboxamide;
N-((S)-1-(((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-丙基-1H-吲哚-2-甲醯胺; N-((S)-1-(((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-propyl-1H-indole-2-carboxamide;
N-((R)-1-(((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-丙基-1H-吲哚-2-甲醯胺; N-((R)-1-(((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-propyl-1H-indole-2-carboxamide;
N-((R)-1-(((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-丙基-1H-吲哚-2-甲醯胺; N-((R)-1-(((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-propyl-1H-indole-2-carboxamide;
N-((R)-1-(((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-丙基-1H-吲哚-2-甲醯胺; N-((R)-1-(((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-propyl-1H-indole-2-carboxamide;
N-((R)-1-(((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-丙基-1H-吲哚-2-甲醯胺; N-((R)-1-(((R)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-propyl-1H-indole-2-carboxamide;
(3aR,6aS)-N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (3aR,6aS)-N-(4-Hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)-2-(1H-indole-2 -carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(3aS,6aR)-N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (3aS,6aR)-N-(4-Hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)-2-(1H-indole-2 -carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
N-(1-((4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-(2-甲基烯丙基)-1H-吲哚-2-甲醯胺; N-(1-((4-hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)amino)-4-methyl-1-oxo Pentan-2-yl)-4-methoxy-1-(2-methylallyl)-1H-indole-2-carboxamide;
N-((S)-1-(((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-(2-甲基烯丙基)-1H-吲哚-2-甲醯胺; N-((S)-1-(((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-(2-methylallyl)-1H-indole-2-carboxamide;
N-((S)-1-(((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-(2-甲基烯丙基)-1H-吲哚-2-甲醯胺; N-((S)-1-(((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-(2-methylallyl)-1H-indole-2-carboxamide;
N-((S)-1-(((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-(2-甲基烯丙基)-1H-吲哚-2-甲醯胺; N-((S)-1-(((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-(2-methylallyl)-1H-indole-2-carboxamide;
N-((S)-1-(((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-(2-甲基烯丙基)-1H-吲哚-2-甲醯胺; N-((S)-1-(((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-(2-methylallyl)-1H-indole-2-carboxamide;
N-((R)-1-(((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-(2-甲基烯丙基)-1H-吲哚-2-甲醯胺; N-((R)-1-(((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-(2-methylallyl)-1H-indole-2-carboxamide;
N-((R)-1-(((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-(2-甲基烯丙基)-1H-吲哚-2-甲醯胺; N-((R)-1-(((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-(2-methylallyl)-1H-indole-2-carboxamide;
N-((R)-1-(((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-(2-甲基烯丙基)-1H-吲哚-2-甲醯胺; N-((R)-1-(((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-(2-methylallyl)-1H-indole-2-carboxamide;
N-((R)-1-(((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-(2-甲基烯丙基)-1H-吲哚-2-甲醯胺; N-((R)-1-(((R)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-(2-methylallyl)-1H-indole-2-carboxamide;
N-(1-氰基-2-(2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N -(1-cyano-2-(2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-(9-hydroxy-9H-fennel-9-carbonyl)-2 - azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
2-(2-(3-氯苯基)-2-羥基乙醯基)-N-(1-氰基-2-(2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(2-(3-Chlorophenyl)-2-hydroxyacetyl) -N- (1-cyano-2-(2-oxopyrrolidin-3-yl)ethyl)-5,5 - Difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3R,4S)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3S,4R)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3R,4R)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3S,4S)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3R,4S)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3S,4R)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3R,4R)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3S,4S)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3R,4S)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3S,4R)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3R,4R)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3S,4S)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3R,4S)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3S,4R)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3R,4R)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
N-[1-氰基-2-[2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N -[1-cyano-2-[2-oxopyrrolidin-3-yl]ethyl]-2-[2-(3,5-dichlorophenyl)-2,2-difluoro-ethyl Acyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ 2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ 2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ 2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ 2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ 2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ 2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ 2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ 2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ 2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ 2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ 2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ 2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ 2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ 2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3R)-2-氧代吸咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2- [2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ 2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide ;
N-(1-氰基-2-(2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N -(1-cyano-2-(2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-(4-methoxy-1H-indole-2-carbonyl )-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代吸咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5- Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N -(1-cyano-2-(2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-(2-methyl-1H-indole-7-carbonyl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N -(1-cyano-2-(oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-(2-hydroxy-2-phenylacryl)-2-aza Bicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N- (1-cyano-2-(2-oxopyrrolidin-3-yl)ethyl)-2-(4-(difluoromethyl)-1H-indole-2-carbonyl)-5, 5-Difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(1-cyano-2-(2-oxopyrrolidin-3-yl)ethyl)-2-(4-(difluoromethyl)-6-fluoro-1H-indole-2-carbonyl )-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-N-(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-N-(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-N-(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-N-(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-N-(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-N-(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-N-(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-N-(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-N-(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-N-(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-N-(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-N-(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-N-(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-N-(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-N-(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-N-(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-[1-氰基-2-[2-氧代吡咯啶-3-基]乙基]-2-[3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N -[1-cyano-2-[2-oxopyrrolidin-3-yl]ethyl]-2-[3-cyclobutyl-2-[(2,2,2-trifluoroacetyl )amino] propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[1-氰基-2-[2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(7-Chloro-4-fluoro-1 H -indole-2-carbonyl) -N- [1-cyano-2-[2-oxo-3-piperidinyl]ethyl]-5 ,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3S,4S)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(7-chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 S )-1-cyano-2-[( 3S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3R,4S)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(7-Chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 S )-1-cyano-2-[( 3S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3S,4R)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(7-chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 S )-1-cyano-2-[( 3S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3R,4R)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(7-chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 S )-1-cyano-2-[( 3S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3S,4S)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(7-Chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 R )-1-cyano-2-[( 3S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3R,4S)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(7-Chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 R )-1-cyano-2-[( 3S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3S,4R)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(7-chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 R )-1-cyano-2-[( 3S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3R,4R)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(7-chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 R )-1-cyano-2-[( 3S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3S,4S)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(7-chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 S )-1-cyano-2-[( 3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3R,4S)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(7-Chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 S )-1-cyano-2-[( 3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3S,4R)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(7-chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 S )-1-cyano-2-[( 3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3R,4R)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(7-chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 S )-1-cyano-2-[( 3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3S,4S)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(7-Chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 R )-1-cyano-2-[( 3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3R,4S)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(7-Chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 R )-1-cyano-2-[( 3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3S,4R)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(7-chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 R )-1-cyano-2-[( 3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3R,4R)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(7-chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 R )-1-cyano-2-[( 3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N -(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-(9-hydroxy-9H-fennel-9-carbonyl)-2 - azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( R )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( R )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( R )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( R )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( S )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( S )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( S )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( R )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( R )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( R )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( R )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N -(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-(4-methoxy-1H-indole-2-carbonyl )-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( R )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( R )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( R )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( R )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( S )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( S )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( S )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( R )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( R )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( R )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( R )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-[1-氰基-2-[2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N- [1-cyano-2-[2-oxo-3-piperidinyl]ethyl]-2-(4,7-difluoro-1 H -indole-2-carbonyl)-5, 5-Difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-[1-氰基-2-[2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N- [1-cyano-2-[2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-(4,6,7-trifluoro-1 H -ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[1-氰基-2-[2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(3-Chloro- 4H -thieno[3,2-b]pyrrole-5-carbonyl) -N- [1-cyano-2-[2-oxo-3-piperidinyl]ethyl Base]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(3-chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 S )-1-cyano- 2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(3-Chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 S )-1-cyano- 2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(3-chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 S )-1-cyano- 2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(3-chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 S )-1-cyano- 2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(3-Chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 R )-1-cyano- 2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(3-Chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 R )-1-cyano- 2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(3-chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 R )-1-cyano- 2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(3-chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 R )-1-cyano- 2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(3-chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 S )-1-cyano- 2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(3-Chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 S )-1-cyano- 2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(3-chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 S )-1-cyano- 2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(3-chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 S )-1-cyano- 2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(3-Chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 R )-1-cyano- 2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(3-Chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 R )-1-cyano- 2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(3-chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 R )-1-cyano- 2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(3-chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 R )-1-cyano- 2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
2-(2-氯-9-羥基-9H-茀-9-羰基)-N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N- (1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-5,5- Difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( S )-1-cyano-2-((S)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( S )-1-cyano-2-((S)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( S )-1-cyano-2-((S)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( S )-1-cyano-2-((S)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( R )-1-cyano-2-((S)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( R )-1-cyano-2-((S)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( R )-1-cyano-2-((S)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( R )-1-cyano-2-((S)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( S )-1-cyano-2-((R)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( S )-1-cyano-2-((R)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( S )-1-cyano-2-((R)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( S )-1-cyano-2-((R)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( R )-1-cyano-2-((R)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( R )-1-cyano-2-((R)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( R )-1-cyano-2-((R)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( R )-1-cyano-2-((R)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-[1-氰基-2-[2-側氧基-3-哌啶基]乙基]-2-[3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N -[1-cyano-2-[2-oxo-3-piperidinyl]ethyl]-2-[3-cyclobutyl-2-[(2,2,2-trifluoroacetyl Base) amino] propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
N-[1-氰基-2-[2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N- [1-cyano-2-[2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-[4-methyl-2-[(2,2, 2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
N-[1-氰基-2-[2-側氧基-3-哌啶基]乙基]-2-[3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N -[1-cyano-2-[2-oxo-3-piperidinyl]ethyl]-2-[3-cyclopropyl-2-[(2,2,2-trifluoroacetyl Base) amino] propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
N-[1-氰基-2-[2-側氧基-3-哌啶基]乙基]-2-[3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N -[1-cyano-2-[2-oxo-3-piperidinyl]ethyl]-2-[3,3-dimethyl-2-[(2,2,2-trifluoro Acetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
N-[1-氰基-2-[2-側氧基-3-哌啶基]乙基]-2-[2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N -[1-cyano-2-[2-oxo-3-piperidinyl]ethyl]-2-[2-(2,5-difluoroaniline)propionyl]-5,5- Difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1S)-1-氟基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-fluoro-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -[(1 R )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -[(1 R )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -[(1 R )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -[(1 R )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -[(1 R )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -[(1 R )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
2-[2-(3-氯-2-甲基-苯胺)丙醯基]-N-[1-氰基-2-[2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-[2-(3-Chloro-2-methyl-aniline)propionyl]-N-[1-cyano-2-[2-oxo-3-piperidinyl]ethyl]-5 ,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3S,4S)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-[(2S)-2-(3-Chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-[(2S)-2-(3-Chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-[(2S)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-[(2S)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-[(2R)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-[(2R)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-[(2R)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-[(2R)-2-(3-Chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-[(2S)-2-(3-Chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-[(2S)-2-(3-Chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-[(2S)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-[(2S)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-[(2R)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-[(2R)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-[(2R)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-[(2R)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-[(2S)-2-(3-Chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3R,4S)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-[(2S)-2-(3-Chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3S,4R)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-[(2S)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3R,4R)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-[(2S)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3S,4S)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-[(2R)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3R,4S)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-[(2R)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3S,4R)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-[(2R)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3R,4R)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-[(2R)-2-(3-Chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3S,4S)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-[(2S)-2-(3-Chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3R,4S)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-[(2S)-2-(3-Chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3S,4R)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-[(2S)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3R,4R)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-[(2S)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3S,4S)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-[(2R)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3R,4S)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-[(2R)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3S,4R)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-[(2R)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3R,4R)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-[(2R)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(4-hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)-2-(2-methyl-4H-thieno[3, 2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-formamide;
(S)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-4-hydroxyl-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 2-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 2-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 2-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 2-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 2-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 2-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 2-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-4-hydroxyl-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 2-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-(4-hydroxy-3-oxo-1-(2-oxopyrrolidine-3- Base) butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-4-hydroxyl-3-oxo-1-(( S) -2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-4-hydroxyl-3-oxo-1-(( R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-4-hydroxyl-3-oxo-1-(( S) -2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-4-hydroxyl-3-oxo-1-(( R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-4-hydroxyl-3-oxo-1-(( S) -2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-4-hydroxyl-3-oxo-1-(( R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-4-hydroxyl-3-oxo-1-(( S) -2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-4-hydroxyl-3-oxo-1-(( R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(4-Hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)-2-(4-methoxy-1H-indole-2 -carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-4-hydroxyl-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-4-hydroxyl-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-(3-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(4-hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)-2-(3-methyl-4H-thieno[3, 2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-formamide;
(S)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(3-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-4-hydroxyl-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 3-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(3-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 3-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(3-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 3-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(3-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 3-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(3-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 3-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(3-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 3-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(3-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 3-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(3-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-4-hydroxyl-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 3-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
2-(4,6-二氟-1H-吲哚-2-羰基)-N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(4,6-Difluoro-1H-indole-2-carbonyl)-N-(4-hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane- 2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-(4,6-二氟-1H-吲哚-2-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-(4,6-difluoro-1H-indole-2-carbonyl)-N-((S)-4-hydroxy-3-oxo-1-((S)-2- Oxypyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-(4,6-二氟-1H-吲哚-2-羰基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-(4,6-difluoro-1H-indole-2-carbonyl)-N-((S)-4-hydroxy-3-oxo-1-((R)-2- Oxypyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-(4,6-二氟-1H-吲哚-2-羰基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-(4,6-difluoro-1H-indole-2-carbonyl)-N-((R)-4-hydroxy-3-oxo-1-((S)-2- Oxypyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-(4,6-二氟-1H-吲哚-2-羰基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-(4,6-difluoro-1H-indole-2-carbonyl)-N-((R)-4-hydroxy-3-oxo-1-((R)-2- Oxypyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-(4,6-二氟-1H-吲哚-2-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-(4,6-difluoro-1H-indole-2-carbonyl)-N-((S)-4-hydroxy-3-oxo-1-((S)-2- Oxypyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-(4,6-二氟-1H-吲哚-2-羰基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-(4,6-difluoro-1H-indole-2-carbonyl)-N-((S)-4-hydroxy-3-oxo-1-((R)-2- Oxypyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-(4,6-二氟-1H-吲哚-2-羰基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-(4,6-difluoro-1H-indole-2-carbonyl)-N-((R)-4-hydroxy-3-oxo-1-((S)-2- Oxypyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-(4,6-二氟-1H-吲哚-2-羰基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-(4,6-difluoro-1H-indole-2-carbonyl)-N-((R)-4-hydroxy-3-oxo-1-((R)-2- Oxypyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
2-(9-氟-9H-茀-9-羰基)-N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; 2-(9-fluoro-9H-fluorene-9-carbonyl)-N-(4-hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(9-氟-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(9-fluoro-9H-fennel-9-carbonyl)-N-((S)-4-hydroxyl-3-oxo-1-((S)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(9-氟-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(9-Fluoro-9H-fennel-9-carbonyl)-N-((S)-4-hydroxy-3-oxo-1-((R)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(9-氟-9H-茀-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(9-Fluoro-9H-fennel-9-carbonyl)-N-((R)-4-hydroxyl-3-oxo-1-((S)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(9-氟-9H-茀-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(9-Fluoro-9H-fennel-9-carbonyl)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(9-氟-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(9-Fluoro-9H-fennel-9-carbonyl)-N-((S)-4-hydroxy-3-oxo-1-((S)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(9-氟-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(9-Fluoro-9H-fennel-9-carbonyl)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(9-氟-9H-茀-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(9-Fluoro-9H-fennel-9-carbonyl)-N-((R)-4-hydroxyl-3-oxo-1-((S)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(9-氟-9H-茀-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(9-Fluoro-9H-fennel-9-carbonyl)-N-((R)-4-hydroxyl-3-oxo-1-((R)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(9-氟-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(9-fluoro-9H-fennel-9-carbonyl)-N-((S)-4-hydroxyl-3-oxo-1-((S)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(9-氟-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(9-Fluoro-9H-fennel-9-carbonyl)-N-((S)-4-hydroxy-3-oxo-1-((R)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(9-氟-9H-茀-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(9-Fluoro-9H-fennel-9-carbonyl)-N-((R)-4-hydroxyl-3-oxo-1-((S)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(9-氟-9H-茀-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(9-Fluoro-9H-fennel-9-carbonyl)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(9-氟-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(9-Fluoro-9H-fennel-9-carbonyl)-N-((S)-4-hydroxy-3-oxo-1-((S)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(9-氟-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(9-Fluoro-9H-fennel-9-carbonyl)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(9-氟-9H-茀-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(9-Fluoro-9H-fennel-9-carbonyl)-N-((R)-4-hydroxyl-3-oxo-1-((S)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(9-氟-9H-茀-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(9-Fluoro-9H-fennel-9-carbonyl)-N-((R)-4-hydroxyl-3-oxo-1-((R)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
2-(9-乙醯胺基-9H-茀-9-羰基)-N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; 2-(9-Acetamido-9H-oxo-9-carbonyl)-N-(4-hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2 -yl) octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((S)-4-hydroxy-3-oxo-1-((S) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((S)-4-hydroxy-3-oxo-1-((R) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((R)-4-hydroxy-3-oxo-1-((S) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((R)-4-hydroxy-3-oxo-1-((R) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((S)-4-hydroxyl-3-oxo-1-((S) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((S)-4-hydroxy-3-oxo-1-((R) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((R)-4-hydroxy-3-oxo-1-((S) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((R)-4-hydroxy-3-oxo-1-((R) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((S)-4-hydroxy-3-oxo-1-((S) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((S)-4-hydroxy-3-oxo-1-((R) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((R)-4-hydroxy-3-oxo-1-((S) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((R)-4-hydroxy-3-oxo-1-((R) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((S)-4-hydroxyl-3-oxo-1-((S) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((S)-4-hydroxy-3-oxo-1-((R) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((R)-4-hydroxy-3-oxo-1-((S) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((R)-4-hydroxy-3-oxo-1-((R) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-(5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; N-(4-Hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)-2-(5-oxo-2-phenylpyrrolidine -2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
2-(2-環戊基-2-羥基-2-苯乙醯基)-N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(2-Cyclopentyl-2-hydroxy-2-phenylacetyl)-N-(4-hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane -2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(3S)-2-(2-環戊基-2-羥基-2-苯乙醯基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (3S)-2-(2-Cyclopentyl-2-hydroxy-2-phenylacetyl)-N-((S)-4-hydroxy-3-oxo-1-((S)-2 -Oxopyrrolidin-3-yl)butan-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-((S)-2-環戊基-2-羥基-2-苯乙醯基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-((S)-2-cyclopentyl-2-hydroxyl-2-phenylacetyl)-N-((S)-4-hydroxyl-3-oxo-1-(( S) -2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-((S)-2-環戊基-2-羥基-2-苯乙醯基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-((S)-2-cyclopentyl-2-hydroxyl-2-phenylacetyl)-N-((S)-4-hydroxyl-3-oxo-1-(( R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-((S)-2-環戊基-2-羥基-2-苯乙醯基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-((S)-2-cyclopentyl-2-hydroxyl-2-phenylacetyl)-N-((R)-4-hydroxyl-3-oxo-1-(( S) -2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-((S)-2-環戊基-2-羥基-2-苯乙醯基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-((S)-2-cyclopentyl-2-hydroxyl-2-phenylacetyl)-N-((R)-4-hydroxyl-3-oxo-1-(( R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-((R)-2-環戊基-2-羥基-2-苯乙醯基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-((R)-2-cyclopentyl-2-hydroxyl-2-phenylacetyl)-N-((S)-4-hydroxyl-3-oxo-1-(( S) -2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-((R)-2-環戊基-2-羥基-2-苯乙醯基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-((R)-2-cyclopentyl-2-hydroxyl-2-phenylacetyl)-N-((S)-4-hydroxyl-3-oxo-1-(( R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-((R)-2-環戊基-2-羥基-2-苯乙醯基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-((R)-2-cyclopentyl-2-hydroxyl-2-phenylacetyl)-N-((R)-4-hydroxyl-3-oxo-1-(( S) -2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-((R)-2-環戊基-2-羥基-2-苯乙醯基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-((R)-2-cyclopentyl-2-hydroxyl-2-phenylacetyl)-N-((R)-4-hydroxyl-3-oxo-1-(( R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-((S)-2-環戊基-2-羥基-2-苯乙醯基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-((S)-2-cyclopentyl-2-hydroxyl-2-phenylacetyl)-N-((S)-4-hydroxyl-3-oxo-1-(( S) -2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-((S)-2-環戊基-2-羥基-2-苯乙醯基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-((S)-2-cyclopentyl-2-hydroxyl-2-phenylacetyl)-N-((S)-4-hydroxyl-3-oxo-1-(( R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-((S)-2-環戊基-2-羥基-2-苯乙醯基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-((S)-2-cyclopentyl-2-hydroxyl-2-phenylacetyl)-N-((R)-4-hydroxyl-3-oxo-1-(( S) -2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-((S)-2-環戊基-2-羥基-2-苯乙醯基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-((S)-2-cyclopentyl-2-hydroxyl-2-phenylacetyl)-N-((R)-4-hydroxyl-3-oxo-1-(( R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-((R)-2-環戊基-2-羥基-2-苯乙醯基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-((R)-2-cyclopentyl-2-hydroxy-2-phenylacetyl)-N-((S)-4-hydroxy-3-oxo-1-(( S) -2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-((R)-2-環戊基-2-羥基-2-苯乙醯基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-((R)-2-cyclopentyl-2-hydroxy-2-phenylacetyl)-N-((S)-4-hydroxy-3-oxo-1-(( R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-((R)-2-環戊基-2-羥基-2-苯乙醯基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-((R)-2-cyclopentyl-2-hydroxyl-2-phenylacetyl)-N-((R)-4-hydroxyl-3-oxo-1-(( S) -2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-((R)-2-環戊基-2-羥基-2-苯乙醯基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-((R)-2-cyclopentyl-2-hydroxyl-2-phenylacetyl)-N-((R)-4-hydroxyl-3-oxo-1-(( R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(1-cyano-2-(2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo [2.2.2] Octane-3-formamide;
(S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy-1H-ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy-1H-ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2,-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2,-(4-methoxy-1H- Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy-1H-ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy-1H-ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy-1H-ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy-1H-ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy-1H-ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-(1-氰基-2-(2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-(1-cyano-2-(2-oxopyrrolidin-3-yl)ethyl) -5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,2S,5S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1R,2S,5S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
N-(1-氰基-2-(2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; N-(1-cyano-2-(2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxy-9H-fenflure-9-carbonyl)-6,6-dimethyl- 3-Azabicyclo[3.1.0]hexane-2-carboxamide;
(1R,2S,5S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1R,2S,5S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
(1R,2S,5S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1R,2S,5S)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
(1R,2S,5S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1R,2S,5S)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
(1R,2S,5S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1R,2S,5S)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
(1S,2S,5R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1S,2S,5R)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
(1S,2S,5R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1S,2S,5R)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
(1S,2S,5R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1S,2S,5R)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
(1S,2S,5R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1S,2S,5R)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
(1R,2R,5S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1R,2R,5S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
(1R,2R,5S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1R,2R,5S)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
(1R,2R,5S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1R,2R,5S)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
(1R,2R,5S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1R,2R,5S)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
(1S,2R,5R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1S,2R,5R)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
(1S,2R,5R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1S,2R,5R)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
(1S,2R,5R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1S,2R,5R)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
(1S,2R,5R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1S,2R,5R)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
N-(1-氰基-2-(2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(1-cyano-2-(2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-((2,2,2-trifluoroacetyl)- Leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(2-氧代吡咯啶-3-基)乙基)-2-(3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(1-cyano-2-(2-oxopyrrolidin-3-yl)ethyl)-2-(3-cyclobutyl-2-(2,2,2-trifluoroacetamido ) propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
2-(2-氯-9-羥基-9H-茀-9-羰基)-N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N- (1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-5,5- Difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( S )-1-cyano-2-((S)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-2-chloro-9-hydroxyl-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-2-Chloro-9-hydroxyl-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-2-chloro-9-hydroxyl-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-2-chloro-9-hydroxyl-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-2-chloro-9-hydroxyl-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-2-chloro-9-hydroxyl-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo [2.2.2] Octane-3-formamide;
(S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-methoxy-1H-ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-methoxy-1H-ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-methoxy-1H-ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-methoxy-1H-ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-methoxy-1H-ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-methoxy-1H-ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-methoxy-1H-ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-methoxy-1H-ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氟基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-fluoro-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
2-(2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl Base)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-2-((3-Chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-2-((3-Chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-2-(3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-2-(3-cyclopropyl-2-((5-methylpyridin-3-yl)amine Base) propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl)-propanylamino)-5,5-difluoro -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
2-((5-氯吡啶-3-基)-丙胺醯)-N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-((5-chloropyridin-3-yl)-propanylamino)-N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-5,5-difluoro -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((5-氯吡啶-3-基)-D-丙胺醯)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((5-Chloropyridin-3-yl)-D-propanylamino)-N-((S)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((5-氯吡啶-3-基)-D-丙胺醯)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((5-Chloropyridin-3-yl)-D-propanylamino)-N-((S)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((5-氯吡啶-3-基)-D-丙胺醯)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((5-Chloropyridin-3-yl)-D-propanylamino)-N-((R)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((5-氯吡啶-3-基)-D-丙胺醯)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((5-Chloropyridin-3-yl)-D-propanylamino)-N-((R)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((5-氯吡啶-3-基)-L-丙胺醯)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((5-Chloropyridin-3-yl)-L-propanylamino)-N-((S)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((5-氯吡啶-3-基)-L-丙胺醯)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((5-Chloropyridin-3-yl)-L-propanylamino)-N-((S)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((5-氯吡啶-3-基)-L-丙胺醯)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((5-Chloropyridin-3-yl)-L-propanylamino)-N-((R)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((5-氯吡啶-3-基)-L-丙胺醯)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((5-Chloropyridin-3-yl)-L-propanylamino)-N-((R)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((5-氯吡啶-3-基)-D-丙胺醯)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((5-Chloropyridin-3-yl)-D-propanylamino)-N-((S)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((5-氯吡啶-3-基)-D-丙胺醯)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((5-Chloropyridin-3-yl)-D-propanylamino)-N-((S)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((5-氯吡啶-3-基)-D-丙胺醯)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((5-Chloropyridin-3-yl)-D-propanamide)-N-((R)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((5-氯吡啶-3-基)-D-丙胺醯)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((5-Chloropyridin-3-yl)-D-propanamide)-N-((R)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((5-氯吡啶-3-基)-L-丙胺醯)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((5-Chloropyridin-3-yl)-L-propanylamino)-N-((S)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((5-氯吡啶-3-基)-L-丙胺醯)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((5-Chloropyridin-3-yl)-L-propanylamino)-N-((S)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((5-氯吡啶-3-基)-L-丙胺醯)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((5-Chloropyridin-3-yl)-L-propanylamino)-N-((R)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((5-氯吡啶-3-基)-L-丙胺醯)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((5-Chloropyridin-3-yl)-L-propanylamino)-N-((R)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((5-氯吡啶-3-基)-D-丙胺醯)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((5-Chloropyridin-3-yl)-D-propanylamino)-N-((S)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((5-氯吡啶-3-基)-D-丙胺醯)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((5-Chloropyridin-3-yl)-D-propanylamino)-N-((S)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((5-氯吡啶-3-基)-D-丙胺醯)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((5-Chloropyridin-3-yl)-D-propanylamino)-N-((R)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((5-氯吡啶-3-基)-D-丙胺醯)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((5-Chloropyridin-3-yl)-D-propanamide)-N-((R)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((5-氯吸啶-3-基)-L-丙胺醯)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((5-Chloropyridin-3-yl)-L-propanylamino)-N-((S)-1-cyano-2-((S)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((5-氯吡啶-3-基)-L-丙胺醯)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((5-Chloropyridin-3-yl)-L-propanylamino)-N-((S)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((5-氯吡啶-3-基)-L-丙胺醯)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((5-Chloropyridin-3-yl)-L-propanylamino)-N-((R)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((5-氯吡啶-3-基)-L-丙胺醯)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((5-Chloropyridin-3-yl)-L-propanylamino)-N-((R)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((5-氯吡啶-3-基)-D-丙胺醯)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((5-Chloropyridin-3-yl)-D-propanylamino)-N-((S)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((5-氯吡啶-3-基)-D-丙胺醯)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((5-Chloropyridin-3-yl)-D-propanylamino)-N-((S)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((5-氯吡啶-3-基)-D-丙胺醯)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((5-Chloropyridin-3-yl)-D-propanamide)-N-((R)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((5-氯吡啶-3-基)-D-丙胺醯)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((5-Chloropyridin-3-yl)-D-propanylamino)-N-((R)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((5-氯吡啶-3-基)-L-丙胺醯)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((5-Chloropyridin-3-yl)-L-propanamide)-N-((S)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((5-氯吡啶-3-基)-L-丙胺醯)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((5-Chloropyridin-3-yl)-L-propanylamino)-N-((S)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((5-氯吡啶-3-基)-L-丙胺醯)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((5-chloropyridin-3-yl)-L-propanylamino)-N-((R)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((5-氯吡啶-3-基)-L-丙胺醯)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((5-Chloropyridin-3-yl)-L-propanylamino)-N-((R)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
2-((3-氯苯基)-丙胺醯)-N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-((3-Chlorophenyl)-propanylamino)-N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2- Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-丙胺醯)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-propanylamino)-N-((S)-1-cyano-2-((S)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-丙胺醯)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-propanylamino)-N-((S)-1-cyano-2-((R)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-丙胺醯)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-propanylamino)-N-((R)-1-cyano-2-((S)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-丙胺醯)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-propanylamino)-N-((R)-1-cyano-2-((R)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-丙胺醯)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-propanylamino)-N-((S)-1-cyano-2-((S)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-丙胺醯)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-propanylamino)-N-((S)-1-cyano-2-((R)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-丙胺醯)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-propanylamino)-N-((R)-1-cyano-2-((S)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-丙胺醯)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-propanylamino)-N-((R)-1-cyano-2-((R)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-丙胺醯)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-propanylamino)-N-((S)-1-cyano-2-((S)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-丙胺醯)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-propanylamino)-N-((S)-1-cyano-2-((R)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-丙胺醯)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-propanylamino)-N-((R)-1-cyano-2-((S)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-丙胺醯)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-propanylamino)-N-((R)-1-cyano-2-((R)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-丙胺醯)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-propanylamino)-N-((S)-1-cyano-2-((S)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-丙胺醯)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-propanylamino)-N-((S)-1-cyano-2-((R)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-丙胺醯)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-propanylamino)-N-((R)-1-cyano-2-((S)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-丙胺醯)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-propanylamino)-N-((R)-1-cyano-2-((R)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-丙胺醯)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-propanylamino)-N-((S)-1-cyano-2-((S)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-丙胺醯)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-propanylamino)-N-((S)-1-cyano-2-((R)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-丙胺醯)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-propanylamino)-N-((R)-1-cyano-2-((S)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-丙胺醯)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-propanylamino)-N-((R)-1-cyano-2-((R)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-丙胺醯)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-propanylamino)-N-((S)-1-cyano-2-((S)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-丙胺醯)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-propanylamino)-N-((S)-1-cyano-2-((R)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-丙胺醯)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-propanylamino)-N-((R)-1-cyano-2-((S)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-丙胺醯)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-propanylamino)-N-((R)-1-cyano-2-((R)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-丙胺醯)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-propanylamino)-N-((S)-1-cyano-2-((S)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-丙胺醯)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-propanylamino)-N-((S)-1-cyano-2-((R)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-丙胺醯)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-propanylamino)-N-((R)-1-cyano-2-((S)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-丙胺醯)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-propanylamino)-N-((R)-1-cyano-2-((R)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-丙胺醯)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-propanylamino)-N-((S)-1-cyano-2-((S)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-丙胺醯)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-propanylamino)-N-((S)-1-cyano-2-((R)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-丙胺醯)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-propanylamino)-N-((R)-1-cyano-2-((S)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-丙胺醯)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-propanylamino)-N-((R)-1-cyano-2-((R)-2-oxopiperidine -3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-2-(3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-2-(3-cyclopropyl-2-((1-methyl-1H-pyrazole-4 -yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌呢-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperene-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌呢-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopernic-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌呢-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperene-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
2-((3-氯-2-甲基苯基)甘胺醯)-N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-((3-Chloro-2-methylphenyl)glycyl)-N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-5,5- Difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯-2-甲基苯基)甘胺醯)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-N-((S)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯-2-甲基苯基)甘胺醯)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-N-((S)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯-2-甲基苯基)甘胺醯)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-N-((R)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯-2-甲基苯基)甘胺醯)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-N-((R)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯-2-甲基苯基)甘胺醯)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-chloro-2-methylphenyl)glycyl)-N-((S)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯-2-甲基苯基)甘胺醯)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-N-((S)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯-2-甲基苯基)甘胺醯)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-N-((R)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯-2-甲基苯基)甘胺醯)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-N-((R)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯-2-甲基苯基)甘胺醯)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-N-((S)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯-2-甲基苯基)甘胺醯)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-N-((S)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯-2-甲基苯基)甘胺醯)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-N-((R)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯-2-甲基苯基)甘胺醯)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-N-((R)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯-2-甲基苯基)甘胺醯)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-N-((S)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯-2-甲基苯基)甘胺醯)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-N-((S)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯-2-甲基苯基)甘胺醯)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-N-((R)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯-2-甲基苯基)甘胺醯)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-N-((R)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(1-((3-chlorophenyl)amino)cyclopropane-1-carbonyl)-N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)- 5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl)-propanamide)-2-azabicyclo[ 2.2.2] Octane-3-formamide;
(S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanylamino)-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-(2-hydroxy-2-phenylacetyl)-2- Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
2-((3-氯苯基)-白胺醯基)-N-(1-氰基-2-(2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-((3-chlorophenyl)-leucyl)-N-(1-cyano-2-(2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro- 2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(2-氧代吡咯啶-3-基)乙基)-2-(3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(1-cyano-2-(2-oxopyrrolidin-3-yl)ethyl)-2-(3-cyclopropyl-2-((5-methylpyridin-3-yl)amine Base) propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
5,5-二氟-N-(4-氟-4-(甲基磺醯基)-1-(2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 5,5-Difluoro-N-(4-fluoro-4-(methylsulfonyl)-1-(2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2 -(9-Hydroxy-9H-fen-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
N-(4-氟-4-(甲基磺醯基)-1-(2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; N-(4-fluoro-4-(methylsulfonyl)-1-(2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
2-(2-乙醯胺基-2-苯乙醯基)-N-(4-氟-4-(甲基磺醯基)-1-(2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; 2-(2-Acetamido-2-phenylacetyl)-N-(4-fluoro-4-(methylsulfonyl)-1-(2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
2-(3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-(4-氟-4-(甲基磺醯基)-1-(2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; 2-(3,3-Dimethyl-2-(2,2,2-trifluoroacetylamino)butyryl)-N-(4-fluoro-4-(methylsulfonyl)-1-( 2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
2-(3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-(4-氟-4-(甲基磺醯基)-1-(2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; 2-(3,3-Dimethyl-2-(2,2,2-trifluoroacetylamino)butyryl)-N-(4-fluoro-4-(methylsulfonyl)-1-( 2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
2-(3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-(4-氟-4-(甲基磺醯基)-1-(2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; 2-(3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N-(4-fluoro-4-(methylsulfonyl Acyl)-1-(2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; 1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N- ((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)eta Hydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-(4-氟-4-(甲基磺醯基)-1-(2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-(4-fluoro-4-(methylsulfonyl)-1-(2-oxopyrrolidine -3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-(4-氟-4-(甲基磺醯基)-1-(2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-(4-fluoro-4-(methylsulfonyl)-1-(2-oxopyrrolidine -3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-(4-氟-4-(甲基磺醯基)-1-(2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-(4-fluoro-4-(methylsulfonyl)-1-(2-oxo Pyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3S,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3S,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3S,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3S,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3S,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3S,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3S,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3S,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3S,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3S,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3S,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3S,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3S,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3S,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3S,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3R,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3R,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3R,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3R,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3R,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3R,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3R,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3R,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3R,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3R,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3R,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3R,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3R,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-Formamide;
(1R,3R,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-Formamide;
(1R,3R,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3R,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
2-(3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-(4-氟-4-(甲基磺醯基)-1-(2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N-(4-fluoro-4-(methylsulfonyl Acyl)-1-(2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N-((S , E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-nitrogen Heterobicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
4-(2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-(2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; 4-(2-((3-Chlorophenyl)-D-leucylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamido)- Ethyl 2-fluoro-5-(2-oxopyrrolidin-3-yl)pent-2-enoate;
(S,Z)-4-((1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3S,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3S,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3S,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3S,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3S,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3S,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3S,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3S,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3R,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3R,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3R,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3R,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3R,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3R,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3R,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3R,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3S,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3S,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3S,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3S,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3S,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3S,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3S,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3S,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3R,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3R,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3R,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3R,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3R,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3R,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3R,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3R,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3S,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3S,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3S,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3S,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3S,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3S,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3S,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3S,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3R,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3R,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3R,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3R,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3R,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3R,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3R,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3R,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3S,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3S,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3S,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3S,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3S,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3S,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3S,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3S,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3R,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3R,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3R,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3R,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3R,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3R,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3R,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3R,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
4-(2-(3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-(2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; 4-(2-(3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2] Octane-3-formamido)-2-fluoro-5-(2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1S,3S,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3S,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,Z)-4-((1S,3S,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3S,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,Z)-4-((1S,3S,4S)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3S,4S)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,Z)-4-((1S,3S,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3S,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,Z)-4-((1R,3S,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3S,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,Z)-4-((1R,3S,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3S,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,Z)-4-((1R,3S,4R)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3S,4R)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,Z)-4-((1R,3S,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3S,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,Z)-4-((1S,3R,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3R,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,Z)-4-((1S,3R,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3R,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,Z)-4-((1S,3R,4S)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3R,4S)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,Z)-4-((1S,3R,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3R,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,Z)-4-((1R,3R,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3R,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,Z)-4-((1R,3R,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3R,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,Z)-4-((1R,3R,4R)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3R,4R)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,Z)-4-((1R,3R,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3R,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1S,3S,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3S,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1S,3S,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3S,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1S,3S,4S)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3S,4S)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1S,3S,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3S,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1R,3S,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3S,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1R,3S,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3S,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1R,3S,4R)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3S,4R)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1R,3S,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3S,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1S,3R,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3R,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1S,3R,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3R,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1S,3R,4S)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3R,4S)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1S,3R,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3R,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1R,3R,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3R,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1R,3R,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3R,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1R,3R,4R)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3R,4R)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1R,3R,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3R,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1S,3S,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3S,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1S,3S,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3S,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1S,3S,4S)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3S,4S)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1S,3S,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3S,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1R,3S,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3S,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1R,3S,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3S,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1R,3S,4R)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3S,4R)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1R,3S,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3S,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1S,3R,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3R,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1S,3R,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3R,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1S,3R,4S)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3R,4S)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1S,3R,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3R,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1R,3R,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3R,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1R,3R,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3R,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1R,3R,4R)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3R,4R)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1R,3R,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3R,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1S,3S,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3S,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1S,3S,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3S,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1S,3S,4S)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3S,4S)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1S,3S,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3S,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1R,3S,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3S,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1R,3S,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3S,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1R,3S,4R)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3S,4R)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1R,3S,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3S,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1S,3R,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3R,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1S,3R,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3R,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1S,3R,4S)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3R,4S)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1S,3R,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3R,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1R,3R,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3R,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1R,3R,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3R,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1R,3R,4R)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3R,4R)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1R,3R,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3R,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-(4-氟-4-(甲基磺醯基)-1-(2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-(4-fluoro-4-(methylsulfonyl)-1-(2-oxo Pyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3S,4S)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3S,4S)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3S,4S)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3S,4S)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,E)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3S,4S)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,E)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3S,4S)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3S,4S)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3S,4R)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3S,4R)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3S,4R)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3S,4R)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3S,4R)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,E)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3S,4R)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,E)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3S,4R)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3S,4R)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3R,4S)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3R,4S)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3R,4S)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3R,4S)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3R,4S)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,E)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3R,4S)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,E)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3R,4S)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3R,4S)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3R,4R)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3R,4R)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3R,4R)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3R,4R)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3R,4R)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,E)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3R,4R)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,E)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3R,4R)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3R,4R)-2-((3-氯-2-甲基苯基)甘胺醯)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
2-((3-氯苯基)甘胺醯)-5,5-二氟-N-(4-氟-4-(甲基磺醯基)-1-(2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-(4-fluoro-4-(methylsulfonyl)-1-(2-oxopyrrolidine-3 -yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3S,4S)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3S,4S)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3S,4S)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3S,4S)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3S,4S)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3S,4S)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3S,4S)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3S,4R)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3S,4R)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3S,4R)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3S,4R)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3S,4R)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3S,4R)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3S,4R)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3S,4R)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3R,4S)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3R,4S)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3R,4S)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3R,4S)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3R,4S)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3R,4S)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3R,4S)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3R,4S)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3R,4R)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3R,4R)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3R,4R)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3R,4R)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3R,4R)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3R,4R)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3R,4R)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3R,4R)-2-((3-氯苯基)甘胺醯)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
8-(4-氟-1H-吲哚-2-羰基)-N-(4-氟-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; 8-(4-fluoro-1H-indole-2-carbonyl)-N-(4-fluoro-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl )-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
8-(4-氟-1H-吲哚-2-羰基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; 8-(4-fluoro-1H-indole-2-carbonyl)-N-((S)-4-fluoro-3-oxo-1-((S)-2-oxopyrrolidine-3- Base) butane-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(S)-8-(4-氟-1H-吲哚-2-羰基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (S)-8-(4-fluoro-1H-indole-2-carbonyl)-N-((S)-4-fluoro-3-oxo-1-((S)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(S)-8-(4-氟-1H-吲哚-2-羰基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (S)-8-(4-fluoro-1H-indole-2-carbonyl)-N-((S)-4-fluoro-3-oxo-1-((R)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(S)-8-(4-氟-1H-吲哚-2-羰基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (S)-8-(4-fluoro-1H-indole-2-carbonyl)-N-((R)-4-fluoro-3-oxo-1-((S)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(S)-8-(4-氟-1H-吲哚-2-羰基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (S)-8-(4-fluoro-1H-indole-2-carbonyl)-N-((R)-4-fluoro-3-oxo-1-((R)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(R)-8-(4-氟-1H-吲哚-2-羰基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (R)-8-(4-fluoro-1H-indole-2-carbonyl)-N-((S)-4-fluoro-3-oxo-1-((S)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(R)-8-(4-氟-1H-吲哚-2-羰基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (R)-8-(4-fluoro-1H-indole-2-carbonyl)-N-((S)-4-fluoro-3-oxo-1-((R)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(R)-8-(4-氟-1H-吲哚-2-羰基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (R)-8-(4-fluoro-1H-indole-2-carbonyl)-N-((R)-4-fluoro-3-oxo-1-((S)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(R)-8-(4-氟-1H-吲哚-2-羰基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (R)-8-(4-fluoro-1H-indole-2-carbonyl)-N-((R)-4-fluoro-3-oxo-1-((R)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
8-(7-氯-1H-吲哚-2-羰基)-N-(4-氟-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; 8-(7-Chloro-1H-indole-2-carbonyl)-N-(4-fluoro-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl )-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
8-(7-氯-1H-吲哚-2-羰基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; 8-(7-Chloro-1H-indole-2-carbonyl)-N-((S)-4-fluoro-3-oxo-1-((S)-2-oxopyrrolidine-3- Base) butane-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(S)-8-(7-氯-1H-吲哚-2-羰基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (S)-8-(7-chloro-1H-indole-2-carbonyl)-N-((S)-4-fluoro-3-oxo-1-((S)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(S)-8-(7-氯-1H-吲哚-2-羰基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (S)-8-(7-chloro-1H-indole-2-carbonyl)-N-((S)-4-fluoro-3-oxo-1-((R)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(S)-8-(7-氯-1H-吲哚-2-羰基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (S)-8-(7-chloro-1H-indole-2-carbonyl)-N-((R)-4-fluoro-3-oxo-1-((S)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(S)-8-(7-氯-1H-吲哚-2-羰基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (S)-8-(7-chloro-1H-indole-2-carbonyl)-N-((R)-4-fluoro-3-oxo-1-((R)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(R)-8-(7-氯-1H-吲哚-2-羰基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (R)-8-(7-chloro-1H-indole-2-carbonyl)-N-((S)-4-fluoro-3-oxo-1-((S)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(R)-8-(7-氯-1H-吲哚-2-羰基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (R)-8-(7-chloro-1H-indole-2-carbonyl)-N-((S)-4-fluoro-3-oxo-1-((R)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(R)-8-(7-氯-1H-吲哚-2-羰基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (R)-8-(7-chloro-1H-indole-2-carbonyl)-N-((R)-4-fluoro-3-oxo-1-((S)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(R)-8-(7-氯-1H-吲哚-2-羰基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (R)-8-(7-chloro-1H-indole-2-carbonyl)-N-((R)-4-fluoro-3-oxo-1-((R)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-(4-氟-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(2-(3-chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-(4-fluoro-3-oxo-1-(2-oxo Pyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((S)-4-fluoro- 3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3S,4S)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((S)-4-fluoro- 3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3S,4S)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((R)-4-fluoro- 3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3S,4S)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((R)-4-fluoro- 3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3S,4R)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((S)-4-fluoro- 3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3S,4R)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((S)-4-fluoro- 3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3S,4R)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((R)-4-fluoro- 3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3S,4R)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((R)-4-fluoro- 3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3R,4S)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((S)-4-fluoro- 3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3R,4S)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((S)-4-fluoro- 3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3R,4S)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((R)-4-fluoro- 3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3R,4S)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((R)-4-fluoro- 3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3R,4R)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((S)-4-fluoro- 3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3R,4R)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((S)-4-fluoro- 3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3R,4R)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((R)-4-fluoro- 3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3R,4R)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((R)-4-fluoro- 3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-(4-氟-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; 2-(2-(3-chlorophenyl)-2,2-difluoroacetyl)-N-(4-fluoro-3-oxo-1-(2-oxopyrrolidin-3-yl) )butane-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-(4-氟-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; 2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-(4-fluoro-3-oxo-1-(2-oxopyrrolidin-3-yl) )butane-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
2-(2-氟-2-(3-氟苯基)丙醯基)-N-(4-氟-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; 2-(2-Fluoro-2-(3-fluorophenyl)propionyl)-N-(4-fluoro-3-oxo-1-(2-oxopyrrolidin-3-yl)butane -2-yl) octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo-1-(( S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-(1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-(2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-(1-(2-oxodihydrofuran-3(2H)-ylidene)- 3-(2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propane-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1S,3S,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1S,3S,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propane-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1S,3S,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1S,3S,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propane-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1S,3S,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1S,3S,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1S,3S,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3S,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propane-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3S,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3S,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3S,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3S,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propane-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3S,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3S,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propane-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3S,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1S,3R,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1S,3R,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1S,3R,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propane-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1S,3R,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1S,3R,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1S,3R,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1S,3R,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propane-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1S,3R,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3R,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propane-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3R,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3R,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3R,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3R,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3R,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3R,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3R,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
2-(2-溴-9-羥基-9H-茀-9-羰基)-N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-5,5- Difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-2-Bromo-9-hydroxyl-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-2-Bromo-9-hydroxyl-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-2-Bromo-9-hydroxyl-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-2-Bromo-9-hydroxyl-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-2-Bromo-9-hydroxyl-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-2-Bromo-9-hydroxyl-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-2-Bromo-9-hydroxyl-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-2-Bromo-9-hydroxyl-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-2-Bromo-9-hydroxyl-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-2-Bromo-9-hydroxyl-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-2-Bromo-9-hydroxyl-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-2-bromo-9-hydroxyl-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-2-bromo-9-hydroxyl-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-2-(2,7-difluoro-9-hydroxy-9H-fennel-9-carbonyl)-5 ,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-2-(2,7-dichloro-9-hydroxy-9H-fennel-9-carbonyl)-5 ,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-(9-hydroxy-9H-fennel-9-carbonyl)octahydro Cyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-(4-fluoro-1H-indole-2-carbonyl)eta Hydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoromethyl)-6-fluoro-1H-indole-2-carbonyl )-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoromethyl)-7-chloro-1H-indole-2-carbonyl )-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-2-(4,7-difluoro-6-chloro-1H-indole-2-carbonyl)- 5,5-Difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; 2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl) -5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((R )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((R )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((R )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((R )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((R )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((R )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((R )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((R )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-2-(4,6-difluoro-7-chloro-1H-indole-2-carbonyl)- 5,5-Difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6-methyl-7-chloro-1H-indole-2-carbonyl )-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-2-(4,7-difluoro-6-methyl-1H-indole-2-carbonyl) -5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7-difluoromethyl-1H-indole-2-carbonyl)- 5,5-Difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
N-(1-氰基-2-(2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; N-(1-cyano-2-(2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy-1H-indole-2-carbonyl)-5,5-di Fluoroctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2-(9-hydroxy-9H-fennel-9-carbonyl)octahydro Cyclopenta[c]pyrrole-1-carboxamide;
N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2-(9-hydroxyl-9H- Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
N-(1-氰基-2-(2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; N-(1-cyano-2-(2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2-(9-hydroxy-9H-fennel-9-carbonyl)octahydro Cyclopenta[c]pyrrole-1-carboxamide;
N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2-(9-hydroxyl-9H- Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxy-9H-fenflure-9-carbonyl)octahydrocyclopenta[c]pyrrole- 1-formamide;
N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H-fennel-9-carbonyl)octa Hydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺;和 (1R,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide; and
(1R,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺。 (1R,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide.
本揭露內容的化合物可以具有一個或多個立構中心,並且每個立構中心可以以(R)或(S)構型獨立存在。在某些實施方式中,本文所述的化合物以旋光或外消旋形式存在。本文所述的化合物包括具有本文所述的治療有用特性的外消旋、旋光、區域異構和立體異構形式或其組合。旋光形式的製備以任何合適的方式實現,作為非限制性實例,包括通過用重結晶技術外消旋形式的解析、由旋光原材料合成、手性合成或使用手性固定相進行層析分離。本文由外消旋式說明的化合物進一步代表兩種對映異構物或其混合物,或者在存在兩個或更多個手性中心的情況下,代表所有非對映異構物或其混合物。 Compounds of the disclosure may possess one or more stereocenters, and each stereocenter may independently exist in the ( R ) or ( S ) configuration. In certain embodiments, the compounds described herein exist in optically active or racemic forms. The compounds described herein include racemic, optical, regioisomeric and stereoisomeric forms or combinations thereof that possess the therapeutically useful properties described herein. Preparation of optically active forms is achieved in any suitable manner including, by way of non-limiting examples, resolution of racemic forms using recrystallization techniques, synthesis from optically active starting materials, chiral synthesis or chromatographic separation using chiral stationary phases. Compounds described herein by racemic formula further represent both enantiomers or mixtures thereof, or where two or more chiral centers are present, all diastereomers or mixtures thereof.
在某些實施方式中,本揭露內容的化合物以互變異構物存在。所有互變異構物均包括在本文所述的化合物的範圍內。 In certain embodiments, compounds of the disclosure exist as tautomers. All tautomers are included within the scope of the compounds described herein.
本文所述的化合物還包括同位素標記的化合物,其中一個或多個原子被具有相同原子序數但原子質量或原子質量數不同於通常在自然界發現的原子質量或原子質量數的原子替代。適於包含在本文所述的化合物中的同位素的實例包括但不限於2H、3H、11C、13C、14C、36Cl、18F、123I、125I、13N、15N、15O、17O、18O、32P和35S。在某些 實施方式中,用較重的同位素比如氘取代提供更高的化學穩定性。可通過任何合適的方法或使用合適的同位素標記的試劑代替否則採用未標記的試劑的方法製備同位素標記的化合物。 Compounds described herein also include isotopically labeled compounds in which one or more atoms are replaced by atoms having the same atomic number but an atomic mass or atomic mass number different from that normally found in nature. Examples of isotopes suitable for inclusion in the compounds described herein include, but are not limited to , 2H , 3H , 11C , 13C , 14C , 36Cl, 18F , 123I , 125I , 13N , 15N , 15 O, 17 O, 18 O, 32 P and 35 S. In certain embodiments, substitution with heavier isotopes such as deuterium provides greater chemical stability. Isotopically labeled compounds may be prepared by any suitable method or method using a suitable isotopically labeled reagent instead of an otherwise unlabeled reagent.
在某些實施方式中,本文所述的化合物通過其他方式標記,包括但不限於使用發色團或熒光部分、生物發光標記或化學發光標記。 In certain embodiments, the compounds described herein are labeled by other means including, but not limited to, the use of chromophores or fluorescent moieties, bioluminescent labels, or chemiluminescent labels.
在本文提供的所有實施方式中,合適可選擇的取代基的實例不旨在限制要求保護的發明的範圍。本揭露內容的化合物可以包含本文提供的任何取代基或取代基的組合。 In all of the embodiments provided herein, examples of suitable optional substituents are not intended to limit the scope of the claimed invention. Compounds of the disclosure may contain any substituent or combination of substituents provided herein.
鹽Salt
本文所述的化合物可與酸或堿形成鹽,並且這種鹽包括在本揭露內容中。術語「鹽」包括在本揭露內容的方法中有用的游離酸或堿的加成鹽。術語「醫藥上可接受的鹽」是指具有在藥學應用中有用的範圍內的毒性特徵的鹽。在某些實施方式中,鹽是醫藥上可接受的鹽。然而,醫藥上不可接受的鹽可以具有比如高結晶度的性質,其在本揭露內容的實踐中具有實用性,諸如例如在本揭露內容的方法中有用的化合物的合成、純化或配製過程中的實用性。 The compounds described herein may form salts with acids or alkalis, and such salts are included in this disclosure. The term "salt" includes free acid or alkali addition salts useful in the methods of the present disclosure. The term "pharmaceutically acceptable salt" refers to a salt having a toxicity profile within the range useful in pharmaceutical use. In certain embodiments, the salt is a pharmaceutically acceptable salt. However, pharmaceutically unacceptable salts may have properties such as high crystallinity, which have utility in the practice of the present disclosure, such as, for example, during the synthesis, purification, or formulation of compounds useful in the methods of the present disclosure. practicality.
合適的醫藥上可接受的酸加成鹽可以由無機酸或有機酸製備。無機酸的實例包括硫酸鹽、硫酸氫鹽(hydrogen sulfate)、鹽酸、氫溴酸、氫碘酸、硝酸、碳酸、硫酸和磷酸(包括磷酸氫鹽和磷酸二氫鹽)。合適的有機酸可以選自脂族、脂環族、芳族、芳脂族、雜環、羧酸和磺酸類的有機酸,其實例包括甲酸、乙酸、丙酸、琥珀酸、乙醇酸、葡糖酸、乳酸、蘋果酸、酒石酸、檸檬酸、抗壞血酸、葡糖醛酸、馬來酸、富馬酸、丙酮酸、天冬胺酸、谷胺酸、苯甲酸、鄰胺基苯甲酸、4-羥基苯甲酸、苯乙酸、扁桃酸、撲酸(或帕莫酸)、甲磺酸、乙磺酸、苯磺酸、泛酸、磺胺酸、2-羥基乙磺酸、三氟甲磺酸、對甲苯磺酸、環己基胺基磺酸、硬脂酸、海藻酸、β-羥基丁酸、水楊酸、半乳糖二酸、半 乳糖醛酸、甘油膦酸和糖精(例如,糖精鹽(saccharinate)、糖酸鹽(saccharate))。相對於本揭露內容的任何化合物,鹽可以由1摩爾當量、1或多於1摩爾當量的酸或堿的部分組成。 Suitable pharmaceutically acceptable acid addition salts can be prepared from inorganic or organic acids. Examples of the inorganic acid include sulfate, hydrogen sulfate, hydrochloric acid, hydrobromic acid, hydroiodic acid, nitric acid, carbonic acid, sulfuric acid, and phosphoric acid (including hydrogen phosphate and dihydrogen phosphate). Suitable organic acids may be selected from aliphatic, cycloaliphatic, aromatic, araliphatic, heterocyclic, carboxylic and sulfonic acids, examples of which include formic acid, acetic acid, propionic acid, succinic acid, glycolic acid, glucose Sugar acid, lactic acid, malic acid, tartaric acid, citric acid, ascorbic acid, glucuronic acid, maleic acid, fumaric acid, pyruvic acid, aspartic acid, glutamic acid, benzoic acid, anthranilic acid, 4 -Hydroxybenzoic acid, phenylacetic acid, mandelic acid, pamoic acid (or pamoic acid), methanesulfonic acid, ethanesulfonic acid, benzenesulfonic acid, pantothenic acid, sulfanilic acid, 2-hydroxyethanesulfonic acid, trifluoromethanesulfonic acid, p-toluenesulfonic acid, cyclamate, stearic acid, alginic acid, β-hydroxybutyric acid, salicylic acid, galactaric acid, semi Lacturonic acid, glycerylphosphonic acid, and saccharin (eg, saccharinate, saccharate). A salt may consist of 1, 1, or more than 1 molar equivalent of the acid or alkali moiety relative to any compound of the disclosure.
本揭露內容的化合物的合適的醫藥上可接受的堿加成鹽包括例如銨鹽和金屬鹽,包括鹼金屬、鹼土金屬和過渡金屬鹽,諸如例如鈣、鎂、鉀、鈉和鋅鹽。醫藥上可接受的堿加成鹽還包括由鹼性胺諸如例如N,N’-二苄基乙二胺、氯普魯卡因、膽鹼、二乙醇胺、乙二胺、葡甲胺(或N-甲葡糖胺)和普魯卡因製備的有機鹽。所有這些鹽可以通過例如使合適的酸或堿與化合物反應而由相應的化合物製備。 Suitable pharmaceutically acceptable alkali addition salts of the compounds of the disclosure include, for example, ammonium salts and metal salts, including alkali metal, alkaline earth metal and transition metal salts, such as, for example, calcium, magnesium, potassium, sodium and zinc salts. Pharmaceutically acceptable alkali addition salts also include those formed from basic amines such as, for example, N , N' -dibenzylethylenediamine, chloroprocaine, choline, diethanolamine, ethylenediamine, meglumine (or N -methylglucamine) and organic salts prepared from procaine. All these salts can be prepared from the corresponding compounds by, for example, reacting the appropriate acid or alkali with the compound.
聯合治療combination therapy
在一個方面,本揭露內容的化合物與用於治療冠狀病毒感染的一種或多種另外的試劑組合用於本揭露內容的方法中。這些另外的試劑可以包括本文鑒定的化合物或組成物,或已知用於治療、預防或減輕冠狀病毒感染的症狀的化合物(例如,商業上可獲得的化合物)。 In one aspect, a compound of the disclosure is used in a method of the disclosure in combination with one or more additional agents for treating a coronavirus infection. These additional agents may include compounds or compositions identified herein, or compounds (eg, commercially available compounds) known to be useful in treating, preventing, or alleviating the symptoms of coronavirus infection.
合成synthesis
本揭露內容進一步提供製備本揭露內容的化合物的方法。本教導的化合物可以通過使用本領域技術人員已知的標準合成方法和程序,根據本文概述的程序,由商業上可獲得的起始原料、文獻中已知的化合物或容易製備的中間體製備。可從相關的科學文獻或本領域的標準教科書中容易地獲得用於製備有機分子以及官能團轉化和操縱的標準合成方法和程序。 The present disclosure further provides methods of preparing the compounds of the present disclosure. Compounds of the present teachings can be prepared from commercially available starting materials, compounds known in the literature, or readily prepared intermediates by using standard synthetic methods and procedures known to those skilled in the art according to the procedures outlined herein. Standard synthetic methods and procedures for the preparation of organic molecules and functional group transformations and manipulations are readily available from the relevant scientific literature or standard textbooks in the field.
應當理解,除非另有說明,在給出典型的或優選的工藝條件(即反應溫度、時間、反應物的摩爾比、溶劑、壓力等)的情況下,也可以使用其他工藝條件。最佳反應條件可以隨所使用的特定反應物或溶劑而變化,但是這種條件可以由本領域技術人員通過常規優化程序來確 定。有機合成領域的技術人員將認識到,出於優化本文所述化合物的形成的目的,可以改變所呈現的合成步驟的性質和順序。 It should be understood that where typical or preferred process conditions (ie, reaction temperatures, times, molar ratios of reactants, solvents, pressures, etc.) are given, other process conditions can also be used unless otherwise stated. Optimum reaction conditions may vary with the particular reactants or solvent used, but such conditions can be determined by one skilled in the art by routine optimization procedures. Certainly. Those skilled in the art of organic synthesis will recognize that the nature and order of the synthetic steps presented can be varied for the purpose of optimizing the formation of the compounds described herein.
可以根據本領域中已知的任何合適的方法來監測本文描述的過程。例如,產物形成可以通過光譜方法(spectroscopic means),比如核磁共振光譜法(例如,1H或13C)、紅外光譜法、分光光度法(例如紫外可見)、質譜法,或通過層析法比如高壓液相層析法(HPLC)、氣相層析法(GC)、凝膠滲透層析發的(GPC)或薄層層析法(TLC)來監測。 The processes described herein can be monitored according to any suitable method known in the art. For example, product formation can be by spectroscopic means, such as nuclear magnetic resonance spectroscopy (e.g., 1 H or 13 C), infrared spectroscopy, spectrophotometry (e.g., UV-visible), mass spectrometry, or by chromatographic methods such as High pressure liquid chromatography (HPLC), gas chromatography (GC), gel permeation chromatography (GPC) or thin layer chromatography (TLC) to monitor.
化合物的製備可以涉及各種化學基團的保護和脫保護。保護和脫保護的需要以及合適保護基團的選擇可以由本領域技術人員容易地確定。保護基團的化學性質可以在例如Greene等人,Protective Groups in Organic Synthesis,第2版(Wiley & Sons,1991)中找到,出於所有目的通過引用將其全部公開內容併入本文。 Preparation of compounds may involve protection and deprotection of various chemical groups. The need for protection and deprotection and the selection of suitable protecting groups can be readily determined by those skilled in the art. The chemistry of protecting groups can be found, for example, in Greene et al., Protective Groups in Organic Synthesis, 2nd Ed. (Wiley & Sons, 1991), the entire disclosure of which is incorporated herein by reference for all purposes.
本文所述的反應或方法可以在有機合成領域的技術人員可以容易選擇的合適溶劑中進行。在進行反應的溫度下,即在溶劑的冷凍溫度至溶劑的沸騰溫度的範圍內的溫度下,合適的溶劑通常與反應物、中間體和/或產物基本上不反應。給定的反應可以在一種溶劑或多於一種溶劑的混合物中進行。取決於特定的反應步驟,可以選擇用於特定反應步驟的合適溶劑。 The reactions or methods described herein can be carried out in suitable solvents which can be readily selected by those skilled in the art of organic synthesis. Suitable solvents are generally substantially nonreactive with the reactants, intermediates and/or products at the temperatures at which the reactions are carried out, ie, temperatures ranging from the solvent's freezing temperature to the solvent's boiling temperature. A given reaction can be carried out in one solvent or a mixture of more than one solvent. Depending on the particular reaction step, a suitable solvent for a particular reaction step can be selected.
例如,可以根據方案1-21中概述的合成方法來製備式(I)的化合物,其中R、R’和R”的每次出現獨立地選自H、可選擇地取代的C1-C6烷基、可選擇地取代的C1-C6環烷基、可選擇地取代的苯基、可選擇地取代的苄基和可選擇地取代的C2-C9雜環基;Ar選自可選擇地取代的C2-C9雜芳基、可選擇地取代的苯基和可選擇地取代的萘基;A1是CRa2或N;A2是CRa3或N;A3是CRa6或N;A4是CRa7或N;T是選自Cl、Br、OMs的離去基團;G1和G2在R1的範圍內定義;n是選自0、1和2的整數;並且其中所有其他取代基都在本揭露內容的範圍內定義。 For example, compounds of formula (I), wherein each occurrence of R, R' and R" are independently selected from H, optionally substituted C 1 -C 6 , can be prepared according to the synthetic methods outlined in Schemes 1-21 Alkyl, optionally substituted C 1 -C 6 cycloalkyl, optionally substituted phenyl, optionally substituted benzyl and optionally substituted C 2 -C 9 heterocyclyl; Ar is selected from Optionally substituted C 2 -C 9 heteroaryl, optionally substituted phenyl and optionally substituted naphthyl; A 1 is CR a2 or N; A 2 is CR a3 or N; A 3 is CR a6 or N; A4 is CR a7 or N; T is a leaving group selected from Cl, Br, OMs; G1 and G2 are defined within the range of R1 ; n is selected from 0, 1 and 2 integer; and where all other substituents are defined within the scope of this disclosure.
方法method
本文中描述的化合物可有效地用於治療、預防和/或改善由一種或多種冠狀病毒(非限制性示例包括α冠狀病毒、β冠狀病毒、γ冠狀病毒和δ冠狀病毒)引起的感染。 The compounds described herein are useful for treating, preventing and/or ameliorating infections caused by one or more coronaviruses (non-limiting examples include alphacoronaviruses, betacoronaviruses, gammacoronaviruses, and deltacoronaviruses).
在某些實施方式中,α冠狀病毒包括但不限於α冠狀病毒1(例如,可傳播的胃腸炎病毒(TGEV)、貓冠狀病毒(FCoV)和犬冠狀病毒(CCoV)、人類冠狀病毒229E(HCoV-229E)、人類冠狀病毒NL63(HCoV-NL63)、長翼蝠冠狀病毒1、長翼蝠冠狀病毒HKU8、豬流行性腹瀉病毒(PEDV)、豬急性腹瀉綜合征冠狀病毒(SADS-CoV)、菊頭蝠冠狀病毒HKU2和黃蝠冠狀病毒512。 In certain embodiments, alphacoronaviruses include, but are not limited to, alphacoronaviruses 1 (e.g., transmissible gastroenteritis virus (TGEV), feline coronavirus (FCoV), and canine coronavirus (CCoV), human coronavirus 229E ( HCoV-229E), human coronavirus NL63 (HCoV-NL63), long-winged bat coronavirus 1, long-winged bat coronavirus HKU8, porcine epidemic diarrhea virus (PEDV), porcine acute diarrhea syndrome coronavirus (SADS-CoV) , Chrysanthemum bat coronavirus HKU2 and yellow bat coronavirus 512.
在某些實施方式中,β冠狀病毒包括但不限於β冠狀病毒1(例如,牛冠狀病毒和人類冠狀病毒OC43(HCoV-OC43))、刺蝟冠狀病毒1、人類冠狀病毒HKU1(HCoV-HKU1)、中東呼吸綜合征相關的冠狀病毒(MERS-CoV)、鼠冠狀病毒(M-CoV)、伏翼蝠冠狀病毒HKU5、果蝠冠狀病毒HKU9(HKU9-1)、嚴重急性呼吸綜合征相關的冠狀病毒1(SARS-CoV或SARS-CoV-1)、嚴重急性呼吸綜合征相關的冠狀病毒2(SARS-CoV-2)和扁顱蝠冠狀病毒HKU4。 In certain embodiments, betacoronaviruses include, but are not limited to, betacoronavirus 1 (e.g., bovine coronavirus and human coronavirus OC43 (HCoV-OC43)), hedgehog coronavirus 1, human coronavirus HKU1 (HCoV-HKU1) , Middle East Respiratory Syndrome-associated coronavirus (MERS-CoV), Murine coronavirus (M-CoV), Pteropus bat coronavirus HKU5, Fruit bat coronavirus HKU9 (HKU9-1), Severe acute respiratory syndrome-associated coronavirus Virus 1 (SARS-CoV or SARS-CoV-1), severe acute respiratory syndrome-associated coronavirus 2 (SARS-CoV-2), and bat coronavirus HKU4.
在某些實施方式中,γ冠狀病毒包括但不限於禽冠狀病毒和白鯨冠狀病毒SW1。 In certain embodiments, gamma coronaviruses include, but are not limited to, avian coronaviruses and beluga coronaviruses SW1.
在某些實施方式中,δ冠狀病毒包括但不限於白頭翁冠狀病毒(Bulbul coronavirus)HKU11和豬冠狀病毒HKU15。 In certain embodiments, deltacoronaviruses include, but are not limited to, Bulbul coronavirus HKU11 and porcine coronavirus HKU15.
在某些實施方式中,本揭露內容的化合物對SARS-CoV-2、SARS-CoV、MERS-CoV、HCoV-OC43、HCoV-229E、HCoV-HKU1和HCoV-NL63中的一種或多種具有活性。 In certain embodiments, compounds of the disclosure are active against one or more of SARS-CoV-2, SARS-CoV, MERS-CoV, HCoV-OC43, HCoV-229E, HCoV-HKU1, and HCoV-NL63.
在一個方面中,本揭露內容提供一種治療、改善或預防受試者中的冠狀病毒感染的方法,該方法包括向所述受試者施用治療有效量的至少一種本揭露內容的化合物和/或至少一種本揭露內容的醫藥組成物。 In one aspect, the present disclosure provides a method of treating, ameliorating or preventing a coronavirus infection in a subject, the method comprising administering to the subject a therapeutically effective amount of at least one compound of the present disclosure and/or At least one pharmaceutical composition of the present disclosure.
在某些實施方式中,向受試者進一步施用用於治療、改善或預防冠狀病毒感染的至少一種另外的藥劑。在某些實施方式中,向受試者共同施用至少一種化合物和/或組成物和至少一種另外的藥劑。在某些實施方式中,至少一種另外的藥劑是RNA-依賴性RNA聚合酶(RdRp)(即,nsp12)的抑制劑或其前藥。在某些實施方式中,至少一種化合物和/或組成物和至少一種另外的藥劑是共同配製的。 In certain embodiments, at least one additional agent for treating, ameliorating or preventing coronavirus infection is further administered to the subject. In certain embodiments, at least one compound and/or composition and at least one additional agent are co-administered to a subject. In certain embodiments, at least one additional agent is an inhibitor of RNA-dependent RNA polymerase (RdRp) (ie, nspl2) or a prodrug thereof. In certain embodiments, at least one compound and/or composition and at least one additional agent are co-formulated.
在某些實施方式中,冠狀病毒選自α冠狀病毒和β冠狀病毒。 In certain embodiments, the coronavirus is selected from alphacoronaviruses and betacoronaviruses.
在某些實施方式中,α冠狀病毒是人類冠狀病毒229E(HCoV-229E)。在某些實施方式中,α冠狀病毒是人類冠狀病毒NL63(HCoV-NL63)。 In certain embodiments, the alphacoronavirus is human coronavirus 229E (HCoV-229E). In certain embodiments, the alphacoronavirus is human coronavirus NL63 (HCoV-NL63).
在某些實施方式中,β冠狀病毒是嚴重急性呼吸綜合征相關的冠狀病毒2(SARS-CoV-2)。在某些實施方式中,β冠狀病毒是嚴重急性呼吸綜合征相關的冠狀病毒1(SARS-CoV或SARS-CoV-1)。在某些實施方式中,β冠狀病毒是中東呼吸綜合征相關的冠狀病毒(MERS-CoV)。在某些實施方式中,β冠狀病毒是人類冠狀病毒OC43(HCoV-OC43)。在某些實施方式中,β冠狀病毒是人類冠狀病毒HKU1(HCoV-HKU1)。 In certain embodiments, the betacoronavirus is severe acute respiratory syndrome-associated coronavirus 2 (SARS-CoV-2). In certain embodiments, the betacoronavirus is severe acute respiratory syndrome-associated coronavirus 1 (SARS-CoV or SARS-CoV-1). In certain embodiments, the betacoronavirus is Middle East Respiratory Syndrome-related coronavirus (MERS-CoV). In certain embodiments, the betacoronavirus is human coronavirus OC43 (HCoV-OC43). In certain embodiments, the betacoronavirus is human coronavirus HKU1 (HCoV-HKU1).
在某些實施方式中,冠狀病毒主蛋白酶(Mpro)被抑制。在某些實施方式中,Mpro是3C-樣蛋白酶(3CLpro)。 In certain embodiments, the coronavirus major protease (M pro ) is inhibited. In certain embodiments, M pro is a 3C-like protease (3CL pro ).
在某些實施方式中,受試者是哺乳動物。在某些實施方式中,哺乳動物是人類。 In certain embodiments, the subject is a mammal. In certain embodiments, the mammal is a human.
醫藥組成物和調配物Pharmaceutical compositions and formulations
本揭露內容提供包括至少一種本揭露內容的化合物或其鹽或溶劑合物的醫藥組成物,其用於實踐本揭露內容的方法。這樣的醫藥組成物可由適合施用至受試者的形式的至少一種本揭露內容的化合物或鹽或溶劑合物組成,或醫藥組成物可以包括至少一種本揭露內容的化合物或其鹽或溶劑合物以及一種或多種醫藥上可接受的載劑、一種或多種另外的成分或這些的一些組合。如本領域眾所周知的,至少一種本揭露內容的化合物可以以生理學上可接受的鹽的形式,比如與生理學上可接受的陽離子或陰離子組合存在於醫藥組成物中。 The present disclosure provides pharmaceutical compositions comprising at least one compound of the present disclosure, or a salt or solvate thereof, for use in practicing the methods of the present disclosure. Such a pharmaceutical composition may consist of at least one compound of the present disclosure or a salt or solvate thereof in a form suitable for administration to a subject, or the pharmaceutical composition may comprise at least one compound of the present disclosure or a salt or solvate thereof and one or more pharmaceutically acceptable carriers, one or more additional ingredients, or some combination of these. As is well known in the art, at least one compound of the present disclosure may be present in a pharmaceutical composition in the form of a physiologically acceptable salt, such as in combination with a physiologically acceptable cation or anion.
在某些實施方式中,可以施用用於實踐本揭露內容的方法的醫藥組成物以遞送在1ng/kg/天和100mg/kg/天之間的劑量。在其他實施方式中,可以施用用於實踐本揭露內容的醫藥組成物以遞送在1ng/kg/天和1,000mg/kg/天之間的劑量。 In certain embodiments, a pharmaceutical composition for practicing the methods of the present disclosure can be administered to deliver a dose of between 1 ng/kg/day and 100 mg/kg/day. In other embodiments, the pharmaceutical compositions used to practice the present disclosure can be administered to deliver doses of between 1 ng/kg/day and 1,000 mg/kg/day.
本揭露內容的醫藥組成物中的活性成分、醫藥上可接受的載劑和任何另外的成分的相對量將變化,這取決於所治療的受試者的身份、體型(size)和病症,並且進一步取決於該組成物被施用的途徑。舉例來說,組成物可以包括在0.1%至100%(w/w)之間的活性成分。 The relative amounts of the active ingredient, the pharmaceutically acceptable carrier, and any additional ingredients in the pharmaceutical compositions of the present disclosure will vary depending on the identity, size and condition of the subject being treated, and It further depends on the route by which the composition is administered. For example, the composition may comprise between 0.1% and 100% (w/w) active ingredient.
用於本揭露內容的方法中的醫藥組成物可以適當地開發用於經鼻、吸入、口服、直腸、陰道、胸膜、腹膜、腸胃外、局部、經皮、經肺、鼻內、含服、眼內、硬膜外、鞘內、靜脈內或另一施用途徑。可以將在本揭露內容的方法中使用的組成物直接施用至哺乳動物或鳥類的中樞神經系統的大腦、腦幹或任何其他部分。其他考慮的調配物包括設計(project)的納米顆粒、微球、脂質體製劑、包被的顆粒、聚合物綴合物、含有活性成分的重新密封的紅細胞以及基於免疫學的調配物。 Pharmaceutical compositions for use in the methods of the present disclosure may be suitably developed for nasal, inhalational, oral, rectal, vaginal, pleural, peritoneal, parenteral, topical, transdermal, pulmonary, intranasal, buccal, Intraocular, epidural, intrathecal, intravenous or another route of administration. The compositions used in the methods of the present disclosure may be administered directly to the cerebrum, brainstem, or any other part of the central nervous system of a mammal or bird. Other contemplated formulations include projected nanoparticles, microspheres, liposomal formulations, coated particles, polymer conjugates, resealed erythrocytes containing the active ingredient, and immunology-based formulations.
在某些實施方式中,本揭露內容的組成物是藥物基質的一部分,其允許處理不溶性材料並改善其生物利用度、開發控釋或緩釋產品以及產生均質組成物。舉例來說,可以使用熱熔擠出、固溶體、固體分散體、尺寸減小技術、分子複合物(例如,環糊精等)、微粒以及顆粒和調配物包衣方法來製備藥物基質。非晶相或結晶相可用於這種工藝中。 In certain embodiments, compositions of the present disclosure are part of a pharmaceutical matrix, which allows for the manipulation and improvement of bioavailability of insoluble materials, the development of controlled or sustained release products, and the creation of homogeneous compositions. For example, hot melt extrusion, solid solutions, solid dispersions, size reduction techniques, molecular complexes (eg, cyclodextrins, etc.), microparticles, and granule and formulation coating methods can be used to prepare drug matrices. Amorphous or crystalline phases can be used in this process.
施用途徑(一種或多種)對技術人員來說是顯而易見的,並且將取決於許多因素,包括所治療的疾病的類型和嚴重程度、所治療的獸醫或人類患者的類型和年齡等。 The route(s) of administration will be apparent to the skilled artisan and will depend on many factors including the type and severity of the disease being treated, the type and age of the veterinary or human patient being treated, and the like.
本文描述的醫藥組成物的調配物可以通過藥理學和製藥學領域中已知的或以後開發的任何方法來製備。通常,這種製備方法包括以下步驟:使活性成分與載劑或一種或多種其他輔助成分結合,並且然後,如果必要或期望,將產品成型或包裝成所需的單劑量或多劑量單位。 Formulations of the pharmaceutical compositions described herein can be prepared by any method known or later developed in the art of pharmacology and pharmacy. In general, such methods of preparation include the steps of bringing into association the active ingredient with the carrier or one or more other accessory ingredients, and then, if necessary or desired, shaping or packaging the product in the desired unit-dose or multi-dose unit.
如本文所使用的,「單位劑量」是包括預定量的活性成分的離散量的醫藥組成物。活性成分的量通常等於將被施用至受試者的活 性成分的劑量或這樣的劑量的方便部分,諸如例如這樣的劑量的一半或三分之一。單位劑型可以是單次日劑量或多次日劑量之一(例如,每天約1-4次或更多次)。當使用多次日劑量時,每次給藥的單位劑型可以相同或不同。 As used herein, a "unit dose" is a discrete quantity of pharmaceutical composition comprising a predetermined quantity of active ingredient. The amount of active ingredient is usually equal to the active ingredient to be administered to the subject. A dose of the sexual ingredient or a convenient fraction of such a dose, such as, for example, half or a third of such a dose. The unit dosage form can be a single daily dose or one of multiple daily doses (eg, about 1-4 or more times per day). When multiple daily doses are used, the unit dosage form may be the same or different for each administration.
儘管本文提供的醫藥組成物的描述主要針對適合於對人類進行倫理施用的醫藥組成物,但是技術人員將理解,這種組成物通常適合於施用至各種動物。為了使組成物適合於向各種動物施用,適合於向人施用的醫藥組成物的改進是眾所周知的,並且普通技術的獸醫藥理師可以僅通過普通的實驗來設計和進行這種改進。預期向其施用本揭露內容的醫藥組成物的受試者包括但不限於人類和其他靈長類動物,哺乳動物,包括與商業相關的哺乳動物,比如牛、豬、馬、綿羊、貓和狗。 Although the description of pharmaceutical compositions provided herein is primarily directed to pharmaceutical compositions suitable for ethical administration to humans, the skilled artisan will appreciate that such compositions are generally suitable for administration to various animals. Modifications of pharmaceutical compositions suitable for human administration in order to make compositions suitable for administration to various animals are well known and can be devised and performed by a veterinary pharmacologist of ordinary skill only by ordinary experimentation. Subjects to which the pharmaceutical compositions of the disclosure are contemplated include, but are not limited to, humans and other primates, mammals, including commercially relevant mammals such as cattle, pigs, horses, sheep, cats, and dogs .
在某些實施方式中,使用一種或多種醫藥上可接受的賦形劑或載劑配製本揭露內容的組成物。在某些實施方式中,本揭露內容的醫藥組成物包括治療有效量的至少一種本揭露內容的化合物和醫藥上可接受的載劑。有用的醫藥上可接受的載劑包括但不限於甘油、水、鹽水、乙醇、重組人類白蛋白(例如,Recombumin®)、可溶凝膠(例如,Gelofusine®)和其他醫藥上可接受的鹽溶液,比如磷酸鹽和有機酸的鹽。在Remington’s Pharmaceutical Sciences(1991,Mack Publication Co.,New Jersey)中描述了這些和其他醫藥上可接受的載劑的實例。 In certain embodiments, compositions of the present disclosure are formulated using one or more pharmaceutically acceptable excipients or carriers. In certain embodiments, pharmaceutical compositions of the present disclosure include a therapeutically effective amount of at least one compound of the present disclosure and a pharmaceutically acceptable carrier. Useful pharmaceutically acceptable carriers include, but are not limited to, glycerol, water, saline, ethanol, recombinant human albumin (e.g., Recombumin®), soluble gels (e.g., Gelofusine®), and other pharmaceutically acceptable salts Solutions such as phosphates and salts of organic acids. Examples of these and other pharmaceutically acceptable carriers are described in Remington's Pharmaceutical Sciences (1991, Mack Publication Co., New Jersey).
載劑可以是溶劑或分散介質,其包含例如水、乙醇、多元醇(例如甘油、丙二醇和液體聚乙二醇等)、重組人類白蛋白、可溶明膠、其合適的混合物和植物油。例如,可以通過使用包衣比如卵磷脂,通過在存在分散體的情況下維持所需的粒徑以及通過使用表面活性劑來維持合適的流動性。可以通過各種抗細菌劑和抗真菌劑,例如對羥基苯甲酸酯、三氯第三丁醇、苯酚、抗壞血酸、硫柳汞等,來防止微生物的作用。在許多情況下,組成物中包括等滲劑,例如糖、氯化鈉或多元醇, 比如甘露糖醇和山梨糖醇。可以通過在組成物中包含延遲吸收的試劑例如單硬脂酸鋁或明膠來實現可注射組成物的延長吸收。 The carrier can be a solvent or dispersion medium containing, for example, water, ethanol, polyol (eg, glycerol, propylene glycol, and liquid polyethylene glycol, and the like), recombinant human albumin, soluble gelatin, suitable mixtures thereof, and vegetable oils. For example, proper fluidity can be maintained by the use of coatings such as lecithin, by maintaining the desired particle size in the presence of dispersions, and by the use of surfactants. Prevention of the action of microorganisms can be prevented by various antibacterial and antifungal agents, for example, parabens, chlorobutanol, phenol, ascorbic acid, thimerosal, and the like. In many cases, the composition includes isotonic agents, such as sugars, sodium chloride, or polyols, Such as mannitol and sorbitol. Prolonged absorption of the injectable compositions can be brought about by including in the composition an agent which delays absorption, for example, aluminum monostearate or gelatin.
調配物可以與常規賦形劑混合使用,即適合於口服、腸胃外、經鼻、吸入、靜脈內、皮下、經皮腸內或本領域已知的任何其他合適的施用方式的醫藥上可接受的有機或無機載劑物質。可以對醫藥製劑進行滅菌,並且如果需要,可以與輔助劑例如潤滑劑、防腐劑、穩定劑、潤濕劑、乳化劑、用於影響滲透壓緩衝劑的鹽、著色劑、調味劑和/或賦予香氣的物質等混合。在需要時,它們也可以與其他活性劑,例如其他鎮痛劑、抗焦慮劑或催眠劑組合。如本文所使用的,「另外的成分」包括但不限於可用作藥物載劑的一種或多種成分。 The formulations may be used in admixture with conventional excipients, i.e., pharmaceutically acceptable formulations suitable for oral, parenteral, nasal, inhalation, intravenous, subcutaneous, transdermal enteral or any other suitable mode of administration known in the art. organic or inorganic carrier substances. The pharmaceutical preparations can be sterilized and, if desired, mixed with auxiliary agents such as lubricants, preservatives, stabilizers, wetting agents, emulsifiers, salts for influencing osmotic pressure buffers, colorants, flavorings and/or Aroma-imparting substances and the like are mixed. They can also be combined, if desired, with other active agents, for example other analgesics, anxiolytics or hypnotics. As used herein, "an additional ingredient" includes, but is not limited to, one or more ingredients that can be used as a pharmaceutical carrier.
本揭露內容的組成物可以包括按組成物的總重量計約0.005%至2.0%的防腐劑。在暴露於環境中的污染物的情況下,防腐劑用於防止變質。根據本揭露內容有用的防腐劑的實例包括但不限於選自苄醇、山梨酸、對羥基苯甲酸、咪脲及其組合的那些。一種這樣的防腐劑是約0.5%至2.0%的苄醇和0.05-0.5%的山梨酸的組合。 Compositions of the present disclosure may include from about 0.005% to 2.0% of a preservative, based on the total weight of the composition. Preservatives are used to prevent spoilage in case of exposure to pollutants in the environment. Examples of preservatives useful in accordance with the present disclosure include, but are not limited to, those selected from the group consisting of benzyl alcohol, sorbic acid, p-hydroxybenzoic acid, mididylurea, and combinations thereof. One such preservative is a combination of about 0.5% to 2.0% benzyl alcohol and 0.05-0.5% sorbic acid.
該組成物可以包括抑制化合物降解的抗氧化劑和螯合劑。對於某些化合物,抗氧化劑是BHT、BHA、α-生育酚和抗壞血酸,按組成物的總重量計,其示例性範圍為按重量計約0.01%至0.3%,或BHT範圍為按重量計0.03%至0.1%。按組成物的總重量計,螯合劑存在的量可以是按重量計0.01%至0.5%。按組成物的總重量計,示例性螯合劑包括在約0.01%至0.20%的重量範圍內或在按重量計0.02%至0.10%的範圍內的乙二胺四乙酸鹽(例如乙二胺四乙酸二鈉)和檸檬酸。螯合劑可用於螯合組成物中的金屬離子,這可能對調配物的保存期限有害。對於某些化合物,儘管BHT和乙二胺四乙酸二鈉分別是示例性的抗氧化劑和螯合劑,但是如本領域技術人員所知,可以用其他合適的和等同的抗氧化劑和螯合劑替代。 The composition may include antioxidants and chelating agents to inhibit degradation of the compounds. For certain compounds, the antioxidants are BHT, BHA, alpha-tocopherol, and ascorbic acid in an exemplary range of about 0.01% to 0.3% by weight, or BHT in the range of 0.03% by weight, based on the total weight of the composition. % to 0.1%. The chelating agent may be present in an amount of 0.01% to 0.5% by weight, based on the total weight of the composition. Exemplary chelating agents include ethylenediaminetetraacetic acid salts (such as ethylenediaminetetraacetic acid salts) in the range of about 0.01% to 0.20% by weight, or in the range of 0.02% to 0.10% by weight, based on the total weight of the composition. disodium acetate) and citric acid. Chelating agents can be used to chelate metal ions in the composition, which can be detrimental to the shelf life of the formulation. For some compounds, although BHT and disodium edetate are exemplary antioxidants and chelating agents, respectively, other suitable and equivalent antioxidants and chelating agents may be substituted as known to those skilled in the art.
可以使用常規方法製備液體懸浮液,以使活性成分懸浮在水性或油性媒介物中。水性媒介物包括例如水和等滲鹽水。油性媒介物 包括例如杏仁油、油性酯、乙醇、植物油比如花生油、橄欖油、芝麻油或椰子油、分餾的植物油和礦物油比如液體石蠟。液體懸浮液可以進一步包括一種或多種另外的成分,包括但不限於懸浮劑、分散劑或潤濕劑、乳化劑、緩和劑、防腐劑、緩衝劑、鹽、調味劑、著色劑和甜味劑。油性懸浮液可以進一步包括增稠劑。已知的懸浮劑包括但不限於山梨糖醇糖漿劑、氫化可食用脂肪、海藻酸鈉、聚乙烯吡咯啶酮、黃蓍樹膠、阿拉伯樹膠和纖維素衍生物比如羧甲基纖維素鈉、甲基纖維素、羥丙甲基纖維素。已知的分散劑或潤濕劑包括但不限於天然存在的磷脂比如卵磷脂,烯化氧與脂肪酸、與長鏈脂族醇、與源自脂肪酸和己糖醇的偏酯或與源自脂肪酸和己糖醇酐的偏酯(例如,分別是聚氧乙烯硬脂酸酯、十七碳亞乙氧基鯨蠟醇、聚氧乙烯山梨醇單油酸酯和聚氧乙烯山梨聚糖單油酸酯)的縮合產物。已知的乳化劑包括但不限於卵磷脂、阿拉伯膠和離子或非離子表面活性劑。已知的防腐劑包括但不限於對羥基苯甲酸甲酯、對羥基苯甲酸乙酯或對羥基苯甲酸正丙酯、抗壞血酸和山梨酸。已知的甜味劑包括例如甘油、丙二醇、山梨糖醇、蔗糖和糖精。 Liquid suspensions may be prepared using conventional methods to suspend the active ingredient in an aqueous or oily vehicle. Aqueous vehicles include, for example, water and isotonic saline. oily vehicle These include, for example, almond oil, oily esters, ethanol, vegetable oils such as arachis oil, olive oil, sesame oil or coconut oil, fractionated vegetable oils and mineral oils such as liquid paraffin. Liquid suspensions may further comprise one or more additional ingredients including, but not limited to, suspending agents, dispersing or wetting agents, emulsifying agents, demulcents, preservatives, buffers, salts, flavoring agents, coloring agents and sweetening agents . The oily suspensions may further comprise a thickening agent. Known suspending agents include, but are not limited to, sorbitol syrup, hydrogenated edible fats, sodium alginate, polyvinylpyrrolidone, gum tragacanth, gum arabic, and cellulose derivatives such as sodium carboxymethylcellulose, formazan, Base cellulose, hypromellose. Known dispersants or wetting agents include, but are not limited to, naturally occurring phospholipids such as lecithin, alkylene oxides with fatty acids, with long chain aliphatic alcohols, with partial esters derived from fatty acids and hexitols or with fatty acids and hexitols. Partial esters of sugar-alcohol anhydrides (e.g., polyoxyethylene stearate, heptadecanylethyleneoxycetyl alcohol, polyoxyethylene sorbitan monooleate and polyoxyethylene sorbitan monooleate, respectively ) condensation products. Known emulsifiers include, but are not limited to, lecithin, acacia, and ionic or nonionic surfactants. Known preservatives include, but are not limited to, methyl, ethyl or n-propyl paraben, ascorbic acid and sorbic acid. Known sweeteners include, for example, glycerin, propylene glycol, sorbitol, sucrose and saccharin.
可以以與液體懸浮液基本相同的方式製備活性成分在水性或油性溶劑中的液體溶液,主要區別在於活性成分是溶解而不是懸浮在溶劑中。如本文所使用的,「油性」液體是包括含碳液體分子並且展現出比水小的極性的液體。本揭露內容的醫藥組成物的液體溶液可包含關於液體懸浮液描述的每種組分,應當理解,懸浮劑不一定會幫助活性成分溶解在溶劑中。水性溶劑包括例如水和等滲鹽水。油性溶劑包括例如杏仁油、油性酯、乙醇、植物油比如花生油、橄欖油、芝麻油或椰子油、分餾的植物油和礦物油比如液體石蠟。 Liquid solutions of active ingredients in aqueous or oily solvents can be prepared in substantially the same manner as liquid suspensions, the main difference being that the active ingredients are dissolved rather than suspended in the solvent. As used herein, an "oily" liquid is a liquid that includes carbon-containing liquid molecules and exhibits less polarity than water. Liquid solutions of the pharmaceutical compositions of the present disclosure may contain each of the components described for liquid suspensions, it being understood that suspending agents will not necessarily aid in dissolving the active ingredients in the solvent. Aqueous solvents include, for example, water and isotonic saline. Oily solvents include, for example, almond oil, oily esters, ethanol, vegetable oils such as arachis oil, olive oil, sesame oil or coconut oil, fractionated vegetable oils and mineral oils such as liquid paraffin.
可以使用已知方法製備本揭露內容的醫藥製劑的粉末狀和顆粒調配物。這樣的調配物可以直接施用至受試者,例如用於形成片劑、填充膠囊,或通過向其中添加水性或油性媒介物來製備水性或油性懸浮液或溶液。這些調配物中的每一種可以進一步包括分散劑或潤濕劑、懸浮劑、離子和非離子表面活性劑和防腐劑中的一種或多種。這些 調配物中還可以包括另外的賦形劑,比如填充劑和甜味劑、調味劑或著色劑。 Powdered and granular formulations of the pharmaceutical agents of the present disclosure can be prepared using known methods. Such formulations can be administered directly to a subject, eg, for forming tablets, filling capsules, or by adding an aqueous or oily vehicle thereto for the preparation of aqueous or oily suspensions or solutions. Each of these formulations may further include one or more of dispersing or wetting agents, suspending agents, ionic and nonionic surfactants and preservatives. These The formulations may also include additional excipients, such as fillers and sweetening, flavoring or coloring agents.
本揭露內容的醫藥組成物也可以水包油乳劑或油包水乳劑的形式製備、包裝或出售。油相可以是植物油比如橄欖油或花生油,礦物油比如液體石蠟,或這些的組合。這樣的組成物可以進一步包含一種或多種乳化劑,比如天然存在的樹膠比如阿拉伯樹膠或黃蓍樹膠;天然存在的磷脂,例如大豆或卵磷脂;源自脂肪酸和己糖醇酐的組合的酯或偏酯,比如山梨聚糖單油酸酯,以及這種偏酯與環氧乙烷的縮合產物,比如聚氧乙烯山梨聚糖單油酸酯。這些乳劑還可以包含另外的成分,包括例如甜味劑或調味劑。 The pharmaceutical compositions of the present disclosure may also be prepared, packaged, or sold in the form of oil-in-water emulsions or water-in-oil emulsions. The oily phase may be a vegetable oil such as olive oil or peanut oil, a mineral oil such as liquid paraffin, or a combination of these. Such compositions may further comprise one or more emulsifiers, such as naturally occurring gums such as acacia or tragacanth; naturally occurring phospholipids such as soy or lecithin; esters or metabolites derived from combinations of fatty acids and hexitol anhydrides; Esters, such as sorbitan monooleate, and condensation products of such partial esters with ethylene oxide, such as polyoxyethylene sorbitan monooleate. These emulsions may also contain additional ingredients including, for example, sweetening or flavoring agents.
用化學組成物浸漬或塗覆材料的方法在本領域中是已知的,並且包括但不限於將化學組成物沉積或結合到表面上的方法,在合成材料(即,比如使用生理學上可降解的材料)期間將化學組成物結合到材料結構中的方法,以及將水性或油性溶液或懸浮液吸收到吸收性材料中的方法,隨後進行乾燥或不進行乾燥。混合組分的方法包括本領域技術人員已知的物理研磨、在固體和懸浮液調配物中使用丸粒以及在透皮貼劑中混合。 Methods of impregnating or coating materials with chemical compositions are known in the art, and include, but are not limited to, methods of depositing or incorporating chemical compositions onto surfaces, in synthetic materials (i.e., such as using physiologically degraded materials), and methods of absorbing aqueous or oily solutions or suspensions into absorbent materials, with or without subsequent drying. Methods of mixing the components include physical milling, the use of pellets in solid and suspension formulations and mixing in transdermal patches known to those skilled in the art.
施用/給藥administration / administration
給藥方案可能會影響有效量的構成。可以在疾病或病症發作之前或之後將治療調配物施用至患者。此外,可以每天或順序施用幾種分開的劑量以及交錯劑量,或者可以連續輸注該劑量,或者可以是推注注射。此外,治療調配物的劑量可以根據治療或預防情況的緊急程度成比例地增加或減少。 Dosage regimens may affect what constitutes an effective amount. Therapeutic formulations can be administered to the patient either before or after the onset of the disease or condition. Furthermore, several divided doses as well as staggered doses may be administered daily or sequentially, or the dose may be infused continuously, or may be a bolus injection. In addition, the dosage of therapeutic formulations may be proportionally increased or decreased as indicated by the exigencies of the therapeutic or prophylactic situation.
可以使用已知的程序,以有效治療本文考慮的疾病或病症的劑量和時間段將本揭露內容的組成物施用至患者,比如哺乳動物,比如人類。實現治療效果所必需的治療化合物的有效量可以根據以下因素而變化,比如所採用的特定化合物的活性;施用時間;該化合物的排泄 速率;治療的持續時間;與該化合物組合使用的其他藥物、化合物或材料;疾病或病症的狀態,所治療患者的年齡、性別、體重、狀況、一般健康狀況以及既往病史,以及醫學領域眾所周知的類似因素。可以調整劑量方案以提供最佳的治療反應。例如,如治療狀況的緊急情況所指示,可以每天施用數個分開的劑量或可以成比例地減少劑量。本揭露內容的治療化合物的有效劑量範圍的非限制性實例為每天約0.01mg/kg至100mg/kg體重。本領域普通技術人員將能夠研究相關因素並確定治療化合物的有效量而無需過度實驗。 Compositions of the present disclosure may be administered to a patient, such as a mammal, such as a human, using known procedures, at dosages and for periods of time effective to treat the diseases or conditions contemplated herein. The effective amount of a therapeutic compound necessary to achieve a therapeutic effect may vary depending on factors such as the activity of the particular compound employed; the time of administration; the excretion of the compound rate; duration of treatment; other drugs, compounds or materials used in combination with the compound; state of the disease or condition, age, sex, weight, condition, general health, and past medical history of the patient being treated, as well as similar factors. Dosage regimens may be adjusted to provide the optimum therapeutic response. For example, several divided doses may be administered daily or the dose may be proportionally reduced as indicated by the exigencies of the therapeutic situation. A non-limiting example of an effective dosage range for a therapeutic compound of the present disclosure is about 0.01 mg/kg to 100 mg/kg body weight per day. Those of ordinary skill in the art will be able to investigate the relevant factors and determine an effective amount of a therapeutic compound without undue experimentation.
可以將該化合物每天幾次頻繁地施用至動物,或者可以更不頻繁地施用,比如每天一次、每週一次、每兩週一次、每月一次或甚至更不頻繁地,比如每幾個月一次,甚至一年一次或更低。應當理解,在非限制性實例中,每天給藥的化合物的量可以每天、每隔一天、每2天、每3天、每4天或每5天施用一次。例如,每隔一天施用一次,可以在星期一開始5mg的每日劑量,在星期三施用第一個隨後5mg的每日劑量,在星期五施用第二個隨後5mg的每日劑量,等等。劑量的頻率對技術人員而言是顯而易見的,並且取決於許多因素,比如但不限於所治療的疾病的類型和嚴重程度以及動物的類型和年齡。 The compound may be administered to the animal frequently several times a day, or may be administered less frequently, such as once a day, once a week, once every two weeks, once a month, or even less frequently, such as once every few months , or even once a year or less. It is understood that the amount of compound administered daily may be administered daily, every other day, every 2 days, every 3 days, every 4 days, or every 5 days, in non-limiting examples. For example, administered every other day, a daily dose of 5 mg may be initiated on Monday, a first subsequent daily dose of 5 mg is administered on Wednesday, a second subsequent daily dose of 5 mg is administered on Friday, and so on. The frequency of dosage will be apparent to the skilled artisan and will depend on many factors such as, but not limited to, the type and severity of the disease being treated and the type and age of the animal.
可以改變本揭露內容的醫藥組成物中活性成分的實際劑量水平,以便獲得有效實現特定患者、組成物和給藥方式所需的治療反應的活性成分的量,而對患者是無毒的。 Actual dosage levels of the active ingredients in the pharmaceutical compositions of the present disclosure may be varied in order to obtain an amount of the active ingredient effective to achieve the desired therapeutic response for a particular patient, composition, and mode of administration, without being toxic to the patient.
具有本領域普通技術的醫生,例如醫師或獸醫,可以容易地確定和開處方所需的有效量的醫藥組成物。例如,醫師或獸醫可以以低於所需要的水平開始在醫藥組成物中使用的本揭露內容化合物的劑量,以便獲得所需的治療效果並逐漸增加劑量,直到獲得所需的效果。 A physician of ordinary skill in the art, such as a physician or veterinarian, can readily determine and prescribe the required effective amount of the pharmaceutical composition. For example, a physician or veterinarian could start dosages of the compounds of the disclosure employed in pharmaceutical compositions at levels lower than that required in order to achieve the desired therapeutic effect and gradually increase the dosage until the desired effect is achieved.
在具體實施方式中,以劑量單位形式配製化合物對於施用的容易性和劑量的均勻性是特別有利的。如本文所使用的劑量單位形式是指適合作為待治療患者的單位劑量的物理上離散的單位;每個單位都包含預定量的治療化合物,該化合物經計算可與所需的藥物媒介物結合 以產生所需的治療效果。本揭露內容的劑量單位形式由以下決定並直接取決於(a)治療化合物的獨特特徵和要實現的特定治療效果,以及(b)在配製/配製用於治療患者的疾病或病症的這種治療化合物的領域中固有的局限性。 In particular embodiments, it is especially advantageous to formulate compounds in dosage unit form for ease of administration and uniformity of dosage. Dosage unit form as used herein refers to physically discrete units suited as unitary dosages for the patients to be treated; each unit containing a predetermined quantity of therapeutic compound calculated to be in association with the required pharmaceutical vehicle to produce the desired therapeutic effect. Dosage unit forms of the present disclosure are dictated by and directly dependent on (a) the unique characteristics of the therapeutic compound and the particular therapeutic effect to be achieved, and (b) the formulation/formulation of such treatment for the disease or condition in the patient. Inherent limitations in the field of compounds.
在某些實施方式中,本揭露內容的組成物以每天1-5次或更多次的範圍內的劑量施用至患者。在其他實施方式中,本揭露內容的組成物以包括但不限於每天一次、每兩天一次、每三天一次至一週一次以及每兩週一次的劑量範圍施用至患者。對於本領域技術人員而言顯而易見的是,本揭露內容的各種組合組成物的施用頻率將因受試者而異,這取決於許多因素,包括但不限於年齡、待治療的疾病或病症、性別、整體健康狀況和其他因素。因此,本揭露內容不應被解釋為限於任何特定的劑量方案,並且將由主治醫師考慮到患者的所有其他因素來確定要施用至任何患者的精確劑量和組成。 In certain embodiments, a composition of the present disclosure is administered to a patient in a dose ranging from 1-5 or more times per day. In other embodiments, a composition of the present disclosure is administered to a patient in a dosage range including, but not limited to, once a day, once every two days, once every three days to once a week, and once every two weeks. It will be apparent to those skilled in the art that the frequency of administration of the various combination compositions of the present disclosure will vary from subject to subject, depending on a number of factors including, but not limited to, age, disease or condition to be treated, sex , overall health and other factors. Accordingly, the present disclosure should not be construed as being limited to any particular dosage regimen, and the precise dosage and composition to be administered to any patient will be determined by the attending physician taking into account all other factors of the patient.
用於施用的本揭露內容的化合物可以在以下範圍內:約1μg至約7,500mg、約20μg至約7,000mg、約40μg至約6,500mg、約80μg至約6,000mg、約100μg至約5,500mg、約200μg至約5,000mg、約400μg至約4,000mg、約800μg至約3,000mg、約1mg至約2,500mg、約2mg至約2,000mg、約5mg至約1,000mg、約10mg至約750mg、約20mg至約600mg、約30mg至約500mg、約40mg至約400mg、約50mg至約300mg、約60mg至約250mg、約70mg至約200mg、約80mg至約150mg和它們之間的任何完整增量和部分增量。 Compounds of the disclosure for administration may range from about 1 μg to about 7,500 mg, about 20 μg to about 7,000 mg, about 40 μg to about 6,500 mg, about 80 μg to about 6,000 mg, about 100 μg to about 5,500 mg, About 200 μg to about 5,000 mg, about 400 μg to about 4,000 mg, about 800 μg to about 3,000 mg, about 1 mg to about 2,500 mg, about 2 mg to about 2,000 mg, about 5 mg to about 1,000 mg, about 10 mg to about 750 mg, about 20 mg to about 600 mg, about 30 mg to about 500 mg, about 40 mg to about 400 mg, about 50 mg to about 300 mg, about 60 mg to about 250 mg, about 70 mg to about 200 mg, about 80 mg to about 150 mg and any whole increments and fractions therebetween increment.
在一些實施方式中,本揭露內容的化合物的劑量為約0.5μg和約5,000mg。在一些實施方式中,本文描述的組成物中使用的本揭露內容的化合物的劑量小於約5,000mg、或小於約4,000mg、或小於約3,000mg、或小於約2,000mg、或小於約1,000mg、或小於約800mg、或小於約600mg、或小於約500mg、或小於約200mg、或小於約50mg。類似地,在一些實施方式中,如本文描述的第二化合物 的劑量小於約1,000mg、或小於約800mg、或小於約600mg、或小於約500mg、或小於約400mg、或小於約300mg、或小於約200mg、或小於約100mg、或小於約50mg、或小於約40mg、或小於約30mg、或小於約25mg、或小於約20mg、或小於約15mg、或小於約10mg、或小於約5mg、或小於約2mg、或小於約1mg、或小於約0.5mg、以及其任何完全增量和部分增量。 In some embodiments, the dose of a compound of the disclosure is between about 0.5 μg and about 5,000 mg. In some embodiments, the dose of a compound of the disclosure used in the compositions described herein is less than about 5,000 mg, or less than about 4,000 mg, or less than about 3,000 mg, or less than about 2,000 mg, or less than about 1,000 mg, Or less than about 800 mg, or less than about 600 mg, or less than about 500 mg, or less than about 200 mg, or less than about 50 mg. Similarly, in some embodiments, a second compound as described herein The dosage is less than about 1,000 mg, or less than about 800 mg, or less than about 600 mg, or less than about 500 mg, or less than about 400 mg, or less than about 300 mg, or less than about 200 mg, or less than about 100 mg, or less than about 50 mg, or less than about 40 mg, or less than about 30 mg, or less than about 25 mg, or less than about 20 mg, or less than about 15 mg, or less than about 10 mg, or less than about 5 mg, or less than about 2 mg, or less than about 1 mg, or less than about 0.5 mg, and Any full and partial increments.
在某些實施方式中,本揭露內容涉及包裝的醫藥組成物,其包含單獨地或與第二種藥物組合地容納治療有效量的本揭露內容化合物的容器;以及使用該化合物治療、預防或減輕患者的疾病或病症的一種或多種症狀的說明書。 In certain embodiments, the present disclosure relates to packaged pharmaceutical compositions comprising a container containing a therapeutically effective amount of a compound of the present disclosure, alone or in combination with a second drug; and using the compound to treat, prevent, or alleviate A description of one or more symptoms of a patient's disease or condition.
術語「容器」包括用於容納醫藥組成物或用於管理穩定性或水吸收的任何接受器(receptacle)。例如,在某些實施方式中,容器是包含醫藥組成物的包裝,比如存在於雙室中的液體(溶液和懸浮液)、半固體、凍乾固體、溶液和粉末或凍乾調配物。在其他實施方式中,容器不是包含醫藥組成物的包裝,即,容器是接受器,比如包含包裝的醫藥組成物或未包裝的醫藥組成物以及醫藥組成物使用說明書的盒子或小瓶。此外,包裝技術是本領域眾所周知的。應當理解,醫藥組成物的使用說明書可以包含在含有醫藥組成物的包裝上,並且因此,說明書與包裝的產品形成增加的功能關係。然而,應當理解,說明書中可能包含有關該化合物執行其預期功能的能力,例如治療、預防或減輕患者的疾病或病症的信息。 The term "container" includes any receptacle for containing a pharmaceutical composition or for managing stability or water absorption. For example, in certain embodiments, the container is a package containing a pharmaceutical composition, such as a liquid (solution and suspension), semi-solid, lyophilized solid, solution and powder or lyophilized formulation present in a dual compartment. In other embodiments, the container is not a package containing a pharmaceutical composition, ie, the container is a receptacle, such as a box or vial containing a packaged or unpackaged pharmaceutical composition and instructions for use of the pharmaceutical composition. Additionally, packaging techniques are well known in the art. It will be appreciated that instructions for use of the pharmaceutical composition may be included on the packaging containing the pharmaceutical composition, and thus the instructions form an increased functional relationship with the packaged product. It should be understood, however, that the instructions may contain information regarding the ability of the compound to perform its intended function, such as treating, preventing or alleviating a disease or condition in a patient.
施用apply
本揭露內容任何組成物的給藥途徑包括吸入、口服、經鼻、直腸、腸胃外、舌下、經皮、經黏膜(例如舌下、舌、(經)含服、(經)尿道、陰道(例如,經陰道和陰道周圍)、鼻(內)和((經)直腸)、膀胱內、肺內、十二指腸內、胃內、鞘內、硬膜外、胸膜內、腹膜內、皮下、肌內、皮內、動脈內、靜脈內、支氣管內、吸入和局部施用。 Routes of administration for any composition of the present disclosure include inhalation, oral, nasal, rectal, parenteral, sublingual, transdermal, transmucosal (e.g., sublingual, lingual, (trans)buccal, (trans)urethral, vaginal (e.g., vaginal and perivaginal), nasal (intra) and ((trans)rectal), intravesical, intrapulmonary, intraduodenal, intragastric, intrathecal, epidural, intrapleural, intraperitoneal, subcutaneous, intramuscular Intradermal, intradermal, intraarterial, intravenous, intrabronchial, inhalation and topical administration.
合適的組成物和劑型包括例如片劑、膠囊、囊片、丸劑、軟膠囊、錠劑、乳劑、分散劑、懸浮劑、溶液、糖漿劑、顆粒劑、珠劑、透皮貼劑、凝膠劑、粉末、丸粒、乳漿劑(magma)、錠劑、乳膏、糊劑、膏藥、洗劑、片劑(discs)、栓劑、用於經鼻或口服施用的液體噴霧劑、用於吸入的乾粉或霧化調配物、用於膀胱內施用的組成物和調配物等。應當理解,可用於本揭露內容的調配物和組成物不限於本文描述的特定調配物和組成物。 Suitable compositions and dosage forms include, for example, tablets, capsules, caplets, pills, softgels, lozenges, emulsions, dispersions, suspensions, solutions, syrups, granules, beads, transdermal patches, gels elixirs, powders, pellets, magmas, lozenges, creams, pastes, plasters, lotions, tablets (discs), suppositories, liquid sprays for nasal or oral administration, for Dry powder or nebulized formulations for inhalation, compositions and formulations for intravesical administration, and the like. It should be understood that formulations and compositions useful in the present disclosure are not limited to the specific formulations and compositions described herein.
口服施用oral administration
對於口服施用,特別地合適的是片劑、錠劑、液體、滴劑、膠囊、囊片和軟膠囊。其他適合口服施用的調配物包括但不限於粉末或顆粒調配物、水性或油性懸浮劑、水性或油性溶液、糊劑、凝膠劑、牙膏、漱口劑、包衣劑、口腔沖洗劑或乳劑。可以根據本領域已知的任何方法來製備預期用於口服使用的組成物,並且這種組成物可以包含選自適合用於製造片劑的惰性、無毒、通常被認為是安全的(GRAS)醫藥上的賦形劑的一種或多種試劑。這種賦形劑包括例如惰性稀釋劑比如乳糖;製粒劑和崩解劑,例如玉米澱粉;黏合劑,比如澱粉;和潤滑劑,比如硬脂酸鎂。 For oral administration, especially suitable are tablets, lozenges, liquids, drops, capsules, caplets and soft capsules. Other formulations suitable for oral administration include, but are not limited to, powder or granule formulations, aqueous or oily suspensions, aqueous or oily solutions, pastes, gels, toothpastes, mouthwashes, coatings, mouth rinses or emulsions . Compositions intended for oral use may be prepared according to any method known in the art, and such compositions may contain an inert, non-toxic, generally recognized as safe (GRAS) medicinal product selected from the group suitable for the manufacture of tablets. One or more agents of the above excipients. Such excipients include, for example, inert diluents such as lactose; granulating and disintegrating agents such as corn starch; binders such as starches; and lubricants such as magnesium stearate.
片劑可以是未被塗覆的,或者可以使用已知方法塗覆,以在受試者的胃腸道中實現延遲崩解,從而提供活性成分的持續釋放和吸收。舉例來說,可以使用比如單硬脂酸甘油酯或二硬脂酸甘油酯的材料塗覆片劑。進一步舉例來說,可以使用在美國專利號4,256,108;4,160,452;和4,265,874中描述的方法塗覆片劑以形成滲透控釋片。片劑可以進一步包含甜味劑、調味劑、著色劑、防腐劑或這些的某種組合以提供醫藥上鮮美(elegant)且可口的製劑。包括活性成分的硬膠囊可以使用生理學上可降解的組成物例如明膠來製備。膠囊包括活性成分,並且可以進一步包括另外的成分,包括例如惰性固體稀釋劑,比如碳酸鈣、磷酸鈣或高嶺土。 Tablets may be uncoated, or may be coated using known methods to effect delayed disintegration in the gastrointestinal tract of a subject so as to provide sustained release and absorption of the active ingredient. Tablets may be coated, for example, with a material such as glyceryl monostearate or glyceryl distearate. By way of further example, tablets may be coated to form osmotic controlled release tablets using the methods described in US Pat. Nos. 4,256,108; 4,160,452; and 4,265,874. Tablets may further contain sweetening agents, flavoring agents, coloring agents, preservatives or some combination of these to provide a pharmaceutically elegant and palatable preparation. Hard capsules containing the active ingredient can be prepared using physiologically degradable compositions such as gelatin. Capsules contain the active ingredient and may further contain additional ingredients including, for example, inert solid diluents such as calcium carbonate, calcium phosphate or kaolin.
包括活性成分的硬膠囊可以使用生理學上可降解的組成物比如明膠來製備。這種硬膠囊包括活性成分,並且可以進一步包含另外的成分,包括例如惰性固體稀釋劑,比如碳酸鈣、磷酸鈣或高嶺土。 Hard capsules containing the active ingredient can be prepared using physiologically degradable compositions such as gelatin. Such hard capsules contain the active ingredient and may further contain additional ingredients including, for example, inert solid diluents such as calcium carbonate, calcium phosphate or kaolin.
包括活性成分的軟膠囊可以使用生理學上可降解的組成物比如來自動物膠原或羥丙甲纖維素(纖維素的改性形式)的明膠來製備,並使用明膠、水和增塑劑比如山梨糖醇或甘油的可選擇的混合物製造。這樣的軟膠囊包括可以與水或油介質比如花生油、液體石蠟或橄欖油混合的活性成分。 Soft capsules comprising the active ingredient can be prepared using a physiologically degradable composition such as gelatin from animal collagen or hypromellose (a modified form of cellulose), and using gelatin, water and a plasticizer such as sorbitol Manufactured with an optional mixture of sugar alcohols or glycerin. Such soft capsules contain the active ingredient which may be mixed with water or an oily medium such as peanut oil, liquid paraffin or olive oil.
對於口服施用,本揭露內容的化合物可以是通過常規方法與醫藥上可接受的賦形劑比如黏合劑;填充劑;潤滑劑;崩解劑;或潤濕劑製備的片劑或膠囊的形式。如果期望的,可以使用合適的方法和包衣材料比如可獲得自Colorcon,West Point,Pa.(例如,OPADRY® OY型、OYC型、有機腸溶型OY-P型、水性腸溶型OY-A型、OY-PM型和OPADRY® White,32K18400)的OPADRY®膜包衣系統塗覆片劑。應當理解,可以使用其他公司的類似類型的膜塗層或聚合產物。 For oral administration, the compounds of the present disclosure may be in the form of tablets or capsules prepared by conventional methods with pharmaceutically acceptable excipients such as binders; fillers; lubricants; disintegrants; or wetting agents. If desired, suitable methods and coating materials such as those available from Colorcon, West Point, Pa. (e.g., OPADRY® Type OY, OYC, Organic Enteric OY-P, Aqueous Enteric OY- Form A, OY-PM and OPADRY® White, 32K18400) coated tablets with the OPADRY® Film Coating System. It should be understood that similar types of film coatings or polymerization products from other companies may be used.
包括活性成分的片劑可以例如通過將活性成分可選擇地與一種或多種另外的成分一起壓制或模制來製備。製備壓制片劑可以通過在合適的裝置中壓制自由流動形式的活性成分比如粉末或顆粒調配物,可選擇地與一種或多種黏合劑、潤滑劑、賦形劑、表面活性劑和分散劑混合。模制片劑可以通過在合適的裝置中模制活性成分、醫藥上可接受的載劑和至少足以潤濕混合物的液體的混合物來製備。用於製造片劑的醫藥上可接受的賦形劑包括但不限於惰性稀釋劑、製粒劑和崩解劑、黏合劑和潤滑劑。已知的分散劑包括但不限於馬鈴薯澱粉和羥甲基澱粉鈉。已知的表面活性劑包括但不限於月桂基硫酸鈉。已知的稀釋劑包括但不限於碳酸鈣、碳酸鈉、乳糖、微晶纖維素、磷酸鈣、磷酸氫鈣和磷酸鈉。已知的製粒劑和崩解劑包括但不限於玉米澱粉和藻酸。已知的黏合劑包括但不限於明膠、阿拉伯膠、預糊化的玉米澱粉、聚乙烯吡 咯啶酮和羥丙基甲基纖維素。已知的潤滑劑包括但不限於硬脂酸鎂、硬脂酸、二氧化矽和滑石。 A tablet comprising the active ingredient may be prepared, for example, by compressing or molding the active ingredient, optionally with one or more additional ingredients. Compressed tablets may be prepared by compressing in a suitable machine the active ingredient in a free-flowing form such as a powder or granule formulation, optionally mixed with one or more binder, lubricant, excipient, surface active and dispersing agents. Molded tablets can be made by molding, in a suitable device, a mixture of the active ingredient, a pharmaceutically acceptable carrier and at least sufficient liquid to wet the mixture. Pharmaceutically acceptable excipients used in the manufacture of tablets include, but are not limited to, inert diluents, granulating and disintegrating agents, binders and lubricants. Known dispersants include, but are not limited to, potato starch and sodium carboxymethyl starch. Known surfactants include, but are not limited to, sodium lauryl sulfate. Known diluents include, but are not limited to, calcium carbonate, sodium carbonate, lactose, microcrystalline cellulose, calcium phosphate, calcium hydrogen phosphate, and sodium phosphate. Known granulating and disintegrating agents include, but are not limited to, corn starch and alginic acid. Known binders include, but are not limited to, gelatin, gum arabic, pregelatinized corn starch, polyvinylpyrrole pyridone and hydroxypropyl methylcellulose. Known lubricants include, but are not limited to, magnesium stearate, stearic acid, silicon dioxide and talc.
製粒技術在製藥領域是眾所周知的,用於改性活性成分的起始粉末或其他顆粒材料。通常將粉末與黏合劑材料混合成較大的永久性自由流動的附聚物或顆粒,稱為「製粒」。例如,使用溶劑的「濕法」製粒工藝的一般特徵是,將粉末與黏合劑材料混合,並在一定條件下用水或有機溶劑潤濕,形成濕的粒狀物料,然後必須將溶劑從中蒸發。 Granulation techniques are well known in the pharmaceutical field and are used to modify active ingredients from starting powders or other granular materials. Powders are usually mixed with a binder material into larger permanent free-flowing agglomerates or granules known as "granulation". For example, the general feature of "wet" granulation using solvents is that a powder is mixed with a binder material and wetted under certain conditions with water or an organic solvent to form a wet granular material from which the solvent must then be evaporated .
熔融製粒通常包括使用在室溫下為固體或半固體的材料(即,具有相對較低的軟化或熔點範圍)在基本上沒有添加水或其他液體溶劑的情況下促進粉末或其他材料的製粒。當加熱到熔點範圍內的溫度時,低熔點固體液化以充當黏合劑或製粒介質。液化的固體將其自身散佈在與之接觸的粉末狀材料的表面上,並在冷卻後形成固體顆粒狀物質,在其中將初始物質黏合在一起。然後可以將所得的熔融製粒提供給壓片機或封裝以製備口服劑型。熔融製粒通過形成固體分散體或固溶體來改善活性物質(即,藥物)的溶解速率和生物利用度。 Melt granulation generally involves the use of materials that are solid or semi-solid at room temperature (i.e., have a relatively low softening or melting point range) to facilitate the preparation of powders or other materials substantially without the addition of water or other liquid solvents. grain. When heated to a temperature in the melting point range, the low melting point solid liquefies to act as a binder or granulation medium. The liquefied solid spreads itself on the surface of the powdered material it comes into contact with and upon cooling forms a solid granular mass in which the starting substances are bound together. The resulting melt granulation can then be fed to a tablet press or packaged to make oral dosage forms. Melt granulation improves the dissolution rate and bioavailability of active substances (ie, drugs) by forming solid dispersions or solid solutions.
美國專利號5,169,645公開了具有改善的流動特性的可直接壓縮的含蠟顆粒。當蠟在熔體中與某些改善流動性的添加劑混合,然後將混合物冷卻並製粒時,可得到顆粒。在某些實施方式中,在蠟(一種或多種)和添加劑(一種或多種)的熔融組成物中只有蠟本身熔融,並且在其他情況下,蠟(一種或多種)和添加劑(一種或多種)二者都將熔融。 US Patent No. 5,169,645 discloses directly compressible waxy particles with improved flow characteristics. Pellets are obtained when wax is mixed in the melt with certain flow-improving additives, then the mixture is cooled and pelletized. In certain embodiments, only the wax itself is melted in the molten composition of the wax(s) and additive(s), and in other cases, the wax(s) and additive(s) Both will melt.
本揭露內容還包括多層片劑,其包括提供用於延遲釋放在本揭露內容的方法中有用的一種或多種化合物的層,和提供用於立即釋放在本揭露內容的方法中有用的一種或多種化合物的其他層。使用蠟/pH敏感的聚合物混合物,可以獲得胃不溶性組成物,其中捕獲(entrap)了活性成分,從而確保了其延遲釋放。 The present disclosure also includes a multilayer tablet comprising a layer providing for delayed release of one or more compounds useful in the methods of the present disclosure and providing for immediate release of one or more compounds useful in the methods of the present disclosure. Additional layers of compound. Using wax/pH sensitive polymer mixtures, it is possible to obtain gastro-insoluble compositions in which the active ingredient is entrapped ensuring its delayed release.
用於口服施用的液體調配物可以是溶液、糖漿劑或懸浮劑的形式。液體調配物可以通過常規方式用醫藥上可接受的添加劑比如懸浮劑(例如,山梨糖醇糖漿劑、甲基纖維素或氫化可食用脂肪);乳化劑 (例如,卵磷脂或阿拉伯膠);非水性媒介物(例如,杏仁油、油性酯或乙醇);和防腐劑(例如對羥基苯甲酸甲酯或對羥基苯甲酸丙酯或山梨酸)製備。適用於口服施用的本揭露內容的醫藥組成物的液體調配物可以以液體形式或乾燥產物的形式製備、包裝和出售,該乾燥產物旨在在使用前用水或另一種合適的載劑重構。 Liquid formulations for oral administration may be in the form of solutions, syrups or suspensions. Liquid formulations may be prepared in a conventional manner with pharmaceutically acceptable additives such as suspending agents (for example, sorbitol syrup, methylcellulose, or hydrogenated edible fats); emulsifying agents; (eg, lecithin or acacia); a non-aqueous vehicle (eg, almond oil, oily esters, or ethanol); and a preservative (eg, methyl or propyl paraben or sorbic acid). Liquid formulations of the pharmaceutical compositions of the present disclosure suitable for oral administration can be prepared, packaged, and sold in liquid form or as a dry product intended for reconstitution with water or another suitable vehicle before use.
腸胃外施用parenteral administration
如本文所使用的,醫藥組成物的「腸胃外施用」包括特徵在於對受試者的組織進行物理破壞和通過組織中的破壞施用醫藥組成物的任何施用途徑。因此腸胃外施用包括但不限於通過注射組成物施用醫藥組成物、通過外科切口施用組成物、通過穿透組織的非外科傷口施用組成物等方式施用醫藥組成物。特別地,預期腸胃外施用包括但不限於皮下、靜脈內、腹膜內、肌內、胸骨內注射和腎透析輸注技術。 As used herein, "parenteral administration" of a pharmaceutical composition includes any route of administration characterized by physical disruption of a subject's tissue and administration of the pharmaceutical composition through the disruption in the tissue. Parenteral administration thus includes, but is not limited to, administering the pharmaceutical composition by injection of the composition, administering the composition through a surgical incision, administering the composition through a non-surgical wound that penetrates tissue, and the like. In particular, parenteral administration is contemplated including, but not limited to, subcutaneous, intravenous, intraperitoneal, intramuscular, intrasternal injection and renal dialysis infusion techniques.
適用於腸胃外施用的醫藥組成物的調配物包括與醫藥上可接受的載劑,比如無菌水或無菌等滲鹽水組合的活性成分。這樣的調配物可以以適合於推注施用或連續施用的形式製備、包裝或出售。可注射調配物可以在單位劑型,比如在含有防腐劑的安瓿或多劑量容器中製備、包裝或出售。還可以在裝置比如患者自控的鎮痛(PCA)裝置中製備、包裝或出售可注射調配物。腸胃外施用的調配物包括但不限於混懸劑、溶液、在油性或水性媒介物中的乳劑、膏劑和可植入的緩釋或生物可降解的調配物。這樣的調配物可以進一步包含一種或多種另外的成分,包括但不限於懸浮劑、穩定劑或分散劑。在用於腸胃外施用的調配物的一個實施方式中,活性成分以乾燥(即,粉末或顆粒)形式提供,以與合適的媒介物(例如,無菌無熱原水)重構,然後腸胃外施用重構的組成物。 Formulations of pharmaceutical compositions suitable for parenteral administration include the active ingredient in combination with a pharmaceutically acceptable carrier, such as sterile water or sterile isotonic saline. Such formulations can be prepared, packaged or sold in a form suitable for bolus administration or continuous administration. Injectable formulations can be prepared, packaged, or sold in unit dosage form, eg, in ampoules or in multi-dose containers, with a preservative. Injectable formulations can also be prepared, packaged, or sold in devices such as patient-controlled analgesia (PCA) devices. Formulations for parenteral administration include, but are not limited to, suspensions, solutions, emulsions in oily or aqueous vehicles, ointments and implantable sustained-release or biodegradable formulations. Such formulations may further comprise one or more additional ingredients including, but not limited to, suspending, stabilizing or dispersing agents. In one embodiment of the formulation for parenteral administration, the active ingredient is provided in dry (i.e., powder or granule) form for reconstitution with a suitable vehicle (e.g., sterile pyrogen-free water) prior to parenteral administration Reconstituted composition.
醫藥組成物可以以無菌可注射的水性或油性懸浮液或溶液的形式製備、包裝或出售。該懸浮液或溶液可以根據已知技術配製,並且除了活性成分外還可以包含另外的成分,比如本文所述的分散劑、潤濕劑或懸浮劑。可以使用無毒的腸胃外可接受的稀釋劑或溶劑,諸如 例如水或1,3-丁二醇來製備這種無菌可注射調配物。其他可接受的稀釋劑和溶劑包括但不限於林格氏溶液、等滲氯化鈉溶液和不揮發性油比如合成的甘油單酯或甘油二酯。有用的其他可腸胃外施用的調配物包括包含活性成分的那些,該活性成分為重組人類白蛋白、流化明膠、脂質體製劑或生物可降解的聚合物體系的組分中的微晶形式。用於持續釋放或植入的組成物可以包括醫藥上可接受的聚合物或疏水材料,比如乳劑、離子交換樹脂、微溶聚合物或微溶鹽。 The pharmaceutical compositions can be prepared, packaged or sold in the form of sterile injectable aqueous or oily suspensions or solutions. This suspension or solution may be formulated according to known techniques and may contain, in addition to the active ingredient, further ingredients such as dispersing, wetting or suspending agents herein described. Nontoxic parenterally acceptable diluents or solvents such as Such sterile injectable formulations are prepared, for example, with water or 1,3-butanediol. Other acceptable diluents and solvents include, but are not limited to, Ringer's solution, isotonic sodium chloride solution, and fixed oils such as synthetic mono- or diglycerides. Other parenterally administrable formulations that are useful include those comprising the active ingredient in microcrystalline form in recombinant human albumin, fluidized gelatin, liposomal formulations or as a component of biodegradable polymer systems. Compositions for sustained release or implantation may include pharmaceutically acceptable polymers or hydrophobic materials such as emulsions, ion exchange resins, sparingly soluble polymers or sparingly soluble salts.
局部施用topical application
局部施用醫藥製劑的障礙是表皮的角質層。角質層是由蛋白質、膽固醇、鞘脂、游離脂肪酸和各種其他脂質組成的高抗蝕層,並且包括角質化細胞和活細胞。限制化合物穿過角質層的滲透率(通量)的因素之一是可以負載或施加到皮膚表面上的活性物質的量。每單位皮膚面積施加的活性物質的量越大,皮膚表面與皮膚下層之間的濃度梯度越大,進而活性物質穿過皮膚的擴散力越大。因此,與其他濃度較低的調配物相比,含有較高濃度的活性物質的調配物更可能導致更多的活性物質以更一致的速率滲透穿過皮膚,所有其他內容都是一樣的。 An obstacle to topical application of pharmaceutical preparations is the stratum corneum of the epidermis. The stratum corneum is a highly resistant layer composed of proteins, cholesterol, sphingolipids, free fatty acids, and various other lipids, and includes keratinocytes and living cells. One of the factors that limits the penetration rate (flux) of a compound across the stratum corneum is the amount of active that can be loaded or applied to the skin surface. The greater the amount of active applied per unit area of skin, the greater the concentration gradient between the surface of the skin and the underlying layers of the skin, and thus the greater the diffusion of the active across the skin. Thus, formulations containing higher concentrations of actives are more likely to result in more actives permeating through the skin at a more consistent rate than other formulations of lower concentrations, all other things being equal.
適用於局部施用的調配物包括但不限於液體或半液體製劑,比如擦劑、洗劑、水包油或油包水乳劑,比如乳膏、藥膏或糊劑,以及溶液或懸浮液。儘管活性成分的濃度可以與活性成分在溶劑中的溶解度極限相同,但是可局部施用的調配物可以例如包括約1%至約10%(w/w)的活性成分。用於局部施用的調配物可以進一步包括一種或多種本文所述的另外的成分。 Formulations suitable for topical administration include, but are not limited to, liquid or semi-liquid preparations such as liniments, lotions, oil-in-water or water-in-oil emulsions such as creams, salves or pastes, and solutions or suspensions. Topically administrable formulations may, for example, comprise from about 1% to about 10% (w/w) active ingredient, although the concentration of the active ingredient may be the same as the solubility limit of the active ingredient in a solvent. Formulations for topical administration may further comprise one or more additional ingredients as described herein.
可以使用滲透促進劑。這些材料增加了藥物穿過皮膚的滲透率。本領域中典型的促進劑包括乙醇、單月桂酸甘油酯、PGML(聚乙二醇單月桂酸酯)、二甲基亞碸等。其他促進劑包括油酸、油醇、乙氧基乙二醇、月桂氮酮、鏈烷羧酸、二甲基亞碸、極性脂質或N-甲基-2-吡咯啶酮。 Penetration enhancers may be used. These materials increase the permeability of drugs through the skin. Typical accelerators in the art include ethanol, glyceryl monolaurate, PGML (polyethylene glycol monolaurate), dimethylsulfoxide, and the like. Other accelerators include oleic acid, oleyl alcohol, ethoxylated glycol, laurocapram, alkanecarboxylic acids, dimethylsulfoxide, polar lipids, or N-methyl-2-pyrrolidone.
用於局部遞送本揭露內容的一些組成物的一種可接受的媒介物可以包含脂質體。脂質體的組成及其用途是本領域已知的(即,美國專利號6,323,219)。 One acceptable vehicle for topical delivery of some compositions of the present disclosure may comprise liposomes. The composition of liposomes and their use are known in the art (ie, US Patent No. 6,323,219).
在可選的實施方式中,局部活性醫藥組成物可以可選擇地與其他成分比如佐劑、抗氧化劑、螯合劑、表面活性劑、發泡劑、潤濕劑、乳化劑、增黏劑、緩衝劑、防腐劑等組合。在其他實施方式中,滲透或滲透促進劑包括在組成物中,並且相對於缺乏滲透促進劑的組成物,對於改善活性成分滲透到皮膚中和穿過角質層是有效的。各種滲透促進劑,包括油酸、油醇、乙氧基乙二醇、月桂氮酮、鏈烷羧酸、二甲基亞碸、極性脂質或N-甲基-2-吡咯啶酮是本領域技術人員已知的。在另一方面,所述組成物可以進一步包含水溶助劑,其起到增加角質層結構的紊亂的作用,並因此允許增加穿過角質層的運輸。各種水溶助劑比如異丙醇、丙二醇或二甲苯磺酸鈉是本領域技術人員已知的。 In alternative embodiments, topically active pharmaceutical compositions may optionally be mixed with other ingredients such as adjuvants, antioxidants, chelating agents, surfactants, foaming agents, wetting agents, emulsifiers, viscosity builders, buffers, Agents, preservatives and other combinations. In other embodiments, a penetration or penetration enhancer is included in the composition and is effective to improve the penetration of the active ingredient into the skin and across the stratum corneum relative to a composition lacking the penetration enhancer. Various penetration enhancers, including oleic acid, oleyl alcohol, ethoxylated glycol, laurocapram, alkane carboxylic acids, dimethylsulfoxide, polar lipids or N-methyl-2-pyrrolidone are known in the art known to the skilled person. In another aspect, the composition may further comprise a hydrotrope, which acts to increase the disorder of the stratum corneum structure and thus allows increased transport across the stratum corneum. Various hydrotropes such as isopropanol, propylene glycol or sodium xylene sulfonate are known to those skilled in the art.
局部活性醫藥組成物應以有效影響所需變化的量施用。如本文所使用的「有效量」是指足以覆蓋需要改變的皮膚表面區域的量。活性化合物應該以按組成物的重量體積計約0.0001%至約15%的量存在。例如,它應該以組成物的約0.0005%至約5%的量存在;例如,它應該以組成物的約0.001%至約1%的量存在。這樣的化合物可以源自合成的或天然的。 Topically active pharmaceutical compositions should be administered in amounts effective to effect the desired change. An "effective amount" as used herein refers to an amount sufficient to cover the area of the skin surface in need of modification. The active compound should be present in an amount of from about 0.0001% to about 15% by weight volume of the composition. For example, it should be present in an amount of about 0.0005% to about 5% of the composition; for example, it should be present in an amount of about 0.001% to about 1% of the composition. Such compounds may be of synthetic or natural origin.
含服施用buccal administration
本揭露內容的醫藥組成物可以適合於含服施用的調配物來製備、包裝或出售。這樣的調配物可以例如為使用常規方法製備的片劑或錠劑的形式,並且可以包含例如0.1至20%(w/w)的活性成分,餘量包括口腔可溶解的或可降解的組成物,以及可選擇地本文所述的一種或多種另外的成分。可選地,適合含服施用的調配物可以包括包含活性成分的粉末狀或氣霧化(aerosolized)或噴霧化(atomized)溶液或懸浮液。當分散時,這種粉末狀、氣霧化或噴霧化的調配物可具有在約0.1 至約200納米範圍內的平均顆粒或液滴尺寸,並且可以進一步包括一種或多種本文所述的另外的成分。本文描述的調配物的實例不是窮舉的,並且應當理解,本揭露內容包括本文未描述但本領域技術人員已知的這些和其他調配物的另外的修改。 The pharmaceutical compositions of the present disclosure may be prepared, packaged, or sold in a formulation suitable for buccal administration. Such formulations may, for example, be in the form of tablets or lozenges prepared using conventional methods, and may contain, for example, 0.1 to 20% (w/w) active ingredient, the balance comprising orally dissolvable or degradable constituents. , and optionally one or more additional ingredients described herein. Alternatively, formulations suitable for buccal administration may include powdered or aerosolized or atomized solutions or suspensions containing the active ingredient. When dispersed, such powdered, aerosolized or nebulized formulations may have to an average particle or droplet size in the range of about 200 nanometers, and may further comprise one or more additional ingredients as described herein. The examples of formulations described herein are not exhaustive, and it is to be understood that this disclosure includes additional modifications of these and other formulations not described herein but known to those skilled in the art.
直腸施用rectal administration
本揭露內容的醫藥組成物可以以適於直腸施用的調配物製備、包裝或出售。這樣的組成物可以是例如栓劑、保留灌腸調配物和用於直腸或結腸灌洗的溶液的形式。 The pharmaceutical compositions of the present disclosure may be prepared, packaged, or sold in formulations suitable for rectal administration. Such compositions may be in the form of, for example, suppositories, retention enema formulations and solutions for rectal or colonic lavage.
栓劑調配物可通過將活性成分與無刺激性的醫藥上可接受的賦形劑混合來製備,該賦形劑在正常室溫(即,約20℃)下呈固體,並且在受試者的直腸溫度(即,在健康人體內約37℃)下呈液體。合適的醫藥上可接受的賦形劑包括但不限於可可脂、聚乙二醇和各種甘油酯。栓劑製劑可以進一步包含各種另外的成分,包括但不限於抗氧化劑和防腐劑。 Suppository formulations can be prepared by mixing the active ingredient with a non-irritating pharmaceutically acceptable excipient which is solid at normal room temperature (ie, about 20°C) and which is stable in the subject's It is liquid at rectal temperature (ie, about 37°C in a healthy human). Suitable pharmaceutically acceptable excipients include, but are not limited to, cocoa butter, polyethylene glycols and various glycerides. Suppository formulations may further contain various additional ingredients including, but not limited to, antioxidants and preservatives.
用於直腸或結腸灌洗的保留灌腸製劑或溶液可通過將活性成分與醫藥上可接受的液體載劑混合來製備。如本領域中眾所周知的,可以使用適合於受試者的直腸解剖結構的遞送裝置來施用灌腸製劑,並且可以將灌腸製劑包裝在遞送裝置中。灌腸製劑可以進一步包含各種另外的成分,包括但不限於抗氧化劑和防腐劑。 Retention enema formulations or solutions for rectal or colonic lavage can be prepared by mixing the active ingredient with a pharmaceutically acceptable liquid carrier. The enema formulation can be administered using a delivery device adapted to the rectal anatomy of the subject, and can be packaged in the delivery device, as is well known in the art. Enema formulations may further contain various additional ingredients including, but not limited to, antioxidants and preservatives.
另外施用形式Additional forms of administration
本揭露內容的另外的劑型包括如在美國專利號6,340,475、6,488,962、6,451,808、5,972,389、5,582,837和5,007,790中描述的劑型。本揭露內容的另外的劑型還包括如在美國專利申請號20030147952、20030104062、20030104053、20030044466、20030039688和20020051820中描述的劑型。本揭露內容的另外的劑型還包括如在PCT申請號WO 03/35041、WO 03/35040、WO 03/35029、WO 03/35177、WO 03/35039、WO 02/96404、WO 02/32416、WO 01/97783、WO 01/56544、WO 01/32217、WO 98/55107、WO 98/11879、WO 97/47285、WO 93/18755和WO 90/11757中描述的劑型。 Additional dosage forms of the present disclosure include dosage forms as described in US Pat. Additional dosage forms of the present disclosure also include dosage forms as described in US Patent Application Nos. 20030147952, 20030104062, 20030104053, 20030044466, 20030039688, and 20020051820. Additional dosage forms of the present disclosure also include those described in PCT Application Nos. WO 03/35041, WO 03/35040, WO 03/35029, WO 03/35177, WO 03/35039, WO 02/96404, WO 02/32416, WO 01/97783, WO 01/56544, WO 01/32217, WO 98/55107, WO 98/11879, WO Dosage forms described in WO 97/47285, WO 93/18755 and WO 90/11757.
控釋調配物和藥物遞送系統:Controlled release formulations and drug delivery systems:
在某些實施方式中,本揭露內容的組成物和/或調配物可以是但不限於短期、快速補償以及受控的例如持續釋放、延遲釋放和脈衝釋放調配物。 In certain embodiments, compositions and/or formulations of the present disclosure may be, but are not limited to, short-term, fast-compensating, and controlled, eg, sustained-release, delayed-release, and pulsed-release formulations.
術語持續釋放在其常規意義上是指可在延長的時間段內逐漸釋放藥物的醫藥調配物,儘管不一定,但在延長的時間段內可導致藥物的血液水平基本恒定。該時間段可以長達一個月或更長時間,並且應該是長於以推注形式施用相同量的釋放。 The term sustained release in its conventional sense refers to a pharmaceutical formulation that gradually releases a drug over an extended period of time, resulting in, though not necessarily, a substantially constant blood level of the drug over an extended period of time. This period of time can be as long as a month or more, and should be longer than the same amount administered as a bolus injection.
為了持續釋放,可以將化合物與合適的聚合物或疏水材料一起配製,所述聚合物或疏水材料為化合物提供持續釋放特性。這樣,用於本揭露內容方法的化合物可以以微粒形式通過例如注射施用,或者以晶片或圓盤形式通過植入施用。 For sustained release, the compounds can be formulated with suitable polymers or hydrophobic materials which impart sustained release characteristics to the compounds. Thus, compounds for use in the methods of the present disclosure may be administered in particulate form by, for example, injection, or in the form of wafers or discs by implantation.
在本揭露內容的某些實施方式中,使用緩釋調配物將本揭露內容中有用的化合物單獨或與另一種藥劑組合施用至受試者。 In certain embodiments of the present disclosure, a compound useful in the present disclosure is administered to a subject using a sustained release formulation, alone or in combination with another agent.
術語延遲釋放在本文中在其常規意義上是指在藥物施用後的一定延遲之後提供藥物的初始釋放的醫藥調配物,並且儘管不是必須的,但是可以包括從約10分鐘直至大約12個小時。 The term delayed release herein refers in its conventional sense to pharmaceutical formulations that provide initial release of the drug after a certain delay after drug administration, and may, though not necessarily, include from about 10 minutes up to about 12 hours.
術語脈衝釋放在本文中在其常規意義上是指以藥物施用後產生脈衝血漿分佈的方式提供藥物釋放的醫藥調配物。 The term pulsed release refers herein in its conventional sense to pharmaceutical formulations that provide drug release in such a way that following drug administration results in a pulsed plasma distribution.
術語立即釋放在其常規意義上是指在藥物施用後立即提供釋放藥物的醫藥調配物。 The term immediate release in its conventional sense refers to pharmaceutical formulations that provide release of the drug immediately after administration of the drug.
如本文所使用的,短期指在藥物施用之後的任何時間段,至多並且包括在藥物施用之後約8小時、約7小時、約6小時、約5小 時、約4小時、約3小時、約2小時、約1小時、約40分鐘、約20分鐘或約10分鐘和其任何或所有完整增量或部分增量。 As used herein, short-term refers to any period of time after drug administration, up to and including about 8 hours, about 7 hours, about 6 hours, about 5 hours after drug administration hours, about 4 hours, about 3 hours, about 2 hours, about 1 hour, about 40 minutes, about 20 minutes, or about 10 minutes and any or all whole or partial increments thereof.
如本文所使用的,快速補償指在藥物施用之後的任何時間段,至多並且包括約8小時、約7小時、約6小時、約5小時、約4小時、約3小時、約2小時、約1小時、約40分鐘、約20分鐘或約10分鐘,以及其任何完整增量和部分增量。 As used herein, rapid compensation refers to any period of time after drug administration, up to and including about 8 hours, about 7 hours, about 6 hours, about 5 hours, about 4 hours, about 3 hours, about 2 hours, about 1 hour, about 40 minutes, about 20 minutes, or about 10 minutes, and any full and partial increments thereof.
僅使用常規實驗,本領域技術人員將認識到或能夠確定本文所述的具體程序、實施方式、權利要求和實施例的許多等同方案。這樣的等同方案被認為在本揭露內容的範圍內,並由所附權利要求書涵蓋。例如,應當理解,利用本領域公認的替代方案並且僅使用常規實驗,包括但不限於反應時間、反應規格(size)/規模(volume)和實驗試劑比如溶劑、催化劑、壓力、大氣條件例如氮氣大氣壓、以及還原劑/氧化劑的反應條件的改進均在本申請的範圍內。 Those skilled in the art will recognize, or be able to ascertain, using no more than routine experimentation, many equivalents to the specific procedures, embodiments, claims, and examples described herein. Such equivalents are considered to be within the scope of this disclosure and are covered by the appended claims. For example, it is understood that art-recognized alternatives are employed and only routine experimentation is used, including but not limited to reaction times, reaction size/volume, and experimental reagents such as solvents, catalysts, pressure, atmospheric conditions such as nitrogen atmosphere , and the improvement of the reaction conditions of the reducing agent/oxidizing agent are all within the scope of the present application.
應當理解,無論在本文何處提供數值和範圍,範圍格式的描述僅是為了方便和簡潔,而不應被解釋為對本揭露內容範圍的僵化限制。因此,這些值和範圍所涵蓋的所有值和範圍意在被涵蓋在本揭露內容的範圍內。此外,本申請還考慮了落入這些範圍內的所有值以及該值的範圍的上限或下限。範圍的描述應被認為已明確公開了所有可能的子範圍以及該範圍內的單個數值,以及在合適時該範圍內的數值的部分整數。例如,對範圍從1到6的描述應被視為已明確公開了從1到3、從1到4、從1到5、從2到4、從2到6、從3到6等的子範圍,以及該範圍內的單個數值,例如1、2、2.7、3、4、5、5.3和6。無論該範圍的廣度如何,這都適用。 It should be understood that wherever values and ranges are provided herein, the description in range format is merely for convenience and brevity and should not be construed as an inflexible limitation on the scope of the disclosure. Accordingly, all values and ranges encompassed by these values and ranges are intended to be encompassed within the scope of this disclosure. In addition, this application also contemplates all values falling within these ranges, as well as the upper or lower limits of that range of values. The description of a range should be considered to have expressly disclosed all possible subranges as well as individual values within that range and, where appropriate, sub-integers of values within that range. For example, a description of a range from 1 to 6 should be considered to have expressly disclosed the range from 1 to 3, from 1 to 4, from 1 to 5, from 2 to 4, from 2 to 6, from 3 to 6, etc. range, and individual values within that range, such as 1, 2, 2.7, 3, 4, 5, 5.3, and 6. This applies regardless of the breadth of the range.
以下實施例進一步闡釋了本揭露內容的方面。然而,它們決不是對本文所述的本揭露內容的教導或公開內容的限制。 The following examples further illustrate aspects of the present disclosure. In no way, however, are limitations on the teaching or disclosure of the disclosure set forth herein.
實施例Example
現在參考以下實施例描述本揭露內容。提供這些實施例僅出於說明的目的,並且本揭露內容不限於這些實施例,而是涵蓋由於本文提供的教導而顯而易見的所有變型。 The present disclosure is now described with reference to the following examples. These examples are provided for the purpose of illustration only, and the present disclosure is not limited to these examples, but covers all modifications apparent as a result of the teaching provided herein.
如本文所使用的,術語「主要非對映異構物」和「次要非映異構物」是指在指定反應條件下獲得的非對映異構物的相對量,其中「主要非對映異構物」的獲得量高於「次要的非映體」的獲得量。在某些實施方式中,主要的非對映異構物保留了用於製備化合物的起始材料的立體化學結構,而次要非對映異構物至少是由於其部分差向異構化作用而導致的。 As used herein, the terms "major diastereomer" and "minor diastereomer" refer to the relative amounts of diastereomers obtained under specified reaction conditions, wherein "major diastereoisomer" "enantiomer" is obtained in higher amounts than the "minor diastereomer". In certain embodiments, the major diastereomer retains the stereochemistry of the starting material used to prepare the compound, while the minor diastereomer is at least partially epimerized And caused.
實施例1:N-((2S)-1-((1-(4-氯噻唑-2-基)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺(化合物1和2)Example 1: N -((2 S )-1-((1-(4-chlorothiazol-2-yl)-1-oxo-3-(( S )-2-oxopyrrolidine-3 -yl)propan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy- 1H -indole-2-carboxamide (compound 1 and 2)
步驟(1):(4-甲氧基-1H-吲哚-2-羰基)-L-白胺酸甲酯Step (1): (4-Methoxy-1H-indole-2-carbonyl)-L-leucine methyl ester
在0℃下向4-甲氧基-1H-吲哚-2-羧酸(2g,10.47mmol)在DMF(20mL)中的攪拌懸浮液加入HATU(5.96g,15.70mmol)。在20分鐘之後,加入L-白胺酸甲酯鹽酸鹽(1.89g,10.47mmol)在DMF(1mL)中的溶液,隨後加入N,N-二異丙基乙胺(5.6mL,31.43mmol)。將反應混合物在0℃下攪拌3小時。將反應物用飽和氯化銨水溶液(10mL)稀釋並分離各層。將水相用CH2Cl2(2×10mL)萃取。將合併後的有機相用飽和碳酸氫鈉水溶液(10mL)、H2O(10mL)、鹽水溶液(10 mL)洗滌,經無水硫酸鈉乾燥,在真空中過濾並濃縮。通過正相SiO2層析法(0至100% EtOAc/庚烷)純化粗殘餘物,得到(4-甲氧基-1H-吲哚-2-羰基)-L-白胺酸甲酯(1.6g,產率48%,觀察到m/z:319[M+H]+)。 To a stirred suspension of 4-methoxy-lH-indole-2-carboxylic acid (2 g, 10.47 mmol) in DMF (20 mL) was added HATU (5.96 g, 15.70 mmol) at 0 °C. After 20 minutes, a solution of L-leucine methyl ester hydrochloride (1.89 g, 10.47 mmol) in DMF (1 mL) was added followed by N,N -diisopropylethylamine (5.6 mL, 31.43 mmol ). The reaction mixture was stirred at 0 °C for 3 hours. The reaction was diluted with saturated aqueous ammonium chloride (10 mL) and the layers were separated. The aqueous phase was extracted with CH2Cl2 (2 x 10 mL). The combined organic phases were washed with saturated aqueous sodium bicarbonate (10 mL), H2O (10 mL), brine solution (10 mL), dried over anhydrous sodium sulfate, filtered and concentrated in vacuo. The crude residue was purified by normal phase SiO2 chromatography (0 to 100% EtOAc/heptane) to afford (4-methoxy-1H-indole-2-carbonyl)-L-leucine methyl ester (1.6 g, 48% yield, observed m/z: 319 [M+H] + ).
步驟(2):(4-甲氧基-1H-吲哚-2-羰基)-L-白胺酸Step (2): (4-methoxy-1H-indole-2-carbonyl)-L-leucine
向(4-甲氧基-1H-吲哚-2-羰基)-L-白胺酸甲酯(3.00g,9.42mmol)在THF(5mL)中的攪拌溶液加入氫氧化鋰(1M水溶液,38mL,37.6mmol)。將反應物在室溫下攪拌1小時。將混合物用鹽酸水溶液(1N)酸化至pH 5並用EtOAc(3×10mL)萃取。將合併後的有機相用H2O(10mL)、鹽水溶液(10mL)洗滌,經無水硫酸鈉乾燥,在真空中過濾並濃縮,得到(4-甲氧基-1H-吲哚-2-羰基)-L-白胺酸,其無需進一步純化即可用於下一步(2.5g,觀察到m/z:305[M+H]+)。 To a stirred solution of (4-methoxy-1H-indole-2-carbonyl)-L-leucine methyl ester (3.00 g, 9.42 mmol) in THF (5 mL) was added lithium hydroxide (1M in water, 38 mL , 37.6 mmol). The reaction was stirred at room temperature for 1 hour. The mixture was acidified to pH 5 with aqueous hydrochloric acid (1 N) and extracted with EtOAc (3 x 10 mL). The combined organic phases were washed with H2O (10 mL), brine solution (10 mL), dried over anhydrous sodium sulfate, filtered and concentrated in vacuo to afford (4-methoxy-1H-indole-2-carbonyl ) -L -leucine, which was used in the next step without further purification (2.5 g, observed m/z: 305 [M+H] + ).
步驟(3):(S)-2-((第三丁氧基羰基)胺基)-3-((S)-2-氧代吡咯啶-3-基)丙酸Step (3): (S)-2-((tert-butoxycarbonyl)amino)-3-((S)-2-oxopyrrolidin-3-yl)propanoic acid
在0℃下向(2S)-2-(第三丁氧基羰基胺基)-3-[(3S)-2-氧代吡咯啶-3-基]丙酸甲酯(10g,34.9mmol)在MeOH(20mL)中的混合物逐滴加入NaOH(4N水溶液,預冷至0℃,35mL,139.7mmol)。在添加期間將內部反應溫度保持在低於0℃。將混合物在0℃下攪拌1小時,並且然後用濃HCl酸化至pH 7,同時將內部溫度保持在低於10℃。在減壓下除去有機溶劑。將混合物用濃HCl酸化至pH 4並用EtOAc (5×100mL)萃取。將合併後的有機相用鹽水溶液(100mL)洗滌,經無水硫酸鈉乾燥,在真空中過濾並濃縮,得到(2S)-2-(第三丁氧基羰基胺基)-3-[(3S)-2-氧代吡咯啶-3-基]丙酸,其無需進一步純化即可用於下一步(9.20g,觀察到m/z:273[M+H]+)。 To (2S)-2-(tert-butoxycarbonylamino)-3-[(3S)-2-oxopyrrolidin-3-yl]propionic acid methyl ester (10g, 34.9mmol) at 0°C The mixture in MeOH (20 mL) was added dropwise with NaOH (4N in water, pre-cooled to 0 °C, 35 mL, 139.7 mmol). The internal reaction temperature was kept below 0°C during the addition. The mixture was stirred at 0°C for 1 hour and then acidified to pH 7 with concentrated HCl while keeping the internal temperature below 10°C. The organic solvent was removed under reduced pressure. The mixture was acidified to pH 4 with concentrated HCl and extracted with EtOAc (5 x 100 mL). The combined organic phases were washed with brine solution (100 mL), dried over anhydrous sodium sulfate, filtered and concentrated in vacuo to afford ( 2S )-2-(tert-butoxycarbonylamino)-3-[( 3S )-2-oxopyrrolidin-3-yl]propionic acid, which was used in the next step without further purification (9.20 g, observed m/z: 273 [M+H] + ).
步驟(4):((S)-1-(甲氧基(甲基)胺基)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基甲酸第三丁酯Step (4): ((S)-1-(methoxy(methyl)amino)-1-oxo-3-((S)-2-oxopyrrolidin-3-yl)propane- 2-yl) tertiary butyl carbamate
在室溫下向(2S)-2-(第三丁氧基羰基胺基)-3-[(3S)-2-氧代吡咯啶-3-基]丙酸(8.66g)在DMF(80mL)中的混合物加入EDC鹽酸鹽(7.32g,38.2mmol)、HOBt一水化物(5.84g,38.2mmol)和N-甲氧基甲胺鹽酸鹽(4.34g,44.5mmol)。將反應物冷卻至0℃,並在5min內逐滴加入三乙胺(11mL,79.5mmol)。將反應物升溫至室溫,過夜。將混合物用EtOAc(50mL)稀釋,並通過CELITE®過濾除去所得固體。將有機相用H2O(100mL)洗滌,並用EtOAc(5×200mL)和CH2Cl2(2×200mL)進一步萃取水相。將合併後的有機相經無水硫酸鈉乾燥,在真空中過濾並濃縮。通過反相HPLC純化殘餘物,得到產物((S)-1-(甲氧基(甲基)胺基)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基甲酸第三丁酯(5.5g,產率55%,來自(2S)-2-(第三丁氧基羰基胺基)-3-[(3S)-2-氧代吡咯啶-3-基]丙酸甲酯,觀察到m/z:316[M+H]+)。 To (2 S )-2-(tertiary butoxycarbonylamino)-3-[(3 S )-2-oxopyrrolidin-3-yl]propanoic acid (8.66g) in DMF at room temperature (80 mL) was added EDC hydrochloride (7.32 g, 38.2 mmol), HOBt monohydrate (5.84 g, 38.2 mmol) and N -methoxymethylamine hydrochloride (4.34 g, 44.5 mmol). The reaction was cooled to 0 °C and triethylamine (11 mL, 79.5 mmol) was added dropwise over 5 min. The reaction was allowed to warm to room temperature overnight. The mixture was diluted with EtOAc (50 mL), and the resulting solid was removed by filtration through CELITE® . The organic phase was washed with H2O (100 mL ), and the aqueous phase was further extracted with EtOAc (5 x 200 mL) and CH2Cl2 (2 x 200 mL). The combined organic phases were dried over anhydrous sodium sulfate, filtered and concentrated in vacuo. Purification of the residue by reverse phase HPLC gave the product ((S)-1-(methoxy(methyl)amino)-1-oxo-3-((S)-2-oxopyrrolidine-3 -yl)propan-2-yl)tert-butyl carbamate (5.5 g, 55% yield, from (2S)-2-(tert-butoxycarbonylamino)-3-[(3S)- Methyl 2-oxopyrrolidin-3-yl]propionate, observed m/z: 316 [M+H] + ).
步驟(S):(S)-2-胺基-N-甲氧基-N-甲基-3-((S)-2-氧代吡咯啶-3-基)丙醯胺鹽酸鹽Step (S): (S)-2-Amino-N-methoxy-N-methyl-3-((S)-2-oxopyrrolidin-3-yl)propionamide hydrochloride
向((S)-1-(甲氧基(甲基)胺基)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基甲酸第三丁酯(0.8g,2.5mmol)在CH2Cl2(20mL)中的溶液加入HCl(4N的1,4-二烷溶液,1.9mL,7.5mmol)。將反應物在室溫下攪拌24小時。在減壓下除去溶劑,得到(S)-2-胺基-N-甲氧基-N-甲基-3-((S)-2-氧代吡咯啶-3-基)丙醯胺鹽酸鹽,其無需進一步純化即可用於下一步(0.6g,m/z:觀察到216[M+H]+)。 To ((S)-1-(methoxy(methyl)amino)-1-oxo-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl) A solution of tert-butyl carbamate (0.8 g, 2.5 mmol) in CH 2 Cl 2 (20 mL) was added to HCl (4N 1,4-di alkane solution, 1.9mL, 7.5mmol). The reaction was stirred at room temperature for 24 hours. The solvent was removed under reduced pressure to give ( S )-2-amino- N -methoxy- N -methyl-3-(( S )-2-oxopyrrolidin-3-yl)propionamide salt Acid salt, which was used in the next step without further purification (0.6 g, m/z: 216 [M+H] + observed).
步驟(6):4-甲氧基-N-((S)-1-(((S)-1-(甲氧基(甲基)胺基)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-1H-吲哚-2-甲醯胺Step (6): 4-methoxy-N-((S)-1-(((S)-1-(methoxy(methyl)amino)-1-oxo-3-(( S)-2-oxopyrrolidin-3-yl)propan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-1H-indole-2-formyl amine
將(2S)-2-[(4-甲氧基-1H-吲哚-2-羰基)胺基]-4-甲基-戊酸(772mg)和HATU(1.74g,4.57mmol)在DMF(5mL)中的混合物在0℃下攪拌10分鐘。加入(2S)-2-胺基-N-甲氧基-N-甲基-3-[(3S)-2-氧代吡咯啶-3-基]丙醯胺(546mg,2.54mmol)在DMF(0.5mL)中的溶液,隨後加入N,N-二異丙基乙胺(1.4mL,7.61mmol)。將反應物在0℃下攪拌1小時,並升溫至室溫,過夜。在減壓下除去溶劑,並通過正相SiO2層析法(0至5% MeOH/CH2Cl2)純化殘餘物,得到4-甲氧基-N-((S)-1-(((S)-1-(甲氧基(甲基)胺基)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-1H-吲哚-2-甲醯胺(1.12g,產率88%,觀察到m/z:502[M+H]+)。 ( 2S )-2-[(4-Methoxy-1H-indole-2-carbonyl)amino]-4-methyl-pentanoic acid (772mg) and HATU (1.74g, 4.57mmol) in DMF (5 mL) was stirred at 0°C for 10 minutes. Add ( 2S )-2-amino- N -methoxy- N -methyl-3-[(3S)-2-oxopyrrolidin-3-yl]propanamide (546mg, 2.54mmol) in A solution in DMF (0.5 mL), followed by the addition of N,N -diisopropylethylamine (1.4 mL, 7.61 mmol). The reaction was stirred at 0 °C for 1 hour and allowed to warm to room temperature overnight. The solvent was removed under reduced pressure and the residue was purified by normal phase SiO2 chromatography (0 to 5% MeOH/ CH2Cl2 ) to afford 4-methoxy- N -(( S )-1-(( ( S )-1-(methoxy(methyl)amino)-1-oxo-3-(( S )-2-oxopyrrolidin-3-yl)propan-2-yl)amino )-4-methyl-1-oxopentan-2-yl)-1H-indole-2-carboxamide (1.12 g, 88% yield, observed m/z: 502 [M+H] + ).
步驟(7):N-((2S)-1-((1-(4-氯噻唑-2-基)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺Step (7): N-((2S)-1-((1-(4-chlorothiazol-2-yl)-1-oxo-3-((S)-2-oxopyrrolidine-3 -yl)propane-2-yl)amino)-4-methyl-1-oxopentane-2-yl)-4-methoxy-1H-indole-2-formamide
將4-甲氧基-N-[(1S)-1-[[(1S)-2-[甲氧基(甲基)胺基]-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]胺甲醯基]-3-甲基-丁基]-1H-吲哚-2-甲醯胺(60mg,0.12mmol)和2-溴-4-氯-噻唑(106mg,0.54mmol)在THF(5mL)中的混合物冷卻至-78℃。向反應逐滴加入n-BuLi(1.6N的己烷溶液,0.34mL,0.54mmol),並將混合物在-78℃下攪拌30分鐘,並且然後在室溫下攪拌3小時。在-78℃下加入另外的2-溴-4-氯-噻唑(30mg,0.152mmol),隨後加入n-BuLi(1.6M己烷溶液,0.1mL,0.16mmol)。將混合物升溫至室溫,並攪拌1小時。通過加入飽和氯化銨水溶液(5mL)淬滅反應物,用EtOAc(3×10mL)萃取,經無水硫酸鈉乾燥,在真空中過濾並濃縮。通過反相HPLC純化殘餘物,得到粗產物,為黃色泡沫。通過正相SiO2層析法(0至5% MeOH/CH2Cl2)進一步純化殘餘物,以提供每種非對映異構物。 4-Methoxy- N -[(1 S )-1-[[(1 S )-2-[methoxy (methyl)amino]-2-oxo-1-[[(3 S )-2-oxopyrrolidin-3-yl]methyl]ethyl]carbamoyl]-3-methyl-butyl]-1H-indole-2-carboxamide (60mg, 0.12mmol ) and 2-bromo-4-chloro-thiazole (106 mg, 0.54 mmol) in THF (5 mL) was cooled to -78 °C. To the reaction was added n -BuLi (1.6N in hexanes, 0.34 mL, 0.54 mmol) dropwise, and the mixture was stirred at -78°C for 30 minutes and then at room temperature for 3 hours. Additional 2-bromo-4-chloro-thiazole (30 mg, 0.152 mmol) was added at -78 °C, followed by n -BuLi (1.6M in hexane, 0.1 mL, 0.16 mmol). The mixture was warmed to room temperature and stirred for 1 hour. The reaction was quenched by the addition of saturated aqueous ammonium chloride (5 mL), extracted with EtOAc (3 x 10 mL), dried over anhydrous sodium sulfate, filtered and concentrated in vacuo. The residue was purified by reverse phase HPLC to give the crude product as a yellow foam. The residue was further purified by normal phase SiO2 chromatography (0 to 5 % MeOH/ CH2Cl2 ) to provide each diastereoisomer.
次要非對映異構物(較快洗脫的非對映異構物)(4.3mg,產率6%):觀察到m/z:560[M+H]+;1H NMR(400MHz,CDCl3):δ 10.12(s,1H),8.65(d,J=6.1Hz,1H),7.12(s,1H),7.02(d,J=8.7Hz,1H),6.95-6.90(m,2H),6.80(s,1H),6.75(d,J=8.3Hz,1H),6.34(d,J=7.8Hz,1H),5.40(ddd,J=11.5,6.1,3.1Hz,1H),4.87(td,J=8.6,5.2Hz,1H),3.79(s,3H),3.15-3.00(m,2H),2.54-2.30(m,2H),2.24(dd,J=13.1,7.1Hz,1H),2.05(ddd,J=13.8,11.5,5.3Hz,1H),2.01(ddd,J=13.9,8.4,3.4Hz,1H),1.83-1.53(m,3H),0.86(dd,J=6.1,3.4Hz,6H)。 Minor diastereomer (faster eluting diastereomer) (4.3 mg, 6% yield): Observed m/z: 560 [M+H] + ; 1 H NMR (400 MHz , CDCl 3 ): δ 10.12(s, 1H), 8.65(d, J=6.1Hz, 1H), 7.12(s, 1H), 7.02(d, J=8.7Hz, 1H), 6.95-6.90(m, 2H), 6.80(s, 1H), 6.75(d, J=8.3Hz, 1H), 6.34(d, J=7.8Hz, 1H), 5.40(ddd, J=11.5, 6.1, 3.1Hz, 1H), 4.87(td, J=8.6, 5.2Hz, 1H), 3.79(s, 3H), 3.15-3.00(m, 2H), 2.54-2.30(m, 2H), 2.24(dd, J=13.1, 7.1Hz, 1H), 2.05(ddd, J=13.8, 11.5, 5.3Hz, 1H), 2.01(ddd, J=13.9, 8.4, 3.4Hz, 1H), 1.83-1.53(m, 3H), 0.86(dd,J= 6.1, 3.4Hz, 6H).
主要非對映異構物(較慢洗脫的非對映異構物):(9.6mg,產率14%):觀察到m/z:560[M+H]+;1H NMR(400MHz,CDCl3):δ 10.26(s,1H),8.78(d,J=6.1Hz,1H),7.43(s,1H),7.29(d,J=8.7Hz,1H),7.18-7.05(m,2H),7.02(s,1H),6.95(d,J=8.3 Hz,1H),6.44(d,J=7.8Hz,1H),5.50(ddd,J=11.5,6.1,3.1Hz,1H),4.97(td,J=8.6,5.2Hz,1H),3.89(s,3H),3.25-3.08(m,2H),2.64-2.40(m,2H),2.34(dd,J=13.1,7.1Hz,1H),2.15(ddd,J=13.8,11.5,5.3Hz,1H),2.01(ddd,J=13.9,8.4,3.4Hz,1H),1.93-1.63(m,3H),0.96(dd,J=6.1,3.4Hz,6H)。 Major diastereomer (slower eluting diastereomer) : (9.6 mg, 14% yield): Observed m/z: 560 [M+H] + ; 1 H NMR (400 MHz , CDCl 3 ): δ 10.26(s, 1H), 8.78(d, J=6.1Hz, 1H), 7.43(s, 1H), 7.29(d, J=8.7Hz, 1H), 7.18-7.05(m, 2H), 7.02(s, 1H), 6.95(d, J=8.3Hz, 1H), 6.44(d, J=7.8Hz, 1H), 5.50(ddd, J=11.5, 6.1, 3.1Hz, 1H), 4.97(td, J=8.6, 5.2Hz, 1H), 3.89(s, 3H), 3.25-3.08(m, 2H), 2.64-2.40(m, 2H), 2.34(dd, J=13.1, 7.1Hz, 1H), 2.15(ddd, J=13.8, 11.5, 5.3Hz, 1H), 2.01(ddd, J=13.9, 8.4, 3.4Hz, 1H), 1.93-1.63(m, 3H), 0.96(dd,J= 6.1, 3.4Hz, 6H).
實施例2:N-((2S)-1-((1-(4-氯噻唑-2-基)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺(化合物3和4)Example 2: N -((2 S )-1-((1-(4-chlorothiazol-2-yl)-1-oxo-3-(( S )-2-oxopyrrolidine-3 -yl)propan-2-yl)amino)-3-cyclohexyl-1-oxopropan-2-yl)-4-methoxy- 1H -indole-2-carboxamide (compound 3 and 4)
用適當的Weinreb醯胺和適當取代的噻唑以與關於N-((2S)-1-((1-(4-氯噻唑-2-基)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺所描述的類似方式來製備N-((2S)-1-((1-(4-氯噻唑-2-基)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺。 With appropriate Weinreb amide and appropriately substituted thiazoles with respect to N -(( 2S )-1-((1-(4-chlorothiazol-2-yl)-1-oxo-3-(( S )-2-oxopyrrolidin-3-yl)propan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy- 1H -ind N -(( 2S )-1-((1-(4-chlorothiazol-2-yl)-1-oxo-3-(( S )-2-oxopyrrolidin-3-yl)propan-2-yl)amino)-3-cyclohexyl-1-oxopropan-2-yl)-4-methoxy- 1H -indole -2-Formamide.
次要非對映異構物:觀察到m/z:600[M+H]+;1H NMR(400MHz,CDCl3):δ 9.76(s,1H),8.88(d,J=6.0Hz,1H),7.47(dd,J=2.5,0.4Hz,1H),7.24-7.17(m,1H),7.16-7.11(m,1H),7.04(d,J=8.2Hz,1H),6.66(d,J=8.2Hz,1H),6.51(d,J=7.8Hz,1H),5.96(s,1H),5.61(q,J=5.5Hz,1H),4.83(td,J=9.0,4.6Hz,1H),4.25-4.2(m,1H),3.95(s,3H),3.24-3.02(m,2H),2.49(s,2H),2.32-2.06(m,2H),1.89-1.62(m,4H),1.45(d,J=9.5Hz,3H),1.31-1.11(m,4H),1.11-0.85(m,2H)。 Minor diastereomer : Observed m/z: 600[M+H] + ; 1 H NMR (400MHz, CDCl 3 ): δ 9.76(s, 1H), 8.88(d, J=6.0Hz, 1H), 7.47(dd, J=2.5, 0.4Hz, 1H), 7.24-7.17(m, 1H), 7.16-7.11(m, 1H), 7.04(d, J=8.2Hz, 1H), 6.66(d , J=8.2Hz, 1H), 6.51(d, J=7.8Hz, 1H), 5.96(s, 1H), 5.61(q, J=5.5Hz, 1H), 4.83(td, J=9.0, 4.6Hz , 1H), 4.25-4.2(m,1H), 3.95(s,3H), 3.24-3.02(m,2H), 2.49(s,2H), 2.32-2.06(m,2H), 1.89-1.62(m ,4H), 1.45(d, J=9.5Hz, 3H), 1.31-1.11(m,4H), 1.11-0.85(m,2H).
主要非對映異構物:觀察到m/z:600[M+H]+;1H NMR (400MHz,CDCl3):δ 9.76(s,1H),8.88(d,J=6.0Hz,1H),7.47(dd,J=2.5,0.4Hz,1H),7.24-7.17(m,1H),7.16-7.11(m,1H),7.04(d,J=8.2Hz,1H),6.66(d,J=8.2Hz,1H),6.51(d,J=7.8Hz,1H),5.96(s,1H),5.61(q,J=5.5Hz,1H),4.83(td,J=9.0,4.6Hz,1H),4.25-4.2(m,1H),3.95(s,3H),3.24-3.02(m,2H),2.49(s,2H),2.32-2.06(m,2H),1.89-1.62(m,4H),1.45(d,J=9.5Hz,3H),1.31-1.11(m,4H),1.11-0.85(m,2H)。 Major diastereomer : Observed m/z: 600[M+H] + ; 1 H NMR (400MHz, CDCl 3 ): δ 9.76(s, 1H), 8.88(d, J=6.0Hz, 1H ), 7.47(dd, J=2.5, 0.4Hz, 1H), 7.24-7.17(m, 1H), 7.16-7.11(m, 1H), 7.04(d, J=8.2Hz, 1H), 6.66(d, J=8.2Hz, 1H), 6.51(d, J=7.8Hz, 1H), 5.96(s, 1H), 5.61(q, J=5.5Hz, 1H), 4.83(td, J=9.0, 4.6Hz, 1H), 4.25-4.2(m,1H), 3.95(s,3H), 3.24-3.02(m,2H), 2.49(s,2H), 2.32-2.06(m,2H), 1.89-1.62(m, 4H), 1.45(d, J=9.5Hz, 3H), 1.31-1.11(m, 4H), 1.11-0.85(m, 2H).
實施例3:9-羥基-N-((S)-4-甲基-1-(((S)-4-(甲胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺(化合物5)Example 3: 9-Hydroxy-N-((S)-4-methyl-1-(((S)-4-(methylamino)-3,4-dioxo-1-((S)- 2-oxopyrrolidin-3-yl)butane-2-yl)amino)-1-oxopentane-2-yl)-9H-oxo-9-formamide (compound 5)
步驟(1):(S)-2-胺基-3-((S)-2-氧代吡咯啶-3-基)丙酸甲酯鹽酸鹽Step (1): Methyl (S)-2-amino-3-((S)-2-oxopyrrolidin-3-yl)propionate hydrochloride
向(S)-2-((第三丁氧基羰基)胺基)-3-((S)-2-氧代吡咯啶-3-基)丙酸甲酯(5.0g,17.4mmol)在CH2Cl2(20mL)中的溶液加入HCl(4M的1,4-二烷溶液,20mL,80.1mmol)。將反應物在室溫下攪拌12小時。將混合物在減壓下濃縮,得到(S)-2-胺基-3-((S)-2-氧代吡咯啶-3-基)丙酸甲酯鹽酸鹽,其無需進一步純化即可用於下一步(3g,觀察到m/z:187[M+H]+)。 To (S)-2-((tertiary butoxycarbonyl)amino)-3-((S)-2-oxopyrrolidin-3-yl)propanoic acid methyl ester (5.0g, 17.4mmol) in A solution in CH 2 Cl 2 (20 mL) was added with HCl (4M in 1,4-di alkane solution, 20mL, 80.1mmol). The reaction was stirred at room temperature for 12 hours. The mixture was concentrated under reduced pressure to afford methyl (S)-2-amino-3-((S)-2-oxopyrrolidin-3-yl)propanoate hydrochloride which was used without further purification In the next step (3g, observed m/z: 187 [M+H] + ).
步驟(2):(S)-2-((S)-2-((第三丁氧基羰基)胺基)-4-甲基戊醯胺)-3-((S)-2-氧代吡咯啶-3-基)丙酸甲酯Step (2): (S)-2-((S)-2-((tert-butoxycarbonyl)amino)-4-methylpentanamide)-3-((S)-2-oxo Methyl pyrrolidin-3-yl)propionate
在-10℃下向(第三丁氧基羰基)-L-白胺酸(10g,43.3mmol)在CH2Cl2(50mL)和DMF(50mL)中的溶液分5份加入HATU(26.5g,69.3mmol),並將混合物攪拌20min。分一份加入粗產物(S)-2-胺基-3-((S)-2-氧代吡咯啶-3-基)丙酸甲酯鹽酸鹽(9.7g),並將混合物在-10℃下攪拌30min。然後在2min內逐滴加入DIPEA(1.7mL,10.5mmol),並將混合物在-10℃下攪拌12小時。將反應混合物用飽和氯化銨水溶液(3×100mL)洗滌,並用CH2Cl2(300mL)萃取。進一步用飽和碳酸氫鈉水溶液(3×100mL)和鹽水溶液(3×100mL)洗滌有機層。將合併後的有機萃取物經無水硫酸鈉乾燥並在真空下濃縮。經由正相SiO2層析法(0-10% MeOH/CH2Cl2)純化殘餘物,得到(S)-2-((S)-2-((第三丁氧基羰基)胺基)-4-甲基戊醯胺)-3-((S)-2-氧代吡咯啶-3-基)丙酸甲酯(12g,產率80%,觀察到m/z:400[M+H]+)。 To a solution of (tert-butoxycarbonyl) -L -leucine (10 g, 43.3 mmol) in CH 2 Cl 2 (50 mL) and DMF (50 mL) was added HATU (26.5 g , 69.3mmol), and the mixture was stirred for 20min. The crude product (S)-methyl 2-amino-3-((S)-2-oxopyrrolidin-3-yl)propanoate hydrochloride (9.7 g) was added in one portion, and the mixture was stirred at - Stir at 10 °C for 30 min. Then DIPEA (1.7 mL, 10.5 mmol) was added dropwise over 2 min, and the mixture was stirred at -10 °C for 12 h. The reaction mixture was washed with saturated aqueous ammonium chloride (3 x 100 mL), and extracted with CH2Cl2 ( 300 mL). The organic layer was further washed with saturated aqueous sodium bicarbonate (3 x 100 mL) and brine solution (3 x 100 mL). The combined organic extracts were dried over anhydrous sodium sulfate and concentrated under vacuum. Purification of the residue via normal phase SiO2 chromatography (0-10% MeOH/ CH2Cl2 ) afforded (S)-2-( ( S)-2-((tert-butoxycarbonyl)amino) -4-Methylpentamide)-3-((S)-2-oxopyrrolidin-3-yl)propanoic acid methyl ester (12 g, yield 80%, observed m/z: 400 [M+ H] + ).
步驟(3):(S)-2-((S)-2-胺基-4-甲基戊醯胺)-3-((S)-2-氧代吡咯啶-3-基)丙酸甲酯Step (3): (S)-2-((S)-2-Amino-4-methylpentanamide)-3-((S)-2-oxopyrrolidin-3-yl)propanoic acid methyl ester
向(S)-2-((S)-2-((第三丁氧基羰基)胺基)-4-甲基戊醯胺)-3-((S)-2-氧代吡咯啶-3-基)丙酸甲酯(10g,25mmol)在CH2Cl2(20mL)中的攪拌溶液加入HCl(4M的1,4-二烷溶液,40mL,160mmol)。將反應混合物在室溫下攪拌12小時,並且然後在減壓下濃縮,得到(S)-2-((S)-2-胺基-4-甲基戊醯胺)-3-((S)-2-氧代吡咯啶-3-基)丙 酸甲酯的鹽酸鹽,其無需進一步純化即可用於下一步(8g,觀察到m/z:300[M+H]+)。 To (S)-2-((S)-2-((tertiary butoxycarbonyl)amino)-4-methylpentanamide)-3-((S)-2-oxopyrrolidine- A stirred solution of methyl 3-yl)propionate (10 g, 25 mmol) in CH 2 Cl 2 (20 mL) was added to HCl (4M in 1,4-di alkane solution, 40mL, 160mmol). The reaction mixture was stirred at room temperature for 12 hours, and then concentrated under reduced pressure to give (S)-2-((S)-2-amino-4-methylpentanamide)-3-((S )-2-oxopyrrolidin-3-yl)propanoic acid methyl ester hydrochloride which was used in the next step without further purification (8 g, observed m/z: 300 [M+H] + ).
步驟(4):(S)-2-((S)-2-(9-羥基-9H-茀-9-甲醯胺基)-4-甲基戊醯胺)-3-((S)-2-氧代吡咯啶-3-基)丙酸甲酯Step (4): (S)-2-((S)-2-(9-Hydroxy-9H-oxo-9-formamido)-4-methylpentanamide)-3-((S) -2-Oxopyrrolidin-3-yl)propionic acid methyl ester
在0℃下向9-羥基-9H-茀-9-羧酸(5.0g,22.1mmol)在CH2Cl2(20mL)中的攪拌懸浮液加入HATU(13.6g,28.8mmol)。在20分鐘之後,加入(S)-2-((S)-2-胺基-4-甲基戊醯胺)-3-((S)-2-氧代吡咯啶-3-基)丙酸甲酯鹽酸鹽(11.1g)在DMF(10mL)中的溶液,隨後加入N,N-二異丙基乙胺(15.4mL,88.5mmol)。將反應物在0℃下攪拌3小時。將反應混合物用飽和氯化銨水溶液(25mL)稀釋並分離各層。用CH2Cl2(2×10mL)進一步萃取水性層。將合併後的有機相用飽和碳酸氫鈉水溶液(25mL)、H2O(25mL)、鹽水溶液(25mL)洗滌,經無水硫酸鈉乾燥並在真空下濃縮。通過正相SiO2層析法(0-5% MeOH/CH2Cl2)純化殘餘物,得到(S)-2-((S)-2-(9-羥基-9H-茀-9-甲醯胺基)-4-甲基戊醯胺)-3-((S)-2-氧代吡咯啶-3-基)丙酸甲酯(6g,產率54%,觀察到m/z:508[M+H]+)。 To a stirred suspension of 9-hydroxy- 9H -tertilene-9-carboxylic acid (5.0 g, 22.1 mmol) in CH2Cl2 (20 mL ) was added HATU (13.6 g, 28.8 mmol) at 0 °C. After 20 minutes, (S)-2-((S)-2-amino-4-methylpentanamide)-3-((S)-2-oxopyrrolidin-3-yl)propane was added A solution of methyl ester hydrochloride (11.1 g) in DMF (10 mL), followed by the addition of N,N -diisopropylethylamine (15.4 mL, 88.5 mmol). The reaction was stirred at 0 °C for 3 hours. The reaction mixture was diluted with saturated aqueous ammonium chloride (25 mL) and the layers were separated. The aqueous layer was further extracted with CH2Cl2 (2 x 10 mL). The combined organic phases were washed with saturated aqueous sodium bicarbonate (25 mL), H2O (25 mL), brine solution (25 mL), dried over anhydrous sodium sulfate and concentrated in vacuo. Purification of the residue by normal phase SiO 2 chromatography (0-5% MeOH/CH 2 Cl 2 ) afforded (S)-2-((S)-2-(9-hydroxy-9H-fennel-9-carba Amino)-4-methylpentanamide)-3-((S)-2-oxopyrrolidin-3-yl)propanoic acid methyl ester (6 g, 54% yield, observed m/z: 508[M+H] + ).
步驟(5):9-羥基-N-((S)-1-(((S)-1-羥基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺Step (5): 9-Hydroxy-N-((S)-1-(((S)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-2- Base) amino)-4-methyl-1-oxopentan-2-yl)-9H-stilbene-9-formamide
在0℃下向(S)-2-((S)-2-(9-羥基-9H-茀-9-甲醯胺基)-4-甲基戊醯胺)-3-((S)-2-氧代吡咯啶-3-基)丙酸甲酯(2g,3.9mmol)在CH2Cl2(20mL)中的攪拌溶液逐滴加入LiBH4(2M的THF溶液,4mL,7.9mmol),持續5min。將反應物在0℃下攪拌2小時。將反應混合物用飽和氯化銨水溶液淬滅,並用EtOAc(2×100mL)萃取。將合併後的有機相用鹽水溶液(20mL)洗滌,經無水硫酸鈉乾燥並在減壓下濃縮。通過正相SiO2層析法(0-10% MeOH/CH2Cl2)純化獲得的粗原料,得到9-羥基-N-((S)-1-(((S)-1-羥基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺(940mg,產率50%,觀察到m/z:480[M+H]+)。 To (S)-2-((S)-2-(9-hydroxy-9H-stilbene-9-formamido)-4-methylpentanamide)-3-((S) A stirred solution of methyl-2-oxopyrrolidin-3-yl)propanoate (2 g, 3.9 mmol) in CH 2 Cl 2 (20 mL) was added dropwise to LiBH 4 (2M in THF, 4 mL, 7.9 mmol) , for 5 minutes. The reaction was stirred at 0 °C for 2 hours. The reaction mixture was quenched with saturated aqueous ammonium chloride and extracted with EtOAc (2 x 100 mL). The combined organic phases were washed with brine solution (20 mL), dried over anhydrous sodium sulfate and concentrated under reduced pressure. The obtained crude material was purified by normal phase SiO2 chromatography (0-10% MeOH/ CH2Cl2 ) to give 9 - hydroxy- N -(( S )-1-((( S )-1-hydroxy- 3-(( S )-2-oxopyrrolidin-3-yl)propan-2-yl)amino)-4-methyl-1-oxopentane-2-yl)-9H-fennel-9 - Formamide (940 mg, 50% yield, observed m/z: 480 [M+H] + ).
步驟(6):9-羥基-N-((S)-4-甲基-1-側氧基-1-(((S)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)戊烷-2-基)-9H-茀-9-甲醯胺Step (6): 9-Hydroxy-N-((S)-4-methyl-1-oxo-1-(((S)-1-oxo-3-((S)-2- Oxypyrrolidin-3-yl)propan-2-yl)amino)pentan-2-yl)-9H-fen-9-carboxamide
在0℃下向9-羥基-N-((S)-1-(((S)-1-羥基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺(1.5g,3.1mmol)在CH2Cl2(15mL)中的攪拌溶液加入NaHCO3(520mg,6.2mmol),隨後在5min內逐滴加入Dess-Martin高碘酸鹽(2.6g,6.3mmol)。將反應物在室溫下攪拌2小時。將混合物用飽和碳酸氫鈉水溶液(10mL)淬滅,並用CH2Cl2(2×100mL)萃取。將合併後的有機相用鹽水溶液(10mL)洗滌,經無水硫酸鈉乾燥並在減壓下濃縮。通過正相SiO2層析法(0-10% MeOH/CH2Cl2)純化殘餘物,得到9-羥基-N-((S)-4-甲基-1-側氧基-1-(((S)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)戊烷-2-基)-9H-茀-9-甲醯胺(900mg,產率60%,觀察到m/z:478[M+H]+)。 9-Hydroxy- N -(( S )-1-((( S )-1-hydroxyl-3-(( S )-2-oxopyrrolidin-3-yl)propane-2- Stirring of (1.5 g, 3.1 mmol) in CH 2 Cl 2 (15 mL) The solution was added NaHCO3 (520 mg, 6.2 mmol), followed by the dropwise addition of Dess-Martin periodate (2.6 g, 6.3 mmol) over 5 min. The reaction was stirred at room temperature for 2 hours. The mixture was quenched with saturated aqueous sodium bicarbonate (10 mL), and extracted with CH2Cl2 (2 x 100 mL) . The combined organic phases were washed with brine solution (10 mL), dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by normal phase SiO2 chromatography (0-10% MeOH/ CH2Cl2 ) to afford 9-hydroxy- N -( ( S )-4-methyl-1-oxo-1-( (( S )-1-oxo-3-(( S )-2-oxopyrrolidin-3-yl)propan-2-yl)amino)pentan-2-yl)-9H-fennel- 9-Formamide (900 mg, 60% yield, observed m/z: 478 [M+H] + ).
步驟(7):(3S)-3-((S)-2-(9-羥基-9H-茀-9-甲醯胺基)-4-甲基戊醯胺)-1-(甲胺基)-1-側氧基-4-((S)-2-氧代吡咯啶-3-基)丁烷-2-基乙酸酯Step (7): (3S)-3-((S)-2-(9-Hydroxy-9H-oxo-9-formamido)-4-methylpentanamide)-1-(methylamino )-1-oxo-4-((S)-2-oxopyrrolidin-3-yl)butane-2-yl acetate
向9-羥基-N-((S)-4-甲基-1-側氧基-1-(((S)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)戊烷-2-基)-9H-茀-9-甲醯胺(500mg,1.1mmol)在CH2Cl2(5mL)中的攪拌溶液加入冰乙酸(0.12mL,2.09mmol)和異氰甲烷(1.6M的CH2Cl2溶液,1.3mL,2.08mmol)。將反應物在室溫下攪拌24小時。將混合物用飽和碳酸氫鈉水溶液(50mL)淬滅,並用CH2Cl2(2×100mL)萃取。將合併後的有機相用飽和水性鹽水溶液(50mL)洗滌,經無水硫酸鈉乾燥並在減壓下濃縮。通過正相SiO2層析法(0-10% MeOH/CH2Cl2)純化殘餘物,得到(3S)-3-((S)-2-(9-羥基-9H-茀-9-甲醯胺基)-4-甲基戊醯胺)-1-(甲胺基)-1-側氧基-4-((S)-2-氧代吡咯啶-3-基)丁烷-2-基乙酸酯(200mg,33%,觀察到m/z:579[M+H]+)。 To 9-hydroxy- N -(( S )-4-methyl-1-oxo-1-((( S )-1-oxo-3-(( S )-2-oxopyrrolidine A stirred solution of -3-yl)propan-2-yl)amino)pentan-2-yl)-9H-fluorene-9-carboxamide (500 mg, 1.1 mmol) in CH2Cl2 (5 mL ) was added Glacial acetic acid (0.12 mL, 2.09 mmol) and isocyanomethane (1.6M in CH2Cl2 , 1.3 mL , 2.08 mmol). The reaction was stirred at room temperature for 24 hours. The mixture was quenched with saturated aqueous sodium bicarbonate (50 mL), and extracted with CH2Cl2 (2 x 100 mL) . The combined organic phases were washed with saturated aqueous brine solution (50 mL), dried over anhydrous sodium sulfate and concentrated under reduced pressure. Purification of the residue by normal phase SiO 2 chromatography (0-10% MeOH/CH 2 Cl 2 ) afforded ( 3S )-3-(( S )-2-(9-hydroxy-9H-terrene-9- Formamido)-4-methylpentanamide)-1-(methylamino)-1-oxo-4-(( S )-2-oxopyrrolidin-3-yl)butane- 2-yl acetate (200 mg, 33%, observed m/z: 579 [M+H] + ).
步驟(8):9-羥基-N-((2S)-1-(((2S)-3-羥基-4-(甲胺基)-4-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺Step (8): 9-Hydroxy-N-((2S)-1-(((2S)-3-Hydroxy-4-(methylamino)-4-oxo-1-((S)-2 -Oxopyrrolidin-3-yl)butane-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9H-oxo-9-formamide
向(3S)-3-((S)-2-(9-羥基-9H-茀-9-甲醯胺基)-4-甲基戊醯胺)-1-(甲胺基)-1-側氧基-4-((S)-2-氧代吡咯啶-3-基)丁烷-2-基乙酸酯(200mg,0.35mmol)在MeOH:H2O(5:1,10mL)中的攪拌溶液 加入LiOH一水化物(76mg,1.73mmol),並將反應物在室溫下攪拌1小時。將混合物用HCl(1N)酸化至pH 4,並用10% MeOH的CH2Cl2溶液(2×100mL)萃取。用鹽水溶液(50mL)洗滌合併後的有機萃取物,經無水硫酸鈉乾燥並在減壓下濃縮,得到9-羥基-N-((2S)-1-(((2S)-3-羥基-4-(甲胺基)-4-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺(160mg,產率86%,觀察到m/z:537[M+H]+)。 To (3 S )-3-(( S )-2-(9-Hydroxy-9H-oxo-9-formamido)-4-methylpentanamide)-1-(methylamino)-1 -Oxy-4-(( S )-2-oxopyrrolidin-3-yl)butan-2-yl acetate (200 mg, 0.35 mmol) in MeOH:H 2 O (5:1, 10 mL ) was added LiOH monohydrate (76 mg, 1.73 mmol) and the reaction was stirred at room temperature for 1 h. The mixture was acidified to pH 4 with HCl (1N) and extracted with 10% MeOH in CH2Cl2 (2 x 100 mL). The combined organic extracts were washed with brine solution (50 mL), dried over anhydrous sodium sulfate and concentrated under reduced pressure to give 9-hydroxy- N -(( 2S )-1-((( 2S )-3- Hydroxy-4-(methylamino)-4-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane-2-yl)amino)-4-methyl- 1-oxopentan-2-yl)-9H-tertil-9-carboxamide (160 mg, 86% yield, observed m/z: 537 [M+H] + ).
步驟(9):9-羥基-N-((S)-4-甲基-1-(((S)-4-(甲胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺Step (9): 9-Hydroxy-N-((S)-4-methyl-1-(((S)-4-(methylamino)-3,4-dioxo-1-((S) -2-oxopyrrolidin-3-yl)butane-2-yl)amino)-1-oxopentane-2-yl)-9H-oxo-9-formamide
在0℃下向9-羥基-N-((2S)-1-(((2S)-3-羥基-4-(甲胺基)-4-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺(170mg,0.32mmol)在CH2Cl2(3mL)中的攪拌溶液加入NaHCO3(39mg,0.48mmol),隨後加入Dess-Martin高碘酸鹽(200mg,0.47mmol)。將所得混合物在室溫下攪拌2小時。將混合物用H2O(100mL)稀釋,並用CH2Cl2(2×100mL)萃取。將合併後的有機相用鹽水溶液(50mL)洗滌,經無水硫酸鈉乾燥並在減壓下濃縮。通過反相HPLC純化殘餘物,得到9-羥基-N-((S)-4-甲基-1-(((S)-4-(甲胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺(50mg,產率29%,觀察到m/z:535[M+H]+);1H NMR(400MHz,DMSO-d6):δ 8.67-8.62(m,1H),8.19(d,1H),7.76(t,2H),7.66(s,1H),7.52-7.21(m,8H),6.78(bs,1H),5.06(t,1H),4.37(t,1H),3.16-2.99(m,2H),2.67-2.64(m,3H),2.32-2.13(m,2H),1.89-1.49(m,5H),0.94-0.83(m,6H)。 9-Hydroxy- N -((2 S )-1-(((2 S )-3-hydroxy-4-(methylamino)-4-oxo-1-(( S ) -2-oxopyrrolidin-3-yl)butane-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9H-oxo-9-formamide ( 170 mg, 0.32 mmol) in CH2Cl2 (3 mL) was added NaHCO3 (39 mg , 0.48 mmol) followed by Dess-Martin periodate (200 mg, 0.47 mmol). The resulting mixture was stirred at room temperature for 2 hours. The mixture was diluted with H 2 O (100 mL), and extracted with CH 2 Cl 2 (2×100 mL). The combined organic phases were washed with brine solution (50 mL), dried over anhydrous sodium sulfate and concentrated under reduced pressure. Purification of the residue by reverse phase HPLC afforded 9-hydroxy- N -(( S )-4-methyl-1-((( S )-4-(methylamino)-3,4-dioxo-1- (( S )-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxopentan-2-yl)-9H-oxopyrrolidin-9-formamide (50mg , yield 29%, observed m/z: 535[M+H] + ); 1 H NMR (400MHz, DMSO-d 6 ): δ 8.67-8.62 (m, 1H), 8.19 (d, 1H), 7.76(t,2H), 7.66(s,1H), 7.52-7.21(m,8H), 6.78(bs,1H), 5.06(t,1H), 4.37(t,1H), 3.16-2.99(m, 2H), 2.67-2.64 (m, 3H), 2.32-2.13 (m, 2H), 1.89-1.49 (m, 5H), 0.94-0.83 (m, 6H).
實施例4:N-((S)-1-(((S)-4-胺基-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺(化合物6)Example 4: N -(( S )-1-((( S )-4-amino-3,4-dioxo-1-(( S )-2-oxopyrrolidin-3-yl)butane Alkyl-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide (compound 6)
步驟(1):(3S)-1-((2,4-二甲氧基苄基)胺基)-3-((S)-2-(9-羥基-9H-茀-9-甲醯胺基)-4-甲基戊醯胺)-1-側氧基-4-((S)-2-氧代吡咯啶-3-基)丁烷-2-基乙酸酯Step (1): (3S)-1-((2,4-Dimethoxybenzyl)amino)-3-((S)-2-(9-Hydroxy-9H-oxo-9-formyl Amino)-4-methylpentanamide)-1-oxo-4-((S)-2-oxopyrrolidin-3-yl)butane-2-yl acetate
在室溫下向9-羥基-N-((S)-4-甲基-1-側氧基-1-((S)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)戊烷-2-基)-9H-茀-9-甲醯胺(400mg,0.84mmol)在CH2Cl2(4mL)中的攪拌溶液加入冰冷的AcOH(0.1ml,1.67mmol),隨後加入1-(異氰基甲基)-2,4-二甲氧基苯(0.16mL,0.92mmol)。將反應物攪拌24小時。將混合物用飽和碳酸氫鈉水溶液(50mL)淬滅,並用CH2Cl2(2×100mL)萃取。將合併後的有機相用鹽水溶液(50mL)洗滌,經無水硫酸鈉乾燥並在減壓下濃縮。通過正相SiO2層析法(0-10% MeOH/CH2Cl2)純化殘餘物,得到((3S)-1-((2,4-二甲氧基苄基)胺基)-3-((S)-2-(9-羥基-9H-茀-9-甲醯胺基)-4-甲基戊醯胺)-1-側氧基-4-((S)-2-氧代吡咯啶-3-基)丁烷-2-基乙酸酯(450mg,產率45%,觀察到m/z:715[M+H]+)。 To 9-hydroxy- N -((S)-4-methyl-1-oxo-1-(( S )-1-oxo-3-(( S )-2-oxo Pyrrolidin-3-yl)propan-2-yl)amino)pentan-2-yl)-9H-stilbene-9-carboxamide (400mg, 0.84mmol) in CH 2 Cl 2 (4mL) The stirred solution was added to ice-cold AcOH (0.1 mL, 1.67 mmol), followed by 1-(isocyanomethyl)-2,4-dimethoxybenzene (0.16 mL, 0.92 mmol). The reaction was stirred for 24 hours. The mixture was quenched with saturated aqueous sodium bicarbonate (50 mL), and extracted with CH2Cl2 (2 x 100 mL) . The combined organic phases were washed with brine solution (50 mL), dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by normal phase SiO2 chromatography (0-10% MeOH/ CH2Cl2 ) to afford ( ( 3S )-1-((2,4-dimethoxybenzyl)amino)- 3-(( S )-2-(9-Hydroxy-9H-oxo-9-formamido)-4-methylpentanamide)-1-oxo-4-(( S )-2- Oxypyrrolidin-3-yl)butan-2-yl acetate (450 mg, 45% yield, observed m/z: 715 [M+H] + ).
步驟(2):N-((2S)-1-(((2S)-4-((2,4-二甲氧基苄基)胺基)-3-羥基-4-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-Step (2): N-((2S)-1-(((2S)-4-((2,4-dimethoxybenzyl)amino)-3-hydroxy-4-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butane-2-yl)amino)-4-methyl-1-oxopentane- 2-基)-9-羥基-9H-茀-9-甲醯胺2-yl)-9-hydroxy-9H-fen-9-formamide
向((3S)-1-((2,4-二甲氧基苄基)胺基)-3-((S)-2-(9-羥基-9H-茀-9-甲醯胺基)-4-甲基戊醯胺)-1-側氧基-4-((S)-2-氧代吡咯啶-3-基)丁烷-2-基乙酸酯(450mg,0.63mmol)在MeOH:H2O(5:1,3mL)中的攪拌溶液加入LiOH一水化物(132mg,3.15mmol),並將反應物在室溫下攪拌1小時。將混合物用HCl(1N)酸化至pH 4,並用EtOAc(2×100mL)萃取。將合併後的有機相用鹽水溶液(50mL)洗滌,經無水硫酸鈉乾燥並在減壓下濃縮,得到N-((2S)-1-(((2S)-4-((2,4-二甲氧基苄基)胺基)-3-羥基-4-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺(350mg,產率82%,觀察到m/z:673[M+H]+)。 To (( 3S )-1-((2,4-dimethoxybenzyl)amino)-3-(( S )-2-(9-hydroxy-9H-trimethoxybenzyl-9-formamido )-4-methylpentanamide)-1-oxo-4-(( S )-2-oxopyrrolidin-3-yl)butane-2-yl acetate (450mg, 0.63mmol) A stirred solution in MeOH:H 2 O (5:1, 3 mL) was added LiOH monohydrate (132 mg, 3.15 mmol) and the reaction was stirred at room temperature for 1 h. The mixture was acidified with HCl (1N) to pH 4 and extracted with EtOAc (2 x 100 mL). The combined organic phases were washed with brine solution (50 mL), dried over anhydrous sodium sulfate and concentrated under reduced pressure to afford N -(( 2S )-1-( ((2 S )-4-((2,4-dimethoxybenzyl)amino)-3-hydroxy-4-oxo-1-(( S )-2-oxopyrrolidine-3 -yl)butane-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-fen-9-carboxamide (350mg, yield 82 %, observed m/z: 673 [M+H] + ).
步驟(3):N-((S)-1-(((S)-4-(環丙基胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺Step (3): N-((S)-1-(((S)-4-(cyclopropylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidine -3-yl)butane-2-yl)amino)-4-methyl-1-oxopentane-2-yl)-9-hydroxyl-9H-stilbene-9-formamide
在0℃下向N-((2S)-1-(((2S)-4-((2,4-二甲氧基苄基)胺基)-3-羥基-4-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺(330mg,0.49mmol)在CH2Cl2(5mL)中的攪拌溶液加入NaHCO3(49mg,0.53mmol),隨後加入Dess-Martin高碘酸鹽(249mg,0.53mmol)。將反應物在室溫下攪拌2小時。將混合物用H2O(20mL)淬滅,並用CH2Cl2(2×100mL)萃取。將合併後的有機萃取物用鹽水溶液(20mL)洗滌,經無水硫 酸鈉乾燥並在減壓下濃縮。通過反相HPLC純化殘餘物,得到N-((S)-1-(((S)-4-((2,4-二甲氧基苄基)胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺(250mg,產率75%,觀察到m/z:671[M+H]+)。 N -((2 S )-1-(((2 S )-4-((2,4-dimethoxybenzyl)amino)-3-hydroxy-4-oxo -1-(( S )-2-oxopyrrolidin-3-yl)butane-2-yl)amino)-4-methyl-1-oxopentane-2-yl)-9-hydroxyl A stirred solution of -9H-Treme-9-formamide (330 mg, 0.49 mmol) in CH 2 Cl 2 (5 mL) was added NaHCO 3 (49 mg, 0.53 mmol), followed by Dess-Martin periodate (249 mg, 0.53 mmol). The reaction was stirred at room temperature for 2 hours. The mixture was quenched with H 2 O (20 mL), and extracted with CH 2 Cl 2 (2×100 mL). The combined organic extracts were washed with brine solution (20 mL), dried over anhydrous sodium sulfate and concentrated under reduced pressure. Purification of the residue by reverse phase HPLC gave N -(( S )-1-((( S )-4-((2,4-dimethoxybenzyl)amino)-3,4-dioxo- 1-(( S )-2-oxopyrrolidin-3-yl)butane-2-yl)amino)-4-methyl-1-oxopentane-2-yl)-9-hydroxyl- 9H-Treme-9-formamide (250 mg, 75% yield, observed m/z: 671 [M+H] + ).
步驟(4):N-((S)-1-(((S)-4-胺基-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺Step (4): N-((S)-1-(((S)-4-amino-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl) Butane-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide
將N-((2S)-1-(((2S)-4-((2,4-二甲氧基苄基)胺基)-3-羥基-4-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺(50mg,0.074mmol)在TFA(0.5mL)中的攪拌溶液加熱至100℃,持續30min。將反應混合物冷卻至室溫,用飽和碳酸氫鈉水溶液(5mL)中和,並用EtOAc(2×10mL)萃取。將合併後的有機相用鹽水溶液(10mL)洗滌,經無水硫酸鈉乾燥並在減壓下濃縮,得到N-((S)-1-(((S)-4-胺基-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺(10mg,產率26%,觀察到m/z:521[M+H]+);1H NMR(400MHz,DMSO-d6):δ 8.68(d,J=9.2Hz,1H),8.61(bs,2H),8.30(d,J=9.2Hz 1H),8.21(d,J=14Hz,1H),7.81-7.67(m,4H),7.51-7.18(m,6H),6.86(s,1H),5.10-5.05(m,1H),4.55-4.38(m,1H),3.16-3.03(m,2H)2.18-1.86(m,2H),1.69-1.55(m,4H),0.94-0.85(m,6H)。 N -((2 S )-1-(((2 S )-4-((2,4-dimethoxybenzyl)amino)-3-hydroxyl-4-oxo-1-( ( S )-2-oxopyrrolidin-3-yl)butane-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-terpineol - A stirred solution of 9-formamide (50 mg, 0.074 mmol) in TFA (0.5 mL) was heated to 100° C. for 30 min. The reaction mixture was cooled to room temperature, neutralized with saturated aqueous sodium bicarbonate (5 mL), and extracted with EtOAc (2 x 10 mL). The combined organic phases were washed with brine solution (10 mL), dried over anhydrous sodium sulfate and concentrated under reduced pressure to afford N -(( S )-1-((( S )-4-amino-3,4 -Dioxy-1-(( S )-2-oxopyrrolidin-3-yl)butane-2-yl)amino)-4-methyl-1-oxopentan-2-yl)- 9-Hydroxy-9H-oxo-9-formamide (10 mg, yield 26%, observed m/z: 521[M+H] + ); 1 H NMR (400MHz, DMSO-d 6 ): δ 8.68 (d,J=9.2Hz, 1H), 8.61(bs,2H), 8.30(d,J=9.2Hz, 1H), 8.21(d,J=14Hz, 1H), 7.81-7.67(m,4H), 7.51 -7.18(m,6H), 6.86(s,1H), 5.10-5.05(m,1H), 4.55-4.38(m,1H), 3.16-3.03(m,2H), 2.18-1.86(m,2H), 1.69-1.55 (m, 4H), 0.94-0.85 (m, 6H).
實施例5:(2S)-N-(4-(環丙基胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-羥基-2,2-二苯基乙醯胺基)-4-甲基戊醯胺(化合物Example 5: (2 S ) -N- (4-(cyclopropylamino)-3,4-dioxo-1-(( S )-2-oxopyrrolidin-3-yl)butane- 2-yl)-2-(2-hydroxy-2,2-diphenylacetamido)-4-methylpentanamide (compound 7)7)
用適當的醛和異氰化物以與關於9-羥基-N-((S)-4-甲基-1-(((S)-4-(甲胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺所描述的類似方式來製備(2S)-N-(4-(環丙基胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-羥基-2,2-二苯基乙醯胺基)-4-甲基戊醯胺;觀察到m/z:563[M+H]+;1H NMR(400MHz,DMSO-d6):δ 8.75(d,1H),8.64(d,1H),7.92(d,1H),7.67(s,1H),7.39-7.24(m,10H),6.84(bs,1H),5.02(bs,1H),4.40(d,1H),3.14(d,1H),3.05(d,1H),2.74-2.72(m,1H),2.4-2.3(m,1H),2.3-2.2(m,1H),1.92-1.83(m,1H),1.75-1.45(m,5H),0.86-0.78(m,6H),0.66-0.56(m,4H)。 With appropriate aldehydes and isocyanides with respect to 9-hydroxy- N -(( S )-4-methyl-1-((( S )-4-(methylamino)-3,4-dioxo- 1-(( S )-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxopentan-2-yl)-9H-oxopyrrolidin-9-formamide A similar manner was described to prepare ( 2S ) -N- (4-(cyclopropylamino)-3,4-dioxo-1-(( S )-2-oxopyrrolidin-3-yl) Butan-2-yl)-2-(2-hydroxy-2,2-diphenylacetamido)-4-methylpentanamide; observed m/z: 563[M+H] + ; 1 H NMR (400MHz, DMSO-d 6 ): δ 8.75(d,1H), 8.64(d,1H), 7.92(d,1H), 7.67(s,1H), 7.39-7.24(m,10H), 6.84(bs,1H), 5.02(bs,1H), 4.40(d,1H), 3.14(d,1H), 3.05(d,1H), 2.74-2.72(m,1H), 2.4-2.3(m, 1H), 2.3-2.2(m, 1H), 1.92-1.83(m, 1H), 1.75-1.45(m, 5H), 0.86-0.78(m, 6H), 0.66-0.56(m, 4H).
實施例6:N-((S)-1-(((S)-4-(乙胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺(化合物8)Example 6: N -(( S )-1-((( S )-4-(ethylamino)-3,4-dioxo-1-(( S )-2-oxopyrrolidine-3- Base) butane-2-yl) amino)-4-methyl-1-oxopentane-2-yl)-9-hydroxyl-9H-stilbene-9-formamide (compound 8)
用適當的醛和異氰化物以與關於9-羥基-N-((S)-4-甲基-1-(((S)-4-(甲胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺所描述的類似方式來製備N-((S)-1-(((S)-4-(乙胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺;觀察到m/z:549[M+H]+;1H NMR(400MHz,DMSO-d6):δ 8.75-8.62(m, 1H),8.24-8.18(m,1H),7.78-7.66(m,3H),7.51-7.21(m,7H),6.79(bs,1H),5.06-4.36(m,2H),2.96-3.17(m,4H),2.32-1.5(m,8H),1.07-0.83(m,9H)。 With appropriate aldehydes and isocyanides with respect to 9-hydroxy- N -(( S )-4-methyl-1-((( S )-4-(methylamino)-3,4-dioxo- 1-(( S )-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxopentan-2-yl)-9H-oxopyrrolidin-9-formamide N -(( S )-1-((( S )-4-(ethylamino)-3,4-dioxo-1-(( S )-2-oxopyrrolidine) was prepared in a similar manner as described -3-yl)butane-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-oxo-9-carboxamide; observed m /z: 549[M+H] + ; 1 H NMR (400MHz, DMSO-d 6 ): δ 8.75-8.62(m, 1H), 8.24-8.18(m, 1H), 7.78-7.66(m, 3H) , 7.51-7.21(m,7H), 6.79(bs,1H), 5.06-4.36(m,2H), 2.96-3.17(m,4H), 2.32-1.5(m,8H), 1.07-0.83(m, 9H).
實施例7:N-((2S)-3-環己基-1-((4-(甲胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺(化合物9)Example 7: N -((2 S )-3-cyclohexyl-1-((4-(methylamino)-3,4-dioxo-1-(( S )-2-oxopyrrolidine- 3-yl)butane-2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide (compound 9)
用適當的醛和異氰化物以與關於9-羥基-N-((S)-4-甲基-1-(((S)-4-(甲胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺所描述的類似方式來製備N-((2S)-3-環己基-1-((4-(甲胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺;觀察到m/z:575[M+H]+;1H NMR(400MHz,DMSO-d6):δ 8.67-8.59(m,1H),8.22-8.16(m,2H),7.78-7.66(m,3H),7.51-7.23(m,6H),6.79(s,1H),5.04-5.02(m,1H),4.41-4.38(m,1H),3.31-3.02(m,3H),2.60(d,J=4.4Hz,3H),2.32-1.89(m,3H),1.86-1.55(m,8H),1.33-0.81(m,8H)。 With appropriate aldehydes and isocyanides with respect to 9-hydroxy- N -(( S )-4-methyl-1-((( S )-4-(methylamino)-3,4-dioxo- 1-(( S )-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxopentan-2-yl)-9H-oxopyrrolidin-9-formamide N -(( 2S )-3-cyclohexyl-1-((4-(methylamino)-3,4-dioxo-1-(( S )-2-oxo Pyrrolidin-3-yl)butan-2-yl)amino)-1-oxopropan-2-yl)-9-hydroxy-9H-oxo-9-carboxamide; observed m/z: 575 [M+H] + ; 1 H NMR (400MHz, DMSO-d 6 ): δ 8.67-8.59 (m, 1H), 8.22-8.16 (m, 2H), 7.78-7.66 (m, 3H), 7.51-7.23 (m,6H), 6.79(s,1H), 5.04-5.02(m,1H), 4.41-4.38(m,1H), 3.31-3.02(m,3H), 2.60(d,J=4.4Hz, 3H ), 2.32-1.89 (m, 3H), 1.86-1.55 (m, 8H), 1.33-0.81 (m, 8H).
實施例8:N-((S)-1-(((S)-4-胺基-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺(化合物10)Example 8: N -(( S )-1-((( S )-4-amino-3,4-dioxo-1-(( S )-2-oxopyrrolidin-3-yl)butane Alkyl-2-yl)amino)-3-cyclohexyl-1-oxopropan-2-yl)-9-hydroxyl-9H-oxo-9-carboxamide (compound 10)
用適當的醛和異氰化物以與關於9-羥基-N-((S)-4-甲基-1-(((S)-4-(甲胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺所描述的類似方式來製備N-((S)-1-(((S)-4-胺基-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺;觀察到m/z:561[M+H]+;1H NMR(400MHz,DMSO-d6):δ 8.57-8.42(m,1H),8.23-8.08(m,2H),7.80-7.17(m,6H),7.51-7.23(m,4H),6.79(d,J=4Hz,1H),5.07-5.05(m,1H),4.42-4.39(m,1H),3.31-3.02(m,2H),2.32-1.49(m,12H),1.35-0.81(m,6H)。 With appropriate aldehydes and isocyanides with respect to 9-hydroxy- N -(( S )-4-methyl-1-((( S )-4-(methylamino)-3,4-dioxo- 1-(( S )-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxopentan-2-yl)-9H-oxopyrrolidin-9-formamide N -(( S )-1-((( S )-4-amino-3,4-dioxo-1-(( S )-2-oxopyrrolidine-3- yl)butan-2-yl)amino)-3-cyclohexyl-1-oxopropan-2-yl)-9-hydroxyl-9H-oxo-9-carboxamide; observed m/z: 561 [M+H] + ; 1 H NMR (400MHz, DMSO-d 6 ): δ 8.57-8.42 (m, 1H), 8.23-8.08 (m, 2H), 7.80-7.17 (m, 6H), 7.51-7.23 (m,4H), 6.79(d,J=4Hz, 1H), 5.07-5.05(m,1H), 4.42-4.39(m,1H), 3.31-3.02(m,2H), 2.32-1.49(m, 12H), 1.35-0.81 (m, 6H).
實施例9:N-(1-((4-(環丙基胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺(化合物11)Example 9: N-(1-((4-(cyclopropylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2 -yl)amino)-4-methyl-1-oxopentane-2-yl)-9-hydroxyl-9H-stilbene-9-formamide (compound 11)
用適當的醛和異氰化物以與關於9-羥基-N-((S)-4-甲基-1-(((S)-4-(甲胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺所描述的類似方式來製備N-(1-((4-(環丙基胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺;觀察到m/z:561[M+H]+;1H NMR(400MHz,DMSO-d6):δ 8.77(d,J=5.2Hz,1H),8.62(d,J=7.2Hz,1H),8.18(d,J=8.8Hz,1H),8.0-7.1(m,8H),6.8(bs,1H),5.1-5.05(m,1H),4.4-4.37(m,3H),3.16-3.02 (m,1H),2.77-2.74(m,1H),2.38-2.3(m,1H),2.2-2.1(m,1H),1.95-1.85(m,1H),1.75-1.50(m,5H),0.93(d,J=6.4Hz,3H),0.86(d,J=6.4Hz,3H),0.67-0.59(m,4H)。 With appropriate aldehydes and isocyanides with respect to 9-hydroxy- N -(( S )-4-methyl-1-((( S )-4-(methylamino)-3,4-dioxo- 1-(( S )-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxopentan-2-yl)-9H-oxopyrrolidin-9-formamide N-(1-((4-(cyclopropylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane Alk-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide; observed m/z: 561 [M +H] + ; 1 H NMR (400MHz, DMSO-d 6 ): δ 8.77 (d, J=5.2Hz, 1H), 8.62 (d, J=7.2Hz, 1H), 8.18 (d, J=8.8Hz , 1H), 8.0-7.1(m,8H), 6.8(bs,1H), 5.1-5.05(m,1H), 4.4-4.37(m,3H), 3.16-3.02(m,1H), 2.77-2.74 (m,1H), 2.38-2.3(m,1H), 2.2-2.1(m,1H), 1.95-1.85(m,1H), 1.75-1.50(m,5H), 0.93(d,J=6.4Hz , 3H), 0.86 (d, J=6.4Hz, 3H), 0.67-0.59 (m, 4H).
實施例10:N-((S)-3-環己基-1-側氧基-1-(((S)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺(化合物12)Example 10: N -(( S )-3-cyclohexyl-1-oxo-1-((( S )-1-oxo-3-(( S )-2-oxopyrrolidine- 3-yl)propan-2-yl)amino)propan-2-yl)-9-hydroxyl- 9H -tila-9-formamide (compound 12)
用適當的醛和異氰化物以與關於9-羥基-N-((S)-4-甲基-1-(((S)-4-(甲胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺所描述的類似方式來製備N-((S)-3-環己基-1-側氧基-1-(((S)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺;觀察到m/z:518[M+H]+;1H NMR(400MHz,DMSO-d6):δ 9.43(s,1H),8.21(m,1H),7.83-7.24(m,9H),6.77(s,1H),4.41-4.35(m,2H),3.91-3.73(m,1H),3.38-2.97(m,4H),2.29-2.08(m,2H),1.99-0.74(m,14H)。 With appropriate aldehydes and isocyanides with respect to 9-hydroxy- N -(( S )-4-methyl-1-((( S )-4-(methylamino)-3,4-dioxo- 1-(( S )-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxopentan-2-yl)-9H-oxopyrrolidin-9-formamide N -(( S )-3-cyclohexyl-1-oxo-1-((( S )-1-oxo-3-(( S )-2-oxo Pyrrolidin-3-yl)propan-2-yl)amino)propan-2-yl ) -9-hydroxy-9H-stilbene-9-carboxamide; observed m/z: 518 [M+H] + ; 1 H NMR (400MHz, DMSO-d 6 ): δ 9.43(s,1H), 8.21(m,1H), 7.83-7.24(m,9H), 6.77(s,1H), 4.41-4.35(m ,2H), 3.91-3.73(m,1H), 3.38-2.97(m,4H), 2.29-2.08(m,2H), 1.99-0.74(m,14H).
實施例11:(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺(化合物13)Example 11: (1 S ,3a R ,6a S ) -N -(( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl) Butane-2-yl)-2-(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide (compound 13)
步驟(1):((苄氧基)甲基)三丁基錫烷Step (1): ((Benzyloxy)methyl)tributylstannane
在-10℃下在氮氣中,在15min內向三丁基氫化錫(100g,346mmol)在乾燥THF(350mL)中的溶液逐滴加入LDA(2M的THF溶液,173mL,346mmol)。在攪拌30min之後,緩慢加入苄基氯甲基醚(23mL,165mmol)在THF(50mL)中的溶液,保持內部反應溫度低於-10℃,並將混合物攪拌1小時。用飽和氯化銨水溶液(250mL)淬滅反應物,用EtOAc(2×500mL)萃取,用鹽水溶液(250mL)洗滌並在減壓下濃縮。通過SiO2層析法(0-20% EtOAc/己烷)純化殘餘物,得到((苄氧基)甲基)三丁基錫烷(50g,產率52%)。1H NMR(400MHz,CDCl3):δ 7.33-7.26(m,5H),4.42(s,2H),3.75(s,2H),1.57-1.49(m,6H),1.34-1.25(m,6H),0.93-0.83(m,15H)。 To a solution of tributyltin hydride (100 g, 346 mmol) in dry THF (350 mL) was added LDA (2M in THF, 173 mL, 346 mmol) dropwise over 15 min at -10 °C under nitrogen. After stirring for 30 min, a solution of benzylchloromethyl ether (23 mL, 165 mmol) in THF (50 mL) was added slowly, keeping the internal reaction temperature below -10 °C, and the mixture was stirred for 1 h. The reaction was quenched with saturated aqueous ammonium chloride (250 mL), extracted with EtOAc (2 x 500 mL), washed with brine solution (250 mL) and concentrated under reduced pressure. The residue was purified by Si02 chromatography (0-20% EtOAc/hexanes) to afford ((benzyloxy)methyl)tributylstannane (50 g, 52% yield). 1 H NMR (400MHz, CDCl 3 ): δ 7.33-7.26 (m, 5H), 4.42 (s, 2H), 3.75 (s, 2H), 1.57-1.49 (m, 6H), 1.34-1.25 (m, 6H) ), 0.93-0.83 (m,15H).
步驟(2):((S)-4-(苄氧基)-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基甲酸第三丁酯:Step (2): ((S)-4-(Benzyloxy)-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amine Tertiary butyl formate:
在氮氣中在-78℃下,在15min內向((苄氧基)甲基)三丁基錫烷(49g,119mmol)在乾燥THF(500mL)中的攪拌溶液緩慢加入n-BuLi(2.3M己烷溶液,52mL,120mmol)。在-78℃下攪拌30min之後,在15min內逐滴加入((S)-1-(甲氧基(甲基)胺基)-1-側氧基-3- ((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基甲酸第三丁酯(根據Hoffman,R.L.et al.,J.Med.Chem.2020,63,12725和Hayashi,Y.et al.,Eur.J.Med.Chem,2013,65,436中的程序製備;12.5g,39.6mmol)在THF(20mL)中的溶液並將溶液攪拌3小時。用飽和氯化銨水溶液(250mL)淬滅反應物並緩慢升溫至室溫。用EtOAc(2×500mL)萃取懸浮液。將合併後的有機相經無水硫酸鈉乾燥並在減壓下濃縮。通過SiO2層析法(20-100% EtOAc/己烷)純化殘餘物,得到((S)-4-(苄氧基)-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基甲酸第三丁酯(9.5g,產率64%,觀察到m/z:377[M+H]+)。 To a stirred solution of ((benzyloxy)methyl)tributylstannane (49 g, 119 mmol) in dry THF (500 mL) was slowly added n -BuLi (2.3 M in hexanes) at -78 °C under nitrogen over 15 min. , 52mL, 120mmol). After stirring at -78°C for 30 min, ((S)-1-(methoxy(methyl)amino)-1-oxo-3-((S)-2-oxo Substituted pyrrolidin-3-yl) propan-2-yl) tert-butyl carbamate (according to Hoffman, RL et al., J. Med. Chem. 2020, 63 , 12725 and Hayashi, Y. et al., Eur .J.Med.Chem , 2013, 65,436 prepared by the procedure; 12.5 g, 39.6 mmol) in THF (20 mL) and the solution was stirred for 3 hours. The reaction was quenched with saturated aqueous ammonium chloride (250 mL) and slowly warmed to room temperature. The suspension was extracted with EtOAc (2 x 500 mL). The combined organic phases were dried over anhydrous sodium sulfate and concentrated under reduced pressure. Purification of the residue by SiO2 chromatography (20-100% EtOAc/hexanes) afforded ((S)-4-(benzyloxy)-3-oxo-1-((S)-2-oxo tert-butylpyrrolidin-3-yl)butan-2-yl)carbamate (9.5 g, 64% yield, observed m/z: 377 [M+H] + ).
步驟(3):(S)-3-((S)-2-胺基-4-(苄氧基)-3-氧代丁基)吡咯啶-2-酮鹽酸鹽Step (3): (S)-3-((S)-2-amino-4-(benzyloxy)-3-oxobutyl)pyrrolidin-2-one hydrochloride
在0℃下向((S)-4-(苄氧基)-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基甲酸第三丁酯(9.5g,25.3mmol)在CH2Cl2(95mL)中的攪拌溶液加入HCl(4N的1,4-二烷溶液,50mL),並將混合物攪拌2小時。將反應混合物在減壓下濃縮。用二乙醚(100mL)研磨油狀殘餘物並通過過濾收集所得固體。將有機相在減壓下濃縮,用二乙醚(100mL)研磨並通過過濾收集所得固體。將合併後的固體在真空下乾燥過夜,得到(S)-3-((S)-2-胺基-4-(苄氧基)-3-氧代丁基)吡咯啶-2-酮鹽酸鹽,其無需進一步純化即可使用(6.5g,觀察到m/z:277[M+H]+)。 To ((S)-4-(benzyloxy)-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amine at 0°C To a stirred solution of tert-butyl carbamate (9.5 g, 25.3 mmol) in CH 2 Cl 2 (95 mL) was added HCl (4N 1,4-di alkane solution, 50 mL), and the mixture was stirred for 2 hours. The reaction mixture was concentrated under reduced pressure. The oily residue was triturated with diethyl ether (100 mL) and the resulting solid was collected by filtration. The organic phase was concentrated under reduced pressure, triturated with diethyl ether (100 mL) and the resulting solid collected by filtration. The combined solids were dried under vacuum overnight to give ( S )-3-(( S )-2-amino-4-(benzyloxy)-3-oxobutyl)pyrrolidin-2-one salt Acid salt, which was used without further purification (6.5 g, observed m/z: 277 [M+H] + ).
步驟(4):(1S,3aR,6aS)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-羧酸乙酯:Step (4): (1S,3aR,6aS)-2-(9-Hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxylic acid ethyl ester:
在0℃下在N2大氣壓中向9-羥基-9H-茀-9-羧酸(0.5g,2.2mmol)在DMF(5mL)中的攪拌溶液加入HATU(1.68g,4.42mmol)。在攪拌30min之後,在5min內緩慢加入(1S,3aR,6aS)-八氫環戊[c]吡咯-1-羧酸乙酯鹽酸鹽(0.97g,4.42mmol)在DMF(0.5mL)和N-甲基嗎啉(1.2mL,11.1mmol)中的溶液。將反應混合物在N2大氣壓中在室溫下攪拌1.5小時。將反應物用H2O(30mL)稀釋,並用EtOAc(2×250mL)萃取。將合併後的有機相用H2O(2×50mL)、鹽水溶液(2×50mL)洗滌,經無水硫酸鈉乾燥並在減壓下濃縮。通過SiO2層析法(20-100% EtOAc/己烷)純化殘餘物,得到(1S,3aR,6aS)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-羧酸鹽(760mg,產率88%,觀察到m/z:392[M+H]+)。 To a stirred solution of 9-hydroxy-9H-tertilene-9-carboxylic acid (0.5 g, 2.2 mmol) in DMF (5 mL) was added HATU (1.68 g, 4.42 mmol) at 0 °C under N2 atmosphere. After stirring for 30 min, ethyl (1S,3aR,6aS)-octahydrocyclopenta[c]pyrrole-1-carboxylate hydrochloride (0.97 g, 4.42 mmol) in DMF (0.5 mL) and Solution in N -methylmorpholine (1.2 mL, 11.1 mmol). The reaction mixture was stirred at room temperature under N 2 atmospheres for 1.5 h. The reaction was diluted with H2O (30 mL) and extracted with EtOAc (2 x 250 mL). The combined organic phases were washed with H2O (2 x 50 mL), brine solution (2 x 50 mL), dried over anhydrous sodium sulfate and concentrated under reduced pressure. Purification of the residue by SiO2 chromatography (20-100% EtOAc/hexanes) afforded ( 1S , 3aR , 6aS )-2-(9-hydroxy-9H-tertene-9-carbonyl)octahydrocyclo Penta[c]pyrrole-1-carboxylate (760 mg, 88% yield, observed m/z: 392 [M+H] + ).
步驟(5):(1S,3aR,6aS)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-羧酸Step (5): (1S,3aR,6aS)-2-(9-Hydroxy-9H-fennel-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxylic acid
在0℃下向0℃下(1S,3aR,6aS)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-羧酸乙酯(390mg,0.99mmol)在MeOH(4mL)中的劇烈攪拌溶液加入NaOH(4M水溶液,1.93mL,7.7mmol)。將所得溶液在0℃下攪拌3小時。將反應混合物用HCl(1N)中和,同時將內部溫度保持在低於10℃。除去過量的甲醇在減壓下並用HCl(2N)將水性層酸化至pH~4-5。將混合物用EtOAc(2×400mL)萃取。用鹽水溶液(250mL)洗滌合併後的有機層,經無水硫酸鈉乾燥並在減壓下濃縮,得到(1S,3aR,6aS)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-羧酸,其無需進一步純化即可使用(390mg,觀察到m/z:364[M+H]+)。 (1S,3aR,6aS)-2-(9-Hydroxy-9H-oxo-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxylic acid ethyl ester (390mg, 0.99 A vigorously stirred solution of mmol) in MeOH (4 mL) was added NaOH (4M in water, 1.93 mL, 7.7 mmol). The resulting solution was stirred at 0 °C for 3 hours. The reaction mixture was neutralized with HCl (1N) while maintaining the internal temperature below 10°C. Excess methanol was removed under reduced pressure and the aqueous layer was acidified to pH~4-5 with HCl (2N). The mixture was extracted with EtOAc (2 x 400 mL). The combined organic layers were washed with brine solution (250 mL), dried over anhydrous sodium sulfate and concentrated under reduced pressure to give (1 S , 3a R , 6a S )-2-(9-hydroxy-9H-fennel-9- Carbonyl) octahydrocyclopenta[c]pyrrole-1-carboxylic acid which was used without further purification (390 mg, observed m/z: 364 [M+H] + ).
步驟(6):(1S,3aR,6aS)-N-((S)-4-(苄氧基)-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺Step (6): (1S,3aR,6aS)-N-((S)-4-(benzyloxy)-3-oxo-1-((S)-2-oxopyrrolidine-3- Base) butane-2-yl)-2-(9-hydroxyl-9H-oxene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide
在N2大氣壓中在0℃下向(1S,3aR,6aS)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-羧酸(380mg)在DMF(4mL)中的攪拌溶液加入HATU(795mg,2.1mmol)。在攪拌30min之後,在N2大氣壓中逐滴加入(S)-3-((S)-2-胺基-4-(苄氧基)-3-氧代丁基)吡咯啶-2-酮鹽酸鹽(392mg,1.25mmol)在DMF(0.5mL)中的溶液,隨後加入N-甲基嗎啉(0.57mL,5.23mmol)。將反應混合物在室溫下攪拌2小時。將反應混合物用H2O(25mL)稀釋,並用EtOAc(2×200mL)萃取。將合併後的有機相用鹽水溶液(2×100mL)洗滌,經無水硫酸鈉乾燥並在減壓下濃縮。通過SiO2層析法(0-10% MeOH/CH2Cl2)純化殘餘物,得到(1S,3aR,6aS)-N-((S)-4-(苄氧基)-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺,為淺黃色膠(280mg,來自(1S,3aR,6aS)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-羧酸的產率43%,觀察到m/z:622[M+H]+)。 To ( 1 S , 3a R , 6a S )-2-(9-hydroxy-9H-fennel-9-carbonyl) octahydrocyclopenta[c]pyrrole-1-carboxylic acid ( 380 mg) in DMF (4 mL) was added to a stirred solution of HATU (795 mg, 2.1 mmol). After stirring for 30 min, ( S )-3-(( S )-2-amino-4-(benzyloxy)-3-oxobutyl)pyrrolidin-2-one was added dropwise under N atmosphere A solution of hydrochloride (392 mg, 1.25 mmol) in DMF (0.5 mL) was added followed by the addition of N -methylmorpholine (0.57 mL, 5.23 mmol). The reaction mixture was stirred at room temperature for 2 hours. The reaction mixture was diluted with H2O (25 mL), and extracted with EtOAc (2 x 200 mL). The combined organic phases were washed with brine solution (2 x 100 mL), dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by SiO2 chromatography (0-10% MeOH/ CH2Cl2 ) to afford ( 1S , 3aR , 6aS ) -N -(( S )-4-(benzyloxy)-3 -Oxy-1-(( S )-2-oxopyrrolidin-3-yl)butan-2-yl)-2-(9-hydroxyl-9H-oxo-9-carbonyl)octahydrocyclopenta [c]pyrrole-1-carboxamide as a pale yellow gum (280 mg from (1S,3aR,6aS)-2-(9-hydroxy-9H-oxene-9-carbonyl)octahydrocyclopenta[c]pyrrole - 43% yield of 1-carboxylic acid, observed m/z: 622 [M+H] + ).
步驟(7):(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺Step (7): (1S,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane -2-yl)-2-(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide
將(1S,3aR,6aS)-N-((S)-4-(苄氧基)-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺(280mg,0.450mmol)和鈀炭催化劑(10%負載於碳,0.25g,2.3mmol)在MeOH(3mL)中的混合物在室溫下在氫氣大氣壓中在50psi下攪拌3小時。通過CELITE®過濾混合物,用MeOH(200mL)洗滌並在減壓下濃縮。通過反相HPLC純化殘餘物,得到(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺(28mg,產率12%,觀察到m/z:532[M+H]+);1H NMR(400MHz,DMSO-d6):δ 8.46(d,1H),7.84-7.77(m,2H),7,65-7.62(m,1H),7.47-7.41(m,2H),7.35-7.31(m,3H),7.23(d,1H),5.99(s,1H),5.09-5.08(m,1H),4.47-4.45(m,1H),4.23-4.15(m,3H),3.20-3.15(m,2H),2.49-2.19(m,6H),1.92-1.88(m,1H),1.68-1.31(m,7H),1.15-1.13(m,1H)。 (1 S ,3a R ,6a S ) -N -(( S )-4-(benzyloxy)-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl )butane-2-yl)-2-(9-hydroxyl-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide (280mg, 0.450mmol) and palladium on carbon catalyst (10 % on carbon, 0.25 g, 2.3 mmol) in MeOH (3 mL) was stirred at room temperature under hydrogen atmosphere at 50 psi for 3 hours. The mixture was filtered through CELITE®, washed with MeOH (200 mL) and concentrated under reduced pressure. Purification of the residue by reverse phase HPLC gave (1S, 3aR , 6aS ) -N -(( S )-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidine- 3-yl)butane-2-yl)-2-(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide (28 mg, yield 12%, observed to m/z: 532[M+H] + ); 1 H NMR (400MHz, DMSO-d 6 ): δ 8.46(d,1H), 7.84-7.77(m,2H), 7,65-7.62(m ,1H), 7.47-7.41(m,2H), 7.35-7.31(m,3H), 7.23(d,1H), 5.99(s,1H), 5.09-5.08(m,1H), 4.47-4.45(m ,1H), 4.23-4.15(m,3H), 3.20-3.15(m,2H), 2.49-2.19(m,6H), 1.92-1.88(m,1H), 1.68-1.31(m,7H), 1.15 -1.13(m,1H).
實施例12:9-羥基-N-((S)-1-(((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4,4-二甲基-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺(化合物14)Example 12: 9-Hydroxy- N -(( S )-1-((( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl )butane-2-yl)amino)-4,4-dimethyl-1-oxopentane-2-yl)-9H-stilbene-9-formamide (compound 14)
通過將(S)-3-((S)-2-胺基-4-(苄氧基)-3-氧代丁基)吡咯啶-2-酮鹽酸鹽與適當的羧酸偶合以與關於(1S,3aR,6aS)-N-((S)-4-羥 基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺所描述的類似方式來製備9-羥基-N-((S)-1-(((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4,4-二甲基-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺;觀察到m/z:522[M+H]+;1H NMR(400MHz,DMSO-d6):δ 8.41(d,1H),8.11(d,1H),7.78-7.75(m,2H),7.63(s,1H),7.41-7.34(m,3H),7.29-7.23(m,3H),6.80(s,1H),5.14(t,1H),4.51-4.48(m,1H),4.39-4.34(m,1H),4.19-4.15(m,2H),3.12(t,1H),2.95-2.89(m,1H),2.21-1.56(m,7H),0.96(s,9H)。 By coupling (S)-3-((S)-2-amino-4-(benzyloxy)-3-oxobutyl)pyrrolidin-2-one hydrochloride with an appropriate carboxylic acid to Regarding (1 S ,3a R ,6a S ) -N -(( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane- 2-yl)-2-(9-hydroxy-9H-oxo-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide was prepared in a manner similar to that described for 9-hydroxy- N -(( S )-1-((( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane-2-yl)amino)-4 ,4-Dimethyl-1-oxopentan-2-yl)-9H-fen-9-formamide; observed m/z: 522[M+H] + ; 1 H NMR (400MHz, DMSO -d 6 ): δ 8.41(d,1H), 8.11(d,1H), 7.78-7.75(m,2H), 7.63(s,1H), 7.41-7.34(m,3H), 7.29-7.23(m ,3H), 6.80(s,1H), 5.14(t,1H), 4.51-4.48(m,1H), 4.39-4.34(m,1H), 4.19-4.15(m,2H), 3.12(t,1H ), 2.95-2.89(m,1H), 2.21-1.56(m,7H), 0.96(s,9H).
實施例13:(3S)-N-(4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物15)Example 13: (3 S )-N-(4-hydroxyl-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane-2-yl)-2- (9-Hydroxy- 9H -Oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide (compound 15)
通過將(S)-3-((S)-2-胺基-4-(苄氧基)-3-氧代丁基)吡咯啶-2-酮鹽酸鹽與適當的羧酸偶合以與關於(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺所描述的類似方式來製備N-(4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:532[M+H]+;1H NMR(400MHz,DMSO-d6):δ 8.59(d,1H),7.84-7.63(m,3H),7.45-7.22(m,5H),5.97(bs,1H),5.09-5.06(m,1H),4.6-4.45(m,1H),4.37(t,1H),4.18-4.25(m,2H),2.8-3.2(m,3H),3.06-3.04(m,1H),2.3-0.7(m,14H)。 By coupling (S)-3-((S)-2-amino-4-(benzyloxy)-3-oxobutyl)pyrrolidin-2-one hydrochloride with an appropriate carboxylic acid to Regarding (1 S ,3a R ,6a S ) -N -(( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane- N- (4-hydroxy-3- Oxy-1-(( S )-2-oxopyrrolidin-3-yl)butane-2-yl)-2-(9-hydroxyl-9H-oxo-9-carbonyl)-2-aza Bicyclo[2.2.2]octane-3-carboxamide; Observed m/z: 532[M+H] + ; 1 H NMR (400MHz, DMSO-d 6 ): δ 8.59(d,1H), 7.84 -7.63(m,3H), 7.45-7.22(m,5H), 5.97(bs,1H), 5.09-5.06(m,1H), 4.6-4.45(m,1H), 4.37(t,1H), 4.18 -4.25(m,2H), 2.8-3.2(m,3H), 3.06-3.04(m,1H), 2.3-0.7(m,14H).
實施例14:N-((S)-3-環己基-1-(((S)-4-羥基-3-側氧基-1-((S)-2-氧代Example 14: N -(( S )-3-cyclohexyl-1-((( S )-4-hydroxy-3-oxo-1-(( S )-2-oxo 吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺(化合物16)Pyrrolidin-3-yl)butane-2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-oxo-9-formamide (compound 16)
通過將(S)-3-((S)-2-胺基-4-(苄氧基)-3-氧代丁基)吡咯啶-2-酮鹽酸鹽與適當的羧酸偶合以與關於(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺所描述的類似方式來製備N-((S)-3-環己基-1-(((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺;觀察到m/z:548[M+H]+;1H NMR(400MHz,DMSO-d6):δ 8.45(d,1H),8.23(d,1H),7.78-7.75(m,2H),7.63(s,1H),7.41-7.23(m,7H),6.79(bs,1H),4.49-4.38(m,2H),4.25-4.12(m,2H),3.11(t,1H),2.96(d,1H),2.19(d,1H),2.06(t,1H),1.95-1.85(m,1H),1.75-1.56(m,9H),1.35(bs,1H),1.23-1.09(m,3H),0.95-0.86(m,2H)。 By coupling (S)-3-((S)-2-amino-4-(benzyloxy)-3-oxobutyl)pyrrolidin-2-one hydrochloride with an appropriate carboxylic acid to Regarding (1 S ,3a R ,6a S ) -N -(( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane- N -(( S )-3- Cyclohexyl-1-((( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane-2-yl)amino)- 1-Oxopropan-2-yl)-9-hydroxy-9H-oxo-9-carboxamide; observed m/z: 548[M+H] + ; 1 H NMR (400MHz, DMSO-d 6 ) : δ 8.45(d,1H), 8.23(d,1H), 7.78-7.75(m,2H), 7.63(s,1H), 7.41-7.23(m,7H), 6.79(bs,1H), 4.49- 4.38(m,2H), 4.25-4.12(m,2H), 3.11(t,1H), 2.96(d,1H), 2.19(d,1H), 2.06(t,1H), 1.95-1.85(m, 1H), 1.75-1.56 (m, 9H), 1.35 (bs, 1H), 1.23-1.09 (m, 3H), 0.95-0.86 (m, 2H).
實施例15:(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺(化合物17)Example 15: (1 S ,3a R ,6a S ) -N -(( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl) Butane-2-yl)-2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide (compound 17)
通過將(S)-3-((S)-2-胺基-4-(苄氧基)-3-氧代丁基)吡咯啶-2-酮鹽酸鹽與適當的羧酸偶合以與關於(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺所描述的類似方式來製備 (1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺;觀察到m/z:497[M+H]+;1H NMR(400MHz,DMSO-d6):δ 11.48(bs,1H),8.72-8.36(m,1H),7.17-6.81(m,3H),6.52-6.44(m,1H),5.14-4.82(m,1H),4.49-3.59(m,9H),3.13-2.32(m,5H),1.94-1.37(m,11H)。 By coupling (S)-3-((S)-2-amino-4-(benzyloxy)-3-oxobutyl)pyrrolidin-2-one hydrochloride with an appropriate carboxylic acid to Regarding (1 S ,3a R ,6a S ) -N -(( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane- 2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide was prepared in a similar manner as described for (1 S , 3a R , 6a S ) -N -(( S )-4-hydroxyl-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane-2-yl)-2-(4- Methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide; observed m/z: 497[M+H] + ; 1 H NMR (400MHz, DMSO- d 6 ): δ 11.48(bs,1H), 8.72-8.36(m,1H), 7.17-6.81(m,3H), 6.52-6.44(m,1H), 5.14-4.82(m,1H), 4.49- 3.59 (m, 9H), 3.13-2.32 (m, 5H), 1.94-1.37 (m, 11H).
實施例16:(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺(化合物18)Example 16: (1 S ,3a R ,6a S ) -N -(( S )-4-hydroxyl-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl) Butane-2-yl)-2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide (Compound 18)
通過將(S)-3-((S)-2-胺基-4-(苄氧基)-3-氧代丁基)吡咯啶-2-酮鹽酸鹽與適當的羧酸偶合以與關於(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺所描述的類似方式來製備(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺;觀察到m/z:467[M+H]+;1H NMR(400MHz,DMSO-d6):δ 11.25(s,1H),8.38(d,1H),7.59-7.58(m,3H),7.34(s,1H),7.18(t,1H),7.03(t,1H),6.92(bs,1H),4.77-4.76(m,1H),4.57-4.43(m,2H),4.22-4.13(m,3H),3.75-3.73(m,1H),3.07-3.05(m,2H),2.79-2.77(m,2H),1.97-1.49(m,10H)。 By coupling (S)-3-((S)-2-amino-4-(benzyloxy)-3-oxobutyl)pyrrolidin-2-one hydrochloride with an appropriate carboxylic acid to Regarding (1 S ,3a R ,6a S ) -N -(( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane- 2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide was prepared in a similar manner as described for (1 S , 3a R , 6a S )- N -(( S )-4-hydroxyl-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane-2-yl)-2-(1H- Indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide; observed m/z: 467[M+H] + ; 1 H NMR (400MHz, DMSO-d 6 ): δ 11.25 (s,1H), 8.38(d,1H), 7.59-7.58(m,3H), 7.34(s,1H), 7.18(t,1H), 7.03(t,1H), 6.92(bs,1H), 4.77-4.76(m,1H), 4.57-4.43(m,2H), 4.22-4.13(m,3H), 3.75-3.73(m,1H), 3.07-3.05(m,2H), 2.79-2.77(m ,2H), 1.97-1.49(m,10H).
實施例17:N-((S)-1-(((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-丙基-1H-吲哚-2-甲醯胺(化合物19)Example 17: N -(( S )-1-((( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane- 2-yl)amino)-4-methyl-1-oxopentane-2-yl)-4-methoxy-1-propyl-1H-indole-2-carboxamide (compound 19)
通過將(S)-3-((S)-2-胺基-4-(苄氧基)-3-氧代丁基)吡咯啶-2-酮鹽酸鹽與適當的羧酸偶合以與關於(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺所描述的類似方式來製備N-((S)-1-(((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-丙基-1H-吲哚-2-甲醯胺;觀察到m/z:515[M+H]+;1H NMR(400MHz,DMSO-d6):δ 8.47(d,1H),8.39(d,1H),7.62(s,1H),7.29(s,1H),7.19-7.10(m,3H),6.56(d,1H),5.05(t,1H),4.48-4.40(m,4H),4.23-4.15(m,2H),3.89(s,3H),3.14-3.03(m,2H),2.35-2.17(m,1H),2.11-2.15(m,1H),1.95-1.92(m,1H),1.73-1.51(m,8H),0.95-0.88(m,6H),0.76(t,1H)。 By coupling (S)-3-((S)-2-amino-4-(benzyloxy)-3-oxobutyl)pyrrolidin-2-one hydrochloride with an appropriate carboxylic acid to Regarding (1 S ,3a R ,6a S ) -N -(( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane- N -(( S )-1- ((( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane-2-yl)amino)-4-methyl- 1-oxopentan-2-yl)-4-methoxy-1-propyl-1H-indole-2-carboxamide; observed m/z: 515[M+H] + ; 1 H NMR (400MHz, DMSO-d 6 ): δ 8.47(d,1H), 8.39(d,1H), 7.62(s,1H), 7.29(s,1H), 7.19-7.10(m,3H), 6.56( d,1H), 5.05(t,1H), 4.48-4.40(m,4H), 4.23-4.15(m,2H), 3.89(s,3H), 3.14-3.03(m,2H), 2.35-2.17( m,1H), 2.11-2.15(m,1H), 1.95-1.92(m,1H), 1.73-1.51(m,8H), 0.95-0.88(m,6H), 0.76(t,1H).
實施例18:N-((S)-1-(((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-(2-甲基烯丙基)-1H-吲哚-2-甲醯胺(化合物20)Example 18: N -(( S )-1-((( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane- 2-yl)amino)-4-methyl-1-oxopentane-2-yl)-4-methoxy-1-(2-methylallyl)-1H-indole-2- Formamide (compound 20)
通過將(S)-3-((S)-2-胺基-4-(苄氧基)-3-氧代丁基)吡咯啶-2-酮鹽酸鹽與適當的羧酸偶合以與關於(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺所描述的類似方式來製備N-((S)-1-(((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)- 4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-(2-甲基烯丙基)-1H-吲哚-2-甲醯胺;觀察到m/z:527[M+H]+;1H NMR(400MHz,DMSO-d6):δ 8.47(d,1H),8.39(d,1H),7.62(s,1H),7.29(s,1H),7.19-7.10(m,3H),6.56(d,1H),5.05(t,1H),4.48-4.40(m,4H),4.23-4.15(m,2H),3.89(s,3H),3.14-3.03(m,2H),2.35-2.17(m,1H),2.11-2.15(m,1H),1.95-1.92(m,1H),1.73-1.51(m,8H),0.95-0.88(m,6H),0.76(t,1H)。 By coupling (S)-3-((S)-2-amino-4-(benzyloxy)-3-oxobutyl)pyrrolidin-2-one hydrochloride with an appropriate carboxylic acid to Regarding (1 S ,3a R ,6a S ) -N -(( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane- N -(( S )-1- ((( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane-2-yl)amino)-4-methyl- 1-oxopentan-2-yl)-4-methoxy-1-(2-methylallyl)-1H-indole-2-carboxamide; observed m/z: 527 [M +H] + ; 1 H NMR (400MHz, DMSO-d 6 ): δ 8.47(d,1H), 8.39(d,1H), 7.62(s,1H), 7.29(s,1H), 7.19-7.10( m,3H), 6.56(d,1H), 5.05(t,1H), 4.48-4.40(m,4H), 4.23-4.15(m,2H), 3.89(s,3H), 3.14-3.03(m, 2H), 2.35-2.17(m,1H), 2.11-2.15(m,1H), 1.95-1.92(m,1H), 1.73-1.51(m,8H), 0.95-0.88(m,6H), 0.76( t,1H).
實施例19:(S)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物21)Example 19: ( S ) -N -(( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(2-Methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-formamide (compound 21)
通過將(S)-3-((S)-2-胺基-4-(苄氧基)-3-氧代丁基)吡咯啶-2-酮鹽酸鹽與適當的羧酸偶合以與關於(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺所描述的類似方式來製備(S)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:487[M+H]+;1H NMR(400MHz,DMSO-d6):δ 11.43(s,1H),8.38(s,1H),7.64(s,1H),6.69(s,1H),4.66-3.86(m,4H),3.25-2.61(m,5H),2.37-1.23(m,15H)。 By coupling (S)-3-((S)-2-amino-4-(benzyloxy)-3-oxobutyl)pyrrolidin-2-one hydrochloride with an appropriate carboxylic acid to Regarding (1 S ,3a R ,6a S ) -N -(( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane- ( S ) -N -(( S )-4-hydroxyl-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane-2-yl)-2-(2-methyl-4H-thieno [3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide; observed m/z: 487[M+H] + ; 1 H NMR (400MHz,DMSO-d 6 ): δ 11.43(s,1H), 8.38(s,1H), 7.64(s,1H), 6.69(s,1H), 4.66-3.86(m,4H), 3.25-2.61 (m, 5H), 2.37-1.23 (m, 15H).
實施例20:(S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物22)Example 20: ( S )-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl) -N -(( S )-4-hydroxy-3-oxo- 1-(( S )-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide (compound 22)
通過將(S)-3-((S)-2-胺基-4-(苄氧基)-3-氧代丁基)吡咯啶-2-酮鹽酸鹽與適當的羧酸偶合以與關於(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺所描述的類似方式來製備(S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:507[M+H]+;1H NMR(400MHz,DMSO-d6):δ 12.13(s,1H),8.40(d,1H),7.63(s,1H),7.38(s,1H),6.83(s,1H),4.66-3.86(m,4H),3.19-2.60(m,2H),2.25-1.39(m,15H)。 By coupling (S)-3-((S)-2-amino-4-(benzyloxy)-3-oxobutyl)pyrrolidin-2-one hydrochloride with an appropriate carboxylic acid to Regarding (1 S ,3a R ,6a S ) -N -(( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane- ( S )-2-(3- Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl) -N -(( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidine -3-yl)butan-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide; observed m/z: 507[M+H] + ; 1 H NMR ( 400MHz, DMSO-d 6 ): δ 12.13(s,1H), 8.40(d,1H), 7.63(s,1H), 7.38(s,1H), 6.83(s,1H), 4.66-3.86(m, 4H), 3.19-2.60 (m, 2H), 2.25-1.39 (m, 15H).
實施例21:(S)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物23)Example 21: ( S ) -N -(( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-formamide (compound 23)
通過將(S)-3-((S)-2-胺基-4-(苄氧基)-3-氧代丁基)吡咯啶-2-酮鹽酸鹽與適當的羧酸偶合以與關於(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺所描述的類似方式來製備(S)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:497[M+H]+;1H NMR(400MHz,DMSO-d6):δ 11.23(s,1H),8.28(s,1H),7.32(s,1H),7.10-7.02(m,2H),6.75-6.74(m,2H),6.50- 6.48(d,1H),4.82-4.13(m,6H),3.87(s,3H),2.24-1.48(m,15H)。 By coupling (S)-3-((S)-2-amino-4-(benzyloxy)-3-oxobutyl)pyrrolidin-2-one hydrochloride with an appropriate carboxylic acid to Regarding (1 S ,3a R ,6a S ) -N -(( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane- ( S ) -N -(( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane-2-yl)-2-(4-methoxy-1H-ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide; observed m/z: 497[M+H] + ; 1 H NMR (400MHz, DMSO-d 6 ): δ 11.23(s,1H), 8.28(s,1H), 7.32(s,1H), 7.10-7.02(m,2H), 6.75-6.74(m,2H), 6.50- 6.48(d,1H) , 4.82-4.13 (m, 6H), 3.87 (s, 3H), 2.24-1.48 (m, 15H).
實施例22:(S)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(3-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物24)Example 22: ( S ) -N -(( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(3-Methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-formamide (compound 24)
通過將(S)-3-((S)-2-胺基-4-(苄氧基)-3-氧代丁基)吡咯啶-2-酮鹽酸鹽與適當的羧酸偶合以與關於(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺所描述的類似方式來製備(S)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(3-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:487[M+H]+;1H NMR(400MHz,DMSO-d6):δ 11.44(s,1H),8.24(d,1H),7.36(s,1H),6.90(d,1H),6.71(d,1H),4.71-4.37(m,3H),4.37-4.02(m,2H),2.37-1.37(m,19H)。 By coupling ( S )-3-(( S )-2-amino-4-(benzyloxy)-3-oxobutyl)pyrrolidin-2-one hydrochloride with an appropriate carboxylic acid to Regarding (1 S ,3a R ,6a S ) -N -(( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane- ( S ) -N -(( S )-4-hydroxyl-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane-2-yl)-2-(3-methyl-4H-thieno [3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide; observed m/z: 487[M+H] + ; 1 H NMR (400MHz,DMSO-d 6 ): δ 11.44(s,1H), 8.24(d,1H), 7.36(s,1H), 6.90(d,1H), 6.71(d,1H), 4.71-4.37(m ,3H), 4.37-4.02(m,2H), 2.37-1.37(m,19H).
實施例23:(S)-2-(4,6-二氟-1H-吲哚-2-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物25)Example 23: ( S )-2-(4,6-difluoro-1H-indole-2-carbonyl) -N -(( S )-4-hydroxyl-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide (compound 25)
通過將(S)-3-((S)-2-胺基-4-(苄氧基)-3-氧代丁基)吡咯啶-2-酮鹽酸鹽與適當的羧酸偶合以與關於(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀- 9-羰基)八氫環戊[c]吡咯-1-甲醯胺所描述的類似方式來製備(S)-2-(4,6-二氟-1H-吲哚-2-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:503[M+H]+;1H NMR(400MHz,DMSO-d6):δ 11.69(s,1H),8.30(d,1H),7.36(s,1H),7.21-6.98(m,1H),6.79(s,2H),4.71-3.94(m,5H),2.38-1.29(m,16H)。 By coupling (S)-3-((S)-2-amino-4-(benzyloxy)-3-oxobutyl)pyrrolidin-2-one hydrochloride with an appropriate carboxylic acid to Regarding (1 S ,3a R ,6a S ) -N -(( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane- ( S )-2-(4, 6-Difluoro-1H-indole-2-carbonyl) -N -(( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl) Butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide; observed m/z: 503[M+H] + ; 1 H NMR (400MHz, DMSO-d 6 ): δ 11.69(s,1H), 8.30(d,1H), 7.36(s,1H), 7.21-6.98(m,1H), 6.79(s,2H), 4.71-3.94(m,5H), 2.38-1.29(m,16H).
實施例24:(1S,3aR,6aS)-2-(9-氟-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺(化合物26)Example 24: (1 S ,3a R ,6a S )-2-(9-fluoro-9H-fennel-9-carbonyl) -N -(( S )-4-hydroxy-3-oxo-1- (( S )-2-oxopyrrolidin-3-yl)butane-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide (compound 26)
通過將(S)-3-((S)-2-胺基-4-(苄氧基)-3-氧代丁基)吡咯啶-2-酮鹽酸鹽與適當的羧酸偶合以與關於(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺所描述的類似方式來製備(1S,3aR,6aS)-2-(9-氟-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺;觀察到m/z:534[M+H]+;1H NMR(400MHz,CD3OD):δ 7.78(dd,2H),7.55-7.44(m,4H),7.36(t,2H),4.64(dd,1H),4.32(d,2H),4.29(d,1H),3.05-2.23(m,5H),2.14-1.18(m,11H),0.78(s,1H)。 By coupling (S)-3-((S)-2-amino-4-(benzyloxy)-3-oxobutyl)pyrrolidin-2-one hydrochloride with an appropriate carboxylic acid to Regarding (1 S ,3a R ,6a S ) -N -(( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane- 2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide was prepared in a similar manner as described for (1 S , 3a R , 6a S )-2-(9-fluoro-9H-fennel-9-carbonyl)-N-((S)-4-hydroxyl-3-oxo-1-((S)-2-oxopyrrolidine-3 -yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide; observed m/z: 534[M+H] + ; 1 H NMR (400MHz, CD 3 OD): δ 7.78(dd,2H), 7.55-7.44(m,4H), 7.36(t,2H), 4.64(dd,1H), 4.32(d,2H), 4.29(d,1H), 3.05-2.23(m ,5H), 2.14-1.18(m,11H), 0.78(s,1H).
實施例25:(1S,3aR,6aS)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺(化合物27)Example 25: (1 S , 3a R , 6a S )-2-(9-Acetamido-9H-Oxime-9-carbonyl) -N -(( S )-4-Hydroxy-3-oxo -1-(( S )-2-oxopyrrolidin-3-yl)butane-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide (compound 27)
步驟(1):9-乙醯胺基-9H-茀-9-羧酸Step (1): 9-Acetamido-9H-Treme-9-carboxylic acid
將9-羥基茀-9-羧酸(550mg,2.07mmol)溶解在乙腈(12mL)中並在0℃下逐滴加入濃硫酸(810mg,8.27mmol)。將混合物在60℃下攪拌3小時,然後冷卻至室溫並緩慢加入水(30mL)。將所得溶液在室溫下再攪拌30分鐘。用EtOAc(3×30mL)萃取水溶液。將合併後的有機相用鹽水(20mL)洗滌,經無水硫酸鈉乾燥,過濾,並在真空下濃縮。向殘餘物加入CH2Cl2(30mL),隨後加入己烷(2mL)並對樣品進行超聲處理。通過過濾收集所得沉澱並乾燥,得到9-乙醯胺基茀-9-羧酸,為灰白色固體(465mg,產率84%,觀察到m/z:268[M+H]+),其無需進一步純化即可使用。 9-Hydroxytilbene-9-carboxylic acid (550 mg, 2.07 mmol) was dissolved in acetonitrile (12 mL) and concentrated sulfuric acid (810 mg, 8.27 mmol) was added dropwise at 0°C. The mixture was stirred at 60 °C for 3 hours, then cooled to room temperature and water (30 mL) was added slowly. The resulting solution was stirred at room temperature for an additional 30 minutes. The aqueous solution was extracted with EtOAc (3 x 30 mL). The combined organic phases were washed with brine (20 mL), dried over anhydrous sodium sulfate, filtered and concentrated under vacuum. To the residue was added CH2Cl2 (30 mL), followed by hexane (2 mL) and the sample was sonicated . The resulting precipitate was collected by filtration and dried to give 9-acetamido fluorene-9-carboxylic acid as an off-white solid (465 mg, 84% yield, observed m/z: 268 [M+H] + ), which did not require It can be used after further purification.
步驟(2):(1S,3aR,6aS)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺 Step (2): (1 S ,3a R ,6a S )-2-(9-Acetamido-9H-Oxyl-9-carbonyl) -N -(( S )-4-Hydroxy-3-oxo Base-1-(( S )-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide
通過將9-乙醯胺基茀-9-羧酸與適當的胺偶合以與關於(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁 烷-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺所描述的類似方式來製備(1S,3aR,6aS)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)八氫環戊[c]吡咯-1-甲醯胺;觀察到m/z:573[M+H]+;1H NMR(400MHz,CD3OD):δ 7.80(dd,2H),7.51(d,1H),7.49-7.43(m,3H),7.33(dd,2H),5.03(dd,1H),4.19(d,1H),3.39(m,2H),2.72(m,1H),2.51(dd,1H),2.46-2.23(m,5H),2.20(d,1H),1.99-1.84(m,6H),1.83-1.73(m,1H),1.52-1.25(m,5H)。 By coupling 9-acetylamino terpene-9-carboxylic acid with the appropriate amine to react with respect to (1 S , 3a R , 6a S ) -N -(( S )-4-hydroxy-3-oxo- - (1 S , 3a R , 6a S )-2-(9-acetamido-9H-oxo-9-carbonyl) -N -(( S )-1 -Cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)octahydrocyclopenta[c]pyrrole-1-carboxamide; observed m/z: 573 [M+ H] + ; 1 H NMR (400MHz, CD 3 OD): δ 7.80(dd,2H), 7.51(d,1H), 7.49-7.43(m,3H), 7.33(dd,2H), 5.03(dd, 1H), 4.19(d,1H), 3.39(m,2H), 2.72(m,1H), 2.51(dd,1H), 2.46-2.23(m,5H), 2.20(d,1H), 1.99-1.84 (m,6H), 1.83-1.73(m,1H), 1.52-1.25(m,5H).
實施例26:(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺(化合物28和29)Example 26: (1 S ,3a R ,6a S ) -N -(( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl) Butane-2-yl)-2-(5-oxo-2-phenylpyrrolidin-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide (Compounds 28 and 29)
通過將(1S,3aR,6aS)-八氫環戊[c]吡咯-1-羧酸乙酯鹽酸鹽與適當的羧酸偶合以與關於(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺所描述的類似方式來製備(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺(非對映異構物的混合物)。通過反相HPLC純化分離非對映異構物的混合物,得到每種差向異構物。 By coupling (1S,3aR,6aS)-octahydrocyclopenta[c]pyrrole-1-carboxylate ethyl ester hydrochloride with an appropriate carboxylic acid to combine with ( 1S , 3aR , 6aS ) -N- (( S )-4-hydroxyl-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane-2-yl)-2-(9-hydroxyl-9H- ( 1S , 3aR , 6aS ) -N -(( S )-4-hydroxy-3 -Oxy-1-(( S )-2-oxopyrrolidin-3-yl)butane-2-yl)-2-(5-oxyl-2-phenylpyrrolidin-2-carbonyl ) octahydrocyclopenta[c]pyrrole-1-carboxamide (mixture of diastereoisomers). The mixture of diastereoisomers was separated by reverse phase HPLC purification to afford each epimer.
主要非對映異構物(化合物28):(較快洗脫的非對映異構物,6.2mg,產率18%):觀察到m/z:511[M+H]+。1H NMR(400MHz,CD3OD):δ 7.45-7.34(m,5H),4.64(dd,1H),4.43-4.29(m,2H),4.26(d,1H),3.48(dd,1H),3.34(dd,2H),3.10(m,1H),2.89 (dd,1H),2.75-2.59(m,1H),2.55(d,2H),2.45(dd,1H),2.41-2.30(m,2H),2.21(m,1H),2.12-1.99(m,1H),1.86(m,3H),1.72-1.48(m,5H)。 Major diastereomer (compound 28) : (faster eluting diastereomer, 6.2 mg, 18% yield): observed m/z: 511 [M+H] + . 1 H NMR (400MHz, CD 3 OD): δ 7.45-7.34(m,5H), 4.64(dd,1H), 4.43-4.29(m,2H), 4.26(d,1H), 3.48(dd,1H) , 3.34(dd,2H), 3.10(m,1H), 2.89 (dd,1H), 2.75-2.59(m,1H), 2.55(d,2H), 2.45(dd,1H), 2.41-2.30(m ,2H), 2.21(m,1H), 2.12-1.99(m,1H), 1.86(m,3H), 1.72-1.48(m,5H).
次要非對映異構物(化合物29):(較慢洗脫的非對映異構物,2.2mg,產率7%):觀察到m/z:511[M+H]+。1H NMR(400MHz,CD3OD):δ 7.52-7.32(m,5H),4.62(dd,1H),4.43-4.23(m,2H),4.12(dd,1H),3.35(dd,3H),3.04-2.82(m,2H),2.78-2.55(m,2H),2.38(m,4H),2.08(m,1H),1.96(m,1H),1.90-1.72(m,4H),1.72-1.50(m,3H),1.37(m,1H)。 Minor diastereomer (compound 29) : (slower eluting diastereomer, 2.2 mg, 7% yield): observed m/z: 511 [M+H] + . 1 H NMR (400MHz, CD 3 OD): δ 7.52-7.32(m,5H), 4.62(dd,1H), 4.43-4.23(m,2H), 4.12(dd,1H), 3.35(dd,3H) , 3.04-2.82(m,2H), 2.78-2.55(m,2H), 2.38(m,4H), 2.08(m,1H), 1.96(m,1H), 1.90-1.72(m,4H), 1.72 -1.50(m,3H), 1.37(m,1H).
實施例27:(3S)-2-(2-環戊基-2-羥基-2-苯乙醯基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物30和31)Example 27: (3 S )-2-(2-cyclopentyl-2-hydroxyl-2-phenylacetyl) -N -(( S )-4-hydroxyl-3-oxo-1-( ( S )-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide (compounds 30 and 31)
步驟(1):(3S)-N-((S)-4-(苄氧基)-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-(4-氯苯基)-2-環戊基-2-羥基乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺Step (1): (3S)-N-((S)-4-(benzyloxy)-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane -2-yl)-2-(2-(4-chlorophenyl)-2-cyclopentyl-2-hydroxyacetyl)-2-azabicyclo[2.2.2]octane-3-formyl amine
在N2大氣壓中在-10℃下向2-(4-氯苯基)-2-環戊基-2-羥基乙酸(350mg,1.4mmol)在DMF(10mL)中的攪拌溶液加入HATU(784mg,2.1mmol)。向混合物逐滴加入(3S)-N-[(2S)-4-(苄氧基)-3-側氧基-1-[(3S)-2-氧代吡咯啶-3-基]丁烷-2-基]-2-氮雜雙環[2.2.2]辛 烷-3-甲醯胺鹽酸鹽(1g,2.1mmol)在DMF(5mL)中的溶液,隨後加入DIPEA(0.96mL,5.5mmol)。將反應混合物在室溫下攪拌2小時並用水(50mL)稀釋。將水相用EtOAc(2×50mL)萃取。將合併後的有機層用水性鹽水溶液(2×50mL)洗滌,經無水硫酸鈉乾燥,過濾,並在真空中濃縮。通過正相SiO2管柱層析法(70-80% EtOAc/己烷)純化粗殘餘物,以提供兩種分離的非對映異構物。 To a stirred solution of 2-( 4 -chlorophenyl)-2-cyclopentyl-2-hydroxyacetic acid (350 mg, 1.4 mmol) in DMF (10 mL) was added HATU (784 mg , 2.1 mmol). ( 3S ) -N -[( 2S )-4-(benzyloxy)-3-oxo-1-[( 3S )-2-oxopyrrolidin-3-yl was added dropwise to the mixture A solution of ]butane-2-yl]-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride (1 g, 2.1 mmol) in DMF (5 mL), followed by addition of DIPEA (0.96 mL, 5.5 mmol). The reaction mixture was stirred at room temperature for 2 hours and diluted with water (50 mL). The aqueous phase was extracted with EtOAc (2 x 50 mL). The combined organic layers were washed with aqueous brine solution (2 x 50 mL), dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. The crude residue was purified by normal phase Si02 column chromatography (70-80% EtOAc/hexanes) to afford the two separated diastereoisomers.
次要非對映異構物(單一非對映異構物I):(較快洗脫的非對映異構物,120mg,產率9%):觀察到m/z:650[M+H]+。 Minor diastereomer (single diastereomer I) : (faster eluting diastereomer, 120 mg, 9% yield): Observed m/z: 650 [M+ H] + .
主要非對映異構物(單一非對映異構物II):(較慢洗脫的非對映異構物,320mg,產率24%):觀察到m/z:650[M+H]+。 Major diastereomer (single diastereomer II) : (slower eluting diastereomer, 320 mg, 24% yield): Observed m/z: 650 [M+H ] + .
步驟(2a):(3S)-2-(2-環戊基-2-羥基-2-苯乙醯基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物30)Step (2a): (3S)-2-(2-cyclopentyl-2-hydroxy-2-phenylacetyl)-N-((S)-4-hydroxy-3-oxo-1-( (S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide (compound 30)
向(3S)-N-[(2S)-4-(苄氧基)-3-側氧基-1-[(3S)-2-氧代吡咯啶-3-基]丁烷-2-基]-2-[2-(4-氯苯基)-2-環戊基-2-羥基乙醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(次要非對映異構物/單一非對映異構物I,100mg,0.15mmol)在MeOH(5mL)中的攪拌溶液加入鈀炭催化劑(10%負載於碳,0.1g,1mmol)。將反應混合物在室溫下在氫氣囊壓力下攪拌2小時,通過Celite®墊過濾並用MeOH(20mL)洗滌。將濾液在真空中濃縮並通過反相製備型HPLC純化粗殘餘物,得到(3S)-2-(2-環戊基-2-羥基-2-苯乙醯基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(次要非對映異構物,單一非對映異構物I),為白色固體(16mg,產率7%,觀察到 m/z:526[M+H]+);1H NMR(400MHz,DMSO-d6):δ 8.19(d,1H),7.59(s,1H),7.46-7.15(m,6H),5.65(s,1H),5.06(t,1H),4.60-4.42(m,1H),4.35-3.79(m,4H),3.26-3.02(m,2H),2.36-0.86(m,22H)。 To (3 S ) -N -[(2 S )-4-(benzyloxy)-3-oxo-1-[(3 S )-2-oxopyrrolidin-3-yl]butane- 2-yl]-2-[2-(4-chlorophenyl)-2-cyclopentyl-2-hydroxyacetyl]-2-azabicyclo[2.2.2]octane-3-formamide A stirred solution of (minor diastereomer/single diastereomer I, 100 mg, 0.15 mmol) in MeOH (5 mL) was added palladium on carbon catalyst (10% on carbon, 0.1 g, 1 mmol). The reaction mixture was stirred at room temperature under a balloon of hydrogen for 2 hours, filtered through a pad of Celite® and washed with MeOH (20 mL). The filtrate was concentrated in vacuo and the crude residue was purified by reverse phase preparative HPLC to give ( 3S )-2-(2-cyclopentyl-2-hydroxy-2-phenylacetyl) -N -(( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane - 3-Formamide (minor diastereomer, single diastereomer I), as a white solid (16 mg, 7% yield, observed m/z: 526 [M+H] + ); 1 H NMR (400MHz, DMSO-d 6 ): δ 8.19(d,1H), 7.59(s,1H), 7.46-7.15(m,6H), 5.65(s,1H), 5.06(t,1H ), 4.60-4.42(m,1H), 4.35-3.79(m,4H), 3.26-3.02(m,2H), 2.36-0.86(m,22H).
步驟(2b):(3S)-2-(2-環戊基-2-羥基-2-苯乙醯基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物31)Step (2b): (3S)-2-(2-cyclopentyl-2-hydroxy-2-phenylacetyl)-N-((S)-4-hydroxy-3-oxo-1-( (S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide (compound 31)
向(3S)-N-[(2S)-4-(苄氧基)-3-側氧基-1-[(3S)-2-氧代吡咯啶-3-基]丁烷-2-基]-2-[2-(4-氯苯基)-2-環戊基-2-羥基乙醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(主要非對映異構物/單一非對映異構物II,290mg,0.45mmol)在MeOH(8mL)中的攪拌溶液加入鈀炭催化劑(10%負載於碳,0.3g,3mmol)。將反應混合物在室溫下在氫氣囊壓力下攪拌2小時,通過CELITE®墊過濾並用MeOH(30mL)洗滌。將濾液在真空中濃縮並通過反相製備型HPLC純化粗殘餘物,得到(3S)-2-(2-環戊基-2-羥基-2-苯乙醯基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(主要非對映異構物/單一非對映異構物II),為白色固體(25mg,產率11%。m/z:526[M+H]+);1H NMR(400MHz,DMSO-d6):δ 8.17(d,1H),7.66(s,1H),7.49-7.11(m,6H),5.66(s,1H),4.58-3.97(m,6H),2.36-0.80(m,24H)。 To (3 S ) -N -[(2 S )-4-(benzyloxy)-3-oxo-1-[(3 S )-2-oxopyrrolidin-3-yl]butane- 2-yl]-2-[2-(4-chlorophenyl)-2-cyclopentyl-2-hydroxyacetyl]-2-azabicyclo[2.2.2]octane-3-formamide A stirred solution of (major diastereomer/single diastereomer II, 290 mg, 0.45 mmol) in MeOH (8 mL) was added palladium on carbon catalyst (10% on carbon, 0.3 g, 3 mmol). The reaction mixture was stirred at room temperature under a balloon of hydrogen for 2 hours, filtered through a pad of CELITE® and washed with MeOH (30 mL). The filtrate was concentrated in vacuo and the crude residue was purified by reverse phase preparative HPLC to give ( 3S )-2-(2-cyclopentyl-2-hydroxy-2-phenylacetyl) -N -(( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane - 3-Formamide (major diastereomer/single diastereomer II) as a white solid (25 mg, 11% yield. m/z: 526 [M+H] + ); 1 H NMR (400MHz, DMSO-d 6 ): δ 8.17(d,1H), 7.66(s,1H), 7.49-7.11(m,6H), 5.66(s,1H), 4.58-3.97(m,6H) , 2.36-0.80 (m, 24H).
實施例28:(S)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-1-(9-羥基-9H-茀-9-羰基)-4-苯基哌 -2-甲醯胺(化合物32) Example 28: ( S ) -N -(( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane-2-yl) -1-(9-Hydroxy-9H-terpine-9-carbonyl)-4-phenylpiperene -2-formamide (compound 32)
步驟(1):1-(第三丁基)2-甲基(S)-4-苯基哌 -1,2-二羧酸酯 Step (1): 1-(tert-butyl)2-methyl(S)-4-phenylpiperene -1,2-dicarboxylate
在室溫下向1-(第三丁基)2-甲基(S)-哌-1,2-二羧酸酯(5.0g,20.5mmol)和苯基硼酸(5.0g,39.3mmol)在CH2Cl2(25mL)中的攪拌溶液加入Cu(OAc)2(2.2g,12.3mmol)並將反應混合物攪拌24小時。將混合物用H2O(100mL)和飽和水性鹽水溶液(50mL)洗滌。將合併後的有機萃取物經無水硫酸鈉乾燥並在減壓下濃縮。通過SiO2管柱層析法(0-10% EtOAc/己烷)純化殘餘物,得到1-(第三丁基)2-甲基(S)-4-苯基哌-1,2-二羧酸酯(2.5g,產率38%,觀察到m/z:321[M+H]+)。 To 1-(tert-butyl)2-methyl( S )-piperene at room temperature - A stirred solution of 1,2-dicarboxylate (5.0 g, 20.5 mmol) and phenylboronic acid (5.0 g, 39.3 mmol) in CH 2 Cl 2 (25 mL) was added to Cu(OAc) 2 (2.2 g, 12.3 mmol) and the reaction mixture was stirred for 24 hours. The mixture was washed with H2O (100 mL) and saturated aqueous brine solution (50 mL). The combined organic extracts were dried over anhydrous sodium sulfate and concentrated under reduced pressure. Purification of the residue by SiO2 column chromatography (0-10% EtOAc/Hexanes) afforded 1-(tert-butyl)2-methyl( S )-4-phenylpiper - 1,2-dicarboxylate (2.5 g, 38% yield, observed m/z: 321 [M+H] + ).
步驟(2) (S)-1-(第三丁氧基羰基)-4-苯基哌 -2-羧酸 Step (2) (S)-1-(tert-butoxycarbonyl)-4-phenylpiperene -2-carboxylic acid
在0℃下向1-(第三丁基)2-甲基(S)-4-苯基哌-1,2-二羧酸酯(3.00g,9.34mmol)在THF:水(2:1,25mL)中的攪拌溶液加入LiOH一水化物(1.6g,37.4mmol)並將反應混合物在室溫下攪拌16小時。將混合物在減壓下濃縮以除去有機溶劑。將殘餘物在EtOAc(10mL)和水(10mL)之間分配,並用HCl(1N)將混合物酸化至pH 3。將有機相用鹽水溶液(10mL)洗滌,經無水硫酸鈉乾燥並在減壓下濃縮。用 正戊烷(5mL)研磨殘餘物並通過過濾收集所得固體,得到(S)-1-(第三丁氧基羰基)-4-苯基哌-2-羧酸(2.2g,產率76%,觀察到m/z:307[M+H]+)。 To 1-(tert-butyl)2-methyl( S )-4-phenylpiperene at 0°C - A stirred solution of 1,2-dicarboxylate (3.00 g, 9.34 mmol) in THF:water (2:1, 25 mL) was added LiOH monohydrate (1.6 g, 37.4 mmol) and the reaction mixture was heated at room temperature Stirring was continued for 16 hours. The mixture was concentrated under reduced pressure to remove the organic solvent. The residue was partitioned between EtOAc (10 mL) and water (10 mL), and the mixture was acidified to pH 3 with HCl (1N). The organic phase was washed with brine solution (10 mL), dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was triturated with n-pentane (5 mL) and the resulting solid was collected by filtration to give ( S )-1-(tert-butoxycarbonyl)-4-phenylpiper -2-Carboxylic acid (2.2 g, 76% yield, observed m/z: 307 [M+H] + ).
步驟(3):(S)-2-(((S)-4-氯-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺甲醯基)-4-苯基哌 -1-羧酸第三丁酯 Step (3): (S)-2-(((S)-4-chloro-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2- base) carbamoyl) -4-phenylpiperidine -1-Tertiary butyl carboxylate
在0℃下向(S)-1-(第三丁氧基羰基)-4-苯基哌-2-羧酸(500mg,1.6mmol)在DMF(5mL)中的攪拌懸浮液加入HATU(937mg,2.5mmol)。在20分鐘之後,加入(S)-3-((S)-2-胺基-4-氯-3-氧代丁基)吡咯啶-2-酮鹽酸鹽(708mg,2.9mmol)在DMF(2mL)中的溶液,隨後逐滴加入N-甲基嗎啉(0.9mL,8.17mmol)。將反應物在0℃下攪拌6小時。用飽和氯化銨水溶液(10mL)稀釋混合物並分離各層。用CH2Cl2(2×10mL)萃取水相。用飽和碳酸氫鈉水溶液(10mL)、H2O(10mL)、鹽水溶液(10mL)洗滌合併後的有機相,用無水硫酸鈉乾燥並在減壓下濃縮。通過正相SiO2層析法(20-100% EtOAc/己烷)純化殘餘物,得到(S)-2-(((S)-4-氯-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺甲醯基)-4-苯基哌-1-羧酸第三丁酯,為白色固體(240mg,產率30%,觀察到m/z:493[M+H]+)。 To ( S )-1-(tert-butoxycarbonyl)-4-phenylpiperene at 0°C - A stirred suspension of 2-carboxylic acid (500 mg, 1.6 mmol) in DMF (5 mL) was added to HATU (937 mg, 2.5 mmol). After 20 minutes, ( S )-3-(( S )-2-amino-4-chloro-3-oxobutyl)pyrrolidin-2-one hydrochloride (708 mg, 2.9 mmol) in DMF was added (2 mL), followed by the dropwise addition of N -methylmorpholine (0.9 mL, 8.17 mmol). The reaction was stirred at 0 °C for 6 hours. The mixture was diluted with saturated aqueous ammonium chloride (10 mL) and the layers were separated. The aqueous phase was extracted with CH2Cl2 (2 x 10 mL). The combined organic phases were washed with saturated aqueous sodium bicarbonate (10 mL), H2O (10 mL), brine solution (10 mL), dried over anhydrous sodium sulfate and concentrated under reduced pressure. Purification of the residue by normal phase SiO2 chromatography (20-100% EtOAc/hexanes) afforded (S)-2-(((S)-4-chloro-3-oxo-1-((S )-2-oxopyrrolidin-3-yl)butan-2-yl)aminoformyl)-4-phenylpiper - tert-butyl 1-carboxylate as a white solid (240 mg, 30% yield, observed m/z: 493 [M+H] + ).
步驟(4):(S)-N-((S)-4-氯-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-4-苯基哌 -2-甲醯胺鹽酸鹽 Step (4): (S)-N-((S)-4-chloro-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl )-4-phenylpiperidine -2-Formamide hydrochloride
向(S)-2-(((S)-4-氯-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺甲醯基)-4-苯基哌-1-羧酸第三丁酯(240mg,0.49mmol)在CH2Cl2(2mL)中的攪拌溶液加入HCl(2mL,4M的1,4-二烷溶液)。將反應混合物在室溫下攪拌12小時,並且然後在減壓下濃縮,得到(S)-N-((S)-4-氯-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-4-苯基哌-2-甲醯胺鹽酸鹽,其無需進一步純化即可使用(220mg,觀察到m/z:393[M+H]+)。 To (S)-2-(((S)-4-chloro-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)amine Acyl)-4-phenylpiperene - A stirred solution of tert-butyl 1-carboxylate (240 mg, 0.49 mmol) in CH 2 Cl 2 (2 mL) was added with HCl (2 mL, 4M of 1,4-di alkane solution). The reaction mixture was stirred at room temperature for 12 hours, and then concentrated under reduced pressure to give ( S ) -N -(( S )-4-chloro-3-oxo-1-(( S )-2- Oxypyrrolidin-3-yl)butan-2-yl)-4-phenylpiper - 2-Formamide hydrochloride which was used without further purification (220 mg, observed m/z: 393 [M+H] + ).
步驟(5):(S)-N-((S)-4-氯-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-1-(9-羥基-9H-茀-9-羰基)-4-苯基哌 -2-甲醯胺 Step (5): (S)-N-((S)-4-chloro-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl )-1-(9-Hydroxy-9H-terpine-9-carbonyl)-4-phenylpiperene -2-Formamide
在0℃下向9-羥基-9H-茀-9-羧酸(260mg,1.1mmol)在DMF(3mL)中的攪拌懸浮液加入HATU(655mg,1.7mmol)。在20分鐘之後,加入(S)-N-((S)-4-氯-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-4-苯基哌-2-甲醯胺鹽酸鹽(984mg,2.3mmol)在DMF(2mL)中的溶液,隨後逐滴加入N-甲基嗎啉(0.6mL,5.7mmol)。將反應物在0℃下攪拌3小時。用飽和氯化銨水溶液(10mL)稀釋混合物並分離各層。用CH2Cl2(2×20mL)萃取水相。用飽和碳酸氫鈉水溶液(10mL)、H2O(10mL)、鹽水溶液(10mL)洗滌合併後的有機相,經無水 硫酸鈉乾燥並在減壓下濃縮。通過正相SiO2層析法(20-100% EtOAc/己烷)純化殘餘物,得到(S)-N-((S)-4-氯-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-1-(9-羥基-9H-茀-9-羰基)-4-苯基哌-2-甲醯胺(20mg,產率6%,觀察到m/z:601[M+H]+)。 To a stirred suspension of 9-hydroxy-9H-tertilene-9-carboxylic acid (260 mg, 1.1 mmol) in DMF (3 mL) was added HATU (655 mg, 1.7 mmol) at 0°C. After 20 minutes, ( S ) -N -(( S )-4-chloro-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane-2- base)-4-phenylpiperene - A solution of 2-formamide hydrochloride (984 mg, 2.3 mmol) in DMF (2 mL), followed by dropwise addition of N -methylmorpholine (0.6 mL, 5.7 mmol). The reaction was stirred at 0 °C for 3 hours. The mixture was diluted with saturated aqueous ammonium chloride (10 mL) and the layers were separated. The aqueous phase was extracted with CH2Cl2 (2 x 20 mL). The combined organic phases were washed with saturated aqueous sodium bicarbonate (10 mL), H2O (10 mL), brine solution (10 mL), dried over anhydrous sodium sulfate and concentrated under reduced pressure. Purification of the residue by normal phase SiO2 chromatography (20-100% EtOAc/hexanes) afforded ( S ) -N -(( S )-4-chloro-3-oxo-1-(( S ) -2-Oxopyrrolidin-3-yl)butane-2-yl)-1-(9-hydroxy-9H-fennel-9-carbonyl)-4-phenylpiper - 2-Formamide (20 mg, yield 6%, observed m/z: 601 [M+H] + ).
步驟(6):(S)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-1-(9-羥基-9H-茀-9-羰基)-4-苯基哌 -2-甲醯胺 Step (6): (S)-N-((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl )-1-(9-Hydroxy-9H-terpine-9-carbonyl)-4-phenylpiperene -2-Formamide
在室溫下在N2大氣壓中向(S)-N-((S)-4-氯-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-1-(9-羥基-9H-茀-9-羰基)-4-苯基哌-2-甲醯胺(100mg,0.166mmol)和苯甲醯基甲酸(19mg,0.133mmol)在DMF(2mL)中的攪拌溶液加入氟化銫(58mg,0.382mmol)。將反應混合物加熱至60℃,持續4小時。將混合物冷卻至室溫,用EtOAc(60mL)稀釋,用H2O(3×30mL)、鹽水溶液(30mL)洗滌,經無水硫酸鎂乾燥並在減壓下濃縮。將殘餘物溶解在MeOH(5mL)中,用N2吹掃並用碳酸鉀(5mg,0.04mmol)處理,伴隨劇烈攪拌1小時。將混合物在減壓下濃縮(水浴溫度保持低於30℃)。通過反相HPLC純化殘餘物,得到(S)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-1-(9-羥基-9H-茀-9-羰基)-4-苯基哌-2-甲醯胺(10mg,產率10%,觀察到m/z:583[M+H]+);1H NMR(400MHz,DMSO-d6):δ 8.56-7.14(m,12H),6.75-6.26(m,2H),5.08-3.31(m,7H),4.28-4.11(m,2H),3.15-2.67(m,6H),2.32-1.96(m,3H),1.75-1.46(m,2H)。 To ( S ) -N -(( S )-4-chloro-3-oxo- 1 -(( S )-2-oxopyrrolidin-3-yl)butyl Alkyl-2-yl)-1-(9-hydroxy-9H-fluorene-9-carbonyl)-4-phenylpiper - A stirred solution of 2-formamide (100 mg, 0.166 mmol) and benzoylformic acid (19 mg, 0.133 mmol) in DMF (2 mL) was added cesium fluoride (58 mg, 0.382 mmol). The reaction mixture was heated to 60 °C for 4 hours. The mixture was cooled to room temperature, diluted with EtOAc (60 mL), washed with H2O (3 x 30 mL), brine solution (30 mL), dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The residue was dissolved in MeOH (5 mL), purged with N2 and treated with potassium carbonate (5 mg, 0.04 mmol) with vigorous stirring for 1 h. The mixture was concentrated under reduced pressure (water bath temperature kept below 30°C). Purification of the residue by reverse phase HPLC afforded ( S ) -N -(( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane -2-yl)-1-(9-hydroxy-9H-fennel-9-carbonyl)-4-phenylpiperene -2-Formamide (10 mg, yield 10%, observed m/z: 583[M+H] + ); 1 H NMR (400MHz, DMSO-d 6 ): δ 8.56-7.14 (m, 12H) , 6.75-6.26(m,2H), 5.08-3.31(m,7H), 4.28-4.11(m,2H), 3.15-2.67(m,6H), 2.32-1.96(m,3H), 1.75-1.46( m,2H).
實施例29:N-((S)-3-環己基-1-(((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-(2,2,2-三氟乙醯胺基)-9H-茀-9-甲醯胺(化合物33)Example 29: N -((S)-3-cyclohexyl-1-((( S )-4-hydroxy-3-oxo-1-(( S )-2-oxopyrrolidine-3- Base) butane-2-yl)amino)-1-oxopropan-2-yl)-9-(2,2,2-trifluoroacetamido)-9H-oxo-9-formamide (compound 33)
步驟(1):(S)-3-環己基-2-(9H-茀-9-甲醯胺基)丙酸甲酯Step (1): (S)-Methyl 3-cyclohexyl-2-(9H-stilbene-9-formamido)propionate
在0℃下向9H-茀-9-羧酸(5.0g,23.8mmol)、(S)-2-胺基-3-環己基丙酸甲酯鹽酸鹽(7.9g,35.6mmol)和PyBOP(24.7g,47.6mmol)在DMF(25mL)中的攪拌溶液加入N,N-二異丙基乙胺(21mL,120mmol)並將反應混合物在室溫下攪拌3小時。用冰冷的水(150mL)稀釋混合物,並用EtOAc(2×200mL)萃取。用H2O(100mL)洗滌合併後的有機萃取物,經無水硫酸鈉乾燥並在減壓下濃縮。通過正相SiO2層析法(0-70% EtOAc/己烷)純化殘餘物,得到(S)-3-環己基-2-(9H-茀-9-甲醯胺基)丙酸甲酯(6g,產率66%,觀察到m/z:378[M+H]+);1H NMR(400MHz,CDCl3):δ 7.79(t,2H),7.68(d,2H),7.48-7.33(m,4H),5.54(d,1H),4.81(s,1H),4.64-4.58(m,1H),3.63(s,3H),1.63-1.49(m,5H),1.45(d,1H),1.29-1.22(m,1H),1.07-0.93(m,4H),0.77-0.72(m,2H)。 To 9H-terpinene-9-carboxylic acid (5.0g, 23.8mmol), (S)-2-amino-3-cyclohexylpropionic acid methyl ester hydrochloride (7.9g, 35.6mmol) and PyBOP at 0°C (24.7 g, 47.6 mmol) in DMF (25 mL) was added to a stirred solution of N,N -diisopropylethylamine (21 mL, 120 mmol) and the reaction mixture was stirred at room temperature for 3 hours. The mixture was diluted with ice-cold water (150 mL), and extracted with EtOAc (2 x 200 mL). The combined organic extracts were washed with H2O (100 mL), dried over anhydrous sodium sulfate and concentrated under reduced pressure. Purification of the residue by normal phase SiO2 chromatography (0-70% EtOAc/hexanes) afforded (S)-methyl 3-cyclohexyl-2-(9H-tertyl-9-carboxamido)propionate (6 g, 66% yield, observed m/z: 378 [M+H] + ); 1 H NMR (400 MHz, CDCl 3 ): δ 7.79 (t, 2H), 7.68 (d, 2H), 7.48- 7.33(m,4H), 5.54(d,1H), 4.81(s,1H), 4.64-4.58(m,1H), 3.63(s,3H), 1.63-1.49(m,5H), 1.45(d, 1H), 1.29-1.22 (m, 1H), 1.07-0.93 (m, 4H), 0.77-0.72 (m, 2H).
步驟(2):(S)-2-(9-胺基-9H-茀-9-甲醯胺基)-3-環己基丙酸甲酯Step (2): (S)-Methyl 2-(9-Amino-9H-Oxa-9-formamido)-3-cyclohexylpropionate
在-78℃下在5min內向(S)-3-環己基-2-(9H-茀-9-甲醯胺基)丙酸甲酯(1.7g,4.5mmol)在THF(17mL)中的攪拌溶液逐滴加入n-BuLi(2.5M己烷溶液,2.7mL,6.75mmol)。將反應物攪拌45分鐘。在-78℃下向上述溶液加入O-(二苯基次膦醯基)羥胺(1.6g,6.7mmol)在THF(10mL)中的溶液。將反應混合物的溫度緩慢升溫直到室溫,並攪拌16小時。將混合物用飽和氯化銨水溶液(50mL)淬滅,並用EtOAc(2×100mL)萃取。將合併後的有機萃取物經無水硫酸鈉乾燥並在減壓下濃縮。通過正相SiO2層析法(2-100% EtOAc/己烷)純化殘餘物,得到(S)-2-(9-胺基-9H-茀-9-甲醯胺基)-3-環己基丙酸甲酯(0.6g,產率34%,觀察到m/z:393[M+H]+);1H NMR(400MHz,DMSO-d6):δ 8.35(d,1H),7.78(d,2H),7.48-7.72(m,6H),4.33(m,1H),3.61(s,3H),2.85(bs,2H),1.72-1.52(m,7H),1.27-1.08(m,6H)。 Stirring of (S)-methyl 3-cyclohexyl-2-(9H-fluorene-9-formamido)propanoate (1.7 g, 4.5 mmol) in THF (17 mL) at -78 °C over 5 min The solution was added dropwise to n -BuLi (2.5M in hexane, 2.7 mL, 6.75 mmol). The reaction was stirred for 45 minutes. To the above solution was added a solution of O- (diphenylphosphinoyl)hydroxylamine (1.6 g, 6.7 mmol) in THF (10 mL) at -78 °C. The temperature of the reaction mixture was slowly warmed up to room temperature and stirred for 16 hours. The mixture was quenched with saturated aqueous ammonium chloride (50 mL), and extracted with EtOAc (2 x 100 mL). The combined organic extracts were dried over anhydrous sodium sulfate and concentrated under reduced pressure. Purification of the residue by normal phase SiO2 chromatography (2-100% EtOAc/Hexanes) afforded (S)-2-(9-amino-9H-tertyl-9-carboxamido)-3-cyclo Methyl hexylpropionate (0.6 g, 34% yield, observed m/z: 393 [M+H] + ); 1 H NMR (400 MHz, DMSO-d 6 ): δ 8.35 (d, 1H), 7.78 (d,2H), 7.48-7.72(m,6H), 4.33(m,1H), 3.61(s,3H), 2.85(bs,2H), 1.72-1.52(m,7H), 1.27-1.08(m ,6H).
步驟(3):(S)-3-環己基-2-(9-(2,2,2-三氟乙醯胺基)-9H-茀-9-甲醯胺基)丙酸甲酯Step (3): (S)-methyl 3-cyclohexyl-2-(9-(2,2,2-trifluoroacetamido)-9H-trifluoroacetamido)propionate
在0℃下向(S)-2-(9-胺基-9H-茀-9-甲醯胺基)-3-環己基丙酸甲酯(600mg,1.53mmol)在CH2Cl2(6mL)中的攪拌溶液加入三乙胺(1mL,3.05mmol)。將反應物攪拌20min。向上述溶液加入三氟乙酸酐(0.31mL,2.3mmol),並將反應物在室溫下攪拌2小時。將反 應物用H2O(20mL)稀釋,並用EtOAc(2×50mL)萃取。將合併後的有機相用鹽水溶液(30mL)洗滌,經無水硫酸鈉乾燥並在減壓下濃縮。通過正相SiO2層析法(0-70% EtOAc/己烷)純化殘餘物,得到(S)-3-環己基-2-(9-(2,2,2-三氟乙醯胺基)-9H-茀-9-甲醯胺基)丙酸甲酯(400mg,產率53%,觀察到m/z:489[M+H]+)。 (S)-2-(9-Amino-9H-tertyl-9-formamido)-3-cyclohexylpropanoic acid methyl ester (600 mg, 1.53 mmol) in CH 2 Cl 2 (6 mL ) was added triethylamine (1 mL, 3.05 mmol). The reaction was stirred for 20 min. To the above solution was added trifluoroacetic anhydride (0.31 mL, 2.3 mmol), and the reaction was stirred at room temperature for 2 hours. The reaction was diluted with H2O (20 mL) and extracted with EtOAc (2 x 50 mL). The combined organic phases were washed with brine solution (30 mL), dried over anhydrous sodium sulfate and concentrated under reduced pressure. Purification of the residue by normal phase SiO2 chromatography (0-70% EtOAc/hexanes) afforded (S)-3-cyclohexyl-2-(9-(2,2,2-trifluoroacetamido )-methyl 9H-Trexa-9-formamido)propionate (400 mg, 53% yield, observed m/z: 489 [M+H] + ).
步驟(4):(S)-3-環己基-2-(9-(2,2,2-三氟乙醯胺基)-9H-茀-9-甲醯胺基)丙酸Step (4): (S)-3-Cyclohexyl-2-(9-(2,2,2-trifluoroacetamido)-9H-trifluoroacetamido)propanoic acid
向(S)-3-環己基-2-(9-(2,2,2-三氟乙醯胺基)-9H-茀-9-甲醯胺基)丙酸甲酯(470mg,0.96mmol)在THF:H2O(4:1,10mL)中的攪拌溶液加入LiOH一水化物(200mg,4.8mmol),並將反應混合物在室溫下攪拌2小時。將混合物在減壓下濃縮,然後用HCl(1N)酸化至pH 4,並用EtOAc(2×50mL)萃取。將合併後的有機相經無水硫酸鈉乾燥並在減壓下濃縮,得到(S)-3-環己基-2-(9-(2,2,2-三氟乙醯胺基)-9H-茀-9-甲醯胺基)丙酸,其無需進一步純化即可用於下一步(420mg,觀察到m/z:475[M+H]+)。 To (S)-3-cyclohexyl-2-(9-(2,2,2-trifluoroacetamido)-9H-stilbene-9-formamido)propanoic acid methyl ester (470mg, 0.96mmol ) in THF: H2O (4:1, 10 mL) was added LiOH monohydrate (200 mg, 4.8 mmol), and the reaction mixture was stirred at room temperature for 2 h. The mixture was concentrated under reduced pressure, then acidified to pH 4 with HCl (1 N), and extracted with EtOAc (2 x 50 mL). The combined organic phases were dried over anhydrous sodium sulfate and concentrated under reduced pressure to obtain ( S )-3-cyclohexyl-2-(9-(2,2,2-trifluoroacetamido)-9H- (420 mg, observed m/z: 475 [M+H] + ).
步驟(5):N-((S)-3-環己基-1-(((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-(2,2,2-三氟乙醯胺基)-9H-茀-9-甲醯胺Step (5): N-((S)-3-cyclohexyl-1-(((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidine-3 -yl)butane-2-yl)amino)-1-oxopropan-2-yl)-9-(2,2,2-trifluoroacetamido)-9H-oxo-9-formyl amine
在0℃下向(S)-3-環己基-2-(9-(2,2,2-三氟乙醯胺基)-9H-茀-9-甲醯胺基)丙酸(400mg)在DMF(5mL)中的攪拌溶液加入(S)-3-((S)-2-胺基-4-羥基-3-氧代丁基)吡咯啶-2-酮鹽酸鹽(375mg,1.7mmol)、HATU(384mg,1.0mmol)和N,N-二異丙基乙胺(0.45mL,2.5mmol)。將混合物在室溫下攪拌1小時。將反應混合物用冰冷的水稀釋,並用EtOAc(2×50mL)萃取。將合併後的有機相用飽和水性鹽水溶液(50mL)洗滌,經無水硫酸鈉乾燥並在減壓下濃縮。通過反相HPLC純化殘餘物,得到N-((S)-3-環己基-1-(((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-(2,2,2-三氟乙醯胺基)-9H-茀-9-甲醯胺(85mg,來自(S)-3-環己基-2-(9-(2,2,2-三氟乙醯胺基)-9H-茀-9-甲醯胺基的產率15%)丙酸,觀察到m/z:643[M+H]+);1H NMR(400MHz,DMSO-d6):δ 10.08(s,1H),8.13(bs,1H),7.88(t,2H),7.69-7.62(m,4H),7.48(t,2H),7.33(q,2H),7.19(d,1H),5.06(t,1H),4.37-4.32(m,2H),4.13-4.04(m,2H),3.15-3.01(m,2H),2.16(m,1H),1.99(m,1H),1.82(m,1H),1.62-1.53(m,6H),1.36(m,3H),1.00(m,4H),0.74-0.63(m,2H)。 To ( S )-3-cyclohexyl-2-(9-(2,2,2-trifluoroacetamido)-9H-stilbene-9-formamido)propionic acid (400mg) at 0°C To a stirred solution in DMF (5 mL) was added ( S )-3-(( S )-2-amino-4-hydroxy-3-oxobutyl)pyrrolidin-2-one hydrochloride (375 mg, 1.7 mmol), HATU (384mg, 1.0mmol) and N,N -diisopropylethylamine (0.45mL, 2.5mmol). The mixture was stirred at room temperature for 1 hour. The reaction mixture was diluted with ice-cold water and extracted with EtOAc (2 x 50 mL). The combined organic phases were washed with saturated aqueous brine solution (50 mL), dried over anhydrous sodium sulfate and concentrated under reduced pressure. Purification of the residue by reverse phase HPLC gave N -(( S )-3-cyclohexyl-1-((( S )-4-hydroxy-3-oxo-1-((S)-2-oxo Pyrrolidin-3-yl)butan-2-yl)amino)-1-oxopropan-2-yl)-9-(2,2,2-trifluoroacetamido)-9H- 9-Formamide (85 mg, a product derived from (S)-3-cyclohexyl-2-(9-(2,2,2-trifluoroacetamido)-9H-trifluoroacetamido) rate 15%) propionic acid, observed m/z: 643[M+H] + ); 1 H NMR (400MHz, DMSO-d 6 ): δ 10.08 (s, 1H), 8.13 (bs, 1H), 7.88 (t,2H), 7.69-7.62(m,4H), 7.48(t,2H), 7.33(q,2H), 7.19(d,1H), 5.06(t,1H), 4.37-4.32(m,2H ), 4.13-4.04(m,2H), 3.15-3.01(m,2H), 2.16(m,1H), 1.99(m,1H), 1.82(m,1H), 1.62-1.53(m,6H), 1.36(m,3H), 1.00(m,4H), 0.74-0.63(m,2H).
實施例30:(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物34)Example 30: (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5 , 5-difluoro-2-(9-hydroxy-9H-fen-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide (compound 34)
步驟(1):((S)-1-胺基-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基甲酸第三丁酯Step (1): ((S)-1-amino-1-oxo-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)carbamic acid third Butyl ester
在密封管中向(2S)-2-(第三丁氧基羰基胺基)-3-[(3S)-2-氧代吡咯啶-3-基]丙酸甲酯(7.0g,24.5mmol)加入氨(7N的MeOH溶液,56mL,392mmol)。將反應混合物在室溫下攪拌64小時。將混合物冷卻至室溫並在減壓下濃縮,以提供N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]胺基甲酸第三丁酯,為白色固體(6.6g,產率99%,觀察到m/z:272[M+H]+)。 To (2S)-2-(tert-butoxycarbonylamino)-3-[(3S)-2-oxopyrrolidin-3-yl]propanoic acid methyl ester (7.0 g, 24.5 mmol ) was added ammonia (7N in MeOH, 56 mL, 392 mmol). The reaction mixture was stirred at room temperature for 64 hours. The mixture was cooled to room temperature and concentrated under reduced pressure to provide N-[(1S)-2-amino-2-oxo-1-[[(3S)-2-oxopyrrolidine-3- tert-butyl]methyl]ethyl]carbamate as a white solid (6.6 g, 99% yield, observed m/z: 272 [M+H] + ).
步驟(2):(S)-2-胺基-3-((S)-2-氧代吡咯啶-3-基)丙烯醯胺Step (2): (S)-2-Amino-3-((S)-2-oxopyrrolidin-3-yl)acrylamide
向N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]胺基甲酸第三丁酯(3.89g,14.3mmol)在2-丙醇(32mL)中的0℃溶液逐滴加入氯化氫(5.5M的2-丙醇溶液,13mL,71.7mmol)。將反應混合物升溫至50℃,並攪拌4小時,然後在室溫下過夜。將混合物冷卻至室溫並傾倒液體。將剩餘的殘餘物在減壓下濃縮並在高真空下乾燥,以提供(S)-2-胺基-3-((S)-2-氧代吡咯啶-3-基)丙烯醯胺的鹽酸鹽,為白色固體(2.98g,產率100%,觀察到m/z:172[M+H]+); 1H NMR(400MHz,甲醇-d 4):δ 4.02(dd,1H),3.43-3.34(m,2H),2.82-2.67(m,1H),2.50-2.37(m,1H),2.13-1.95(m,2H),1.95-1.81(m,1H)。 To N-[(1S)-2-amino-2-oxo-1-[[(3S)-2-oxopyrrolidin-3-yl]methyl]ethyl]carbamate A solution of the ester (3.89 g, 14.3 mmol) in 2-propanol (32 mL) at 0 °C was added dropwise to hydrogen chloride (5.5 M in 2-propanol, 13 mL, 71.7 mmol). The reaction mixture was warmed to 50 °C and stirred for 4 hours, then at room temperature overnight. The mixture was cooled to room temperature and the liquid was decanted. The remaining residue was concentrated under reduced pressure and dried under high vacuum to afford (S) -2-amino-3-(( S )-2-oxopyrrolidin-3-yl)acrylamide Hydrochloride salt as a white solid (2.98 g, 100% yield, observed m/z: 172 [M+H] + ); 1 H NMR (400 MHz, methanol- d 4 ): δ 4.02 (dd, 1H) , 3.43-3.34 (m, 2H), 2.82-2.67 (m, 1H), 2.50-2.37 (m, 1H), 2.13-1.95 (m, 2H), 1.95-1.81 (m, 1H).
步驟(3):(1S,3S,4S)-5,5-二氟-3-[[(E,1S)-3-氟-3-甲基磺醯基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]烯丙基]胺甲醯基]-2-氮雜雙環[2.2.2]辛烷-2-羧酸第三丁酯Step (3): (1S,3S,4S)-5,5-Difluoro-3-[[(E,1S)-3-fluoro-3-methylsulfonyl-1-[[(3S)- 2-Oxopyrrolidin-3-yl]methyl]allyl]carbamoyl]-2-azabicyclo[2.2.2]octane-2-carboxylic acid tert-butyl ester
向(1S,3S,4S)-2-第三丁氧基羰基-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-羧酸(80mg,0.27mmol)和(2S)-2-胺基-3-[(3S)-2-氧代吡咯啶-3-基]丙烯醯胺鹽酸鹽(57mg,0.27mmol)在CH2Cl2:THF(1:1,2mL)中的溶液加入HOBt一水化物(84mg,0.55mmol)、EDC鹽酸鹽(68mg,0.36mmol)和DIPEA(192μL,1.10mmol)。將反應混合物在室溫下攪拌2小時。向該混合物加入H2O(5mL)和水性鹽水溶液(5mL)。用EtOAc(3×15mL)萃取水相。將合併後的有機相經無水硫酸鈉乾燥,過濾,並在減壓下濃縮。通過正相SiO2層析法(0-8% MeOH/CH2Cl2)純化粗殘餘物,得到(1S,3S,4S)-3-[[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]胺甲醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-2-羧酸第三丁酯,為白色固體(50mg,產率41%,觀察到m/z:445[M+H]+)。 To (1 S ,3 S ,4 S )-2-tert-butoxycarbonyl-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxylic acid (80mg, 0.27mmol ) and ( 2S )-2-amino-3-[( 3S )-2-oxopyrrolidin-3-yl]acrylamide hydrochloride (57mg, 0.27mmol) in CH2Cl2 : THF To a solution in (1:1, 2 mL) was added HOBt monohydrate (84 mg, 0.55 mmol), EDC hydrochloride (68 mg, 0.36 mmol) and DIPEA (192 μL, 1.10 mmol). The reaction mixture was stirred at room temperature for 2 hours. To the mixture were added H2O (5 mL) and aqueous brine solution (5 mL). The aqueous phase was extracted with EtOAc (3 x 15 mL). The combined organic phases were dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The crude residue was purified by normal phase SiO2 chromatography (0-8% MeOH/ CH2Cl2 ) to afford (1S,3S,4S)-3-[ [ (1S)-2-amino-2-end Oxy-1-[[(3S)-2-oxopyrrolidin-3-yl]methyl]ethyl]carbamoyl]-5,5-difluoro-2-azabicyclo[2.2.2 ] tert-butyl octane-2-carboxylate as a white solid (50 mg, 41% yield, observed m/z: 445 [M+H] + ).
步驟(4):(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺Step (4): (1S,3S,4S)-N-[(1S)-2-Amino-2-oxo-1-[[(3S)-2-oxopyrrolidin-3-yl] Methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide
向(1S,3S,4S)-3-[[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]胺甲醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-2-羧酸第三丁酯(50mg,0.11mmol)在CH2Cl2(1mL)中的溶液加入鹽酸(4N的1,4-二烷溶液,1mL)。將反應混合物在室溫下攪拌30min並在減壓下濃縮,得到(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺的鹽酸鹽,為白色固體(43mg,產率100%,觀察到m/z:345[M+H]+),其無需進一步純化即可用於下一步。 To (1S,3S,4S)-3-[[(1S)-2-amino-2-oxo-1-[[(3S)-2-oxopyrrolidin-3-yl]methyl] Ethyl]carbamoyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-2-carboxylic acid tert-butyl ester (50mg, 0.11mmol) in CH 2 Cl 2 (1mL ) solution in hydrochloric acid (4N 1,4-di alkane solution, 1 mL). The reaction mixture was stirred at room temperature for 30 min and concentrated under reduced pressure to give (1 S ,3 S ,4 S ) -N -[(1 S )-2-amino-2-oxo-1-[ [(3 S )-2-oxopyrrolidin-3-yl]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide Hydrochloride salt, as a white solid (43 mg, 100% yield, observed m/z: 345 [M+H] + ), which was used in the next step without further purification.
步驟(5):(1S,3S,4S)-N-((S)-1-胺基-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺Step (5): (1S,3S,4S)-N-((S)-1-amino-1-oxo-3-((S)-2-oxopyrrolidin-3-yl)propane -2-yl)-5,5-difluoro-2-(9-hydroxy-9H-fen-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide
在0℃下向(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽(74mg,0.19mmol)和9-羥基茀-9-羧酸(44mg,0.19mmol)在DMF(2mL)中的溶液加入HATU(96mg,0.25mmol),隨後加入DIEA(84μL,0.49mmol)。將反應混合物在0℃下攪拌10min,然後升溫至室溫,並再攪拌30分鐘。通過反相HPLC純化該混合物,得到(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]-5,5-二氟-2-(9-羥基茀-9-羰基)-2-氮雜雙環[2.2.2] 辛烷-3-甲醯胺,為白色泡沫(55mg,產率51%,觀察到m/z:553[M+H]+)。 (1 S ,3 S ,4 S ) -N -[(1 S )-2-amino-2-oxo-1-[[(3 S )-2-oxopyrrolidine -3-yl]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride (74mg, 0.19mmol) and 9-hydroxy To a solution of terpene-9-carboxylic acid (44 mg, 0.19 mmol) in DMF (2 mL) was added HATU (96 mg, 0.25 mmol) followed by DIEA (84 μL, 0.49 mmol). The reaction mixture was stirred at 0 °C for 10 min, then allowed to warm to room temperature and stirred for an additional 30 min. The mixture was purified by reverse phase HPLC to give ( 1S , 3S , 4S ) -N -[( 1S )-2-amino-2-oxo-1-[[( 3S )-2- Oxypyrrolidin-3-yl]methyl]ethyl]-5,5-difluoro-2-(9-hydroxyl-9-carbonyl)-2-azabicyclo[2.2.2]octane-3 - Formamide as a white foam (55 mg, 51% yield, observed m/z: 553 [M+H] + ).
步驟(6):(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺Step (6): (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5 -Difluoro-2-(9-hydroxy-9H-fen-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide
將(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]-5,5-二氟-2-(9-羥基茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(55mg,0.10mmol)和Burgess試劑(48mg,0.20mmol)在CH2Cl2(1mL)中的溶液在室溫下攪拌2小時。將反應混合物在減壓下濃縮並通過反相HPLC純化粗原料,得到(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-5,5-二氟-2-(9-羥基茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺,為白色固體(29mg,產率55%,觀察到m/z:535[M+H]+);1H NMR(400MHz,CDCl3):δ 7.71-7.64(m,2H),7.55-7.49(m,1H),7.46-7.37(m,3H),7.37-7.29(m,2H),5.92(s,1H),5.75(s,1H),4.83(m,1H),4.53(s,1H),3.54-3.40(m,2H),3.15(s,1H),2.74(m,1H),2.57-2.34(m,3H),2.10(m,1H),2.02-1.89(m,1H),1.47-1.6(m,3H),1.31(m,3H)。 (1 S ,3 S ,4 S ) -N -[(1 S )-2-amino-2-oxo-1-[[(3 S )-2-oxopyrrolidin-3-yl ]methyl]ethyl]-5,5-difluoro-2-(9-hydroxyl-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide (55mg, 0.10 mmol) and Burgess reagent (48 mg, 0.20 mmol) in CH2Cl2 (1 mL) was stirred at room temperature for 2 hours. The reaction mixture was concentrated under reduced pressure and the crude material was purified by reverse phase HPLC to give ( 1S , 3S , 4S ) -N -[( 1S )-1-cyano-2-[( 3S )- 2-Oxopyrrolidin-3-yl]ethyl]-5,5-difluoro-2-(9-hydroxyl-9-carbonyl)-2-azabicyclo[2.2.2]octane-3- Formamide, as a white solid (29 mg, 55% yield, observed m/z: 535[M+H] + ); 1 H NMR (400MHz, CDCl 3 ): δ 7.71-7.64 (m, 2H), 7.55-7.49(m,1H), 7.46-7.37(m,3H), 7.37-7.29(m,2H), 5.92(s,1H), 5.75(s,1H), 4.83(m,1H), 4.53( s,1H), 3.54-3.40(m,2H), 3.15(s,1H), 2.74(m,1H), 2.57-2.34(m,3H), 2.10(m,1H), 2.02-1.89(m, 1H), 1.47-1.6(m, 3H), 1.31(m, 3H).
實施例31:(1S,3S,4S)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物35)Example 31: (1 S ,3 S ,4 S )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano Base-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide ( Compound 35)
通過將(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-5,5-二氟-2-(9-羥基茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:495[M+H]+;1H NMR(400MHz,CDCl3):δ 8.94(s,1H),7.34(d,2H),7.31(s,1H),7.17(d,1H),6.00(s,1H),5.26(s,1H),4.78-4.70(m,1H),4.54(s,1H),3.89(s,1H),3.44(dd,2H),2.64(s,2H),2.46(s,1H),2.40-2.30(m,1H),2.13(d,2H),1.99(d,1H),1.77(d,3H),1.05(s,1H)。 By adding (1 S ,3 S ,4 S ) -N -[(1S)-2-amino-2-oxo-1-[[(3 S )-2-oxopyrrolidin-3-yl ]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride is coupled with an appropriate carboxylic acid to react with respect to ( 1S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-5,5-difluoro-2 -(1 S ,3 S ,4 S )-2-(1 S ,3 S ,4 S )-2- (( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidine-3 -yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide; observed m/z: 495[M+H] + ; 1 H NMR (400MHz, CDCl 3 ): δ 8.94(s,1H), 7.34(d,2H), 7.31(s,1H), 7.17(d,1H), 6.00(s,1H), 5.26(s,1H), 4.78-4.70(m,1H), 4.54(s,1H), 3.89(s,1H), 3.44(dd,2H), 2.64(s,2H), 2.46(s,1H), 2.40-2.30(m, 1H), 2.13(d, 2H), 1.99(d, 1H), 1.77(d, 3H), 1.05(s, 1H).
實施例32:(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物36)Example 32: (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl] -2-[2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3 - formamide (compound 36)
通過將(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-5,5-二氟-2-(9-羥基茀-9-羰基)-2-氮 雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:549[M+H]+;1H NMR(400MHz,CD3OD):δ 7.67(q,1H),7.59-7.56(m,2H),5.10-4.99(m,1H),4.71(m,1H),4.63(s,1H),4.39-4.20(m,1H),3.77-3.51(m,2H),2.74-2.58(m,2H),2.37-2.26(m,1H),1.97-1.75(m,4H),1.69-1.56(m,3H),1.48(m,1H)。 By adding (1 S ,3 S ,4 S ) -N -[(1S)-2-amino-2-oxo-1-[[(3 S )-2-oxopyrrolidin-3-yl ]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride is coupled with an appropriate carboxylic acid to react with respect to ( 1S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-5,5-difluoro-2 -(9-Hydroxyfen-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide was prepared in a similar manner as described for (1 S ,3 S ,4 S ) -N- [(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[2-(3,5-dichlorophenyl)- 2,2-Difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide; observed m/z: 549 [M+H] + ; 1 H NMR (400MHz, CD 3 OD): δ 7.67(q,1H), 7.59-7.56(m,2H), 5.10-4.99(m,1H), 4.71(m,1H), 4.63(s, 1H), 4.39-4.20(m,1H), 3.77-3.51(m,2H), 2.74-2.58(m,2H), 2.37-2.26(m,1H), 1.97-1.75(m,4H), 1.69- 1.56(m,3H), 1.48(m,1H).
實施例33:(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物37)Example 33: (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5 ,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide (compound 37)
通過將(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-5,5-二氟-2-(9-羥基茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:500[M+H]+;1H NMR(400MHz,CDCl3):δ 9.80(s,1H),8.61(s,1H),7.17(s,1H),6.94(d,2H),6.49(s,1H),6.08(s,1H),5.02(s,1H),4.80(d,2H),3.95(s,3H),3.25(s,2H),2.79(s,1H),2.47(d,2H),2.24(d,5H),1.97(d,3H),1.75(s,2H)。 By adding (1 S ,3 S ,4 S ) -N -[(1S)-2-amino-2-oxo-1-[[(3 S )-2-oxopyrrolidin-3-yl ]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride is coupled with an appropriate carboxylic acid to react with respect to ( 1S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-5,5-difluoro-2 -(9-Hydroxyfen-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide was prepared in a similar manner as described for (1 S ,3 S ,4 S ) -N- (( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-(4-methoxy-1H- Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide; observed m/z: 500[M+H] + ; 1 H NMR (400MHz, CDCl 3 ) : δ 9.80(s,1H), 8.61(s,1H), 7.17(s,1H), 6.94(d,2H), 6.49(s,1H), 6.08(s,1H), 5.02(s,1H) , 4.80(d,2H), 3.95(s,3H), 3.25(s,2H), 2.79(s,1H), 2.47(d,2H), 2.24(d,5H), 1.97(d,3H), 1.75(s,2H).
實施例34:(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物38)Example 34: (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5 ,5-difluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide (compound 38)
通過將(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-5,5-二氟-2-(9-羥基茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:484[M+H]+;1H NMR(400MHz,CD3OD):δ 7.52(d,1H),7.05(dt,2H),6.20(s,1H),5.19(dd,1H),4.90-4.86(m,1H),4.03(s,1H),3.30-3.28(m,1H),2.72-2.61(m,2H),2.45(s,3H),2.47-2.06(m,5H),2.03-1.80(m,4H),1.80-1.43(m,2H)。 By adding (1 S ,3 S ,4 S ) -N -[(1S)-2-amino-2-oxo-1-[[(3 S )-2-oxopyrrolidin-3-yl ]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride is coupled with an appropriate carboxylic acid to react with respect to ( 1S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-5,5-difluoro-2 -(9-Hydroxyfen-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide was prepared in a similar manner as described for (1 S ,3 S ,4 S ) -N- (( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-(2-methyl-1H-ind Indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide; observed m/z: 484[M+H] + ; 1 H NMR (400MHz, CD 3 OD) : δ 7.52(d,1H), 7.05(dt,2H), 6.20(s,1H), 5.19(dd,1H), 4.90-4.86(m,1H), 4.03(s,1H), 3.30-3.28( m,1H), 2.72-2.61(m,2H), 2.45(s,3H), 2.47-2.06(m,5H), 2.03-1.80(m,4H), 1.80-1.43(m,2H).
實施例35:(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物39)Example 35: (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5 , 5-difluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-formamide (compound 39)
通過將(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲 醯胺鹽酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-5,5-二氟-2-(9-羥基茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:475[M+H]+;1H NMR(400MHz,CD3OD):δ 8.54(s,1H),7.49(d,2H),7.36(t,2H),7.26(t,1H),5.09(dd,1H),4.46(s,1H),4.33(s,1H),3.37-3.33(m,2H),2.79(dd,1H),2.51-2.27(m,4H),2.05-1.80(m,3H),1.62(d,2H),1.53(s,3H),1.38(s,1H),1.28(t,1H)。 By adding (1 S ,3 S ,4 S ) -N -[(1S)-2-amino-2-oxo-1-[[(3 S )-2-oxopyrrolidin-3-yl ]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride is coupled with an appropriate carboxylic acid to react with respect to ( 1S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-5,5-difluoro-2 -(9-Hydroxyfen-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide was prepared in a similar manner as described for (1 S ,3 S ,4 S ) -N- (( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-(( R )-2-hydroxy- 2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide; observed m/z: 475[M+H] + ; 1 H NMR (400MHz, CD 3 OD ): δ 8.54(s,1H), 7.49(d,2H), 7.36(t,2H), 7.26(t,1H), 5.09(dd,1H), 4.46(s,1H), 4.33(s,1H ), 3.37-3.33(m,2H), 2.79(dd,1H), 2.51-2.27(m,4H), 2.05-1.80(m,3H), 1.62(d,2H), 1.53(s,3H), 1.38(s,1H), 1.28(t,1H).
實施例36:(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物40)Example 36: (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2 -(4-(Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide (compound 40)
通過將(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-5,5-二氟-2-(9-羥基茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:520[M+H]+;1H NMR(400MHz,CD3CN):δ 10.61(s,1H),8.72(s,1H),7.69(d,1H),7.38-7.29(m,2H),7.28-6.88(m,2H),6.45 (s,1H),4.83-4.60(m,3H),3.36-3.22(m,2H),2.79-2.74(m,1H),2.62-2.48(m,1H),2.47-2.26(m,3H),2.05-1.68(m,7H)。 By adding (1 S ,3 S ,4 S ) -N -[(1S)-2-amino-2-oxo-1-[[(3 S )-2-oxopyrrolidin-3-yl ]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride is coupled with an appropriate carboxylic acid to react with respect to ( 1S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-5,5-difluoro-2 -(9-Hydroxyfen-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide was prepared in a similar manner as described for (1 S ,3 S ,4 S ) -N- (( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4-(difluoromethyl)-1H-indole-2 -carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide; observed m/z: 520[M+H] + ; 1 H NMR (400MHz, CD 3 CN): δ 10.61(s,1H), 8.72(s,1H), 7.69(d,1H), 7.38-7.29(m,2H), 7.28-6.88(m,2H), 6.45 (s,1H ), 4.83-4.60(m,3H), 3.36-3.22(m,2H), 2.79-2.74(m,1H), 2.62-2.48(m,1H), 2.47-2.26(m,3H), 2.05-1.68 (m,7H).
實施例37:(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物41)Example 37: (1 S ,3 S ,4 S )-N-(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2 -(4-(Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide (Compound 41)
通過將(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-5,5-二氟-2-(9-羥基茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:538[M+H]+;1H NMR(400MHz,CD3CN):δ 10.69(s,1H),8.74(s,1H),7.42(d,1H),7.29-6.93(m,3H),6.46(s,1H),4.85-4.60(m,3H),3.39-3.24(m,1H),2.78-2.74(m,1H),2.65-2.46(m,1H),2.44-1.96(m,8H),1.88-1.65(m,3H)。 By adding (1 S ,3 S ,4 S ) -N -[(1S)-2-amino-2-oxo-1-[[(3 S )-2-oxopyrrolidin-3-yl ]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride is coupled with an appropriate carboxylic acid to react with respect to ( 1S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-5,5-difluoro-2 (1 S , 3 S , 4 S )-N- (( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4-(difluoromethyl)-6-fluoro-1H- Indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide; observed m/z: 538[M+H] + ; 1 H NMR (400MHz, CD 3 CN): δ 10.69(s,1H), 8.74(s,1H), 7.42(d,1H), 7.29-6.93(m,3H), 6.46(s,1H), 4.85-4.60 (m,3H), 3.39-3.24(m,1H), 2.78-2.74(m,1H), 2.65-2.46(m,1H), 2.44-1.96(m,8H), 1.88-1.65(m,3H) .
實施例38:(S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物42)Example 38: ( S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-formamide (compound 42)
通過將(S)-N-((S)-1-胺基-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-5,5-二氟-2-(9-羥基茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:464[M+H]+;1H NMR(400MHz,DMSO-d6):δ 11.28(s,1H),8.66(s,1H),7.41(s,1H),7.11-7.02(m,2H),7.72(s,1H),6.50(d,1H),4.95-4.93(m,1H),4.56(s,1H),4.50(s,1H),3.88(s,3H),3.15-3.06(m,2H),2.45-2.32(m,1H),2.21(s,1H),2.18-2.05(m,2H),1.90-1.50(m,10H)。 By adding ( S ) -N -(( S )-1-amino-1-oxo-3-(( S )-2-oxopyrrolidin-3-yl)propan-2-yl)-2 -Azabicyclo[2.2.2]octane-3-formamide hydrochloride is coupled with an appropriate carboxylic acid to combine with (1 S ,3 S ,4 S ) -N -[(1 S )-1- Cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-5,5-difluoro-2-(9-hydroxyl-9-carbonyl)-2-aza ( S ) -N -((S)-1-cyano-2-(( S )-2-oxopyrrolidine -3-yl)ethyl)-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide; observed m /z: 464[M+H] + ; 1 H NMR (400MHz, DMSO-d 6 ): δ 11.28(s, 1H), 8.66(s, 1H), 7.41(s, 1H), 7.11-7.02(m ,2H), 7.72(s,1H), 6.50(d,1H), 4.95-4.93(m,1H), 4.56(s,1H), 4.50(s,1H), 3.88(s,3H), 3.15- 3.06(m,2H), 2.45-2.32(m,1H), 2.21(s,1H), 2.18-2.05(m,2H), 1.90-1.50(m,10H).
實施例39:(1S,3S,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物43)Example 39: (1 S ,3 S ,4 S )-2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-(( S )-1-cyano Base-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide ( Compound 43)
通過將(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-5,5-二氟-2-(9-羥基茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((S)-2-氧代吡 咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:510[M+H]+;1H NMR(400MHz,CD3OD):δ 7.26-7.13(m,1H),6.95-6.74(m,1H),5.12-5.01(m,1H),4.90-4.88(m,1H),4.78-4.53(m,1H),3.30-3.21(m,2H),2.77-2.53(m,2H),2.52-2.16(m,5H),2.00-1.72(m,5H)。 By adding (1 S ,3 S ,4 S ) -N -[(1 S )-2-amino-2-oxo-1-[[(3 S )-2-oxopyrrolidine-3- Base]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride is coupled with an appropriate carboxylic acid to react with respect to (1 S , 3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-5,5-difluoro- ( 1S , 3S , 4S )-2 -(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-(( S )-1-cyano-2-(( S )-2-oxopyrrolidine- 3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide; observed m/z: 510[M+H] + ; 1 H NMR (400MHz, CD 3 OD): δ 7.26-7.13(m,1H), 6.95-6.74(m,1H), 5.12-5.01(m,1H), 4.90-4.88(m,1H), 4.78-4.53( m,1H), 3.30-3.21(m,2H), 2.77-2.53(m,2H), 2.52-2.16(m,5H), 2.00-1.72(m,5H).
實施例40:(1R,2S,5S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺(化合物44)Example 40: (1 R ,2 S ,5 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-3 -(9-Hydroxy-9H-fen-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-formamide (compound 44)
通過將(S)-2-胺基-3-((S)-2-氧代吡咯啶-3-基)丙醯胺鹽酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1R,2S,5S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺;觀察到m/z:499[M+H]+;1H NMR(400MHz,CD3OD):δ 7.79(dd,2H),7.47(m,2H),7.37(d,2H),7.32(d,2H),5.07(m,1H),4.30(s,1H),3.43-3.34(m,2H),2.75(m,1H),2.53(dd,1H),2.46-2.33(m,2H),2.31(d,1H),1.98-1.85(m,2H),1.17(d,1H),1.11(dd,1H),0.85(s,3H),0.49(s,3H)。 By coupling ( S )-2-amino-3-(( S )-2-oxopyrrolidin-3-yl)propionamide hydrochloride with the appropriate carboxylic )-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-(9-hydroxyl- 9H-Treme-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide was prepared in a similar manner as described for ( 1R , 2S , 5S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxy-9H-oxo-9-carbonyl)-6,6-di Methyl-3-azabicyclo[3.1.0]hexane-2-carboxamide; observed m/z: 499[M+H] + ; 1 H NMR (400MHz, CD 3 OD): δ 7.79( dd,2H), 7.47(m,2H), 7.37(d,2H), 7.32(d,2H), 5.07(m,1H), 4.30(s,1H), 3.43-3.34(m,2H), 2.75 (m,1H), 2.53(dd,1H), 2.46-2.33(m,2H), 2.31(d,1H), 1.98-1.85(m,2H), 1.17(d,1H), 1.11(dd,1H ), 0.85(s,3H), 0.49(s,3H).
實施例41:(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物45)Example 41: (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl] -2-[(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-aza Bicyclo[2.2.2]octane-3-carboxamide (Compound 45)
步驟(1):N-[(1S)-2-[(1S,3S,4S)-3-[[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]胺甲醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-2-基]-1-(環丁基甲基)-2-側氧基-乙基]胺基甲酸第三丁酯Step (1): N-[(1S)-2-[(1S,3S,4S)-3-[[(1S)-2-Amino-2-oxo-1-[[(3S)- 2-Oxopyrrolidin-3-yl]methyl]ethyl]carbamoyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-2-yl]-1- (Cyclobutylmethyl)-2-oxo-ethyl]carbamate tertiary butyl ester
向(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽(43mg,0.11mmol)和(2S)-2-(第三丁氧基羰基胺基)-3-環丁基-丙酸(27mg,0.11mmol)在DMF(2mL)中的溶液加入HATU(64mg,0.17mmol),隨後加入DIPEA(79μL,0.45mmol)。將反應混合物在室溫下攪拌2小時。將反應混合物用EtOAc(30mL)稀釋,用0.5N水性鹽酸溶液(10mL)和水性鹽水溶液(10mL)洗滌。將有機相經無水硫酸鈉乾燥,過濾,並在減壓下濃縮。通過正相SiO2層析法(0-4% MeOH/CH2Cl2)純化粗殘餘物,得到N-[(1S)-2-[(1S,3S,4S)-3-[[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]胺甲醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-2-基]-1-(環丁基甲基)-2-側氧基-乙基]胺基甲酸第三丁酯,為白色固體(29mg,產率45%,觀察到m/z:570[M+H]+)。 To (1 S ,3 S ,4 S ) -N -[(1 S )-2-amino-2-oxo-1-[[(3 S )-2-oxopyrrolidin-3-yl ]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride (43mg, 0.11mmol) and (2 S )-2- A solution of (tert-butoxycarbonylamino)-3-cyclobutyl-propionic acid (27 mg, 0.11 mmol) in DMF (2 mL) was added with HATU (64 mg, 0.17 mmol) followed by DIPEA (79 μL, 0.45 mmol) ). The reaction mixture was stirred at room temperature for 2 hours. The reaction mixture was diluted with EtOAc (30 mL), washed with 0.5N aqueous hydrochloric acid solution (10 mL) and aqueous brine solution (10 mL). The organic phase was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The crude residue was purified by normal phase SiO2 chromatography (0-4% MeOH/ CH2Cl2 ) to afford N-[(1S)-2-[( 1S ,3S,4S)-3-[[(1S )-2-amino-2-oxo-1-[[(3S)-2-oxopyrrolidin-3-yl]methyl]ethyl]carbamoyl]-5,5-difluoro -Tertiary butyl 2-azabicyclo[2.2.2]oct-2-yl]-1-(cyclobutylmethyl)-2-oxo-ethyl]carbamate as a white solid (29 mg, Yield 45%, observed m/z: 570 [M+H] + ).
步驟(2):(1S,3S,4S)-2-[(2S)-2-胺基-3-環丁基-丙醯基]-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽Step (2): (1S,3S,4S)-2-[(2S)-2-Amino-3-cyclobutyl-propionyl]-N-[(1S)-2-Amino-2- Oxy-1-[[(3S)-2-oxopyrrolidin-3-yl]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane- 3-Formamide hydrochloride
向N-[(1S)-2-[(1S,3S,4S)-3-[[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]胺甲醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-2-基]-1-(環丁基甲基)-2-側氧基-乙基]胺基甲酸第三丁酯(29mg,0.05mmol)在CH2Cl2(1mL)中的溶液加入鹽酸(4N的1,4-二烷溶液,1mL)。將反應混合物在室溫下攪拌1小時,並在減壓下濃縮,得到(1S,3S,4S)-2-[(2S)-2-胺基-3-環丁基-丙醯基]-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽,為白色固體(26mg,產率>100%,觀察到m/z:470[M+H]+),其無需進一步純化即可用於下一步。 To N-[(1S)-2-[(1S,3S,4S)-3-[[(1S)-2-amino-2-oxo-1-[[(3S)-2-oxo Pyrrolidin-3-yl]methyl]ethyl]aminoformyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-2-yl]-1-(cyclobutylmethyl )-tert-butyl 2-oxo-ethyl]carbamate (29 mg, 0.05 mmol) in CH 2 Cl 2 (1 mL) was added hydrochloric acid (4N 1,4-di alkane solution, 1 mL). The reaction mixture was stirred at room temperature for 1 h and concentrated under reduced pressure to give ( 1S , 3S , 4S )-2-[( 2S )-2-amino-3-cyclobutyl-propane Acyl] -N -[(1 S )-2-amino-2-oxo-1-[[(3 S )-2-oxopyrrolidin-3-yl]methyl]ethyl]- 5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride as a white solid (26 mg, yield >100%, observed m/z: 470 [M +H] + ), which was used in the next step without further purification.
步驟(3):(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺Step (3): (1S,3S,4S)-N-[(1S)-2-Amino-2-oxo-1-[[(3S)-2-oxopyrrolidin-3-yl] Methyl]ethyl]-2-[(2S)-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro -2-Azabicyclo[2.2.2]octane-3-carboxamide
向(1S,3S,4S)-2-[(2S)-2-胺基-3-環丁基-丙醯基]-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽(26mg,0.05mmol)在MeOH(1mL)中的溶液加入2,2,2-三氟乙酸乙酯(61μL,0.51mmol)和DIPEA(27μL,0.15mmol)。將反應混合物在室溫下攪拌30min。向反應混合物加入飽和碳酸氫鈉水溶液(10mL)並用EtOAc(3×15mL) 萃取水相。將合併後的有機相經無水硫酸鈉乾燥,過濾,並在減壓下濃縮,得到(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺,為白色固體(29mg,產率>100%,觀察到m/z:566[M+H]+),其無需進一步純化即可用於下一步。 To (1 S ,3 S ,4 S )-2-[(2 S )-2-amino-3-cyclobutyl-propionyl] -N -[(1 S )-2-amino-2 -Oxy-1-[[(3 S )-2-oxopyrrolidin-3-yl]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane Alkane-3-carboxamide hydrochloride (26 mg, 0.05 mmol) in MeOH (1 mL) was added ethyl 2,2,2-trifluoroacetate (61 μL, 0.51 mmol) and DIPEA (27 μL, 0.15 mmol) . The reaction mixture was stirred at room temperature for 30 min. Saturated aqueous sodium bicarbonate (10 mL) was added to the reaction mixture and the aqueous phase was extracted with EtOAc (3 x 15 mL). The combined organic phases were dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure to give ( 1S , 3S , 4S ) -N -[( 1S )-2-amino-2-oxo Base-1-[[(3S)-2-oxopyrrolidin-3-yl]methyl]ethyl]-2-[( 2S )-3-cyclobutyl-2-[(2,2, 2-Trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide as a white solid (29 mg, yield >100%, observed m/z: 566 [M+H] + ), which was used in the next step without further purification.
步驟(4):(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺Step (4): (1S,3S,4S)-N-[(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2S)-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2.2 ]octane-3-formamide
向(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(29mg,0.05mmol)在CH2Cl2(1mL)中的溶液加入Burgess試劑(36mg,0.15mmol)。將反應混合物在室溫下攪拌2小時,並在減壓下濃縮。通過反相HPLC純化粗殘餘物,得到(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺,為白色膜(5mg,產率18%,觀察到m/z:548[M+H]+);1H NMR(400MHz,CD3OD):δ 5.05(dd,1H),4.72(dd,1H),4.51(dd,1H),4.38(s,1H),3.34-3.32(m,1H),2.74-2.61(m,1H),2.59(s,1H),2.53-2.04(m,8H),1.98-1.60(m,12H)。 To (1 S ,3 S ,4 S ) -N -[(1 S )-2-amino-2-oxo-1-[[(3 S )-2-oxopyrrolidin-3-yl ]methyl]ethyl]-2-[( 2S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5- To a solution of difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide (29 mg, 0.05 mmol) in CH2Cl2 (1 mL ) was added Burgess reagent (36 mg, 0.15 mmol). The reaction mixture was stirred at room temperature for 2 hours, and concentrated under reduced pressure. Purification of the crude residue by reverse phase HPLC afforded ( 1S , 3S , 4S ) -N -[( 1S )-1-cyano-2-[( 3S )-2-oxopyrrolidine-3 -yl]ethyl]-2-[(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-di Fluoro-2-azabicyclo[2.2.2]octane-3-carboxamide as a white film (5 mg, 18% yield, observed m/z: 548[M+H] + ); 1 H NMR (400MHz, CD 3 OD): δ 5.05(dd,1H), 4.72(dd,1H), 4.51(dd,1H), 4.38(s,1H), 3.34-3.32(m,1H), 2.74-2.61( m, 1H), 2.59 (s, 1H), 2.53-2.04 (m, 8H), 1.98-1.60 (m, 12H).
實施例42:(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙Example 42: (1 S ,3 S ,4 S )-N-(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl 基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物46)base)-5,5-difluoro-2-((2,2,2-trifluoroacetyl) -D -leucyl)-2-azabicyclo[2.2.2]octane-3- Formamide (Compound 46)
通過將(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:536[M+H]+;1H NMR(400MHz,CD3OD):δ 5.18-5.01(m,1H),4.99-4.89(m,1H),4.48-4.43(m,1H),4.36(s,2H),3.37-3.32(m,2H),2.91-2.51(m,3H),2.45-2.22(m,3H),2.13(s,1H),2.06-1.49(m,7H),1.00-0.83(m,6H)。 By adding (1 S ,3 S ,4 S ) -N -[(1 S )-2-amino-2-oxo-1-[[(3 S )-2-oxopyrrolidine-3- Base]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride is coupled with an appropriate carboxylic acid to react with respect to (1 S , 3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[(2 S ) -3-Cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide was prepared in a similar manner as described for ( 1S , 3S , 4S )-N-(( S )-1-cyano-2-(( S )-2-oxopyrrolidine- 3-yl)ethyl)-5,5-difluoro-2-((2,2,2-trifluoroacetyl) -D -leucyl)-2-azabicyclo[2.2.2] Octane-3-carboxamide; Observed m/z: 536[M+H] + ; 1 H NMR (400MHz, CD 3 OD): δ 5.18-5.01(m,1H), 4.99-4.89(m, 1H), 4.48-4.43(m,1H), 4.36(s,2H), 3.37-3.32(m,2H), 2.91-2.51(m,3H), 2.45-2.22(m,3H), 2.13(s, 1H), 2.06-1.49 (m, 7H), 1.00-0.83 (m, 6H).
實施例43:(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物47)Example 43: (1 S ,3 S ,4 S )-N-(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2 -(( R )-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2] Octane-3-formamide (Compound 47)
通過將(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲 醯胺鹽酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:548[M+H]+;1H NMR(400MHz,CD3CN):δ 8.00-7.92(m,2H),6.19(s,1H),4.93-4.65(m,3H),4.36(s 1H),4.25(s,1H),3.31-3.11(m,2H),2.67(s,1H),2.51-2.42(m,1H),2.40-2.12(m,4H),2.05-1.94(m,2H),1.94-1.61(m,12H)。 By adding (1 S ,3 S ,4 S ) -N -[(1 S )-2-amino-2-oxo-1-[[(3 S )-2-oxopyrrolidine-3- Base]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride is coupled with an appropriate carboxylic acid to react with respect to (1 S , 3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[(2 S ) -3-Cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide was prepared in a similar manner as described for ( 1S , 3S , 4S )-N-(( S )-1-cyano-2-(( S )-2-oxopyrrolidine- 3-yl)ethyl)-2-(( R )-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2 -Azabicyclo[2.2.2]octane-3-carboxamide; observed m/z: 548[M+H] + ; 1 H NMR (400MHz, CD 3 CN): δ 8.00-7.92(m, 2H), 6.19(s,1H), 4.93-4.65(m,3H), 4.36(s 1H), 4.25(s,1H), 3.31-3.11(m,2H), 2.67(s,1H), 2.51- 2.42 (m, 1H), 2.40-2.12 (m, 4H), 2.05-1.94 (m, 2H), 1.94-1.61 (m, 12H).
實施例44:(1S,3S,4S)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物48)Example 44: (1 S ,3 S ,4 S )-2-(7-chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 S )-1-cyano- 2-[( 3S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide ( Compound 48)
步驟(1):(2S,4S)-2-(第三丁氧基羰基胺基)-4-(2-氰乙基)戊二酸二甲酯Step (1): Dimethyl (2S,4S)-2-(tert-butoxycarbonylamino)-4-(2-cyanoethyl)glutarate
在-78℃下向(2S)-2-(第三丁氧基羰基胺基)戊二酸二甲酯(12g,44mmol)在THF(100mL)中的溶液逐滴加入LiHMDS(1.0M的THF溶液,100mL,100mmol)。將混合物在-78℃下攪拌1小時,並逐滴加入3-溴丙腈(3.9mL,47mmol)。將反應混合物在-78℃下攪拌4小時,並用飽和氯化銨水溶液(100mL)淬滅。將混合物升溫至室溫,並用EtOAc(3×100mL)萃取。將合併後的有機相經無水硫酸鈉乾燥, 過濾,並在減壓下濃縮。通過正相SiO2層析法(20-35% EtOAc/己烷)純化粗殘餘物,得到(2S,4S)-2-(第三丁氧基羰基胺基)-4-(2-氰乙基)戊二酸二甲酯,為淺黃色油(4.9g,產率34%,觀察到m/z:329[M+H]+)。 To a solution of dimethyl (2S)-2-(tert-butoxycarbonylamino)glutarate (12 g, 44 mmol) in THF (100 mL) was added LiHMDS (1.0 M in THF) dropwise at -78°C solution, 100 mL, 100 mmol). The mixture was stirred at -78°C for 1 hour, and 3-bromopropionitrile (3.9 mL, 47 mmol) was added dropwise. The reaction mixture was stirred at -78°C for 4 hours and quenched with saturated aqueous ammonium chloride (100 mL). The mixture was warmed to room temperature and extracted with EtOAc (3 x 100 mL). The combined organic phases were dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. Purification of the crude residue by normal phase SiO2 chromatography (20-35% EtOAc/hexanes) afforded (2S,4S)-2-(tert-butoxycarbonylamino)-4-(2-cyanoethyl base) dimethyl glutarate as pale yellow oil (4.9 g, 34% yield, observed m/z: 329 [M+H] + ).
步驟(2):(2S)-2-(第三丁氧基羰基胺基)-3-[(3S)-2-側氧基-3-哌啶基]丙酸甲酯Step (2): Methyl (2S)-2-(tert-butoxycarbonylamino)-3-[(3S)-2-oxo-3-piperidinyl]propionate
在0℃下向(2S,4S)-2-(第三丁氧基羰基胺基)-4-(2-氰乙基)戊二酸二甲酯(3.9g,12mmol)在無水MeOH(16mL)中的溶液加入六水氯化鈷(II)(1.7g,7.1mmol)。在0℃下向該混合物分批加入四氫化硼鈉(2.7g,71mmol),並將反應混合物升溫至室溫,並攪拌4小時。向反應混合物加入飽和氯化銨水溶液(40mL),並將混合物在真空中濃縮以除去MeOH。用EtOAc(3×60mL)萃取水相,並用飽和氯化銨水溶液(60mL)和水性鹽水溶液(60mL)洗滌合併後的有機相。將有機相經無水硫酸鈉乾燥,過濾,並在真空中濃縮。通過正相SiO2層析法(0-4% MeOH/CH2Cl2)純化粗殘餘物,得到(2S)-2-(第三丁氧基羰基胺基)-3-[(3S)-2-側氧基-3-哌啶基]丙酸甲酯,為白色固體(1.7g,產率49%,觀察到m/z:301[M+H]+)。 Dimethyl (2S,4S)-2-(tert-butoxycarbonylamino)-4-(2-cyanoethyl)glutarate (3.9 g, 12 mmol) was dissolved in anhydrous MeOH (16 mL) at 0 °C ) was added cobalt(II) chloride hexahydrate (1.7 g, 7.1 mmol). To this mixture was added sodium borohydride (2.7 g, 71 mmol) in portions at 0° C., and the reaction mixture was warmed to room temperature and stirred for 4 hours. To the reaction mixture was added saturated aqueous ammonium chloride (40 mL), and the mixture was concentrated in vacuo to remove MeOH. The aqueous phase was extracted with EtOAc (3 x 60 mL), and the combined organic phases were washed with saturated aqueous ammonium chloride solution (60 mL) and aqueous brine solution (60 mL). The organic phase was dried over anhydrous sodium sulfate, filtered and concentrated in vacuo. The crude residue was purified by normal phase SiO2 chromatography (0-4% MeOH/ CH2Cl2 ) to afford (2S)-2-(tert-butoxycarbonylamino)-3 - [(3S)- Methyl 2-oxo-3-piperidinyl]propionate as a white solid (1.7 g, 49% yield, observed m/z: 301 [M+H] + ).
步驟(3):N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]胺基甲酸第三丁酯Step (3): N-[(1S)-2-amino-2-oxo-1-[[(3S)-2-oxo-3-piperidinyl]methyl]ethyl]amine tertiary butyl carbamate
在密封管中向(2S)-2-(第三丁氧基羰基胺基)-3-[(3S)-2-側氧基-3-哌啶基]丙酸甲酯(1.7g,5.8mmol)加入氨(7N的MeOH溶 液,12mL,96mmol)並將反應混合物在70℃下攪拌40小時。將混合物冷卻至室溫並在真空中濃縮。通過正相SiO2層析法(0-8% MeOH/CH2Cl2)純化粗殘餘物,得到N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]胺基甲酸第三丁酯,為白色固體(1.2g,產率70%,觀察到m/z:286[M+H]+)。 Add (2S)-2-(tert-butoxycarbonylamino)-3-[(3S)-2-oxo-3-piperidinyl]propanoic acid methyl ester (1.7 g, 5.8 mmol) Ammonia (7N in MeOH, 12 mL, 96 mmol) was added and the reaction mixture was stirred at 70 °C for 40 h. The mixture was cooled to room temperature and concentrated in vacuo. The crude residue was purified by normal phase SiO2 chromatography (0-8% MeOH/ CH2Cl2 ) to afford N- [ (1S)-2-amino-2-oxo-1-[[(3S )-tert-butyl 2-oxo-3-piperidinyl]methyl]ethyl]carbamate as a white solid (1.2 g, yield 70%, observed m/z: 286 [M+ H] + ).
步驟(4):(2S)-2-胺基-3-[(3S)-2-側氧基-3-哌啶基]丙烯醯胺Step (4): (2S)-2-Amino-3-[(3S)-2-oxo-3-piperidinyl]acrylamide
向N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]胺基甲酸第三丁酯(1.0g,3.6mmol)加入鹽酸(4N的1,4-二烷溶液,4mL)。將反應混合物在室溫下攪拌2小時,並在真空中濃縮,得到(2S)-2-胺基-3-[(3S)-2-側氧基-3-哌啶基]丙烯醯胺的鹽酸鹽,為白色固體(0.8g,觀察到m/z:186[M+H]+),其無需進一步純化即可用於下一步。 To the third Butyl ester (1.0g, 3.6mmol) was added with hydrochloric acid (4N 1,4-di alkane solution, 4 mL). The reaction mixture was stirred at room temperature for 2 hours and concentrated in vacuo to give ( 2S )-2-amino-3-[( 3S )-2-oxo-3-piperidinyl]acryloyl The hydrochloride salt of the amine, as a white solid (0.8 g, observed m/z: 186 [M+H] + ), was used in the next step without further purification.
步驟(5):(1S,3S,4S)-3-[[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]胺甲醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-2-羧酸第三丁酯Step (5): (1S,3S,4S)-3-[[(1S)-2-Amino-2-oxo-1-[[(3S)-2-oxo-3-piperidine Base]methyl]ethyl]aminoformyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-2-carboxylic acid tert-butyl ester
在0℃下向(1S,3S,4S)-2-第三丁氧基羰基-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-羧酸(583mg,2.0mmol)和(2S)-2-胺基-3-[(3S)-2-側氧基-3-哌啶基]丙烯醯胺鹽酸鹽(443mg,2.0mmol)在CH2Cl2:THF(1:1,6mL)中的溶液加入HOBt一水化物(613mg,4.0 mmol),隨後加入EDC鹽酸鹽(498mg,2.6mmol)和DIPEA(1.4mL,8.0mmol)。將反應混合物升溫至室溫,並攪拌2小時。向該混合物加入H2O(15mL)和水性鹽水溶液(15mL)。用EtOAc(3×60mL)萃取水相。將合併後的有機相經無水硫酸鈉乾燥,過濾,並在真空中濃縮。通過正相SiO2層析法(0-8% MeOH/CH2Cl2)純化粗殘餘物,得到(1S,3S,4S)-3-[[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]胺甲醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-2-羧酸第三丁酯,為白色固體(620mg,產率68%,觀察到m/z:459[M+H]+)。 To (1 S ,3 S ,4 S )-2-tert-butoxycarbonyl-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxylic acid ( 583mg, 2.0mmol) and ( 2S )-2-amino-3-[( 3S )-2-oxo-3-piperidinyl]acrylamide hydrochloride (443mg, 2.0mmol) in CH A solution of 2 Cl 2 :THF (1:1, 6 mL) was added HOBt monohydrate (613 mg, 4.0 mmol), followed by EDC hydrochloride (498 mg, 2.6 mmol) and DIPEA (1.4 mL, 8.0 mmol). The reaction mixture was warmed to room temperature and stirred for 2 hours. To the mixture was added H2O (15 mL) and aqueous brine solution (15 mL). The aqueous phase was extracted with EtOAc (3 x 60 mL). The combined organic phases were dried over anhydrous sodium sulfate, filtered and concentrated in vacuo. The crude residue was purified by normal phase SiO2 chromatography (0-8% MeOH/ CH2Cl2 ) to afford (1S,3S,4S)-3-[ [ (1S)-2-amino-2-end Oxygen-1-[[(3S)-2-oxo-3-piperidinyl]methyl]ethyl]carbamoyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Tert-butyl octane-2-carboxylate as a white solid (620 mg, 68% yield, observed m/z: 459 [M+H] + ).
步驟(6):(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺Step (6): (1S,3S,4S)-N-[(1S)-2-Amino-2-oxo-1-[[(3S)-2-oxo-3-piperidinyl ]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide
向(1S,3S,4S)-3-[[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]胺甲醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-2-羧酸第三丁酯(565mg,1.2mmol)在CH2Cl2(2mL)中的溶液加入鹽酸(4N的1,4-二烷溶液,4mL)。將反應混合物在室溫下攪拌18小時,並在真空中濃縮,得到(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺的鹽酸鹽,為白色固體(480mg,產率99%,觀察到m/z:359[M+H]+),其無需進一步純化即可用於下一步。 To (1S,3S,4S)-3-[[(1S)-2-amino-2-oxo-1-[[(3S)-2-oxo-3-piperidinyl]methyl ]ethyl]carbamoyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-2-carboxylic acid tert-butyl ester (565 mg, 1.2 mmol) in CH 2 Cl 2 ( 2mL) solution in hydrochloric acid (4N 1,4-bis alkane solution, 4 mL). The reaction mixture was stirred at room temperature for 18 hours and concentrated in vacuo to give ( 1S , 3S , 4S ) -N -[( 1S )-2-amino-2-oxo-1- [[(3 S )-2-oxo-3-piperidinyl]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl The hydrochloride salt of the amine, as a white solid (480 mg, 99% yield, observed m/z: 359 [M+H] + ), was used in the next step without further purification.
步驟(7):(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]-2-(7-氯-4-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺Step (7): (1S,3S,4S)-N-[(1S)-2-Amino-2-oxo-1-[[(3S)-2-oxo-3-piperidinyl ]methyl]ethyl]-2-(7-chloro-4-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3 - formamide
向(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽(30mg,0.08mmol)和7-氯-4-氟-1H-吲哚-2-羧酸(16mg,0.08mmol)在DMF(1mL)中的溶液加入HATU(43mg,0.11mmol),隨後加入DIPEA(53μL,0.30mmol)。將反應混合物在室溫下攪拌1小時。用EtOAc(30mL)稀釋混合物,用0.5M水性鹽酸溶液(10mL)和水性鹽水溶液(10mL)洗滌。將有機相經無水硫酸鈉乾燥,過濾,並在真空中濃縮。通過正相SiO2層析法(0-8% MeOH/CH2Cl2)純化粗殘餘物,得到(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]-2-(7-氯-4-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺,為灰白色固體(27mg,產率64%,觀察到m/z:554[M+H]+)。 To (1 S ,3 S ,4 S ) -N -[(1 S )-2-amino-2-oxo-1-[[(3 S )-2-oxo-3-piperidine Base]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride (30mg, 0.08mmol) and 7-chloro-4- A solution of fluoro- 1H -indole-2-carboxylic acid (16 mg, 0.08 mmol) in DMF (1 mL) was added HATU (43 mg, 0.11 mmol) followed by DIPEA (53 μL, 0.30 mmol). The reaction mixture was stirred at room temperature for 1 hour. The mixture was diluted with EtOAc (30 mL), washed with 0.5M aqueous hydrochloric acid solution (10 mL) and aqueous brine solution (10 mL). The organic phase was dried over anhydrous sodium sulfate, filtered and concentrated in vacuo. The crude residue was purified by normal phase SiO2 chromatography (0-8% MeOH/ CH2Cl2 ) to afford ( 1S , 3S , 4S ) -N -[( 1S )-2-amino- 2-oxo-1-[[(3 S )-2-oxo-3-piperidinyl]methyl]ethyl]-2-(7-chloro-4-fluoro-1 H -indole -2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide as an off-white solid (27 mg, 64% yield, observed m/z: 554 [M+H] + ).
步驟(8):(1S,3S,4S)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺Step (8): (1S,3S,4S)-2-(7-chloro-4-fluoro-1H-indole-2-carbonyl)-N-[(1S)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide
向(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]-2-(7-氯-4-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(27mg,0.05mmol)在CH2Cl2(1 mL)中的溶液加入Burgess試劑(35mg,0.15mmol)。將反應混合物在室溫下攪拌1小時,並在真空中濃縮。通過反相HPLC純化粗殘餘物,得到(1S,3S,4S)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺,為白色固體(10mg,產率39%,觀察到m/z:536[M+H]+);1H NMR(400MHz,CD3OD):δ 7.20(dd,1H),6.95(s,1H),6.79(t,1H),5.22-5.10(m,1H),4.75(s,1H),4.66(s,1H),3.29-3.20(m,2H),2.70(s,1H),2.58-2.35(m,3H),2.34-2.14(m,2H),2.10-1.69(m,7H),1.65-1.50(m,1H)。 To (1 S ,3 S ,4 S ) -N -[(1 S )-2-amino-2-oxo-1-[[(3 S )-2-oxo-3-piperidine Base]methyl]ethyl]-2-(7-chloro-4-fluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane - To a solution of 3-formamide (27 mg, 0.05 mmol) in CH2Cl2 (1 mL) was added Burgess reagent (35 mg, 0.15 mmol ). The reaction mixture was stirred at room temperature for 1 hour and concentrated in vacuo. Purification of the crude residue by reverse phase HPLC afforded ( 1S , 3S , 4S )-2-(7-chloro-4-fluoro- 1H -indole-2-carbonyl) -N -[( 1S ) -1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane- 3-Formamide as a white solid (10 mg, 39% yield, observed m/z: 536 [M+H]+); 1 H NMR (400 MHz, CD 3 OD): δ 7.20 (dd, 1H) , 6.95(s,1H), 6.79(t,1H), 5.22-5.10(m,1H), 4.75(s,1H), 4.66(s,1H), 3.29-3.20(m,2H), 2.70(s ,1H), 2.58-2.35(m,3H), 2.34-2.14(m,2H), 2.10-1.69(m,7H), 1.65-1.50(m,1H).
實施例45:(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物49)Example 45: ( 1S , 3S , 4S ) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5 , 5-difluoro-2-(9-hydroxy-9H-fen-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide (compound 49)
通過將(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:549[M+H]+;1H NMR(400MHz,CD3OD):δ 7.80(t,2H),7.56-7.43(m,3H),7.39(dd,3H),5.16(dd,1H),4.53(s,1H),3.21(s,1H),2.61(m,1H),2.53-2.40(m,2H),2.14(dd,1H),1.95(m,3H),1.70-1.37(m,5H),1.36-1,10(m,4H)。 By adding (1 S ,3 S ,4 S ) -N -[(1 S )-2-amino-2-oxo-1-[[(3 S )-2-oxo-3-piper Pyridyl]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride is coupled with an appropriate carboxylic acid to react with respect to (1 S ,3 S ,4 S )-2-(7-chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 S )-1-cyano-2-[(3 S ) -2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide was prepared in a similar manner ( 1 S ,3 S ,4 S )- N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro -2-(9-Hydroxy-9H-fen-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide; observed m/z: 549[M+H] + ; 1 H NMR (400MHz, CD 3 OD): δ 7.80(t,2H), 7.56-7.43(m,3H), 7.39(dd,3H), 5.16(dd,1H), 4.53(s,1H), 3.21 (s,1H), 2.61(m,1H), 2.53-2.40(m,2H), 2.14(dd,1H), 1.95(m,3H), 1.70-1.37(m,5H), 1.36-1,10 (m,4H).
實施例46:(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物50)Example 46: (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5 ,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide (Compound 50)
通過將(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:514[M+H]+;1H NMR(400MHz,CD3OD):δ 7.15(t,1H),7.02(d,1H),6.85(d,1H),6.51(s,1H),5.15(d,1H),4.9(s,2H),4.72(s,1H),3.90(d,3H),3.26(s,1H),2.98(s,1H),2.68(s,1H),2.57-2.34(m,3H),2.26(s,3H),2.04-1.64(m,6H)。 By adding (1 S ,3 S ,4 S ) -N -[(1 S )-2-amino-2-oxo-1-[[(3 S )-2-oxo-3-piper Pyridyl]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride is coupled with an appropriate carboxylic acid to react with respect to (1 S ,3 S ,4 S )-2-(7-chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 S )-1-cyano-2-[(3 S ) -2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide was prepared in a similar manner ( 1 S ,3 S ,4 S )- N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro -2-(4-Methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide; observed m/z: 514 [M+H ] + ; 1 H NMR (400MHz, CD 3 OD): δ 7.15(t, 1H), 7.02(d, 1H), 6.85(d, 1H), 6.51(s, 1H), 5.15(d, 1H), 4.9(s,2H), 4.72(s,1H), 3.90(d,3H), 3.26(s,1H), 2.98(s,1H), 2.68(s,1H), 2.57-2.34(m,3H) , 2.26(s,3H), 2.04-1.64(m,6H).
實施例47:(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物51)Example 47: (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl ]-2-(4,7-difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide (compound 51)
通過將(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:520[M+H]+;1H NMR(400MHz,CD3OD):δ 6.96-6.86(ddd,2H),6.77-6.63(m,1H),5.21-5.10(m,1H),5.10-4.92(m,1H),4.80-4.71(d,2H),3.29-3.05(m,2H),2.69(s,1H),2.60-2.37(m,3H),2.37-2.15(m,2H),2.10-2.01(m,1H),2.01-1.71(m,6H),1.68-1.48(m,1H),1.29(s,1H)。 By adding (1 S ,3 S ,4 S ) -N -[(1 S )-2-amino-2-oxo-1-[[(3 S )-2-oxo-3-piper Pyridyl]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride is coupled with an appropriate carboxylic acid to react with respect to (1 S ,3 S ,4 S )-2-(7-chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 S )-1-cyano-2-[(3 S ) -2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide was prepared in a similar manner ( 1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2-( 4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide; observed m/z: 520[M+H] + ; 1 H NMR (400MHz, CD 3 OD): δ 6.96-6.86 (ddd, 2H), 6.77-6.63 (m, 1H), 5.21-5.10 (m, 1H), 5.10-4.92 (m,1H), 4.80-4.71(d,2H), 3.29-3.05(m,2H), 2.69(s,1H), 2.60-2.37(m,3H), 2.37-2.15(m,2H), 2.10 -2.01(m,1H), 2.01-1.71(m,6H), 1.68-1.48(m,1H), 1.29(s,1H).
實施例48:(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物52)Example 48: (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl ]-5,5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide (Compound 52)
通過將(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:538[M+H]+;1H NMR(400MHz,CD3OD):δ 6.95 (s,1H),6.90-6.62(m,1H),5.19-4.92(m,1H),4.84-4.66(m,2H),3.29-3.19(m,2H),3.14(s,1H),2.69(s,1H),2.60-2.36(m,3H),2.36-2.17(m,2H),2.10-2.00(m,1H),1.99-1.71(m,7H),1.69-1.47(m,1H)。 By adding (1 S ,3 S ,4 S ) -N -[(1 S )-2-amino-2-oxo-1-[[(3 S )-2-oxo-3-piper Pyridyl]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride is coupled with an appropriate carboxylic acid to react with respect to (1 S ,3 S ,4 S )-2-(7-chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 S )-1-cyano-2-[(3 S ) -2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide was prepared in a similar manner ( 1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5 -Difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide; m/ z: 538[M+H] + ; 1 H NMR (400MHz, CD 3 OD): δ 6.95 (s, 1H), 6.90-6.62 (m, 1H), 5.19-4.92 (m, 1H), 4.84-4.66 (m,2H), 3.29-3.19(m,2H), 3.14(s,1H), 2.69(s,1H), 2.60-2.36(m,3H), 2.36-2.17(m,2H), 2.10-2.00 (m, 1H), 1.99-1.71 (m, 7H), 1.69-1.47 (m, 1H).
實施例49:(1S,3S,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物53)Example 49: (1 S ,3 S ,4 S )-2-(3-Chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 S )-1 -cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3- Formamide (Compound 53)
通過將(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:524[M+H]+;1H NMR(400MHz,CD3OD):δ 7.19(s,1H),6.89(s,1H),5.09(s,1H),4.72(s,1H),3.25(s,2H),2.67(s,1H),2.60-2.34(m,3H),2.34-2.14(m,3H),2.05(s,1H),1.99-1.67(m,7H),1.55(s,1H)。 By adding (1 S ,3 S ,4 S ) -N -[(1 S )-2-amino-2-oxo-1-[[(3 S )-2-oxo-3-piper Pyridyl]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride is coupled with an appropriate carboxylic acid to react with respect to (1 S ,3 S ,4 S )-2-(7-chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 S )-1-cyano-2-[(3 S ) -2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide was prepared in a similar manner ( 1 S ,3 S ,4 S )-2-(3-chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 S )-1-cyano-2 -[( 3S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide; Observation to m/z: 524[M+H] + ; 1 H NMR (400MHz, CD 3 OD): δ 7.19(s,1H), 6.89(s,1H), 5.09(s,1H), 4.72(s, 1H), 3.25(s,2H), 2.67(s,1H), 2.60-2.34(m,3H), 2.34-2.14(m,3H), 2.05(s,1H), 1.99-1.67(m,7H) , 1.55(s,1H).
實施例50:(1S,3S,4S)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物54、55和56)Example 50: (1 S ,3 S ,4 S )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( S )-1-cyano-2-( (S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide (compounds 54, 55 and 56)
通過將(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽與適當的羧酸(化合物54)偶合以與以與關於(1S,3S,4S)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺,為非對映異構物的混合物,:m/z:583[M+H]+;1H NMR(400MHz,CD3OD):δ 7.79(q,2H),7.53-7.47(m,3H),7.43-7.36(m,2H),5.17(m,1H),4.54(s,1H),3.21(s,1H),2.59(s,1H),2.48(d,2H),2.13(s,1H),1.98-1.78(m,3H),1.58(d,4H),1.43-1.18(m,4H),1.01(s,1H)。分離非對映異構物混合物隨後通過在CHIRALCEL OJ柱上使用20% IPA進行手性SFC,得到每種差向異構物。 By adding (1 S ,3 S ,4 S ) -N -[(1 S )-2-amino-2-oxo-1-[[(3 S )-2-oxo-3-piper Pyridyl]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride was coupled with an appropriate carboxylic acid ( compound 54 ) to With respect to (1 S ,3 S ,4 S )-2-(7-chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 S )-1-cyano-2 -[( 3S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide as described (1 S ,3 S ,4 S )-2-(2-chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( S )-1-cyano-2- ((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide, diastereomeric Mixture of isomers: m/z: 583[M+H] + ; 1 H NMR (400MHz, CD 3 OD): δ 7.79 (q, 2H), 7.53-7.47 (m, 3H), 7.43-7.36 (m,2H), 5.17(m,1H), 4.54(s,1H), 3.21(s,1H), 2.59(s,1H), 2.48(d,2H), 2.13(s,1H), 1.98- 1.78(m,3H), 1.58(d,4H), 1.43-1.18(m,4H), 1.01(s,1H). Separation of the diastereomeric mixture followed by chiral SFC on a CHIRALCEL OJ column using 20% IPA afforded each epimer.
次要非對映異構物(化合物55):(單一非對映異構物I,較快洗脫的非對映異構物):(3.8mg,產率25%,觀察到m/z:583[M+H]+)。1H NMR(400MHz,CD3OD):δ 7.80(dd,2H),7.57-7.48(m,3H),7.45-7.36(m,2H),5.16(dd,1H),4.55(d,1H),3.2(bs,1H),2.64-2.57(m,1H),2.55-2.41(m,2H),2.34(s,2H),2.2(m,1H),2.01-1.78(m,3H),1.63(d,3H),1.38(q,3H),1.22(s,1H)。 Minor diastereomer (compound 55) : (single diastereomer I, faster eluting diastereomer): (3.8 mg, 25% yield, observed m/z : 583[M+H] + ). 1 H NMR (400MHz, CD 3 OD): δ 7.80(dd,2H), 7.57-7.48(m,3H), 7.45-7.36(m,2H), 5.16(dd,1H), 4.55(d,1H) , 3.2(bs,1H), 2.64-2.57(m,1H), 2.55-2.41(m,2H), 2.34(s,2H), 2.2(m,1H), 2.01-1.78(m,3H), 1.63 (d,3H), 1.38(q,3H), 1.22(s,1H).
主要非對映異構物(化合物56):(單一非對映異構物II,較慢洗脫的非對映異構物):(4.2mg,產率30%,觀察到m/z:583[M+H]+)。1H NMR(400MHz,CD3OD):δ 7.78(m,2H),7.53-7.46(m,3H),7.40(d,2H),5.18(m,1H),4.54(s,1H),3.22(s,1H), 2.60(s,1H),2.55-2.41(m,2H),2.34(s,2H),2.15(s,1H),2.00-1.82(m,3H),1.63(d,3H),1.38(d,2H),1.23(s,1H),1.03(s,1H)。 Major diastereomer (compound 56) : (single diastereomer II, slower eluting diastereomer): (4.2 mg, 30% yield, observed m/z: 583[M+H] + ). 1 H NMR (400MHz, CD 3 OD): δ 7.78(m,2H), 7.53-7.46(m,3H), 7.40(d,2H), 5.18(m,1H), 4.54(s,1H), 3.22 (s,1H), 2.60(s,1H), 2.55-2.41(m,2H), 2.34(s,2H), 2.15(s,1H), 2.00-1.82(m,3H), 1.63(d,3H ), 1.38(d,2H), 1.23(s,1H), 1.03(s,1H).
實施例51:(S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物57)Example 51: ( S ) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-formamide (compound 57)
通過將(2S)-2-胺基-3-[(3S)-2-側氧基-3-哌啶基]丙烯醯胺鹽酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:478[M+H]+;1H NMR(400MHz,DMSO-d6):δ 11.27(s,1H),8.66(s,1H),7.26(s,1H),7.11-7.03(m,2H),6.73(s,1H),6.51(d,1H),5.05-4.99(m,1H),4.54(s,1H),4.45(s,1H),3.88(s,3H),3.06(m,2H),2.24-2.21(m,3H),2.12(m,1H),1.86-1.75(m,4H),1.72-1.66(m,4H),1.54-1.50(m,3H),1.40-1.36(m,1H)。 By coupling ( 2S )-2-amino-3-[ ( 3S )-2-oxo-3-piperidinyl]acrylamide hydrochloride with an appropriate carboxylic acid to ,3 S ,4 S )-2-(7-chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 S )-1-cyano-2-[(3 S ) -2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide was prepared in a similar manner ( S ) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-2-(4-methoxy-1H-indole -2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide; observed m/z: 478[M+H] + ; 1 H NMR (400MHz, DMSO-d 6 ) : δ 11.27(s,1H), 8.66(s,1H), 7.26(s,1H), 7.11-7.03(m,2H), 6.73(s,1H), 6.51(d,1H), 5.05-4.99( m,1H), 4.54(s,1H), 4.45(s,1H), 3.88(s,3H), 3.06(m,2H), 2.24-2.21(m,3H), 2.12(m,1H), 1.86 -1.75(m,4H), 1.72-1.66(m,4H), 1.54-1.50(m,3H), 1.40-1.36(m,1H).
實施例52:(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物58)Example 52: (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl ]-2-[(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-nitrogen Heterobicyclo[2.2.2]octane-3-carboxamide (Compound 58)
步驟(1):N-[(1S)-2-[(1S,3S,4S)-3-[[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]胺甲醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-2-基]-1-(環丁基甲基)-2-側氧基-乙基]胺基甲酸第三丁酯Step (1): N-[(1S)-2-[(1S,3S,4S)-3-[[(1S)-2-Amino-2-oxo-1-[[(3S)- 2-oxo-3-piperidinyl]methyl]ethyl]carbamoyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-2-yl]-1 -(Cyclobutylmethyl)-2-oxo-ethyl]carbamate tertiary butyl ester
向(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽(45mg,0.11mmol)和(2S)-2-(第三丁氧基羰基胺基)-3-環丁基-丙酸(28mg,0.11mmol)在DMF(2mL)中的溶液加入HATU(65mg,0.17mmol)和DIPEA(80μL,0.46mmol)。將反應混合物在室溫下攪拌2小時。用EtOAc(30mL)稀釋混合物,用0.5M水性鹽酸溶液(10mL)和水性鹽水溶液(10mL)洗滌。將有機相經無水硫酸鈉乾燥,過濾,並在真空中濃縮。通過正相SiO2層析法(0-4% MeOH/CH2Cl2)純化粗殘餘物,得到N-[(1S)-2-[(1S,3S,4S)-3-[[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]胺甲醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-2-基]-1-(環丁基甲基)-2-側氧基-乙基]胺基甲酸第三丁酯,為無色油(50mg,產率75%,觀察到m/z:584[M+H]+)。 To (1 S ,3 S ,4 S ) -N -[(1 S )-2-amino-2-oxo-1-[[(3 S )-2-oxo-3-piperidine Base]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride (45mg, 0.11mmol) and (2 S )-2 A solution of -(tert-butoxycarbonylamino)-3-cyclobutyl-propionic acid (28 mg, 0.11 mmol) in DMF (2 mL) was added with HATU (65 mg, 0.17 mmol) and DIPEA (80 μL, 0.46 mmol) . The reaction mixture was stirred at room temperature for 2 hours. The mixture was diluted with EtOAc (30 mL), washed with 0.5M aqueous hydrochloric acid solution (10 mL) and aqueous brine solution (10 mL). The organic phase was dried over anhydrous sodium sulfate, filtered and concentrated in vacuo. The crude residue was purified by normal phase SiO2 chromatography (0-4% MeOH/ CH2Cl2 ) to afford N-[(1S)-2-[( 1S ,3S,4S)-3-[[(1S )-2-amino-2-oxo-1-[[(3S)-2-oxo-3-piperidinyl]methyl]ethyl]carbamoyl]-5,5-di Tertiary butyl fluoro-2-azabicyclo[2.2.2]oct-2-yl]-1-(cyclobutylmethyl)-2-oxo-ethyl]carbamate as a colorless oil (50mg , yield 75%, observed m/z: 584 [M+H] + ).
步驟(2):(1S,3S,4S)-2-[(2S)-2-胺基-3-環丁基-丙醯基]-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽Step (2): (1S,3S,4S)-2-[(2S)-2-Amino-3-cyclobutyl-propionyl]-N-[(1S)-2-Amino-2- Oxy-1-[[(3S)-2-oxy-3-piperidinyl]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide hydrochloride
向N-[(1S)-2-[(1S,3S,4S)-3-[[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]胺甲醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-2-基]-1-(環丁基甲基)-2-側氧基-乙基]胺基甲酸第三丁酯(50mg,0.09mmol)在CH2Cl2(1mL)中的溶液加入鹽酸(4N的1,4-二烷溶液,3mL)。將反應混合物在室溫下攪拌15小時,並在真空中濃縮,得到(1S,3S,4S)-2-[(2S)-2-胺基-3-環丁基-丙醯基]-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽,為白色固體(45mg,觀察到m/z:484[M+H]+),其無需進一步純化即可用於下一步。 To N-[(1S)-2-[(1S,3S,4S)-3-[[(1S)-2-amino-2-oxo-1-[[(3S)-2-oxo Base-3-piperidinyl]methyl]ethyl]aminoformyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-2-yl]-1-(cyclobutylmethyl Hydrochloric acid ( 4N 1,4 - di alkane solution, 3 mL). The reaction mixture was stirred at room temperature for 15 hours and concentrated in vacuo to afford ( 1S , 3S , 4S )-2-[( 2S )-2-amino-3-cyclobutyl-propionyl Base]- N -[(1 S )-2-amino-2-oxo-1-[[(3 S )-2-oxo-3-piperidinyl]methyl]ethyl]- 5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride as a white solid (45 mg, observed m/z: 484 [M+H] + ), It was used in the next step without further purification.
步驟(3):(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺Step (3): (1S,3S,4S)-N-[(1S)-2-Amino-2-oxo-1-[[(3S)-2-oxo-3-piperidinyl ]methyl]ethyl]-2-[(2S)-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-di Fluoro-2-azabicyclo[2.2.2]octane-3-carboxamide
向(1S,3S,4S)-2-[(2S)-2-胺基-3-環丁基-丙醯基]-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽(45mg,0.09mmol)在MeOH(1mL)中的溶液加入2,2,2-三氟乙酸乙酯(103μL,0.87mmol)和DIPEA(45μL,0.26mmol)。將反應混合物在室溫下攪拌30min。向該混合物加入飽和碳酸氫鈉水溶液(10mL)並用EtOAc(3×15mL)萃取水相。將合併後的有機相經無水硫酸鈉乾燥,過濾,並在真空中濃縮, 得到(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺,為無色油(50mg,產率100%,觀察到m/z:580[M+H]+),其無需進一步純化即可用於下一步。 To (1 S ,3 S ,4 S )-2-[(2 S )-2-amino-3-cyclobutyl-propionyl] -N -[(1 S )-2-amino-2 -Oxy-1-[[(3S)-2-oxy-3-piperidinyl]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane Alkane-3-carboxamide hydrochloride (45 mg, 0.09 mmol) in MeOH (1 mL) was added ethyl 2,2,2-trifluoroacetate (103 μL, 0.87 mmol) and DIPEA (45 μL, 0.26 mmol) . The reaction mixture was stirred at room temperature for 30 min. To the mixture was added saturated aqueous sodium bicarbonate (10 mL) and the aqueous phase was extracted with EtOAc (3 x 15 mL). The combined organic phases were dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo to give ( 1S , 3S , 4S ) -N -[( 1S )-2-amino-2-oxo -1-[[(3 S )-2-oxo-3-piperidinyl]methyl]ethyl]-2-[(2 S )-3-cyclobutyl-2-[(2,2 ,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide as a colorless oil (50 mg, yield Yield 100%, observed m/z: 580 [M+H] + ), which was used in the next step without further purification.
步驟(4):(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺Step (4): (1S,3S,4S)-N-[(1S)-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide
向(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(50mg,0.09mmol)在CH2Cl2(1mL)中的溶液加入Burgess試劑(62mg,0.26mmol)。將反應混合物在室溫下攪拌1小時,並在真空中濃縮。通過反相HPLC純化粗殘餘物,得到(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺,為白色固體(14mg,產率28%,觀察到m/z:562[M+H]+);1H NMR(400MHz,CD3OD):δ 5.10(dd,1H),4.72(dd,1H),4.52-4.47(m,1H),4.38(s,1H),3.29-3.16(m,2H),2.59(s,1H),2.56-2.36(m,4H),2.30-1.99(m,7H),1.97-1.63(m,10H),1.58-1.47(m,1H)。 To (1 S ,3 S ,4 S ) -N -[(1 S )-2-amino-2-oxo-1-[[(3 S )-2-oxo-3-piperidine base]methyl]ethyl]-2-[( 2S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5 - To a solution of difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide (50 mg, 0.09 mmol) in CH2Cl2 (1 mL ) was added Burgess reagent (62 mg, 0.26 mmol). The reaction mixture was stirred at room temperature for 1 hour and concentrated in vacuo. Purification of the crude residue by reverse phase HPLC afforded ( 1S , 3S , 4S ) -N -[( 1S )-1-cyano-2-[( 3S )-2-oxo-3- Piperidinyl]ethyl]-2-[(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5- Difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide as a white solid (14 mg, 28% yield, observed m/z: 562[M+H] + ); 1 H NMR (400MHz, CD 3 OD): δ 5.10(dd,1H), 4.72(dd,1H), 4.52-4.47(m,1H), 4.38(s,1H), 3.29-3.16(m,2H), 2.59 (s, 1H), 2.56-2.36 (m, 4H), 2.30-1.99 (m, 7H), 1.97-1.63 (m, 10H), 1.58-1.47 (m, 1H).
實施例53:(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-Example 53: (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl ]-5,5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]- 2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物59)2-Azabicyclo[2.2.2]octane-3-carboxamide (compound 59)
通過將(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:550[M+H]+;1H NMR(400MHz,CD3OD):δ 5.20-5.06(m,1H),4.97-4.89(m,1H),4.52-4.40(m,1H),4.37-4.28(m,1H),3.29-3.21(m,2H),2.59(s,1H),2.55-2.20(m,4H),2.16-1.43(m,13H),0.96(d,4H),0.92(d,1H),0.83(d,1H)。 By adding (1 S ,3 S ,4 S ) -N -[(1 S )-2-amino-2-oxo-1-[[(3 S )-2-oxo-3-piper Pyridyl]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride is coupled with an appropriate carboxylic acid to react with respect to (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2-[(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2.2] (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-side Oxy-3-piperidinyl]ethyl]-5,5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amine Base]pentyl]-2-azabicyclo[2.2.2]octane-3-carboxamide; observed m/z: 550[M+H] + ; 1 H NMR (400MHz, CD 3 OD) : δ 5.20-5.06(m,1H), 4.97-4.89(m,1H), 4.52-4.40(m,1H), 4.37-4.28(m,1H), 3.29-3.21(m,2H), 2.59(s ,1H), 2.55-2.20(m,4H), 2.16-1.43(m,13H), 0.96(d,4H), 0.92(d,1H), 0.83(d,1H).
實施例54:(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物60)Example 54: (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl ]-5,5-difluoro-2-[(2R)-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo [2.2.2] Octane-3-formamide (Compound 60)
通過將(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲 醯胺鹽酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:550[M+H]+;1H NMR(400MHz,CD3OD)δ:5.09(dd,1H),4.85(dd,1H),4.51(s,1H),4.41(s,1H),3.29-3.20(m,2H),2.59(d,1H),2.55-2.37(m,3H),2.32-1.45(m,13H),0.97(dd,6H)。 By adding (1 S ,3 S ,4 S ) -N -[(1 S )-2-amino-2-oxo-1-[[(3 S )-2-oxo-3-piper Pyridyl]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride is coupled with an appropriate carboxylic acid to react with respect to (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2-[(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2.2] (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-side Oxy-3-piperidinyl]ethyl]-5,5-difluoro-2-[(2R)-4-methyl-2-[(2,2,2-trifluoroacetyl)amino ]pentyl]-2-azabicyclo[2.2.2]octane-3-carboxamide; observed m/z: 550[M+H] + ; 1 H NMR (400MHz, CD 3 OD)δ : 5.09(dd,1H), 4.85(dd,1H), 4.51(s,1H), 4.41(s,1H), 3.29-3.20(m,2H), 2.59(d,1H), 2.55-2.37(m ,3H), 2.32-1.45(m,13H), 0.97(dd,6H).
實施例55:(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物61)Example 55: (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl ]-2-[(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-nitrogen Heterobicyclo[2.2.2]octane-3-carboxamide (Compound 61)
通過將(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:548[M+H]+;1H NMR(400MHz,CD3OD):δ 5.09(dd,1H),4.58-4.49(m,2H),3.29-3.20(m,2H),2.63-2.37(m,4H),2.32-1.69(m,12H),1.57-1.36(m,2H),1.00-0.84(m,1H),0.60-0.43(m,2H),0.27-0.07(m, 1H)。 By adding (1 S ,3 S ,4 S ) -N -[(1 S )-2-amino-2-oxo-1-[[(3 S )-2-oxo-3-piper Pyridyl]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride is coupled with an appropriate carboxylic acid to react with respect to (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2-[(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2.2] (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-side Oxy-3-piperidinyl]ethyl]-2-[(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl] -5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide; observed m/z: 548[M+H] + ; 1 H NMR (400MHz, CD 3 OD ): δ 5.09(dd,1H), 4.58-4.49(m,2H), 3.29-3.20(m,2H), 2.63-2.37(m,4H), 2.32-1.69(m,12H), 1.57-1.36( m, 2H), 1.00-0.84(m, 1H), 0.60-0.43(m, 2H), 0.27-0.07(m, 1H).
實施例56:(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物62)Example 56: (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl ]-2-[(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-nitrogen Heterobicyclo[2.2.2]octane-3-carboxamide (Compound 62)
通過將(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:562[M+H]+;1H NMR(400MHz,CD3OD):δ 5.12(dd,1H),4.80(dd,1H),4.49-4.42(m,1H),4.32(s,1H),3.29-3.20(m,2H),2.63-1.45(m,23H)。 By adding (1 S ,3 S ,4 S ) -N -[(1 S )-2-amino-2-oxo-1-[[(3 S )-2-oxo-3-piper Pyridyl]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride is coupled with an appropriate carboxylic acid to react with respect to (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2-[(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2.2] (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-side Oxy-3-piperidinyl]ethyl]-2-[(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl] -5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide; observed m/z: 562[M+H] + ; 1 H NMR (400MHz, CD 3 OD ): δ 5.12(dd,1H), 4.80(dd,1H), 4.49-4.42(m,1H), 4.32(s,1H), 3.29-3.20(m,2H), 2.63-1.45(m,23H) .
實施例57:(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物63)Example 57: (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl ]-2-[(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-aza Bicyclo[2.2.2]octane-3-carboxamide (Compound 63)
通過將(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:550[M+H]+;1H NMR(400MHz,CD3OD):δ 5.17-5.03(m,1H),4.47(d,2H),3.29-3.23(m,2H),2.61-2.18(m,5H),2.12-1.68(m,8H),1.60-1.48(m,1H),1.02(d,10H)。 By adding (1 S ,3 S ,4 S ) -N -[(1 S )-2-amino-2-oxo-1-[[(3 S )-2-oxo-3-piper Pyridyl]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride is coupled with an appropriate carboxylic acid to react with respect to (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2-[(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2.2] (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-side Oxy-3-piperidinyl]ethyl]-2-[(2R)-3,3-dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]- 5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide; observed m/z: 550[M+H] + ; 1 H NMR (400MHz, CD 3 OD) : δ 5.17-5.03(m,1H), 4.47(d,2H), 3.29-3.23(m,2H), 2.61-2.18(m,5H), 2.12-1.68(m,8H), 1.60-1.48(m ,1H), 1.02(d,10H).
實施例58:(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物64)Example 58: ( 1S , 3S , 4S ) -N -[( 1S )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl] -2-[(2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide (Compound 64)
步驟(1):(2S)-2-(2,5-二氟苯胺)丙酸Step (1): (2S)-2-(2,5-difluoroaniline)propionic acid
向(2S)-2-胺基丙酸(89mg,1.00mmol)和2-溴-1,4-二氟-苯(0.06mL,0.50mmol)在DMSO(3mL)中的溶液加入磷酸鉀(212mg,1.00mmol)和碘化銅(19mg,0.10mmol)。將反應混合物用氮氣吹掃5min並在100℃下在微波反應器中攪拌3小時。通過CELITE®過 濾混合物並通過反相HPLC純化,得到(2S)-2-(2,5-二氟苯胺)丙酸,為白色固體(42mg,產率42%,觀察到m/z:202[M+H]+)。 To a solution of ( 2S )-2-aminopropionic acid (89 mg, 1.00 mmol) and 2-bromo-1,4-difluoro-benzene (0.06 mL, 0.50 mmol) in DMSO (3 mL) was added potassium phosphate ( 212mg, 1.00mmol) and copper iodide (19mg, 0.10mmol). The reaction mixture was purged with nitrogen for 5 min and stirred at 100 °C for 3 h in a microwave reactor. Filtration of the mixture through CELITE® and purification by reverse phase HPLC afforded ( 2S )-2-(2,5-difluoroaniline)propionic acid as a white solid (42 mg, 42% yield, observed m/z: 202 [M+H] + ).
步驟(2):(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺Step (2): (1S,3S,4S)-N-[(1S)-2-Amino-2-oxo-1-[[(3S)-2-oxo-3-piperidinyl ]methyl]ethyl]-2-[(2S)-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide
向(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽(30mg,0.08mmol)和(2S)-2-(2,5-二氟苯胺)丙酸(15mg,0.08mmol)在CH2Cl2:THF(1:1,2mL)中的溶液加入HOBt一水化物(23mg,0.15mmol),隨後加入EDC鹽酸鹽(19mg,0.10mmol)和DIPEA(53μL,0.30mmol)。將反應混合物在室溫下攪拌1小時。向該混合物加入H2O(10mL)並用EtOAc(2×30mL)萃取水相。將合併後的有機相經無水硫酸鈉乾燥,過濾,並在真空中濃縮。通過正相SiO2層析法(0-10% MeOH/CH2Cl2)純化粗殘餘物,得到(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺,為白色固體(24mg,產率58%,觀察到m/z:542[M+H]+)。 To (1 S ,3 S ,4 S ) -N -[(1 S )-2-amino-2-oxo-1-[[(3 S )-2-oxo-3-piperidine Base]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride (30mg, 0.08mmol) and (2 S )-2 -(2,5-Difluoroaniline)propionic acid (15 mg, 0.08 mmol ) in CH2Cl2 :THF (1:1, 2 mL) was added HOBt monohydrate (23 mg, 0.15 mmol) followed by EDC Hydrochloride (19 mg, 0.10 mmol) and DIPEA (53 μL, 0.30 mmol). The reaction mixture was stirred at room temperature for 1 hour. To the mixture was added H2O (10 mL) and the aqueous phase was extracted with EtOAc (2 x 30 mL). The combined organic phases were dried over anhydrous sodium sulfate, filtered and concentrated in vacuo. The crude residue was purified by normal phase SiO2 chromatography (0-10% MeOH/ CH2Cl2 ) to afford ( 1S , 3S , 4S ) -N -[( 1S )-2-amino- 2-oxo-1-[[(3 S )-2-oxo-3-piperidinyl]methyl]ethyl]-2-[(2 S )-2-(2,5-di Fluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide as a white solid (24 mg, 58% yield, observed m/z : 542[M+H] + ).
步驟(3):(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺Step (3): (1S,3S,4S)-N-[(1S)-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide
向(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(24mg,0.04mmol)在無水CH2Cl2(1mL)中的溶液加入Burgess試劑(32mg,0.13mmol)。將反應混合物在室溫下攪拌2小時,並在真空中濃縮。通過反相HPLC純化粗殘餘物,得到(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺,為白色固體(0.8mg,產率3%,觀察到m/z:524[M+H]+);1H NMR(400MHz,CD3OD):δ 7.00-6.85(m,1H),6.57-6.42(m,1H),6.39-6.20(m,1H),5.09(dd,1H),4.59-4.44(m,2H),3.29-3.21(m,1H),2.63-1.70(m,12H),1.59-1.35(m,4H),1.29(s,3H)。 To (1 S ,3 S ,4 S ) -N -[(1 S )-2-amino-2-oxo-1-[[(3 S )-2-oxo-3-piperidine Base] methyl] ethyl] -2-[(2S)-2-(2,5-difluoroaniline) propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane To a solution of alkane-3-carboxamide (24 mg, 0.04 mmol) in anhydrous CH2Cl2 (1 mL) was added Burgess reagent (32 mg, 0.13 mmol). The reaction mixture was stirred at room temperature for 2 hours and concentrated in vacuo. Purification of the crude residue by reverse phase HPLC afforded ( 1S , 3S , 4S ) -N -[( 1S )-1-cyano-2-[( 3S )-2-oxo-3- Piperidinyl]ethyl]-2-[(2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane Alkane-3-carboxamide as a white solid (0.8 mg, 3% yield, observed m/z: 524 [M+H] + ); 1 H NMR (400 MHz, CD 3 OD): δ 7.00-6.85 (m,1H), 6.57-6.42(m,1H), 6.39-6.20(m,1H), 5.09(dd,1H), 4.59-4.44(m,2H), 3.29-3.21(m,1H), 2.63 -1.70(m,12H), 1.59-1.35(m,4H), 1.29(s,3H).
實施例59:(1S,3S,4S)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物65)Example 59: (1 S ,3 S ,4 S )-2-[(2 R )-2-(3-chloro-2-methyl-aniline)propionyl] -N -[(1 S )- 1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3 - formamide (compound 65)
通過將(1S,3S,4S)-N-[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲 醯胺鹽酸鹽與適當的羧酸偶合以與關於1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:536[M+H]+;1H NMR(400MHz,CD3OD):δ 7.00(t,1H),6.71(d,1H),6.51(d,1H),5.16-4.97(m,1H),4.67-4.34(m,2H),3.26-3.05(m,2H),2.64-2.11(m,6H),1.84(d,3H),1.62-0.82(m,12H)。 By adding (1 S ,3 S ,4 S ) -N -[(1 S )-2-amino-2-oxo-1-[[(3 S )-2-oxo-3-piper Pyridyl]methyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride is coupled with an appropriate carboxylic acid to react with about 1S , 3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2-[(2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide (1 S ,3 S ,4 S )-2-[(2 R )-2-(3-chloro-2-methyl-aniline)propionyl] -N -[(1 S )-1-cyano -2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide ; Observed m/z: 536 [M+H] + ; 1 H NMR (400 MHz, CD 3 OD): δ 7.00 (t, 1H), 6.71 (d, 1H), 6.51 (d, 1H), 5.16- 4.97 (m, 1H), 4.67-4.34 (m, 2H), 3.26-3.05 (m, 2H), 2.64-2.11 (m, 6H), 1.84 (d, 3H), 1.62-0.82 (m, 12H).
實施例60:(1S,3S,4S)-2-[(2R)-2-(3-氯苯胺基)-4-甲基-戊醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物66)Example 60: (1 S ,3 S ,4 S )-2-[(2 R )-2-(3-chloroanilino)-4-methyl-pentyl] -N -[(1 S ) -1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane- 3-Formamide (Compound 66)
步驟(1):(1S,3S,4S)-3-(((S)-1-胺基-1-側氧基-3-((S)-2-氧代哌啶-3-基)丙烷-2-基)胺甲醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-2-羧酸第三丁酯Step (1): (1S,3S,4S)-3-(((S)-1-amino-1-oxo-3-((S)-2-oxopiperidin-3-yl) Propan-2-yl)carbamoyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-2-carboxylic acid tert-butyl ester
向(1S,3S,4S)-2-第三丁氧基羰基-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-羧酸(80mg,0.27mmol)和(2S)-2-胺基-3-[(3S)-2-氧代哌啶-3-基]丙烯醯胺鹽酸鹽(57mg,0.27mmol)在CH2Cl2:THF(1:1,2mL)中的溶液加入HOBt一水化物(84mg,0.55mmol)、EDC 鹽酸鹽(69mg,0.36mmol)和DIPEA(192μL,1.1mmol)。將反應混合物在室溫下攪拌2小時。向該混合物加入H2O(5mL)和水性鹽水溶液(5mL)。用EtOAc(3×15mL)萃取水相。將合併後的有機相經無水硫酸鈉乾燥,過濾,並在減壓下濃縮。通過正相SiO2層析法(0-8% MeOH/CH2Cl2)純化粗殘餘物,得到(1S,3S,4S)-3-(((S)-1-胺基-1-側氧基-3-((S)-2-氧代哌啶-3-基)丙烷-2-基)胺甲醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-2-羧酸第三丁酯,為白色固體(50mg,產率41%,觀察到m/z:445[M+H]+)。 To (1 S ,3 S ,4 S )-2-tert-butoxycarbonyl-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxylic acid (80mg, 0.27mmol ) and ( 2S )-2-amino-3-[( 3S )-2-oxopiperidin-3-yl]acrylamide hydrochloride (57mg, 0.27mmol) in CH2Cl2 : THF To a solution in (1:1, 2 mL) was added HOBt monohydrate (84 mg, 0.55 mmol), EDC hydrochloride (69 mg, 0.36 mmol) and DIPEA (192 μL, 1.1 mmol). The reaction mixture was stirred at room temperature for 2 hours. To the mixture were added H2O (5 mL) and aqueous brine solution (5 mL). The aqueous phase was extracted with EtOAc (3 x 15 mL). The combined organic phases were dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The crude residue was purified by normal phase SiO2 chromatography (0-8% MeOH/ CH2Cl2 ) to afford (1S,3S,4S)-3-(((S)-1-amino-1-end Oxy-3-((S)-2-oxopiperidin-3-yl)propan-2-yl)carbamoyl)-5,5-difluoro-2-azabicyclo[2.2.2] Tert-butyl octane-2-carboxylate as a white solid (50 mg, 41% yield, observed m/z: 445 [M+H] + ).
步驟(2):(1S,3S,4S)-3-[[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]胺甲醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-2-羧酸第三丁酯Step (2): (1S,3S,4S)-3-[[(1S)-2-Amino-2-oxo-1-[[(3S)-2-oxo-3-piperidine Base]methyl]ethyl]aminoformyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-2-carboxylic acid tert-butyl ester
向(1S,3S,4S)-3-[[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3-哌啶基]甲基]乙基]胺甲醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-2-羧酸第三丁酯(395mg,0.86mmol)在無水CH2Cl2(3mL)中的溶液加入Burgess試劑(411mg,1.7mmol)。將反應混合物在室溫下攪拌3小時,並用H2O(10mL)淬滅。用EtOAc(3×15mL)萃取水相。將合併後的有機相經無水硫酸鈉乾燥,過濾,並在真空下濃縮。通過正相SiO2管柱層析法(0-8% MeOH/CH2Cl2)純化粗殘餘物,得到(1S,3S,4S)-3-[[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]胺甲醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-2-羧酸第三丁酯,為白色固體(340mg,產率90%,觀察到m/z:441[M+H]+)。 To (1S,3S,4S)-3-[[(1S)-2-amino-2-oxo-1-[[(3S)-2-oxo-3-piperidinyl]methyl ]ethyl]carbamoyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-2-carboxylic acid tert-butyl ester (395 mg, 0.86 mmol) in anhydrous CH 2 Cl 2 To the solution in (3 mL) was added Burgess reagent (411 mg, 1.7 mmol). The reaction mixture was stirred at room temperature for 3 hours and quenched with H2O (10 mL). The aqueous phase was extracted with EtOAc (3 x 15 mL). The combined organic phases were dried over anhydrous sodium sulfate, filtered and concentrated under vacuum. The crude residue was purified by normal phase SiO 2 column chromatography (0-8% MeOH/CH 2 Cl 2 ) to afford (1S,3S,4S)-3-[[(1S)-1-cyano-2 -[(3S)-2-oxo-3-piperidinyl]ethyl]aminoformyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-2-carboxy tert-Butyl acid as a white solid (340 mg, 90% yield, observed m/z: 441 [M+H] + ).
步驟(3):(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙Step (3): (1S,3S,4S)-N-[(1S)-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]B 基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺Base]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide
向(1S,3S,4S)-3-[[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]胺甲醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-2-羧酸第三丁酯(60mg,0.14mmol)在EtOH(5mL)中的溶液加入對甲苯磺酸一水化物(29mg,0.15mmol)。將反應混合物在80℃下攪拌1.5小時,並在真空下濃縮,以提供標題化合物(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺的對甲苯磺酸鹽,為無色油(70mg,產率>100%,觀察到m/z:341[M+H]+),其無需進一步純化即可用於下一步。 To (1S,3S,4S)-3-[[(1S)-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]carbamoyl]- A solution of tert-butyl 5,5-difluoro-2-azabicyclo[2.2.2]octane-2-carboxylate (60 mg, 0.14 mmol) in EtOH (5 mL) was added to p-toluenesulfonic acid monohydrate (29 mg, 0.15 mmol). The reaction mixture was stirred at 80 °C for 1.5 hours and concentrated in vacuo to afford the title compound ( 1S , 3S , 4S ) -N -[( 1S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide p-toluenesulfonate , as a colorless oil (70 mg, >100% yield, observed m/z: 341 [M+H] + ), which was used in the next step without further purification.
步驟(4):(2R)-2-[(5-氯-3-吡啶基)胺基]丙酸Step (4): (2R)-2-[(5-Chloro-3-pyridyl)amino]propionic acid
向(2R)-2-胺基-4-甲基-戊酸(262mg,2.0mmol)和1-溴-3-氯-苯(118μL,1.0mmol)在DMSO(3mL)中的溶液加入磷酸三鉀(425mg,2.0mmol)和碘化銅(38mg,0.2mmol)。將反應混合物用氮氣吹掃5min並在100℃下攪拌3小時。將反應混合物過濾並通過反相HPLC純化,得到(2R)-2-(3-氯苯胺基)-4-甲基-戊酸,為黃色固體(68mg,產率28%,觀察到m/z:242[M+H]+)。 To a solution of ( 2R )-2-amino-4-methyl-pentanoic acid (262 mg, 2.0 mmol) and 1-bromo-3-chloro-benzene (118 μL, 1.0 mmol) in DMSO (3 mL) was added phosphoric acid Tripotassium (425 mg, 2.0 mmol) and copper iodide (38 mg, 0.2 mmol). The reaction mixture was purged with nitrogen for 5 min and stirred at 100 °C for 3 h. The reaction mixture was filtered and purified by reverse phase HPLC to afford ( 2R )-2-(3-chloroanilino)-4-methyl-pentanoic acid as a yellow solid (68 mg, 28% yield, observed m/ z: 242[M+H] + ).
步驟(5):(1S,3S,4S)-2-[(2R)-2-(3-氯苯胺基)-4-甲基-戊醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺Step (5): (1S,3S,4S)-2-[(2R)-2-(3-Chloroanilino)-4-methyl-pentyl]-N-[(1S)-1-cyano Base-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide
向(2R)-2-(3-氯苯胺基)-4-甲基-戊酸(17mg,0.07mmol)和(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺4-甲苯磺酸鹽(35mg,0.07mmol)在DMF(0.5mL)中的溶液逐滴加入DIPEA(48μL,0.27mmol)和HATU(31mg,0.08mmol)在DMF(0.5mL)中的溶液。將反應混合物在室溫下攪拌30min並通過反相製備型HPLC純化,得到(1S,3S,4S)-2-[(2R)-2-(3-氯苯胺基)-4-甲基-戊醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺,為白色固體(8mg,產率21%,觀察到m/z:564[M+H]+);1H NMR(400MHz,CD3OD):δ 7.13-7.00(m,1H),6.71-6.44(m,3H),5.13-5.01(m,1H),4.62(s,1H),4.43(d,1H),4.37-4.07(m,1H),3.25-3.09(m,2H),2.56-2.38(m,3H),2.30-2.09(m,3H),1.96-1.50(m,10H),1.45-1.33(m,1H),1.05-0.93(m,6H)。 To (2 R )-2-(3-chloroanilino)-4-methyl-pentanoic acid (17 mg, 0.07 mmol) and (1 S ,3 S ,4 S ) -N -[(1 S )-1 -cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3- A solution of formamide 4-tosylate (35 mg, 0.07 mmol) in DMF (0.5 mL) was added dropwise to a solution of DIPEA (48 μL, 0.27 mmol) and HATU (31 mg, 0.08 mmol) in DMF (0.5 mL) solution. The reaction mixture was stirred at room temperature for 30 min and purified by reverse phase preparative HPLC to give ( 1S , 3S , 4S )-2-[( 2R )-2-(3-chloroanilino)-4- Methyl-pentyl] -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-di Fluoro-2-azabicyclo[2.2.2]octane-3-carboxamide as a white solid (8 mg, 21% yield, observed m/z: 564[M+H] + ); 1 H NMR (400MHz, CD 3 OD): δ 7.13-7.00(m,1H), 6.71-6.44(m,3H), 5.13-5.01(m,1H), 4.62(s,1H), 4.43(d,1H), 4.37-4.07(m,1H), 3.25-3.09(m,2H), 2.56-2.38(m,3H), 2.30-2.09(m,3H), 1.96-1.50(m,10H), 1.45-1.33(m ,1H), 1.05-0.93 (m,6H).
實施例61:(1S,3S,4S)-2-[(2R)-2-(3-氯苯胺基)-3-環丙基-丙醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物67)Example 61: (1 S ,3 S ,4 S )-2-[(2 R )-2-(3-chloroanilino)-3-cyclopropyl-propionyl] -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-formamide (compound 67)
通過將(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺4-甲苯磺酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-2-[(2R)-2-(3-氯苯胺基)-4- 甲基-戊醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-2-[(2R)-2-(3-氯苯胺基)-3-環丙基-丙醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:562[M+H]+;1H NMR(400MHz,CD3OD):δ 7.13-7.00(m,1H),6.71-6.44(m,3H),5.13-5.01(m,1H),4.62(s,1H),4.43(d,1H),4.37-4.07(m,1H),3.25-3.09(m,2H),2.56-2.38(m,2H),2.30-2.09(m,2H),1.96-1.50(m,10H),1.45-1.33(m,1H),1.05-0.93(m,6H)。 By adding (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]- 5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamide 4-toluenesulfonate was coupled with an appropriate carboxylic acid to react with respect to ( 1S , 3S , 4S ) -2-[(2 R )-2-(3-chloroanilino)-4-methyl-pentyl] -N -[(1 S )-1-cyano-2-[(3 S )- 2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide was prepared in an analogous manner (1 S ,3 S ,4 S )-2-[(2 R )-2-(3-chloroanilino)-3-cyclopropyl-propionyl] -N -[(1 S )-1-cyano -2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide ; Observed m/z: 562[M+H] + ; 1 H NMR (400MHz, CD 3 OD): δ 7.13-7.00 (m, 1H), 6.71-6.44 (m, 3H), 5.13-5.01 (m ,1H), 4.62(s,1H), 4.43(d,1H), 4.37-4.07(m,1H), 3.25-3.09(m,2H), 2.56-2.38(m,2H), 2.30-2.09(m ,2H), 1.96-1.50(m,10H), 1.45-1.33(m,1H), 1.05-0.93(m,6H).
實施例62:(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(5-甲基-3-吡啶基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物68)Example 62: (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl ]-2-[(2 R )-3-cyclopropyl-2-[(5-methyl-3-pyridyl)amino]propionyl]-5,5-difluoro-2-azabicyclo [2.2.2] Octane-3-formamide (Compound 68)
通過將(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺4-甲苯磺酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-2-[(2R)-2-(3-氯苯胺基)-4-甲基-戊醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(5-甲基-3-吡啶基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:543[M+H]+;1H NMR(400MHz,CD3OD):δ 7.87-7.75(m,1H),7.66(d,1H),7.02-6.90(m,1H),5.22-5.00(m,1H),4.61(s,1H),4.54-4.36(m,2H),3.24-3.08(m,2H),2.55(s,1H),2.50-2.37(m,2H),2.34-2.17(m,6H), 1.98-1.21(m,10H),0.96-0.81(m,1H),0.56-0.45(m,2H),0.25-0.01(m,2H)。 By adding (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]- 5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamide 4-toluenesulfonate was coupled with an appropriate carboxylic acid to react with respect to ( 1S , 3S , 4S ) -2-[(2 R )-2-(3-chloroanilino)-4-methyl-pentyl] -N -[(1 S )-1-cyano-2-[(3 S )- 2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide was prepared in an analogous manner (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2-[( 2 R )-3-cyclopropyl-2-[(5-methyl-3-pyridyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane Alkane-3-carboxamide; Observed m/z: 543[M+H] + ; 1 H NMR (400MHz, CD 3 OD): δ 7.87-7.75 (m, 1H), 7.66 (d, 1H), 7.02-6.90(m,1H), 5.22-5.00(m,1H), 4.61(s,1H), 4.54-4.36(m,2H), 3.24-3.08(m,2H), 2.55(s,1H), 2.50-2.37(m,2H), 2.34-2.17(m,6H), 1.98-1.21(m,10H), 0.96-0.81(m,1H), 0.56-0.45(m,2H), 0.25-0.01(m ,2H).
實施例63:(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物69)Example 63: (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl ]-2-[(2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl Amine (Compound 69)
通過將(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺4-甲苯磺酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-2-[(2R)-2-(3-氯苯胺基)-4-甲基-戊醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:524[M+H]+;1H NMR(400MHz,CD3OD):δ 7.02-6.78(m,1H),6.61-6.41(m,1H),6.36-6.24(m,1H),5.21-5.00(m,1H),4.63-4.39(m,3H),3.23-3.12(m,2H),2.60-1.04(m,17H)。 By adding (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]- 5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamide 4-toluenesulfonate was coupled with an appropriate carboxylic acid to react with respect to ( 1S , 3S , 4S ) -2-[(2 R )-2-(3-chloroanilino)-4-methyl-pentyl] -N -[(1 S )-1-cyano-2-[(3 S )- 2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide was prepared in an analogous manner (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2-[( 2 R )-2-(2,5-difluoroaniline) propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide; m/ z: 524[M+H] + ; 1 H NMR (400MHz, CD 3 OD): δ 7.02-6.78 (m, 1H), 6.61-6.41 (m, 1H), 6.36-6.24 (m, 1H), 5.21 -5.00(m,1H), 4.63-4.39(m,3H), 3.23-3.12(m,2H), 2.60-1.04(m,17H).
實施例64:(1S,3S,4S)-2-[(2R)-2-[(5-氯-3-吡啶基)胺基]丙醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物70)Example 64: (1 S ,3 S ,4 S )-2-[(2 R )-2-[(5-chloro-3-pyridyl)amino]propionyl] -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-formamide (compound 70)
通過將(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺4-甲苯磺酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-2-[(2R)-2-(3-氯苯胺基)-4-甲基-戊醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-2-[(2R)-2-[(5-氯-3-吡啶基)胺基]丙醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:523[M+H]+;1H NMR(400MHz,CD3OD):δ 8.09(d,1H),7.91(d,1H),7.65-7.58(m,1H),5.12-5.00(m,1H),4.62-4.45(m,3H),3.23-3.12(m,2H),2.61(s,1H),2.55-2.18(m,5H),1.97-1.73(m,5H),1.65-1.30(m,6H)。 By adding (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]- 5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamide 4-toluenesulfonate was coupled with an appropriate carboxylic acid to react with respect to ( 1S , 3S , 4S ) -2-[(2 R )-2-(3-chloroanilino)-4-methyl-pentyl] -N -[(1 S )-1-cyano-2-[(3 S )- 2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide was prepared in an analogous manner (1 S ,3 S ,4 S )-2-[(2 R )-2-[(5-chloro-3-pyridyl)amino]propionyl] -N -[(1 S )-1-cyano -2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide ; Observed m/z: 523 [M+H] + ; 1 H NMR (400MHz, CD 3 OD): δ 8.09 (d, 1H), 7.91 (d, 1H), 7.65-7.58 (m, 1H), 5.12-5.00(m,1H), 4.62-4.45(m,3H), 3.23-3.12(m,2H), 2.61(s,1H), 2.55-2.18(m,5H), 1.97-1.73(m,5H ), 1.65-1.30(m,6H).
實施例65:(1S,3S,4S)-2-[(2R)-2-(3-氯苯胺基)丙醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物71)Example 65: (1 S ,3 S ,4 S )-2-[(2 R )-2-(3-chloroanilino)propionyl] -N -[(1 S )-1-cyano- 2-[( 3S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide ( Compound 71)
通過將(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺4-甲苯磺酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-2-[(2R)-2-(3-氯苯胺基)-4-甲基-戊醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5- 二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-2-[(2R)-2-(3-氯苯胺基)丙醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:522[M+H]+;1H NMR(400MHz,CD3OD):δ 7.10(t,1H),6.73-6.64(m,2H),6.61-6.55(m,1H),5.14-5.03(m,1H),4.57-4.43(m,2H),4.38(q,1H),3.21-3.11(m,2H),2.61-2.37(m,3H),2.35-2.13(m,3H),1.94-1.71(m,5H),1.65-1.48(m,2H),1.46-1.29(m,4H)。 By adding (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]- 5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamide 4-toluenesulfonate was coupled with an appropriate carboxylic acid to react with respect to ( 1S , 3S , 4S ) -2-[(2 R )-2-(3-chloroanilino)-4-methyl-pentyl] -N -[(1 S )-1-cyano-2-[(3 S )- 2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide was prepared in a similar manner (1 S ,3 S ,4 S )-2-[(2 R )-2-(3-chloroanilino)propionyl] -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide; observed m/z: 522[M+H]+; 1H NMR (400MHz, CD 3 OD): δ 7.10(t,1H), 6.73-6.64(m,2H), 6.61-6.55(m,1H), 5.14-5.03(m, 1H), 4.57-4.43(m,2H), 4.38(q,1H), 3.21-3.11(m,2H), 2.61-2.37(m,3H), 2.35-2.13(m,3H), 1.94-1.71( m, 5H), 1.65-1.48 (m, 2H), 1.46-1.29 (m, 4H).
實施例66:(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(1-甲基吡唑基-4-基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物72)Example 66: (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl ]-2-[(2 R )-3-cyclopropyl-2-[(1-methylpyrazolyl-4-yl)amino]propionyl]-5,5-difluoro-2-nitrogen Heterobicyclo[2.2.2]octane-3-carboxamide (compound 72)
通過將(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺4-甲苯磺酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-2-[(2R)-2-(3-氯苯胺基)-4-甲基-戊醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(1-甲基吡唑基-4-基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:532[M+H]+;1H NMR(400MHz,CD3OD):δ 7.23(d,1H),7.16(d,1H),5.12(dd,1H),4.58(s,1H),4.47(d,1H),4.05(t,1H),3.79(s,3H),3.25-3.16(m,2H),2.60-1.19(m,14H),0.96-0.74(m,3H),0.52-0.45(m,2H),0.17-0.09(m,2H)。 By adding (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]- 5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamide 4-toluenesulfonate was coupled with an appropriate carboxylic acid to react with respect to ( 1S , 3S , 4S ) -2-[(2 R )-2-(3-chloroanilino)-4-methyl-pentyl] -N -[(1 S )-1-cyano-2-[(3 S )- 2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide was prepared in an analogous manner (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2-[( 2 R )-3-cyclopropyl-2-[(1-methylpyrazolyl-4-yl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2.2 ]octane-3-carboxamide; Observed m/z: 532[M+H] + ; 1 H NMR (400MHz, CD 3 OD): δ 7.23(d,1H), 7.16(d,1H), 5.12(dd,1H), 4.58(s,1H), 4.47(d,1H), 4.05(t,1H), 3.79(s,3H), 3.25-3.16(m,2H), 2.60-1.19(m, 14H), 0.96-0.74 (m, 3H), 0.52-0.45 (m, 2H), 0.17-0.09 (m, 2H).
實施例67:(1S,3S,4S)-2-[2-(3-氯-2-甲基-苯胺)乙醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物73)Example 67: ( 1S , 3S , 4S )-2-[2-(3-Chloro-2-methyl-aniline)acetyl] -N -[( 1S )-1-cyano- 2-[( 3S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide ( Compound 73)
通過將(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺4-甲苯磺酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-2-[(2R)-2-(3-氯苯胺基)-4-甲基-戊醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-2-[2-(3-氯-2-甲基-苯胺)乙醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:522[M+H]+;1H NMR(400MHz,CD3OD):δ 7.09-6.93(m,1H),6.79-6.65(m,1H),6.58-6.45(m,1H),5.18-5.02(m,1H),4.60-4.49(m,1H),4.38(d,1H),4.09(d,2H),3.27-3.19(m,2H),2.62(s,1H),2.52-1.40(m,16H)。 By adding (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]- 5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamide 4-toluenesulfonate was coupled with an appropriate carboxylic acid to react with respect to ( 1S , 3S , 4S ) -2-[(2 R )-2-(3-chloroanilino)-4-methyl-pentyl] -N -[(1 S )-1-cyano-2-[(3 S )- 2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide was prepared in an analogous manner (1 S ,3 S ,4 S )-2-[2-(3-Chloro-2-methyl-aniline)acetyl] -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide; observed m/z: 522[M+H] + ; 1 H NMR (400MHz, CD 3 OD): δ 7.09-6.93 (m, 1H), 6.79-6.65 (m, 1H), 6.58-6.45 (m, 1H), 5.18-5.02 (m,1H), 4.60-4.49(m,1H), 4.38(d,1H), 4.09(d,2H), 3.27-3.19(m,2H), 2.62(s,1H), 2.52-1.40(m ,16H).
實施例68:(1S,3S,4S)-2-[1-(3-氯苯胺基)環丙烷羰基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物74)Example 68: (1 S ,3 S ,4 S )-2-[1-(3-Chloroanilino)cyclopropanecarbonyl] -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide (compound 74)
通過將(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺4-甲苯磺酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-2-[(2R)-2-(3-氯苯胺基)-4-甲基-戊醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-2-[1-(3-氯苯胺基)環丙烷羰基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:534[M+H]+;1H NMR(400MHz,CD3OD):δ 7.04(t,1H),6.72(t,1H),6.63-6.59(m,2H),5.08(dd,1H),4.89-4.83(m,1H),4.39-4.34(m,1H),3.35-3.34(m,2H),3.30-3.25(m,1H),2.59-2.37(m,3H),2.27-1.98(m,3H),1.93-1.67(m,6H),1.59-1.26(m,3H),1.09-0.99(m,1H),0.85-0.75(m,1H)。 By adding (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]- 5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamide 4-toluenesulfonate was coupled with an appropriate carboxylic acid to react with respect to ( 1S , 3S , 4S ) -2-[(2 R )-2-(3-chloroanilino)-4-methyl-pentyl] -N -[(1 S )-1-cyano-2-[(3 S )- 2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide was prepared in an analogous manner (1 S ,3 S ,4 S )-2-[1-(3-chloroanilino)cyclopropanecarbonyl] -N -[(1 S )-1-cyano-2-[(3 S )-2-side Oxy-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide; observed m/z: 534 [M+H ] + ; 1 H NMR (400MHz, CD 3 OD): δ 7.04(t,1H), 6.72(t,1H), 6.63-6.59(m,2H), 5.08(dd,1H), 4.89-4.83(m ,1H), 4.39-4.34(m,1H), 3.35-3.34(m,2H), 3.30-3.25(m,1H), 2.59-2.37(m,3H), 2.27-1.98(m,3H), 1.93 -1.67(m,6H), 1.59-1.26(m,3H), 1.09-0.99(m,1H), 0.85-0.75(m,1H).
實施例69:(3S)-N-[1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物75)Example 69: (3 S ) -N- [1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2-[(2 R )-2 -(2,5-difluoroaniline)propionyl]-2-azabicyclo[2.2.2]octane-3-carboxamide (compound 75)
通過將(S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺4-甲苯磺酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-2-[(2R)-2-(3-氯苯胺基)-4-甲基-戊醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(3S)-N-[1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:488[M+H]+;1H NMR(400MHz,CD3OD):δ 7.04-6.78(m,1H),6.64-6.43(m,1H),6.38-6.18(m,1H),5.17-4.98(m,1H),4.84-3.92(m,3H),3.25-3.08(m, 1H),2.63-0.65(m,20H)。 By adding ( S ) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-2-azabicyclo[2.2.2] Octane-3-formamide 4-toluenesulfonate was coupled with an appropriate carboxylic acid to react with respect to (1 S ,3 S ,4 S )-2-[(2 R )-2-(3-chloroanilino )-4-methyl-pentyl] -N -[( 1S )-1-cyano-2-[( 3S )-2-oxo-3-piperidinyl]ethyl]-5 , 5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide to prepare (3 S ) -N- [1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2-[(2 R )-2-(2,5-difluoroaniline)propionyl]-2-azabicyclo[2.2. 2] Octane-3-carboxamide; Observed m/z: 488[M+H]+; 1 H NMR (400MHz, CD 3 OD): δ 7.04-6.78(m, 1H), 6.64-6.43( m, 1H), 6.38-6.18(m, 1H), 5.17-4.98(m, 1H), 4.84-3.92(m, 3H), 3.25-3.08(m, 1H), 2.63-0.65(m, 20H).
實施例70:(3S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物76)Example 70: (3 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2-[( 2 S )-2-(2,5-difluoroaniline)propionyl]-2-azabicyclo[2.2.2]octane-3-carboxamide (compound 76)
通過將(S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺4-甲苯磺酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-2-[(2R)-2-(3-氯苯胺基)-4-甲基-戊醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(3S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:488[M+H]+;1H NMR(400MHz,CD3OD):δ 7.00-6.85(m,1H),6.62-6.40(m,1H),6.36-6.21(m,1H),5.15-4.96(m,1H),4.62-4.42(m,1H),4.31-3.99(m,2H),3.29-3.23(m,1H),2.61-0.85(m,20H)。 By adding ( S ) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-2-azabicyclo[2.2.2] Octane-3-formamide 4-toluenesulfonate was coupled with an appropriate carboxylic acid to react with respect to (1 S ,3 S ,4 S )-2-[(2 R )-2-(3-chloroanilino )-4-methyl-pentyl] -N -[( 1S )-1-cyano-2-[( 3S )-2-oxo-3-piperidinyl]ethyl]-5 , 5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide to prepare (3 S ) -N -[(1 S )-1-cyano-2 -[(3 S )-2-oxo-3-piperidinyl]ethyl]-2-[(2 S )-2-(2,5-difluoroaniline)propionyl]-2-nitrogen Heterobicyclo[2.2.2]octane-3-carboxamide; observed m/z: 488[M+H] + ; 1 H NMR (400MHz, CD 3 OD): δ 7.00-6.85 (m, 1H) , 6.62-6.40(m,1H), 6.36-6.21(m,1H), 5.15-4.96(m,1H), 4.62-4.42(m,1H), 4.31-3.99(m,2H), 3.29-3.23( m, 1H), 2.61-0.85 (m, 20H).
實施例71:(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(單一非對映異構物I)(化合物77和78)Example 71: (1 S ,3 S ,4 S ) -N -((S)-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5 , 5-difluoro-2-(2-hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide (single diastereoisomer I)( Compounds 77 and 78)
通過將(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺4-甲苯磺酸 鹽與適當的羧酸偶合以與關於(1S,3S,4S)-2-[(2R)-2-(3-氯苯胺基)-4-甲基-戊醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(非對映異構物的混合物)。通過在CHIRALCEL IC柱上使用MeOH/CH3CN進行手性SFC(1:1等度,25%流動相)來分離非對映異構物。 By adding (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]- 5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamide 4-toluenesulfonate was coupled with an appropriate carboxylic acid to react with respect to ( 1S , 3S , 4S ) -2-[(2 R )-2-(3-chloroanilino)-4-methyl-pentyl] -N -[(1 S )-1-cyano-2-[(3 S )- 2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide was prepared in an analogous manner (1 S ,3 S ,4 S ) -N -((S)-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro- 2-(2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide (mixture of diastereoisomers). The diastereoisomers were separated by chiral SFC on a CHIRALCEL IC column using MeOH/ CH3CN (1:1 isocratic, 25% mobile phase).
次要非對映異構物(化合物77):(單一非對映異構物I,較快洗脫的非對映異構物):(1mg,產率3%,觀察到m/z:475[M+H]+);1H NMR(400MHz,CD3OD):δ 1H NMR(400MHz,CD3OD):δ 7.41(s,5H),5.50(d,1H),5.06-4.98(m,1H),4.45(s,1H),4.19(s,1H),2.54(d,2H),2.27(m,1H),2.10-1.96(m,3H),1.95-1.79(m,2H),1.77-1.50(m,6H),1.30(d,2H)。 Minor diastereomer (compound 77) : (single diastereomer I, faster eluting diastereomer): (1 mg, 3% yield, observed m/z: 475[M+H] + ); 1 H NMR (400MHz, CD 3 OD): δ 1 H NMR (400MHz, CD 3 OD): δ 7.41(s,5H), 5.50(d,1H), 5.06-4.98 (m,1H), 4.45(s,1H), 4.19(s,1H), 2.54(d,2H), 2.27(m,1H), 2.10-1.96(m,3H), 1.95-1.79(m,2H ), 1.77-1.50(m,6H), 1.30(d,2H).
次要非對映異構物(化合物78):(單一非對映異構物II,較慢洗脫的非對映異構物):(2.4mg,產率7%,觀察到m/z:475[M+H]+);1H NMR(400MHz,CD3OD):δ 7.56-7.23(m,5H),5.41(s,1H),5.13(dd,1H),4.45(s,1H),4.19(s,1H),3.28-3.24(m,1H),2.62-2.32(m,3H),2.14-2.04(m,1H),2.02-1.63(m,7H),1.56(d,2H),1.39-1.04(m,2H)。 Minor diastereomer (compound 78) : (single diastereomer II, slower eluting diastereomer): (2.4 mg, 7% yield, observed m/z : 475[M+H] + ); 1 H NMR (400MHz, CD 3 OD): δ 7.56-7.23 (m, 5H), 5.41 (s, 1H), 5.13 (dd, 1H), 4.45 (s, 1H ), 4.19(s,1H), 3.28-3.24(m,1H), 2.62-2.32(m,3H), 2.14-2.04(m,1H), 2.02-1.63(m,7H), 1.56(d,2H ), 1.39-1.04(m,2H).
實施例72:(1S,3S,4S)-2-[(2R)-2-(3-氯苯胺基)-4-甲基-戊醯基]-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物79)Example 72: (1 S ,3 S ,4 S )-2-[(2 R )-2-(3-chloroanilino)-4-methyl-pentyl] -N -[(1 S ) -1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3- Formamide (compound 79)
步驟(1):(1S,3S,4S)-3-[[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙Step (1): (1S,3S,4S)-3-[[(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl 基]胺甲醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-2-羧酸第三丁酯Base]carbamoyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-2-carboxylic acid tert-butyl ester
向(1S,3S,4S)-3-[[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]胺甲醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-2-羧酸第三丁酯(134mg,0.3mmol)在無水CH2Cl2(3mL)中的溶液加入Burgess試劑(144mg,0.6mmol)。將反應混合物在室溫下攪拌2小時。向反應混合物加入飽和碳酸氫鈉水溶液(8mL)和水性鹽水溶液(8mL)。用EtOAc(3×15mL)萃取水相並將合併後的有機相經無水硫酸鈉乾燥,過濾,並在真空下濃縮。通過正相SiO2管柱層析法(5-10% MeOH/CH2Cl2)純化粗殘餘物,得到(1S,3S,4S)-3-[[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]胺甲醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-2-羧酸第三丁酯,為白色固體(94mg,產率73%,觀察到m/z:427[M+H]+)。 To (1S,3S,4S)-3-[[(1S)-2-amino-2-oxo-1-[[(3S)-2-oxopyrrolidin-3-yl]methyl] Ethyl]carbamoyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-2-carboxylic acid tert-butyl ester (134 mg, 0.3 mmol) in anhydrous CH 2 Cl 2 ( 3 mL) was added Burgess reagent (144 mg, 0.6 mmol). The reaction mixture was stirred at room temperature for 2 hours. To the reaction mixture were added saturated aqueous sodium bicarbonate solution (8 mL) and aqueous brine solution (8 mL). The aqueous phase was extracted with EtOAc (3 x 15 mL) and the combined organic phases were dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. The crude residue was purified by normal phase SiO2 column chromatography (5-10% MeOH/ CH2Cl2 ) to afford (1S,3S,4S)-3-[[(1S)-1-cyano- 2 -[(3S)-2-Oxopyrrolidin-3-yl]ethyl]aminoformyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-2-carboxylic acid Tert-butyl ester, as a white solid (94 mg, 73% yield, observed m/z: 427 [M+H] + ).
步驟(2):(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺4-甲苯磺酸鹽Step (2): (1S,3S,4S)-N-[(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl]-5,5 -Difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide 4-toluenesulfonate
向(1S,3S,4S)-3-[[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]胺甲醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-2-羧酸第三丁酯(37mg,0.09mmol)在EtOH(1mL)中的溶液加入對甲苯磺酸一水化物(18mg,0.1mmol)。將反應混合物在90℃下攪拌1小時,並在真空中濃縮,得到(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3- 基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺4-甲苯磺酸鹽,為無色油(43mg,產率99%,觀察到m/z:327[M+H]+),其無需進一步純化即可用於下一步。 To (1S,3S,4S)-3-[[(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl]carbamoyl]-5 , A solution of tert-butyl 5-difluoro-2-azabicyclo[2.2.2]octane-2-carboxylate (37 mg, 0.09 mmol) in EtOH (1 mL) was added p-toluenesulfonic acid monohydrate ( 18 mg, 0.1 mmol). The reaction mixture was stirred at 90 °C for 1 h and concentrated in vacuo to give ( 1S , 3S , 4S ) -N -[( 1S )-1-cyano-2-[( 3S )- 2-oxopyrrolidin-3-yl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide 4-toluenesulfonate, colorless oil (43 mg, 99% yield, observed m/z: 327 [M+H] + ), which was used in the next step without further purification.
步驟(3):(1S,3S,4S)-2-[(2R)-2-(3-氯苯胺基)-4-甲基-戊醯基]-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺Step (3): (1S,3S,4S)-2-[(2R)-2-(3-Chloroanilino)-4-methyl-pentyl]-N-[(1S)-1-cyano Base-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide
向(2R)-2-(3-氯苯胺基)-4-甲基-戊酸(21mg,0.09mmol)和(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺4-甲苯磺酸鹽(43mg,0.09mmol)在DMF(0.5mL)中的溶液加入DIPEA(60μL,0.35mmol)。將混合物冷卻至0℃並逐滴加入HATU(39mg,0.1mmol)在DMF(0.5mL)中的溶液。將反應混合物升溫至室溫並在室溫下攪拌30min。過濾混合物並通過反相製備型HPLC純化,得到(1S,3S,4S)-2-[(2R)-2-(3-氯苯胺基)-4-甲基-戊醯基]-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺,為白色固體(16mg,產率34%,觀察到m/z:550[M+H]+);1H NMR(400MHz,CD3OD):δ 7.16-6.99(m,1H),6.70-6.42(m,3H),5.13-4.96(m,1H),4.60(s,1H),4.48-4.36(m,1H),4.30-4.16(m,1H),3.18-2.94(m,2H),2.72-2.47(m,2H),2.40-1.45(m,13H),1.11-0.89(m,6H)。 To (2 R )-2-(3-chloroanilino)-4-methyl-pentanoic acid (21 mg, 0.09 mmol) and (1 S ,3 S ,4 S ) -N -[(1 S )-1 -cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl A solution of amide 4-tosylate (43 mg, 0.09 mmol) in DMF (0.5 mL) was added DIPEA (60 μL, 0.35 mmol). The mixture was cooled to 0 °C and a solution of HATU (39 mg, 0.1 mmol) in DMF (0.5 mL) was added dropwise. The reaction mixture was warmed to room temperature and stirred at room temperature for 30 min. The mixture was filtered and purified by reverse phase preparative HPLC to give ( 1S , 3S , 4S )-2-[( 2R )-2-(3-chloroanilino)-4-methyl-pentyl] - N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-5,5-difluoro-2-azabicyclo[ 2.2.2] Octane-3-carboxamide as a white solid (16 mg, 34% yield, observed m/z: 550 [M+H] + ); 1 H NMR (400 MHz, CD 3 OD): δ 7.16-6.99(m,1H), 6.70-6.42(m,3H), 5.13-4.96(m,1H), 4.60(s,1H), 4.48-4.36(m,1H), 4.30-4.16(m, 1H), 3.18-2.94 (m, 2H), 2.72-2.47 (m, 2H), 2.40-1.45 (m, 13H), 1.11-0.89 (m, 6H).
實施例73:(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丙基-2-[(5-甲基-3-吡啶基)胺基]丙醯基]-5,5-二氟Example 73: (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl] -2-[(2 R )-3-cyclopropyl-2-[(5-methyl-3-pyridyl)amino]propionyl]-5,5-difluoro -2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物80)-2-Azabicyclo[2.2.2]octane-3-formamide (Compound 80)
通過將(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺4-甲苯磺酸鹽和適當的羧酸偶合以與關於(1S,3S,4S)-2-[(2R)-2-(3-氯苯胺基)-4-甲基-戊醯基]-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丙基-2-[(5-甲基-3-吡啶基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:529[M+H]+;1H NMR(400MHz,CD3OD):δ 7.80(d,1H),7.64(d,1H),7.00-6.87(m,1H),5.05-4.98(m,1H),4.61(s,1H),4.53-4.42(m,2H),3.10-2.99(m,1H),2.96-2.84(m,1H),2.66-2.52(m,2H),2.41-2.21(m,7H),1.95-1.49(m,7H),1.34-1.21(m,1H),0.97-0.84(m,1H),0.57-0.48(m,2H),0.25-0.12(m,2H)。 By adding (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-5 , 5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide 4-toluenesulfonate and appropriate carboxylic acid coupling with respect to (1 S ,3 S ,4 S )- 2-[(2 R )-2-(3-chloroanilino)-4-methyl-pentyl] -N -[(1 S )-1-cyano-2-[(3 S )-2 -Oxopyrrolidin-3-yl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide was prepared in an analogous manner ( 1S , 3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[(2 R ) -3-Cyclopropyl-2-[(5-methyl-3-pyridyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3 - Formamide; Observed m/z: 529[M+H] + ; 1 H NMR (400MHz, CD 3 OD): δ 7.80(d,1H), 7.64(d,1H), 7.00-6.87(m ,1H), 5.05-4.98(m,1H), 4.61(s,1H), 4.53-4.42(m,2H), 3.10-2.99(m,1H), 2.96-2.84(m,1H), 2.66-2.52 (m,2H), 2.41-2.21(m,7H), 1.95-1.49(m,7H), 1.34-1.21(m,1H), 0.97-0.84(m,1H), 0.57-0.48(m,2H) , 0.25-0.12 (m, 2H).
實施例74:(1S,3S,4S)-5,5-二氟-N-[(E,1S)-3-氟-3-甲基磺醯基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]烯丙基]-2-(9-羥基茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物81)Example 74: (1 S ,3 S ,4 S )-5,5-difluoro- N -[( E ,1 S )-3-fluoro-3-methylsulfonyl-1-[[(3 S )-2-oxopyrrolidin-3-yl]methyl]allyl]-2-(9-hydroxyl-9-carbonyl)-2-azabicyclo[2.2.2]octane-3- Formamide (Compound 81)
步驟(1):N-[(1S)-1-(羥甲基)-2-[(3S)-2-氧代吡咯啶-3-基]乙基]胺基甲酸第三丁酯Step (1): tertiary butyl N-[(1S)-1-(hydroxymethyl)-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl]carbamate
在3小時內向(2S)-2-(第三丁氧基羰基胺基)-3-[(3S)-2-氧代吡咯啶-3-基]丙酸甲酯(3.8g,13.4mmol)在MeOH(200mL)中的溶液分批加入四氫化硼鈉(8.1g,215mmol)。將反應混合物在室溫下攪拌16小時。向該混合物加入H2O(150mL)並將其在真空中濃縮以除去MeOH。然後用EtOAc(3×200mL)萃取水相。將合併後的有機相經無水硫酸鈉乾燥,過濾,並在真空下濃縮。將粗殘餘物用Et2O(30mL)研磨並過濾,以得到N-[(1S)-1-(羥甲基)-2-[(3S)-2-氧代吡咯啶-3-基]乙基]胺基甲酸第三丁酯,為白色固體(3.3g,產率95%,觀察到m/z:259[M+H]+)。 To (2S)-2-(tert-butoxycarbonylamino)-3-[(3S)-2-oxopyrrolidin-3-yl]propanoic acid methyl ester (3.8 g, 13.4 mmol) within 3 hours Sodium borohydride (8.1 g, 215 mmol) was added portionwise to a solution in MeOH (200 mL). The reaction mixture was stirred at room temperature for 16 hours. To the mixture was added H2O (150 mL) and it was concentrated in vacuo to remove MeOH. The aqueous phase was then extracted with EtOAc (3 x 200 mL). The combined organic phases were dried over anhydrous sodium sulfate, filtered and concentrated under vacuum. The crude residue was triturated with Et2O (30 mL) and filtered to give N-[(1S)-1-(hydroxymethyl)-2-[(3S)-2-oxopyrrolidin-3-yl] tert-butyl ethyl]carbamate as a white solid (3.3 g, 95% yield, observed m/z: 259 [M+H] + ).
步驟(2):N-[(1S)-1-甲醯基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]胺基甲酸第三丁酯Step (2): tertiary butyl N-[(1S)-1-formyl-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl]carbamate
向N-[(1S)-1-(羥甲基)-2-[(3S)-2-氧代吡咯啶-3-基]乙基]胺基甲酸第三丁酯(3.3g,12.7mmol)在CH2Cl2(50mL)中的溶液加入Dess-Martin高碘酸鹽(8.5g,20mmol)和碳酸氫鈉(1.7g,20mmol)。將反應混合物在室溫下攪拌2小時,過濾,並在真空下濃縮。通過正相SiO2管柱層析法(0-10% MeOH/CH2Cl2)純化粗殘餘物,得到N-[(1S)-1-甲醯基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]胺基甲酸第三丁酯,為黃色固體(2.0g,產率62%,觀察到m/z:257[M+H]+)。 To tertiary butyl N-[(1S)-1-(hydroxymethyl)-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl]carbamate (3.3g, 12.7mmol ) in CH2Cl2 (50 mL ) was added Dess-Martin periodate (8.5 g, 20 mmol) and sodium bicarbonate (1.7 g, 20 mmol). The reaction mixture was stirred at room temperature for 2 hours, filtered, and concentrated under vacuum. The crude residue was purified by normal phase SiO 2 column chromatography (0-10% MeOH/CH 2 Cl 2 ) to afford N-[(1S)-1-formyl-2-[(3S)-2- tert-butyl oxopyrrolidin-3-yl]ethyl]carbamate as a yellow solid (2.0 g, 62% yield, observed m/z: 257 [M+H] + ).
步驟(3):1-[乙氧基-[氟(甲基磺醯基)甲基]磷醯基]環氧乙烷Step (3): 1-[Ethoxy-[fluoro(methylsulfonyl)methyl]phosphoryl]oxirane
在-78℃下向1-[乙氧基(甲基磺醯基甲基)磷醯基]環氧乙烷(1.0g,4.3mmol)在THF(12mL)中的溶液逐滴加入KHMDS(1.0M的THF溶液,5.4mL,5.4mmol)。將反應混合物在-78℃下攪拌45min並加入SelectfluorTM(2.3g,6.5mmol)。將混合物在-78℃下攪拌5min並加入DMF(8mL)。將反應混合物升溫至0℃,並攪拌3小時。在0℃下向該混合物加入CH2Cl2(10mL)和飽和氯化銨水溶液(10mL)。將混合物緩慢升溫至室溫,同時攪拌並在真空下濃縮以除去揮發物。用CH2Cl2(3×25mL)萃取水相。用飽和碳酸氫鈉水溶液(20mL)和水性鹽水溶液(20mL)洗滌合併後的有機相,經無水硫酸鈉乾燥,在真空中過濾並濃縮。通過正相SiO2管柱層析法(20-50% EtOAc/己烷)純化粗殘餘物,得到1-[乙氧基-[氟(甲基磺醯基)甲基]磷醯基]環氧乙烷,為無色油(504mg,產率47%,觀察到m/z:249[M+H]+)。 To a solution of 1-[ethoxy(methylsulfonylmethyl)phosphoryl]oxirane (1.0 g, 4.3 mmol) in THF (12 mL) was added KHMDS (1.0 M in THF, 5.4 mL, 5.4 mmol). The reaction mixture was stirred at -78°C for 45 min and Selectfluor ™ (2.3 g, 6.5 mmol) was added. The mixture was stirred at -78°C for 5 min and DMF (8 mL) was added. The reaction mixture was warmed to 0 °C and stirred for 3 hours. To the mixture were added CH2Cl2 (10 mL ) and saturated aqueous ammonium chloride (10 mL) at 0 °C. The mixture was slowly warmed to room temperature with stirring and concentrated in vacuo to remove volatiles. The aqueous phase was extracted with CH2Cl2 (3 x 25 mL). The combined organic phases were washed with saturated aqueous sodium bicarbonate solution (20 mL) and aqueous brine solution (20 mL), dried over anhydrous sodium sulfate, filtered and concentrated in vacuo. The crude residue was purified by normal phase SiO2 column chromatography (20-50% EtOAc/hexanes) to afford the 1-[ethoxy-[fluoro(methylsulfonyl)methyl]phosphoryl] ring Oxyethane, a colorless oil (504 mg, 47% yield, observed m/z: 249 [M+H] + ).
步驟(4):((S)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)胺基甲酸第三丁酯Step (4): ((S)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-ene-2- base) tertiary butyl carbamate
在-78℃下的溶液向1-[乙氧基-[氟(甲基磺醯基)甲基]磷醯基]環氧乙烷(496mg,2mmol)在無水THF(6mL)中逐滴加入KHMDS(1.0M的THF溶液,2.1mL,2.1mmol)。將混合物在-78℃下攪拌30min並在-78℃下分2批逐滴加入N-[(1S)-1-甲醯基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]胺基甲酸第三丁酯(769mg,3mmol)在無水THF(4mL)中的溶液。將反應混合物在-78℃下攪拌2小時,用H2O(15mL)淬滅並緩慢升溫至室溫。用EtOAc(3×20mL)萃取水相。將合併後的有機相經無水硫酸鈉乾燥,過濾,並在真空下濃縮。通過正相SiO2層 析法(50-100% EtOAc/CH2Cl2)純化粗殘餘物,得到N-[(Z,1S)-3-氟-3-甲基磺醯基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]烯丙基]胺基甲酸第三丁酯,為白色固體(較快洗脫的異構物,174mg,產率25%,觀察到m/z:351[M+H]+);和N-[(E,1S)-3-氟-3-甲基磺醯基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]烯丙基]胺基甲酸第三丁酯,為白色固體(較慢洗脫的異構物,180mg,產率26%,觀察到m/z:351[M+H]+)。 Solution at -78 °C To 1-[ethoxy-[fluoro(methylsulfonyl)methyl]phosphoryl]oxirane (496 mg, 2 mmol) in anhydrous THF (6 mL) was added dropwise KHMDS (1.0 M in THF, 2.1 mL, 2.1 mmol). The mixture was stirred at -78°C for 30min and N-[(1S)-1-formyl-2-[(3S)-2-oxopyrrolidine-3- A solution of tert-butyl]ethyl]carbamate (769 mg, 3 mmol) in anhydrous THF (4 mL). The reaction mixture was stirred at -78 °C for 2 h, quenched with H2O (15 mL) and slowly warmed to room temperature. The aqueous phase was extracted with EtOAc (3 x 20 mL). The combined organic phases were dried over anhydrous sodium sulfate, filtered and concentrated under vacuum. The crude residue was purified by normal phase SiO 2 chromatography (50-100% EtOAc/CH 2 Cl 2 ) to afford N-[(Z,1S)-3-fluoro-3-methylsulfonyl-1-[ Tertiary butyl [(3S)-2-oxopyrrolidin-3-yl]methyl]allyl]carbamate as a white solid (faster eluting isomer, 174 mg, 25% yield , observed m/z: 351 [M+H] + ); and N-[(E,1S)-3-fluoro-3-methylsulfonyl-1-[[(3S)-2-oxo tertiary butyl pyrrolidin-3-yl]methyl]allyl]carbamate as a white solid (slower eluting isomer, 180 mg, 26% yield, observed m/z: 351 [ M+H] + ).
步驟(5):(3S)-3-[(E,2S)-2-胺基-4-氟-4-甲基磺醯基-丁-3-烯基]吡咯啶-2-酮Step (5): (3S)-3-[(E,2S)-2-Amino-4-fluoro-4-methylsulfonyl-but-3-enyl]pyrrolidin-2-one
向N-[(E,1S)-3-氟-3-甲基磺醯基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]烯丙基]胺基甲酸第三丁酯(174mg,0.5mmol)在CH2Cl2(1mL)中的溶液加入鹽酸(4M的1,4-二烷溶液,2mL)。將反應混合物在室溫下攪拌30min並在真空下濃縮。將粗殘餘物用Et2O(5mL)研磨並過濾,得到(3S)-3-[(E,2S)-2-胺基-4-氟-4-甲基磺醯基-丁-3-烯基]吡咯啶-2-酮的鹽酸鹽,為白色固體(108mg,產率76%,觀察到m/z:251[M+H]+)。 To N-[(E,1S)-3-fluoro-3-methylsulfonyl-1-[[(3S)-2-oxopyrrolidin-3-yl]methyl]allyl]amino To a solution of tert-butyl formate (174 mg, 0.5 mmol) in CH 2 Cl 2 (1 mL) was added hydrochloric acid (4M in 1,4-di alkane solution, 2 mL). The reaction mixture was stirred at room temperature for 30 min and concentrated under vacuum. The crude residue was triturated with Et2O (5 mL) and filtered to give ( 3S )-3-[( E , 2S )-2-amino-4-fluoro-4-methylsulfonyl-butan- Hydrochloride salt of 3-enyl]pyrrolidin-2-one as a white solid (108 mg, 76% yield, observed m/z: 251 [M+H] + ).
步驟(6):(1S,3S,4S)-5,5-二氟-3-[[(E,1S)-3-氟-3-甲基磺醯基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]烯丙基]胺甲醯基]-2-氮雜雙環[2.2.2]辛烷-2-羧酸第三丁酯Step (6): (1S,3S,4S)-5,5-Difluoro-3-[[(E,1S)-3-fluoro-3-methylsulfonyl-1-[[(3S)- 2-Oxopyrrolidin-3-yl]methyl]allyl]carbamoyl]-2-azabicyclo[2.2.2]octane-2-carboxylic acid tert-butyl ester
向(1S,3S,4S)-2-第三丁氧基羰基-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-羧酸(51mg,0.17mmol)和(3S)-3-[(E,2S)-2-胺基-4-氟-4-甲基磺醯基-丁-3-烯基]吡咯啶-2-酮鹽酸鹽(50mg,0.17mmol)在CH2Cl2(2mL)中的溶液加入2-吡啶酚1-氧化物(39mg,0.35mmol)、EDC.HCl(43mg,0.23mmol)和DIPEA(122μL,0.7mmol)。將反應混合物在室溫下攪拌2小時。用CH2Cl2(30mL)稀釋混合物,用0.5N水性鹽酸(10mL)和水性鹽水溶液(10mL)洗滌。將有機相經無水硫酸鈉乾燥,過濾,並在真空下濃縮。通過正相SiO2管柱層析法(0-4% MeOH/CH2Cl2)純化粗殘餘物,得到(1S,3S,4S)-5,5-二氟-3-[[(E,1S)-3-氟-3-甲基磺醯基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]烯丙基]胺甲醯基]-2-氮雜雙環[2.2.2]辛烷-2-羧酸第三丁酯,為淺白色固體(32mg,產率35%,觀察到m/z:524[M+H]+)。 To (1 S ,3 S ,4 S )-2-tert-butoxycarbonyl-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxylic acid (51mg, 0.17mmol ) and ( 3S )-3-[( E , 2S )-2-amino-4-fluoro-4-methylsulfonyl-but-3-enyl]pyrrolidin-2-one hydrochloride (50 mg, 0.17 mmol) in CH 2 Cl 2 (2 mL) was added 2-pyridinol 1-oxide (39 mg, 0.35 mmol), EDC.HCl (43 mg, 0.23 mmol) and DIPEA (122 μL, 0.7 mmol) . The reaction mixture was stirred at room temperature for 2 hours. The mixture was diluted with CH2Cl2 (30 mL), washed with 0.5N aqueous hydrochloric acid (10 mL) and aqueous brine solution (10 mL ). The organic phase was dried over anhydrous sodium sulfate, filtered and concentrated under vacuum. The crude residue was purified by normal phase SiO 2 column chromatography (0-4% MeOH/CH 2 Cl 2 ) to afford (1S,3S,4S)-5,5-difluoro-3-[[(E, 1S)-3-fluoro-3-methylsulfonyl-1-[[(3S)-2-oxopyrrolidin-3-yl]methyl]allyl]carbamoyl]-2-nitrogen Tert-butyl heterobicyclo[2.2.2]octane-2-carboxylate as off-white solid (32 mg, 35% yield, observed m/z: 524 [M+H] + ).
步驟(7):(1S,3S,4S)-5,5-二氟-N-[(E,1S)-3-氟-3-甲基磺醯基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]烯丙基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺Step (7): (1S,3S,4S)-5,5-Difluoro-N-[(E,1S)-3-fluoro-3-methylsulfonyl-1-[[(3S)-2 -Oxopyrrolidin-3-yl]methyl]allyl]-2-azabicyclo[2.2.2]octane-3-carboxamide
向(1S,3S,4S)-5,5-二氟-3-[[(E,1S)-3-氟-3-甲基磺醯基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]烯丙基]胺甲醯基]-2-氮雜雙環[2.2.2]辛烷-2-羧酸第三丁酯(32mg,0.06mmol)在CH2Cl2(1mL)中的溶液加入鹽酸(4M的1,4-二烷溶液,2mL)。將反應混合物在室溫下攪拌1小時,並在真空中濃縮。將粗殘餘物用Et2O(5mL)研磨並過濾,得到(1S,3S,4S)-5,5-二氟-N-[(E,1S)-3-氟-3-甲基磺醯基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]烯丙基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺的鹽酸鹽,為白色固體(定量獲得30mg,觀察到m/z:424[M+H]+),其 無需進一步純化即可用於下一步。 To (1S,3S,4S)-5,5-difluoro-3-[[(E,1S)-3-fluoro-3-methylsulfonyl-1-[[(3S)-2-oxo Pyrrolidin-3-yl]methyl]allyl]carbamoyl]-2-azabicyclo[2.2.2]octane-2-carboxylic acid tert-butyl ester (32mg, 0.06mmol) in CH2 A solution in Cl 2 (1 mL) was added with hydrochloric acid (4M 1,4-di alkane solution, 2 mL). The reaction mixture was stirred at room temperature for 1 hour and concentrated in vacuo. The crude residue was triturated with Et2O (5 mL) and filtered to give ( 1S , 3S , 4S )-5,5-difluoro- N -[( E , 1S )-3-fluoro-3- Methylsulfonyl-1-[[(3 S )-2-oxopyrrolidin-3-yl]methyl]allyl]-2-azabicyclo[2.2.2]octane-3-methyl The hydrochloride salt of the amide, a white solid (30 mg obtained quantitatively, observed m/z: 424 [M+H] + ), was used in the next step without further purification.
步驟(8):(1S,3S,4S)-5,5-二氟-N-[(E,1S)-3-氟-3-甲基磺醯基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]烯丙基]-2-(9-羥基茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺Step (8): (1S,3S,4S)-5,5-Difluoro-N-[(E,1S)-3-fluoro-3-methylsulfonyl-1-[[(3S)-2 -Oxopyrrolidin-3-yl]methyl]allyl]-2-(9-hydroxyl-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formamide
向(1S,3S,4S)-5,5-二氟-N-[(E,1S)-3-氟-3-甲基磺醯基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]烯丙基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽(15mg,0.03mmol)和9-羥基茀-9-羧酸(7.4mg,0.03mmol)在DMF(0.5mL)中的溶液加入DIPEA(23μL,0.13mmol)和HATU(19mg,0.05mmol)。將反應混合物在室溫下攪拌15min,過濾並通過反相HPLC純化,得到(1S,3S,4S)-5,5-二氟-N-[(E,1S)-3-氟-3-甲基磺醯基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]烯丙基]-2-(9-羥基茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺,為無色膜(3.9mg,產率19%,觀察到m/z:632[M+H]+),1H NMR(400MHz,CD3OD):δ 7.87-7.77(m,2H),7.58-7.44(m,3H),7.44-7.35(m,3H),6.16(dd,1H),5.03-4.95(m,1H),4.54(d,1H),3.47-3.37(m,2H),3.19(d,1H),3.11(s,3H),2.82(m,1H),2.59-2.49(m,1H),2.41(s,1H),2.22(m,1H),1.93-1.83(m,1H),1.65(m,1H),1.51(t,2H),1.46-1.37(m,1H),1.34-1.17(m,2H),0.92(s,1H)。 To (1 S ,3 S ,4 S )-5,5-difluoro- N -[( E ,1 S )-3-fluoro-3-methylsulfonyl-1-[[(3 S )- 2-oxopyrrolidin-3-yl]methyl]allyl]-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride (15mg, 0.03mmol) and 9-hydroxy To a solution of terpene-9-carboxylic acid (7.4 mg, 0.03 mmol) in DMF (0.5 mL) was added DIPEA (23 μL, 0.13 mmol) and HATU (19 mg, 0.05 mmol). The reaction mixture was stirred at room temperature for 15 min, filtered and purified by reverse phase HPLC to afford ( 1S , 3S , 4S )-5,5-difluoro- N -[( E , 1S )-3-fluoro -3-Methylsulfonyl-1-[[(3 S )-2-oxopyrrolidin-3-yl]methyl]allyl]-2-(9-hydroxyl-9-carbonyl)- 2-Azabicyclo[2.2.2]octane-3-carboxamide as a colorless film (3.9 mg, 19% yield, observed m/z: 632 [M+H] + ), 1 H NMR ( 400MHz, CD 3 OD): δ 7.87-7.77(m,2H), 7.58-7.44(m,3H), 7.44-7.35(m,3H), 6.16(dd,1H), 5.03-4.95(m,1H) , 4.54(d,1H), 3.47-3.37(m,2H), 3.19(d,1H), 3.11(s,3H), 2.82(m,1H), 2.59-2.49(m,1H), 2.41(s ,1H), 2.22(m,1H), 1.93-1.83(m,1H), 1.65(m,1H), 1.51(t,2H), 1.46-1.37(m,1H), 1.34-1.17(m,2H ), 0.92(s,1H).
實施例75:(3S,3aS,6aR)-N-[(E,1S)-3-氟-3-甲基磺醯基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]烯丙基]-2-(9-羥基茀-9-羰基)-3,3a,4,5,6,6a-六氫-1H-環戊二烯并[c]吡咯-3-甲醯胺(化合物82)Example 75: (3 S ,3a S ,6a R ) -N -[( E ,1 S )-3-fluoro-3-methylsulfonyl-1-[[(3 S )-2-oxo Pyrrolidin-3-yl]methyl]allyl]-2-(9-hydroxyl-9-carbonyl)-3,3a,4,5,6,6a-hexahydro-1H-cyclopentadiene [c] Pyrrole-3-carboxamide (compound 82)
通過將(3S)-3-[(E,2S)-2-胺基-4-氟-4-甲基磺醯基-丁-3-烯基]吡咯啶-2-酮鹽酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-5,5-二氟-N-[(E,1S)-3-氟-3-甲基磺醯基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]烯丙基]-2-(9-羥基茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(3S,3aS,6aR)-N-[(E,1S)-3-氟-3-甲基磺醯基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]烯丙基]-2-(9-羥基茀-9-羰基)-3,3a,4,5,6,6a-六氫-1H-環戊二烯并[c]吡咯-3-甲醯胺,為白色固體;觀察到m/z:596[M+H]+;1H NMR(400MHz,CD3OD):δ 8.63(d,1H),7.82-7.75(m,2H),7.52-7.42(m,2H),7.42-7.31(m,2H),6.13(dd,1H),4.99-4.92(m,1H),4.20(d,1H),3.64(d,1H),3.45-3.36(m,2H),3.11(s,3H),2.87-2.74(m,1H),2.68-2.59(m,1H),2.55-2.16(m,5H),1.94-1.82(m,1H),1.84-1.72(m,1H),1.68-1.36(m,4H),0.94-0.86(m,1H),0.69-0.56(m,1H)。 By adding ( 3S )-3-[( E , 2S )-2-amino-4-fluoro-4-methylsulfonyl-but-3-enyl]pyrrolidin-2-one hydrochloride Coupling with an appropriate carboxylic acid to react with ( 1S , 3S , 4S )-5,5-difluoro- N -[( E , 1S )-3-fluoro-3-methylsulfonyl-1 -[[(3 S )-2-oxopyrrolidin-3-yl]methyl]allyl]-2-(9-hydroxyl-9-carbonyl)-2-azabicyclo[2.2.2] (3 S ,3a S ,6a R ) -N -[( E ,1 S )-3-fluoro-3-methylsulfonyl-1- [[(3 S )-2-oxopyrrolidin-3-yl]methyl]allyl]-2-(9-hydroxyl-9-carbonyl)-3,3a,4,5,6,6a - Hexahydro-1H-cyclopenta[c]pyrrole-3-carboxamide as a white solid; observed m/z: 596[M+H] + ; 1 H NMR (400MHz, CD 3 OD) : δ 8.63(d,1H), 7.82-7.75(m,2H), 7.52-7.42(m,2H), 7.42-7.31(m,2H), 6.13(dd,1H), 4.99-4.92(m,1H ), 4.20(d,1H), 3.64(d,1H), 3.45-3.36(m,2H), 3.11(s,3H), 2.87-2.74(m,1H), 2.68-2.59(m,1H), 2.55-2.16(m,5H), 1.94-1.82(m,1H), 1.84-1.72(m,1H), 1.68-1.36(m,4H), 0.94-0.86(m,1H), 0.69-0.56(m ,1H).
實施例76:(3S,3aS,6aR)-2-[(2R)-2-乙醯胺基-2-苯基-乙醯基]-N-[(E,1S)-3-氟-3-甲基磺醯基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]烯丙基]-3,3a,4,5,6,6a-六氫-1H-環戊二烯并[c]吡咯-3-甲醯胺(化合物83)Example 76: (3 S ,3a S ,6a R )-2-[(2 R )-2-Acetamido-2-phenyl-acetyl] -N -[( E ,1 S )- 3-Fluoro-3-methylsulfonyl-1-[[(3 S )-2-oxopyrrolidin-3-yl]methyl]allyl]-3,3a,4,5,6, 6a-hexahydro-1H-cyclopentadieno[c]pyrrole-3-carboxamide (compound 83)
通過將(3S)-3-[(E,2S)-2-胺基-4-氟-4-甲基磺醯基-丁-3-烯基]吡咯啶-2-酮鹽酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-5,5-二氟-N-[(E,1S)-3-氟-3-甲基磺醯基-1-[[(3S)-2-氧代吡咯啶-3-基]甲 基]烯丙基]-2-(9-羥基茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(3S,3aS,6aR)-2-[(2R)-2-乙醯胺基-2-苯基-乙醯基]-N-[(E,1S)-3-氟-3-甲基磺醯基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]烯丙基]-3,3a,4,5,6,6a-六氫-1H-環戊二烯并[c]吡咯-3-甲醯胺,為白色固體;觀察到m/z:563[M+H]+;1H NMR(400MHz,CD3OD):δ 8.59(d,1H),8.35(d,1H),8.12(s,1H),7.48-7.31(m,3H),6.21(dd,1H),5.68-5.56(m,1H),4.19(d,1H),3.98(m,1H),3.38-3.32(m,2H),3.26-3.06(m,4H),2.78-2.52(m,3H),2.46-2.34(m,1H),2.31-2.20(m,1H),1.99(s,3H),1.96-1.77(m,2H),1.72-1.54(m,2H),1.53-1.35(m,3H),1.04-0.87(m,1H)。 By adding ( 3S )-3-[( E , 2S )-2-amino-4-fluoro-4-methylsulfonyl-but-3-enyl]pyrrolidin-2-one hydrochloride Coupling with an appropriate carboxylic acid to react with ( 1S , 3S , 4S )-5,5-difluoro- N -[( E , 1S )-3-fluoro-3-methylsulfonyl-1 -[[(3 S )-2-oxopyrrolidin-3-yl]methyl]allyl]-2-(9-hydroxyl-9-carbonyl)-2-azabicyclo[2.2.2] (3 S ,3a S ,6a R )-2-[(2 R )-2-acetamido-2-phenyl-acetyl] was prepared in a similar manner as described for octane-3-formamide - N -[( E ,1 S )-3-fluoro-3-methylsulfonyl-1-[[(3 S )-2-oxopyrrolidin-3-yl]methyl]allyl] -3,3a,4,5,6,6a-Hexahydro-1H-cyclopenta[c]pyrrole-3-carboxamide as a white solid; observed m/z: 563 [M+H] + ; 1 H NMR (400MHz, CD 3 OD): δ 8.59(d,1H), 8.35(d,1H), 8.12(s,1H), 7.48-7.31(m,3H), 6.21(dd,1H) , 5.68-5.56(m,1H), 4.19(d,1H), 3.98(m,1H), 3.38-3.32(m,2H), 3.26-3.06(m,4H), 2.78-2.52(m,3H) , 2.46-2.34(m,1H), 2.31-2.20(m,1H), 1.99(s,3H), 1.96-1.77(m,2H), 1.72-1.54(m,2H), 1.53-1.35(m, 3H), 1.04-0.87 (m, 1H).
實施例77:(3S,3aS,6aR)-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-N-[(Z,1S)-3-氟-3-甲基磺醯基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]烯丙基]-3,3a,4,5,6,6a-六氫-1H-環戊二烯并[c]吡咯-3-甲醯胺(化合物84)Example 77: ( 3S , 3aS , 6aR )-2-[( 2S )-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino] Butyl] -N -[( Z ,1 S )-3-fluoro-3-methylsulfonyl-1-[[(3 S )-2-oxopyrrolidin-3-yl]methyl]allyl Base]-3,3a,4,5,6,6a-hexahydro-1H-cyclopentadieno[c]pyrrole-3-carboxamide (compound 84)
步驟(1):(3S,3aS,6aR)-2-[(2S)-2-(第三丁氧基羰基胺基)-3,3-二甲基-丁醯基]-3,3a,4,5,6,6a-六氫-1H-環戊二烯并[c]吡咯-3-羧酸乙酯Step (1): (3S,3aS,6aR)-2-[(2S)-2-(tert-butoxycarbonylamino)-3,3-dimethyl-butyryl]-3,3a,4, 5,6,6a-Hexahydro-1H-cyclopenta[c]pyrrole-3-carboxylic acid ethyl ester
向(3S,3aS,6aR)-1,2,3,3a,4,5,6,6a-八氫環戊[c]吡咯-3-羧酸乙酯鹽酸鹽(439mg,2mmol)和(2S)-2-(第三丁氧基羰基胺基)-3,3-二甲基-丁酸(463mg,2mmol)在DMF(8mL)中的溶液加入DIPEA(1.4mL,8mmol)和HATU(1.1g,3mmol)。將反應混合物 在室溫下攪拌1小時。向反應混合物加入EtOAc(100mL)並將有機相用0.5M水性鹽酸(50mL)和水性鹽水溶液(50mL)洗滌。然後將有機相經無水硫酸鈉乾燥,過濾,並在真空下濃縮。通過正相SiO2管柱層析法(10-20% EtOAc/己烷)純化粗殘餘物,得到(3S,3aS,6aR)-2-[(2S)-2-(第三丁氧基羰基胺基)-3,3-二甲基-丁醯基]-3,3a,4,5,6,6a-六氫-1H-環戊二烯并[c]吡咯-3-羧酸乙酯,為無色油(435mg,產率55%,觀察到m/z:397[M+H]+)。 To (3S,3aS,6aR)-1,2,3,3a,4,5,6,6a-octahydrocyclopenta[c]pyrrole-3-carboxylic acid ethyl ester hydrochloride (439mg, 2mmol) and ( 2S )-2-(tert-butoxycarbonylamino)-3,3-dimethyl-butanoic acid (463 mg, 2 mmol) in DMF (8 mL) was added DIPEA (1.4 mL, 8 mmol) and HATU (1.1 g, 3 mmol). The reaction mixture was stirred at room temperature for 1 hour. EtOAc (100 mL) was added to the reaction mixture and the organic phase was washed with 0.5M aqueous hydrochloric acid (50 mL) and aqueous brine solution (50 mL). The organic phase was then dried over anhydrous sodium sulfate, filtered and concentrated under vacuum. Purification of the crude residue by normal phase SiO column chromatography (10-20% EtOAc/hexanes) afforded (3S,3aS,6aR)-2-[(2S)-2-(tert-butoxycarbonyl Amino)-3,3-dimethyl-butyryl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxylic acid ethyl ester, for Colorless oil (435 mg, 55% yield, observed m/z: 397 [M+H] + ).
步驟(2):(3S,3aS,6aR)-2-[(2S)-2-(第三丁氧基羰基胺基)-3,3-二甲基-丁醯基]-3,3a,4,5,6,6a-六氫-1H-環戊二烯并[c]吡咯-3-羧酸Step (2): (3S,3aS,6aR)-2-[(2S)-2-(tert-butoxycarbonylamino)-3,3-dimethyl-butyryl]-3,3a,4, 5,6,6a-Hexahydro-1H-cyclopenta[c]pyrrole-3-carboxylic acid
向(3S,3aS,6aR)-2-[(2S)-2-(第三丁氧基羰基胺基)-3,3-二甲基-丁醯基]-3,3a,4,5,6,6a-六氫-1H-環戊二烯并[c]吡咯-3-羧酸乙酯(435mg,1.1mmol)在1,4-二烷(2mL)中的溶液加入氫氧化鋰(53mg,2.2mmol)在H2O(4mL)中的溶液。將反應混合物在室溫下攪拌30min。向該混合物加入1M水性鹽酸(8mL)並用EtOAc(3×30mL)萃取水相。將合併後的有機相經無水硫酸鈉乾燥,過濾,並在真空下濃縮,得到(3S,3aS,6aR)-2-[(2S)-2-(第三丁氧基羰基胺基)-3,3-二甲基-丁醯基]-3,3a,4,5,6,6a-六氫-1H-環戊二烯并[c]吡咯-3-羧酸,為白色固體(定量獲得410mg,觀察到m/z:369[M+H]+),其無需進一步純化即可用於下一步。 To (3S,3aS,6aR)-2-[(2S)-2-(tertiary butoxycarbonylamino)-3,3-dimethyl-butyryl]-3,3a,4,5,6, 6a-Hexahydro-1H-cyclopentadieno[c]pyrrole-3-carboxylic acid ethyl ester (435mg, 1.1mmol) in 1,4-bis A solution in alkanes (2 mL) was added to a solution of lithium hydroxide (53 mg, 2.2 mmol) in H2O (4 mL). The reaction mixture was stirred at room temperature for 30 min. To the mixture was added 1M aqueous hydrochloric acid (8 mL) and the aqueous phase was extracted with EtOAc (3 x 30 mL). The combined organic phases were dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo to give ( 3S , 3aS , 6aR )-2-[( 2S )-2-(tert-butoxycarbonylamine base)-3,3-dimethyl-butyryl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxylic acid as a white solid ( 410 mg was obtained quantitatively, m/z observed: 369 [M+H] + ), which was used in the next step without further purification.
步驟(3):(3S,3aS,6aR)-2-[(2S)-2-胺基-3,3-二甲基-丁醯基]-3,3a,4,5,6,6a-六氫-1H-環戊二烯并[c]吡咯-3-羧酸鹽酸鹽Step (3): (3S,3aS,6aR)-2-[(2S)-2-Amino-3,3-dimethyl-butyryl]-3,3a,4,5,6,6a-hexahydro -1H-cyclopenta[c]pyrrole-3-carboxylate hydrochloride
向(3S,3aS,6aR)-2-[(2S)-2-(第三丁氧基羰基胺基)-3,3-二甲基-丁醯基]-3,3a,4,5,6,6a-六氫-1H-環戊二烯并[c]吡咯-3-羧酸(404mg,1.1mmol)在CH2Cl2(1mL)中的溶液加入4M鹽酸的1,4-二烷溶液(4mL)。將反應混合物在室溫下攪拌30min並在真空下濃縮。在Et2O(10mL)中研磨粗殘餘物並過濾,得到(3S,3aS,6aR)-2-[(2S)-2-胺基-3,3-二甲基-丁醯基]-3,3a,4,5,6,6a-六氫-1H-環戊二烯并[c]吡咯-3-羧酸的鹽酸鹽,為白色固體(235mg,產率70%,觀察到m/z:269[M+H]+)。 To (3 S ,3a S ,6a R )-2-[(2 S )-2-(tertiary butoxycarbonylamino)-3,3-dimethyl-butyryl]-3,3a,4, A solution of 5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxylic acid (404 mg, 1.1 mmol) in CH 2 Cl 2 (1 mL) was added to 1,4- two alkane solution (4 mL). The reaction mixture was stirred at room temperature for 30 min and concentrated under vacuum. The crude residue was triturated in Et2O (10 mL) and filtered to give ( 3S , 3aS , 6aR )-2-[( 2S )-2-amino-3,3-dimethyl-butyryl] - The hydrochloride salt of 3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxylic acid as a white solid (235 mg, yield 70%, observed m/z: 269[M+H] + ).
步驟(4):(3S,3aS,6aR)-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-3,3a,4,5,6,6a-六氫-1H-環戊二烯并[c]吡咯-3-羧酸Step (4): (3S,3aS,6aR)-2-[(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]- 3,3a,4,5,6,6a-Hexahydro-1H-cyclopenta[c]pyrrole-3-carboxylic acid
在0℃下向(3S,3aS,6aR)-2-[(2S)-2-胺基-3,3-二甲基-丁醯基]-3,3a,4,5,6,6a-六氫-1H-環戊二烯并[c]吡咯-3-羧酸鹽酸鹽(235mg,0.8mmol)在MeOH(2mL)中的溶液加入TEA(752μL,5.4mmol),隨後三氟乙酸乙酯(257μL,2.16mmol)。將反應混合物在室溫下攪拌2小時。向反應混合物加入1M水性鹽酸(10mL)並用EtOAc(3×25mL)萃取水相。將合併後的有機相經無水硫酸鈉乾燥,過濾,並在真空下濃縮,得到(3S,3aS,6aR)-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-3,3a,4,5,6,6a-六氫-1H-環戊二烯并[c]吡咯-3-羧酸,為白色固體(242mg,產率86%,觀察到m/z:365[M+H]+)。 To (3 S ,3a S ,6a R )-2-[(2 S )-2-amino-3,3-dimethyl-butyryl]-3,3a,4,5,6, A solution of 6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxylate hydrochloride (235 mg, 0.8 mmol) in MeOH (2 mL) was added with TEA (752 μL, 5.4 mmol), followed by trifluoro Ethyl acetate (257 μL, 2.16 mmol). The reaction mixture was stirred at room temperature for 2 hours. 1M aqueous hydrochloric acid (10 mL) was added to the reaction mixture and the aqueous phase was extracted with EtOAc (3 x 25 mL). The combined organic phases were dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo to give ( 3S , 3aS , 6aR )-2-[( 2S )-3,3-dimethyl-2- [(2,2,2-Trifluoroacetyl)amino]butyryl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxy Acid as a white solid (242 mg, 86% yield, observed m/z: 365 [M+H] + ).
步驟(5):(3S,3aS,6aR)-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺Step (5): (3S,3aS,6aR)-2-[(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amine 基]丁醯基]-N-[(Z,1S)-3-氟-3-甲基磺醯基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]烯丙基]-3,3a,4,5,6,6a-六氫-1H-環戊二烯并[c]吡咯-3-甲醯胺Base]butyryl]-N-[(Z,1S)-3-fluoro-3-methylsulfonyl-1-[[(3S)-2-oxopyrrolidin-3-yl]methyl]allyl base]-3,3a,4,5,6,6a-hexahydro-1H-cyclopentadieno[c]pyrrole-3-carboxamide
向(3S,3aS,6aR)-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-3,3a,4,5,6,6a-六氫-1H-環戊二烯并[c]吡咯-3-羧酸(55mg,0.15mmol)和(3S)-3-[(Z,2S)-2-胺基-4-氟-4-甲基磺醯基-丁-3-烯基]吡咯啶-2-酮鹽酸鹽(43mg,0.15mmol)在丁烷-2-酮(1mL)中的溶液加入2-羥基吡啶1-氧化物(4.17mg,0.04mmol),並將混合物冷卻至0℃。向該混合物逐滴加入DIPEA(105μL,78mg,0.6mmol)和(3S)-3-[(Z,2S)-2-胺基-4-氟-4-甲基磺醯基-丁-3-烯基]吡咯啶-2-酮鹽酸鹽(43mg,0.15mmol)在丁烷-2-酮(0.5mL)中的溶液。將反應混合物在室溫下攪拌2小時。向反應混合物加入EtOAc(50mL)並將有機相用1M水性鹽酸(20mL)和水性鹽水溶液(20mL)洗滌。將有機相經無水硫酸鈉乾燥,過濾,並在真空下濃縮。通過正相SiO2管柱層析法(2-5% MeOH/CH2Cl2)純化粗殘餘物並且然後通過反相HPLC再次純化,得到(3S,3aS,6aR)-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-N-[(Z,1S)-3-氟-3-甲基磺醯基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]烯丙基]-3,3a,4,5,6,6a-六氫-1H-環戊二烯并[c]吡咯-3-甲醯胺,為白色固體(31mg,產率35%,觀察到m/z:597[M+H]+);1H NMR(400MHz,CD3OD):δ 8.49(d,1H),6.00(dd,1H),5.52-5.35(m,1H),4.65(s,1H),4.08(d,1H),3.96(m,1H),3.76(m,1H),3.23(s,3H),2.88-2.68(m,2H),2.62(m,1H),2.33(m,1H),2.22-2.09(m,2H),1.98-1.59(m,7H),1.55-1.43(m,2H),1.06(s,9H)。 To (3 S ,3a S ,6a R )-2-[(2 S )-3,3-dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]- 3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxylic acid (55mg, 0.15mmol) and ( 3S )-3-[( Z ,2 S )-2-amino-4-fluoro-4-methylsulfonyl-but-3-enyl]pyrrolidin-2-one hydrochloride (43mg, 0.15mmol) in butane-2-one ( 1 mL) was added 2-hydroxypyridine 1-oxide (4.17 mg, 0.04 mmol), and the mixture was cooled to 0°C. To this mixture was added dropwise DIPEA (105 μL, 78 mg, 0.6 mmol) and ( 3S )-3-[( Z , 2S )-2-amino-4-fluoro-4-methylsulfonyl-butyl- A solution of 3-enyl]pyrrolidin-2-one hydrochloride (43 mg, 0.15 mmol) in butan-2-one (0.5 mL). The reaction mixture was stirred at room temperature for 2 hours. EtOAc (50 mL) was added to the reaction mixture and the organic phase was washed with 1M aqueous hydrochloric acid (20 mL) and aqueous brine solution (20 mL). The organic phase was dried over anhydrous sodium sulfate, filtered and concentrated under vacuum. The crude residue was purified by normal phase SiO 2 column chromatography (2-5% MeOH/CH 2 Cl 2 ) and then repurified by reverse phase HPLC to give ( 3S , 3aS , 6aR )-2-[ (2 S )-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl] -N -[( Z ,1 S )-3-fluoro-3 -Methylsulfonyl-1-[[(3 S )-2-oxopyrrolidin-3-yl]methyl]allyl]-3,3a,4,5,6,6a-hexahydro- 1H-cyclopenta[c]pyrrole-3-carboxamide as a white solid (31 mg, 35% yield, observed m/z: 597 [M+H] + ); 1 H NMR (400 MHz, CD 3 OD): δ 8.49(d,1H), 6.00(dd,1H), 5.52-5.35(m,1H), 4.65(s,1H), 4.08(d,1H), 3.96(m,1H), 3.76(m,1H), 3.23(s,3H), 2.88-2.68(m,2H), 2.62(m,1H), 2.33(m,1H), 2.22-2.09(m,2H), 1.98-1.59( m,7H), 1.55-1.43(m,2H), 1.06(s,9H).
實施例78:(3S,3aS,6aR)-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-N-[(E,1S)-3-氟-3-甲基磺醯基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]烯丙基]-3,3a,4,5,6,6a-六氫-1H-環戊二烯并[c]吡咯-3-甲醯胺(化合物85)Example 78: ( 3S , 3aS , 6aR )-2-[( 2S )-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino] Butyl] -N -[( E ,1 S )-3-fluoro-3-methylsulfonyl-1-[[(3 S )-2-oxopyrrolidin-3-yl]methyl]allyl Base]-3,3a,4,5,6,6a-hexahydro-1H-cyclopentadieno[c]pyrrole-3-carboxamide (compound 85)
通過將(3S)-3-[(E,2S)-2-胺基-4-氟-4-甲基磺醯基-丁-3-烯基]吡咯啶-2-酮鹽酸鹽和適當的羧酸偶合以與關於(3S,3aS,6aR)-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-N-[(Z,1S)-3-氟-3-甲基磺醯基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]烯丙基]-3,3a,4,5,6,6a-六氫-1H-環戊二烯并[c]吡咯-3-甲醯胺所描述的類似方式來製備(3S,3aS,6aR)-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-N-[(E,1S)-3-氟-3-甲基磺醯基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]烯丙基]-3,3a,4,5,6,6a-六氫-1H-環戊二烯并[c]吡咯-3-甲醯胺,為白色固體;觀察到m/z:597[M+H]+;1H NMR(400MHz,CD3OD):δ 8.65(d,1H),6.14(dd,1H),4.99-4.92(m,1H),4.66(s,1H),4.08(d,1H),4.01-3.93(m,1H),3.82-3.72(m,1H),3.13-3.09(m,3H),2.88-2.54(m,3H),2.43-2.33(m,1H),2.26-2.11(m,2H),1.99-1.61(m,7H),1.60-1.42(m,2H),1.07(s,9H)。 By adding ( 3S )-3-[( E , 2S )-2-amino-4-fluoro-4-methylsulfonyl-but-3-enyl]pyrrolidin-2-one hydrochloride and appropriate carboxylic acid coupling with respect to (3 S ,3a S ,6a R )-2-[(2 S )-3,3-dimethyl-2-[(2,2,2-trifluoroacetyl base)amino]butyryl] -N -[( Z ,1 S )-3-fluoro-3-methylsulfonyl-1-[[(3 S )-2-oxopyrrolidin-3-yl] Methyl]allyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxamide was prepared in a manner similar to that described (3 S ,3a S ,6a R )-2-[(2 S )-3,3-dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl] -N -[( E ,1 S )-3-fluoro-3-methylsulfonyl-1-[[(3 S )-2-oxopyrrolidin-3-yl]methyl]allyl]-3,3a, 4,5,6,6a-Hexahydro-1H-cyclopenta[c]pyrrole-3-carboxamide as a white solid; observed m/z: 597[M+H] + ; 1 H NMR (400MHz, CD 3 OD): δ 8.65(d,1H), 6.14(dd,1H), 4.99-4.92(m,1H), 4.66(s,1H), 4.08(d,1H), 4.01-3.93( m,1H), 3.82-3.72(m,1H), 3.13-3.09(m,3H), 2.88-2.54(m,3H), 2.43-2.33(m,1H), 2.26-2.11(m,2H), 1.99-1.61(m,7H), 1.60-1.42(m,2H), 1.07(s,9H).
實施例79:(3S,3aS,6aR)-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-N-[(E,1S)-3-氟-3-甲基磺醯基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]烯丙基]-3,3a,4,5,6,6a-六氫-1H-環戊二烯并[c]吡咯-3-甲醯胺(化合物86)Example 79: ( 3S , 3aS , 6aR )-2-[( 2S )-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino] Butyl] -N -[( E ,1 S )-3-fluoro-3-methylsulfonyl-1-[[(3 S )-2-oxopyrrolidin-3-yl]methyl]allyl Base]-3,3a,4,5,6,6a-hexahydro-1H-cyclopentadieno[c]pyrrole-3-carboxamide (Compound 86)
通過將(S)-3-((S,E)-2-胺基-4-氟-4-(甲基磺醯基)丁-3-烯-1-基)吡咯啶-2-酮鹽酸鹽和適當的羧酸偶合以與關於(3S,3aS,6aR)-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-N-[(Z,1S)-3-氟-3-甲基磺醯基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]烯丙基]-3,3a,4,5,6,6a-六氫-1H-環戊二烯并[c]吡咯-3-甲醯胺所描述的類似方式來製備(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺,為白色固體;觀察到m/z:633[M+H]+;1H NMR(400MHz,DMSO-d6):δ 9.36(d,1H),8.51(d,1H),7.68-7.53(m,1H),6.18-6.00(m,1H),4.88-4.73(m,1H),4.56-4.50(m,1H),4.19(d,1H),3.87-3.73(m,2H),3.21(s,3H),3.15(t,1H),3.09-3.00(m,1H),2.99-2.91(m,1H),2.45-2.36(m,3H),2.31-1.88(m,5H),1.68-1.55(m,1H),1.44-1.33(m,1H),1.03-0.94(m,9H)。 By adding ( S )-3-(( S , E )-2-amino-4-fluoro-4-(methylsulfonyl)but-3-en-1-yl)pyrrolidin-2-one salt Acid salts and appropriate carboxylic acids coupled to (3 S ,3a S ,6a R )-2-[(2 S )-3,3-dimethyl-2-[(2,2,2-trifluoro Acetyl)amino]butyryl] -N -[( Z ,1 S )-3-fluoro-3-methylsulfonyl-1-[[(3 S )-2-oxopyrrolidine-3- yl]methyl]allyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxamide in a manner similar to that described ( 1 S ,3a R ,6a S )-2-(( S )-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro - N -(( S , E )-4-fluoro-4-(methylsulfonyl)-1-(( S )-2-oxopyrrolidin-3-yl)but-3-ene-2- base) octahydrocyclopenta[ c ]pyrrole-1-carboxamide, as a white solid; observed m/z: 633[M+H] + ; 1 H NMR (400MHz, DMSO-d 6 ): δ 9.36 ( d,1H), 8.51(d,1H), 7.68-7.53(m,1H), 6.18-6.00(m,1H), 4.88-4.73(m,1H), 4.56-4.50(m,1H), 4.19( d,1H), 3.87-3.73(m,2H), 3.21(s,3H), 3.15(t,1H), 3.09-3.00(m,1H), 2.99-2.91(m,1H), 2.45-2.36( m, 3H), 2.31-1.88 (m, 5H), 1.68-1.55 (m, 1H), 1.44-1.33 (m, 1H), 1.03-0.94 (m, 9H).
實施例80:(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物87)Example 80: (1 S ,3 S ,4 S )-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-(( S ,E)-4- Fluoro-4-(methylsulfonyl)-1-(( S )-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2 ] Octane-3-formamide (compound 87)
通過將(1S,3S,4S)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯 基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-5,5-二氟-N-[(E,1S)-3-氟-3-甲基磺醯基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]烯丙基]-2-(9-羥基茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:601[M+H]+;1H NMR(400MHz,DMSO-d 6,353K):δ 11.39(s,1H),8.53(d,1H),7.57(d,1H),7.33(s,1H),7.26(d,1H),7.06(t,1H),6.83(s,1H),6.21-6.07(m,1H),4.86-4.60(m,3H),3.17(s,3H),3.15-3.00(m,2H),2.67(s,1H),2.46-2.00(m,6H),1.78-1.58(m,4H),1.53-1.49(m,1H)。 By adding (1 S ,3 S ,4 S )-5,5-difluoro-N-(( S , E )-4-fluoro-4-(methylsulfonyl)-1-((S)- 2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride is coupled with an appropriate carboxylic acid to With respect to (1 S ,3 S ,4 S )-5,5-difluoro- N -[( E ,1 S )-3-fluoro-3-methylsulfonyl-1-[[(3 S ) -2-Oxopyrrolidin-3-yl]methyl]allyl]-2-(9-hydroxyl-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl ( 1S , 3S , 4S )-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-(( S ,E )-4-fluoro-4-(methylsulfonyl)-1-(( S )-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo [2.2.2] Octane-3-formamide; Observed m/z: 601[M+H] + ; 1 H NMR (400MHz, DMSO- d 6 , 353K): δ 11.39(s, 1H), 8.53(d,1H), 7.57(d,1H), 7.33(s,1H), 7.26(d,1H), 7.06(t,1H), 6.83(s,1H), 6.21-6.07(m,1H) , 4.86-4.60(m,3H), 3.17(s,3H), 3.15-3.00(m,2H), 2.67(s,1H), 2.46-2.00(m,6H), 1.78-1.58(m,4H) , 1.53-1.49 (m, 1H).
實施例81:(1S,3S,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物88)Example 81: (1 S ,3 S ,4 S )-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-5,5-difluoro-N-( ( S , E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2 -Azabicyclo[2.2.2]octane-3-formamide (Compound 88)
通過將(1S,3S,4S)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-5,5-二氟-N-[(E,1S)-3-氟-3-甲基磺醯基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]烯丙基]-2-(9-羥基茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:607 [M+H]+;1H NMR(400MHz,DMSO-d 6):δ 12.28-12.23(m,1H),8.79-8.48(m,1H),7.83-7.55(m,1H),7.46-7.39(m,1H),6.98-6.45(m,1H),6.21-6.03(m,1H),4.86-4.74(m,2H),4.71-4.44(m,1H),3.29-3.21(m,3H),3.18(s,2H),2.63(s,1H),2.39(dd,1H),2.29-2.02(m,4H),1.81-1.27(m,6H)。 By adding (1 S ,3 S ,4 S )-5,5-difluoro-N-(( S ,E)-4-fluoro-4-(methylsulfonyl)-1-(( S )- 2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride is coupled with an appropriate carboxylic acid to With respect to (1 S ,3 S ,4 S )-5,5-difluoro- N -[( E ,1 S )-3-fluoro-3-methylsulfonyl-1-[[(3 S ) -2-Oxopyrrolidin-3-yl]methyl]allyl]-2-(9-hydroxyl-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl ( 1S , 3S , 4S )-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-5,5-difluoro -N-(( S , E )-4-fluoro-4-(methylsulfonyl)-1-(( S )-2-oxopyrrolidin-3-yl)but-3-ene-2- base)-2-azabicyclo[2.2.2]octane-3-carboxamide; observed m/z: 607 [M+H] + ; 1 H NMR (400MHz, DMSO- d 6 ): δ 12.28 -12.23(m,1H), 8.79-8.48(m,1H), 7.83-7.55(m,1H), 7.46-7.39(m,1H), 6.98-6.45(m,1H), 6.21-6.03(m, 1H), 4.86-4.74(m,2H), 4.71-4.44(m,1H), 3.29-3.21(m,3H), 3.18(s,2H), 2.63(s,1H), 2.39(dd,1H) , 2.29-2.02 (m, 4H), 1.81-1.27 (m, 6H).
實施例82:(1S,3S,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物89)Example 82: (1 S ,3 S ,4 S )-2-(4,7-difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-(( S , E ) -4-fluoro-4-(methylsulfonyl)-1-(( S )-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[ 2.2.2] Octane-3-formamide (compound 89)
通過將(1S,3S,4S)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽與適當的羧酸偶合以與關於(1S,3S,4S)-5,5-二氟-N-[(E,1S)-3-氟-3-甲基磺醯基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]烯丙基]-2-(9-羥基茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:603[M+H]+;1H NMR(400MHz,DMSO-d 6,353K):δ 12.20(s,1H),8.53(d,1H),7.35(s,1H),6.98-6.85(m,1H),6.90-6.72(m,2H),6.21-6.03(m,1H),4.86-4.61(m,3H),3.17(s,4H),2.69-2.67(m,1H),2.54-2.52(m,1H),2.46-2.38(m,1H),2.34(dd,1H),2.29-2.04(m,4H),1.77-1.43(m,5H)。 By adding (1 S ,3 S ,4 S )-5,5-difluoro-N-(( S , E )-4-fluoro-4-(methylsulfonyl)-1-(( S )- 2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride is coupled with an appropriate carboxylic acid to With respect to (1 S ,3 S ,4 S )-5,5-difluoro- N -[( E ,1 S )-3-fluoro-3-methylsulfonyl-1-[[(3 S ) -2-Oxopyrrolidin-3-yl]methyl]allyl]-2-(9-hydroxyl-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl ( 1S , 3S , 4S )-2-(4,7-difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-(( S ,E)-4-fluoro-4-(methylsulfonyl)-1-(( S )-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2- Azabicyclo[2.2.2]octane-3-carboxamide; observed m/z: 603[M+H] + ; 1 H NMR (400MHz, DMSO- d 6, 353K): δ 12.20(s, 1H), 8.53(d,1H), 7.35(s,1H), 6.98-6.85(m,1H), 6.90-6.72(m,2H), 6.21-6.03(m,1H), 4.86-4.61(m, 3H), 3.17(s,4H), 2.69-2.67(m,1H), 2.54-2.52(m,1H), 2.46-2.38(m,1H), 2.34(dd,1H), 2.29-2.04(m, 4H), 1.77-1.43 (m, 5H).
實施例83:(1S,3S,4S)-2-(3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯Example 83: (1 S ,3 S ,4 S )-2-(3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl 基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(單一非對映異構物I)(化合物90和91)Base)-5,5-difluoro-N-(( S , E )-4-fluoro-4-(methylsulfonyl)-1-(( S )-2-oxopyrrolidin-3-yl )but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide (single diastereoisomer I) (compounds 90 and 91)
在0℃下向4-甲苯磺醯氯(131mg,0.69mmol)在THF(5mL)中的溶液加入(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁酸(130mg,0.57mmol)、DIEA(0.26mL,1.49mmol)和DMAP(83mg,0.68mmol)。將反應混合物升溫至20℃,並攪拌2小時。加入(1S,3S,4S)-5,5-二氟-N-[(E,1S)-3-氟-3-甲基磺醯基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]烯丙基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽(263mg,0.57mmol)在THF(15mL)中的溶液。在12小時之後,將反應混合物用水(10mL)淬滅並用乙酸乙酯(15mL×3)萃取。將合併後的有機層經硫酸鈉乾燥並在減壓下濃縮。通過反相HPLC純化粗產物,得到(1S,3S,4S)-2-(3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(60mg,產率36%,觀察到m/z:633[M+H]+)。通過在LUX Cellulose-2柱上使用80:20己烷/EtOH進行SFC(0.1% iPrNH2)分離非對映異構物。 To a solution of 4-toluenesulfonyl chloride (131 mg, 0.69 mmol) in THF (5 mL) was added (2S)-3,3-dimethyl-2-[(2,2,2-trifluoro Acetyl)amino]butanoic acid (130 mg, 0.57 mmol), DIEA (0.26 mL, 1.49 mmol) and DMAP (83 mg, 0.68 mmol). The reaction mixture was warmed to 20 °C and stirred for 2 hours. Add (1 S ,3 S ,4 S )-5,5-difluoro-N-[( E ,1 S )-3-fluoro-3-methylsulfonyl-1-[[(3 S )- 2-oxopyrrolidin-3-yl]methyl]allyl]-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride (263mg, 0.57mmol) in THF (15mL ) in the solution. After 12 hours, the reaction mixture was quenched with water (10 mL) and extracted with ethyl acetate (15 mL×3). The combined organic layers were dried over sodium sulfate and concentrated under reduced pressure. Purification of the crude product by reverse-phase HPLC afforded ( 1S , 3S , 4S )-2-(3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)- 5,5-Difluoro-N-(( S , E )-4-fluoro-4-(methylsulfonyl)-1-(( S )-2-oxopyrrolidin-3-yl)butan- 3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide (60 mg, 36% yield, observed m/z: 633 [M+H] + ). The diastereoisomers were separated by SFC (0.1% iPrNH2 ) on a LUX Cellulose-2 column using 80:20 hexane/ EtOH .
次要非對映異構物(化合物90):(單一非對映異構物I,較快洗脫的非對映異構物):(3mg,產率0.8%,觀察到m/z:633[M+H]+);1H NMR(400MHz,DMSO-d 6):δ 10.08-9.43(m,1 H),8.83-8.50(m,1H),7.69(s,1H),6.19-6.08(m,1H),4.93-4.72(m,2H),4.63-4.16(m,2H),3.30-3.28(m,3H),3.25-2.88(m,2H),2.59(s,1H),2.41-2.00(m,6H),1.97-1.47(m,5H),1.02-1.00(m,9H)。 Minor diastereomer (compound 90) : (single diastereomer I, faster eluting diastereomer): (3 mg, 0.8% yield, observed m/z: 633[M+H] + ); 1 H NMR (400MHz, DMSO- d 6 ): δ 10.08-9.43(m, 1H), 8.83-8.50(m, 1H), 7.69(s, 1H), 6.19- 6.08(m,1H), 4.93-4.72(m,2H), 4.63-4.16(m,2H), 3.30-3.28(m,3H), 3.25-2.88(m,2H), 2.59(s,1H), 2.41-2.00 (m, 6H), 1.97-1.47 (m, 5H), 1.02-1.00 (m, 9H).
主要非對映異構物(化合物91):(單一非對映異構物II,較 慢洗脫的非對映異構物):(12mg,產率3%,觀察到m/z:633[M+H]+);1H NMR(400MHz,DMSO-d 6):δ 9.35(d,1H),8.55(d,1H),7.59(s,1H),6.12(dd,1H),4.85-4.75(m,2H),4.62(s,1H),4.41(s,1H),3.25(s,3H),3.20-3.13(m,1H),3.08-3.01(m,1H),2.51-2.20(m,5H),2.07-2.00(m,2H),1.67-1.57(m,4H),1.44-1.36(m,1H),1.02(s,9H)。 Major diastereomer (compound 91) : (single diastereomer II, slower eluting diastereomer): (12 mg, 3% yield, observed m/z: 633 [M+H] + ); 1 H NMR (400MHz, DMSO- d 6 ): δ 9.35(d,1H), 8.55(d,1H), 7.59(s,1H), 6.12(dd,1H), 4.85 -4.75(m,2H), 4.62(s,1H), 4.41(s,1H), 3.25(s,3H), 3.20-3.13(m,1H), 3.08-3.01(m,1H), 2.51-2.20 (m,5H), 2.07-2.00(m,2H), 1.67-1.57(m,4H), 1.44-1.36(m,1H), 1.02(s,9H).
實施例84:(Z,4S)-4-[[(1S,3S,4S)-2-[(2R)-2-(3-氯苯胺基)-4-甲基-戊醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-羰基]胺基]-2-氟-5-[(3S)-2-氧代吡咯啶-3-基]戊-2-烯酸乙酯(化合物92)Example 84: (Z,4S)-4-[[(1S,3S,4S)-2-[(2R)-2-(3-chloroanilino)-4-methyl-pentyl]-5 ,5-Difluoro-2-azabicyclo[2.2.2]octane-3-carbonyl]amino]-2-fluoro-5-[(3S)-2-oxopyrrolidin-3-yl]pentane -2-enoic acid ethyl ester (compound 92)
步驟(1):(Z,4S)-4-(第三丁氧基羰基胺基)-2-氟-5-[(3S)-2-氧代吡咯啶-3-基]戊-2-烯酸乙酯Step (1): (Z,4S)-4-(tert-butoxycarbonylamino)-2-fluoro-5-[(3S)-2-oxopyrrolidin-3-yl]pentan-2- ethyl acrylate
在-78℃下向2-二乙氧基磷醯基-2-氟-乙酸乙酯(1.9g,7.8mmol)在無水THF(10mL)中的溶液逐滴加入KHMDS(1M的THF溶液,8.5mL,8.5mmol)。將反應混合物在-78℃下攪拌30min並在-78℃下逐滴加入N-[(1S)-1-甲醯基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]胺基甲酸第三丁酯(2.0g,7.8mmol)在THF(5mL)中的溶液。將反應混合物在-78℃下攪拌2小時,並緩慢升溫至0℃。向反應混合物加入H2O(30mL)並用EtOAc(3×50mL)萃取水相。將合併後的有機相經無水硫酸鈉乾燥,過濾,並在真空下濃縮。通過正相SiO2管柱層析法(1-4% MeOH/CH2Cl2)純化粗殘餘物,得到(Z,4S)-4-(第三丁氧基羰基胺基)-2-氟-5-[(3S)-2-氧代吡咯啶-3-基]戊-2-烯酸乙酯,為白色固體(1.0g,產率38%,觀察到m/z:345[M+H]+)。 To a solution of ethyl 2-diethoxyphosphoryl-2-fluoro-acetate (1.9 g, 7.8 mmol) in anhydrous THF (10 mL) was added KHMDS (1 M in THF, 8.5 mL, 8.5 mmol). The reaction mixture was stirred at -78°C for 30 min and N-[(1S)-1-formyl-2-[(3S)-2-oxopyrrolidin-3-yl] was added dropwise at -78°C A solution of tert-butyl ethyl]carbamate (2.0 g, 7.8 mmol) in THF (5 mL). The reaction mixture was stirred at -78°C for 2 hours and slowly warmed to 0°C. H2O (30 mL) was added to the reaction mixture and the aqueous phase was extracted with EtOAc (3 x 50 mL). The combined organic phases were dried over anhydrous sodium sulfate, filtered and concentrated under vacuum. The crude residue was purified by normal phase SiO2 column chromatography (1-4% MeOH/ CH2Cl2 ) to afford (Z,4S)-4-(tert-butoxycarbonylamino)-2-fluoro -Ethyl 5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoate as a white solid (1.0 g, 38% yield, observed m/z: 345 [M+ H] + ).
步驟(2):(Z,4S)-4-胺基-2-氟-5-[(3S)-2-氧代吡咯啶-3-基]戊-2-烯酸乙酯Step (2): (Z,4S)-4-Amino-2-fluoro-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoic acid ethyl ester
向(Z,4S)-4-(第三丁氧基羰基胺基)-2-氟-5-[(3S)-2-氧代吡咯啶-3-基]戊-2-烯酸乙酯(240mg,0.7mmol)在CH2Cl2(2mL)中的溶液加入鹽酸(4M的1.4-二烷溶液,2mL,8mmol)。將反應混合物在室溫下攪拌1小時,並在真空中濃縮,以提供(Z,4S)-4-胺基-2-氟-5-[(3S)-2-氧代吡咯啶-3-基]戊-2-烯酸乙酯的鹽酸鹽,為白色固體(定量獲得195mg,觀察到m/z:245[M+H]+)。 To (Z,4S)-4-(tert-butoxycarbonylamino)-2-fluoro-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoic acid ethyl ester (240 mg, 0.7 mmol) in CH 2 Cl 2 (2 mL) was added hydrochloric acid (4M of 1.4-di alkane solution, 2mL, 8mmol). The reaction mixture was stirred at room temperature for 1 hour and concentrated in vacuo to provide (Z,4S)-4-amino-2-fluoro-5-[(3S)-2-oxopyrrolidine-3- Hydrochloride of ethyl]pent-2-enoic acid ethyl ester as a white solid (quantitatively obtained 195 mg, observed m/z: 245 [M+H] + ).
步驟(3):(1S,3S,4S)-3-[[(Z,1S)-4-乙氧基-3-氟-4-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]丁-2-烯基]胺甲醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-2-羧酸第三丁酯Step (3): (1S,3S,4S)-3-[[(Z,1S)-4-ethoxy-3-fluoro-4-oxo-1-[[(3S)-2-oxo Pyrrolidin-3-yl]methyl]but-2-enyl]carbamoyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-2-carboxylic acid third Butyl ester
向(1S,3S,4S)-2-第三丁氧基羰基-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-羧酸(202mg,0.7mmol)和(Z,4S)-4-胺基-2-氟-5-[(3S)-2-氧代吡咯啶-3-基]戊-2-烯酸乙酯鹽酸鹽(195mg,0.7mmol)在CH2Cl2/THF(1:1混合物,4mL)中的溶液加入HOBt一水化物(213 mg,1.4mmol),隨後加入EDC鹽酸鹽(173mg,0.9mmol)和DIPEA(485μL,2.8mmol)。將反應混合物在室溫下攪拌16小時。向反應混合物加入H2O(15mL)和水性鹽水溶液(15mL)。用EtOAc(3×60mL)萃取水相。將合併後的有機相經無水硫酸鈉乾燥,過濾,並在真空下濃縮。通過正相SiO2管柱層析法(0-10% MeOH/CH2Cl2)純化粗殘餘物,得到(1S,3S,4S)-3-[[(Z,1S)-4-乙氧基-3-氟-4-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]丁-2-烯基]胺甲醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-2-羧酸第三丁酯,為無色油(285mg,產率79.3%,觀察到m/z:518[M+H]+)。 To (1 S ,3 S ,4 S )-2-tert-butoxycarbonyl-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxylic acid (202mg, 0.7mmol ) and ethyl (Z,4S)-4-amino-2-fluoro-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoate hydrochloride (195mg, 0.7 mmol) in CH 2 Cl 2 /THF (1:1 mixture, 4 mL) was added HOBt monohydrate (213 mg, 1.4 mmol), followed by EDC hydrochloride (173 mg, 0.9 mmol) and DIPEA (485 μL, 2.8 mmol). The reaction mixture was stirred at room temperature for 16 hours. H2O (15 mL) and aqueous brine solution (15 mL) were added to the reaction mixture. The aqueous phase was extracted with EtOAc (3 x 60 mL). The combined organic phases were dried over anhydrous sodium sulfate, filtered and concentrated under vacuum. The crude residue was purified by normal phase SiO 2 column chromatography (0-10% MeOH/CH 2 Cl 2 ) to afford (1S,3S,4S)-3-[[(Z,1S)-4-ethoxy Base-3-fluoro-4-oxo-1-[[(3S)-2-oxopyrrolidin-3-yl]methyl]but-2-enyl]carbamoyl]-5,5 - tert-butyl difluoro-2-azabicyclo[2.2.2]octane-2-carboxylate as a colorless oil (285mg, yield 79.3%, observed m/z: 518[M+H] + ).
步驟(4):(Z,4S)-4-[[(1S,3S,4S)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-羰基]胺基]-2-氟-5-[(3S)-2-氧代吡咯啶-3-基]戊-2-烯酸乙酯Step (4): (Z,4S)-4-[[(1S,3S,4S)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carbonyl]amino] -2-Fluoro-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoic acid ethyl ester
向(1S,3S,4S)-3-[[(Z,1S)-4-乙氧基-3-氟-4-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]丁-2-烯基]胺甲醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-2-羧酸第三丁酯(285mg,0.55mmol)在CH2Cl2(1mL)中的溶液加入鹽酸(4M的二烷溶液,1mL,4mmol)。將反應混合物在室溫下攪拌1小時,並在真空中濃縮,以提供(Z,4S)-4-[[(1S,3S,4S)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-羰基]胺基]-2-氟-5-[(3S)-2-氧代吡咯啶-3-基]戊-2-烯酸乙酯的鹽酸鹽,為白色固體(250mg,產率100.0%,觀察到m/z:418[M+H]+),其無需進一步純化即可用於下一步。 To (1S,3S,4S)-3-[[(Z,1S)-4-ethoxy-3-fluoro-4-oxo-1-[[(3S)-2-oxopyrrolidine- 3-yl]methyl]but-2-enyl]carbamoyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-2-carboxylic acid tert-butyl ester (285mg , 0.55 mmol) in CH 2 Cl 2 (1 mL) was added hydrochloric acid (4M di alkane solution, 1 mL, 4 mmol). The reaction mixture was stirred at room temperature for 1 hour and concentrated in vacuo to provide (Z,4S)-4-[[(1S,3S,4S)-5,5-difluoro-2-azabicyclo[ 2.2.2] Octane-3-carbonyl]amino]-2-fluoro-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoic acid ethyl ester hydrochloride, It was a white solid (250 mg, yield 100.0%, observed m/z: 418 [M+H] + ), which was used in the next step without further purification.
步驟(5):(Z,4S)-4-[[(1S,3S,4S)-2-[(2R)-2-(3-氯苯胺基)-4-甲基-戊醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-羰基]胺基]-2-氟-5-[(3S)-2-Step (5): (Z,4S)-4-[[(1S,3S,4S)-2-[(2R)-2-(3-Chloroanilino)-4-methyl-pentyl]- 5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-carbonyl]amino]-2-fluoro-5-[(3S)-2- 氧代吡咯啶-3-基]戊-2-烯酸乙酯Oxypyrrolidin-3-yl]pent-2-enoic acid ethyl ester
向(Z,4S)-4-[[(1S,3S,4S)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-羰基]胺基]-2-氟-5-[(3S)-2-氧代吡咯啶-3-基]戊-2-烯酸乙酯鹽酸鹽(40mg,0.09mmol)和(2R)-2-(3-氯苯胺基)-4-甲基-戊酸(21mg,0.09mmol)在DMF(0.5mL)中的溶液逐滴加入DIPEA(62μL,0.35mmol)和HATU(44mg,0.11mmol)在DMF(0.5mL)中的溶液。將反應混合物在室溫下攪拌30min並通過反相HPLC純化,得到(Z,4S)-4-[[(1S,3S,4S)-2-[(2R)-2-(3-氯苯胺基)-4-甲基-戊醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-羰基]胺基]-2-氟-5-[(3S)-2-氧代吡咯啶-3-基]戊-2-烯酸乙酯,為白色固體(16mg,產率29%,觀察到m/z:641[M+H]+)。1H NMR(400MHz,CD3OD):δ 7.07(t,1H),6.73-6.38(m,3H),5.83(dd,1H),5.48-5.31(m,1H),4.58(d,1H),4.46-4.38(m,1H),4.38-4.08(m,3H),3.20-2.96(m,2H),2.67(q,1H),2.48(s,1H),2.34-1.21(m,16H),0.99(dd,6H)。 To (Z,4S)-4-[[(1S,3S,4S)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carbonyl]amino]-2-fluoro -5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoic acid ethyl ester hydrochloride (40mg, 0.09mmol) and (2 R )-2-(3-chloroanilino )-4-Methyl-valeric acid (21 mg, 0.09 mmol) in DMF (0.5 mL) was added dropwise to DIPEA (62 μL, 0.35 mmol) and HATU (44 mg, 0.11 mmol) in DMF (0.5 mL) solution. The reaction mixture was stirred at room temperature for 30 min and purified by reverse phase HPLC to give (Z,4S)-4-[[(1S,3S,4S)-2-[(2R)-2-(3-chloroanilino )-4-methyl-pentyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carbonyl]amino]-2-fluoro-5-[(3S) -Ethyl 2-oxopyrrolidin-3-yl]pent-2-enoate as a white solid (16 mg, 29% yield, observed m/z: 641 [M+H] + ). 1 H NMR (400MHz, CD 3 OD): δ 7.07(t,1H), 6.73-6.38(m,3H), 5.83(dd,1H), 5.48-5.31(m,1H), 4.58(d,1H) , 4.46-4.38(m,1H), 4.38-4.08(m,3H), 3.20-2.96(m,2H), 2.67(q,1H), 2.48(s,1H), 2.34-1.21(m,16H) , 0.99 (dd,6H).
實施例85:(Z,4S)-4-[[(1S,3S,4S)-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-羰基]胺基]-2-氟-5-[(3S)-2-氧代吡咯啶-3-基]戊-2-烯酸乙酯(化合物93)Example 85: (Z,4S)-4-[[(1S,3S,4S)-2-[(2R)-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl )amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carbonyl]amino]-2-fluoro-5-[(3S)-2- Oxypyrrolidin-3-yl]pent-2-enoic acid ethyl ester (compound 93)
步驟(1):(Z,4S)-4-[[(1S,3S,4S)-2-[(2R)-2-(第三丁氧基羰基胺基)-3-環丁基-丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-羰基]胺基]-2-氟-Step (1): (Z,4S)-4-[[(1S,3S,4S)-2-[(2R)-2-(tert-butoxycarbonylamino)-3-cyclobutyl-propane Acyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carbonyl]amino]-2-fluoro- 5-[(3S)-2-氧代吡咯啶-3-基]戊-2-烯酸乙酯5-[(3S)-2-Oxopyrrolidin-3-yl]pent-2-enoic acid ethyl ester
向(Z,4S)-4-[[(1S,3S,4S)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-羰基]胺基]-2-氟-5-[(3S)-2-氧代吡咯啶-3-基]戊-2-烯酸乙酯鹽酸鹽(50mg,0.11mmol)和(2R)-2-(第三丁氧基羰基胺基)-3-環丁基-丙酸(27mg,0.11mmol)在DMF(1mL)中的溶液加入DIPEA(77μL,0.44mmol)和HATU(54mg,0.14mmol)。將反應混合物在室溫下攪拌30min,過濾並通過反相HPLC純化,得到(Z,4S)-4-[[(1S,3S,4S)-2-[(2R)-2-(第三丁氧基羰基胺基)-3-環丁基-丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-羰基]胺基]-2-氟-5-[(3S)-2-氧代吡咯啶-3-基]戊-2-烯酸乙酯,為無色油(28mg,產率39%,觀察到m/z:643[M+H]+)。 To (Z,4S)-4-[[(1S,3S,4S)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carbonyl]amino]-2-fluoro -5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoic acid ethyl ester hydrochloride (50mg, 0.11mmol) and (2 R )-2-(tert-butoxy To a solution of carbonylamino)-3-cyclobutyl-propionic acid (27 mg, 0.11 mmol) in DMF (1 mL) was added DIPEA (77 μL, 0.44 mmol) and HATU (54 mg, 0.14 mmol). The reaction mixture was stirred at room temperature for 30 min, filtered and purified by reverse phase HPLC to give (Z,4S)-4-[[(1S,3S,4S)-2-[(2R)-2-(tert-butyl Oxycarbonylamino)-3-cyclobutyl-propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carbonyl]amino]-2-fluoro- Ethyl 5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoate as a colorless oil (28 mg, 39% yield, observed m/z: 643 [M+H] + ).
步驟(2):(Z,4S)-4-[[(1S,3S,4S)-2-[(2R)-2-胺基-3-環丁基-丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-羰基]胺基]-2-氟-5-[(3S)-2-氧代吡咯啶-3-基]戊-2-烯酸乙酯Step (2): (Z,4S)-4-[[(1S,3S,4S)-2-[(2R)-2-Amino-3-cyclobutyl-propionyl]-5,5- Difluoro-2-azabicyclo[2.2.2]octane-3-carbonyl]amino]-2-fluoro-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2- ethyl acrylate
向(Z,4S)-4-[[(1S,3S,4S)-2-[(2R)-2-(第三丁氧基羰基胺基)-3-環丁基-丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-羰基]胺基]-2-氟-5-[(3S)-2-氧代吡咯啶-3-基]戊-2-烯酸乙酯(28mg,0.04mmol)在CH2Cl2(1mL)中的溶液加入鹽酸(4M的二烷溶液,1mL,4mmol)。將反應混合物在室溫下攪拌30min並在真空下濃縮,以提供 (Z,4S)-4-[[(1S,3S,4S)-2-[(2R)-2-胺基-3-環丁基-丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-羰基]胺基]-2-氟-5-[(3S)-2-氧代吡咯啶-3-基]戊-2-烯酸乙酯的鹽酸鹽,為白色固體(定量獲得25mg,觀察到m/z:543[M+H]+),其無需進一步純化即可用於下一步。 To (Z,4S)-4-[[(1S,3S,4S)-2-[(2R)-2-(3-butoxycarbonylamino)-3-cyclobutyl-propionyl]- 5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-carbonyl]amino]-2-fluoro-5-[(3S)-2-oxopyrrolidin-3-yl] A solution of ethyl pent-2-enoate (28 mg, 0.04 mmol) in CH 2 Cl 2 (1 mL) was added to hydrochloric acid (4M di alkane solution, 1 mL, 4 mmol). The reaction mixture was stirred at room temperature for 30 min and concentrated under vacuum to provide (Z,4S)-4-[[(1S,3S,4S)-2-[(2R)-2-amino-3-cyclo Butyl-propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carbonyl]amino]-2-fluoro-5-[(3S)-2-oxo Ethylpyrrolidin-3-yl]pent-2-enoate hydrochloride as a white solid (25 mg obtained quantitatively, observed m/z: 543 [M+H] + ), which was used without further purification in the next step.
步驟(3):(Z,4S)-4-[[(1S,3S,4S)-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-羰基]胺基]-2-氟-5-[(3S)-2-氧代吡咯啶-3-基]戊-2-烯酸乙酯Step (3): (Z,4S)-4-[[(1S,3S,4S)-2-[(2R)-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl Base)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carbonyl]amino]-2-fluoro-5-[(3S)-2 -Oxopyrrolidin-3-yl]pent-2-enoic acid ethyl ester
向(Z,4S)-4-[[(1S,3S,4S)-2-[(2R)-2-胺基-3-環丁基-丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-羰基]胺基]-2-氟-5-[(3S)-2-氧代吡咯啶-3-基]戊-2-烯酸乙酯鹽酸鹽(25mg,0.04mmol)在MeOH(1mL)中的溶液加入三氟乙酸乙酯(51μL,0.43mmol)和DIPEA(23μL,0.13mmol)。將反應混合物在室溫下攪拌30min。向反應混合物加入飽和碳酸氫鈉水溶液(10mL)並用EtOAc(3×15mL)萃取水相。將合併後的有機相經無水硫酸鈉乾燥,過濾,並在真空下濃縮。通過反相HPLC純化粗殘餘物,得到(Z,4S)-4-[[(1S,3S,4S)-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-羰基]胺基]-2-氟-5-[(3S)-2-氧代吡咯啶-3-基]戊-2-烯酸乙酯,為白色固體(11mg,產率41%,觀察到m/z:639[M+H]+)。1H NMR(400MHz,CD3OD):δ 5.97-5.68(m,1H),5.51-5.31(m,1H),4.81-4.68(m,1H),4.43(d,1H),4.38-4.23(m,4H),3.37-3.33(m,1H),2.82-1.47(m,21H),1.35(t,3H)。 To (Z,4S)-4-[[(1S,3S,4S)-2-[(2R)-2-amino-3-cyclobutyl-propionyl]-5,5-difluoro-2 -Azabicyclo[2.2.2]octane-3-carbonyl]amino]-2-fluoro-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoic acid ethyl ester To a solution of hydrochloride (25 mg, 0.04 mmol) in MeOH (1 mL) was added ethyl trifluoroacetate (51 μL, 0.43 mmol) and DIPEA (23 μL, 0.13 mmol). The reaction mixture was stirred at room temperature for 30 min. Saturated aqueous sodium bicarbonate (10 mL) was added to the reaction mixture and the aqueous phase was extracted with EtOAc (3 x 15 mL). The combined organic phases were dried over anhydrous sodium sulfate, filtered and concentrated under vacuum. The crude residue was purified by reverse phase HPLC to give (Z,4S)-4-[[(1S,3S,4S)-2-[(2R)-3-cyclobutyl-2-[(2,2,2 -Trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carbonyl]amino]-2-fluoro-5-[ Ethyl (3S)-2-oxopyrrolidin-3-yl]pent-2-enoate as a white solid (11 mg, 41% yield, observed m/z: 639 [M+H] + ). 1 H NMR (400MHz, CD 3 OD): δ 5.97-5.68(m,1H), 5.51-5.31(m,1H), 4.81-4.68(m,1H), 4.43(d,1H), 4.38-4.23( m, 4H), 3.37-3.33 (m, 1H), 2.82-1.47 (m, 21H), 1.35 (t, 3H).
實施例86:(1S,3S,4S)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-Example 86: (1 S ,3 S ,4 S )-2-((3-chloro-2-methylphenyl)glycyl)-5,5-difluoro-N- ((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物94)(( S , E )-4-fluoro-4-(methylsulfonyl)-1-(( S )-2-oxopyrrolidin-3-yl)but-3-en-2-yl)- 2-Azabicyclo[2.2.2]octane-3-carboxamide (compound 94)
步驟(1):2-(3-氯-2-甲基-苯胺)乙酸甲酯Step (1): Methyl 2-(3-chloro-2-methyl-aniline)acetate
用氮氣對3-氯-2-甲基苯胺(1.7mL,14.1mmol)、溴乙酸甲酯(1.5mL,15.7mmol)和DIEA(3.7mL,21.2mmol)在DMF(20mL)中的混合物進行脫氣。將混合物在90℃下在氮大氣壓下攪拌12小時。用EtOAc(150mL)稀釋混合物,用水(30mL)和鹽水溶液(50mL)洗滌。將合併後的有機相經無水硫酸鈉乾燥,在真空中過濾並濃縮。通過正相SiO2層析法(0-30% EtOAc/石油醚)純化殘餘物,得到2-(3-氯-2-甲基-苯胺)乙酸甲酯,為黃色固體(2.4g,產率62%,78%純度,觀察到m/z:214[M+H]+)。1H NMR(400MHz,CD3OD):δ 6.97(t,1H),6.72(d,1H),6.70(d,1H),3.99(s,2H),3.71(s,3H),2.24(s,3H)。 A mixture of 3-chloro-2-methylaniline (1.7 mL, 14.1 mmol), methyl bromoacetate (1.5 mL, 15.7 mmol) and DIEA (3.7 mL, 21.2 mmol) in DMF (20 mL) was degassed with nitrogen. gas. The mixture was stirred at 90° C. for 12 hours under a nitrogen atmosphere. The mixture was diluted with EtOAc (150 mL), washed with water (30 mL) and brine solution (50 mL). The combined organic phases were dried over anhydrous sodium sulfate, filtered and concentrated in vacuo. Purification of the residue by normal phase SiO2 chromatography (0-30% EtOAc/petroleum ether) gave methyl 2-(3-chloro-2-methyl-aniline)acetate as a yellow solid (2.4 g, yield 62%, 78% purity, observed m/z: 214 [M+H] + ). 1 H NMR (400MHz, CD 3 OD): δ 6.97(t,1H), 6.72(d,1H), 6.70(d,1H), 3.99(s,2H), 3.71(s,3H), 2.24(s ,3H).
步驟(2):2-(3-氯-2-甲基-苯胺)乙酸Step (2): 2-(3-Chloro-2-methyl-aniline)acetic acid
向2-(3-氯-2-甲基-苯胺)乙酸甲酯(1.0g,4.7mmol)在甲醇(8mL)中的溶液加入氫氧化鋰一水化物(393mg,9.4mmol)和水(2mL)。將混合物在室溫下攪拌12小時。將反應混合物濃縮並加入水性HCl(0.5N)以將pH調節至1。過濾混合物,收集白色固體並乾燥,得到 2-(3-氯-2-甲基-苯胺)乙酸,為黃色固體,其無需進一步純化即可用於下一步(0.9g,產率96%);觀察到m/z:200[M+H]+)。1H NMR(400MHz,CD3OD):δ 6.98(t,1H),6.70(d,1H),6.40(d,1H),3.93(s,2H),2.24(s,3H)。 To a solution of methyl 2-(3-chloro-2-methyl-aniline)acetate (1.0 g, 4.7 mmol) in methanol (8 mL) was added lithium hydroxide monohydrate (393 mg, 9.4 mmol) and water (2 mL ). The mixture was stirred at room temperature for 12 hours. The reaction mixture was concentrated and aqueous HCl (0.5N) was added to adjust the pH to 1. The mixture was filtered and the white solid was collected and dried to give 2-(3-chloro-2-methyl-aniline)acetic acid as a yellow solid which was used in the next step without further purification (0.9 g, 96% yield); observation to m/z: 200[M+H] + ). 1 H NMR (400 MHz, CD 3 OD): δ 6.98 (t, 1H), 6.70 (d, 1H), 6.40 (d, 1H), 3.93 (s, 2H), 2.24 (s, 3H).
步驟(3):(1S,3S,4S)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺Step (3): (1S,3S,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,E)- 4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2 .2] Octane-3-carboxamide
向(1S,3S,4S)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽(45mg,98μmol)在DMF(1mL)中的混合物加入HATU(48mg,0.13mmol)、DIEA(85μL,0.49mmol)和2-(3-氯-2-甲基-苯胺)乙酸(20mg,0.098mmol)。將混合物在室溫下攪拌1小時。將反應混合物用EtOAc(10mL)稀釋,並用水(10mL)洗滌。將有機層用鹽水溶液(5mL)洗滌,經無水硫酸鈉乾燥,過濾並在減壓下濃縮。通過反相HPLC純化殘餘物,得到(1S,3S,4S)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺,為白色固體(27mg,產率4l%,觀察到m/z:605[M+H]+)。1H NMR(400MHz,CD3OD):δ 7.18-7.09(m,1H),7.07-6.92(m,1H),6.88-6.73(m,1H),6.23-6.08(m,1H),4.99-4.90(m,2H),4.33(s,1H),4.30-4.18(m,2H),3.31-3.19(m,2H),3.16-3.10(m,3H),2.72-2.57(m,2H),2.51-2.35(m,2H),2.33(s,3H),2.30-2.11(m,3H),1.93-1.73(m,4H),1.66-160(m,1H)。 To (1 S ,3 S ,4 S )-5,5-difluoro- N -(( S ,E)-4-fluoro-4-(methylsulfonyl)-1-(( S )-2 -Oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride (45 mg, 98 μmol) in DMF ( 1 mL) was added HATU (48 mg, 0.13 mmol), DIEA (85 μL, 0.49 mmol) and 2-(3-chloro-2-methyl-aniline)acetic acid (20 mg, 0.098 mmol). The mixture was stirred at room temperature for 1 hour. The reaction mixture was diluted with EtOAc (10 mL) and washed with water (10 mL). The organic layer was washed with brine solution (5 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. Purification of the residue by reverse-phase HPLC gave ( 1S , 3S , 4S )-2-((3-chloro-2-methylphenyl)glycinyl)-5,5-difluoro- N- (( S , E )-4-fluoro-4-(methylsulfonyl)-1-(( S )-2-oxopyrrolidin-3-yl)but-3-en-2-yl)- 2-Azabicyclo[2.2.2]octane-3-carboxamide as a white solid (27 mg, 41 % yield, observed m/z: 605 [M+H] + ). 1 H NMR (400MHz, CD 3 OD): δ 7.18-7.09(m,1H), 7.07-6.92(m,1H), 6.88-6.73(m,1H), 6.23-6.08(m,1H), 4.99- 4.90(m,2H), 4.33(s,1H), 4.30-4.18(m,2H), 3.31-3.19(m,2H), 3.16-3.10(m,3H), 2.72-2.57(m,2H), 2.51-2.35(m,2H), 2.33(s,3H), 2.30-2.11(m,3H), 1.93-1.73(m,4H), 1.66-160(m,1H).
實施例87:(1S,3S,4S)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物95)Example 87: (1 S ,3 S ,4 S )-2-((3-chlorophenyl)glycinyl)-5,5-difluoro-N-(( S , E )-4-fluoro -4-(Methylsulfonyl)-1-(( S )-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2] Octane-3-formamide (compound 95)
步驟(1):2-(3-氯苯胺基)乙酸甲酯Step (1): Methyl 2-(3-chloroanilino)acetate
用氮氣對溴乙酸甲酯(1.5mL,15.7mmol)、3-氯苯胺(1.7mL,15.7mmol)和碳酸鉀(2.2g,15.7mmol)在DMF(40mL)中的混合物進行脫氣。將混合物在室溫下攪拌12小時。將反應混合物在水(200mL)和EtOAc(50mL)之間分配。將有機相分離,用鹽水溶液(50mL)洗滌,經無水硫酸鈉乾燥,過濾並濃縮。通過正相SiO2層析法(0-10% EtOAc/石油醚)純化殘餘物,得到2-(3-氯苯胺基)乙酸甲酯,為白色固體(1.4g,產率43%,觀察到m/z:200[M+H]+)。1H NMR(400MHz,CDCl3):δ 7.03(t,1H),6.65(d,1H),6.51-6.49(m,1H),6.43-6.40(m,1H),3.83(s,2H),3.73(s,3H)。 A mixture of methyl bromoacetate (1.5 mL, 15.7 mmol), 3-chloroaniline (1.7 mL, 15.7 mmol) and potassium carbonate (2.2 g, 15.7 mmol) in DMF (40 mL) was degassed with nitrogen. The mixture was stirred at room temperature for 12 hours. The reaction mixture was partitioned between water (200 mL) and EtOAc (50 mL). The organic phase was separated, washed with brine solution (50 mL), dried over anhydrous sodium sulfate, filtered and concentrated. Purification of the residue by normal phase SiO2 chromatography (0-10% EtOAc/petroleum ether) afforded methyl 2-(3-chloroanilino)acetate as a white solid (1.4 g, 43% yield, observed m/z: 200[M+H] + ). 1 H NMR (400MHz, CDCl 3 ): δ 7.03(t,1H), 6.65(d,1H), 6.51-6.49(m,1H), 6.43-6.40(m,1H), 3.83(s,2H), 3.73(s,3H).
步驟(2):2-(3-氯苯胺基)乙酸Step (2): 2-(3-Chloroanilino)acetic acid
向2-(3-氯苯胺基)乙酸甲酯(0.7g,3.5mmol)在THF(18mL)中的溶液加入氫氧化鋰一水化物(912mg,21.7mmol)和水(3.5mL)。將混合物在室溫下攪拌1小時。將殘餘物用H2O(50mL)稀釋,加 入水性HCl(1N)以將pH調節至3並用乙酸乙酯(50mL×2)萃取。將合併後的有機相用鹽水溶液(50mL)洗滌,經無水硫酸鈉乾燥,過濾並在減壓下濃縮,得到2-(3-氯苯胺基)乙酸,為黃色固體,其無需進一步純化即可用於下一步(0.66g,產率91%,觀察到m/z:186[M+H]+)。 To a solution of methyl 2-(3-chloroanilino)acetate (0.7 g, 3.5 mmol) in THF (18 mL) was added lithium hydroxide monohydrate (912 mg, 21.7 mmol) and water (3.5 mL). The mixture was stirred at room temperature for 1 hour. The residue was diluted with H 2 O (50 mL), aqueous HCl (1 N) was added to adjust the pH to 3 and extracted with ethyl acetate (50 mL×2). The combined organic phases were washed with brine solution (50 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to give 2-(3-chloroanilino)acetic acid as a yellow solid which was used without further purification In the next step (0.66 g, 91% yield, observed m/z: 186 [M+H] + ).
步驟(3):(1S,3S,4S)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺Step (3): (1S,3S,4S)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4 -(Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide
向(1S,3S,4S)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽(78mg,0.17mol)和2-(3-氯苯胺基)乙酸(31mg,0.17mmol)在DMF(2mL)中的溶液加入HATU(84mg,0.22mol)和DIEA(148μL,0.85mmol)。將混合物在室溫下攪拌1小時。將反應混合物用EtOAc(50mL)稀釋,並用鹽水溶液(3×50mL)洗滌。將合併後的有機相經無水硫酸鈉乾燥,過濾並濃縮。通過反相HPLC純化殘餘物,得到(1S,3S,4S)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺,為白色固體(16mg,產率15%,觀察到m/z:591[M+H]+);1H NMR(400MHz,CD3OD):δ 7.25-7.15(m,1H),7.10-6.75(m,3H),6.10-5.95(m,1H),4.86-4.79(m,1H),4.44(s,1H),4.28-4.06(m,3H),3.21(td,2H),3.20-3.10(m,2H),3.02(s,3H),2.60-2.44(m,2H),2.41-2.21(m,2H),2.19-1.97(m,3H),1.79-1.58(m,4H),1.57-1.46(m,1H)。 To (1 S ,3 S ,4 S )-5,5-difluoro- N -(( S , E )-4-fluoro-4-(methylsulfonyl)-1-(( S )-2 -Oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride (78mg, 0.17mol) and 2 To a solution of -(3-chloroanilino)acetic acid (31 mg, 0.17 mmol) in DMF (2 mL) was added HATU (84 mg, 0.22 mol) and DIEA (148 μL, 0.85 mmol). The mixture was stirred at room temperature for 1 hour. The reaction mixture was diluted with EtOAc (50 mL) and washed with brine solution (3 x 50 mL). The combined organic phases were dried over anhydrous sodium sulfate, filtered and concentrated. Purification of the residue by reverse-phase HPLC gave ( 1S , 3S , 4S )-2-((3-chlorophenyl)glycinyl)-5,5-difluoro- N -(( S , E )-4-fluoro-4-(methylsulfonyl)-1-(( S )-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo [2.2.2] Octane-3-formamide, as a white solid (16 mg, yield 15%, observed m/z: 591 [M+H] + ); 1 H NMR (400MHz, CD 3 OD) : δ 7.25-7.15(m,1H), 7.10-6.75(m,3H), 6.10-5.95(m,1H), 4.86-4.79(m,1H), 4.44(s,1H), 4.28-4.06(m ,3H), 3.21(td,2H), 3.20-3.10(m,2H), 3.02(s,3H), 2.60-2.44(m,2H), 2.41-2.21(m,2H), 2.19-1.97(m ,3H), 1.79-1.58(m,4H), 1.57-1.46(m,1H).
實施例88:8-(4-氟-1H-吲哚-2-羰基)-N-[(1S)-3-氟-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]丙基]-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺(化合物96和97)Example 88: 8-(4-Fluoro- 1H -indole-2-carbonyl) -N -[( 1S )-3-fluoro-2-oxo-1-[[( 3S )-2 -Oxopyrrolidin-3-yl]methyl]propyl]-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide (compounds 96 and 97)
步驟(1):8-(4-氟-1H-吲哚-2-羰基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-羧酸甲酯Step (1): Methyl 8-(4-fluoro-1H-indole-2-carbonyl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxylate
向5-氧雜-8-氮雜螺[3.5]壬烷-9-羧酸甲酯鹽酸鹽(141mg,0.64mmol)、4-氟-1H-吲哚-2-羧酸(114mg,0.64mmol)和HATU(363mg,0.95mmol)在NMP(3.2mL)中的溶液加入DIPEA(333μL,1.9mmol)。將反應混合物在室溫下攪拌3小時。向反應混合物加入水性HCl(1N,3mL)和水(3mL)。將混合物用EtOAc(3×20mL)萃取3次。用水溶液洗滌合併後的有機相鹽(2次),經無水硫酸鈉乾燥,過濾,並在真空下濃縮。通過正相SiO2管柱層析法(25-100% EtOAc/己烷)純化粗殘餘物,得到8-(4-氟-1H-吲哚-2-羰基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-羧酸甲酯,為白色固體(175mg,產率80%,觀察到m/z:347[M+H]+)。 To 5-oxa-8-azaspiro[3.5]nonane-9-carboxylic acid methyl ester hydrochloride (141mg, 0.64mmol), 4-fluoro- 1H -indole-2-carboxylic acid (114mg, 0.64 mmol) and HATU (363 mg, 0.95 mmol) in NMP (3.2 mL) was added DIPEA (333 μL, 1.9 mmol). The reaction mixture was stirred at room temperature for 3 hours. Aqueous HCl (1 N, 3 mL) and water (3 mL) were added to the reaction mixture. The mixture was extracted 3 times with EtOAc (3 x 20 mL). The combined organic phase salts were washed with aqueous solution (2x), dried over anhydrous sodium sulfate, filtered and concentrated in vacuo. Purification of the crude residue by normal phase SiO column chromatography (25-100% EtOAc/hexanes) afforded 8-(4-fluoro-1H-indole-2-carbonyl)-5-oxa-8- Methyl azaspiro[3.5]nonane-9-carboxylate as a white solid (175 mg, 80% yield, observed m/z: 347 [M+H] + ).
步驟(2):8-(4-氟-1H-吲哚-2-羰基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-羧酸Step (2): 8-(4-fluoro-1H-indole-2-carbonyl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxylic acid
向8-(4-氟-1H-吲哚-2-羰基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-羧酸甲酯(175mg,0.51mmol)在THF(2.5mL)中的溶液加入LiOH(1N的水溶液,556μL,0.56mmol)。將反應混合物在室溫下攪拌30分鐘。向反應混合物加入水,隨後加入HCl(1N的水溶液),直到pH達到2。將混合物用EtOAc(3×15mL)萃取。將合併後的有機相經無水硫酸鈉乾燥,過濾,並在真空下濃縮,得到8-(4-氟-1H-吲哚-2-羰基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-羧酸,為白色泡沫(定量獲得181mg,觀察到m/z:333[M+H]+),其無需進一步純化即可用於下一步。 To 8-(4-fluoro-1H-indole-2-carbonyl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxylic acid methyl ester (175mg, 0.51mmol) in THF (2.5 mL) was added LiOH (IN in water, 556 μL, 0.56 mmol). The reaction mixture was stirred at room temperature for 30 minutes. Water was added to the reaction mixture followed by HCl (1 N in water) until pH 2 was reached. The mixture was extracted with EtOAc (3 x 15 mL). The combined organic phases were dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo to give 8-(4-fluoro- 1H -indole-2-carbonyl)-5-oxa-8-azaspiro[ 3.5] Nonane-9-carboxylic acid as a white foam (181 mg obtained quantitatively, observed m/z: 333 [M+H] + ), which was used in the next step without further purification.
步驟(3):(3S)-3-[(2S)-2-胺基-4-氟-3-側氧基-丁基]吡咯啶-2-酮Step (3): (3S)-3-[(2S)-2-Amino-4-fluoro-3-oxo-butyl]pyrrolidin-2-one
向N-[(1S)-3-氟-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]丙基]胺基甲酸第三丁酯(200mg,0.69mmol;根據國際申請號PCT/CN2021/076400中描述的程序製備,其通過引用以其整體併入本文)在CH2Cl2(3.5mL)中的溶液逐滴加入HCl(4N的1,4-二烷溶液,694μL,2.8mmol)。將反應混合物在室溫下攪拌15分鐘。向該混合物加入MeOH(0.1mL)。將反應混合物在室溫下攪拌1.5小時,並在真空下濃縮,以提供(3S)-3-[(2S)-2-胺基-4-氟-3-側氧基-丁基]吡咯啶-2-酮的鹽酸鹽,為白色泡沫(定量獲得130mg,觀察到m/z:389[M+H]+),其無需進一步純化即可用於下一步。 To N-[(1S)-3-fluoro-2-oxo-1-[[(3S)-2-oxopyrrolidin-3-yl]methyl]propyl]carbamate tertiary butyl ester (200 mg, 0.69 mmol; prepared according to the procedure described in International Application No. PCT/CN2021/076400, which is incorporated herein by reference in its entirety) in CH 2 Cl 2 (3.5 mL) was added dropwise in HCl (4N 1,4-di alkane solution, 694 μL, 2.8 mmol). The reaction mixture was stirred at room temperature for 15 minutes. To this mixture was added MeOH (0.1 mL). The reaction mixture was stirred at room temperature for 1.5 hours and concentrated in vacuo to afford ( 3S )-3-[( 2S )-2-amino-4-fluoro-3-oxo-butyl] The hydrochloride salt of pyrrolidin-2-one as a white foam (130 mg quantified, observed m/z: 389 [M+H] + ) was used in the next step without further purification.
步驟(4):8-(4-氟-1H-吲哚-2-羰基)-N-[(1S)-3-氟-2-側氧基-1-[[(3S)-Step (4): 8-(4-fluoro-1H-indole-2-carbonyl)-N-[(1S)-3-fluoro-2-oxo-1-[[(3S)- 2-氧代吡咯啶-3-基]甲基]丙基]-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺2-oxopyrrolidin-3-yl]methyl]propyl]-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide
向8-(4-氟-1H-吲哚-2-羰基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-羧酸(60mg,0.18mmol)和(3S)-3-[(2S)-2-胺基-4-氟-3-側氧基-丁基]吡咯啶-2-酮鹽酸鹽(48mg,0.21mmol)在CH2Cl2(0.9mL)和THF(0.9mL)中的溶液加入DCC(74mg,0.36mmol)。將反應混合物在室溫下攪拌2小時。向該混合物加入DMA(0.39mL)。將反應混合物在室溫下攪拌21小時,並且然後過濾。將濾液在真空中濃縮。將粗殘餘物首先通過正相SiO2管柱層析法(0-10% MeOH/CH2Cl2)純化並且然後通過反相製備型HPLC純化,得到分離的非對映異構物。 To 8-(4-fluoro- 1H -indole-2-carbonyl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxylic acid (60mg, 0.18mmol) and (3 S ) -3-[( 2S )-2-amino-4-fluoro-3-oxo-butyl]pyrrolidin-2-one hydrochloride (48 mg, 0.21 mmol) in CH 2 Cl 2 (0.9 mL ) and THF (0.9 mL) was added DCC (74 mg, 0.36 mmol). The reaction mixture was stirred at room temperature for 2 hours. To this mixture was added DMA (0.39 mL). The reaction mixture was stirred at room temperature for 21 hours, and then filtered. The filtrate was concentrated in vacuo. The crude residue was purified first by normal phase SiO 2 column chromatography (0-10% MeOH/CH 2 Cl 2 ) and then by reverse phase preparative HPLC to afford the separated diastereoisomers.
次要非對映異構物(化合物96):(較快洗脫的非對映異構物,單一非對映異構物I):(1.2mg,產率1%,觀察到m/z:503[M+H]+);1H NMR(400MHz,CD3OD):δ 8.55(d,1H),7.32-7.23(m,1H),7.19(td,1H),6.97(s,1H),6.76(dd,1H),5.19-5.07(m,1H),4.56-4.36(m,1H),4.35-4.15(m,2H),4.02(s,1H),3.82(d,2H),2.60-2.26(m,4H),2.27-1.99(m,5H),1.99-1.63(m,4H)。 Minor diastereomer (compound 96) : (faster eluting diastereomer, single diastereomer I): (1.2 mg, 1% yield, observed m/z : 503[M+H] + ); 1 H NMR (400MHz, CD 3 OD): δ 8.55(d,1H), 7.32-7.23(m,1H), 7.19(td,1H), 6.97(s,1H ), 6.76(dd,1H), 5.19-5.07(m,1H), 4.56-4.36(m,1H), 4.35-4.15(m,2H), 4.02(s,1H), 3.82(d,2H), 2.60-2.26 (m, 4H), 2.27-1.99 (m, 5H), 1.99-1.63 (m, 4H).
次要非對映異構物(化合物97):(較慢洗脫的非對映異構物,單一非對映異構物II):(1.9mg,產率2%,觀察到m/z:503[M+H]+);1H NMR(400MHz,CD3OD):δ 7.27(d,1H),7.23-7.12(m,1H),6.98(s,1H),6.76(dd,1H),5.31-5.02(m,2H),4.57-4.34(m,1H),4.33-4.15(m,2H),3.84(d,2H),3.41-3.21(m,2H),2.60-2.30(m,4H),2.28-1.97(m,5H),1.97-1.64(m,5H)。 Minor diastereomer (compound 97) : (slower eluting diastereomer, single diastereomer II): (1.9 mg, 2% yield, observed m/z : 503[M+H] + ); 1 H NMR (400MHz, CD 3 OD): δ 7.27(d,1H), 7.23-7.12(m,1H), 6.98(s,1H), 6.76(dd,1H ), 5.31-5.02(m,2H), 4.57-4.34(m,1H), 4.33-4.15(m,2H), 3.84(d,2H), 3.41-3.21(m,2H), 2.60-2.30(m ,4H), 2.28-1.97(m,5H), 1.97-1.64(m,5H).
實施例89:8-(7-氯-1H-吲哚-2-羰基)-N-[(1S)-3-氟-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]丙基]-5-氧雜-8-氮雜螺[3.5]壬烷-9-Example 89: 8-(7-Chloro- 1H -indole-2-carbonyl) -N -[( 1S )-3-fluoro-2-oxo-1-[[( 3S )-2 -Oxopyrrolidin-3-yl]methyl]propyl]-5-oxa-8-azaspiro[3.5]nonane-9- 甲醯胺(化合物98和99)Formamide (Compounds 98 and 99)
通過將(3S)-3-[(2S)-2-胺基-4-氟-3-側氧基-丁基]吡咯啶-2-酮鹽酸鹽與適當的羧酸偶合以與關於8-(4-氟-1H-吲哚-2-羰基)-N-[(1S)-3-氟-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]丙基]-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺所描述的類似方式來製備8-(7-氯-1H-吲哚-2-羰基)-N-[(1S)-3-氟-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]丙基]-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺,以獲得8-(7-氯-1H-吲哚-2-羰基)-N-[(1S)-3-氟-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]丙基]-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺的分離的非對映異構物。 By coupling ( 3S )-3-[( 2S )-2-amino-4-fluoro-3-oxo-butyl]pyrrolidin-2-one hydrochloride with an appropriate carboxylic acid to About 8-(4-fluoro-1 H -indole-2-carbonyl) -N -[(1 S )-3-fluoro-2-oxo-1-[[(3 S )-2-oxo 8-(7-chloro-1 H -indole-2-carbonyl) -N -[(1 S )-3-fluoro-2-oxo-1-[[(3 S )-2-oxopyrrolidin-3-yl]methyl ]propyl]-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide to obtain 8-(7-chloro- 1H -indole-2-carbonyl) -N- [ (1 S )-3-fluoro-2-oxo-1-[[(3 S )-2-oxopyrrolidin-3-yl]methyl]propyl]-5-oxa-8-nitrogen Isolated diastereoisomers of heterospiro[3.5]nonane-9-carboxamide.
主要非對映異構物(化合物98):(單一非對映異構物I,較快洗脫的非對映異構物):(3.7mg,產率5%,觀察到m/z:519[M+H]+);1H NMR(400MHz,CD3OD):δ 7.68-7.52(m,1H),7.33-7.22(m,1H),7.14-7.02(m,1H),6.97(s,1H),5.37-5.04(m,2H),4.59-4.22(m,2H),4.14(s,1H),3.81(s,2H),3.41-3.22(m,3H),2.62-2.27(m,3H),2.27-2.12(m,3H),2.12-1.97(m,1H),1.97-1.61(m,4H)。 Major diastereomer (compound 98) : (single diastereomer I, faster eluting diastereomer): (3.7 mg, 5% yield, observed m/z: 519[M+H] + ); 1 H NMR (400MHz, CD 3 OD): δ 7.68-7.52 (m, 1H), 7.33-7.22 (m, 1H), 7.14-7.02 (m, 1H), 6.97 ( s,1H), 5.37-5.04(m,2H), 4.59-4.22(m,2H), 4.14(s,1H), 3.81(s,2H), 3.41-3.22(m,3H), 2.62-2.27( m, 3H), 2.27-2.12 (m, 3H), 2.12-1.97 (m, 1H), 1.97-1.61 (m, 4H).
次要非對映異構物(化合物99):(單一非對映異構物II,較慢洗脫的非對映異構物):(1.6mg,產率2%,觀察到m/z:519[M+H]+);1H NMR(400MHz,CD3OD):δ 7.68-7.52(m,1H),7.27(ddd,1H),7.11-7.02(m,1H),6.97(s,1H),5.36-5.04(m,2H),4.57-4.08(m,3H),3.82(s,2H),3.41-3.21(m,1H),2.61-2.28(m,4H),2.28-2.13(m,3H),2.13-2.00(m,2H),1.99-1.65(m,4H)。 Minor diastereomer (compound 99) : (single diastereomer II, slower eluting diastereomer): (1.6 mg, 2% yield, observed m/z : 519[M+H] + ); 1 H NMR (400MHz, CD 3 OD): δ 7.68-7.52(m, 1H), 7.27(ddd, 1H), 7.11-7.02(m, 1H), 6.97(s ,1H), 5.36-5.04(m,2H), 4.57-4.08(m,3H), 3.82(s,2H), 3.41-3.21(m,1H), 2.61-2.28(m,4H), 2.28-2.13 (m,3H), 2.13-2.00(m,2H), 1.99-1.65(m,4H).
實施例90:(1S,3S,4S)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙Example 90: (1 S ,3 S ,4 S )-2-(2-(3-chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro- N -(( S )-4-fluoro-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabis 環[2.2.2]辛烷-3-甲醯胺(化合物100)Cyclo[2.2.2]octane-3-carboxamide (compound 100)
通過將(3S)-3-[(2S)-2-胺基-4-氟-3-側氧基-丁基]吡咯啶-2-酮鹽酸鹽與適當的羧酸偶合以與關於8-(7-氯-1H-吲哚-2-羰基)-N-[(1S)-3-氟-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]丙基]-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺所描述的類似方式來製備(1S,3S,4S)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺;觀察到m/z:550[M+H]+;1H NMR(400MHz,CD3OD):δ 7.67(q,1H),7.61-7.52(m,3H),5.24-5.01(m,2H),4.33-4.29(m,1H),4.21-4.08(m,1H),3.83-3.74(m,1H),3.62-3.54(m,2H),3.29-3.09(m,2H),2.83-2.76(m,1H),2.68-2.54(m,2H),2.36-2.30(m,1H),1.85-1.68(m,6H),1.33(s,1H)。 By coupling ( 3S )-3-[( 2S )-2-amino-4-fluoro-3-oxo-butyl]pyrrolidin-2-one hydrochloride with an appropriate carboxylic acid to Regarding 8-(7-chloro-1 H -indole-2-carbonyl) -N -[(1 S )-3-fluoro-2-oxo-1-[[(3 S )-2-oxo Pyrrolidin-3-yl]methyl]propyl]-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide was prepared in a similar manner as described (1 S , 3 S , 4 S )-2-(2-(3-chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro- N -(( S )-4-fluoro-3-oxo -1-(( S )-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide; observed m/ z: 550[M+H] + ; 1 H NMR (400MHz, CD 3 OD): δ 7.67(q, 1H), 7.61-7.52(m, 3H), 5.24-5.01(m, 2H), 4.33-4.29 (m,1H), 4.21-4.08(m,1H), 3.83-3.74(m,1H), 3.62-3.54(m,2H), 3.29-3.09(m,2H), 2.83-2.76(m,1H) , 2.68-2.54 (m, 2H), 2.36-2.30 (m, 1H), 1.85-1.68 (m, 6H), 1.33 (s, 1H).
實施例91:(1S,3aR,6aS)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺(化合物101)Example 91: (1 S ,3a R ,6a S )-2-(2-(3-chlorophenyl)-2,2-difluoroacetyl) -N -(( S )-4-fluoro- 3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane-2-yl)octahydrocyclopenta[ c ]pyrrole-1-carboxamide (compound 101)
通過將(3S)-3-[(2S)-2-胺基-4-氟-3-側氧基-丁基]吡咯啶-2-酮鹽酸鹽與適當的羧酸偶合以與關於8-(7-氯-1H-吲哚-2-羰基)-N-[(1S)-3-氟-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]丙基]-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺所描述的類似方式來製備(1S,3aR,6aS)- 2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺;觀察到m/z:514[M+H]+;1H NMR(400MHz,CD3OD):δ 7.62-7.47(m,4H),5.24-4.98(m,1H),4.71(dd,1H),4.44-4.13(m,2H),3.74(dd,1H),3.51(d,1H),3.29-3.12(m,2H),2.78-2.70(m,1H),2.70-2.55(m,2H),2.35-229(m,1H),2.15(s,1H),2.12-2.00(m,1H),1.98-1.92(m,1H),1.89-1.77(m,2H),1.75-1.63(m,3H),1.32-1.24(m,1H)。 By coupling ( 3S )-3-[( 2S )-2-amino-4-fluoro-3-oxo-butyl]pyrrolidin-2-one hydrochloride with an appropriate carboxylic acid to Regarding 8-(7-chloro-1 H -indole-2-carbonyl) -N -[(1 S )-3-fluoro-2-oxo-1-[[(3 S )-2-oxo Pyrrolidin-3-yl]methyl]propyl]-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide was prepared in a similar manner as described (1 S , 3a R , 6a S )-2-(2-(3-chlorophenyl)-2,2-difluoroacetyl) -N -(( S )-4-fluoro-3-oxo-1-(( S ) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[ c ]pyrrole-1-carboxamide; observed m/z: 514[M+H] + ; 1 H NMR (400MHz, CD 3 OD): δ 7.62-7.47(m,4H), 5.24-4.98(m,1H), 4.71(dd,1H), 4.44-4.13(m,2H), 3.74(dd,1H) , 3.51(d,1H), 3.29-3.12(m,2H), 2.78-2.70(m,1H), 2.70-2.55(m,2H), 2.35-229(m,1H), 2.15(s,1H) , 2.12-2.00 (m, 1H), 1.98-1.92 (m, 1H), 1.89-1.77 (m, 2H), 1.75-1.63 (m, 3H), 1.32-1.24 (m, 1H).
實施例92:(1S,3aR,6aS)-2-(2,2-二氟-2-(3-氟苯基)乙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺(化合物102)Example 92: (1 S ,3a R ,6a S )-2-(2,2-difluoro-2-(3-fluorophenyl)acetyl) -N -(( S )-4-fluoro- 3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butane-2-yl)octahydrocyclopenta[ c ]pyrrole-1-carboxamide (compound 102)
通過將(1S,3aR,6aS)-2-(2,2-二氟-2-(3-氟苯基)乙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺與適當的羧酸偶合以與關於8-(7-氯-1H-吲哚-2-羰基)-N-[(1S)-3-氟-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]丙基]-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺所描述的類似方式來製備(1S,3aR,6aS)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺;觀察到m/z:498[M+H]+;1H NMR(400MHz,CD3OD):δ 7.67(q,1H),7.61-7.52(m,3H),5.24-5.01(m,2H),4.33-4.29(m,1H),4.21-4.08(m,1H),3.83-3.74(m,1H),3.62-3.54(m,2H),3.29-3.09(m,2H),2.79(ddd,1H),2.63(dtd,2H),2.32(ddt,1H),2.04-1.97(m,2H),1.87-1.82(m,2H),1.75-1.67(m,3H),1.33(s,1H)。 By adding (1 S ,3a R ,6a S )-2-(2,2-difluoro-2-(3-fluorophenyl)acetyl) -N -(( S )-4-fluoro-3- Oxy-1-(( S )-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[ c ]pyrrole-1-carboxamide is coupled with an appropriate carboxylic acid to With respect to 8-(7-chloro-1 H -indole-2-carbonyl) -N -[(1 S )-3-fluoro-2-oxo-1-[[(3 S )-2-oxo Pyrrolidin-3-yl]methyl]propyl]-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide was prepared in a manner similar to that described for (1 S , 3a R , 6a S )-2-(2-(3-chlorophenyl)-2,2-difluoroacetyl) -N -(( S )-4-fluoro-3-oxo-1-(( S )-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[ c ]pyrrole-1-carboxamide; observed m/z: 498[M+H] + ; 1 H NMR (400MHz, CD 3 OD): δ 7.67(q,1H), 7.61-7.52(m,3H), 5.24-5.01(m,2H), 4.33-4.29(m,1H), 4.21-4.08(m ,1H), 3.83-3.74(m,1H), 3.62-3.54(m,2H), 3.29-3.09(m,2H), 2.79(ddd,1H), 2.63(dtd,2H), 2.32(ddt,1H ), 2.04-1.97(m,2H), 1.87-1.82(m,2H), 1.75-1.67(m,3H), 1.33(s,1H).
實施例93:(1S,3aR,6aS)-2-(2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺(化合物103和104)Example 93: (1 S ,3a R ,6a S )-2-(2-fluoro-2-(3-fluorophenyl)propionyl) -N -(( S )-4-fluoro-3-side Oxy-1-(( S )-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[ c ]pyrrole-1-carboxamide (Compounds 103 and 104)
通過將(1S,3aR,6aS)-2-(2,2-二氟-2-(3-氟苯基)乙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺與適當的羧酸偶合以與關於8-(7-氯-1H-吲哚-2-羰基)-N-[(1S)-3-氟-2-側氧基-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]丙基]-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺所描述的類似方式來製備(1S,3aR,6aS)-2-(2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺(非對映異構物的混合物)。通過反相HPLC分離(1S,3aR,6aS)-2-(2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺(非對映異構物的混合物,25mg)。 By adding (1 S ,3a R ,6a S )-2-(2,2-difluoro-2-(3-fluorophenyl)acetyl) -N -(( S )-4-fluoro-3- Oxy-1-(( S )-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[ c ]pyrrole-1-carboxamide is coupled with an appropriate carboxylic acid to With respect to 8-(7-chloro-1 H -indole-2-carbonyl) -N -[(1 S )-3-fluoro-2-oxo-1-[[(3 S )-2-oxo Pyrrolidin-3-yl]methyl]propyl]-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide was prepared in a manner similar to that described for (1 S , 3a R , 6a S )-2-(2-fluoro-2-(3-fluorophenyl) propionyl) -N -(( S )-4-fluoro-3-side oxy-1-(( S )-2 -oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[ c ]pyrrole-1-carboxamide (mixture of diastereoisomers). (1 S , 3a R , 6a S )-2-(2-fluoro-2-(3-fluorophenyl)propionyl) -N -(( S )-4-fluoro-3- Oxy-1-(( S )-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[ c ]pyrrole-1-carboxamide (diastereoisomer mixture, 25mg).
次要非對映異構物(化合物103):(單一非對映異構物I,較快洗脫的非對映異構物):(5.1mg,產率10%,觀察到m/z:494[M+H]+);1H NMR(400MHz,CD3OD):δ 7.44(d,1H),7.27-7.04(m,3H),5.23-5.00(m,1H),4.71(s,1H),4.28(s,2H),3.91-3.32(m,4H),2.73-2.31(m,4H),2.02-1.35(m,11H),0.76(s,1H)。 Minor diastereomer (compound 103) : (single diastereomer I, faster eluting diastereomer): (5.1 mg, 10% yield, observed m/z : 494[M+H] + ); 1 H NMR (400MHz, CD 3 OD): δ 7.44(d, 1H), 7.27-7.04(m, 3H), 5.23-5.00(m, 1H), 4.71(s ,1H), 4.28(s,2H), 3.91-3.32(m,4H), 2.73-2.31(m,4H), 2.02-1.35(m,11H), 0.76(s,1H).
主要非對映異構物(化合物104):(單一非對映異構物II,較慢洗脫的非對映異構物):(5.6mg,產率11%,觀察到m/z:494[M+H]+);1H NMR(400MHz,CD3OD):δ 7.43(t,1H),7.28-7.05(m,3H),5.23-5.00(m,1H),4.69(d,1H),4.30(d,1H),4.25-4.11(m,1H),3.85(s,1H),3.57(s,1H),3.37(d,2H),2.72-2.49(m,4H),2.40-2.32(m,1H),1.91-1.79(m,4H),1.77-1.72(m,2H), 1.70-1.59(s,2H),1.51(q,1H),1.46-1.36(m,1H),0.82-0.70(m,1H)。 Major diastereomer (compound 104) : (single diastereomer II, slower eluting diastereomer): (5.6 mg, 11% yield, observed m/z: 494[M+H] + ); 1 H NMR (400MHz, CD 3 OD): δ 7.43(t,1H), 7.28-7.05(m,3H), 5.23-5.00(m,1H), 4.69(d, 1H), 4.30(d,1H), 4.25-4.11(m,1H), 3.85(s,1H), 3.57(s,1H), 3.37(d,2H), 2.72-2.49(m,4H), 2.40 -2.32(m,1H), 1.91-1.79(m,4H), 1.77-1.72(m,2H), 1.70-1.59(s,2H), 1.51(q,1H), 1.46-1.36(m,1H) , 0.82-0.70 (m, 1H).
實施例94:(1S,3S,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-[(1S,2E)-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]-2-(2-氧代四氫呋喃-3-基亞基)乙基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物105)Example 94: (1 S ,3 S ,4 S )-5,5-difluoro-2-(4-methoxy-1 H -indole-2-carbonyl) -N -[(1 S ,2 E )-1-[[( 3S )-2-oxopyrrolidin-3-yl]methyl]-2-(2-oxotetrahydrofuran-3-ylidene)ethyl]-2-aza Bicyclo[2.2.2]octane-3-carboxamide (compound 105)
步驟(1):((S)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基甲酸第三丁酯(順式/反式異構物)Step (1): ((S)-1-(2-oxodihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propane -2-yl) tertiary butyl carbamate (cis/trans isomer)
在0℃下向N-[(1S)-1-甲醯基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]胺基甲酸第三丁酯(115mg,0.45mmol)和3-二乙氧基磷醯基四氫呋喃-2-酮(100mg,0.45mmol)在THF(0.9mL)中的溶液分批加入碳酸鉀(10M的H2O中的懸浮液,135μL,1.35mmol)。將反應混合物攪拌22小時,逐漸升溫至室溫。向反應混合物加入水(20mL)。將混合物用二乙醚(3×15mL),然後用CH2Cl2(3×15mL)萃取。將合併後的有機物用水性鹽水溶液(15mL)洗滌,經無水硫酸鈉乾燥,過濾,並在真空下濃縮。通過正相SiO2管柱層析法(40-60%丙酮/CH2Cl2)純化粗殘餘物,得到N-[(1S,2E)-2-(2-氧代四氫呋喃-3-基亞基)-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]胺基甲酸第三丁酯,為白色固體(41mg,產率28%,觀察到m/z:225[M-Boc]+)和N-[(1S,2Z)-2-(2-氧代四氫呋喃- 3-基亞基)-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]胺基甲酸第三丁酯,為白色固體(52mg,產率36%,觀察到m/z:225[M-Boc]+)。 tertiary butyl N-[(1S)-1-formyl-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl]carbamate (115 mg, 0.45 mmol) and 3-diethoxyphosphoryltetrahydrofuran-2-one (100mg, 0.45mmol) in THF (0.9mL) were added portionwise to a suspension of potassium carbonate (10M in H 2 O, 135 μL, 1.35 mmol). The reaction mixture was stirred for 22 hours, gradually warming to room temperature. Water (20 mL) was added to the reaction mixture. The mixture was extracted with diethyl ether (3 x 15 mL), then CH2Cl2 (3 x 15 mL). The combined organics were washed with aqueous brine solution (15 mL), dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. The crude residue was purified by normal phase SiO2 column chromatography (40-60% acetone/ CH2Cl2 ) to afford N-[(1S, 2E )-2-(2-oxotetrahydrofuran-3-ylidene base)-1-[[(3S)-2-oxopyrrolidin-3-yl]methyl]ethyl]carbamate as a white solid (41 mg, yield 28%, observed m /z: 225[M-Boc] + ) and N-[(1S,2Z)-2-(2-oxotetrahydrofuran-3-yl subunit)-1-[[(3S)-2-oxopyrrole tert-butylpyridin-3-yl]methyl]ethyl]carbamate as a white solid (52 mg, 36% yield, observed m/z: 225 [M-Boc] + ).
步驟(2):(3S)-3-[(2S,3E)-2-胺基-3-(2-氧代四氫呋喃-3-基亞基)丙基]吡咯啶-2-酮Step (2): (3S)-3-[(2S,3E)-2-Amino-3-(2-oxotetrahydrofuran-3-ylidene)propyl]pyrrolidin-2-one
向N-[(1S,2E)-2-(2-氧代四氫呋喃-3-基亞基)-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]胺基甲酸第三丁酯(41mg,0.13mmol)在CH2Cl2(0.65mL)中的溶液逐滴加入鹽酸(4N的1,4-二烷溶液,128μL,0.51mmol)。將反應混合物在室溫下攪拌15分鐘。向該混合物加入MeOH(0.1mL)。將反應混合物在室溫下攪拌22小時,並在真空下濃縮,以提供(3S)-3-[(2S,3E)-2-胺基-3-(2-氧代四氫呋喃-3-基亞基)丙基]吡咯啶-2-酮的鹽酸鹽,為白色泡沫(定量獲得33mg,觀察到m/z:225[M+H]+),其無需進一步純化即可用於下一步。 To N-[(1S,2E)-2-(2-oxotetrahydrofuran-3-yl subunit)-1-[[(3S)-2-oxopyrrolidin-3-yl]methyl]ethyl ] A solution of tert-butyl carbamate (41 mg, 0.13 mmol) in CH 2 Cl 2 (0.65 mL) was added dropwise to hydrochloric acid (4N 1,4-di alkane solution, 128 μL, 0.51 mmol). The reaction mixture was stirred at room temperature for 15 minutes. To this mixture was added MeOH (0.1 mL). The reaction mixture was stirred at room temperature for 22 hours and concentrated in vacuo to provide ( 3S )-3-[( 2S , 3E )-2-amino-3-(2-oxotetrahydrofuran-3 -Yylidene)propyl]pyrrolidin-2-one hydrochloride as a white foam (33 mg obtained quantitatively, observed m/z: 225 [M+H] + ), which was used without further purification in the following step.
步驟(3):(1S,3S,4S)-5,5-二氟-3-[[(1S,2E)-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]-2-(2-氧代四氫呋喃-3-基亞基)乙基]胺甲醯基]-2-氮雜雙環[2.2.2]辛烷-2-羧酸第三丁酯Step (3): (1S,3S,4S)-5,5-Difluoro-3-[[(1S,2E)-1-[[(3S)-2-oxopyrrolidin-3-yl]methanol Base]-2-(2-oxotetrahydrofuran-3-ylidene)ethyl]aminoformyl]-2-azabicyclo[2.2.2]octane-2-carboxylic acid tert-butyl ester
在0℃下向(3S)-3-[(2S,3E)-2-胺基-3-(2-氧代四氫呋喃-3-基亞基)丙基]吡咯啶-2-酮鹽酸鹽(33mg,0.13mmol)、(1S,3S,4S)-2-第三丁氧基羰基-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-羧酸(31mg, 0.10mmol)和EDC(36mg,0.19mmol)在DMA(1.1mL)中的溶液加入DMAP(38mg,0.32mmol)。將反應混合物在0℃下攪拌2小時。向該混合物加入DIPEA(18μL,0.10mmol)並在3小時後再加入DIPEA(18μL,0.10mmol)。將反應物攪拌20小時,逐漸升溫至室溫。向反應混合物加入鹽酸(1N的水溶液,5mL)和水(5mL)。將混合物用EtOAc(3×15mL)萃取。用水性鹽水溶液(3×10mL)洗滌合併後的有機相,經無水硫酸鈉乾燥,過濾,並在真空下濃縮。通過正相SiO2管柱層析法(2-10% MeOH/CH2Cl2)純化粗殘餘物,得到(1S,3S,4S)-5,5-二氟-3-[[(1S,2E)-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]-2-(2-氧代四氫呋喃-3-基亞基)乙基]胺甲醯基]-2-氮雜雙環[2.2.2]辛烷-2-羧酸第三丁酯,為白色固體(12mg,產率23%,觀察到m/z:498[M+H]+)。 To (3 S )-3-[(2 S ,3 E )-2-amino-3-(2-oxotetrahydrofuran-3-ylidene)propyl]pyrrolidin-2-one at 0°C Hydrochloride (33 mg, 0.13 mmol), (1 S ,3 S ,4 S )-2-tert-butoxycarbonyl-5,5-difluoro-2-azabicyclo[2.2.2]octane- To a solution of 3-carboxylic acid (31 mg, 0.10 mmol) and EDC (36 mg, 0.19 mmol) in DMA (1.1 mL) was added DMAP (38 mg, 0.32 mmol). The reaction mixture was stirred at 0 °C for 2 hours. To this mixture was added DIPEA (18 μL, 0.10 mmol) and after 3 hours further DIPEA (18 μL, 0.10 mmol) was added. The reaction was stirred for 20 hours, gradually warming to room temperature. Hydrochloric acid (1N in water, 5 mL) and water (5 mL) were added to the reaction mixture. The mixture was extracted with EtOAc (3 x 15 mL). The combined organic phases were washed with aqueous brine solution (3 x 10 mL), dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. The crude residue was purified by normal phase SiO 2 column chromatography (2-10% MeOH/CH 2 Cl 2 ) to afford (1S,3S,4S)-5,5-difluoro-3-[[(1S, 2E)-1-[[(3S)-2-oxopyrrolidin-3-yl]methyl]-2-(2-oxotetrahydrofuran-3-ylidene)ethyl]carbamoyl]- Tert-butyl 2-azabicyclo[2.2.2]octane-2-carboxylate as a white solid (12 mg, 23% yield, observed m/z: 498 [M+H] + ).
步驟(4):(1S,3S,4S)-5,5-二氟-N-[(1S,2E)-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]-2-(2-氧代四氫呋喃-3-基亞基)乙基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽Step (4): (1S,3S,4S)-5,5-Difluoro-N-[(1S,2E)-1-[[(3S)-2-oxopyrrolidin-3-yl]methyl ]-2-(2-oxotetrahydrofuran-3-ylidene)ethyl]-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride
向(1S,3S,4S)-5,5-二氟-3-[[(1S,2E)-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]-2-(2-氧代四氫呋喃-3-基亞基)乙基]胺甲醯基]-2-氮雜雙環[2.2.2]辛烷-2-羧酸第三丁酯(12mg,0.02mmol)在CH2Cl2(0.47mL)中的溶液逐滴加入鹽酸(4N的1,4-二烷溶液,24μL,0.9mmol)。將反應混合物在室溫下攪拌15分鐘。向該混合物加入MeOH(0.1mL)。將反應混合物在室溫下攪拌28小時並在真空下濃縮,以提供(1S,3S,4S)-5,5-二氟-N-[(1S,2E)-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]-2-(2-氧代四氫呋喃-3-基亞基)乙基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺的鹽酸鹽,為白色泡沫(定量獲得10mg,觀察到m/z:398[M+H]+), 其無需進一步純化即可用於下一步。 To (1S,3S,4S)-5,5-difluoro-3-[[(1S,2E)-1-[[(3S)-2-oxopyrrolidin-3-yl]methyl]-2 -(2-Oxotetrahydrofuran-3-ylidene)ethyl]carbamoyl]-2-azabicyclo[2.2.2]octane-2-carboxylic acid tert-butyl ester (12mg, 0.02mmol) A solution in CH 2 Cl 2 (0.47 mL) was added dropwise with hydrochloric acid (4N 1,4-di alkane solution, 24 μL, 0.9 mmol). The reaction mixture was stirred at room temperature for 15 minutes. To this mixture was added MeOH (0.1 mL). The reaction mixture was stirred at room temperature for 28 hours and concentrated under vacuum to provide ( 1S , 3S , 4S )-5,5-difluoro- N -[( 1S , 2E )-1-[ [(3 S )-2-oxopyrrolidin-3-yl]methyl]-2-(2-oxotetrahydrofuran-3-ylidene)ethyl]-2-azabicyclo[2.2.2] Octane-3-carboxamide hydrochloride as a white foam (10 mg obtained quantitatively, observed m/z: 398 [M+H] + ), which was used in the next step without further purification.
步驟(5):(1S,3S,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-[(1S,2E)-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]-2-(2-氧代四氫呋喃-3-基亞基)乙基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺Step (5): (1S,3S,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-[(1S,2E)-1- [[(3S)-2-oxopyrrolidin-3-yl]methyl]-2-(2-oxotetrahydrofuran-3-ylidene)ethyl]-2-azabicyclo[2.2.2] Octane-3-formamide
向(1S,3S,4S)-5,5-二氟-N-[(1S,2E)-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]-2-(2-氧代四氫呋喃-3-基亞基)乙基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽(10mg,0.02mmol)、4-甲氧基-1H-吲哚-2-羧酸(3.9mg,0.02mmol)和HATU(14mg,0.04mmol)在NMP(0.66mL)中的溶液加入NMM(8.7μL,0.08mmol)。將反應混合物在室溫下攪拌4小時。向該混合物加入鹽酸(1N的水溶液,5mL)和水(5mL)。將混合物用EtOAc(3×10mL)萃取。將合併後的有機物用水性鹽水溶液(3×10mL)洗滌,經無水硫酸鈉乾燥,過濾,並在真空下濃縮。通過反相HPLC純化粗殘餘物,得到(1S,3S,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-[(1S,2E)-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]-2-(2-氧代四氫呋喃-3-基亞基)乙基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺,為白色固體(4.8mg,產率43%,觀察到m/z:571[M+H]+)。1H NMR(400MHz,CD3OD):δ 7.18(d,1H),7.07(d,1H),7.00-6.76(m,1H),6.67-6.28(m,2H),5.30-4.93(m,2H),4.75(s,1H),4.54(s,1H),4.45-4.16(m,1H),4.05(s,1H),4.00-3.80(m,3H),3.14-2.81(m,2H),2.85-2.62(m,2H),2.62-2.27(m,4H),2.27-1.99(m,2H),1.99-1.72(m,3H),1.72-1.22(m,2H)。 To (1 S ,3 S ,4 S )-5,5-difluoro- N -[(1 S ,2 E )-1-[[(3 S )-2-oxopyrrolidin-3-yl] Methyl]-2-(2-oxotetrahydrofuran-3-ylidene)ethyl]-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride (10mg, 0.02mmol) , 4-Methoxy- 1H -indole-2-carboxylic acid (3.9mg, 0.02mmol) and HATU (14mg, 0.04mmol) in NMP (0.66mL) was added to NMM (8.7μL, 0.08mmol) . The reaction mixture was stirred at room temperature for 4 hours. To the mixture were added hydrochloric acid (1N in water, 5 mL) and water (5 mL). The mixture was extracted with EtOAc (3 x 10 mL). The combined organics were washed with aqueous brine solution (3 x 10 mL), dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. Purification of the crude residue by reverse phase HPLC afforded ( 1S , 3S , 4S )-5,5-difluoro-2-(4-methoxy- 1H -indole-2-carbonyl) -N- [(1 S ,2 E )-1-[[(3 S )-2-oxopyrrolidin-3-yl]methyl]-2-(2-oxotetrahydrofuran-3-ylidene)ethyl ]-2-Azabicyclo[2.2.2]octane-3-carboxamide as a white solid (4.8 mg, 43% yield, observed m/z: 571 [M+H] + ). 1 H NMR (400MHz, CD 3 OD): δ 7.18(d,1H), 7.07(d,1H), 7.00-6.76(m,1H), 6.67-6.28(m,2H), 5.30-4.93(m, 2H), 4.75(s,1H), 4.54(s,1H), 4.45-4.16(m,1H), 4.05(s,1H), 4.00-3.80(m,3H), 3.14-2.81(m,2H) , 2.85-2.62 (m, 2H), 2.62-2.27 (m, 4H), 2.27-1.99 (m, 2H), 1.99-1.72 (m, 3H), 1.72-1.22 (m, 2H).
實施例95:(1S,3S,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-Example 95: (1 S ,3 S ,4 S )-5,5-difluoro-2-(4-methoxy-1 H -indole-2-carbonyl) -N- [(1S,2Z)-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]-2-(2-氧代四氫呋喃-3-基亞基)乙基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物106)[(1 S ,2 Z )-1-[[(3 S )-2-oxopyrrolidin-3-yl]methyl]-2-(2-oxotetrahydrofuran-3-ylidene)ethyl ]-2-Azabicyclo[2.2.2]octane-3-carboxamide (compound 106)
步驟(1):(3S)-3-[(2S,3Z)-2-胺基-3-(2-氧代四氫呋喃-3-基亞基)丙基]吡咯啶-2-酮Step (1): (3S)-3-[(2S,3Z)-2-Amino-3-(2-oxotetrahydrofuran-3-ylidene)propyl]pyrrolidin-2-one
向N-[(1S,2Z)-2-(2-氧代四氫呋喃-3-基亞基)-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]乙基]胺基甲酸第三丁酯(52mg,0.16mmol)在CH2Cl2(0.8mL)中的溶液逐滴加入鹽酸(4N的1,4-二烷溶液,160μL,0.64mmol)。將反應混合物在室溫下攪拌15分鐘。向該混合物加入MeOH(0.1mL)。將反應混合物在室溫下攪拌3小時並在真空下濃縮,以提供(3S)-3-[(2S,3Z)-2-胺基-3-(2-氧代四氫呋喃-3-基亞基)丙基]吡咯啶-2-酮的鹽酸鹽,為白色泡沫(42mg,觀察到m/z:225[M+H]+),其無需進一步純化即可用於下一步。 To N-[(1S,2Z)-2-(2-oxotetrahydrofuran-3-yl subunit)-1-[[(3S)-2-oxopyrrolidin-3-yl]methyl]ethyl ] A solution of tert-butyl carbamate (52 mg, 0.16 mmol) in CH 2 Cl 2 (0.8 mL) was added dropwise to hydrochloric acid (4N 1,4-di alkane solution, 160 μL, 0.64 mmol). The reaction mixture was stirred at room temperature for 15 minutes. To this mixture was added MeOH (0.1 mL). The reaction mixture was stirred at room temperature for 3 hours and concentrated in vacuo to provide ( 3S )-3-[( 2S , 3Z )-2-amino-3-(2-oxotetrahydrofuran-3- The hydrochloride salt of (ylidene)propyl]pyrrolidin-2-one as a white foam (42 mg, observed m/z: 225 [M+H] + ) was used in the next step without further purification.
步驟(2):(1S,3S,4S)-5,5-二氟-3-[[(1S,2Z)-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]-2-(2-氧代四氫呋喃-3-基亞基)乙基]胺甲醯基]-2-氮雜雙環[2.2.2]辛烷-2-羧酸第三丁鹽Step (2): (1S,3S,4S)-5,5-Difluoro-3-[[(1S,2Z)-1-[[(3S)-2-oxopyrrolidin-3-yl]methanol Base]-2-(2-oxotetrahydrofuran-3-ylidene)ethyl]aminoformyl]-2-azabicyclo[2.2.2]octane-2-carboxylic acid third butyl salt
在0℃下向(3S)-3-[(2S,3Z)-2-胺基-3-(2-氧代四氫呋喃-3-基亞基)丙基]吡咯啶-2-酮鹽酸鹽(42mg,0.16mmol)、(1S,3S,4S)-2-第三丁氧基羰基-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-羧酸(39mg,0.13mmol)和EDC(46mg,0.24mmol)在DMA(1.3mL)中的溶液加入DMAP(49mg,0.13mmol)。將混合物在0℃下攪拌2小時。向反應混合物加入DIPEA(23μL,0.13mmol)並在3小時後再加入DIPEA(23μL,0.13mmol)。將反應物攪拌20小時,逐漸升溫至室溫。向反應混合物加入鹽酸(1N的水溶液,5mL)和水(5mL)。將混合物用EtOAc(3×15mL)萃取。用水性鹽水溶液(3×10mL)洗滌合併後的有機相,經無水硫酸鈉乾燥,過濾,並在真空下濃縮。通過正相SiO2管柱層析法(2-10% MeOH/CH2Cl2)純化粗殘餘物,得到(1S,3S,4S)-5,5-二氟-3-[[(1S,2Z)-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]-2-(2-氧代四氫呋喃-3-基亞基)乙基]胺甲醯基]-2-氮雜雙環[2.2.2]辛烷-2-羧酸第三丁鹽,為白色固體(27mg,產率40%,觀察到m/z:498[M+H]+)。 To (3 S )-3-[(2 S ,3 Z )-2-amino-3-(2-oxotetrahydrofuran-3-ylidene)propyl]pyrrolidin-2-one at 0°C Hydrochloride (42 mg, 0.16 mmol), (1 S ,3 S ,4 S )-2-tert-butoxycarbonyl-5,5-difluoro-2-azabicyclo[2.2.2]octane- A solution of 3-carboxylic acid (39 mg, 0.13 mmol) and EDC (46 mg, 0.24 mmol) in DMA (1.3 mL) was added with DMAP (49 mg, 0.13 mmol). The mixture was stirred at 0 °C for 2 hours. DIPEA (23 μL, 0.13 mmol) was added to the reaction mixture and another DIPEA (23 μL, 0.13 mmol) was added after 3 hours. The reaction was stirred for 20 hours, gradually warming to room temperature. Hydrochloric acid (1N in water, 5 mL) and water (5 mL) were added to the reaction mixture. The mixture was extracted with EtOAc (3 x 15 mL). The combined organic phases were washed with aqueous brine solution (3 x 10 mL), dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. The crude residue was purified by normal phase SiO 2 column chromatography (2-10% MeOH/CH 2 Cl 2 ) to afford (1S,3S,4S)-5,5-difluoro-3-[[(1S, 2Z)-1-[[(3S)-2-oxopyrrolidin-3-yl]methyl]-2-(2-oxotetrahydrofuran-3-yllidene)ethyl]aminoformyl]- 2-Azabicyclo[2.2.2]octane-2-carboxylic acid tert-butyl salt as a white solid (27 mg, 40% yield, observed m/z: 498 [M+H] + ).
步驟(3):(1S,3S,4S)-5,5-二氟-N-[(1S,2Z)-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]-2-(2-氧代四氫呋喃-3-基亞基)乙基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺Step (3): (1S,3S,4S)-5,5-Difluoro-N-[(1S,2Z)-1-[[(3S)-2-oxopyrrolidin-3-yl]methyl ]-2-(2-Oxotetrahydrofuran-3-ylidene)ethyl]-2-azabicyclo[2.2.2]octane-3-carboxamide
向(1S,3S,4S)-5,5-二氟-3-[[(1S,2Z)-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]-2-(2-氧代四氫呋喃-3-基亞基)乙基]胺甲醯基]-2-氮 雜雙環[2.2.2]辛烷-2-羧酸第三丁鹽(27mg,0.05mmol)在CH2Cl2(1.1mL)中的溶液逐滴加入鹽酸(4N的1,4-二烷溶液,53μL,0.21mmol)。將反應混合物在室溫下攪拌15分鐘。向該混合物加入MeOH(0.1mL)。將反應混合物在室溫下攪拌29小時,並在真空下濃縮,以提供(1S,3S,4S)-5,5-二氟-N-[(1S,2Z)-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]-2-(2-氧代四氫呋喃-3-基亞基)乙基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺的鹽酸鹽,為白色泡沫(定量獲得23mg,觀察到m/z:398[M+H]+),其無需進一步純化即可用於下一步。 To (1S,3S,4S)-5,5-difluoro-3-[[(1S,2Z)-1-[[(3S)-2-oxopyrrolidin-3-yl]methyl]-2 -(2-Oxotetrahydrofuran-3-ylidene)ethyl]carbamoyl]-2-azabicyclo[2.2.2]octane-2-carboxylic acid tert-butyl salt (27mg, 0.05mmol) A solution in CH 2 Cl 2 (1.1 mL) was added dropwise with hydrochloric acid (4N 1,4-di alkane solution, 53 μL, 0.21 mmol). The reaction mixture was stirred at room temperature for 15 minutes. To this mixture was added MeOH (0.1 mL). The reaction mixture was stirred at room temperature for 29 hours and concentrated under vacuum to provide ( 1S , 3S , 4S )-5,5-difluoro- N -[( 1S , 2Z )-1- [[(3 S )-2-oxopyrrolidin-3-yl]methyl]-2-(2-oxotetrahydrofuran-3-yllidene)ethyl]-2-azabicyclo[2.2.2 ] Octane-3-carboxamide hydrochloride as a white foam (23 mg obtained quantitatively, observed m/z: 398 [M+H] + ), which was used in the next step without further purification.
步驟(4):(1S,3S,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-[(1S,2Z)-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]-2-(2-氧代四氫呋喃-3-基亞基)乙基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺Step (4): (1S,3S,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-[(1S,2Z)-1- [[(3S)-2-oxopyrrolidin-3-yl]methyl]-2-(2-oxotetrahydrofuran-3-ylidene)ethyl]-2-azabicyclo[2.2.2] Octane-3-formamide
向(1S,3S,4S)-5,5-二氟-N-[(1S,2Z)-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]-2-(2-氧代四氫呋喃-3-基亞基)乙基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺鹽酸鹽(23mg,0.05mmol)、4-甲氧基-1H-吲哚-2-羧酸(8.5mg,0.04mmol)和HATU(31mg,0.08mmol)在NMP(0.89mL)中的溶液加入N-甲基嗎啉(NMM)(20μL,0.018mmol)。將反應混合物在室溫下攪拌4小時。向反應混合物加入鹽酸(1N的水溶液,5mL)和水(5mL)。將混合物用EtOAc(3×10mL)萃取。將合併後的有機物用水性鹽水溶液(3×10mL)洗滌,經無水硫酸鈉乾燥,過濾,並在真空下濃縮。通過反相HPLC純化粗殘餘物,得到(1S,3S,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-[(1S,2Z)-1-[[(3S)-2-氧代吡咯啶-3-基]甲基]-2-(2-氧代四氫呋喃-3-基亞基)乙基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺,為白色固體(13mg,產率53%,觀察到m/z:571 [M+H]+);1H NMR(400MHz,CD3OD):δ 7.15(dd,1H),7.04(dt,1H),6.96-6.71(m,1H),6.49(s,1H),6.25-5.95(m,1H),5.77-5.41(m,1H),5.25-4.65(m,3H),4.41-4.19(m,2H),4.03-3.80(m,3H),3.06-2.74(m,3H),2.68(s,2H),2.60-2.35(m,2H),2.35-1.93(m,4H),1.93-1.59(m,4H),1.59-1.20(m,1H)。 To (1 S ,3 S ,4 S )-5,5-difluoro- N -[(1 S ,2 Z )-1-[[(3 S )-2-oxopyrrolidin-3-yl] Methyl]-2-(2-oxotetrahydrofuran-3-ylidene)ethyl]-2-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride (23mg, 0.05mmol) , 4-Methoxy- 1H -indole-2-carboxylic acid (8.5mg, 0.04mmol) and HATU (31mg, 0.08mmol) in NMP (0.89mL) were added to N-methylmorpholine (NMM ) (20 μL, 0.018 mmol). The reaction mixture was stirred at room temperature for 4 hours. Hydrochloric acid (1N in water, 5 mL) and water (5 mL) were added to the reaction mixture. The mixture was extracted with EtOAc (3 x 10 mL). The combined organics were washed with aqueous brine solution (3 x 10 mL), dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. Purification of the crude residue by reverse phase HPLC afforded ( 1S , 3S , 4S )-5,5-difluoro-2-(4-methoxy- 1H -indole-2-carbonyl) -N- [(1 S ,2 Z )-1-[[(3 S )-2-oxopyrrolidin-3-yl]methyl]-2-(2-oxotetrahydrofuran-3-ylidene)ethyl ]-2-Azabicyclo[2.2.2]octane-3-carboxamide as a white solid (13 mg, 53% yield, observed m/z: 571 [M+H] + ); 1 H NMR (400MHz, CD 3 OD): δ 7.15(dd,1H), 7.04(dt,1H), 6.96-6.71(m,1H), 6.49(s,1H), 6.25-5.95(m,1H), 5.77- 5.41(m,1H), 5.25-4.65(m,3H), 4.41-4.19(m,2H), 4.03-3.80(m,3H), 3.06-2.74(m,3H), 2.68(s,2H), 2.60-2.35 (m, 2H), 2.35-1.93 (m, 4H), 1.93-1.59 (m, 4H), 1.59-1.20 (m, 1H).
實施例96:(1S,3S,4S)-2-(2-溴-9-羥基-茀-9-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物107和108)Example 96: (1 S ,3 S ,4 S )-2-(2-Bromo-9-hydroxy-fennel-9-carbonyl) -N -[(1 S )-1-cyano-2-[( 3S )-2-oxo-3-piperidinyl] ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide (compounds 107 and 108 )
步驟(1):2-溴-9-三甲基甲矽氧基-茀-9-腈Step (1): 2-Bromo-9-trimethylsilyloxy-fluorene-9-carbonitrile
向2-溴茀-9-酮(100mg,0.36mmol)在CH2Cl2(0.39mL)中的溶液加入NMO(14mg,0.12mmol),隨後加入三甲基甲矽烷基氰化物(72μL,0.58mmol)。將反應混合物攪拌在氮氣中在室溫下3小時。向該混合物加入水(5mL)。將混合物用CH2Cl2(3×10mL)萃取。將合併後的有機物用水性鹽水溶液(10mL)洗滌,經無水硫酸鈉乾燥,過濾,並在真空下濃縮,得到2-溴-9-三甲基甲矽氧基-茀-9-腈,為白色固體(115mg,產率83%,觀察到m/z:331[M-CN]+),其無需進一步純化即可用於下一步。 To a solution of 2-bromofin-9-one (100 mg, 0.36 mmol) in CH 2 Cl 2 (0.39 mL) was added NMO (14 mg, 0.12 mmol) followed by trimethylsilyl cyanide (72 μL, 0.58 mmol). The reaction mixture was stirred under nitrogen at room temperature for 3 hours. Water (5 mL) was added to the mixture. The mixture was extracted with CH2Cl2 (3 x 10 mL). The combined organics were washed with aqueous brine solution (10 mL), dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo to afford 2-bromo-9-trimethylsilyloxy-terrene-9-carbonitrile as White solid (115 mg, 83% yield, observed m/z: 331 [M-CN] + ), which was used in the next step without further purification.
步驟(2):2-溴-9-羥基-茀-9-羧酸Step (2): 2-Bromo-9-hydroxy-tertilene-9-carboxylic acid
向2-溴-9-三甲基甲矽氧基-茀-9-腈(115mg,0.32mmol)在1,4二烷(0.64mL)中的溶液加入HCl(5N的水溶液,642μL,3.2mmol)。將反應混合物在100℃下攪拌17小時。將混合物升溫至室溫並加入水(5mL)。將混合物用EtOAc(3×10mL)萃取。將合併後的有機物用水性鹽水溶液(10mL)洗滌,經無水硫酸鈉乾燥,過濾,並在真空下濃縮。將粗原料用CH2Cl2(5mL)稀釋並過濾。將過濾後的固體放入MeOH中並在真空下濃縮,得到2-溴-9-羥基-茀-9-羧酸,為白色固體(65mg,產率66%,觀察到m/z:287[M-OH]+),其無需進一步純化即可用於下一步。 To 2-bromo-9-trimethylsilyloxy-fen-9-carbonitrile (115 mg, 0.32 mmol) in 1,4 di To the solution in alkanes (0.64 mL) was added HCl (5N in water, 642 μL, 3.2 mmol). The reaction mixture was stirred at 100 °C for 17 hours. The mixture was warmed to room temperature and water (5 mL) was added. The mixture was extracted with EtOAc (3 x 10 mL). The combined organics were washed with aqueous brine solution (10 mL), dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. The crude material was diluted with CH2Cl2 ( 5 mL) and filtered. The filtered solid was taken up in MeOH and concentrated in vacuo to afford 2-bromo-9-hydroxy-tertilene-9-carboxylic acid as a white solid (65 mg, 66% yield, observed m/z: 287[ M-OH] + ), which was used in the next step without further purification.
步驟(3):(1S,3S,4S)-2-(2-溴-9-羥基-茀-9-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺Step (3): (1S,3S,4S)-2-(2-Bromo-9-hydroxy-fennel-9-carbonyl)-N-[(1S)-1-cyano-2-[(3S)- 2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide
在0℃下向2-溴-9-羥基-茀-9-羧酸(65mg,0.21mmol)和(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺4-甲苯磺酸(110mg,0.21mmol)在DMF(1mL)中的溶液加入HATU(146mg,0.38mmol)和DIPEA(149μL,0.85mmol)。將反應混合物升至室溫,並攪拌4小時。向該混合物加入HCl(1N的水溶液,5mL)和水(10mL)。將混合物用EtOAc(3×10mL)萃取。將合併後的有機物用水性碳酸氫鈉/鹽水混合物(1:1,5mL),然後用鹽水溶液(5mL)洗滌,經無水硫酸鈉乾燥,過濾,並在 真空下濃縮。將粗殘餘物首先通過正相SiO2管柱層析法(0-6% MeOH/CH2Cl2)純化。然後將殘餘物通過反相HPLC再次純化,以提供分離的非對映異構物(1S,3S,4S)-2-(2-溴-9-羥基-茀-9-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺。 2-Bromo-9-hydroxy-tertilene-9-carboxylic acid (65 mg, 0.21 mmol) and (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano- 2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide 4 - A solution of toluenesulfonic acid (110 mg, 0.21 mmol) in DMF (1 mL) was added with HATU (146 mg, 0.38 mmol) and DIPEA (149 μL, 0.85 mmol). The reaction mixture was warmed to room temperature and stirred for 4 hours. To the mixture were added HCl (IN in water, 5 mL) and water (10 mL). The mixture was extracted with EtOAc (3 x 10 mL). The combined organics were washed with an aqueous sodium bicarbonate/brine mixture (1:1, 5 mL), then brine solution (5 mL), dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. The crude residue was first purified by normal phase SiO 2 column chromatography (0-6% MeOH/CH 2 Cl 2 ). The residue was then repurified by reverse phase HPLC to afford the separated diastereoisomers ( 1S , 3S , 4S )-2-(2-bromo-9-hydroxy-terpine-9-carbonyl)- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[ 2.2.2] Octane-3-carboxamide.
主要非對映異構物(化合物107):(單一非對映異構物I,較快洗脫的非對映異構物):(14mg,產率11%,觀察到m/z:627[M+H]+);1H NMR(400MHz,CD3OD):δ 7.89-7.68(m,3H),7.68-7.59(m,2H),7.59-7.47(m,3H),7.47-7.37(m,2H),5.17(td,1H),4.55(d,1H),2.59(q,1H),2.55-2.43(m,3H),2.43-2.29(m,1H),2.21-2.01(m,2H),2.01-1.74(m,4H),1.58(d,5H),1.33(s,2H),1.00(s,1H) Major diastereomer (compound 107) : (single diastereomer I, faster eluting diastereomer): (14 mg, 11% yield, observed m/z: 627 [M+H] + ); 1 H NMR (400MHz, CD 3 OD): δ 7.89-7.68(m,3H), 7.68-7.59(m,2H), 7.59-7.47(m,3H), 7.47-7.37 (m,2H), 5.17(td,1H), 4.55(d,1H), 2.59(q,1H), 2.55-2.43(m,3H), 2.43-2.29(m,1H), 2.21-2.01(m ,2H), 2.01-1.74(m,4H), 1.58(d,5H), 1.33(s,2H), 1.00(s,1H)
次要非對映異構物(化合物108):(單一非對映異構物II,較慢洗脫的非對映異構物):(12mg,產率9%,觀察到m/z:627[M+H]+);1H NMR(400MHz,CD3OD):δ 7.80(ddd,1H),7.76-7.69(m,1H),7.69-7.60(m,2H),7.56-7.46(m,2H),7.46-7.36(m,2H),5.17(td,1H),4.54(s,1H),2.59(d,1H),2.55-2.39(m,2H),2.23-2.05(m,1H),1.95(ddd,2H),1.89-1.77(m,1H),1.68-1.43(m,4H),1.51-1.17(m,3H),1.02(s,1H)。 Minor diastereomer (compound 108) : (single diastereomer II, slower eluting diastereomer): (12 mg, 9% yield, observed m/z: 627[M+H] + ); 1 H NMR (400MHz, CD 3 OD): δ 7.80 (ddd, 1H), 7.76-7.69 (m, 1H), 7.69-7.60 (m, 2H), 7.56-7.46 ( m,2H), 7.46-7.36(m,2H), 5.17(td,1H), 4.54(s,1H), 2.59(d,1H), 2.55-2.39(m,2H), 2.23-2.05(m, 1H), 1.95 (ddd, 2H), 1.89-1.77 (m, 1H), 1.68-1.43 (m, 4H), 1.51-1.17 (m, 3H), 1.02 (s, 1H).
實施例97:(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-(2,7-二氟-9-羥基-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物109)Example 97: (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl ]-2-(2,7-difluoro-9-hydroxy-fen-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide (compound 109)
通過將(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺4-甲苯磺酸與適當的羧酸偶合以與關於(1S,3S,4S)-2-(2-溴-9-羥基-茀-9-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-(2,7-二氟-9-羥基-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺,得到白色固體(12mg,產率7%,觀察到m/z:585[M+H]+)。1H NMR(400MHz,CD3OD):δ 7.79(qd,2H),7.28-7.20(m,3H),7.15(dd,1H),5.17(dt,1H),4.56(d,1H),2.65-2.43(m,3H),2.21-2.02(m,2H),2.02-1.87(m,3H),1.87-1.75(m,1H),1.74-1.51(m,5H),1.37(s,2H),1.13-0.80(m,1H)。 By adding (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]- 5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamide 4-toluenesulfonic acid was coupled with an appropriate carboxylic acid to react with respect to (1 S ,3 S ,4 S )- 2-(2-Bromo-9-hydroxy-tertene-9-carbonyl) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl ]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide to prepare (1 S ,3 S ,4 S ) -N- [(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2-(2,7-difluoro-9-hydroxy-terpineol -9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide to give a white solid (12 mg, yield 7%, observed m/z: 585 [M+H] + ). 1 H NMR (400MHz, CD 3 OD): δ 7.79(qd, 2H), 7.28-7.20(m, 3H), 7.15(dd, 1H), 5.17(dt, 1H), 4.56(d, 1H), 2.65 -2.43(m,3H), 2.21-2.02(m,2H), 2.02-1.87(m,3H), 1.87-1.75(m,1H), 1.74-1.51(m,5H), 1.37(s,2H) , 1.13-0.80 (m, 1H).
實施例98:(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-(2,7-二氯-9-羥基-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺(化合物110)Example 98: (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl ]-2-(2,7-dichloro-9-hydroxyl-fen-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide (compound 110)
通過將(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺4-甲苯磺酸與適當的羧酸偶合以與關於(1S,3S,4S)-2-(2-溴-9-羥基-茀-9-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺所描述的類似方式來製備(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-(2,7-二氯-9-羥基-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺,得到白色固體(4.4mg,產率3%,觀察到m/z:617[M+H]+);1H NMR(400MHz,CD3OD): δ 7.87-7.72(m,2H),7.51(dddd,3H),7.45-7.29(m,1H),5.17(dt,1H),4.55(s,1H),2.96(d,1H),2.66-2.42(m,3H),2.13(s,2H),1.95(ddd,3H),1.87-1.66(m,2H),1.60(s,3H),1.47-1.25(m,3H),1.18-0.76(m,1H)。 By adding (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]- 5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamide 4-toluenesulfonic acid was coupled with an appropriate carboxylic acid to react with respect to (1 S ,3 S ,4 S )- 2-(2-Bromo-9-hydroxy-tertene-9-carbonyl) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl ]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide to prepare (1 S ,3 S ,4 S ) -N- [(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2-(2,7-dichloro-9-hydroxy-terpineol -9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide to give a white solid (4.4 mg, 3% yield, observed m/z: 617[M+H] + ); 1 H NMR (400MHz, CD 3 OD): δ 7.87-7.72(m, 2H), 7.51(dddd, 3H), 7.45-7.29(m, 1H), 5.17(dt, 1H), 4.55(s,1H), 2.96(d,1H), 2.66-2.42(m,3H), 2.13(s,2H), 1.95(ddd,3H), 1.87-1.66(m,2H), 1.60 (s, 3H), 1.47-1.25 (m, 3H), 1.18-0.76 (m, 1H).
實施例99:(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺(化合物111)Example 99: (1 S ,3a R ,6a S ) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5 , 5-difluoro-2-(9-hydroxy- 9H -fen-9-carbonyl)octahydrocyclopenta[ c ]pyrrole-1-carboxamide (compound 111)
步驟(1):(1S,3aR,6aS)-1-(((S)-1-胺基-1-側氧基-3-((S)-2-氧代哌啶-3-基)丙烷-2-基)胺甲醯基)-5,5-二氟六氫環戊二烯并[c]吡咯-2(1H)-羧酸苄酯Step (1): (1S,3aR,6aS)-1-(((S)-1-amino-1-oxo-3-((S)-2-oxopiperidin-3-yl) Propan-2-yl)carbamoyl)-5,5-difluorohexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate benzyl ester
將(2S)-2-胺基-3-[(3S)-2-側氧基-3-哌啶基]丙醯胺鹽酸鹽(195mg,0.880mmol)和(1S,3aR,6aS)-2-((苄氧基)羰基)-5,5-二氟八氫環戊[c]吡咯-1-羧酸(286mg,0.880mmol)溶解在DMF(8mL)中,並將反應混合物冷卻至0℃。將EDCI(231mg,1.20mmol)、HOBt一水化物(283mg,1.85mmol)和DIPEA(640μL,3.70mmol)按順序加入反應混合物。將混合物升溫至室溫,並攪拌18小時。將反應混合物用H2O(15ml)稀釋,並用EtOAc(3×20mL)萃取。將合併後的有機層經無水硫酸鈉乾燥,過濾,並在減壓下濃縮。通過正相SiO2層析法 (10:1:0.02,CH2Cl2/MeOH/TEA)純化粗殘餘物,得到(3S,3aS,6aR)-3-[[(1S)-2-胺基-2-側氧基-1-[[(3S)-2-側氧基-3哌啶基]甲基]乙基]胺甲醯基]-5,5-二氟1,3,3a,4,6,6a六氫環戊二烯并[c]吡咯-2-羧酸苄酯,為黃色油(200mg,產率46%,觀察到m/z:493[M+H]+)。 (2 S )-2-amino-3-[(3 S )-2-oxo-3-piperidinyl] propionamide hydrochloride (195 mg, 0.880 mmol) and (1 S , 3a R , 6aS )-2-((benzyloxy)carbonyl)-5,5-difluorooctahydrocyclopenta[ c ]pyrrole-1-carboxylic acid (286 mg, 0.880 mmol) was dissolved in DMF (8 mL), and The reaction mixture was cooled to 0 °C. EDCI (231 mg, 1.20 mmol), HOBt monohydrate (283 mg, 1.85 mmol) and DIPEA (640 μL, 3.70 mmol) were sequentially added to the reaction mixture. The mixture was warmed to room temperature and stirred for 18 hours. The reaction mixture was diluted with H2O (15ml) and extracted with EtOAc (3 x 20mL). The combined organic layers were dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The crude residue was purified by normal phase SiO2 chromatography (10:1:0.02, CH2Cl2 /MeOH/TEA) to afford (3S,3aS,6aR)-3- [ [(1S)-2-amino -2-oxo-1-[[(3S)-2-oxo-3 piperidinyl]methyl]ethyl]carbamoyl]-5,5-difluoro 1,3,3a, 4,6,6a Benzyl hexahydrocyclopenta[c]pyrrole-2-carboxylate as yellow oil (200 mg, 46% yield, observed m/z: 493 [M+H] + ).
步驟(2):(1S,3aR,6aS)-N-((S)-1-胺基-1-側氧基-3-((S)-2-氧代哌啶-3-基)丙烷-2-基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺氫溴酸鹽Step (2): (1S,3aR,6aS)-N-((S)-1-Amino-1-oxo-3-((S)-2-oxopiperidin-3-yl)propane -2-yl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide hydrobromide
將(1S,3aR,6aS)-1-(((S)-1-胺基-1-側氧基-3-((S)-2-氧代哌啶-3-基)丙烷-2-基)胺甲醯基)-5,5-二氟六氫環戊二烯并[c]吡咯-2(1H)-羧酸苄酯(179mg,0.362mmol)溶解在CH2Cl2(3mL)中。逐滴加入HBr(48%的H2O溶液,84μL,0.51mmol),並將混合物在室溫下攪拌16小時。將反應混合物在減壓下濃縮。將混合物用MTBE(3×3ml)洗滌並在減壓下濃縮,得到(1S,3aR,6aS)-N-((S)-1-胺基-1-側氧基-3-((S)-2-氧代哌啶-3-基)丙烷-2-基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺氫溴酸鹽,為黃色固體(159mg,產率100%,觀察到m/z:359[M+H]+),其無需進一步純化即可用於下一步。 (1S,3aR,6aS)-1-(((S)-1-amino-1-oxo-3-((S)-2-oxopiperidin-3-yl)propane-2- ( 179 mg, 0.362 mmol) was dissolved in CH2Cl2 (3 mL) middle. HBr (48% in H 2 O, 84 μL, 0.51 mmol) was added dropwise, and the mixture was stirred at room temperature for 16 hours. The reaction mixture was concentrated under reduced pressure. The mixture was washed with MTBE (3×3ml) and concentrated under reduced pressure to give ( 1S , 3aR , 6aS ) -N -(( S )-1-amino-1-oxo-3-( ( S )-2-oxopiperidin-3-yl)propan-2-yl)-5,5-difluorooctahydrocyclopenta[ c ]pyrrole-1-carboxamide hydrobromide as a yellow solid (159 mg, 100% yield, observed m/z: 359 [M+H] + ), which was used in the next step without further purification.
步驟(3):(1S,3aR,6aS)-N-((S)-1-胺基-1-側氧基-3-((S)-2-氧代哌啶-3-基)丙烷-2-基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺Step (3): (1S,3aR,6aS)-N-((S)-1-Amino-1-oxo-3-((S)-2-oxopiperidin-3-yl)propane -2-yl)-5,5-difluoro-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide
在0℃下向(1S,3aR,6aS)-N-((S)-1-胺基-1-側氧基-3-((S)-2-氧代哌啶-3-基)丙烷-2-基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺氫溴酸鹽(159mg,0.362mmol)在DMF(5mL)中的溶液加入9-羥基茀-9-羧酸(82mg,0.36mmol)、DIEA(150μL,0.870mmol)和HATU(172mg,0.452mmol)。將混合物升溫至室溫,並在氮大氣壓下攪拌2小時。將反應混合物用H2O(15mL)稀釋,並用iPrOH/CHCl3(2:5的混合物,3×15mL)萃取。將合併後的有機層用鹽水溶液(15mL)洗滌,經無水硫酸鈉乾燥,過濾,並在減壓下濃縮,得到粗殘餘物。通過反相HPLC純化殘餘物,得到(1S,3aR,6aS)-N-((S)-1-胺基-1-側氧基-3-((S)-2-氧代哌啶-3-基)丙烷-2-基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺,為白色固體(123mg,產率60%,觀察到m/z:567[M+H]+)。 (1 S ,3a R ,6a S ) -N -(( S )-1-amino-1-oxo-3-(( S )-2-oxopiperidine-3- A solution of (159 mg, 0.362 mmol ) in DMF (5 mL) was added to 9- Hydroxystilbene-9-carboxylic acid (82 mg, 0.36 mmol), DIEA (150 μL, 0.870 mmol) and HATU (172 mg, 0.452 mmol). The mixture was warmed to room temperature and stirred under nitrogen atmosphere for 2 hours. The reaction mixture was diluted with H 2 O (15 mL), and extracted with i PrOH/CHCl 3 (2:5 mixture, 3×15 mL). The combined organic layers were washed with brine solution (15 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure to give a crude residue. Purification of the residue by reverse phase HPLC gave ( 1S , 3aR , 6aS ) -N -(( S )-1-amino-1-oxo-3-(( S )-2-oxopiper Pyridin-3-yl)propan-2-yl)-5,5-difluoro-2-(9-hydroxy- 9H -fen-9-carbonyl)octahydrocyclopenta[ c ]pyrrole-1-carboxamide , as a white solid (123 mg, 60% yield, observed m/z: 567 [M+H] + ).
步驟(4):(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺Step (4): (1S,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5 -Difluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide
將(1S,3aR,6aS)-N-((S)-1-胺基-1-側氧基-3-((S)-2-氧代哌啶-3-基)丙烷-2-基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺(113mg,0.199μmol)和Burgess試劑(143mg,0.598mmol)在CH2Cl2(2mL)中的混合物在室溫下在氮大氣壓下攪拌 2小時。在完成之後,將反應混合物在減壓下濃縮。通過反相HPLC純化殘餘物,得到(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺,為白色固體(35.4mg,產率32%,觀察到m/z:549[M+H]+);1H NMR(400MHz,DMSO-d6):δ 8.98(d,1H),7.84(dd,2H),7.56(s,1H),7.49-7.43(m,2H),7.37-7.26(m,4H),6.05(s,1H),5.04(q,1H),4.33(d,1H),3.14-3.09(m,3H),2.62-2.54(m,2H),2.47-2.46(m,1H),2.36-2.28(m,3H),2.19-2.12(m,1H),2.04-1.98(m,1H),1.95-1.90(m,1H),1.80-1.76(m,2H),1.67-1.63(m,1H),1.47-1.39(m,1H),1.07-1.03(m,1H)。 (1 S ,3a R ,6a S ) -N -(( S )-1-amino-1-oxo-3-(( S )-2-oxopiperidin-3-yl)propane- 2-yl)-5,5-difluoro-2-(9-hydroxy- 9H -fen-9-carbonyl)octahydrocyclopenta[ c ]pyrrole-1-carboxamide (113 mg, 0.199 μmol) and Burgess A mixture of the reagent (143 mg, 0.598 mmol) in CH2Cl2 (2 mL) was stirred at room temperature under a nitrogen atmosphere for 2 hours. After completion, the reaction mixture was concentrated under reduced pressure. Purification of the residue by reverse phase HPLC afforded ( 1S , 3aR , 6aS ) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl) Ethyl)-5,5-difluoro-2-(9-hydroxy- 9H -oxa-9-carbonyl)octahydrocyclopenta[ c ]pyrrole-1-carboxamide as a white solid (35.4 mg, yielding 32% observed m/z: 549[M+H] + ); 1 H NMR (400MHz, DMSO-d 6 ): δ 8.98(d,1H), 7.84(dd,2H), 7.56(s, 1H), 7.49-7.43(m,2H), 7.37-7.26(m,4H), 6.05(s,1H), 5.04(q,1H), 4.33(d,1H), 3.14-3.09(m,3H) , 2.62-2.54(m,2H), 2.47-2.46(m,1H), 2.36-2.28(m,3H), 2.19-2.12(m,1H), 2.04-1.98(m,1H), 1.95-1.90( m,1H), 1.80-1.76(m,2H), 1.67-1.63(m,1H), 1.47-1.39(m,1H), 1.07-1.03(m,1H).
實施例100:(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺(化合物112)Example 100: (1 S ,3a R ,6a S ) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5 , 5-difluoro-2-(4-fluoro-1 H -indole-2-carbonyl)octahydrocyclopenta[ c ]pyrrole-1-carboxamide (compound 112)
通過將(1S,3aR,6aS)-N-((S)-1-胺基-1-側氧基-3-((S)-2-氧代哌啶-3-基)丙烷-2-基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺氫溴酸鹽與適當的羧酸偶合以與關於(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺所描述的類似方式來製備(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺;觀察到m/z:502[M+H]+;1H NMR(400MHz,CD3OD):δ 8.54(s,1H),7.32-7.04(m,3H),6.75(t,1H),4.58(s,1H),4.42-4.38(m,1H),4.06-4.02(m,1H),3.19-3.13(m, 3H),2.91(s,1H),2.63-2.28(m,7H),1.98-1.61(m,5H)。 By adding (1 S ,3a R ,6a S ) -N -(( S )-1-amino-1-oxo-3-(( S )-2-oxopiperidin-3-yl)propane -2-yl)-5,5-difluorooctahydrocyclopenta[ c ]pyrrole-1-carboxamide hydrobromide is coupled with an appropriate carboxylic acid to combine with (1 S , 3a R , 6a S )- N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-(9-hydroxy- 9H ( 1S , 3aR , 6aS ) -N -(( S )-1-cyano -2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-(4-fluoro-1 H -indole-2-carbonyl)octahydrocyclo Penta[ c ]pyrrole-1-carboxamide; observed m/z: 502[M+H] + ; 1 H NMR (400MHz, CD 3 OD): δ 8.54(s, 1H), 7.32-7.04(m ,3H), 6.75(t,1H), 4.58(s,1H), 4.42-4.38(m,1H), 4.06-4.02(m,1H), 3.19-3.13(m, 3H), 2.91(s,1H) ), 2.63-2.28(m,7H), 1.98-1.61(m,5H).
實施例101:(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺(化合物113)Example 101: (1 S ,3a R ,6a S ) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-2 -(4-(Difluoromethyl)-6-fluoro- 1H -indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[ c ]pyrrole-1-carboxamide (compound 113)
通過將(1S,3aR,6aS)-N-((S)-1-胺基-1-側氧基-3-((S)-2-氧代哌啶-3-基)丙烷-2-基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺氫溴酸鹽與適當的羧酸偶合以與關於(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺所描述的類似方式來製備(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺;觀察到m/z:552[M+H]+;1H NMR(400MHz,CD3OD):δ 7.30(d,1H),7.19(s,1H),7.11(d,1H),5.17-5.02(m,1H),4.61-4.54(m,1H),4.40-4.35(m,1H),4.05-4.00(m,1H),3.28-3.10(m,3H),2.96-2.90(m,1H),2.62-2.23(m,6H),2.07-1.62(m,5H),1.62-1.43(m,1H)。 By adding (1 S ,3a R ,6a S ) -N -(( S )-1-amino-1-oxo-3-(( S )-2-oxopiperidin-3-yl)propane -2-yl)-5,5-difluorooctahydrocyclopenta[ c ]pyrrole-1-carboxamide hydrobromide is coupled with an appropriate carboxylic acid to combine with (1 S , 3a R , 6a S )- N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-(9-hydroxy- 9H ( 1S , 3aR , 6aS ) -N -(( S )-1-cyano -2-(( S )-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoromethyl)-6-fluoro-1 H -indole-2-carbonyl)- 5,5-Difluorooctahydrocyclopenta[ c ]pyrrole-1-carboxamide; observed m/z: 552[M+H] + ; 1 H NMR (400MHz, CD 3 OD): δ 7.30(d ,1H), 7.19(s,1H), 7.11(d,1H), 5.17-5.02(m,1H), 4.61-4.54(m,1H), 4.40-4.35(m,1H), 4.05-4.00(m ,1H), 3.28-3.10(m,3H), 2.96-2.90(m,1H), 2.62-2.23(m,6H), 2.07-1.62(m,5H), 1.62-1.43(m,1H).
實施例102:(1S,3aR,6aS)-2-(7-氯-4-(二氟甲基)-1H-吲哚-2-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺(化合物114)Example 102: (1 S ,3a R ,6a S )-2-(7-Chloro-4-(difluoromethyl)-1 H -indole-2-carbonyl) -N -(( S )-1 -cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[ c ]pyrrole-1-carboxamide (compound 114)
通過將(1S,3aR,6aS)-N-((S)-1-胺基-1-側氧基-3-((S)-2-氧代哌啶-3-基)丙烷-2-基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺氫溴酸鹽與適當的羧酸偶合以與關於(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺所描述的類似方式來製備(1S,3aR,6aS)-2-(7-氯-4-(二氟甲基)-1H-吲哚-2-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺;觀察到m/z:568[M+H]+;1H NMR(400MHz,DMSO-d6):δ 12.13(s,1H),9.05(d,1H),7.59-7.47(m,1H),7.42(d,1H),7.37-7.30(m,1H),7.20(s,1H),6.91-6.77(m,1H),5.13-4.88(m,1H),4.72-4.44(m,1H),4.26-4.02(m,1H),3.89(dd,1H),3.09(s,2H),3.00-2.70(m,2H),2.48-2.36(m,2H),2.35-2.23(m,2H),2.18-2.00(m,1H),1.94-1.75(m,2H),1.70(dd,1H),1.57(d,1H),1.51-1.04(m,2H)。 By adding (1 S ,3a R ,6a S ) -N -(( S )-1-amino-1-oxo-3-(( S )-2-oxopiperidin-3-yl)propane -2-yl)-5,5-difluorooctahydrocyclopenta[ c ]pyrrole-1-carboxamide hydrobromide is coupled with an appropriate carboxylic acid to combine with (1 S , 3a R , 6a S )- N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-(9-hydroxy- 9H (1 S , 3a R , 6a S )-2-(7-chloro-4-(di Fluoromethyl) -1H -indole-2-carbonyl) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)- 5,5-Difluorooctahydrocyclopenta[ c ]pyrrole-1-carboxamide; Observed m/z: 568[M+H] + ; 1 H NMR (400MHz, DMSO-d 6 ): δ 12.13( s,1H), 9.05(d,1H), 7.59-7.47(m,1H), 7.42(d,1H), 7.37-7.30(m,1H), 7.20(s,1H), 6.91-6.77(m, 1H), 5.13-4.88(m,1H), 4.72-4.44(m,1H), 4.26-4.02(m,1H), 3.89(dd,1H), 3.09(s,2H), 3.00-2.70(m, 2H), 2.48-2.36(m,2H), 2.35-2.23(m,2H), 2.18-2.00(m,1H), 1.94-1.75(m,2H), 1.70(dd,1H), 1.57(d, 1H), 1.51-1.04 (m, 2H).
實施例103:(1S,3aR,6aS)-2-(6-氯-4,7-二氟-1H-吲哚-2-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺(化合物115)Example 103: (1 S ,3a R ,6a S )-2-(6-chloro-4,7-difluoro-1 H -indole-2-carbonyl) -N -(( S )-1-cyano Base-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[ c ]pyrrole-1-carboxamide (compound 115)
通過將(1S,3aR,6aS)-N-((S)-1-胺基-1-側氧基-3-((S)-2- 氧代哌啶-3-基)丙烷-2-基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺氫溴酸鹽與適當的羧酸偶合以與關於(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺所描述的類似方式來製備(1S,3aR,6aS)-2-(6-氯-4,7-二氟-1H-吲哚-2-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺;觀察到m/z:554[M+H]+;1H NMR(400MHz,DMSO-d6):δ 12.78-12.61(m,1H),9.19-8.97(m,1H),7.62-7.38(m,1H),7.29-6.76(m,2H),5.11-4.84(m,1H),4.81-4.45(m,1H),4.21(t,1H),3.98-3.72(m,1H),3.16-2.90(m,3H),2.89-2.70(m,1H),2.45-2.05(m,5H),2.04-1.09(m,6H)。 By adding (1 S ,3a R ,6a S ) -N -(( S )-1-amino-1-oxo-3-(( S )-2-oxopiperidin-3-yl)propane -2-yl)-5,5-difluorooctahydrocyclopenta[ c ]pyrrole-1-carboxamide hydrobromide is coupled with an appropriate carboxylic acid to combine with (1 S , 3a R , 6a S )- N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-(9-hydroxy- 9H (1 S , 3a R , 6a S )-2- ( 6-chloro-4,7- Difluoro- 1H -indole-2-carbonyl) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5, 5-Difluorooctahydrocyclopenta[ c ]pyrrole-1-carboxamide; Observed m/z: 554[M+H] + ; 1 H NMR (400MHz, DMSO-d 6 ): δ 12.78-12.61( m,1H), 9.19-8.97(m,1H), 7.62-7.38(m,1H), 7.29-6.76(m,2H), 5.11-4.84(m,1H), 4.81-4.45(m,1H), 4.21(t,1H), 3.98-3.72(m,1H), 3.16-2.90(m,3H), 2.89-2.70(m,1H), 2.45-2.05(m,5H), 2.04-1.09(m,6H ).
實施例104:(1S,3aR,6aS)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺(化合物116)Example 104: (1 S ,3a R ,6a S )-2-(3-chloro-4 H -thieno[3,2- b ]pyrrole-5-carbonyl) -N -(( S )-1- Cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[ c ]pyrrole-1-carboxamide (Compound 116)
通過將(1S,3aR,6aS)-N-((S)-1-胺基-1-側氧基-3-((S)-2-氧代哌啶-3-基)丙烷-2-基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺氫溴酸鹽與適當的羧酸偶合以與關於(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺所描述的類似方式來製備(1S,3aR,6aS)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺;觀察到m/z:524[M+H]+;1H NMR(400MHz,DMSO-d6):δ 12.20(s,1H),9.20-8.92(m,1H),7.54(s,1H),7.45(s,1H),7.08(s,1H),5.13-4.89(m,1H),4.76-4.41(m,1H),4.25-4.03(m,1H),3.86(d,1H),3.09(s,3H),2.81- 2.63(m,1H),2.49-2.18(m,5H),2.16-2.01(m,1H),1.94-1.50(m,4H),1.48-1.25(m,1H)。 By adding (1 S ,3a R ,6a S ) -N -(( S )-1-amino-1-oxo-3-(( S )-2-oxopiperidin-3-yl)propane -2-yl)-5,5-difluorooctahydrocyclopenta[ c ]pyrrole-1-carboxamide hydrobromide is coupled with an appropriate carboxylic acid to combine with (1 S , 3a R , 6a S )- N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-(9-hydroxy- 9H ( 1S , 3aR , 6aS )-2-(3-chloro- 4H -thiophene And[3,2-b]pyrrole-5-carbonyl) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5 ,5-Difluorooctahydrocyclopenta[ c ]pyrrole-1-carboxamide; observed m/z: 524[M+H] + ; 1 H NMR (400MHz, DMSO-d 6 ): δ 12.20(s ,1H), 9.20-8.92(m,1H), 7.54(s,1H), 7.45(s,1H), 7.08(s,1H), 5.13-4.89(m,1H), 4.76-4.41(m,1H ), 4.25-4.03(m,1H), 3.86(d,1H), 3.09(s,3H), 2.81- 2.63(m,1H), 2.49-2.18(m,5H), 2.16-2.01(m,1H ), 1.94-1.50 (m, 4H), 1.48-1.25 (m, 1H).
實施例105:(1S,3aR,6aS)-2-(7-氯-4,6-二氟-1H-吲[哚-2-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺(化合物117)Example 105: (1 S ,3a R ,6a S )-2-(7-Chloro-4,6-difluoro-1 H -indole-2-carbonyl) -N -(( S )-1- Cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[ c ]pyrrole-1-carboxamide (compound 117)
通過將(1S,3aR,6aS)-N-((S)-1-胺基-1-側氧基-3-((S)-2-氧代哌啶-3-基)丙烷-2-基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺氫溴酸鹽與適當的羧酸偶合以與關於(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺所描述的類似方式來製備(1S,3aR,6aS)-2-(7-氯-4,6-二氟-1H-吲哚-2-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺;觀察到m/z:554[M+H]+;1H NMR(400MHz,DMSO):δ 11.99(s,1H),8.85(d,1H),7.27(s,1H),7.16-6.94(m,2H),5.06-4.91(m,1H),4.60(s,1H),4.21-4.00(m,1H),3.86(dd,1H),3.16-3.08(m,2H),3.04-2.97(m,1H),2.89-2.80(m,1H),2.59-2.51(m,1H),2.44-2.04(m,5H),1.92-1.35(m,5H)。 By adding (1 S ,3a R ,6a S ) -N -(( S )-1-amino-1-oxo-3-(( S )-2-oxopiperidin-3-yl)propane -2-yl)-5,5-difluorooctahydrocyclopenta[ c ]pyrrole-1-carboxamide hydrobromide is coupled with an appropriate carboxylic acid to combine with (1 S , 3a R , 6a S )- N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-(9-hydroxy- 9H (1 S , 3a R , 6a S )-2- ( 7-chloro-4,6- Difluoro- 1H -indole-2-carbonyl) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5, 5-Difluorooctahydrocyclopenta[ c ]pyrrole-1-carboxamide; Observed m/z: 554[M+H] + ; 1 H NMR (400MHz, DMSO): δ 11.99 (s, 1H), 8.85(d,1H), 7.27(s,1H), 7.16-6.94(m,2H), 5.06-4.91(m,1H), 4.60(s,1H), 4.21-4.00(m,1H), 3.86( dd,1H), 3.16-3.08(m,2H), 3.04-2.97(m,1H), 2.89-2.80(m,1H), 2.59-2.51(m,1H), 2.44-2.04(m,5H), 1.92-1.35(m,5H).
實施例106:(3S,3aS,6aR)-2-(7-氯-4-氟-6-甲基-1H-吲哚-2-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-1,3,3a,4,6,6a-六氫環戊二烯并[c]吡咯-3-甲醯胺(化合物118)Example 106: ( 3S , 3aS , 6aR )-2-(7-Chloro-4-fluoro-6-methyl- 1H -indole-2-carbonyl) -N -[( 1S )- 1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-1,3,3a,4,6,6a-hexahydro Cyclopenta[ c ]pyrrole-3-carboxamide (Compound 118)
通過將(1S,3aR,6aS)-N-((S)-1-胺基-1-側氧基-3-((S)-2-氧代哌啶-3-基)丙烷-2-基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺氫溴酸鹽與適當的羧酸偶合以與關於(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺所描述的類似方式來製備(3S,3aS,6aR)-2-(7-氯-4-氟-6-甲基-1H-吲哚-2-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-1,3,3a,4,6,6a-六氫環戊二烯并[c]吡咯-3-甲醯胺;觀察到m/z:550[M+H]+;1H NMR(400MHz,DMSO-d6):δ 11.35-11.27(m,1H),8.86-8.82(m,1H),7.27(s,1H),7.00-6.84(m,1H),6.75-6.64(m,1H),5.05-4.93(m,1H),4.71-4.56(m,1H),4.18-4.04(m,1H),3.92-3.81(m,1H),3.17-3.08(m,2H),3.03-2.97(m,1H),2.88-2.78(m,1H),2.59-2.53(m,1H),2.46-2.30(m,3H),2.29-2.09(m,3H),1.91-1.49(m,3H),1.46-1.33(m,2H)。 By adding (1 S ,3a R ,6a S ) -N -(( S )-1-amino-1-oxo-3-(( S )-2-oxopiperidin-3-yl)propane -2-yl)-5,5-difluorooctahydrocyclopenta[ c ]pyrrole-1-carboxamide hydrobromide is coupled with an appropriate carboxylic acid to combine with (1 S , 3a R , 6a S )- N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-(9-hydroxy- 9H (3 S , 3a S , 6a R )-2-(7-chloro-4- fluoro- 6-Methyl- 1H -indole-2-carbonyl) -N -[( 1S )-1-cyano-2-[( 3S )-2-oxo-3-piperidinyl]Ethan base]-5,5-difluoro-1,3,3a,4,6,6a-hexahydrocyclopenta[ c ]pyrrole-3-carboxamide; observed m/z: 550 [M+ H] + ; 1 H NMR (400MHz, DMSO-d 6 ): δ 11.35-11.27 (m, 1H), 8.86-8.82 (m, 1H), 7.27 (s, 1H), 7.00-6.84 (m, 1H) , 6.75-6.64(m,1H), 5.05-4.93(m,1H), 4.71-4.56(m,1H), 4.18-4.04(m,1H), 3.92-3.81(m,1H), 3.17-3.08( m,2H), 3.03-2.97(m,1H), 2.88-2.78(m,1H), 2.59-2.53(m,1H), 2.46-2.30(m,3H), 2.29-2.09(m,3H), 1.91-1.49 (m, 3H), 1.46-1.33 (m, 2H).
實施例107:(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺(化合物119)Example 107: (1 S ,3a R ,6a S ) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-2 -(4,7-Difluoro-6-methyl- 1H -indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[ c ]pyrrole-1-carboxamide (compound 119)
通過將(1S,3aR,6aS)-N-((S)-1-胺基-1-側氧基-3-((S)-2- 氧代哌啶-3-基)丙烷-2-基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺氫溴酸鹽與適當的羧酸偶合以與關於(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺所描述的類似方式來製備(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺;觀察到m/z:534[M+H]+;1H NMR(400MHz,DMSO-d6):δ 11.92(s,1H),8.86-8.84(m,1H),7.27(s,1H),6.98-6.93(m,1H),6.92-6.73-6.69(m,1H),5.04-4.99(m,1H),4.68-4.55(m,1H),4.22-4.01(m,1H),3.92-3.81(m,1H),3.18-3.09(m,3H),3.04-2.97(m,1H),2.64-2.61(m,1H),2.50-2.49(m,1H),2.48-2.45(m,1H),2.44-2.43(m,3H),2.40-2.05(m,3H),1.90-1.82(m,2H),1.68-1.51(m,2H),1.42-1.33(m,1H)。 By adding (1 S ,3a R ,6a S ) -N -(( S )-1-amino-1-oxo-3-(( S )-2-oxopiperidin-3-yl)propane -2-yl)-5,5-difluorooctahydrocyclopenta[ c ]pyrrole-1-carboxamide hydrobromide is coupled with an appropriate carboxylic acid to combine with (1 S , 3a R , 6a S )- N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-(9-hydroxy- 9H ( 1S , 3aR , 6aS ) -N -(( S )-1-cyano -2-(( S )-2-oxopiperidin-3-yl)ethyl)-2-(4,7-difluoro-6-methyl-1 H -indole-2-carbonyl)-5 ,5-Difluorooctahydrocyclopenta[ c ]pyrrole-1-carboxamide; observed m/z: 534[M+H] + ; 1 H NMR (400MHz, DMSO-d 6 ): δ 11.92(s ,1H), 8.86-8.84(m,1H), 7.27(s,1H), 6.98-6.93(m,1H), 6.92-6.73-6.69(m,1H), 5.04-4.99(m,1H), 4.68 -4.55(m,1H), 4.22-4.01(m,1H), 3.92-3.81(m,1H), 3.18-3.09(m,3H), 3.04-2.97(m,1H), 2.64-2.61(m, 1H), 2.50-2.49(m,1H), 2.48-2.45(m,1H), 2.44-2.43(m,3H), 2.40-2.05(m,3H), 1.90-1.82(m,2H), 1.68- 1.51(m,2H), 1.42-1.33(m,1H).
實施例108:(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(7-(二氟甲基)-4-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺(化合物120)Example 108: (1 S ,3a R ,6a S ) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-2 -(7-(Difluoromethyl)-4-fluoro- 1H -indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[ c ]pyrrole-1-carboxamide (compound 120)
通過將(1S,3aR,6aS)-N-((S)-1-胺基-1-側氧基-3-((S)-2-氧代哌啶-3-基)丙烷-2-基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺氫溴酸鹽與適當的羧酸偶合以與關於(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺所描述的類似方式來製備(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(7-(二氟甲基)-4-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺;觀察到m/z:552[M+H]+; 1H NMR(400MHz,DMSO-d6):δ 12.13(s,1H),9.25-8.96(m,1H),7.80-7.38(m,3H),7.22(s,1H),7.06-6.78(m,1H),5.13-4.88(m,1H),4.52(d,1H),4.24(t,1H),4.02-3.74(m,1H),3.13-3.02(m,2H),2.99-2.84(m,1H),2.82-2.64(m,1H),2.51(s,1H),2.48-2.34(m,2H),2.33-2.21(m,2H),2.20-1.49(m,5H),1.47-1.36(m,1H)。 By adding (1 S ,3a R ,6a S ) -N -(( S )-1-amino-1-oxo-3-(( S )-2-oxopiperidin-3-yl)propane -2-yl)-5,5-difluorooctahydrocyclopenta[ c ]pyrrole-1-carboxamide hydrobromide is coupled with an appropriate carboxylic acid to combine with (1 S , 3a R , 6a S )- N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-(9-hydroxy- 9H ( 1S , 3aR , 6aS ) -N -(( S )-1-cyano -2-(( S )-2-oxopiperidin-3-yl)ethyl)-2-(7-(difluoromethyl)-4-fluoro-1 H -indole-2-carbonyl)- 5,5-Difluorooctahydrocyclopenta[ c ]pyrrole-1-carboxamide; Observed m/z: 552[M+H] + ; 1 H NMR (400MHz, DMSO-d 6 ): δ 12.13( s,1H), 9.25-8.96(m,1H), 7.80-7.38(m,3H), 7.22(s,1H), 7.06-6.78(m,1H), 5.13-4.88(m,1H), 4.52( d,1H), 4.24(t,1H), 4.02-3.74(m,1H), 3.13-3.02(m,2H), 2.99-2.84(m,1H), 2.82-2.64(m,1H), 2.51( s,1H), 2.48-2.34(m,2H), 2.33-2.21(m,2H), 2.20-1.49(m,5H), 1.47-1.36(m,1H).
實施例109:(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺(化合物121)Example 109: (1 S ,3a R ,6a S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5 ,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide (compound 121)
通過將(1S,3aR,6aS)-N-((S)-1-胺基-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺氫溴酸鹽與適當的羧酸偶合以與關於(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺所描述的類似方式來製備(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺;觀察到m/z:500[M+H]+;1H NMR(400MHz,CD3OD):δ 7.21-7.13(m,1H),7.13-6.80(m,2H),6.51(d,1H),5.05(m,1H),4.41-4.06(m,1H),4.05-3.82(m,4H),3.23-3.11(m,1H),3.08-2.83(m,2H),2.81-1.99(m,8H),1.99-1.59(m,2H),1.50-1.23(m,2H)。 By adding (1 S ,3a R ,6a S ) -N -(( S )-1-amino-1-oxo-3-(( S )-2-oxopyrrolidin-3-yl)propane -2-yl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide hydrobromide is coupled with an appropriate carboxylic acid to combine with (1 S , 3a R , 6a S )- N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-(9-hydroxy- 9H ( 1S , 3aR , 6aS ) -N -(( S )-1-cyano -2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-(4-methoxy- 1H -indole-2-carbonyl)eta Hydrocyclopenta[ c ]pyrrole-1-carboxamide; Observed m/z: 500[M+H] + ; 1 H NMR (400MHz, CD 3 OD): δ 7.21-7.13 (m, 1H), 7.13 -6.80(m,2H), 6.51(d,1H), 5.05(m,1H), 4.41-4.06(m,1H), 4.05-3.82(m,4H), 3.23-3.11(m,1H), 3.08 -2.83(m,2H), 2.81-1.99(m,8H), 1.99-1.59(m,2H), 1.50-1.23(m,2H).
實施例110:N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-4,4-二氟-Example 110: N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro- 2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺(化合物122和123)2-(9-Hydroxy-9H-fennel-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide (Compounds 122 and 123)
通過將(1S,3aR,6aS)-N-((S)-1-胺基-1-側氧基-3-((S)-2-氧代哌啶-3-基)丙烷-2-基)-4,4-二氟八氫環戊[c]吡咯-1-甲醯胺鹽酸鹽與適當的羧酸偶合以與關於(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺所描述的類似方式來製備N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺(非對映異構物的混合物)。通過反相HPLC分離N-((S)-1-氰基-2-(( S )-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺(非對映異構物的混合物,41mg)。 By adding (1 S ,3a R ,6a S ) -N -(( S )-1-amino-1-oxo-3-(( S )-2-oxopiperidin-3-yl)propane -2-yl)-4,4-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide hydrochloride is coupled with an appropriate carboxylic acid to combine with (1 S , 3a R , 6a S ) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-(9-hydroxy-9 H - N -(( S )-1-cyano-2-(( S ) -2 -oxo Piperidin-3-yl)ethyl)-4,4-difluoro-2-(9-hydroxy-9H-oxene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide (non-para mixture of enantiomers). N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2-(9 -Hydroxy-9H-Treph-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide (mixture of diastereoisomers, 41 mg).
次要非對映異構物(化合物122):(單一非對映異構物I,較快洗脫的非對映異構物):(4.6mg,產率11%,觀察到m/z:549[M+H]+)。1H NMR(400MHz,CD3OD):δ 8.95(d,1H),7.82(dd,2H),7.48(s,2H),7.44-7.28(m,4H),5.05(m,1H),4.41(s,1H),3.75-3.52(m,1H),3.26(m,4H),2.66-2.53(m,2H),2.42-2.33(m,1H),2.05-1.82(m,3H),1.76-1.66(m,2H),1.62-1.57(d,1H),1.28-1.20(m,2H),0.95-0.87(s,1H)。 Minor diastereomer (compound 122) : (single diastereomer I, faster eluting diastereomer): (4.6 mg, 11% yield, observed m/z : 549[M+H] + ). 1 H NMR (400MHz, CD 3 OD): δ 8.95(d,1H), 7.82(dd,2H), 7.48(s,2H), 7.44-7.28(m,4H), 5.05(m,1H), 4.41 (s,1H), 3.75-3.52(m,1H), 3.26(m,4H), 2.66-2.53(m,2H), 2.42-2.33(m,1H), 2.05-1.82(m,3H), 1.76 -1.66(m,2H), 1.62-1.57(d,1H), 1.28-1.20(m,2H), 0.95-0.87(s,1H).
主要非對映異構物(化合物123):(單一非對映異構物II,較慢洗脫的非對映異構物):(5.2mg,產率13%,觀察到m/z:549[M+H]+)。1H NMR(400MHz,CDCl3):δ 8.39(s,1H),7.69(dd,2H),7.44(q,2H),7.39-7.26(m,4H),4.93(s,1H),4.43(s,1H),3.35(s,1H),2.90-2.82(m,2H),2.79-2.72(m,2H),2.62-2.41(m,5H),2.13(s,1H),1.99-1.93(m,1H),1.88-1.83(m,1H),1.68- 1.64(m,1H),1.31-1.19(m,2H),0.92-0.85(s,1H)。 Major diastereomer (compound 123) : (single diastereomer II, slower eluting diastereomer): (5.2 mg, 13% yield, observed m/z: 549[M+H] + ). 1 H NMR (400MHz, CDCl 3 ): δ 8.39(s,1H), 7.69(dd,2H), 7.44(q,2H), 7.39-7.26(m,4H), 4.93(s,1H), 4.43( s,1H), 3.35(s,1H), 2.90-2.82(m,2H), 2.79-2.72(m,2H), 2.62-2.41(m,5H), 2.13(s,1H), 1.99-1.93( m,1H), 1.88-1.83(m,1H), 1.68-1.64(m,1H), 1.31-1.19(m,2H), 0.92-0.85(s,1H).
實施例111:(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺(化合物124)Example 111: (1 S ,3a R ,6a S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-4 , 4-difluoro-2-(9-hydroxy- 9H -fen-9-carbonyl)octahydrocyclopenta[ c ]pyrrole-1-carboxamide (compound 124)
通過將(1S,3aR,6aS)-N-((S)-1-胺基-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-4,4-二氟八氫環戊[c]吡咯-1-甲醯胺氫溴酸鹽與適當的羧酸偶合以與關於(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺所描述的類似方式來製備(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺;觀察到m/z:535[M+H]+;1H NMR(400MHz,DMSO-d6):δ 8.98(d,1H),8.30(s,1H),7.90-7.68(m,3H),7.49-7.38(m,2H),7.37-7.22(m,4H),6.29-6.04(m,1H),4.98(q,1H),4.29(d,1H),4.06-3.49(m,1H),3.22-3.10(m,2H),2.91-2.73(m,1H),2.64-2.55(m,2H),2.46-2.37(m,1H),2.28-2.08(m,2H),2.02-1.86(m,2H),1.86-1.53(m,3H)。 By adding (1 S ,3a R ,6a S ) -N -(( S )-1-amino-1-oxo-3-(( S )-2-oxopyrrolidin-3-yl)propane -2-yl)-4,4-difluorooctahydrocyclopenta[ c ]pyrrole-1-carboxamide hydrobromide is coupled with an appropriate carboxylic acid to combine with (1 S , 3a R , 6a S )- N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-(9-hydroxy- 9H ( 1S , 3aR , 6aS ) -N -(( S )-1-cyano -2-(( S )-2-Oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2-(9-hydroxy- 9H -fennel-9-carbonyl)octahydrocyclopenta [ c ] pyrrole-1-carboxamide; observed m/z: 535[M+H] + ; 1 H NMR (400MHz, DMSO-d 6 ): δ 8.98(d,1H), 8.30(s,1H ), 7.90-7.68(m,3H), 7.49-7.38(m,2H), 7.37-7.22(m,4H), 6.29-6.04(m,1H), 4.98(q,1H), 4.29(d,1H ), 4.06-3.49(m,1H), 3.22-3.10(m,2H), 2.91-2.73(m,1H), 2.64-2.55(m,2H), 2.46-2.37(m,1H), 2.28-2.08 (m,2H), 2.02-1.86(m,2H), 1.86-1.53(m,3H).
實施例112:(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺(化合物125)Example 112: (1 S ,3a R ,6a S ) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-2 -(9-Hydroxy- 9H -fen-9-carbonyl)octahydrocyclopenta[ c ]pyrrole-1-carboxamide (compound 125)
通過將(1S,3aR,6aS)-N-((S)-1-胺基-1-側氧基-3-((S)-2-氧代哌啶-3-基)丙烷-2-基)八氫環戊[c]吡咯-1-甲醯胺氫溴酸鹽與適當的羧酸偶合以與關於(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺所描述的類似方式來製備(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺;觀察到m/z:513[M+H]+;1H NMR(400MHz,CD3OD):δ 7.78(dd,2H),7.46(q,2H),7.36(dd,4H),5.11(dd,1H),4.20(d,1H),2.65-2.61(m,2H),2.54-2.46(m,1H),2.42-2.38(m,1H),2.31-2.27(m,2H),2.17-2.00(m,2H),1.98-1.90(m,2H),1.88-1.76(m,2H),1.74-1.28(m,7H),0.68-0.60(m,1H)。 By adding (1 S ,3a R ,6a S ) -N -(( S )-1-amino-1-oxo-3-(( S )-2-oxopiperidin-3-yl)propane -2-yl)octahydrocyclopenta[ c ]pyrrole-1-carboxamide hydrobromide is coupled with an appropriate carboxylic acid to combine with ( 1S , 3aR , 6aS ) -N -(( S )- 1-Cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-(9-hydroxy- 9H -oxopiperidin-9-carbonyl) ( 1S ,3aR,6aS)-N-((S ) -1 - cyano-2 - (( S ) -2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxy- 9H -fluorene-9-carbonyl)octahydrocyclopenta[ c ]pyrrole-1-carboxamide; observed m /z: 513[M+H] + ; 1 H NMR (400MHz, CD 3 OD): δ 7.78 (dd, 2H), 7.46 (q, 2H), 7.36 (dd, 4H), 5.11 (dd, 1H) , 4.20(d,1H), 2.65-2.61(m,2H), 2.54-2.46(m,1H), 2.42-2.38(m,1H), 2.31-2.27(m,2H), 2.17-2.00(m, 2H), 1.98-1.90 (m, 2H), 1.88-1.76 (m, 2H), 1.74-1.28 (m, 7H), 0.68-0.60 (m, 1H).
實施例113:MExample 113: M propro 測定determination
SARS-COV-2主蛋白酶(從大腸桿菌中克隆、表達和純化的)和熒光底物(在其N-末端和C-末端分別與淬滅劑:熒光團對連接的肽底物)被用來確定化合物的抑制效力。主蛋白酶(Mpro)對底物的裂解導致熒光信號的產生,其強度與該酶裂解的底物量成正比。預計Mpro的抑制劑的存在會降低熒光強度。 SARS-COV-2 main protease (cloned, expressed and purified from E. coli) and fluorescent substrate (peptide substrate linked to quencher:fluorophore pair at its N-terminus and C-terminus, respectively) were used To determine the inhibitory potency of the compound. Cleavage of the substrate by the main protease (M pro ) results in the generation of a fluorescent signal whose intensity is proportional to the amount of substrate cleaved by the enzyme. The presence of inhibitors of Mpro is expected to reduce the fluorescence intensity.
為了確定Mpro抑制劑的抑制活性,一式兩份準備了包括8點半對數稀釋滴定系列的化合物的連續稀釋液。在加入熒光底物之前,將這些化合物與SARS-COV-2 Mpro酶在黑色的實心的½面積的96孔板中在室溫下預溫育30分鐘。將由酶、化合物和底物組成的反應混合物在最終DMSO濃度為1%的測定緩衝液中在30℃下再溫育90分鐘。溫育期結束後,使用ENVISION® HTS多標簽平板閱讀器(PerkinElmer,Shelton,CT)在Ex/Em波長=340nm/490nm下對平板進行分析。 To determine the inhibitory activity of Mpro inhibitors, serial dilutions of compounds comprising an 8-point half-log dilution titration series were prepared in duplicate. These compounds were pre-incubated with the SARS-COV-2 M pro enzyme in black solid ½ area 96-well plates for 30 min at room temperature prior to the addition of the fluorogenic substrate. The reaction mixture consisting of enzyme, compound and substrate was incubated for an additional 90 min at 30 °C in assay buffer with a final DMSO concentration of 1%. After the incubation period, the plates were analyzed using the ENVISION® HTS multi-label plate reader (PerkinElmer, Shelton, CT) at Ex/Em wavelengths = 340nm/490nm.
將觀察到作為化合物濃度的函數的熒光信號與未處理(無化合物)的對照進行比較,以確定抑制百分比。通過使用微軟Excel軟件中的XL-Fit模塊[IDBS,Boston,MA]的4參數曲線擬合算法,確定基 於劑量反應曲線的化合物的濃度,該濃度產生酶活性的半最大值抑制(IC50)。 The fluorescence signal observed as a function of compound concentration was compared to untreated (no compound) controls to determine percent inhibition. Determine the concentration of the compound that produces half-maximal inhibition ( IC50 ) of the enzyme activity based on the dose-response curve by using the 4-parameter curve-fitting algorithm of the XL-Fit module [IDBS, Boston, MA] in Microsoft Excel software .
列舉的實施方式Enumerated implementations
提供以下示例性實施方式,其編號不應解釋為指定重要程度: The following exemplary embodiments are provided, the numbering of which should not be construed as specifying a degree of importance:
實施方式1提供式(I)的化合物,或其鹽、溶劑合物、幾何異構物、立體異構物、互變異構物或任何混合物: Embodiment 1 provides a compound of formula (I), or a salt, solvate, geometric isomer, stereoisomer, tautomer or any mixture thereof:
其中: in:
R1選自、、、 R 1 is selected from , , ,
R2a和R2b各自獨立地選自H、可選擇地取代的C1-C12烷基、可選擇地取代的C3-C12環烷基、可選擇地取代的C2-C12雜環基和C7-C12芳烷基, R 2a and R 2b are each independently selected from H, optionally substituted C 1 -C 12 alkyl, optionally substituted C 3 -C 12 cycloalkyl, optionally substituted C 2 -C 12 hetero Cyclic and C 7 -C 12 aralkyl,
其中R2a和RA以及R2a和R2b中的一個或多個可以與它們所鍵合的原子結合以形成可選擇地取代的C3-C12雜環基或可選擇地取代的C3-C12環烷基,其中其兩個可選擇的取代基可以與它們所 鍵合的原子結合以形成可選擇地取代的C3-C12環烷基、可選擇地取代的C2-C12雜環基或可選擇地取代的苯基;R3是; wherein R 2a and R A and one or more of R 2a and R 2b may be combined with the atoms to which they are bonded to form an optionally substituted C 3- C 12 heterocyclyl or an optionally substituted C 3 -C 12 cycloalkyl, wherein two optional substituents thereof can combine with the atoms to which they are bonded to form optionally substituted C 3 -C 12 cycloalkyl, optionally substituted C 2 -C 12 heterocyclyl or optionally substituted phenyl; R 3 is ;
L選自可選擇地取代的C1-C3亞烷基、-C(=O)-*、-C(=O)(可選擇地取代的C1-C2亞烷基)-*、-(可選擇地取代的C1-C2亞烷基)-C(=O)-*和鍵,其中*表示L和R4a之間的鍵; L is selected from optionally substituted C 1 -C 3 alkylene, -C(=O)-*, -C(=O)(optionally substituted C 1 -C 2 alkylene)-*, -(optionally substituted C 1 -C 2 alkylene)-C(=O)-* and a bond, wherein * represents the bond between L and R 4a ;
R4a選自可選擇地取代的苯基、可選擇地取代的C2-C9雜芳基、 R 4a is selected from optionally substituted phenyl, optionally substituted C 2 -C 9 heteroaryl,
其中在R4a中,可選擇地取代的苯基或可選擇地取代的C2-C9雜芳基被至少一個鹵素取代;R4b是H; Wherein in R 4a , optionally substituted phenyl or optionally substituted C 2 -C 9 heteroaryl is substituted by at least one halogen; R 4b is H;
R4c選自、和; R 4c is selected from , and ;
R5a選自H、-C(=O)(可選擇地取代的C1-C6烷基)、-C(=O)(C1-C6鹵代烷基)和可選擇地取代的C1-C6烷基; R 5a is selected from H, -C(=O) (optionally substituted C 1 -C 6 alkyl), -C(=O) (C 1 -C 6 haloalkyl) and optionally substituted C 1 -C 6 alkyl;
R5b選自H、可選擇地取代的C1-C6烷基和可選擇地取代的C2-C6烯基; R 5b is selected from H, optionally substituted C 1 -C 6 alkyl and optionally substituted C 2 -C 6 alkenyl;
R5c選自H和鹵素; R is selected from H and halogen;
R6a選自H、可選擇地取代的C1-C6烷基和可選擇地取代的苯基; R 6a is selected from H, optionally substituted C 1 -C 6 alkyl and optionally substituted phenyl;
R6b是H, R6b is H,
或R6a和R6b與它們所鍵合的碳原子結合以形成可選擇地取代的C3-C8環烷基; or R 6a and R 6b are combined with the carbon atoms to which they are bonded to form an optionally substituted C 3 -C 8 cycloalkyl;
R6c選自C(=O)(可選擇地取代的C1-C6鹵代烷基)、C(=O)(可選擇地取代的C1-C6烷基)、可選擇地取代的C2-C9雜芳基和可選擇地取代的苯基; R 6c is selected from C(=O) (optionally substituted C 1 -C 6 haloalkyl), C(=O) (optionally substituted C 1 -C 6 alkyl), optionally substituted C 2 -C Heteroaryl and optionally substituted phenyl;
R7a和R7b(如果存在)各自獨立地選自H、鹵素、ORB、可選擇地取代的C1-C6烷基、可選擇地取代的C3-C8環烷基、可選擇地取代的C2-C9雜環基和可選擇地取代的萘基; R 7a and R 7b (if present) are each independently selected from H, halogen, OR B , optionally substituted C 1 -C 6 alkyl, optionally substituted C 3 -C 8 cycloalkyl, optionally Ground substituted C 2 -C 9 heterocyclyl and optionally substituted naphthyl;
Ra1、Ra2、Ra3、Ra4、Ra5、Ra6、Ra7、Ra8、Ra9和Ra10(如果存在)的每次出現獨立地選自H、鹵素、CN、NO2、可選擇地取代的C1-C6烷基、可選擇地取代的C3-C8環烷基、可選擇地取代的C1-C6烷氧基、可選擇地取代的C3-C8環烷氧基、可選擇地取代的C2-C8雜環烷基、可選擇地取代的苯基、可選擇地取代的萘基、可選擇地取代的C-2-C9雜芳基、ORB、N(RB)(RC)、NO2、C(=O)N(RB)(RC)、C(=O)RB、C(=O)ORB、OC(=O)RB、OC(=O)ORB、SRB、S(=O)RB、S(=O)2RB、N(RB)S(=O)2RC、N(RB)C(=O)RC和S(=O)2N(RB)(RC); Each occurrence of R a1 , R a2 , R a3 , R a4 , R a5 , R a6 , R a7 , R a8 , R a9 and R a10 (if present) is independently selected from H, halogen, CN, NO 2 , Optionally substituted C 1 -C 6 alkyl, optionally substituted C 3 -C 8 cycloalkyl, optionally substituted C 1 -C 6 alkoxy, optionally substituted C 3 -C 8 cycloalkoxy, optionally substituted C 2 -C 8 heterocycloalkyl, optionally substituted phenyl, optionally substituted naphthyl, optionally substituted C- 2 -C 9 heteroaryl base, OR B , N(R B )(R C ), NO 2 , C(=O)N(R B )(R C ), C(=O)R B , C(=O)OR B , OC (=O)R B , OC(=O)OR B , SR B , S(=O)R B , S(=O) 2 R B , N(R B )S(=O) 2 R C , N (R B )C(=O)R C and S(=O) 2 N(R B )(R C );
Rb1、Rb2和Rb3(如果存在)的每次出現獨立地選自H、鹵素、可選擇地取代的C1-C6烷基、可選擇地取代的C3-C8環烷基、可選擇地取代的C1-C6烷氧基、可選擇地取代的C3-C8環烷氧基、可選擇地取代的C2-C8雜環烷基、可選擇地取代的苯基、可選擇地取代的萘基、可選擇地取代的C2-C9雜芳基、C(=O)N(RB)(RC)、C(=O)RB、C(=O)ORB、S(=O)RB、S(=O)2RB和S(=O)2N(RB)(RC), Each occurrence of R b1 , R b2 and R b3 (if present) is independently selected from H, halogen, optionally substituted C 1 -C 6 alkyl, optionally substituted C 3 -C 8 cycloalkyl , optionally substituted C 1 -C 6 alkoxy, optionally substituted C 3 -C 8 cycloalkoxy, optionally substituted C 2 -C 8 heterocycloalkyl, optionally substituted Phenyl, optionally substituted naphthyl, optionally substituted C 2 -C 9 heteroaryl, C(=O)N(R B )(R C ), C(=O) RB , C( =O)OR B , S(=O) RB , S(=O) 2 R B and S(=O) 2 N(R B )(R C ),
其中選自Rb1、Rb2和Rb3的兩個成對取代基可以與它們所鍵合的碳原子結合以形成可選擇地取代的C2-C8雜環烷基或可選擇地取代的C3-C8環烷基; wherein two pairs of substituents selected from R b1 , R b2 and R b3 can be combined with the carbon atoms to which they are bonded to form an optionally substituted C 2 -C 8 heterocycloalkyl or an optionally substituted C 3 -C 8 cycloalkyl;
Rc1、Rc2、Rc3、Rc4、Rc5、Rc6、Rc7、Rc8、Rc9、Rc10和Rc11(如果存在)的每次出現獨立地選自H、鹵素、CN、NO2、可選擇地取代的C1-C6烷基、可選擇地取代的C3-C8環烷基、可選擇地取代的C1-C6烷氧基、可選擇地取代的C3-C8環烷氧基、雜環基、苯基、萘基、雜芳基、ORB、N(RB)(RC)、NO2、C(=O)N(RB)(RC)、C(=O)RB、C(=O)ORB、 OC(=O)RB、OC(=O)ORB、SRB、S(=O)RB、S(=O)2RB、N(RB)S(=O)2RC、N(RB)C(=O)RC和S(=O)2N(RB)(RC); Each occurrence of R c1 , R c2 , R c3 , R c4 , R c5 , R c6 , R c7 , R c8 , R c9 , R c10 and R c11 (if present) is independently selected from H, halogen, CN, NO 2 , optionally substituted C 1 -C 6 alkyl, optionally substituted C 3 -C 8 cycloalkyl, optionally substituted C 1 -C 6 alkoxy, optionally substituted C 3 -C 8 cycloalkoxy, heterocyclyl, phenyl, naphthyl, heteroaryl, OR B , N(R B )(R C ), NO 2 , C(=O)N(R B )( R C ), C(=O)R B , C(=O)OR B , OC(=O)R B , OC(=O)OR B , SR B , S(=O)R B , S(= O) 2 R B , N( RB )S(=O) 2 R C , N( RB )C(=O)R C and S(=O) 2 N( RB )(R C );
RA、RB和RC的每次出現獨立地選自H、-C(=O)(可選擇地取代的C1-C6烷基)、-C(=O)(可選擇地取代的C1-C6鹵代烷基)、可選擇地取代的C1-C6烷基、可選擇地取代的C1-C3鹵代烷基、可選擇地取代的C3-C8環烷基、可選擇地取代的C1-C6烷氧基和可選擇地取代的C3-C8環烷氧基、可選擇地取代的苯基、可選擇地取代的萘基和可選擇地取代的C2-C9雜芳基; Each occurrence of R A , R B and R C is independently selected from H, -C(=O) (optionally substituted C 1 -C 6 alkyl), -C(=O) (optionally substituted C 1 -C 6 haloalkyl), optionally substituted C 1 -C 6 alkyl, optionally substituted C 1 -C 3 haloalkyl, optionally substituted C 3 -C 8 cycloalkyl, Optionally substituted C 1 -C 6 alkoxy and optionally substituted C 3 -C 8 cycloalkoxy, optionally substituted phenyl, optionally substituted naphthyl and optionally substituted C 2 -C 9 heteroaryl;
RD選自H、-C(=O)RB和-S(=O)2RB; RD is selected from H, -C( = O) RB and -S(=O) 2RB ;
RE選自H、C1-C6烷基和C1-C6鹵代烷基; R E is selected from H, C 1 -C 6 alkyl and C 1 -C 6 haloalkyl;
X的每次出現獨立地選自O、S和N(RB); each occurrence of X is independently selected from O, S and N( RB );
Y(如果存在)選自I、Br、Cl、F和ORD; Y (if present) is selected from I, Br, Cl, F and OR D ;
Z1和Z2各自獨立地選自H和鹵素;和 Z and Z are each independently selected from H and halogen; and
其中如果R1是4-甲氧基-1H-吲哚基,則適用下列至少一項: Wherein if R is 4-methoxy- 1H -indolyl, at least one of the following applies:
(a)R2a不是異丙基且R2b不是H, (a) R 2a is not isopropyl and R 2b is not H,
(b)R2a不是H且R2b不是異丙基,或 (b) R 2a is not H and R 2b is not isopropyl, or
(c)R4a不是-C(=O)CH2OH或-C(=O)CH2OP(=O)(OH)2。 (c) R 4a is not -C(=O)CH 2 OH or -C(=O)CH 2 OP(=O)(OH) 2 .
實施方式2提供實施方式1所述的化合物,其選自: Embodiment 2 provides the compound described in Embodiment 1, which is selected from:
實施方式3提供實施方式1或2所述的化合物,其中R2a和R2b中的一個選自甲基、乙基、正丙基、異丙基、環丙基、環丙基甲基、正丁基、第二丁基、第三丁基、環丁基、甲基環丁基、正戊基、第二戊基、第三戊基、新戊基、環戊基、環戊基甲基、正己基、第二己基、第三己基、新己基、環己基和環己基甲基。 Embodiment 3 provides the compound described in Embodiment 1 or 2, wherein one of R 2a and R 2b is selected from methyl, ethyl, n-propyl, isopropyl, cyclopropyl, cyclopropylmethyl, n- Butyl, second butyl, third butyl, cyclobutyl, methylcyclobutyl, n-pentyl, second pentyl, third pentyl, neopentyl, cyclopentyl, cyclopentylmethyl , n-hexyl, second hexyl, third hexyl, neohexyl, cyclohexyl and cyclohexylmethyl.
實施方式4提供實施方式1-3中任一項所述的化合物,其中R2a和R2b中的一個是H。 Embodiment 4 provides the compound of any one of embodiments 1-3, wherein one of R 2a and R 2b is H.
實施方式5提供實施方式1所述的化合物,其選自: Embodiment 5 provides the compound described in Embodiment 1, which is selected from:
其中: in:
R8選自H、可選擇地取代的C1-C6烷基、可選擇地取代的C2-C6烯基、可選擇地取代的C3-C8環烷基、可選擇地取代的C2-C9雜環基、可選擇地取代的苯基、可選擇地取代的萘基、可選擇地取代的C2-C9雜芳基, R 8 is selected from H, optionally substituted C 1 -C 6 alkyl, optionally substituted C 2 -C 6 alkenyl, optionally substituted C 3 -C 8 cycloalkyl, optionally substituted C 2 -C 9 heterocyclyl, optionally substituted phenyl, optionally substituted naphthyl, optionally substituted C 2 -C 9 heteroaryl,
其中每個可選擇地取代的C1-C6烷基、可選擇地取代的C2-C9雜芳基和可選擇地取代的苯基可選擇地被選自C1-C6烷基、C1-C6烷氧基和可選擇地取代的吡啶基的至少一個取代基取代;和 Rd1、Rd2、Rd3、Rd4、Rd5、Rd6、Rd7、Rd8、Rd9和Rd10(如果存在)的每次出現獨立地選自H、鹵素、CN、NO2、可選擇地取代的C1-C6烷基、可選擇地取代的C3-C8環烷基、可選擇地取代的C1-C6烷氧基、可選擇地取代的C3-C8環烷氧基、雜環基、苯基、萘基、雜芳基、ORB、N(RB)(RC)、NO2、C(=O)N(RB)(RC)、C(=O)RB、C(=O)ORB、OC(=O)RB、OC(=O)ORB、SRB、S(=O)RB、S(=O)2RB、N(RB)S(=O)2RC、N(RB)C(=O)RC和S(=O)2N(RB)(RC), wherein each of the optionally substituted C 1 -C 6 alkyl, the optionally substituted C 2 -C 9 heteroaryl and the optionally substituted phenyl is optionally selected from the group consisting of C 1 -C 6 alkyl , C 1 -C 6 alkoxy and optionally substituted pyridyl by at least one substituent; and R d1 , R d2 , R d3 , R d4 , R d5 , R d6 , R d7 , R d8 , R Each occurrence of d9 and Rd10 (if present) is independently selected from H, halogen, CN, NO2 , optionally substituted C1 - C6 alkyl, optionally substituted C3 - C8 cycloalkane radical, optionally substituted C 1 -C 6 alkoxy, optionally substituted C 3 -C 8 cycloalkoxy, heterocyclyl, phenyl, naphthyl, heteroaryl, OR B , N( R B )(R C ), NO 2 , C(=O)N(R B )(R C ), C(=O)R B , C(=O)OR B , OC(=O)R B , OC(=O)OR B , SR B , S(=O)R B , S(=O) 2 R B , N(R B )S(=O) 2 R C , N(R B )C(= O)R C and S(=O) 2 N(R B )(R C ),
其中選自Rd1、Rd2、Rd3、Rd4、Rd5、Rd6、Rd7、Rd8、Rd9和Rd10的兩個取代基--可以與它們所鍵合的原子結合以形成可選擇地取代的C3-C8環烷基或可選擇地取代的C2-C8雜環烷基。 wherein two substituents selected from R d1 , R d2 , R d3 , R d4 , R d5 , R d6 , R d7 , R d8 , R d9 and R d10 - can combine with the atoms to which they are bonded to form Optionally substituted C 3 -C 8 cycloalkyl or optionally substituted C 2 -C 8 heterocycloalkyl.
實施方式6提供實施方式1和3-5中任一項所述的化合物,其選自: Embodiment 6 provides the compound described in any one of Embodiments 1 and 3-5, which is selected from:
實施方式7提供實施方式5或6所述的化合物,其中適用下列至少一項: Embodiment 7 provides the compound described in Embodiment 5 or 6, wherein at least one of the following applies:
(a)Rd1、Rd2、Rd3、Rd4、Rd5、Rd6、Rd7、Rd8、Rd9和Rd10(如果存在)中的每一個是H; (a) each of Rd1 , Rd2 , Rd3 , Rd4 , Rd5 , Rd6 , Rd7 , Rd8 , Rd9 and Rd10 (if present) is H;
(b)Rd1、Rd2、Rd3、Rd4、Rd5、Rd6、Rd7、Rd8、Rd9和Rd10(如果存在)中的九個是H; (b) nine of Rd1 , Rd2 , Rd3 , Rd4 , Rd5 , Rd6 , Rd7 , Rd8 , Rd9 and Rd10 (if present) are H;
(c)Rd1、Rd2、Rd3、Rd4、Rd5、Rd6、Rd7、Rd8、Rd9和Rd10(如果存在)中的八個是H; (c) eight of Rd1 , Rd2 , Rd3 , Rd4 , Rd5 , Rd6 , Rd7 , Rd8 , Rd9 and Rd10 (if present) are H;
(d)Rd1、Rd2、Rd3、Rd4、Rd5、Rd6、Rd7、Rd8、Rd9和Rd10(如果存在)中的七個是H; (d) seven of Rd1 , Rd2 , Rd3 , Rd4 , Rd5 , Rd6 , Rd7 , Rd8 , Rd9 and Rd10 (if present) are H;
(e)Rd1、Rd2、Rd3、Rd4、Rd5、Rd6、Rd7、Rd8、Rd9和Rd10(如果存在)中的六個是H; (e) six of Rd1 , Rd2 , Rd3 , Rd4 , Rd5 , Rd6 , Rd7 , Rd8 , Rd9 and Rd10 (if present) are H;
(f)Rd1、Rd2、Rd3、Rd4、Rd5、Rd6、Rd7、Rd8、Rd9和Rd10(如果存在)中的五個是H; (f) five of Rd1 , Rd2 , Rd3 , Rd4 , Rd5 , Rd6 , Rd7 , Rd8 , Rd9 and Rd10 (if present) are H;
(g)Rd1、Rd2、Rd3、Rd4、Rd5、Rd6、Rd7、Rd8、Rd9和Rd10(如果存在)中的四個是H; (g) four of Rd1 , Rd2 , Rd3 , Rd4 , Rd5 , Rd6 , Rd7 , Rd8 , Rd9 and Rd10 (if present) are H;
(h)Rd1、Rd2、Rd3、Rd4、Rd5、Rd6、Rd7、Rd8、Rd9和Rd10(如果存在)中的三個是H; (h) three of Rd1 , Rd2 , Rd3 , Rd4 , Rd5 , Rd6 , Rd7 , Rd8 , Rd9 and Rd10 (if present) are H;
(i)Rd1、Rd2、Rd3、Rd4、Rd5、Rd6、Rd7、Rd8、Rd9和Rd10(如果存在)中的兩個是H;和 (i) two of Rd1 , Rd2 , Rd3 , Rd4 , Rd5 , Rd6 , Rd7 , Rd8 , Rd9 and Rd10 (if present) are H; and
(j)Rd1、Rd2、Rd3、Rd4、Rd5、Rd6、Rd7、Rd8、Rd9和Rd10(如果存在)中的一個是H; (j) one of Rd1 , Rd2 , Rd3 , Rd4 , Rd5 , Rd6 , Rd7 , Rd8 , Rd9 and Rd10 (if present) is H;
實施方式8提供實施方式1和3-7中任一項所述的化合物,其選自: Embodiment 8 provides the compound described in any one of Embodiments 1 and 3-7, which is selected from:
實施方式9提供實施方式1-8中任一項所述的化合物,其中Ra1、Ra2、Ra3、Ra4、Ra5、Ra6、Ra7、Ra8、Ra9和Ra10(如果存在)各自獨立地選自H、Me、Br、Cl、F、OMe和CF2H。 Embodiment 9 provides the compound according to any one of embodiments 1-8, wherein R a1 , R a2 , R a3 , R a4 , R a5 , R a6 , R a7 , R a8 , R a9 and R a10 (if present) are each independently selected from H, Me, Br, Cl, F, OMe and CF2H .
實施方式10提供實施方式1-9中任一項所述的化合物,其中適用下列至少一項: Embodiment 10 provides the compound of any one of Embodiments 1-9, wherein at least one of the following applies:
(a)Ra1、Ra2、Ra3、Ra4、Ra5、Ra6、Ra7、Ra8、Ra9和Ra10(如果存在)中的每一個是H; (a) each of R a1 , R a2 , R a3 , R a4 , R a5 , R a6 , R a7 , R a8 , R a9 and R a10 (if present) is H;
(b)Ra1、Ra2、Ra3、Ra4、Ra5、Ra6、Ra7、Ra8、Ra9和Ra10(如果存在)中的九個是H; (b) nine of R a1 , R a2 , R a3 , R a4 , R a5 , R a6 , R a7 , R a8 , R a9 and R a10 (if present) are H;
(c)Ra1、Ra2、Ra3、Ra4、Ra5、Ra6、Ra7、Ra8、Ra9和Ra10(如果存在)中的八個是H; (c) eight of R a1 , R a2 , R a3 , R a4 , R a5 , R a6 , R a7 , R a8 , R a9 and R a10 (if present) are H;
(d)Ra1、Ra2、Ra3、Ra4、Ra5、Ra6、Ra7、Ra8、Ra9和Ra10(如果存在)中的七個是H; (d) seven of R a1 , R a2 , R a3 , R a4 , R a5 , R a6 , R a7 , R a8 , R a9 and R a10 (if present) are H;
(e)Ra1、Ra2、Ra3、Ra4、Ra5、Ra6、Ra7、Ra8、Ra9和Ra10(如果存在)中的六個是H; (e) six of R a1 , R a2 , R a3 , R a4 , R a5 , R a6 , R a7 , R a8 , R a9 and R a10 (if present) are H;
(f)Ra1、Ra2、Ra3、Ra4、Ra5、Ra6、Ra7、Ra8、Ra9和Ra10(如果存在)中的五個是H; (f) five of R a1 , R a2 , R a3 , R a4 , R a5 , R a6 , R a7 , R a8 , R a9 and R a10 (if present) are H;
(g)Ra1、Ra2、Ra3、Ra4、Ra5、Ra6、Ra7、Ra8、Ra9和Ra10(如果存在)中的四個是H; (g) four of R a1 , R a2 , R a3 , R a4 , R a5 , R a6 , R a7 , R a8 , R a9 and R a10 (if present) are H;
(h)Ra1、Ra2、Ra3、Ra4、Ra5、Ra6、Ra7、Ra8、Ra9和Ra10(如果存在)中的三個是H; (h) three of R a1 , R a2 , R a3 , R a4 , R a5 , R a6 , R a7 , R a8 , R a9 and R a10 (if present) are H;
(i)Ra1、Ra2、Ra3、Ra4、Ra5、Ra6、Ra7、Ra8、Ra9和Ra10(如果存在)中的兩個是H;和 (i) two of R a1 , R a2 , R a3 , R a4 , R a5 , R a6 , R a7 , R a8 , R a9 and R a10 (if present) are H; and
(j)Ra1、Ra2、Ra3、Ra4、Ra5、Ra6、Ra7、Ra8、Ra9和Ra10(如果存在)中的一個是H。 (j) one of R a1 , R a2 , R a3 , R a4 , R a5 , R a6 , R a7 , R a8 , R a9 and R a10 (if present) is H.
實施方式11提供實施方式1-8中任一項所述的化合物,其中R1選自: Embodiment 11 provides the compound described in any one of Embodiments 1-8, wherein R is selected from:
實施方式12提供實施方式1-8和11中任一項所述的化合物,其中R6a選自H、甲基、異丁基、第三丁基、環丙基甲基、環丁基甲 基,和苯基。 Embodiment 12 provides the compound of any one of embodiments 1-8 and 11, wherein R is selected from H, methyl, isobutyl, tert-butyl, cyclopropylmethyl, cyclobutylmethyl, and phenyl.
實施方式13提供實施方式1-8和11中任一項所述的化合物,其中R6a和R6b與它們所鍵合的碳原子結合以形成環丙基。 Embodiment 13 provides the compound of any one of Embodiments 1-8 and 11, wherein R 6a and R 6b combine with the carbon atom to which they are bonded to form cyclopropyl.
實施方式14提供實施方式1-8和11-13中任一項所述的化合物,其中R6c選自C(=O)CF3、C(=O)CH3、被選自C1-C6烷基和鹵素的至少一個取代基取代的吡啶基、被選自C1-C6烷基和鹵素的至少一個取代基取代的吡唑基和被選自C1-C6烷基和鹵素的至少一個取代基取代的苯基。 Embodiment 14 provides the compound according to any one of embodiments 1-8 and 11-13, wherein R 6c is selected from C(=O)CF 3 , C(=O)CH 3 , is selected from C 1 -C Pyridyl substituted by at least one substituent of 6 alkyl and halogen, pyrazolyl substituted by at least one substituent selected from C 1 -C 6 alkyl and halogen, and pyrazolyl substituted by at least one substituent selected from C 1 -C 6 alkyl and halogen A phenyl group substituted with at least one substituent.
實施方式15提供實施方式1-8和11-14中任一項所述的化合物,其中R6c選自C(=O)CF3、C(=O)CH3、、、 Embodiment 15 provides the compound according to any one of embodiments 1-8 and 11-14, wherein R 6c is selected from C(=O)CF 3 , C(=O)CH 3 , , ,
實施方式16提供實施方式1-10中任一項所述的化合物,其中R7a和R7b各自獨立地選自H、OH、Me、環戊基和F。 Embodiment 16 provides the compound of any one of embodiments 1-10, wherein R 7a and R 7b are each independently selected from H, OH, Me, cyclopentyl, and F.
實施方式17提供實施方式1-16中任一項所述的化合物,其中R1選自: Embodiment 17 provides the compound of any one of embodiments 1-16, wherein R is selected from:
實施方式18提供實施方式1-17中任一項所述的化合物,其中R3選自: Embodiment 18 provides the compound of any one of Embodiments 1-17, wherein R is selected from:
實施方式19提供實施方式1-18中任一項所述的化合物, 其中L是鍵。 Embodiment 19 provides the compound described in any one of Embodiments 1-18, where L is a bond.
實施方式20提供實施方式1-19中任一項所述的化合物,其中R4c選自: Embodiment 20 provides the compound of any one of embodiments 1-19, wherein R is selected from:
實施方式21提供實施方式1-20中任一項所述的化合物,其中適用下列至少一項: Embodiment 21 provides the compound of any one of embodiments 1-20, wherein at least one of the following applies:
(a)Rc1、Rc2、Rc3、Rc4、Rc5、Rc6、Rc7、Rc8、Rc9、Rc10和Rc11(如果存在)中的每一個是H; (a) each of Rc1 , Rc2 , Rc3 , Rc4 , Rc5 , Rc6 , Rc7 , Rc8 , Rc9 , Rc10 and Rc11 (if present) is H;
(b)Rc1、Rc2、Rc3、Rc4、Rc5、Rc6、Rc7、Rc8、Rc9、Rc10和Rc11(如果存在)中的十個是H; (b) ten of R c1 , R c2 , R c3 , R c4 , R c5 , R c6 , R c7 , R c8 , R c9 , R c10 and R c11 (if present) are H;
(c)Rc1、Rc2、Rc3、Rc4、Rc5、Rc6、Rc7、Rc8、Rc9、Rc10和Rc11(如果存在)中的九個是H; (c) nine of R c1 , R c2 , R c3 , R c4 , R c5 , R c6 , R c7 , R c8 , R c9 , R c10 and R c11 (if present) are H;
(d)Rc1、Rc2、Rc3、Rc4、Rc5、Rc6、Rc7、Rc8、Rc9、Rc10和Rc11(如果存在)中的八個是H; (d) eight of Rc1 , Rc2 , Rc3 , Rc4 , Rc5 , Rc6 , Rc7 , Rc8 , Rc9 , Rc10 and Rc11 (if present) are H;
(e)Rc1、Rc2、Rc3、Rc4、Rc5、Rc6、Rc7、Rc8、Rc9、Rc10和Rc11(如果存在)中的七個是H; (e) seven of Rc1 , Rc2 , Rc3 , Rc4 , Rc5 , Rc6 , Rc7 , Rc8 , Rc9 , Rc10 and Rc11 (if present) are H;
(f)Rc1、Rc2、Rc3、Rc4、Rc5、Rc6、Rc7、Rc8、Rc9、Rc10和Rc11(如果存在)中的六個是H; (f) six of Rc1 , Rc2 , Rc3 , Rc4 , Rc5 , Rc6 , Rc7 , Rc8 , Rc9 , Rc10 and Rc11 (if present) are H;
(g)Rc1、Rc2、Rc3、Rc4、Rc5、Rc6、Rc7、Rc8、Rc9、Rc10和Rc11(如果存在)中的五個是H; (g) five of Rc1 , Rc2 , Rc3 , Rc4 , Rc5 , Rc6 , Rc7 , Rc8 , Rc9 , Rc10 and Rc11 (if present) are H;
(h)Rc1、Rc2、Rc3、Rc4、Rc5、Rc6、Rc7、Rc8、Rc9、Rc10和Rc11(如果存在)中的四個是H; (h) four of Rc1 , Rc2 , Rc3 , Rc4 , Rc5 , Rc6 , Rc7 , Rc8 , Rc9 , Rc10 and Rc11 (if present) are H;
(i)Rc1、Rc2、Rc3、Rc4、Rc5、Rc6、Rc7、Rc8、Rc9、Rc10和Rc11(如果存在)中的三個是H; (i) three of Rc1 , Rc2 , Rc3 , Rc4 , Rc5 , Rc6 , Rc7 , Rc8 , Rc9 , Rc10 and Rc11 (if present) are H;
(j)Rc1、Rc2、Rc3、Rc4、Rc5、Rc6、Rc7、Rc8、Rc9、Rc10和Rc11(如果存在)中的兩個是H;和 (j) two of Rc1 , Rc2 , Rc3 , Rc4 , Rc5 , Rc6 , Rc7 , Rc8 , Rc9 , Rc10 and Rc11 (if present) are H; and
(k)Rc1、Rc2、Rc3、Rc4、Rc5、Rc6、Rc7、Rc8、Rc9、Rc10和Rc11(如果存在)中的一個是H。 (k) One of R c1 , R c2 , R c3 , R c4 , R c5 , R c6 , R c7 , R c8 , R c9 , R c10 and R c11 (if present) is H.
實施方式22提供實施方式1-21中任一項所述的化合物,其中適用下列至少一項: Embodiment 22 provides the compound of any one of embodiments 1-21, wherein at least one of the following applies:
(a)Rb1、Rb2和Rb3(如果存在)中的每一個是H; (a) each of R b1 , R b2 and R b3 (if present) is H;
(b)Rb1、Rb2和Rb3(如果存在)中的兩個是H;和 (b) two of R b1 , R b2 and R b3 (if present) are H; and
(c)Rb1、Rb2和Rb3(如果存在)中的一個是H。 (c) One of R b1 , R b2 and R b3 (if present) is H.
實施方式23提供實施方式1-22中任一項所述的化合物,其中R4a選自CN、CHO、、、、、 Embodiment 23 provides the compound of any one of embodiments 1-22, wherein R 4a is selected from CN, CHO, , , , ,
實施方式24提供實施方式1-23中任一項所述的化合物,其中R4c選自、、、、和 Embodiment 24 provides the compound of any one of embodiments 1-23, wherein R is selected from , , , , and
實施方式25提供實施方式1-24中任一項所述的化合物, 其中R3選自、、、、、、 Embodiment 25 provides the compound of any one of embodiments 1-24, wherein R is selected from , , , , , ,
實施方式26提供實施方式1-25中任一項所述的化合物,其中可選擇地取代的烷基、可選擇地取代的環烷基和可選擇地取代的雜環烷基的每次出現獨立地被選自下列的至少一個可選擇地取代:C1-C6烷基、C3-C8環烷基、C1-C6羥烷基、鹵素、CN、ORI、N(RI)(RII)、C1-C6烷氧基、C3-C8環烷氧基、C1-C6鹵代烷氧基、C3-C8鹵代環烷氧基、可選擇地取代的苯基、可選擇地取代的C2-C9雜芳基、C(=O)RI、C(=O)ORI、OC(=O)RI、OC(=O)ORI、SRI、S(=O)RI、S(=O)2RI、S(=O)2N(RI)(RII)、S(=O)2NRIC(=O)NHRII、N(RI)S(=O)2RII、N(RI)C(=O)RII和C(=O)NRIRII,其中RI和RII各自獨立地選自H、-C(=O)(C1-C6烷基)、-C(=O)(C1-C6鹵代烷基)、C1-C6烷基、C1-C3鹵代烷基、C3-C8環烷基、C1-C6烷氧基和C3-C8環烷氧基、苯基、萘基和C2- C9雜芳基。 Embodiment 26 provides the compound of any one of embodiments 1-25, wherein each occurrence of optionally substituted alkyl, optionally substituted cycloalkyl, and optionally substituted heterocycloalkyl is independently is optionally substituted by at least one of the following: C 1 -C 6 alkyl, C 3 -C 8 cycloalkyl, C 1 -C 6 hydroxyalkyl, halogen, CN, OR I , N(R I )(R II ), C 1 -C 6 alkoxy, C 3 -C 8 cycloalkoxy, C 1 -C 6 haloalkoxy, C 3 -C 8 halocycloalkoxy, optionally substituted phenyl, optionally substituted C 2 -C 9 heteroaryl, C(=O)R I , C(=O)OR I , OC(=O)R I , OC(=O)OR I , SR I , S(=O)R I , S(=O) 2 R I , S(=O) 2 N(R I )(R II ), S(=O) 2 NR I C(=O)NHR II , N(R I )S(=O) 2 R II , N(R I )C(=O)R II and C(=O)NR I R II , wherein R I and R II are each independently selected from H, -C(=O)(C 1 -C 6 alkyl), -C(=O)(C 1 -C 6 haloalkyl), C 1 -C 6 alkyl, C 1 -C 3 haloalkyl, C 3 -C 8 cycloalkyl, C 1 -C 6 alkoxy and C 3 -C 8 cycloalkoxy, phenyl, naphthyl and C 2 -C 9 heteroaryl.
實施方式27提供實施方式1-26中任一項所述的化合物,其中可選擇地取代的苯基、可選擇地取代的萘基、可選擇地取代的雜環基和可選擇地取代的雜芳基的每次出現獨立地可選擇地被選自下列的至少一個取代基取代:C1-C6烷基、C3-C8環烷基、苯基、C1-C6羥烷基、C1-C6烷氧基、C3-C8環烷氧基、C1-C6鹵代烷基、C1-C6鹵代烷氧基、C3-C8鹵代環烷氧基、鹵素、CN、ORI、N(RI)(RII)、NO2、C(=O)N(RI)(RII)、C(=O)RI、C(=O)ORI、OC(=O)RI、OC(=O)ORI、SRI、S(=O)RI、S(=O)2RI、N(RI)S(=O)2RII、N(RI)C(=O)RII和S(=O)2N(RI)(RII),其中RI和RII各自獨立地選自H、-C(=O)(C1-C6烷基)、-C(=O)(C1-C6鹵代烷基)、C1-C6烷基、C1-C3鹵代烷基、C3-C8環烷基、C1-C6烷氧基和C3-C8環烷氧基、苯基、萘基和C2-C9雜芳基。 Embodiment 27 provides the compound of any one of embodiments 1-26, wherein optionally substituted phenyl, optionally substituted naphthyl, optionally substituted heterocyclyl, and optionally substituted heterocyclyl Each occurrence of aryl is independently optionally substituted with at least one substituent selected from the group consisting of C 1 -C 6 alkyl, C 3 -C 8 cycloalkyl, phenyl, C 1 -C 6 hydroxyalkyl , C 1 -C 6 alkoxy, C 3 -C 8 cycloalkoxy, C 1 -C 6 haloalkyl, C 1 -C 6 haloalkoxy, C 3 -C 8 halocycloalkoxy, halogen , CN, OR I , N(R I )(R II ), NO 2 , C(=O)N(R I )(R II ), C(=O)R I , C(=O)OR I , OC(=O)R I , OC(=O)OR I , SR I , S(=O)R I , S(=O) 2 R I , N(R I )S(=O) 2 R II , N(R I )C(=O)R II and S(=O) 2 N(R I )(R II ), wherein R I and R II are each independently selected from H, -C(=O)(C 1 -C 6 alkyl), -C(=O)(C 1 -C 6 haloalkyl), C 1 -C 6 alkyl, C 1 -C 3 haloalkyl, C 3 -C 8 cycloalkyl, C 1 -C 6 alkoxy and C 3 -C 8 cycloalkoxy, phenyl, naphthyl and C 2 -C 9 heteroaryl.
實施方式28提供實施方式1-27中任一項所述的化合物,其選自: Embodiment 28 provides the compound of any one of Embodiments 1-27, selected from the group consisting of:
N-(3-環己基-1-側氧基-1-((1-側氧基-3-(2-氧代吡咯啶-3-基)丙烷-2-基)胺基)丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-(3-cyclohexyl-1-oxo-1-((1-oxo-3-(2-oxopyrrolidin-3-yl)propan-2-yl)amino)propane-2 -yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-((S)-3-環己基-1-側氧基-1-(((S)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-oxo-1-(((S)-1-oxo-3-((S)-2-oxopyrrolidin-3-yl) Propan-2-yl)amino)propan-2-yl)-9-hydroxyl-9H-tila-9-carboxamide;
N-((S)-3-環己基-1-側氧基-1-(((S)-1-側氧基-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-oxo-1-(((S)-1-oxo-3-((R)-2-oxopyrrolidin-3-yl) Propan-2-yl)amino)propan-2-yl)-9-hydroxyl-9H-tila-9-carboxamide;
N-((S)-3-環己基-1-側氧基-1-(((R)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-oxo-1-(((R)-1-oxo-3-((S)-2-oxopyrrolidin-3-yl) Propan-2-yl)amino)propan-2-yl)-9-hydroxyl-9H-tila-9-carboxamide;
N-((S)-3-環己基-1-側氧基-1-(((R)-1-側氧基-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-oxo-1-(((R)-1-oxo-3-((R)-2-oxopyrrolidin-3-yl) Propan-2-yl)amino)propan-2-yl)-9-hydroxyl-9H-tila-9-carboxamide;
N-((R)-3-環己基-1-側氧基-1-(((S)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-oxo-1-(((S)-1-oxo-3-((S)-2-oxopyrrolidin-3-yl) Propan-2-yl)amino)propan-2-yl)-9-hydroxyl-9H-tila-9-carboxamide;
N-((R)-3-環己基-1-側氧基-1-(((S)-1-側氧基-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-oxo-1-(((S)-1-oxo-3-((R)-2-oxopyrrolidin-3-yl) Propan-2-yl)amino)propan-2-yl)-9-hydroxyl-9H-tila-9-carboxamide;
N-((R)-3-環己基-1-側氧基-1-(((R)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-oxo-1-(((R)-1-oxo-3-((S)-2-oxopyrrolidin-3-yl) Propan-2-yl)amino)propan-2-yl)-9-hydroxyl-9H-tila-9-carboxamide;
N-((R)-3-環己基-1-側氧基-1-(((R)-1-側氧基-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-oxo-1-(((R)-1-oxo-3-((R)-2-oxopyrrolidin-3-yl) Propan-2-yl)amino)propan-2-yl)-9-hydroxyl-9H-tila-9-carboxamide;
N-(4-(環丙基胺基)-3,4-二氧-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-羥基-2,2-二苯基乙醯胺基)-4-甲基戊醯胺; N-(4-(cyclopropylamino)-3,4-dioxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)-2-(2-hydroxyl-2 , 2-diphenylacetamido)-4-methylpentanamide;
(S)-N-((S)-4-(環丙基胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-羥基-2,2-二苯基乙醯胺基)-4-甲基戊醯胺; (S)-N-((S)-4-(cyclopropylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2 -yl)-2-(2-hydroxy-2,2-diphenylacetamido)-4-methylpentanamide;
(S)-N-((S)-4-(環丙基胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-羥基-2,2-二苯基乙醯胺基)-4-甲基戊醯胺; (S)-N-((S)-4-(cyclopropylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2 -yl)-2-(2-hydroxy-2,2-diphenylacetamido)-4-methylpentanamide;
(S)-N-((R)-4-(環丙基胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-羥基-2,2-二苯基乙醯胺基)-4-甲基戊醯胺; (S)-N-((R)-4-(cyclopropylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2 -yl)-2-(2-hydroxy-2,2-diphenylacetamido)-4-methylpentanamide;
(S)-N-((R)-4-(環丙基胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-羥基-2,2-二苯基乙醯胺基)-4-甲基戊醯胺; (S)-N-((R)-4-(cyclopropylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2 -yl)-2-(2-hydroxy-2,2-diphenylacetamido)-4-methylpentanamide;
(R)-N-((S)-4-(環丙基胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-羥基-2,2-二苯基乙醯胺基)-4-甲基戊醯胺; (R)-N-((S)-4-(cyclopropylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2 -yl)-2-(2-hydroxy-2,2-diphenylacetamido)-4-methylpentanamide;
(R)-N-((S)-4-(環丙基胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-羥基-2,2-二苯基乙醯胺基)-4-甲基戊醯胺; (R)-N-((S)-4-(cyclopropylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2 -yl)-2-(2-hydroxy-2,2-diphenylacetamido)-4-methylpentanamide;
(R)-N-((R)-4-(環丙基胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-羥基-2,2-二苯基乙醯胺基)-4-甲基戊醯胺; (R)-N-((R)-4-(cyclopropylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2 -yl)-2-(2-hydroxy-2,2-diphenylacetamido)-4-methylpentanamide;
(R)-N-((R)-4-(環丙基胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-羥基-2,2-二苯基乙醯胺基)-4-甲基戊醯胺; (R)-N-((R)-4-(cyclopropylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2 -yl)-2-(2-hydroxy-2,2-diphenylacetamido)-4-methylpentanamide;
N-(3-環己基-1-((4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-(3-cyclohexyl-1-((4-hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)amino)-1-oxo Propan-2-yl)-9-hydroxyl-9H-oxo-9-carboxamide;
N-((S)-3-環己基-1-(((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-(((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-((S)-3-環己基-1-(((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-(((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-((S)-3-環己基-1-(((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-(((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-((S)-3-環己基-1-(((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-(((R)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-((R)-3-環己基-1-(((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-(((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-((R)-3-環己基-1-(((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-(((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-((R)-3-環己基-1-(((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-(((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-((R)-3-環己基-1-(((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-(((R)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-1-(9-羥基-9H-茀-9-羰基)-4-苯基哌-2-甲醯胺; N-(4-Hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)-1-(9-hydroxy-9H-oxo-9-carbonyl) -4-Phenylpiperidine -2-Formamide;
(S)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-1-(9-羥基-9H-茀-9-羰基)-4-苯基哌-2-甲醯胺; (S)-N-((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-1-( 9-Hydroxy-9H-terpinene-9-carbonyl)-4-phenylpiperene -2-Formamide;
(S)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-1-(9-羥基-9H-茀-9-羰基)-4-苯基哌-2-甲醯胺; (S)-N-((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-1-( 9-Hydroxy-9H-terpinene-9-carbonyl)-4-phenylpiperene -2-Formamide;
(S)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-1-(9-羥基-9H-茀-9-羰基)-4-苯基哌-2-甲醯胺; (S)-N-((R)-4-hydroxyl-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-1-( 9-Hydroxy-9H-terpinene-9-carbonyl)-4-phenylpiperene -2-Formamide;
(S)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-1-(9-羥基-9H-茀-9-羰基)-4-苯基哌-2-甲醯胺; (S)-N-((R)-4-hydroxyl-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-1-( 9-Hydroxy-9H-terpinene-9-carbonyl)-4-phenylpiperene -2-Formamide;
(R)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-1-(9-羥基-9H-茀-9-羰基)-4-苯基哌-2-甲醯胺; (R)-N-((S)-4-hydroxyl-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-1-( 9-Hydroxy-9H-terpinene-9-carbonyl)-4-phenylpiperene -2-Formamide;
(R)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-1-(9-羥基-9H-茀-9-羰基)-4-苯基哌-2-甲醯胺; (R)-N-((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-1-( 9-Hydroxy-9H-terpinene-9-carbonyl)-4-phenylpiperene -2-Formamide;
(R)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-1-(9-羥基-9H-茀-9-羰基)-4-苯基哌-2-甲醯胺; (R)-N-((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-1-( 9-Hydroxy-9H-terpinene-9-carbonyl)-4-phenylpiperene -2-Formamide;
(R)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-1-(9-羥基-9H-茀-9-羰基)-4-苯基哌-2-甲醯胺; (R)-N-((R)-4-hydroxyl-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-1-( 9-Hydroxy-9H-terpinene-9-carbonyl)-4-phenylpiperene -2-Formamide;
9-羥基-N-(4-甲基-1-((4-(甲胺基)-3,4-二氧-1-(2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-(4-methyl-1-((4-(methylamino)-3,4-dioxo-1-(2-oxopyrrolidin-3-yl)butane-2- Base) amino)-1-oxopentan-2-yl)-9H-stilbene-9-carboxamide;
9-羥基-N-((S)-4-甲基-1-(((S)-4-(甲胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((S)-4-methyl-1-(((S)-4-(methylamino)-3,4-dioxo-1-((S)-2-oxo Pyrrolidin-3-yl)butan-2-yl)amino)-1-oxopentan-2-yl)-9H-oxo-9-carboxamide;
9-羥基-N-((S)-4-甲基-1-(((S)-4-(甲胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((S)-4-methyl-1-(((S)-4-(methylamino)-3,4-dioxo-1-((R)-2-oxo Pyrrolidin-3-yl)butan-2-yl)amino)-1-oxopentan-2-yl)-9H-oxo-9-carboxamide;
9-羥基-N-((S)-4-甲基-1-(((R)-4-(甲胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((S)-4-methyl-1-(((R)-4-(methylamino)-3,4-dioxo-1-((S)-2-oxo Pyrrolidin-3-yl)butan-2-yl)amino)-1-oxopentan-2-yl)-9H-oxo-9-carboxamide;
9-羥基-N-((S)-4-甲基-1-(((R)-4-(甲胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((S)-4-methyl-1-(((R)-4-(methylamino)-3,4-dioxo-1-((R)-2-oxo Pyrrolidin-3-yl)butan-2-yl)amino)-1-oxopentan-2-yl)-9H-oxo-9-carboxamide;
9-羥基-N-((R)-4-甲基-1-(((S)-4-(甲胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((R)-4-methyl-1-(((S)-4-(methylamino)-3,4-dioxo-1-((S)-2-oxo Pyrrolidin-3-yl)butan-2-yl)amino)-1-oxopentan-2-yl)-9H-oxo-9-carboxamide;
9-羥基-N-((R)-4-甲基-1-(((S)-4-(甲胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((R)-4-methyl-1-(((S)-4-(methylamino)-3,4-dioxo-1-((R)-2-oxo Pyrrolidin-3-yl)butan-2-yl)amino)-1-oxopentan-2-yl)-9H-oxo-9-carboxamide;
9-羥基-N-((R)-4-甲基-1-(((R)-4-(甲胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((R)-4-methyl-1-(((R)-4-(methylamino)-3,4-dioxo-1-((S)-2-oxo Pyrrolidin-3-yl)butan-2-yl)amino)-1-oxopentan-2-yl)-9H-oxo-9-carboxamide;
9-羥基-N-((R)-4-甲基-1-(((R)-4-(甲胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((R)-4-methyl-1-(((R)-4-(methylamino)-3,4-dioxo-1-((R)-2-oxo Pyrrolidin-3-yl)butan-2-yl)amino)-1-oxopentan-2-yl)-9H-oxo-9-carboxamide;
N-(1-((4-(乙胺基)-3,4-二氧-1-(2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-(1-((4-(ethylamino)-3,4-dioxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)amino)-4-methanol Base-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((S)-1-(((S)-4-(乙胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((S)-4-(ethylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-((S)-1-(((S)-4-(乙胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((S)-4-(ethylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-((S)-1-(((R)-4-(乙胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((R)-4-(ethylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-((S)-1-(((R)-4-(乙胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((R)-4-(ethylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-((R)-1-(((S)-4-(乙胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((S)-4-(ethylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-((R)-1-(((S)-4-(乙胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((S)-4-(ethylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-((R)-1-(((R)-4-(乙胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((R)-4-(ethylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-((R)-1-(((R)-4-(乙胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((R)-4-(ethylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-formamide;
N-(1-((1-(4-氯噻唑-2-基)-1-側氧基-3-(2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-(1-((1-(4-chlorothiazol-2-yl)-1-oxo-3-(2-oxopyrrolidin-3-yl)propan-2-yl)amino)- 4-Methyl-1-oxopentan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((S)-1-(((S)-1-(4-氯噻唑-2-基)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((S)-1-(((S)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((S)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((S)-1-(((S)-1-(4-氯噻唑-2-基)-1-側氧基-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((S)-1-(((S)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((R)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((S)-1-(((R)-1-(4-氯噻唑-2-基)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((S)-1-(((R)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((S)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((S)-1-(((R)-1-(4-氯噻唑-2-基)-1-側氧基-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((S)-1-(((R)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((R)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((R)-1-(((S)-1-(4-氯噻唑-2-基)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((R)-1-(((S)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((S)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((R)-1-(((S)-1-(4-氯噻唑-2-基)-1-側氧基-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((R)-1-(((S)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((R)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((R)-1-(((R)-1-(4-氯噻唑-2-基)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((R)-1-(((R)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((S)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((R)-1-(((R)-1-(4-氯噻唑-2-基)-1-側氧基-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((R)-1-(((R)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((R)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-(3-環己基-1-((4-(甲胺基)-3,4-二氧-1-(2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-(3-cyclohexyl-1-((4-(methylamino)-3,4-dioxo-1-(2-oxopyrrolidin-3-yl)butan-2-yl)amino )-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((S)-3-環己基-1-(((S)-4-(甲胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-(((S)-4-(methylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidine-3 -yl)butane-2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((S)-3-環己基-1-(((S)-4-(甲胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-(((S)-4-(methylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidine-3 -yl)butane-2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((S)-3-環己基-1-(((R)-4-(甲胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-(((R)-4-(methylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidine-3 -yl)butane-2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((S)-3-環己基-1-(((R)-4-(甲胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-(((R)-4-(methylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidine-3 -yl)butane-2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-3-環己基-1-(((S)-4-(甲胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-(((S)-4-(methylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidine-3 -yl)butane-2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-3-環己基-1-(((S)-4-(甲胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-(((S)-4-(methylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidine-3 -yl)butane-2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-3-環己基-1-(((R)-4-(甲胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-(((R)-4-(methylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidine-3 -yl)butane-2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-3-環己基-1-(((R)-4-(甲胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-(((R)-4-(methylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidine-3 -yl)butane-2-yl)amino)-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-(1-((4-胺基-3,4-二氧-1-(2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-(1-((4-amino-3,4-dioxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)amino)-3-cyclohexyl-1 -Oxopropan-2-yl)-9-hydroxy-9H-oxo-9-carboxamide;
N-((S)-1-(((S)-4-胺基-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((S)-4-amino-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-3-cyclohexyl-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((S)-1-(((S)-4-胺基-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((S)-4-amino-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-3-cyclohexyl-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((S)-1-(((R)-4-胺基-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((R)-4-amino-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-3-cyclohexyl-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((S)-1-(((R)-4-胺基-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((R)-4-amino-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-3-cyclohexyl-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-1-(((S)-4-胺基-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((S)-4-amino-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-3-cyclohexyl-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-1-(((S)-4-胺基-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((S)-4-amino-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-3-cyclohexyl-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-1-(((R)-4-胺基-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((R)-4-amino-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-3-cyclohexyl-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-1-(((R)-4-胺基-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((R)-4-amino-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-3-cyclohexyl-1-oxopropan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-(1-((4-(環丙基胺基)-3,4-二氧-1-(2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-(1-((4-(cyclopropylamino)-3,4-dioxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)amino)-4 -Methyl-1-oxopentan-2-yl)-9-hydroxy-9H-stilbene-9-carboxamide;
N-((S)-1-(((S)-4-(環丙基胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((S)-4-(cyclopropylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl) Butane-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((S)-1-(((S)-4-(環丙基胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((S)-4-(cyclopropylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl) Butane-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((S)-1-(((R)-4-(環丙基胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((R)-4-(cyclopropylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl) Butane-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((S)-1-(((R)-4-(環丙基胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((R)-4-(cyclopropylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl) Butane-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-1-(((S)-4-(環丙基胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((S)-4-(cyclopropylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl) Butane-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-1-(((S)-4-(環丙基胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((S)-4-(cyclopropylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl) Butane-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-1-(((R)-4-(環丙基胺基)-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((R)-4-(cyclopropylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl) Butane-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-1-(((R)-4-(環丙基胺基)-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((R)-4-(cyclopropylamino)-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl) Butane-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
(3aR,6aS)-N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (3aR,6aS)-N-(4-Hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)-2-(4-methoxy- 1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(3aS,6aR)-N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (3aS,6aR)-N-(4-Hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)-2-(4-methoxy- 1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
N-(1-((4-胺基-3,4-二氧-1-(2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-(1-((4-amino-3,4-dioxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)amino)-4-methyl-1 -Oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((S)-1-(((S)-4-胺基-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((S)-4-amino-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((S)-1-(((S)-4-胺基-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((S)-4-amino-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((S)-1-(((R)-4-胺基-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((R)-4-amino-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((S)-1-(((R)-4-胺基-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((S)-1-(((R)-4-amino-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-1-(((S)-4-胺基-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((S)-4-amino-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-1-(((S)-4-胺基-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((S)-4-amino-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-1-(((R)-4-胺基-3,4-二氧-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((R)-4-amino-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-((R)-1-(((R)-4-胺基-3,4-二氧-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-9-羥基-9H-茀-9-甲醯胺; N-((R)-1-(((R)-4-amino-3,4-dioxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2- Base) amino)-4-methyl-1-oxopentan-2-yl)-9-hydroxyl-9H-stilbene-9-carboxamide;
N-(1-((1-(4-氯噻唑-2-基)-1-側氧基-3-(2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-(1-((1-(4-chlorothiazol-2-yl)-1-oxo-3-(2-oxopyrrolidin-3-yl)propan-2-yl)amino)- 3-cyclohexyl-1-oxopropan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((S)-1-(((S)-1-(4-氯噻唑-2-基)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((S)-1-(((S)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((S)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-3-cyclohexyl-1-oxopropan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((S)-1-(((S)-1-(4-氯噻唑-2-基)-1-側氧基-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((S)-1-(((S)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((R)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-3-cyclohexyl-1-oxopropan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((S)-1-(((R)-1-(4-氯噻唑-2-基)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((S)-1-(((R)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((S)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-3-cyclohexyl-1-oxopropan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((S)-1-(((R)-1-(4-氯噻唑-2-基)-1-側氧基-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((S)-1-(((R)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((R)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-3-cyclohexyl-1-oxopropan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((R)-1-(((S)-1-(4-氯噻唑-2-基)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((R)-1-(((S)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((S)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-3-cyclohexyl-1-oxopropan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((R)-1-(((S)-1-(4-氯噻唑-2-基)-1-側氧基-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((R)-1-(((S)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((R)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-3-cyclohexyl-1-oxopropan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((R)-1-(((R)-1-(4-氯噻唑-2-基)-1-側氧基-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((R)-1-(((R)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((S)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-3-cyclohexyl-1-oxopropan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
N-((R)-1-(((R)-1-(4-氯噻唑-2-基)-1-側氧基-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)胺基)-3-環己基-1-氧代丙烷-2-基)-4-甲氧基-1H-吲哚-2-甲醯胺; N-((R)-1-(((R)-1-(4-chlorothiazol-2-yl)-1-oxo-3-((R)-2-oxopyrrolidine-3- Base) propan-2-yl) amino)-3-cyclohexyl-1-oxopropan-2-yl)-4-methoxy-1H-indole-2-carboxamide;
(3aR,6aS)-N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (3aR,6aS)-N-(4-hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)-2-(9-hydroxyl-9H- Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(3aS,6aR)-N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (3aS,6aR)-N-(4-hydroxyl-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)-2-(9-hydroxyl-9H- Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(4-methoxy-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
9-羥基-N-(1-((4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4,4-二甲基-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-(1-((4-hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)amino)-4,4- Dimethyl-1-oxopentan-2-yl)-9H-oxo-9-formamide;
9-羥基-N-((S)-1-(((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4,4-二甲基-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((S)-1-(((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane- 2-yl)amino)-4,4-dimethyl-1-oxopentan-2-yl)-9H-stilbene-9-carboxamide;
9-羥基-N-((S)-1-(((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4,4-二甲基-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((S)-1-(((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane- 2-yl)amino)-4,4-dimethyl-1-oxopentan-2-yl)-9H-stilbene-9-carboxamide;
9-羥基-N-((S)-1-(((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4,4-二甲基-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((S)-1-(((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane- 2-yl)amino)-4,4-dimethyl-1-oxopentan-2-yl)-9H-stilbene-9-carboxamide;
9-羥基-N-((S)-1-(((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4,4-二甲基-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((S)-1-(((R)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane- 2-yl)amino)-4,4-dimethyl-1-oxopentan-2-yl)-9H-stilbene-9-carboxamide;
9-羥基-N-((R)-1-(((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4,4-二甲基-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((R)-1-(((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane- 2-yl)amino)-4,4-dimethyl-1-oxopentan-2-yl)-9H-stilbene-9-carboxamide;
9-羥基-N-((R)-1-(((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4,4-二甲基-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((R)-1-(((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane- 2-yl)amino)-4,4-dimethyl-1-oxopentan-2-yl)-9H-stilbene-9-carboxamide;
9-羥基-N-((R)-1-(((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4,4-二甲基-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((R)-1-(((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane- 2-yl)amino)-4,4-dimethyl-1-oxopentan-2-yl)-9H-stilbene-9-carboxamide;
9-羥基-N-((R)-1-(((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4,4-二甲基-1-氧代戊烷-2-基)-9H-茀-9-甲醯胺; 9-Hydroxy-N-((R)-1-(((R)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane- 2-yl)amino)-4,4-dimethyl-1-oxopentan-2-yl)-9H-stilbene-9-carboxamide;
N-(3-環己基-1-((4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-(2,2,2-三氟乙醯胺基)-9H-茀-9-甲醯胺; N-(3-cyclohexyl-1-((4-hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)amino)-1-oxo Propan-2-yl)-9-(2,2,2-trifluoroacetamido)-9H-stilbene-9-carboxamide;
N-((S)-3-環己基-1-(((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-(2,2,2-三氟乙醯胺基)-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-(((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-(2,2,2-trifluoroacetamido)-9H-oxo-9-formamide;
N-((S)-3-環己基-1-(((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-(2,2,2-三氟乙醯胺基)-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-(((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-(2,2,2-trifluoroacetamido)-9H-oxo-9-formamide;
N-((S)-3-環己基-1-(((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-(2,2,2-三氟乙醯胺基)-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-(((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-(2,2,2-trifluoroacetamido)-9H-oxo-9-formamide;
N-((S)-3-環己基-1-(((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-(2,2,2-三氟乙醯胺基)-9H-茀-9-甲醯胺; N-((S)-3-cyclohexyl-1-(((R)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-(2,2,2-trifluoroacetamido)-9H-oxo-9-formamide;
N-((R)-3-環己基-1-(((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-(2,2,2-三氟乙醯胺基)-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-(((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-(2,2,2-trifluoroacetamido)-9H-oxo-9-formamide;
N-((R)-3-環己基-1-(((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-(2,2,2-三氟乙醯胺基)-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-(((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-(2,2,2-trifluoroacetamido)-9H-oxo-9-formamide;
N-((R)-3-環己基-1-(((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-(2,2,2-三氟乙醯胺基)-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-(((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-(2,2,2-trifluoroacetamido)-9H-oxo-9-formamide;
N-((R)-3-環己基-1-(((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-1-氧代丙烷-2-基)-9-(2,2,2-三氟乙醯胺基)-9H-茀-9-甲醯胺; N-((R)-3-cyclohexyl-1-(((R)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane -2-yl)amino)-1-oxopropan-2-yl)-9-(2,2,2-trifluoroacetamido)-9H-oxo-9-formamide;
N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(4-Hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)-2-(9-hydroxy-9H-oxo-9-carbonyl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-4-hydroxyl-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 9-Hydroxy-9H-Oxane-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 9-Hydroxy-9H-Oxane-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 9-Hydroxy-9H-Oxane-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 9-Hydroxy-9H-Oxane-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 9-Hydroxy-9H-Oxane-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 9-Hydroxy-9H-Oxane-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 9-Hydroxy-9H-Oxane-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-4-hydroxyl-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 9-Hydroxy-9H-Oxane-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-((4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-丙基-1H-吲哚-2-甲醯胺; N-(1-((4-hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)amino)-4-methyl-1-oxo Pentane-2-yl)-4-methoxy-1-propyl-1H-indole-2-carboxamide;
N-((S)-1-(((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-丙基-1H-吲哚-2-甲醯胺; N-((S)-1-(((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-propyl-1H-indole-2-carboxamide;
N-((S)-1-(((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-丙基-1H-吲哚-2-甲醯胺; N-((S)-1-(((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-propyl-1H-indole-2-carboxamide;
N-((S)-1-(((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-丙基-1H-吲哚-2-甲醯胺; N-((S)-1-(((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-propyl-1H-indole-2-carboxamide;
N-((S)-1-(((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-丙基-1H-吲哚-2-甲醯胺; N-((S)-1-(((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-propyl-1H-indole-2-carboxamide;
N-((R)-1-(((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-丙基-1H-吲哚-2-甲醯胺; N-((R)-1-(((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-propyl-1H-indole-2-carboxamide;
N-((R)-1-(((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-丙基-1H-吲哚-2-甲醯胺; N-((R)-1-(((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-propyl-1H-indole-2-carboxamide;
N-((R)-1-(((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-丙基-1H-吲哚-2-甲醯胺; N-((R)-1-(((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-propyl-1H-indole-2-carboxamide;
N-((R)-1-(((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-丙基-1H-吲哚-2-甲醯胺; N-((R)-1-(((R)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-propyl-1H-indole-2-carboxamide;
(3aR,6aS)-N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (3aR,6aS)-N-(4-Hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)-2-(1H-indole-2 -carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(3aS,6aR)-N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (3aS,6aR)-N-(4-Hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)-2-(1H-indole-2 -carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-(1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
N-(1-((4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-(2-甲基烯丙基)-1H-吲哚-2-甲醯胺; N-(1-((4-hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)amino)-4-methyl-1-oxo Pentan-2-yl)-4-methoxy-1-(2-methylallyl)-1H-indole-2-carboxamide;
N-((S)-1-(((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-(2-甲基烯丙基)-1H-吲哚-2-甲醯胺; N-((S)-1-(((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-(2-methylallyl)-1H-indole-2-carboxamide;
N-((S)-1-(((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-(2-甲基烯丙基)-1H-吲哚-2-甲醯胺; N-((S)-1-(((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-(2-methylallyl)-1H-indole-2-carboxamide;
N-((S)-1-(((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-(2-甲基烯丙基)-1H-吲哚-2-甲醯胺; N-((S)-1-(((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-(2-methylallyl)-1H-indole-2-carboxamide;
N-((S)-1-(((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-(2-甲基烯丙基)-1H-吲哚-2-甲醯胺; N-((S)-1-(((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-(2-methylallyl)-1H-indole-2-carboxamide;
N-((R)-1-(((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-(2-甲基烯丙基)-1H-吲哚-2-甲醯胺; N-((R)-1-(((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-(2-methylallyl)-1H-indole-2-carboxamide;
N-((R)-1-(((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-(2-甲基烯丙基)-1H-吲哚-2-甲醯胺; N-((R)-1-(((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-(2-methylallyl)-1H-indole-2-carboxamide;
N-((R)-1-(((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-(2-甲基烯丙基)-1H-吲哚-2-甲醯胺; N-((R)-1-(((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-(2-methylallyl)-1H-indole-2-carboxamide;
N-((R)-1-(((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)胺基)-4-甲基-1-氧代戊烷-2-基)-4-甲氧基-1-(2-甲基烯丙基)-1H-吲哚-2-甲醯胺; N-((R)-1-(((R)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) Amino)-4-methyl-1-oxopentan-2-yl)-4-methoxy-1-(2-methylallyl)-1H-indole-2-carboxamide;
N-(1-氰基-2-(2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-第-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N -(1-cyano-2-(2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-(9-hydroxy-9H-9-carbonyl)-2 - azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
2-(2-(3-氯苯基)-2-羥基乙醯基)-N-(1-氰基-2-(2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(2-(3-Chlorophenyl)-2-hydroxyacetyl) -N- (1-cyano-2-(2-oxopyrrolidin-3-yl)ethyl)-5,5 - Difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3R,4S)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3S,4R)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3R,4R)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3S,4S)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3R,4S)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3S,4R)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3R,4R)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( S )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3S,4S)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3R,4S)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3S,4R)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3R,4R)-2-((S)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(( S )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3S,4S)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3R,4S)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3S,4R)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3R,4R)-2-((R)-2-(3-氯苯基)-2-羥基乙醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(( R )-2-(3-chlorophenyl)-2-hydroxyacetyl) -N -(( R )-1-cyano-2- (( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
N-[1-氰基-2-[2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N -[1-cyano-2-[2-oxopyrrolidin-3-yl]ethyl]-2-[2-(3,5-dichlorophenyl)-2,2-difluoro-ethyl Acyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ 2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ 2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ 2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ 2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ 2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ 2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ 2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ 2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ 2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ 2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ 2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ 2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ 2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ 2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ 2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[2-(3,5-二氯苯基)-2,2-二氟-乙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ 2-(3,5-Dichlorophenyl)-2,2-difluoro-acetyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide ;
N-(1-氰基-2-(2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N -(1-cyano-2-(2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-(4-methoxy-1H-indole-2-carbonyl )-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N -(1-cyano-2-(2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-(2-methyl-1H-indole-7-carbonyl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-甲基-1H-吲哚-7-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(2-methyl-1H-indole-7-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(氧代吡咯啶-3-基)乙基)-5,5-二氟-2-(2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N -(1-cyano-2-(oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-(2-hydroxy-2-phenylacryl)-2-aza Bicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( S )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯丙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-di Fluoro-2-(( R )-2-hydroxy-2-phenylacryl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N- (1-cyano-2-(2-oxopyrrolidin-3-yl)ethyl)-2-(4-(difluoromethyl)-1H-indole-2-carbonyl)-5, 5-Difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(1-cyano-2-(2-oxopyrrolidin-3-yl)ethyl)-2-(4-(difluoromethyl)-6-fluoro-1H-indole-2-carbonyl )-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-N-(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-N-(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-N-(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-N-(( S )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-N-(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-N-(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-N-(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-N-(( R )-1-cyano-2-(( S )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-N-(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-N-(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-N-(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-N-(( S )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-N-(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-N-(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-N-(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-N-(( R )-1-cyano-2-(( R )-2-oxopyrrolidin-3-yl)ethyl)-2-(4- (Difluoromethyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-[1-氰基-2-[2-氧代吡咯啶-3-基]乙基]-2-[3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N -[1-cyano-2-[2-oxopyrrolidin-3-yl]ethyl]-2-[3-cyclobutyl-2-[(2,2,2-trifluoroacetyl )amino] propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3S)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3R)-2-氧代吡咯啶-3-基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxopyrrolidin-3-yl]ethyl]-2-[ (2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[1-氰基-2-[2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(7-Chloro-4-fluoro-1 H -indole-2-carbonyl) -N- [1-cyano-2-[2-oxo-3-piperidinyl]ethyl]-5 ,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3S,4S)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(7-chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 S )-1-cyano-2-[( 3S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3R,4S)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(7-Chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 S )-1-cyano-2-[( 3S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3S,4R)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(7-chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 S )-1-cyano-2-[( 3S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3R,4R)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(7-chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 S )-1-cyano-2-[( 3S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3S,4S)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(7-Chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 R )-1-cyano-2-[( 3S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3R,4S)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(7-Chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 R )-1-cyano-2-[( 3S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3S,4R)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(7-chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 R )-1-cyano-2-[( 3S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3R,4R)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(7-chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 R )-1-cyano-2-[( 3S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3S,4S)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(7-chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 S )-1-cyano-2-[( 3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3R,4S)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(7-Chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 S )-1-cyano-2-[( 3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3S,4R)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(7-chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 S )-1-cyano-2-[( 3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3R,4R)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(7-chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 S )-1-cyano-2-[( 3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3S,4S)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(7-Chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 R )-1-cyano-2-[( 3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3R,4S)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(7-Chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 R )-1-cyano-2-[( 3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3S,4R)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(7-chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 R )-1-cyano-2-[( 3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3R,4R)-2-(7-氯-4-氟-1H-吲哚-2-羰基)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(7-chloro-4-fluoro-1 H -indole-2-carbonyl) -N -[(1 R )-1-cyano-2-[( 3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N -(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-(9-hydroxy-9H-fennel-9-carbonyl)-2 - azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( R )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( R )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( R )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( R )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( S )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( S )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( S )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( R )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( R )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( R )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( R )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(9-hydroxy-9H-oxa-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N -(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-(4-methoxy-1H-indole-2-carbonyl )-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( S )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( R )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( R )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( R )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( R )-1-cyano-2-(( S )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( S )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( S )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( S )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( S )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -(( R )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -(( R )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -(( R )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -(( R )-1-cyano-2-(( R )-2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-[1-氰基-2-[2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N- [1-cyano-2-[2-oxo-3-piperidinyl]ethyl]-2-(4,7-difluoro-1 H -indole-2-carbonyl)-5, 5-Difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- (4,7-Difluoro- 1H -indole-2-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-[1-氰基-2-[2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N- [1-cyano-2-[2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-(4,6,7-trifluoro-1 H -ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-(4,6,7-三氟-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-(4,6,7-trifluoro-1 H -indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[1-氰基-2-[2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(3-Chloro- 4H -thieno[3,2-b]pyrrole-5-carbonyl) -N- [1-cyano-2-[2-oxo-3-piperidinyl]ethyl Base]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(3-chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 S )-1-cyano- 2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(3-Chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 S )-1-cyano- 2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(3-chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 S )-1-cyano- 2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(3-chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 S )-1-cyano- 2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(3-Chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 R )-1-cyano- 2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(3-Chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 R )-1-cyano- 2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(3-chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 R )-1-cyano- 2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(3-chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 R )-1-cyano- 2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(3-chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 S )-1-cyano- 2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(3-Chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 S )-1-cyano- 2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(3-chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 S )-1-cyano- 2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(3-chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 S )-1-cyano- 2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(3-Chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 R )-1-cyano- 2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(3-Chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 R )-1-cyano- 2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(3-chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 R )-1-cyano- 2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(3-chloro-4 H -thieno[3,2-b]pyrrole-5-carbonyl) -N -[(1 R )-1-cyano- 2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
2-(2-氯-9-羥基-9H-茀-9-羰基)-N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N- (1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-5,5- Difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( S )-1-cyano-2-((S)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( S )-1-cyano-2-((S)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( S )-1-cyano-2-((S)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( S )-1-cyano-2-((S)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( R )-1-cyano-2-((S)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( R )-1-cyano-2-((S)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( R )-1-cyano-2-((S)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( R )-1-cyano-2-((S)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( S )-1-cyano-2-((R)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( S )-1-cyano-2-((R)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( S )-1-cyano-2-((R)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( S )-1-cyano-2-((R)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( R )-1-cyano-2-((R)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( R )-1-cyano-2-((R)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( R )-1-cyano-2-((R)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( R )-1-cyano-2-((R)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-[1-氰基-2-[2-側氧基-3-哌啶基]乙基]-2-[3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N -[1-cyano-2-[2-oxo-3-piperidinyl]ethyl]-2-[3-cyclobutyl-2-[(2,2,2-trifluoroacetyl Base) amino] propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丁基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclobutyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
N-[1-氰基-2-[2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N- [1-cyano-2-[2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-[4-methyl-2-[(2,2, 2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2S)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-difluoro-2-[(2 S )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S ) -N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-[(2R)-4-甲基-2-[(2,2,2-三氟乙醯基)胺基]戊醯基]-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-5, 5-Difluoro-2-[(2 R )-4-methyl-2-[(2,2,2-trifluoroacetyl)amino]pentyl]-2-azabicyclo[2.2. 2] Octane-3-formamide;
N-[1-氰基-2-[2-側氧基-3-哌啶基]乙基]-2-[3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N -[1-cyano-2-[2-oxo-3-piperidinyl]ethyl]-2-[3-cyclopropyl-2-[(2,2,2-trifluoroacetyl Base) amino] propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 S )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3-環丙基-2-[(2,2,2-三氟乙醯基)胺基]丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2 R )-3-cyclopropyl-2-[(2,2,2-trifluoroacetyl)amino]propionyl]-5,5-difluoro-2-azabicyclo[2.2 .2] octane-3-carboxamide;
N-[1-氰基-2-[2-側氧基-3-哌啶基]乙基]-2-[3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N -[1-cyano-2-[2-oxo-3-piperidinyl]ethyl]-2-[3,3-dimethyl-2-[(2,2,2-trifluoro Acetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2S)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 S )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-3,3-二甲基-2-[(2,2,2-三氟乙醯基)胺基]丁醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3 R )-2-oxo-3-piperidinyl]ethyl]-2- [(2R)-3,3-Dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butyryl]-5,5-difluoro-2-azabicyclo[2.2. 2] Octane-3-formamide;
N-[1-氰基-2-[2-側氧基-3-哌啶基]乙基]-2-[2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N -[1-cyano-2-[2-oxo-3-piperidinyl]ethyl]-2-[2-(2,5-difluoroaniline)propionyl]-5,5- Difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -[(1 R )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -[(1 R )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2S)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -[(1 R )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 S )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 R )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 R )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 R )-1-cyano-2-[(3S)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 S )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S )- N -[(1 S )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R )- N -[(1 S )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R )- N -[(1 S )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )- N -[(1 R )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 R ,4 S ) -N -[(1 R )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 S ,4 R ) -N -[(1 R )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-2-[(2R)-2-(2,5-二氟苯胺)丙醯基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 R ,3 R ,4 R ) -N -[(1 R )-1-cyano-2-[(3R)-2-oxo-3-piperidinyl]ethyl]-2-[ (2 R )-2-(2,5-difluoroaniline)propionyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
2-[2-(3-氯-2-甲基-苯胺)丙醯基]-N-[1-氰基-2-[2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-[2-(3-Chloro-2-methyl-aniline)propionyl]-N-[1-cyano-2-[2-oxo-3-piperidinyl]ethyl]-5 ,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3S,4S)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-[(2S)-2-(3-Chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-[(2S)-2-(3-Chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-[(2S)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-[(2S)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-[(2R)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-[(2R)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-[(2R)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-[(2R)-2-(3-Chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-[(2S)-2-(3-Chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-[(2S)-2-(3-Chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-[(2S)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-[(2S)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-[(2R)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-[(2R)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-[(2R)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3S)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-[(2R)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3S)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-[(2S)-2-(3-Chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3R,4S)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-[(2S)-2-(3-Chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3S,4R)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-[(2S)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3R,4R)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-[(2S)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3S,4S)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-[(2R)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3R,4S)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-[(2R)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3S,4R)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-[(2R)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3R,4R)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1S)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-[(2R)-2-(3-Chloro-2-methyl-aniline)propionyl]-N-[(1S)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3S,4S)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-[(2S)-2-(3-Chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3R,4S)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-[(2S)-2-(3-Chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3S,4R)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-[(2S)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3R,4R)-2-[(2S)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-[(2S)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3S,4S)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-[(2R)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3R,4S)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-[(2R)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3S,4R)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-[(2R)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1R,3R,4R)-2-[(2R)-2-(3-氯-2-甲基-苯胺)丙醯基]-N-[(1R)-1-氰基-2-[(3R)-2-側氧基-3-哌啶基]乙基]-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-[(2R)-2-(3-chloro-2-methyl-aniline)propionyl]-N-[(1R)-1-cyano-2-[( 3R)-2-oxo-3-piperidinyl]ethyl]-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(4-hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)-2-(2-methyl-4H-thieno[3, 2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-formamide;
(S)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-4-hydroxyl-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 2-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 2-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 2-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 2-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 2-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 2-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 2-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(2-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-4-hydroxyl-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 2-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-(4-hydroxy-3-oxo-1-(2-oxopyrrolidine-3- Base) butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-4-hydroxyl-3-oxo-1-(( S) -2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-4-hydroxyl-3-oxo-1-(( R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-4-hydroxyl-3-oxo-1-(( S) -2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-4-hydroxyl-3-oxo-1-(( R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-4-hydroxyl-3-oxo-1-(( S) -2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-4-hydroxyl-3-oxo-1-(( R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-4-hydroxyl-3-oxo-1-(( S) -2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-4-hydroxyl-3-oxo-1-(( R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(4-Hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)-2-(4-methoxy-1H-indole-2 -carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-4-hydroxyl-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-4-hydroxyl-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-(3-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(4-hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)-2-(3-methyl-4H-thieno[3, 2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-formamide;
(S)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(3-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-4-hydroxyl-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 3-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(3-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 3-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(3-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 3-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(3-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 3-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(3-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 3-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(3-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-4-hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 3-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(3-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-4-hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 3-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(3-甲基-4H-噻吩并[3,2-b]吡咯-5-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-4-hydroxyl-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-( 3-methyl-4H-thieno[3,2-b]pyrrole-5-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
2-(4,6-二氟-1H-吲哚-2-羰基)-N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(4,6-Difluoro-1H-indole-2-carbonyl)-N-(4-hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane- 2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-(4,6-二氟-1H-吲哚-2-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-(4,6-difluoro-1H-indole-2-carbonyl)-N-((S)-4-hydroxy-3-oxo-1-((S)-2- Oxypyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-(4,6-二氟-1H-吲哚-2-羰基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-(4,6-difluoro-1H-indole-2-carbonyl)-N-((S)-4-hydroxy-3-oxo-1-((R)-2- Oxypyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-(4,6-二氟-1H-吲哚-2-羰基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-(4,6-difluoro-1H-indole-2-carbonyl)-N-((R)-4-hydroxy-3-oxo-1-((S)-2- Oxypyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-(4,6-二氟-1H-吲哚-2-羰基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-(4,6-difluoro-1H-indole-2-carbonyl)-N-((R)-4-hydroxy-3-oxo-1-((R)-2- Oxypyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-(4,6-二氟-1H-吲哚-2-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-(4,6-difluoro-1H-indole-2-carbonyl)-N-((S)-4-hydroxy-3-oxo-1-((S)-2- Oxypyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-(4,6-二氟-1H-吲哚-2-羰基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-(4,6-difluoro-1H-indole-2-carbonyl)-N-((S)-4-hydroxy-3-oxo-1-((R)-2- Oxypyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-(4,6-二氟-1H-吲哚-2-羰基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-(4,6-difluoro-1H-indole-2-carbonyl)-N-((R)-4-hydroxy-3-oxo-1-((S)-2- Oxypyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-(4,6-二氟-1H-吲哚-2-羰基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-(4,6-difluoro-1H-indole-2-carbonyl)-N-((R)-4-hydroxy-3-oxo-1-((R)-2- Oxypyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
2-(9-氟-9H-第-9-羰基)-N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; 2-(9-fluoro-9H-9-carbonyl)-N-(4-hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(9-氟-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(9-fluoro-9H-fennel-9-carbonyl)-N-((S)-4-hydroxyl-3-oxo-1-((S)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(9-氟-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(9-Fluoro-9H-fennel-9-carbonyl)-N-((S)-4-hydroxy-3-oxo-1-((R)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(9-氟-9H-第-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(9-fluoro-9H-9-carbonyl)-N-((R)-4-hydroxy-3-oxo-1-((S)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(9-氟-9H-茀-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(9-Fluoro-9H-fennel-9-carbonyl)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(9-氟-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(9-Fluoro-9H-fennel-9-carbonyl)-N-((S)-4-hydroxy-3-oxo-1-((S)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(9-氟-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(9-Fluoro-9H-fennel-9-carbonyl)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(9-氟-9H-茀-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(9-Fluoro-9H-fennel-9-carbonyl)-N-((R)-4-hydroxyl-3-oxo-1-((S)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(9-氟-9H-茀-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(9-Fluoro-9H-fennel-9-carbonyl)-N-((R)-4-hydroxyl-3-oxo-1-((R)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(9-氟-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(9-fluoro-9H-fennel-9-carbonyl)-N-((S)-4-hydroxyl-3-oxo-1-((S)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(9-氟-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(9-Fluoro-9H-fennel-9-carbonyl)-N-((S)-4-hydroxy-3-oxo-1-((R)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(9-氟-9H-茀-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(9-Fluoro-9H-fennel-9-carbonyl)-N-((R)-4-hydroxyl-3-oxo-1-((S)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(9-氟-9H-茀-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(9-Fluoro-9H-fennel-9-carbonyl)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(9-氟-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(9-Fluoro-9H-fennel-9-carbonyl)-N-((S)-4-hydroxy-3-oxo-1-((S)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(9-氟-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(9-Fluoro-9H-fennel-9-carbonyl)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(9-氟-9H-茀-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(9-Fluoro-9H-fennel-9-carbonyl)-N-((R)-4-hydroxyl-3-oxo-1-((S)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(9-氟-9H-茀-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(9-Fluoro-9H-fennel-9-carbonyl)-N-((R)-4-hydroxyl-3-oxo-1-((R)-2- Oxypyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
2-(9-乙醯胺基-9H-茀-9-羰基)-N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; 2-(9-Acetamido-9H-oxo-9-carbonyl)-N-(4-hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2 -yl) octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((S)-4-hydroxy-3-oxo-1-((S) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((S)-4-hydroxy-3-oxo-1-((R) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((R)-4-hydroxy-3-oxo-1-((S) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((R)-4-hydroxy-3-oxo-1-((R) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((S)-4-hydroxyl-3-oxo-1-((S) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((S)-4-hydroxy-3-oxo-1-((R) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((R)-4-hydroxy-3-oxo-1-((S) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((R)-4-hydroxy-3-oxo-1-((R) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((S)-4-hydroxy-3-oxo-1-((S) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((S)-4-hydroxy-3-oxo-1-((R) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((R)-4-hydroxy-3-oxo-1-((S) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((R)-4-hydroxy-3-oxo-1-((R) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((S)-4-hydroxyl-3-oxo-1-((S) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((S)-4-hydroxy-3-oxo-1-((R) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((R)-4-hydroxy-3-oxo-1-((S) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(9-乙醯胺基-9H-茀-9-羰基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(9-Acetamido-9H-oxo-9-carbonyl)-N-((R)-4-hydroxy-3-oxo-1-((R) -2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-(5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; N-(4-Hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl)-2-(5-oxo-2-phenylpyrrolidine -2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-(5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-(5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((S)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((S)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-((R)-5-側氧基-2-苯基吡咯啶-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-4-Hydroxy-3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl) -2-((R)-5-oxo-2-phenylpyrrolidinyl-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
2-(2-環戊基-2-羥基-2-苯乙醯基)-N-(4-羥基-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(2-Cyclopentyl-2-hydroxy-2-phenylacetyl)-N-(4-hydroxy-3-oxo-1-(2-oxopyrrolidin-3-yl)butane -2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(3S)-2-(2-環戊基-2-羥基-2-苯乙醯基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (3S)-2-(2-Cyclopentyl-2-hydroxy-2-phenylacetyl)-N-((S)-4-hydroxy-3-oxo-1-((S)-2 -Oxopyrrolidin-3-yl)butan-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-((S)-2-環戊基-2-羥基-2-苯乙醯基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-((S)-2-cyclopentyl-2-hydroxyl-2-phenylacetyl)-N-((S)-4-hydroxyl-3-oxo-1-(( S) -2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-((S)-2-環戊基-2-羥基-2-苯乙醯基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-((S)-2-cyclopentyl-2-hydroxyl-2-phenylacetyl)-N-((S)-4-hydroxyl-3-oxo-1-(( R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-((S)-2-環戊基-2-羥基-2-苯乙醯基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-((S)-2-cyclopentyl-2-hydroxyl-2-phenylacetyl)-N-((R)-4-hydroxyl-3-oxo-1-(( S) -2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-((S)-2-環戊基-2-羥基-2-苯乙醯基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-((S)-2-cyclopentyl-2-hydroxyl-2-phenylacetyl)-N-((R)-4-hydroxyl-3-oxo-1-(( R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-((R)-2-環戊基-2-羥基-2-苯乙醯基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-((R)-2-cyclopentyl-2-hydroxyl-2-phenylacetyl)-N-((S)-4-hydroxyl-3-oxo-1-(( S) -2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-((R)-2-環戊基-2-羥基-2-苯乙醯基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-((R)-2-cyclopentyl-2-hydroxyl-2-phenylacetyl)-N-((S)-4-hydroxyl-3-oxo-1-(( R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-((R)-2-環戊基-2-羥基-2-苯乙醯基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-((R)-2-cyclopentyl-2-hydroxyl-2-phenylacetyl)-N-((R)-4-hydroxyl-3-oxo-1-(( S) -2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-2-((R)-2-環戊基-2-羥基-2-苯乙醯基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-2-((R)-2-cyclopentyl-2-hydroxyl-2-phenylacetyl)-N-((R)-4-hydroxyl-3-oxo-1-(( R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-((S)-2-環戊基-2-羥基-2-苯乙醯基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-((S)-2-cyclopentyl-2-hydroxyl-2-phenylacetyl)-N-((S)-4-hydroxyl-3-oxo-1-(( S) -2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-((S)-2-環戊基-2-羥基-2-苯乙醯基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-((S)-2-cyclopentyl-2-hydroxyl-2-phenylacetyl)-N-((S)-4-hydroxyl-3-oxo-1-(( R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-((S)-2-環戊基-2-羥基-2-苯乙醯基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-((S)-2-cyclopentyl-2-hydroxyl-2-phenylacetyl)-N-((R)-4-hydroxyl-3-oxo-1-(( S) -2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-((S)-2-環戊基-2-羥基-2-苯乙醯基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-((S)-2-cyclopentyl-2-hydroxyl-2-phenylacetyl)-N-((R)-4-hydroxyl-3-oxo-1-(( R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-((R)-2-環戊基-2-羥基-2-苯乙醯基)-N-((S)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-((R)-2-cyclopentyl-2-hydroxy-2-phenylacetyl)-N-((S)-4-hydroxy-3-oxo-1-(( S) -2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-((R)-2-環戊基-2-羥基-2-苯乙醯基)-N-((S)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-((R)-2-cyclopentyl-2-hydroxy-2-phenylacetyl)-N-((S)-4-hydroxy-3-oxo-1-(( R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-((R)-2-環戊基-2-羥基-2-苯乙醯基)-N-((R)-4-羥基-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-((R)-2-cyclopentyl-2-hydroxyl-2-phenylacetyl)-N-((R)-4-hydroxyl-3-oxo-1-(( S) -2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-2-((R)-2-環戊基-2-羥基-2-苯乙醯基)-N-((R)-4-羥基-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-2-((R)-2-cyclopentyl-2-hydroxyl-2-phenylacetyl)-N-((R)-4-hydroxyl-3-oxo-1-(( R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(1-cyano-2-(2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo [2.2.2] Octane-3-formamide;
(S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy-1H-ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy-1H-ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2,-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2,-(4-methoxy-1H- Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy-1H-ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy-1H-ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy-1H-ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy-1H-ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy-1H-ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-(1-氰基-2-(2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-(1-cyano-2-(2-oxopyrrolidin-3-yl)ethyl) -5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((S )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((R )-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,2S,5S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1R,2S,5S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
N-(1-氰基-2-(2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; N-(1-cyano-2-(2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxy-9H-fenflure-9-carbonyl)-6,6-dimethyl- 3-Azabicyclo[3.1.0]hexane-2-carboxamide;
(1R,2S,5S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1R,2S,5S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
(1R,2S,5S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1R,2S,5S)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
(1R,2S,5S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1R,2S,5S)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
(1R,2S,5S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1R,2S,5S)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
(1S,2S,5R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1S,2S,5R)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
(1S,2S,5R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1S,2S,5R)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
(1S,2S,5R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1S,2S,5R)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
(1S,2S,5R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1S,2S,5R)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
(1R,2R,5S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1R,2R,5S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
(1R,2R,5S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1R,2R,5S)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
(1R,2R,5S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1R,2R,5S)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
(1R,2R,5S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1R,2R,5S)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
(1S,2R,5R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1S,2R,5R)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
(1S,2R,5R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1S,2R,5R)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
(1S,2R,5R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1S,2R,5R)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
(1S,2R,5R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-3-(9-羥基-9H-茀-9-羰基)-6,6-二甲基-3-氮雜雙環[3.1.0]己烷-2-甲醯胺; (1S,2R,5R)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-3-(9-hydroxyl-9H -Treme-9-carbonyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;
N-(1-氰基-2-(2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(1-cyano-2-(2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2-((2,2,2-trifluoroacetyl)- Leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-D-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-D-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-((2,2,2-三氟乙醯基)-L-白胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro-2 -((2,2,2-trifluoroacetyl)-L-leucyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(2-氧代吡咯啶-3-基)乙基)-2-(3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(1-cyano-2-(2-oxopyrrolidin-3-yl)ethyl)-2-(3-cyclobutyl-2-(2,2,2-trifluoroacetamido ) propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formyl amine;
2-(2-氯-9-羥基-9H-茀-9-羰基)-N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N- (1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-5,5- Difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1 S ,3 S ,4 S )-2-(2-Chloro-9-hydroxy-9H-fennel-9-carbonyl) -N -(( S )-1-cyano-2-((S)- 2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-2-chloro-9-hydroxyl-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-2-氯-9-羥基-9H-第-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-2-Chloro-9-hydroxy-9H-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-2-Chloro-9-hydroxyl-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-2-氯-9-羥基-9H-第-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-2-Chloro-9-hydroxy-9H-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-2-chloro-9-hydroxyl-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-2-chloro-9-hydroxyl-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-2-chloro-9-hydroxyl-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-2-氯-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-2-chloro-9-hydroxyl-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-2-氯-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-2-Chloro-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-2-(4-methoxy-1H-indole-2-carbonyl)-2-azabicyclo [2.2.2] Octane-3-formamide;
(S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-methoxy-1H-ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-methoxy-1H-ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-methoxy-1H-ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-methoxy-1H-ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-methoxy-1H-ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-methoxy-1H-ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-methoxy-1H-ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-methoxy-1H-ind Indole-2-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
2-(2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl Base)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-2-((3-Chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-2-((3-Chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((S)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-2-((3-氯苯基)胺基)-3-環丙基丙醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-2-((3-chlorophenyl)amino)-3-cyclopropylpropionyl)-N-((R)-1-cyano -2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-2-(3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-2-(3-cyclopropyl-2-((5-methylpyridin-3-yl)amine Base) propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl)-propanamidoyl)-5,5-di Fluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-D-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5- Difluorophenyl)-L-propanylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
2-((5-氯吡啶-3-基)-丙胺醯基)-N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-((5-Chloropyridin-3-yl)-propanylamino)-N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-5,5-di Fluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((5-氯吡啶-3-基)-D-丙胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((5-Chloropyridin-3-yl)-D-propanylamino)-N-((S)-1-cyano-2-((S)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((5-氯吡啶-3-基)-D-丙胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((5-Chloropyridin-3-yl)-D-propanylamino)-N-((S)-1-cyano-2-((R)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((5-氯吡啶-3-基)-D-丙胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((5-Chloropyridin-3-yl)-D-propanylamino)-N-((R)-1-cyano-2-((S)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((5-氯吡啶-3-基)-D-丙胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((5-Chloropyridin-3-yl)-D-propanylamino)-N-((R)-1-cyano-2-((R)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((5-氯吡啶-3-基)-L-丙胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((5-Chloropyridin-3-yl)-L-propanylamino)-N-((S)-1-cyano-2-((S)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((5-氯吡啶-3-基)-L-丙胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((5-Chloropyridin-3-yl)-L-propanylamino)-N-((S)-1-cyano-2-((R)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((5-氯吡啶-3-基)-L-丙胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((5-Chloropyridin-3-yl)-L-propanylamino)-N-((R)-1-cyano-2-((S)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((5-氯吡啶-3-基)-L-丙胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((5-Chloropyridin-3-yl)-L-propanylamino)-N-((R)-1-cyano-2-((R)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((5-氯吡啶-3-基)-D-丙胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((5-Chloropyridin-3-yl)-D-propanylamino)-N-((S)-1-cyano-2-((S)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((5-氯吡啶-3-基)-D-丙胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((5-Chloropyridin-3-yl)-D-propanylamino)-N-((S)-1-cyano-2-((R)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((5-氯吡啶-3-基)-D-丙胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((5-Chloropyridin-3-yl)-D-propanylamino)-N-((R)-1-cyano-2-((S)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((5-氯吡啶-3-基)-D-丙胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((5-Chloropyridin-3-yl)-D-propanylamino)-N-((R)-1-cyano-2-((R)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((5-氯吡啶-3-基)-L-丙胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((5-Chloropyridin-3-yl)-L-propanylamino)-N-((S)-1-cyano-2-((S)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((5-氯吡啶-3-基)-L-丙胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((5-Chloropyridin-3-yl)-L-propanylamino)-N-((S)-1-cyano-2-((R)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((5-氯吡啶-3-基)-L-丙胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((5-Chloropyridin-3-yl)-L-propanylamino)-N-((R)-1-cyano-2-((S)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((5-氯吡啶-3-基)-L-丙胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((5-Chloropyridin-3-yl)-L-propanylamino)-N-((R)-1-cyano-2-((R)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((5-氯吡啶-3-基)-D-丙胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((5-Chloropyridin-3-yl)-D-propanylamino)-N-((S)-1-cyano-2-((S)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((5-氯吡啶-3-基)-D-丙胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((5-Chloropyridin-3-yl)-D-propanylamino)-N-((S)-1-cyano-2-((R)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((5-氯吡啶-3-基)-D-丙胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((5-Chloropyridin-3-yl)-D-propanylamino)-N-((R)-1-cyano-2-((S)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((5-氯吡啶-3-基)-D-丙胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((5-Chloropyridin-3-yl)-D-propanylamino)-N-((R)-1-cyano-2-((R)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((5-氯吡啶-3-基)-L-丙胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((5-Chloropyridin-3-yl)-L-propanylamino)-N-((S)-1-cyano-2-((S)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((5-氯吡啶-3-基)-L-丙胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((5-Chloropyridin-3-yl)-L-propanylamino)-N-((S)-1-cyano-2-((R)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((5-氯吡啶-3-基)-L-丙胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((5-Chloropyridin-3-yl)-L-propanylamino)-N-((R)-1-cyano-2-((S)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((5-氯吡啶-3-基)-L-丙胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((5-Chloropyridin-3-yl)-L-propanylamino)-N-((R)-1-cyano-2-((R)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((5-氯吡啶-3-基)-D-丙胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((5-Chloropyridin-3-yl)-D-propanylamino)-N-((S)-1-cyano-2-((S)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((5-氯吡啶-3-基)-D-丙胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((5-Chloropyridin-3-yl)-D-propanylamino)-N-((S)-1-cyano-2-((R)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((5-氯吡啶-3-基)-D-丙胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((5-Chloropyridin-3-yl)-D-propanylamino)-N-((R)-1-cyano-2-((S)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((5-氯吡啶-3-基)-D-丙胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((5-Chloropyridin-3-yl)-D-propanylamino)-N-((R)-1-cyano-2-((R)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((5-氯吡啶-3-基)-L-丙胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((5-Chloropyridin-3-yl)-L-propanylamino)-N-((S)-1-cyano-2-((S)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((5-氯吡啶-3-基)-L-丙胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((5-Chloropyridin-3-yl)-L-propanylamino)-N-((S)-1-cyano-2-((R)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((5-氯吡啶-3-基)-L-丙胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((5-Chloropyridin-3-yl)-L-propanylamino)-N-((R)-1-cyano-2-((S)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((5-氯吡啶-3-基)-L-丙胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((5-Chloropyridin-3-yl)-L-propanylamino)-N-((R)-1-cyano-2-((R)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
2-((3-氯苯基)-丙胺醯基)-N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-((3-Chlorophenyl)-propanylamino)-N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 - azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-丙胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-propanylamino)-N-((S)-1-cyano-2-((S)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-丙胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-propanylamino)-N-((S)-1-cyano-2-((R)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-丙胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-propanylamino)-N-((R)-1-cyano-2-((S)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-丙胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-propanylamino)-N-((R)-1-cyano-2-((R)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-丙胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-propanylamino)-N-((S)-1-cyano-2-((S)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-丙胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-propanylamino)-N-((S)-1-cyano-2-((R)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-丙胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-propanylamino)-N-((R)-1-cyano-2-((S)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-丙胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-propanylamino)-N-((R)-1-cyano-2-((R)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-丙胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-propanylamino)-N-((S)-1-cyano-2-((S)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-丙胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-propanylamino)-N-((S)-1-cyano-2-((R)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-丙胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-propanylamino)-N-((R)-1-cyano-2-((S)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-丙胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-propanylamino)-N-((R)-1-cyano-2-((R)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-丙胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-propanylamino)-N-((S)-1-cyano-2-((S)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-丙胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-propanylamino)-N-((S)-1-cyano-2-((R)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-丙胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-propanylamino)-N-((R)-1-cyano-2-((S)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-丙胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-propanylamino)-N-((R)-1-cyano-2-((R)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-丙胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-propanylamino)-N-((S)-1-cyano-2-((S)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-丙胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-propanylamino)-N-((S)-1-cyano-2-((R)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-丙胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-propanylamino)-N-((R)-1-cyano-2-((S)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-丙胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-propanylamino)-N-((R)-1-cyano-2-((R)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-丙胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-propanylamino)-N-((S)-1-cyano-2-((S)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-丙胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-propanylamino)-N-((S)-1-cyano-2-((R)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-丙胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-propanylamino)-N-((R)-1-cyano-2-((S)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-丙胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-propanylamino)-N-((R)-1-cyano-2-((R)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-丙胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-propanylamino)-N-((S)-1-cyano-2-((S)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-丙胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-propanylamino)-N-((S)-1-cyano-2-((R)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-丙胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-propanylamino)-N-((R)-1-cyano-2-((S)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-丙胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-propanylamino)-N-((R)-1-cyano-2-((R)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-丙胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-propanylamino)-N-((S)-1-cyano-2-((S)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-丙胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-propanylamino)-N-((S)-1-cyano-2-((R)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-丙胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-propanylamino)-N-((R)-1-cyano-2-((S)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-丙胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-propanylamino)-N-((R)-1-cyano-2-((R)-2-oxopiper Pyridin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-2-(3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-2-(3-cyclopropyl-2-((1-methyl-1H-pyrazole-4 -yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((S)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((R)-3-環丙基-2-((1-甲基-1H-吡唑-4-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((1-methyl-1H-pyrazol-4-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane -3-Formamide;
2-((3-氯-2-甲基苯基)甘胺醯基)-N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-((3-Chloro-2-methylphenyl)glycyl)-N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-5,5 - Difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯-2-甲基苯基)甘胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-N-((S)-1-cyano-2-((S)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯-2-甲基苯基)甘胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-N-((S)-1-cyano-2-((R)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯-2-甲基苯基)甘胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-N-((R)-1-cyano-2-((S)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯-2-甲基苯基)甘胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-N-((R)-1-cyano-2-((R)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯-2-甲基苯基)甘胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-N-((S)-1-cyano-2-((S)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯-2-甲基苯基)甘胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-N-((S)-1-cyano-2-((R)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯-2-甲基苯基)甘胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-N-((R)-1-cyano-2-((S)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯-2-甲基苯基)甘胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-N-((R)-1-cyano-2-((R)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯-2-甲基苯基)甘胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-N-((S)-1-cyano-2-((S)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯-2-甲基苯基)甘胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-N-((S)-1-cyano-2-((R)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯-2-甲基苯基)甘胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-N-((R)-1-cyano-2-((S)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯-2-甲基苯基)甘胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-N-((R)-1-cyano-2-((R)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯-2-甲基苯基)甘胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-N-((S)-1-cyano-2-((S)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯-2-甲基苯基)甘胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-N-((S)-1-cyano-2-((R)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯-2-甲基苯基)甘胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-N-((R)-1-cyano-2-((S)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯-2-甲基苯基)甘胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-N-((R)-1-cyano-2-((R)-2- Oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(1-((3-chlorophenyl)amino)cyclopropane-1-carbonyl)-N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)- 5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-(1-((3-氯苯基)胺基)環丙烷-1-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(1-((3-Chlorophenyl)amino)cyclopropane-1-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl)-propanamidoyl)-2-azabicyclo [2.2.2] Octane-3-formamide;
(S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-L-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-L-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-((2,5-二氟苯基)-D-丙胺醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-((2,5-difluorophenyl )-D-propanyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-(2-hydroxy-2-phenylacetyl)-2- Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((S)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((S)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-((R)-2-羥基-2-苯乙醯基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -((R)-2-Hydroxy-2-phenylacetyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
2-((3-氯苯基)-白胺醯基)-N-(1-氰基-2-(2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-((3-chlorophenyl)-leucyl)-N-(1-cyano-2-(2-oxopyrrolidin-3-yl)ethyl)-5,5-difluoro- 2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-D-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((S)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((S)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)-L-leucyl)-N-((R)-1-cyano-2-((R)-2-oxo Pyrrolidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(2-氧代吡咯啶-3-基)乙基)-2-(3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(1-cyano-2-(2-oxopyrrolidin-3-yl)ethyl)-2-(3-cyclopropyl-2-((5-methylpyridin-3-yl)amine Base) propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((S)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((S)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-((R)-3-環丙基-2-((5-甲基吡啶-3-基)胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-((R)-3 -Cyclopropyl-2-((5-methylpyridin-3-yl)amino)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-methyl Amide;
5,5-二氟-N-(4-氟-4-(甲基磺醯基)-1-(2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 5,5-Difluoro-N-(4-fluoro-4-(methylsulfonyl)-1-(2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2 -(9-Hydroxy-9H-fen-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-第-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridine-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-第-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridine-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-第-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridine-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-第-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridine-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-第-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridine-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrole Pyridin-3-yl)but-3-en-2-yl)-2-(9-hydroxy-9H-oxene-9-carbonyl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
N-(4-氟-4-(甲基磺醯基)-1-(2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; N-(4-fluoro-4-(methylsulfonyl)-1-(2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-第-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-第-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)-2-(9-hydroxy-9H-fluorene-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
2-(2-乙醯胺基-2-苯乙醯基)-N-(4-氟-4-(甲基磺醯基)-1-(2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; 2-(2-Acetamido-2-phenylacetyl)-N-(4-fluoro-4-(methylsulfonyl)-1-(2-oxopyrrolidin-3-yl)butyl -3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((S,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,E)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-乙醯胺基-2-苯乙醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-Acetamido-2-phenylacetyl)-N-((R,Z)-4-fluoro-4-(methylsulfonyl Base)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
2-(3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-(4-氟-4-(甲基磺醯基)-1-(2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; 2-(3,3-Dimethyl-2-(2,2,2-trifluoroacetylamino)butyryl)-N-(4-fluoro-4-(methylsulfonyl)-1-( 2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
2-(3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-(4-氟-4-(甲基磺醯基)-1-(2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; 2-(3,3-Dimethyl-2-(2,2,2-trifluoroacetylamino)butyryl)-N-(4-fluoro-4-(methylsulfonyl)-1-( 2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,E) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((S,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-N-((R,Z) -4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c] Pyrrole-1-carboxamide;
2-(3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-(4-氟-4-(甲基磺醯基)-1-(2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; 2-(3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N-(4-fluoro-4-(methylsulfonyl Acyl)-1-(2-oxopyrrolidin-3-yl)but-3-en-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; 1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N- ((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)eta Hydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) Octahydrocyclopenta[c]pyrrole-1-carboxamide;
2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-(4-氟-4-(甲基磺醯基)-1-(2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-(4-fluoro-4-(methylsulfonyl)-1-(2-oxopyrrolidine -3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-(4-氟-4-(甲基磺醯基)-1-(2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-(4-fluoro-4-(methylsulfonyl)-1-(2-oxopyrrolidine -3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3S,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3S,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1S,3R,4S)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(7-Chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
(1R,3R,4R)-2-(7-氯-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(7-chloro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methyl Sulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-methan Amide;
2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-(4-氟-4-(甲基磺醯基)-1-(2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-(4-fluoro-4-(methylsulfonyl)-1-(2-oxo Pyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3S,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3S,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3S,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3S,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3S,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3S,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3S,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3S,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3S,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3S,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3S,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3S,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3S,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3S,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3S,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3R,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3R,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3R,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3R,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3R,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3R,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3R,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1S,3R,4S)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3R,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3R,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,E)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3R,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3R,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3R,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3R,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,E)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3R,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4- (Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
(1R,3R,4R)-2-(4,7-二氟-1H-吲哚-2-羰基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(4,7-Difluoro-1H-indole-2-carbonyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4- (Methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane- 3-formamide;
2-(3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-(4-氟-4-(甲基磺醯基)-1-(2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N-(4-fluoro-4-(methylsulfonyl Acyl)-1-(2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N-((S , E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-nitrogen Heterobicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((S,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,E)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-3,3-二甲基-2-(2,2,2-三氟乙醯胺基)丁醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-3,3-Dimethyl-2-(2,2,2-trifluoroacetamido)butyryl)-5,5-difluoro-N -((R,Z)-4-fluoro-4-(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl) -2-Azabicyclo[2.2.2]octane-3-carboxamide;
4-(2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-(2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; 4-(2-((3-Chlorophenyl)-D-leucylamino)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-formamido)- Ethyl 2-fluoro-5-(2-oxopyrrolidin-3-yl)pent-2-enoate;
(S,Z)-4-((1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3S,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3S,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3S,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3S,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3S,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3S,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3S,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3S,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3R,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3R,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3R,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3R,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3R,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3R,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3R,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3R,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3S,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3S,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3S,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3S,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3S,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3S,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3S,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3S,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3R,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3R,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3R,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3R,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3R,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3R,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3R,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,E)-4-((1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3R,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3S,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3S,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3S,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3S,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3S,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3S,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3S,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3S,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3R,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3R,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3R,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3R,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3R,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3R,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3R,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,Z)-4-((1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3R,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3S,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1S,3S,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3S,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3S,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1S,3S,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3S,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3S,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1R,3S,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3S,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3S,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1R,3S,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3S,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3R,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1S,3R,4S)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3R,4S)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3R,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1S,3R,4S)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3R,4S)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3R,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1R,3R,4R)-2-((3-氯苯基)-D-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3R,4R)-2-((3-chlorophenyl)-D-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3R,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(R,E)-4-((1R,3R,4R)-2-((3-氯苯基)-L-白胺醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3R,4R)-2-((3-chlorophenyl)-L-leucyl)-5,5-difluoro-2-azabicyclo[2.2 .2] Octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
4-(2-(3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-(2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; 4-(2-(3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl)-5,5-difluoro-2-azabicyclo[2.2.2] Octane-3-formamido)-2-fluoro-5-(2-oxopyrrolidin-3-yl)pent-2-enoic acid ethyl ester;
(S,Z)-4-((1S,3S,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3S,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,Z)-4-((1S,3S,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3S,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,Z)-4-((1S,3S,4S)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3S,4S)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,Z)-4-((1S,3S,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3S,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,Z)-4-((1R,3S,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3S,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,Z)-4-((1R,3S,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3S,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,Z)-4-((1R,3S,4R)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3S,4R)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,Z)-4-((1R,3S,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3S,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,Z)-4-((1S,3R,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3R,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,Z)-4-((1S,3R,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3R,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,Z)-4-((1S,3R,4S)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3R,4S)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,Z)-4-((1S,3R,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1S,3R,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,Z)-4-((1R,3R,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3R,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,Z)-4-((1R,3R,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3R,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,Z)-4-((1R,3R,4R)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3R,4R)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,Z)-4-((1R,3R,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,Z)-4-((1R,3R,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1S,3S,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3S,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1S,3S,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3S,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1S,3S,4S)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3S,4S)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1S,3S,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3S,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1R,3S,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3S,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1R,3S,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3S,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1R,3S,4R)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3S,4R)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1R,3S,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3S,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1S,3R,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3R,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1S,3R,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3R,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1S,3R,4S)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3R,4S)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1S,3R,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1S,3R,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1R,3R,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3R,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1R,3R,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3R,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1R,3R,4R)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3R,4R)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(S,E)-4-((1R,3R,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (S,E)-4-((1R,3R,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1S,3S,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3S,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1S,3S,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3S,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1S,3S,4S)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3S,4S)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1S,3S,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3S,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1R,3S,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3S,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1R,3S,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3S,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1R,3S,4R)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3S,4R)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1R,3S,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3S,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1S,3R,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3R,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1S,3R,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3R,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1S,3R,4S)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3R,4S)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1S,3R,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1S,3R,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1R,3R,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3R,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1R,3R,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3R,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1R,3R,4R)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3R,4R)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,Z)-4-((1R,3R,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,Z)-4-((1R,3R,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1S,3S,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3S,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1S,3S,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3S,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1S,3S,4S)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3S,4S)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1S,3S,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3S,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1R,3S,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3S,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1R,3S,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3S,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1R,3S,4R)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3S,4R)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1R,3S,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3S,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1S,3R,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3R,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1S,3R,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3R,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1S,3R,4S)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3R,4S)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1S,3R,4S)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1S,3R,4S)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1R,3R,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3R,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1R,3R,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3R,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1R,3R,4R)-2-((R)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((S)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3R,4R)-2-((R)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((S)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
(R,E)-4-((1R,3R,4R)-2-((S)-3-環丁基-2-(2,2,2-三氟乙醯胺基)丙醯基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺基)-2-氟-5-((R)-2-氧代吡咯啶-3-基)戊-2-烯酸乙酯; (R,E)-4-((1R,3R,4R)-2-((S)-3-cyclobutyl-2-(2,2,2-trifluoroacetamido)propionyl) -5,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamido)-2-fluoro-5-((R)-2-oxopyrrolidin-3-yl ) ethyl pent-2-enoate;
2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-(4-氟-4-(甲基磺醯基)-1-(2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-(4-fluoro-4-(methylsulfonyl)-1-(2- Oxypyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4 -(Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3S,4S)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4 -(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3S,4S)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4 -(Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3S,4S)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4 -(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3S,4S)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,E)-4-fluoro-4 -(Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3S,4S)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,E)-4-fluoro-4 -(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3S,4S)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4 -(Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3S,4S)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4 -(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3S,4R)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4 -(Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3S,4R)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4 -(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3S,4R)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4 -(Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3S,4R)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4 -(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3S,4R)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,E)-4-fluoro-4 -(Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3S,4R)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,E)-4-fluoro-4 -(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3S,4R)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4 -(Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3S,4R)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4 -(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3R,4S)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4 -(Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3R,4S)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4 -(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3R,4S)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4 -(Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3R,4S)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4 -(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3R,4S)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,E)-4-fluoro-4 -(Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3R,4S)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,E)-4-fluoro-4 -(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3R,4S)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4 -(Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
(1S,3R,4S)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4 -(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3R,4R)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4 -(Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3R,4R)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4 -(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3R,4R)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4 -(Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3R,4R)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4 -(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3R,4R)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,E)-4-fluoro-4 -(Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3R,4R)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,E)-4-fluoro-4 -(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3R,4R)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4 -(Methylsulfonyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
(1R,3R,4R)-2-((3-氯-2-甲基苯基)甘胺醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chloro-2-methylphenyl)glycyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4 -(methylsulfonyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane -3-Formamide;
2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-(4-氟-4-(甲基磺醯基)-1-(2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-(4-fluoro-4-(methylsulfonyl)-1-(2-oxopyrrolidine- 3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl Acyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl Acyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl Acyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl Acyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)glycinyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl Acyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)glycinyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl Acyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl Acyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3S,4S)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl Acyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl Acyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl Acyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl Acyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl Acyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl Acyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl Acyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)glycinyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl Acyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3S,4R)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((3-Chlorophenyl)glycinyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl Acyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl Acyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl Acyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl Acyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl Acyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)glycinyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl Acyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)glycinyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl Acyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)glycinyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl Acyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1S,3R,4S)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((3-Chlorophenyl)glycinyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl Acyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl Acyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((S,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,E)-4-fluoro-4-(methylsulfonyl Acyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl Acyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((S,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((S,Z)-4-fluoro-4-(methylsulfonyl Acyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl Acyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((R,E)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((R,E)-4-fluoro-4-(methylsulfonyl Acyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((S)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl Acyl)-1-((S)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
(1R,3R,4R)-2-((3-氯苯基)甘胺醯基)-5,5-二氟-N-((R,Z)-4-氟-4-(甲基磺醯基)-1-((R)-2-氧代吡咯啶-3-基)丁-3-烯-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((3-Chlorophenyl)glycyl)-5,5-difluoro-N-((R,Z)-4-fluoro-4-(methylsulfonyl Acyl)-1-((R)-2-oxopyrrolidin-3-yl)but-3-en-2-yl)-2-azabicyclo[2.2.2]octane-3-formyl amine;
8-(4-氟-1H-吲哚-2-羰基)-N-(4-氟-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; 8-(4-fluoro-1H-indole-2-carbonyl)-N-(4-fluoro-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl )-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
8-(4-氟-1H-吲哚-2-羰基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; 8-(4-fluoro-1H-indole-2-carbonyl)-N-((S)-4-fluoro-3-oxo-1-((S)-2-oxopyrrolidine-3- Base) butane-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(S)-8-(4-氟-1H-吲哚-2-羰基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (S)-8-(4-fluoro-1H-indole-2-carbonyl)-N-((S)-4-fluoro-3-oxo-1-((S)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(S)-8-(4-氟-1H-吲哚-2-羰基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (S)-8-(4-fluoro-1H-indole-2-carbonyl)-N-((S)-4-fluoro-3-oxo-1-((R)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(S)-8-(4-氟-1H-吲哚-2-羰基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (S)-8-(4-fluoro-1H-indole-2-carbonyl)-N-((R)-4-fluoro-3-oxo-1-((S)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(S)-8-(4-氟-1H-吲哚-2-羰基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (S)-8-(4-fluoro-1H-indole-2-carbonyl)-N-((R)-4-fluoro-3-oxo-1-((R)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(R)-8-(4-氟-1H-吲哚-2-羰基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (R)-8-(4-fluoro-1H-indole-2-carbonyl)-N-((S)-4-fluoro-3-oxo-1-((S)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(R)-8-(4-氟-1H-吲哚-2-羰基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (R)-8-(4-fluoro-1H-indole-2-carbonyl)-N-((S)-4-fluoro-3-oxo-1-((R)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(R)-8-(4-氟-1H-吲哚-2-羰基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (R)-8-(4-fluoro-1H-indole-2-carbonyl)-N-((R)-4-fluoro-3-oxo-1-((S)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(R)-8-(4-氟-1H-吲哚-2-羰基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (R)-8-(4-fluoro-1H-indole-2-carbonyl)-N-((R)-4-fluoro-3-oxo-1-((R)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
8-(7-氯-1H-吲哚-2-羰基)-N-(4-氟-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; 8-(7-Chloro-1H-indole-2-carbonyl)-N-(4-fluoro-3-oxo-1-(2-oxopyrrolidin-3-yl)butane-2-yl )-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
8-(7-氯-1H-吲哚-2-羰基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; 8-(7-Chloro-1H-indole-2-carbonyl)-N-((S)-4-fluoro-3-oxo-1-((S)-2-oxopyrrolidine-3- Base) butane-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(S)-8-(7-氯-1H-吲哚-2-羰基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (S)-8-(7-chloro-1H-indole-2-carbonyl)-N-((S)-4-fluoro-3-oxo-1-((S)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(S)-8-(7-氯-1H-吲哚-2-羰基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (S)-8-(7-chloro-1H-indole-2-carbonyl)-N-((S)-4-fluoro-3-oxo-1-((R)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(S)-8-(7-氯-1H-吲哚-2-羰基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (S)-8-(7-chloro-1H-indole-2-carbonyl)-N-((R)-4-fluoro-3-oxo-1-((S)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(S)-8-(7-氯-1H-吲哚-2-羰基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (S)-8-(7-chloro-1H-indole-2-carbonyl)-N-((R)-4-fluoro-3-oxo-1-((R)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(R)-8-(7-氯-1H-吲哚-2-羰基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (R)-8-(7-chloro-1H-indole-2-carbonyl)-N-((S)-4-fluoro-3-oxo-1-((S)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(R)-8-(7-氯-1H-吲哚-2-羰基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (R)-8-(7-chloro-1H-indole-2-carbonyl)-N-((S)-4-fluoro-3-oxo-1-((R)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(R)-8-(7-氯-1H-吲哚-2-羰基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (R)-8-(7-chloro-1H-indole-2-carbonyl)-N-((R)-4-fluoro-3-oxo-1-((S)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
(R)-8-(7-氯-1H-吲哚-2-羰基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-5-氧雜-8-氮雜螺[3.5]壬烷-9-甲醯胺; (R)-8-(7-chloro-1H-indole-2-carbonyl)-N-((R)-4-fluoro-3-oxo-1-((R)-2-oxopyrrole Pyridin-3-yl)butan-2-yl)-5-oxa-8-azaspiro[3.5]nonane-9-carboxamide;
2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-(4-氟-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(2-(3-chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-(4-fluoro-3-oxo-1-(2-oxo Pyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((S)-4-fluoro- 3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3S,4S)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((S)-4-fluoro- 3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3S,4S)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((R)-4-fluoro- 3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3S,4S)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((R)-4-fluoro- 3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3S,4R)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((S)-4-fluoro- 3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3S,4R)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((S)-4-fluoro- 3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3S,4R)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((R)-4-fluoro- 3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3S,4R)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((R)-4-fluoro- 3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3R,4S)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((S)-4-fluoro- 3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3R,4S)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((S)-4-fluoro- 3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3R,4S)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((R)-4-fluoro- 3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1S,3R,4S)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((R)-4-fluoro- 3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3R,4R)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((S)-4-fluoro- 3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3R,4R)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((S)-4-fluoro- 3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3R,4R)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((R)-4-fluoro- 3-oxo-1-((S)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
(1R,3R,4R)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-5,5-二氟-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-5,5-difluoro-N-((R)-4-fluoro- 3-oxo-1-((R)-2-oxopyrrolidin-3-yl)butane-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide ;
2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-(4-氟-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; 2-(2-(3-chlorophenyl)-2,2-difluoroacetyl)-N-(4-fluoro-3-oxo-1-(2-oxopyrrolidin-3-yl) )butane-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(2-(3-氯苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(2-(3-Chlorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-(4-氟-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; 2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-(4-fluoro-3-oxo-1-(2-oxopyrrolidin-3-yl) )butane-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((S)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(2-(3-氟苯基)-2,2-二氟乙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(2-(3-fluorophenyl)-2,2-difluoroacetyl)-N-((R)-4-fluoro-3-oxo-1 -((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
2-(2-氟-2-(3-氟苯基)丙醯基)-N-(4-氟-3-側氧基-1-(2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; 2-(2-Fluoro-2-(3-fluorophenyl)propionyl)-N-(4-fluoro-3-oxo-1-(2-oxopyrrolidin-3-yl)butane -2-yl) octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo-1-(( S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((S)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((S)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((S)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((S)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((S)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-((R)-2-氟-2-(3-氟苯基)丙醯基)-N-((R)-4-氟-3-側氧基-1-((R)-2-氧代吡咯啶-3-基)丁烷-2-基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-((R)-2-fluoro-2-(3-fluorophenyl)propionyl)-N-((R)-4-fluoro-3-oxo- 1-((R)-2-oxopyrrolidin-3-yl)butan-2-yl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-(1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-(2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-(1-(2-oxodihydrofuran-3(2H)-ylidene)- 3-(2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1S,3S,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1S,3S,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1S,3S,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1S,3S,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1S,3S,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1S,3S,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1S,3S,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3S,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3S,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3S,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3S,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3S,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propane-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3S,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3S,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propane-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3S,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1S,3R,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1S,3R,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1S,3R,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1S,3R,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1S,3R,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propane-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1S,3R,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1S,3R,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propane-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1S,3R,4S)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3R,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3R,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3R,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3R,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((S,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((S,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3R,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3R,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,E)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,E)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3R,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((S)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((S)-2-oxopyrrolidin-3-yl)propane-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
(1R,3R,4R)-5,5-二氟-2-(4-甲氧基-1H-吲哚-2-羰基)-N-((R,Z)-1-(2-氧代二氫呋喃-3(2H)-基亞基)-3-((R)-2-氧代吡咯啶-3-基)丙烷-2-基)-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-5,5-Difluoro-2-(4-methoxy-1H-indole-2-carbonyl)-N-((R,Z)-1-(2-oxo Dihydrofuran-3(2H)-ylidene)-3-((R)-2-oxopyrrolidin-3-yl)propan-2-yl)-2-azabicyclo[2.2.2]octane Alkane-3-carboxamides;
2-(2-溴-9-羥基-9H-茀-9-羰基)-N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; 2-(2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-5,5- Difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-(2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-(2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S)-2-oxo Piperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((S)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-2-Bromo-9-hydroxyl-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-2-((R)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((S)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-2-Bromo-9-hydroxyl-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-2-((R)-2-Bromo-9-hydroxyl-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((S)-2-Bromo-9-hydroxyl-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-2-Bromo-9-hydroxyl-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-2-Bromo-9-hydroxyl-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-2-((R)-2-Bromo-9-hydroxyl-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-2-Bromo-9-hydroxyl-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((S)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((S)-2-Bromo-9-hydroxy-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-2-Bromo-9-hydroxyl-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-2-Bromo-9-hydroxyl-9H-fennel-9-carbonyl)-N-((S)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-2-bromo-9-hydroxyl-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((S) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-2-((R)-2-溴-9-羥基-9H-茀-9-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-2-((R)-2-bromo-9-hydroxyl-9H-fennel-9-carbonyl)-N-((R)-1-cyano-2-((R) -2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-2-(2,7-difluoro-9-hydroxy-9H-fennel-9-carbonyl)-5 ,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氟-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Fluoro-9-hydroxy-9H-fluorene-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-2-(2,7-dichloro-9-hydroxy-9H-fennel-9-carbonyl)-5 ,5-Difluoro-2-azabicyclo[2.2.2]octane-3-formamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3S,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3S,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3S,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3S,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1S,3R,4S)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1S,3R,4S)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
(1R,3R,4R)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(2,7-二氯-9-羥基-9H-茀-9-羰基)-5,5-二氟-2-氮雜雙環[2.2.2]辛烷-3-甲醯胺; (1R,3R,4R)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(2,7-di Chloro-9-hydroxy-9H-fennel-9-carbonyl)-5,5-difluoro-2-azabicyclo[2.2.2]octane-3-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-(9-hydroxy-9H-fennel-9-carbonyl)octahydro Cyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2-(4-fluoro-1H-indole-2-carbonyl)eta Hydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟-2-(4-氟-1H-吲哚-2-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-5,5-difluoro-2 -(4-fluoro-1H-indole-2-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoromethyl)-6-fluoro-1H-indole-2-carbonyl )-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-6-氟-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-6-fluoro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoromethyl)-7-chloro-1H-indole-2-carbonyl )-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-(二氟甲基)-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-(difluoro Methyl)-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-2-(4,7-difluoro-6-chloro-1H-indole-2-carbonyl)- 5,5-Difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; 2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl) -5,5-Difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((R )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((R )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((R )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-2-(3-Chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((R )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((R )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((R )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((S)-1-cyano-2-((R )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((S )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-2-(3-氯-4H-噻吩并[3,2-b]吡咯-5-羰基)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-2-(3-chloro-4H-thieno[3,2-b]pyrrole-5-carbonyl)-N-((R)-1-cyano-2-((R )-2-oxopiperidin-3-yl)ethyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-2-(4,6-difluoro-7-chloro-1H-indole-2-carbonyl)- 5,5-Difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,6-二氟-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,6-di Fluoro-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6-methyl-7-chloro-1H-indole-2-carbonyl )-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-6-甲基-7-氯-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-6 -Methyl-7-chloro-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-2-(4,7-difluoro-6-methyl-1H-indole-2-carbonyl) -5,5-Difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4,7-二氟-6-甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4,7-di Fluoro-6-methyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7-difluoromethyl-1H-indole-2-carbonyl)- 5,5-Difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(4-氟-7-二氟甲基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(4-fluoro-7 -Difluoromethyl-1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
N-(1-氰基-2-(2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; N-(1-cyano-2-(2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy-1H-indole-2-carbonyl)-5,5-di Fluoroctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-2-(4-甲氧基-1H-吲哚-2-羰基)-5,5-二氟八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-2-(4-methoxy -1H-indole-2-carbonyl)-5,5-difluorooctahydrocyclopenta[c]pyrrole-1-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2-(9-hydroxy-9H-fennel-9-carbonyl)octahydro Cyclopenta[c]pyrrole-1-carboxamide;
N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2-(9-hydroxyl-9H- Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
N-(1-氰基-2-(2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; N-(1-cyano-2-(2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2-(9-hydroxy-9H-fennel-9-carbonyl)octahydro Cyclopenta[c]pyrrole-1-carboxamide;
N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2-(9-hydroxyl-9H- Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代吡咯啶-3-基)乙基)-4,4-二氟-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopyrrolidin-3-yl)ethyl)-4,4-difluoro-2 -(9-hydroxy-9H-fen-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
N-(1-氰基-2-(2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; N-(1-cyano-2-(2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxy-9H-fenflure-9-carbonyl)octahydrocyclopenta[c]pyrrole- 1-formamide;
N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H-fennel-9-carbonyl)octa Hydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1S,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1S,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aR,6aS)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aR,6aS)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((S)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺; (1R,3aS,6aR)-N-((S)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide;
(1R,3aS,6aR)-N-((R)-1-氰基-2-((S)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺;和 (1R,3aS,6aR)-N-((R)-1-cyano-2-((S)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide; and
(1R,3aS,6aR)-N-((R)-1-氰基-2-((R)-2-氧代哌啶-3-基)乙基)-2-(9-羥基-9H-茀-9-羰基)八氫環戊[c]吡咯-1-甲醯胺。 (1R,3aS,6aR)-N-((R)-1-cyano-2-((R)-2-oxopiperidin-3-yl)ethyl)-2-(9-hydroxyl-9H -Oxa-9-carbonyl)octahydrocyclopenta[c]pyrrole-1-carboxamide.
實施方式29提供一種醫藥組成物,其包括至少一種實施方式1-28中任一項所述的化合物和醫藥上可接受的載劑。 Embodiment 29 provides a pharmaceutical composition, which includes at least one compound according to any one of Embodiments 1-28 and a pharmaceutically acceptable carrier.
實施方式30提供實施方式29所述的醫藥組成物,進一步包括至少一種用於治療、改善和/或預防冠狀病毒感染的另外的藥劑。 Embodiment 30 provides the pharmaceutical composition described in Embodiment 29, further comprising at least one additional agent for treating, improving and/or preventing coronavirus infection.
實施方式31提供實施方式30所述的醫藥組成物,其中至少一種另外的藥劑是RNA-依賴性RNA聚合酶(RdRp)(即,nsp12)的抑制劑或其前藥。 Embodiment 31 provides the pharmaceutical composition of embodiment 30, wherein the at least one additional agent is an inhibitor of RNA-dependent RNA polymerase (RdRp) (ie, nspl2) or a prodrug thereof.
實施方式32提供一種治療、改善和/或預防受試者中冠狀病毒感染的方法,該方法包括向受試者施用治療有效量的至少一種實施方式1-28中任一項所述的化合物和/或至少一種實施方式29-31中任一項所述的醫藥組成物。 Embodiment 32 provides a method for treating, improving and/or preventing coronavirus infection in a subject, the method comprising administering to the subject a therapeutically effective amount of at least one compound described in any one of Embodiments 1-28 and /or at least one pharmaceutical composition according to any one of embodiments 29-31.
實施方式33提供實施方式32所述的方法,其中向受試者進一步施用用於治療、改善和/或預防冠狀病毒感染的至少一種另外的藥劑。 Embodiment 33 provides the method of embodiment 32, wherein at least one additional agent for treating, ameliorating and/or preventing coronavirus infection is further administered to the subject.
實施方式34提供實施方式33所述的方法,其中向受試者共同施用該至少一種另外的藥劑和該至少一種化合物和/或組成物。 Embodiment 34 provides the method of embodiment 33, wherein the at least one additional agent and the at least one compound and/or composition are co-administered to the subject.
實施方式35提供實施方式34所述的方法,其中至少一種另外的藥劑是RNA-依賴性RNA聚合酶(RdRp)(即,nsp12)的抑制劑或其前藥。 Embodiment 35 provides the method of embodiment 34, wherein the at least one additional agent is an inhibitor of RNA-dependent RNA polymerase (RdRp) (ie, nspl2) or a prodrug thereof.
實施方式36提供實施方式34或35所述的方法,其中至少一種另外的藥劑和至少一種化合物和/或組成物是共同配製的。 Embodiment 36 provides the method of embodiment 34 or 35, wherein at least one additional agent and at least one compound and/or composition are co-formulated.
實施方式37提供實施方式32-36中任一項所述的方法,其中冠狀病毒選自α冠狀病毒和β冠狀病毒。 Embodiment 37 provides the method of any one of embodiments 32-36, wherein the coronavirus is selected from an alphacoronavirus and a betacoronavirus.
實施方式38提供實施方式37所述的方法,其中α冠狀病毒選自人類冠狀病毒229E(HCoV-229E)和人類冠狀病毒NL63(HCoV-NL63)。 Embodiment 38 provides the method of embodiment 37, wherein the alphacoronavirus is selected from human coronavirus 229E (HCoV-229E) and human coronavirus NL63 (HCoV-NL63).
實施方式39提供實施方式38所述的方法,其中β冠狀病毒選自嚴重急性呼吸綜合征相關的冠狀病毒2(SARS-CoV-2)、嚴重急性呼吸綜合征相關的冠狀病毒1(SARS-CoV或SARS-CoV-1)、中東呼吸綜合征相關的冠狀病毒(MERS-CoV)、人類冠狀病毒OC43(HCoV-OC43)和人類冠狀病毒HKU1(HCoV-HKU1)。 Embodiment 39 provides the method described in embodiment 38, wherein the beta coronavirus is selected from severe acute respiratory syndrome-associated coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome-associated coronavirus 1 (SARS-CoV or SARS-CoV-1), Middle East respiratory syndrome-related coronavirus (MERS-CoV), human coronavirus OC43 (HCoV-OC43), and human coronavirus HKU1 (HCoV-HKU1).
實施方式40提供實施方式37或39所述的方法,其中β冠狀病毒是SARS-CoV-2。 Embodiment 40 provides the method of embodiment 37 or 39, wherein the betacoronavirus is SARS-CoV-2.
實施方式41提供實施方式32-40中任一項所述的方法,其中冠狀病毒主蛋白酶(Mpro)被抑制。 Embodiment 41 provides the method of any one of embodiments 32-40, wherein the coronavirus main protease (M pro ) is inhibited.
實施方式42提供實施方式41所述的方法,其中Mpro是3C-樣蛋白酶(3CLpro)。 Embodiment 42 provides the method of embodiment 41, wherein M pro is 3C-like protease (3CL pro ).
實施方式43提供實施方式32-42中任一項所述的方法,其中受試者是哺乳動物。 Embodiment 43 provides the method of any one of embodiments 32-42, wherein the subject is a mammal.
實施方式44提供實施方式43所述的方法,其中哺乳動物是人類。 Embodiment 44 provides the method of embodiment 43, wherein the mammal is a human.
本文使用的術語和表達用作描述術語而非限制性的,並且 使用這些術語和表達無意排除所示和描述的特徵或其部分的任何等價物,但是應認識到,在本申請的實施方式的範圍內可以進行各種修改。因此,應理解,儘管本申請描述了具體實施方式和可選擇的特徵,但是本領域普通技術人員可採用本文公開的組成物、方法和概念的修改和變化,並且這種修改和變化被認為在本申請的實施方式的範圍內。 The terms and expressions used herein are used as terms of description rather than limitation, and The use of these terms and expressions is not intended to exclude any equivalents to the features shown and described, or parts thereof, but it will be recognized that various modifications may be made within the scope of the embodiments of the application. Accordingly, it is to be understood that while this application describes specific embodiments and optional features, that modifications and variations of the compositions, methods and concepts disclosed herein may be employed by one of ordinary skill in the art, and that such modifications and variations are considered to be within the scope of the embodiments of the present application.
Claims (44)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202163249450P | 2021-09-28 | 2021-09-28 | |
US63/249,450 | 2021-09-28 | ||
US202263389713P | 2022-07-15 | 2022-07-15 | |
US63/389,713 | 2022-07-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW202330513A true TW202330513A (en) | 2023-08-01 |
Family
ID=85783447
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW111136366A TW202330513A (en) | 2021-09-28 | 2022-09-26 | ) inhibitors and methods using same |
Country Status (2)
Country | Link |
---|---|
TW (1) | TW202330513A (en) |
WO (1) | WO2023055702A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2023002233A (en) | 2020-08-24 | 2023-03-15 | Gilead Sciences Inc | Phospholipid compounds and uses thereof. |
TWI811812B (en) | 2020-10-16 | 2023-08-11 | 美商基利科學股份有限公司 | Phospholipid compounds and uses thereof |
WO2024031089A1 (en) | 2022-08-05 | 2024-02-08 | Gilead Sciences, Inc. | Sars-cov2 main protease inhibitors |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5760246A (en) * | 1996-12-17 | 1998-06-02 | Biller; Scott A. | Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
US20210347727A1 (en) * | 2017-06-23 | 2021-11-11 | Blade Therapeutics, Inc. | Calpain modulators and therapeutic uses thereof |
TW202204338A (en) * | 2020-04-17 | 2022-02-01 | 美商帕迪斯生物科學公司 | Inhibitors of cysteine proteases and methods of use thereof |
-
2022
- 2022-09-26 TW TW111136366A patent/TW202330513A/en unknown
- 2022-09-27 WO PCT/US2022/044799 patent/WO2023055702A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2023055702A1 (en) | 2023-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11780826B2 (en) | Bisamide sarcomere activating compounds and uses thereof | |
TW202330513A (en) | ) inhibitors and methods using same | |
JP6553748B2 (en) | Fused ring compounds, pharmaceutical compositions and uses thereof | |
DE69201956T2 (en) | PYRROLIDINE AND THIAZOLIDE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THEM. | |
JP4636021B2 (en) | 2-cyanopyrrolidinecarboxamide compound | |
EP1697308B1 (en) | Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer's disease | |
EP3538526A1 (en) | Cyclobutane- and azetidine-containing mono and spirocyclic compounds as alpha v integrin inhibitors | |
PT2176220E (en) | Pyrrolidin-2-one derivatives as androgen receptor modulators | |
US20060223884A1 (en) | Compounds and compositions for use in the prevention and treatment of obesity and related syndromes | |
KR20240035513A (en) | antiviral compounds | |
TWI826492B (en) | Substituted tetrahydrocyclopenta[c]pyrroles, substituted dihydropyrrolizines, analogues thereof, and methods using same | |
AU2018251087B2 (en) | Substituted N-arylethyl-2-aminoquinoline-4-carboxamides and use thereof | |
WO2010065861A2 (en) | Inhibitors of bace 1 and methods for treating alzheimer's disease | |
CA3113573A1 (en) | Isoxazole carboxamide compounds and uses thereof | |
NO176398B (en) | Analogous Process for Preparing Therapeutically Active 2,3-Dihydro-1- (Pyridinylamino) Indoles | |
TW202317515A (en) | Protease inhibitors for treatment of coronavirus infections | |
CA3025253A1 (en) | Heterocyclic prolinamide derivatives | |
HUT52477A (en) | Process for producing substituted pyrrolidine-2-carboxylic acid derivatives and pharmaceutical compositions comprising such compounds | |
TW201311679A (en) | Nitrogen-containing heterocyclic compound | |
AU2007260298A1 (en) | Pyrrolidine compounds as renin inhibitors | |
WO2024018403A1 (en) | Substituted imidazoamide compounds, and methods using same | |
TW202333663A (en) | Rxfp1 agonists | |
WO2024059087A1 (en) | 3-(1h-indole-2-carbonyl)-6,6-dimethyl-n-((s)-1-oxo-3-((s)-2-oxopyrrolidin-3-yl)p ropan-2-yl)-3-azabicyclo[3.1.0]hexane-2-carboxamide derivatives as mpro inhibitors for the treatment of coronavirus infections | |
WO2024112621A1 (en) | 2-amino-n-(4-amino-3,4-dioxo-1-(2-oxopyrrolidin-3-yl)butan-2-yl)benzamide derivatives as protease inhibitors for treating or preventing coronavirus infection | |
EA042825B1 (en) | BISAMIDE COMPOUNDS THAT ACTIVATE SARCOMERES AND VARIANTS OF THEIR APPLICATION |